Citrus Sinensis ID: 013557

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-
Protein Sequence
MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMKSPILKSPRGRCFSSQLVTSV
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHcccccccccccccccEEEEEEEccccccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEcccccEEEEEEEcccccHHHHccccccccccHHHHHHHHHHcccccHHHHcccccccccccccccEEccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcEEcHHHHHHHHccccHHHccccccccEEEEEEEcccccccccccccEEEEEEEcccccccccHHHHHHHHHHHHHccccHHEEEEEEEccccEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccccccccccccccEEEEEccccccccHHHHHcccccccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHccHHHHccHHHcccccHHHHHHHHHHHHHHHHcHcccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcc
Coil and Loop (DISEMBL)
mgncyswkkvdaslsshatsgdtklpdkngnfsmasslktnksekrpsgnfsmprtecdilscpnlkaftFSELKnatrnfrpdsligeggfgyvykgwidehtleaarpGVGMVIAVKklkpegfqghKEWLSEVNylgqlhhpnlVKLIGFCLDGENRLLVyeympkgslenhlfrrgarplpwTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNaklsdfglakagptgdrthvstqvmgtrgyaapeylatgrltakcdvYSFGVVLLELLSgrravdktrvGAEQNlvdwakpylgdrrkLFRIMDiklegqypqkGAYMVAILALQCISEAKVRPSMSEVLSALeqlppprdpaspsnsdpqviysphvkspmrpnsphlkshlrnnydspvnmsprsplpphmkspilksprgrcfssqlvtsv
Flexible Loop (DISEMBL)
MGNCYSWKKVDASlsshatsgdtklpdkngnfsmasslktnksekrpsgnfSMPRTECDILSCPNLKAFTFSELKnatrnfrpdsligeGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFglakagptgdrthvstqvmgtrGYAAPEYLATGRLTAKCDVYSFGVVLLELLsgrravdktrvgaeqnlvdwakpylgdrrKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMkspilksprgrcfssqlvtsv
Low Complexity Region (SEG)
MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMKSPILKSPRGRCFSSQLVTSV
Disordered region (IsUnstruct)
********************************************************ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEA**********************************************************************************************
Disordered Region (DISOPRED)
MGN****************************************************************AFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQ*******************************************************************************
Disordered Region (DISEMBL)
MGNCYSWKKVD***********TKLPDKNGNFSMASSL*************SMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQL*************PQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMKSPILKSPRGRCFSSQLVTSV
Disordered Region (DISPRO)
************************************************************LSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPP***************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMKSPILKSPRGRCFSSQLVTSV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	441	2.2.26 [Sep-21-2011]
O49840	426	Protein kinase 2B, chloro	yes	no	0.832	0.861	0.713	1e-156
O49839	426	Protein kinase 2A, chloro	no	no	0.820	0.849	0.689	1e-147
Q06548	410	Protein kinase APK1A, chl	no	no	0.793	0.853	0.647	1e-132
P46573	412	Protein kinase APK1B, chl	no	no	0.702	0.752	0.706	1e-131
P43293	389	Probable serine/threonine	no	no	0.859	0.974	0.586	1e-131
O48814	395	Serine/threonine-protein	no	no	0.727	0.812	0.631	1e-119
Q8H186	389	Probable receptor-like pr	no	no	0.727	0.825	0.623	1e-117
Q9SRH7	490	Receptor-like serine/thre	no	no	0.712	0.640	0.623	1e-116
Q9LFP7	493	Probable receptor-like pr	no	no	0.770	0.689	0.570	1e-116
Q8GXZ3	410	Serine/threonine-protein	no	no	0.680	0.731	0.614	1e-105

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  550 bits (1417), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 269/377 (71%), Positives = 317/377 (84%), Gaps = 10/377 (2%)

Query: 54  PRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG 113
           PRTE +ILS PNLKAFTF+ELKNATRNFRPDSL+GEGGFGYV+KGWID  TL A++PG G
Sbjct: 56  PRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSG 115

Query: 114 MVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           +V+AVKKLK EG+QGHKEWL+EVNYLGQL HPNLVKL+G+C++GENRLLVYE+MPKGSLE
Sbjct: 116 IVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLE 175

Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
           NHLFRRGA+PL W +R+KVAIGAA+GL+FLH+A+ QVIYRDFKA+NILLD+EFN+KLSDF
Sbjct: 176 NHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDF 235

Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDK 293
           GLAKAGPTGD+THVSTQVMGT GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDK
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295

Query: 294 TRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS 352
           ++VG EQ+LVDWA PYLGD+RKLFRIMD +L GQYPQKGAY  A LALQC++ +AK+RP 
Sbjct: 296 SKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPK 355

Query: 353 MSEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHL-KSHLRNNYDSP-VNM 410
           MSEVL+ L+QL   +      N   Q      + SP   N   + KS  R +YD P +++
Sbjct: 356 MSEVLAKLDQLESTKPGTGVGNRQAQ------IDSPRGSNGSIVQKSPRRYSYDRPLLHI 409

Query: 411 SP-RSPLPPHMKSPILK 426
           +P  SPLP H  SP ++
Sbjct: 410 TPGASPLPTHNHSPRVR 426

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  521 bits (1341), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 260/377 (68%), Positives = 312/377 (82%), Gaps = 15/377 (3%)

Query: 55  RTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           RTE +ILS PNLKAFTF+ELKNAT+NFR D+L+GEGGFG V+KGWID+ +L A+RPG G+
Sbjct: 60  RTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGI 119

Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           V+AVK+LKPEGFQGHKEWL+EVNYLGQL HPNLV L+G+C +GENRLLVYE+MPKGSLEN
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179

Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG 234
           HLFRRGA+PL W +R+KVA+GAA+GL+FLHEA+ QVIYRDFKA+NILLD++FNAKLSDFG
Sbjct: 180 HLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239

Query: 235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT 294
           LAKAGPTGD THVST+V+GT GYAAPEY+ATGRLTAK DVYSFGVVLLEL+SGRRA+D +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299

Query: 295 RVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM 353
             G E +LVDWA PYLGD+RKLFRIMD KL GQYPQKGA+  A LALQC++ +AK+RP M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359

Query: 354 SEVLSALEQLPPPRDPASPSNSDPQVIYSP--HVKSPMRPNSPHLKSHLRNNYDSP-VNM 410
           SEVL  LEQL      A P     Q + SP  H  S M+      KS +R ++D P ++M
Sbjct: 360 SEVLVTLEQL---ESVAKPGTKHTQ-MESPRFHHSSVMQ------KSPVRYSHDRPLLHM 409

Query: 411 SP-RSPLPPHMKSPILK 426
           +P  SPLP + +SP ++
Sbjct: 410 TPGASPLPSYTQSPRVR 426

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  470 bits (1210), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 237/366 (64%), Positives = 290/366 (79%), Gaps = 16/366 (4%)

Query: 1   MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDI 60
           MG C S  +V A  S  +T  D K  D     S ASS+       RPS     PRTE +I
Sbjct: 1   MGICLS-AQVKAESSGASTKYDAK--DIGSLGSKASSVSV-----RPS-----PRTEGEI 47

Query: 61  LSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK 120
           L  PNLK+F+F+ELK+ATRNFRPDS++GEGGFG V+KGWIDE +L A+RPG G+VIAVKK
Sbjct: 48  LQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKK 107

Query: 121 LKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG 180
           L  +G+QGH+EWL+EVNYLGQ  H +LVKLIG+CL+ E+RLLVYE+MP+GSLENHLFRRG
Sbjct: 108 LNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 167

Query: 181 A--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              +PL W LR+KVA+GAA+GL+FLH +E +VIYRDFK SNILLDSE+NAKLSDFGLAK 
Sbjct: 168 LYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKD 227

Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA 298
           GP GD++HVST+VMGT GYAAPEYLATG LT K DVYSFGVVLLELLSGRRAVDK R   
Sbjct: 228 GPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSG 287

Query: 299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSMSEVL 357
           E+NLV+WAKPYL ++RK+FR++D +L+ QY  + A  VA L+L+C+ +E K+RP+MSEV+
Sbjct: 288 ERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVV 347

Query: 358 SALEQL 363
           S LE +
Sbjct: 348 SHLEHI 353

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  469 bits (1208), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 221/313 (70%), Positives = 269/313 (85%), Gaps = 3/313 (0%)

Query: 54  PRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG 113
           PRTE +IL  PNLK+FTF+ELK ATRNFRPDS++GEGGFG V+KGWIDE TL A++PG G
Sbjct: 42  PRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTG 101

Query: 114 MVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           +VIAVKKL  +G+QGH+EWL+EVNYLGQ  HPNLVKLIG+CL+ E+RLLVYE+MP+GSLE
Sbjct: 102 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 161

Query: 174 NHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
           NHLFRRG+  +PL WTLR+KVA+GAA+GL+FLH AE  VIYRDFK SNILLDSE+NAKLS
Sbjct: 162 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLS 221

Query: 232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV 291
           DFGLAK GPTGD++HVST++MGT GYAAPEYLATG LT K DVYS+GVVLLE+LSGRRAV
Sbjct: 222 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 281

Query: 292 DKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR 350
           DK R   EQ LV+WA+P L ++RKLFR++D +L+ QY  + A  VA LAL+C++ E K+R
Sbjct: 282 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 341

Query: 351 PSMSEVLSALEQL 363
           P+M+EV+S LE +
Sbjct: 342 PNMNEVVSHLEHI 354

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  468 bits (1204), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/399 (58%), Positives = 301/399 (75%), Gaps = 20/399 (5%)

Query: 1   MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFS-MPRTECD 59
           MG C+S  ++   ++S +T   +K   ++G            S+   + +FS MPRTE +
Sbjct: 1   MGGCFS-NRIKTDIAS-STWLSSKFLSRDG------------SKGSSTASFSYMPRTEGE 46

Query: 60  ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK 119
           IL   NLK F+ SELK+ATRNFRPDS++GEGGFG V+KGWIDE +L  ++PG G+VIAVK
Sbjct: 47  ILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVK 106

Query: 120 KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR 179
           +L  EGFQGH+EWL+E+NYLGQL HPNLVKLIG+CL+ E+RLLVYE+M +GSLENHLFRR
Sbjct: 107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166

Query: 180 GA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           G   +PL W  R+++A+GAARGL+FLH A+ QVIYRDFKASNILLDS +NAKLSDFGLA+
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLAR 226

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
            GP GD +HVST+VMGT+GYAAPEYLATG L+ K DVYSFGVVLLELLSGRRA+DK +  
Sbjct: 227 DGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPV 286

Query: 298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV 356
            E NLVDWA+PYL ++R+L R+MD +L+GQY    A  +A+LAL CIS +AK RP+M+E+
Sbjct: 287 GEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEI 346

Query: 357 LSALEQLPPPRDPASPSNSDPQVIYSPHV-KSPMRPNSP 394
           +  +E+L   ++ AS    +PQ+     + KSP   N P
Sbjct: 347 VKTMEELHIQKE-ASKEQQNPQISIDNIINKSPQAVNYP 384

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  428 bits (1101), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 206/326 (63%), Positives = 263/326 (80%), Gaps = 5/326 (1%)

Query: 55  RTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           +TE +ILS   +K+FTF+ELK ATRNFRPDS+IGEGGFG V+KGW+DE TL   +PG G+
Sbjct: 41  KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100

Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           VIAVKKL  EGFQGH+EWL+E+NYLGQL HPNLVKLIG+CL+ E+RLLVYE+M KGSLEN
Sbjct: 101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160

Query: 175 HLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD 232
           HLFRRGA  +PLPW LR+ VA+ AA+GL+FLH    +VIYRD KASNILLD+++NAKLSD
Sbjct: 161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSD 220

Query: 233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD 292
           FGLA+ GP GD ++VST+VMGT GYAAPEY+++G L A+ DVYSFGV+LLE+LSG+RA+D
Sbjct: 221 FGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALD 280

Query: 293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP 351
             R   E+NLVDWA+PYL  +RK+  I+D +L+ QY  + A  +A +A+QC+S E K RP
Sbjct: 281 HNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRP 340

Query: 352 SMSEVLSALEQLPPPRDPASPSNSDP 377
           +M +V+ AL+QL    +   PS ++P
Sbjct: 341 TMDQVVRALQQLQD--NLGKPSQTNP 364

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  422 bits (1084), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 204/327 (62%), Positives = 255/327 (77%), Gaps = 6/327 (1%)

Query: 55  RTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           +TE +ILS   +K+F+F+ELK ATRNFR DS++GEGGFG V++GW+DE TL   +   G+
Sbjct: 35  KTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGL 94

Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           VIAVK+L P+GFQGH+EWL+E+NYLGQL HPNLVKLIG+CL+ E RLLVYE+M KGSLEN
Sbjct: 95  VIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLEN 154

Query: 175 HLFRRGAR---PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
           HLF  G +   PL W LRIKVA+ AA+GL+FLH    +VIYRD KASNILLDS+FNAKLS
Sbjct: 155 HLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLS 214

Query: 232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV 291
           DFGLA+ GP G++++VST+VMGT GYAAPEY++TG L A+ DVYSFGVVLLELL GR+A+
Sbjct: 215 DFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQAL 274

Query: 292 DKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR 350
           D  R   EQNLVDWA+PYL  RRK+  I+D +L  QY  +GA  +A +A+QC+S E K R
Sbjct: 275 DHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSR 334

Query: 351 PSMSEVLSALEQLPPPRDPASPSNSDP 377
           P+M +V+ AL QL        P+N DP
Sbjct: 335 PTMDQVVRALVQLQDS--VVKPANVDP 359

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  418 bits (1074), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 199/319 (62%), Positives = 256/319 (80%), Gaps = 5/319 (1%)

Query: 57  ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
           E +I S  +LK F+F +LK ATRNFRP+SL+GEGGFG V+KGW++E+     +PG G+ +
Sbjct: 114 ELNIYS--HLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV 171

Query: 117 AVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL 176
           AVK L P+G QGHKEWL+E+NYLG L HPNLVKL+G+C++ + RLLVYE+MP+GSLENHL
Sbjct: 172 AVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 231

Query: 177 FRRGARPLPWTLRIKVAIGAARGLSFLHE-AEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
           FRR + PLPW++R+K+A+GAA+GLSFLHE A + VIYRDFK SNILLD E+NAKLSDFGL
Sbjct: 232 FRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGL 290

Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
           AK  P   +THVST+VMGT GYAAPEY+ TG LT+K DVYSFGVVLLE+L+GRR++DK R
Sbjct: 291 AKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350

Query: 296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS 354
              E NLV+WA+P+L D+R+ +R++D +LEG +  KGA  V  LA QC+S ++K+RP MS
Sbjct: 351 PNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMS 410

Query: 355 EVLSALEQLPPPRDPASPS 373
           EV+  L+ LP  +D AS S
Sbjct: 411 EVVEVLKPLPHLKDMASAS 429

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  417 bits (1072), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 203/356 (57%), Positives = 266/356 (74%), Gaps = 16/356 (4%)

Query: 33  SMASSLKTNKSEKRPSGNFSMPRTECDILSCP-------------NLKAFTFSELKNATR 79
           +M S     KS  +P G  S   T  +  S               +L+ FTF++LK +TR
Sbjct: 81  TMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTR 140

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           NFRP+SL+GEGGFG V+KGWI+E+     +PG G+ +AVK L P+G QGHKEWL+E+N+L
Sbjct: 141 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFL 200

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
           G L HPNLVKL+G+C++ + RLLVYE+MP+GSLENHLFRR + PLPW++R+K+A+GAA+G
Sbjct: 201 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKG 259

Query: 200 LSFLHE-AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           LSFLHE A + VIYRDFK SNILLD+++NAKLSDFGLAK  P   +THVST+VMGT GYA
Sbjct: 260 LSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 319

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
           APEY+ TG LT+K DVYSFGVVLLE+L+GRR++DK R   E NLV+WA+P+L D+R+ +R
Sbjct: 320 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 379

Query: 319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDPASPS 373
           ++D +LEG +  KGA  V  LA QC+S + K+RP MS+V+ AL+ LP  +D AS S
Sbjct: 380 LLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSS 435

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  383 bits (983), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 188/306 (61%), Positives = 235/306 (76%), Gaps = 6/306 (1%)

Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGFQ 127
           FT  EL+  T++FRPD ++GEGGFG VYKG+ID++     R G+  + +AVK L  EG Q
Sbjct: 57  FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNL----RVGLKSLPVAVKVLNKEGLQ 112

Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
           GH+EWL+EVN+LGQL HPNLVKLIG+C + ++RLLVYE+M +GSLENHLFR+   PL W+
Sbjct: 113 GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWS 172

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
            R+ +A+GAA+GL+FLH AE+ VIYRDFK SNILLDS++ AKLSDFGLAKAGP GD THV
Sbjct: 173 RRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 232

Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK 307
           ST+VMGT GYAAPEY+ TG LTA+ DVYSFGVVLLE+L+GR++VDKTR   EQNLVDWA+
Sbjct: 233 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWAR 292

Query: 308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISE-AKVRPSMSEVLSALEQLPPP 366
           P L D+RKL +I+D +LE QY  + A     LA  C+S+  K RP MS+V+  LE L   
Sbjct: 293 PKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCT 352

Query: 367 RDPASP 372
            D   P
Sbjct: 353 GDALIP 358

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
225425762	420	PREDICTED: protein kinase 2B, chloroplas	0.938	0.985	0.703	1e-173
224111270	417	predicted protein [Populus trichocarpa]	0.936	0.990	0.702	1e-170
449469651	401	PREDICTED: protein kinase 2B, chloroplas	0.857	0.942	0.756	1e-168
255558180	419	Protein kinase APK1A, chloroplast precur	0.938	0.988	0.707	1e-167
224099729	418	predicted protein [Populus trichocarpa]	0.931	0.983	0.683	1e-165
356500447	414	PREDICTED: LOW QUALITY PROTEIN: protein	0.925	0.985	0.689	1e-164
356498210	422	PREDICTED: LOW QUALITY PROTEIN: protein	0.904	0.945	0.697	1e-164
357486685	410	Protein kinase 2B [Medicago truncatula]	0.913	0.982	0.683	1e-163
217071950	410	unknown [Medicago truncatula]	0.875	0.941	0.713	1e-163
48209875	420	putative protein kinase [Solanum demissu	0.938	0.985	0.677	1e-160

>gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera]

 Score =  615 bits (1587), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 304/432 (70%), Positives = 354/432 (81%), Gaps = 18/432 (4%)

Query: 1   MGNCY-SWKKVDASLSSHATS--GDTKLPDKNGNFSMASSLKT-NKSEKRPSGNFSMPRT 56
           MGNC  S  +VD++ SSH TS  G +K+  K  N S  S+L   + SE+  + +F  PR+
Sbjct: 1   MGNCLDSSARVDSTQSSHTTSASGASKVVSKTSNSSAPSTLTVPSYSERSTAESFPTPRS 60

Query: 57  ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
           E +IL  P+LKAF+F++LKNATRNFRPDSL+GEGGFGYV+KGWIDE TL A +PG GMVI
Sbjct: 61  EGEILPSPSLKAFSFNDLKNATRNFRPDSLLGEGGFGYVFKGWIDEQTLAAVKPGSGMVI 120

Query: 117 AVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL 176
           AVKKLKPEGFQGHKEWL+EVNYLGQLHHPNLVKLIG+CL+GENRLLVYE+MPKGSLENHL
Sbjct: 121 AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 180

Query: 177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
           FRRG +PL W +RI+VAIGAARGLSFLH+AE QVIYRDFKASNILLD+EFNAKLSDFGLA
Sbjct: 181 FRRGPQPLSWAVRIRVAIGAARGLSFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 240

Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV 296
           KAGPTGDRTHVSTQVMGT GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDKT++
Sbjct: 241 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKI 300

Query: 297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSMSE 355
           G EQNLVDWAKPYLGD+R+LFRIMD KLEGQYPQKGA+M A LALQC+ +EAKVRP MSE
Sbjct: 301 GVEQNLVDWAKPYLGDKRRLFRIMDTKLEGQYPQKGAFMAATLALQCLNTEAKVRPRMSE 360

Query: 356 VLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPR-S 414
           VL+ LEQ+  P++ A    S+   +  P  KSP+R               SP+N++PR S
Sbjct: 361 VLATLEQIQSPKNAAKHIQSEQHTVSIPVQKSPLR------------QQHSPLNLTPRAS 408

Query: 415 PLPPHMKSPILK 426
           PLP + +SP ++
Sbjct: 409 PLPSYRQSPRVR 420

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa]

 Score =  603 bits (1554), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 302/430 (70%), Positives = 345/430 (80%), Gaps = 17/430 (3%)

Query: 1   MGNCY--SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTEC 58
           MGNC   S  KVD++ SSH   G +++  +  + S+ SSL       R S     PR+E 
Sbjct: 1   MGNCLDSSSAKVDSTQSSH-NPGASRISSRTSHSSVPSSLTIPSYSGRSSECLPTPRSEG 59

Query: 59  DILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           +ILS PNLKAF+F+ELKNATRNFRPDSL+GEGGFGYV+KGWIDEHTL AA+PG GMV+AV
Sbjct: 60  EILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGYVFKGWIDEHTLTAAKPGSGMVVAV 119

Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           KKLKPEGFQGHKEWL+EVNYLGQLHHPNLVKLIG+CL+GENRLLVYE+MPKGSLENHLFR
Sbjct: 120 KKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 179

Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
           RG +PL W +RIKVAIGAARGLSFLH+A+ QVIYRDFKASNILLD+EFNAKLSDFGLAKA
Sbjct: 180 RGPQPLSWAIRIKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKA 239

Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA 298
           GPTGDRTHVSTQVMGT GYAAPEY+ATGRLTAK DVYSFGVVLLE LSGRRAVDK++VG 
Sbjct: 240 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEFLSGRRAVDKSKVGV 299

Query: 299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL 357
           EQNLVDW KPYLGD+RKLFRIMD KL GQYPQKGA+M A LALQC+S EAKVRP MSEVL
Sbjct: 300 EQNLVDWVKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSTEAKVRPRMSEVL 359

Query: 358 SALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPV-NMSPRSPL 416
           + LEQ+  P+        + Q + +P  +SPMR            ++ SPV   +  SPL
Sbjct: 360 ATLEQIESPKGAVKNIQLEHQTVQTPVRQSPMR------------HHRSPVIPTASASPL 407

Query: 417 PPHMKSPILK 426
           P H +SP L+
Sbjct: 408 PSHHQSPRLR 417

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449469651|ref|XP_004152532.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus]

 Score =  597 bits (1539), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 302/399 (75%), Positives = 331/399 (82%), Gaps = 21/399 (5%)

Query: 22  DTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNF 81
           D K  D+ G+ S AS    +     PS    + RTE +IL  PNLKAFT+SELKNAT+NF
Sbjct: 19  DPKTHDRKGH-SSASLRSPSLGGNTPSRGLQVHRTEGEILLSPNLKAFTYSELKNATKNF 77

Query: 82  RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           RPDSLIGEGGFG+VYKGWIDEHTLEA RPG GMV+AVKKLKPEGFQGHKEWLSEVNYLGQ
Sbjct: 78  RPDSLIGEGGFGHVYKGWIDEHTLEAVRPGAGMVVAVKKLKPEGFQGHKEWLSEVNYLGQ 137

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           LHHPNLVKLIGFCLDG++RLLVYEYM KGSLENHLFRRGARPL W +RIKVAIGAARGL+
Sbjct: 138 LHHPNLVKLIGFCLDGDSRLLVYEYMSKGSLENHLFRRGARPLSWAIRIKVAIGAARGLT 197

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH++E+ VIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT+GYAAPE
Sbjct: 198 FLHDSEEPVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPE 257

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
           Y+ATGRLTAKCDVYSFGVVLLELLSGRRAVDKT+VG EQNLV+WA+PYL D+RKLFRIMD
Sbjct: 258 YIATGRLTAKCDVYSFGVVLLELLSGRRAVDKTKVGVEQNLVEWARPYLADKRKLFRIMD 317

Query: 322 IKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIY 381
           IKLEGQYPQK AYM  +LALQCI EAK RP MSEVL ALEQLP  +              
Sbjct: 318 IKLEGQYPQKAAYMTTVLALQCIREAKFRPQMSEVLYALEQLPLVK-------------- 363

Query: 382 SPHVKSPMRPNSPHLKSHLRNNYDSPVN-MSPR--SPLP 417
             HV +  R NSP  KS LR+ Y SP+N M+P+  SPLP
Sbjct: 364 --HVDT-QRANSPGPKSPLRHKYPSPLNSMTPKPSSPLP 399

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis]

 Score =  595 bits (1534), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 305/431 (70%), Positives = 345/431 (80%), Gaps = 17/431 (3%)

Query: 1   MGNCY--SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKT-NKSEKRPSGNFSMPRTE 57
           MGNC   S  KVD +  SH  SG +++  +    S+ SSL   + SE+  S     PRTE
Sbjct: 1   MGNCLDSSAAKVDTTQGSHTPSGASRISSRTSRSSVPSSLTIPSYSERSSSECLPTPRTE 60

Query: 58  CDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIA 117
            +ILS PNLKAF F+ELKNATRNFRPDSL+GEGGFGYV+KGWIDEHTL AARPG GMV+A
Sbjct: 61  GEILSSPNLKAFCFNELKNATRNFRPDSLLGEGGFGYVFKGWIDEHTLSAARPGSGMVVA 120

Query: 118 VKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF 177
           VKKLKPEGFQGHKEWL+EV YLGQLHHPNLVKLIG+CL+GENRLLVYE+MPKGSLENHLF
Sbjct: 121 VKKLKPEGFQGHKEWLTEVRYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180

Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           RRG +PL W +RIKVA+GAARGLSFLH+A+ QVIYRDFKASNILLD+EFNAKLSDFGLAK
Sbjct: 181 RRGPQPLSWAVRIKVAVGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAK 240

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
            GPTGDRTHVSTQVMGT GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDKT+VG
Sbjct: 241 EGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVG 300

Query: 298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV 356
            EQNLVDWAKPYL D+RKLFRIMD KL GQYPQK A+M A LALQC+S EAK RP MSEV
Sbjct: 301 IEQNLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKSAHMAANLALQCLSTEAKARPRMSEV 360

Query: 357 LSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPR-SP 415
           L+ LEQ+  P+     S+S+   I  P  KSPMR             + SP+N++P  SP
Sbjct: 361 LATLEQIESPKTAGRLSHSEHPSIQIPVRKSPMR------------QHHSPLNLTPSASP 408

Query: 416 LPPHMKSPILK 426
           LP H +SP ++
Sbjct: 409 LPSHRQSPRVR 419

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 296/433 (68%), Positives = 341/433 (78%), Gaps = 22/433 (5%)

Query: 1   MGNCY--SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTEC 58
           MGNC   S  +VD++ SSH           + +   +S    + S K  S  F  PR+E 
Sbjct: 1   MGNCLDSSAARVDSTQSSHTPGASRISSRTSRSSVPSSLTIPSYSGKSSSDCFPTPRSEG 60

Query: 59  DILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           +ILS PNLKAF+F+ELK+ATRNFRPDSL+GEGGFG V+KGWIDE+TL A++PG GMV+AV
Sbjct: 61  EILSSPNLKAFSFNELKSATRNFRPDSLLGEGGFGCVFKGWIDENTLTASKPGSGMVVAV 120

Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           KKLKPEGFQGHKEWL+EVNYLGQLHHPNLVKLIG+C++GENRLLVYE+MPKGSLENHLFR
Sbjct: 121 KKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCVEGENRLLVYEFMPKGSLENHLFR 180

Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
           RG +PL W +R+KVAIGAARGLSFLH+A+ QVIYRDFKASNILLD+EFNAKLSDFGLAKA
Sbjct: 181 RGPQPLSWAVRVKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKA 240

Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA 298
           GPTGDRTHVSTQVMGT GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDKT+VG 
Sbjct: 241 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVGV 300

Query: 299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL 357
           EQNL DWAKPYLGD+RKLFRIMD KL GQYPQKGA+M A LALQC+S EAKVRP MSEVL
Sbjct: 301 EQNLADWAKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSNEAKVRPRMSEVL 360

Query: 358 SALEQLPPPRDPASPSNSDPQVIYSPHVKSPMR----PNSPHLKSHLRNNYDSPVNMSPR 413
           + LE +  P+  A  S S+ Q + +P  +SPMR    P +P   +               
Sbjct: 361 ATLENIESPKGAAKNSRSEQQTVQTPVRQSPMRHHHAPGTPPASA--------------- 405

Query: 414 SPLPPHMKSPILK 426
           SPLP H +SP L+
Sbjct: 406 SPLPSHHQSPRLR 418

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  586 bits (1510), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 297/431 (68%), Positives = 341/431 (79%), Gaps = 23/431 (5%)

Query: 1   MGNCY-SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECD 59
           MGNC  S  KVDA+ SS +TS          + S+ S      SEK  + +   PR+E +
Sbjct: 1   MGNCLDSSAKVDAAQSSRSTSASGISKTTPSSLSIPS-----YSEKSNASSLPTPRSEGE 55

Query: 60  ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK 119
           ILS PNLK FTF+ELKNATRNFRPDSL+GEGGFGYVYKGWIDEHT  A++PG GMV+AVK
Sbjct: 56  ILSSPNLKPFTFNELKNATRNFRPDSLLGEGGFGYVYKGWIDEHTFTASKPGSGMVVAVK 115

Query: 120 KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR 179
           +LKPEGFQGHKEWL+EVNYLGQL+HPNLVKLIG+CL+GENRLLVYE+MPKGSLENHLFRR
Sbjct: 116 RLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 175

Query: 180 GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG 239
           G +PL W++R+KVAIGAARGLSFLH A+ QVIYRDFKASNILLD+EFN+KLSDFGLAKAG
Sbjct: 176 GPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAG 235

Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE 299
           PTGDRTHVSTQVMGT+GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDKT  G E
Sbjct: 236 PTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITGME 295

Query: 300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSMSEVLS 358
           QNLVDWAKPYL D+R+LFRIMD KLEGQYPQKGA+  A LALQC+ SEAK RP M+EVL+
Sbjct: 296 QNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEVLA 355

Query: 359 ALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPR-SPLP 417
            LEQ+  P+     S+S+   + +P  KSP R               SP+N++P  SPLP
Sbjct: 356 TLEQIEAPKTAGRNSHSEHHRLQTPVRKSPARNR-------------SPLNLTPTASPLP 402

Query: 418 --PHMKSPILK 426
             P + S  LK
Sbjct: 403 AXPAIASCALK 413

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  585 bits (1509), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 293/420 (69%), Positives = 336/420 (80%), Gaps = 21/420 (5%)

Query: 1   MGNCY-SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECD 59
           MGNC  S  KVDA+ SS +TS          + S+ S      SEK  + +   PR+E +
Sbjct: 1   MGNCLDSSAKVDAAQSSKSTSASGISKTTPSSLSIPS-----YSEKSNASSLPTPRSEGE 55

Query: 60  ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK 119
           ILS PNLK FTF+ELKNATRNFRPDSL+GEGGFGYVYKGWIDEHT  A++PG GMV+AVK
Sbjct: 56  ILSSPNLKPFTFNELKNATRNFRPDSLLGEGGFGYVYKGWIDEHTFTASKPGSGMVVAVK 115

Query: 120 KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR 179
           +LKPEGFQGHKEWL+EVNYLGQL+HPNLVKLIG+CL+GENRLLVYE+MPKGSLENHLFRR
Sbjct: 116 RLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 175

Query: 180 GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG 239
           G +PL W++R+KVAIGAARGLSFLH A+ QVIYRDFKASNILLD+EFN+KLSDFGLAKAG
Sbjct: 176 GPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAG 235

Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE 299
           PTGDRTHVSTQVMGT+GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDKT  G E
Sbjct: 236 PTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITGME 295

Query: 300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSMSEVLS 358
           QNLVDWAKPYL D+R+LFRIMD KLEGQYPQKGA+  A LALQC+ SEAK RP M+EVL+
Sbjct: 296 QNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEVLA 355

Query: 359 ALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPR-SPLP 417
            LEQ+  P+     S+S+   + +P  KSP R               SP+N++P  SPLP
Sbjct: 356 TLEQIEAPKTAGRNSHSEHHRVQTPVRKSPARNR-------------SPLNLTPTASPLP 402

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula]

 Score =  582 bits (1501), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 292/427 (68%), Positives = 344/427 (80%), Gaps = 24/427 (5%)

Query: 1   MGNCY-SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGN--FSMPRTE 57
           MGNC  S  KVDA+ SS +TSG +K        +  SSL       + + +     PR+E
Sbjct: 1   MGNCLDSSAKVDAAQSSRSTSGTSK--------TTPSSLTIPSYSDKSNSSSLLPTPRSE 52

Query: 58  CDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIA 117
            +ILS PNLKAF+F+ELKNATRNFRPDSL+GEGGFG+VYKGWIDEHT  AA+PG GMV+A
Sbjct: 53  GEILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGHVYKGWIDEHTFTAAKPGSGMVVA 112

Query: 118 VKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF 177
           VK+LKPEG+QGHKEWL+EVNYLGQLHHPNLVKLIG+CL+GENRLLVYE+MPKGSLENHLF
Sbjct: 113 VKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 172

Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           RRG +PL W++R+KVAIGAARGLSFLH A+ QVIYRDFKASNILLD+EFN+KLSDFGLAK
Sbjct: 173 RRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAK 232

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
           AGPTGDRTHVSTQV+GT+GYAAPEY+ATGRLTAK DVYSFGVV+LELLSGRRAVDKT  G
Sbjct: 233 AGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIAG 292

Query: 298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV 356
            +QNLVDWAKPYLGD+R+LFRIMD KLEGQYPQKGA+M A LALQC++ EAK RPSM+EV
Sbjct: 293 VDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTEV 352

Query: 357 LSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPL 416
           L+ LEQ+  P+  +  S S+   +++P  +SP R  +P        +Y +P      SPL
Sbjct: 353 LATLEQIEAPKHASRNSLSEHHRVHAPVRRSPARNRTP--------SYVTPTA----SPL 400

Query: 417 PPHMKSP 423
           P   +SP
Sbjct: 401 PSVRQSP 407

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|217071950|gb|ACJ84335.1| unknown [Medicago truncatula]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 284/398 (71%), Positives = 333/398 (83%), Gaps = 12/398 (3%)

Query: 1   MGNCY-SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGN--FSMPRTE 57
           MGNC  S  KVDA+ SS +TSG +K        +  SSL       + + +     PR+E
Sbjct: 1   MGNCLDSSAKVDAAQSSRSTSGTSK--------TTPSSLTIPSYSDKSNSSSLLPTPRSE 52

Query: 58  CDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIA 117
            +ILS PNLKAF+F+ELKNATRNFRPDSL+GEGGFG+VYKGWIDEHT  AA+PG GMV+A
Sbjct: 53  GEILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGHVYKGWIDEHTFTAAKPGSGMVVA 112

Query: 118 VKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF 177
           VK+LKPEG+QGHKEWL+EVNYLGQLHHPNLVKLIG+CL+GENRLLVYE+MPKGSLENHLF
Sbjct: 113 VKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 172

Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           RRG +PL W++R+KVAIGAARGLSFLH A+ QVIYRDFKASNILLD+EFN+KLSDFGLAK
Sbjct: 173 RRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAK 232

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
           AGPTGDRTHVSTQV+GT+GYAAPEY+ATGRLTAK DVYSFGVV+LELLSGRRAVDKT  G
Sbjct: 233 AGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIAG 292

Query: 298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV 356
            +QNLVDWAKPYLGD+R+LFRIMD KLEGQYPQKGA+M A LALQC++ EAK RPSM+EV
Sbjct: 293 VDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTEV 352

Query: 357 LSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSP 394
           L+ LEQ+  P+  +  S S+   +++P  +SP R  +P
Sbjct: 353 LATLEQIEAPKHASRNSLSEHHRVHAPVRRSPARNRTP 390

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|48209875|gb|AAT40481.1| putative protein kinase [Solanum demissum]

 Score =  570 bits (1469), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 296/437 (67%), Positives = 348/437 (79%), Gaps = 23/437 (5%)

Query: 1   MGNCY-SWKKVDASLSSHATSG--DTKLPDKNGNFSMASSLKT-NKSEKRPSGNFSMPRT 56
           MGNC  S  +V+A+LSS   S    ++ PD+  N S+ SSL   +   K  S +   PR+
Sbjct: 1   MGNCVGSSARVEATLSSTTPSAYEASRFPDRKSNSSVPSSLSIPSYGRKSSSESLPTPRS 60

Query: 57  ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
           E +IL  PN+K+F+F+ELKNATRNFRPDSL+GEGGFG V+KGWID  TL A++PG G+VI
Sbjct: 61  ESEILFSPNVKSFSFNELKNATRNFRPDSLLGEGGFGCVFKGWIDAQTLTASKPGSGIVI 120

Query: 117 AVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL 176
           AVKKLKPEGFQGHKEWL+EVNYLGQL HPNLVKLIG+C+DG+N LLVYE+MPKGSLENHL
Sbjct: 121 AVKKLKPEGFQGHKEWLTEVNYLGQLRHPNLVKLIGYCIDGDNHLLVYEFMPKGSLENHL 180

Query: 177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
           FRRG +PL W  RIKVAIGAARGL+FLH+A++QVIYRDFKASNILLD+EFN+KLSDFGLA
Sbjct: 181 FRRGPQPLNWATRIKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDFGLA 240

Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV 296
           KAGPTGDRTHVSTQVMGT+GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVD T+V
Sbjct: 241 KAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDNTKV 300

Query: 297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSE 355
           G EQNLVDWAKPYLGD+RKLFRIMD KLEGQYPQKGAY  A LA QC+S E K+RP MSE
Sbjct: 301 GIEQNLVDWAKPYLGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPKMSE 360

Query: 356 VLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPR-S 414
           VL+ALE+L  P+  +  S+++ + I SP   SPMR            ++ SP++M+P  S
Sbjct: 361 VLTALEELQSPKGVSKLSHTEHRAIPSPVAVSPMR------------HHRSPLHMTPSAS 408

Query: 415 PLPPHMKSPILKSPRGR 431
           P   +      KSPRGR
Sbjct: 409 PFQAYQ-----KSPRGR 420

Source: Solanum demissum

Species: Solanum demissum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.941	0.974	0.668	3.5e-146
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.936	0.969	0.646	3.1e-138
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.841	0.900	0.687	1.8e-133
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.852	0.971	0.650	1.2e-127
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.748	0.780	0.673	1.4e-119
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.859	0.974	0.591	2.3e-119
TAIR|locus:2019180	399	AT1G74490 [Arabidopsis thalian	0.827	0.914	0.620	1.4e-117
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.818	0.913	0.573	6.1e-110
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.945	0.920	0.509	1.3e-107
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.827	0.744	0.567	1.7e-107

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1428 (507.7 bits), Expect = 3.5e-146, P = 3.5e-146
 Identities = 288/431 (66%), Positives = 340/431 (78%)

Query:     1 MGNCY-SWKKVDASLSS-HATSGD--TKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRT 56
             MGNC  S  KVD+S  S HA S    +++  K    ++ SSL  N      S     PRT
Sbjct:     1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVES--LPTPRT 58

Query:    57 ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
             E +ILS PNLKAFTF+ELKNATRNFRPDSL+GEGGFGYV+KGWID  TL A++PG G+V+
Sbjct:    59 EGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVV 118

Query:   117 AVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL 176
             AVKKLK EG+QGHKEWL+EVNYLGQL HPNLVKL+G+C++GENRLLVYE+MPKGSLENHL
Sbjct:   119 AVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL 178

Query:   177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
             FRRGA+PL W +R+KVAIGAA+GL+FLH+A+ QVIYRDFKA+NILLD+EFN+KLSDFGLA
Sbjct:   179 FRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLA 238

Query:   237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV 296
             KAGPTGD+THVSTQVMGT GYAAPEY+ATGRLTAK DVYSFGVVLLELLSGRRAVDK++V
Sbjct:   239 KAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKV 298

Query:   297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSE 355
             G EQ+LVDWA PYLGD+RKLFRIMD +L GQYPQKGAY  A LALQC++ +AK+RP MSE
Sbjct:   299 GMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSE 358

Query:   356 VLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHL-KSHLRNNYDSPV-NMSP- 412
             VL+ L+QL   +      N   Q+       SP   N   + KS  R +YD P+ +++P 
Sbjct:   359 VLAKLDQLESTKPGTGVGNRQAQI------DSPRGSNGSIVQKSPRRYSYDRPLLHITPG 412

Query:   413 RSPLPPHMKSP 423
              SPLP H  SP
Sbjct:   413 ASPLPTHNHSP 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 1353 (481.3 bits), Expect = 3.1e-138, P = 3.1e-138
 Identities = 280/433 (64%), Positives = 333/433 (76%)

Query:     1 MGNCY-SWKKVDASLSS-HATSGDT--KLPDKNGNFSMASSLKTNKSEKRPS-GNFSMPR 55
             MGNC  S  KVD S  S HA S  +  K+  K    +  S L T       S G     R
Sbjct:     1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60

Query:    56 TECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMV 115
             TE +ILS PNLKAFTF+ELKNAT+NFR D+L+GEGGFG V+KGWID+ +L A+RPG G+V
Sbjct:    61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120

Query:   116 IAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENH 175
             +AVK+LKPEGFQGHKEWL+EVNYLGQL HPNLV L+G+C +GENRLLVYE+MPKGSLENH
Sbjct:   121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180

Query:   176 LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
             LFRRGA+PL W +R+KVA+GAA+GL+FLHEA+ QVIYRDFKA+NILLD++FNAKLSDFGL
Sbjct:   181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGL 240

Query:   236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
             AKAGPTGD THVST+V+GT GYAAPEY+ATGRLTAK DVYSFGVVLLEL+SGRRA+D + 
Sbjct:   241 AKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSN 300

Query:   296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS 354
              G E +LVDWA PYLGD+RKLFRIMD KL GQYPQKGA+  A LALQC++ +AK+RP MS
Sbjct:   301 GGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMS 360

Query:   355 EVLSALEQLPPPRDPASPSNSDPQVIYSP--HVKSPMRPNSPHLKSHLRNNYDSPV-NMS 411
             EVL  LEQL      A P     Q+  SP  H  S M+      KS +R ++D P+ +M+
Sbjct:   361 EVLVTLEQL---ESVAKPGTKHTQM-ESPRFHHSSVMQ------KSPVRYSHDRPLLHMT 410

Query:   412 P-RSPLPPHMKSP 423
             P  SPLP + +SP
Sbjct:   411 PGASPLPSYTQSP 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 1308 (465.5 bits), Expect = 1.8e-133, P = 1.8e-133
 Identities = 262/381 (68%), Positives = 301/381 (79%)

Query:     1 MGNCYSWK-KVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPS---GNFSMPRT 56
             MGNC+ +  KV    S +   G +++  K    S  SSL    S         +   PR+
Sbjct:     1 MGNCFGFSAKVGNRESPYR--GSSRISAKRSQSSRLSSLTIQSSSYNDDTSVASLQTPRS 58

Query:    57 ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
             E ++L+ P LKAFTF+ELK ATRNFRPDS+IGEGGFGYVYKGWIDE TL  ++PG GMV+
Sbjct:    59 EGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVV 118

Query:   117 AVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN-RLLVYEYMPKGSLENH 175
             AVKKLK EGFQGH++WL+EV+ LG+LHH NLVKLIG+C  G++ RLLVYEYMPKGSLENH
Sbjct:   119 AVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENH 178

Query:   176 LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
             LFRRGA P+PW  RIKVAIGAARGL+FLHEA  QVIYRDFKASNILLDSEFNAKLSDFGL
Sbjct:   179 LFRRGAEPIPWRTRIKVAIGAARGLAFLHEA--QVIYRDFKASNILLDSEFNAKLSDFGL 236

Query:   236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
             AK GPTGDRTHVSTQVMGT+GYAAPEY+ATGR+TAK DVYSFGVVLLELLSGR  VDKT+
Sbjct:   237 AKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTK 296

Query:   296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS 354
             VG E+NLVDWA PYLGD+RK+FRIMD KL GQYP KGA + A  ALQC++ E K+RP MS
Sbjct:   297 VGVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMS 356

Query:   355 EVLSALEQLPPPRDPASPSNS 375
             +VLS LE+L       S SNS
Sbjct:   357 DVLSTLEELEMTLKSGSISNS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
 Identities = 253/389 (65%), Positives = 301/389 (77%)

Query:     1 MGNCY-SWKKVDASLSSHATSGDTKLPDKNGNFSMASSLK----TNKSEKRPSGNFSMPR 55
             MGNC  S  +V    S+    G +++  K    S  SSL     +N S    S +   PR
Sbjct:     1 MGNCLDSSARVGNRESTFG--GSSRISRKPNQSSRLSSLTIPSYSNNSFTTSSWSNLTPR 58

Query:    56 TECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMV 115
             +E ++L  P LKAFTF+ELK ATRNF+P+S+IGEGGFG VYKGWI E +L  ++PG GMV
Sbjct:    59 SEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMV 118

Query:   116 IAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENH 175
             +AVKKLK EGFQGHKEWL+EV+YLG+LHH NLVKLIG+CL+GE RLLVYEYMPKGSLENH
Sbjct:   119 VAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENH 178

Query:   176 LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
             LFRRGA P+PW  R+KVA  AARGLSFLHEA+  VIYRDFKASNILLD +FNAKLSDFGL
Sbjct:   179 LFRRGAEPIPWKTRMKVAFSAARGLSFLHEAK--VIYRDFKASNILLDVDFNAKLSDFGL 236

Query:   236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
             AKAGPTGDRTHV+TQV+GT+GYAAPEY+ATGRLT+K DVYSFGVVLLELLSGR  +DK++
Sbjct:   237 AKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSK 296

Query:   296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS 354
             VG E+NLVDWA PYL DRRK+FRIMD KL GQYP KGA   A +AL+C++ E K+RP M+
Sbjct:   297 VGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMA 356

Query:   355 EVLSALEQLPPPRDPASPSNSDPQVIYSP 383
             +VLS L+QL      +    S   ++ SP
Sbjct:   357 DVLSTLQQL---ETSSKKMGSTQNIVMSP 382

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
 Identities = 225/334 (67%), Positives = 277/334 (82%)

Query:    34 MASSLKTNKSEKRPSGNF-SMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGF 92
             M+S    +   K  S +  + PRTE +IL  PNLK+FTF+ELK ATRNFRPDS++GEGGF
Sbjct:    32 MSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGF 91

Query:    93 GYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIG 152
             G V+KGWIDE TL A++PG G+VIAVKKL  +G+QGH+EWL+EVNYLGQ  HPNLVKLIG
Sbjct:    92 GSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIG 151

Query:   153 FCLDGENRLLVYEYMPKGSLENHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQV 210
             +CL+ E+RLLVYE+MP+GSLENHLFRRG+  +PL WTLR+KVA+GAA+GL+FLH AE  V
Sbjct:   152 YCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSV 211

Query:   211 IYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTA 270
             IYRDFK SNILLDSE+NAKLSDFGLAK GPTGD++HVST++MGT GYAAPEYLATG LT 
Sbjct:   212 IYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTT 271

Query:   271 KCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQ 330
             K DVYS+GVVLLE+LSGRRAVDK R   EQ LV+WA+P L ++RKLFR++D +L+ QY  
Sbjct:   272 KSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSM 331

Query:   331 KGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
             + A  VA LAL+C++ E K+RP+M+EV+S LE +
Sbjct:   332 EEACKVATLALRCLTFEIKLRPNMNEVVSHLEHI 365

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 1175 (418.7 bits), Expect = 2.3e-119, P = 2.3e-119
 Identities = 236/399 (59%), Positives = 302/399 (75%)

Query:     1 MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFS-MPRTECD 59
             MG C+S  ++   ++S +T   +K   ++G  S  SS          + +FS MPRTE +
Sbjct:     1 MGGCFS-NRIKTDIAS-STWLSSKFLSRDG--SKGSS----------TASFSYMPRTEGE 46

Query:    60 ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK 119
             IL   NLK F+ SELK+ATRNFRPDS++GEGGFG V+KGWIDE +L  ++PG G+VIAVK
Sbjct:    47 ILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVK 106

Query:   120 KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR 179
             +L  EGFQGH+EWL+E+NYLGQL HPNLVKLIG+CL+ E+RLLVYE+M +GSLENHLFRR
Sbjct:   107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166

Query:   180 GA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
             G   +PL W  R+++A+GAARGL+FLH A+ QVIYRDFKASNILLDS +NAKLSDFGLA+
Sbjct:   167 GTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLAR 226

Query:   238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
              GP GD +HVST+VMGT+GYAAPEYLATG L+ K DVYSFGVVLLELLSGRRA+DK +  
Sbjct:   227 DGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPV 286

Query:   298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV 356
              E NLVDWA+PYL ++R+L R+MD +L+GQY    A  +A+LAL CIS +AK RP+M+E+
Sbjct:   287 GEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEI 346

Query:   357 LSALEQLPPPRDPASPSNSDPQVIYSPHV-KSPMRPNSP 394
             +  +E+L   ++ AS    +PQ+     + KSP   N P
Sbjct:   347 VKTMEELHIQKE-ASKEQQNPQISIDNIINKSPQAVNYP 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)]

 Score = 1158 (412.7 bits), Expect = 1.4e-117, P = 1.4e-117
 Identities = 239/385 (62%), Positives = 284/385 (73%)

Query:     1 MGNCY-SWKK--------VDASLSSHATSGDTKLPDKNGNFSMASSLK---TNKSEKRPS 48
             MGNC+ S  K        +D+S++S   S       ++ N S   SLK   T K E   +
Sbjct:     1 MGNCFESCSKRNDNEDDNLDSSVNSKPFSRANSDTGRSSNLSYPWSLKPLITRKCEAISA 60

Query:    49 GNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAA 108
                  P  E DI+    LK+FT  ELKNAT NF P+SLIGEGGFG+V+KG I+       
Sbjct:    61 --LPPPHKEGDIMHSQYLKSFTLDELKNATGNFCPESLIGEGGFGFVHKGCIN------G 112

Query:   109 RPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMP 168
              PG+ + +AVKKLK EG QGHKEWL EVNYLG+LHHPNLVKLIG+ L+ E+RLLVYE++P
Sbjct:   113 GPGIELAVAVKKLKTEGLQGHKEWLREVNYLGRLHHPNLVKLIGYSLENEHRLLVYEHLP 172

Query:   169 KGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA 228
              GSLENHLF R +  L W+LR+KVAIGAARGL FLHEA  QVIYRDFKA+NILLDS FNA
Sbjct:   173 NGSLENHLFERSSSVLSWSLRMKVAIGAARGLCFLHEANDQVIYRDFKAANILLDSGFNA 232

Query:   229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             KLSDFGLAK GP  +R+HV+T+VMGT GYAAPEYLATG LT KCDVYSFGVVLLE+LSGR
Sbjct:   233 KLSDFGLAKEGPKDNRSHVTTEVMGTEGYAAPEYLATGHLTTKCDVYSFGVVLLEILSGR 292

Query:   289 RAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAK 348
             R +DK++   E+NLVDWA PYL D+RK+FRIMD KL GQYPQK A+M++ LALQCI + K
Sbjct:   293 RVIDKSKSREEENLVDWATPYLRDKRKVFRIMDTKLVGQYPQKAAFMMSFLALQCIGDVK 352

Query:   349 VRPSMSEVLSALEQLPPPRDPASPS 373
             VRPSM EV+S LE++P PR   S S
Sbjct:   353 VRPSMLEVVSLLEKVPIPRHRKSRS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
 Identities = 218/380 (57%), Positives = 285/380 (75%)

Query:     1 MGNCYSWKKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDI 60
             MG+C+S  +V A +  +  S D         + +  SL + KS    +   +  +TE +I
Sbjct:     1 MGSCFS-SRVKADIFHNGKSSDL--------YGL--SLSSRKSSSTVA---AAQKTEGEI 46

Query:    61 LSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK 120
             LS   +K+FTF+ELK ATRNFRPDS+IGEGGFG V+KGW+DE TL   +PG G+VIAVKK
Sbjct:    47 LSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKK 106

Query:   121 LKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG 180
             L  EGFQGH+EWL+E+NYLGQL HPNLVKLIG+CL+ E+RLLVYE+M KGSLENHLFRRG
Sbjct:   107 LNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRG 166

Query:   181 A--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
             A  +PLPW LR+ VA+ AA+GL+FLH    +VIYRD KASNILLD+++NAKLSDFGLA+ 
Sbjct:   167 AYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARD 226

Query:   239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA 298
             GP GD ++VST+VMGT GYAAPEY+++G L A+ DVYSFGV+LLE+LSG+RA+D  R   
Sbjct:   227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query:   299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL 357
             E+NLVDWA+PYL  +RK+  I+D +L+ QY  + A  +A +A+QC+S E K RP+M +V+
Sbjct:   287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query:   358 SALEQLPPPRDPASPSNSDP 377
              AL+QL    +   PS ++P
Sbjct:   347 RALQQLQD--NLGKPSQTNP 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
 Identities = 222/436 (50%), Positives = 302/436 (69%)

Query:     3 NCYSWK-KVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDIL 61
             +C S + KVD+S+++ A   + K   +      A +  T  +E   SG+ S P    ++ 
Sbjct:    28 SCISSRSKVDSSMNATAVIAEPKKVIEKLEGHPAPTKDTGCAE---SGS-STPLMSGELK 83

Query:    62 SCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL 121
                 L+ F F++LK ATRNFRP+SL+GEGGFG V+KGWI+E+     +PG G+ +AVK L
Sbjct:    84 YSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 143

Query:   122 KPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
              P+G QGHKEWL+E+N+LG L HP+LVKL+G+C++ + RLLVYE+MP+GSLENHLFRR  
Sbjct:   144 NPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRR-T 202

Query:   182 RPLPWTLRIKVAIGAARGLSFLHE-AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
              PLPW++R+K+A+GAA+GL+FLHE AE+ VIYRDFK SNILLD E+NAKLSDFGLAK  P
Sbjct:   203 LPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 262

Query:   241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ 300
                ++HVST+VMGT GYAAPEY+ TG LT K DVYSFGVVLLE+L+GRR+VDK+R   EQ
Sbjct:   263 DEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQ 322

Query:   301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA 359
             NLV+W +P+L D+++ +R++D +LEG Y  KGA     +A QC++ ++K RP MSEV+ A
Sbjct:   323 NLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEA 382

Query:   360 LEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYD----SPVNMSPRSP 415
             L+ LP  +D AS S+S   +   P  K+ +R       S  RN       S +N+   SP
Sbjct:   383 LKPLPNLKDFASSSSSFQTM--QPVAKNGVRTQGGGFVS--RNGPPMRSLSSLNLPQASP 438

Query:   416 LPPHMKSPILKSPRGR 431
                  +SP    P+G+
Sbjct:   439 YRYARQSP---KPKGK 451

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1063 (379.3 bits), Expect = 1.7e-107, P = 1.7e-107
 Identities = 211/372 (56%), Positives = 274/372 (73%)

Query:     6 SWKKVDASLS-SHATSGD-TKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSC 63
             S   V+ SL+ S +T G  + +   N       S  T  S    S +  +   E +I S 
Sbjct:    61 STSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELNIYS- 119

Query:    64 PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
              +LK F+F +LK ATRNFRP+SL+GEGGFG V+KGW++E+     +PG G+ +AVK L P
Sbjct:   120 -HLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNP 178

Query:   124 EGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
             +G QGHKEWL+E+NYLG L HPNLVKL+G+C++ + RLLVYE+MP+GSLENHLFRR   P
Sbjct:   179 DGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-P 237

Query:   184 LPWTLRIKVAIGAARGLSFLHE-AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
             LPW++R+K+A+GAA+GLSFLHE A + VIYRDFK SNILLD E+NAKLSDFGLAK  P  
Sbjct:   238 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDE 297

Query:   243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL 302
              +THVST+VMGT GYAAPEY+ TG LT+K DVYSFGVVLLE+L+GRR++DK R   E NL
Sbjct:   298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357

Query:   303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE 361
             V+WA+P+L D+R+ +R++D +LEG +  KGA  V  LA QC+S ++K+RP MSEV+  L+
Sbjct:   358 VEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLK 417

Query:   362 QLPPPRDPASPS 373
              LP  +D AS S
Sbjct:   418 PLPHLKDMASAS 429

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O49840	APK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7135	0.8321	0.8615	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00037020001 SubName- Full=Chromosome chr1 scaffold_84, whole genome shotgun sequence; (420 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	441
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-37
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-34
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-25
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-19
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  179 bits (457), Expect = 1e-53
 Identities = 91/285 (31%), Positives = 138/285 (48%), Gaps = 38/285 (13%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL 142
              +GEG FG VYKG     TL+    G  + +AVK LK +   Q  +E+L E   + +L
Sbjct: 4   GKKLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            HPN+VKL+G C + E  ++V EYMP G L ++L +   + L  +  +  A+  ARG+ +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG---YAA 259
           L    +  I+RD  A N L+      K+SDFGL++     D   V     G +    + A
Sbjct: 119 LE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK----GGKLPIRWMA 172

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
           PE L  G+ T+K DV+SFGV+L E+ +          G E        PY G       +
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTL---------GEE--------PYPGM--SNAEV 213

Query: 320 MDIKLEGQYPQKGAYM---VAILALQC-ISEAKVRPSMSEVLSAL 360
           ++   +G    K       +  L LQC   + + RP+ SE++  L
Sbjct: 214 LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (453), Expect = 1e-53
 Identities = 72/201 (35%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           +GEGGFG VY     +          G  +A+K +K E      E  L E+  L +L+HP
Sbjct: 1   LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VKL G   D  +  LV EY   GSL++ L       L     +++ +    GL +LH 
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH- 109

Query: 206 AEQQVIYRDFKASNILLDS-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL- 263
               +I+RD K  NILLDS     KL+DFGL+K   +         ++GT  Y APE L 
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166

Query: 264 ATGRLTAKCDVYSFGVVLLEL 284
             G  + K D++S GV+L EL
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  178 bits (454), Expect = 3e-53
 Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 39/282 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG VYKG      L+       + +AVK LK +   Q  +E+L E   + +L HP
Sbjct: 7   LGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VKL+G C + E   +V EYM  G L ++L R+    L  +  +  A+  ARG+ +L  
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG---YAAPEY 262
             +  I+RD  A N L+      K+SDFGL++     D         G +    + APE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR----GGKLPIRWMAPES 174

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI 322
           L  G+ T+K DV+SFGV+L E+ +          G +        PY G       +++ 
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTL---------GEQ--------PYPGM--SNEEVLEY 215

Query: 323 KLEGQYPQKGAYM---VAILALQC-ISEAKVRPSMSEVLSAL 360
              G    +       +  L LQC   + + RP+ SE++  L
Sbjct: 216 LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  174 bits (443), Expect = 1e-51
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 17/209 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYL 139
           +     +GEG FG VY    D+ T        G ++A+K +K +  +  +E  L E+  L
Sbjct: 1   YEILEKLGEGSFGKVYLA-RDKKT--------GKLVAIKVIKKKKIKKDRERILREIKIL 51

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L HPN+V+L     D +   LV EY   G L + L +RG             I     
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI--LSA 109

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L +LH   + +++RD K  NILLD + + KL+DFGLA+    G++    T V GT  Y A
Sbjct: 110 LEYLH--SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYMA 164

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L         D++S GV+L ELL+G+
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (433), Expect = 4e-50
 Identities = 86/254 (33%), Positives = 119/254 (46%), Gaps = 31/254 (12%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNY 138
           +     +G G FG VYK         A   G G ++AVK LK      +  +    E+  
Sbjct: 1   YELLRKLGSGSFGTVYK---------AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           L +L HPN+V+LI    D ++  LV EY   G L ++L R G  PL      K+A+   R
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILR 109

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           GL +LH     +I+RD K  NILLD     K++DFGLAK       + ++T V GT  Y 
Sbjct: 110 GLEYLH--SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYM 165

Query: 259 APEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
           APE L  G     K DV+S GV+L ELL+G+                  +  L   + + 
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIR 212

Query: 318 RIMDIKLEGQYPQK 331
           RI+   LE   P+ 
Sbjct: 213 RILGPPLEFDEPKW 226

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  168 bits (428), Expect = 2e-49
 Identities = 72/205 (35%), Positives = 109/205 (53%), Gaps = 15/205 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG VYKG     TL+    G    +AVK LK     +  +E+L E + + +L HP
Sbjct: 7   LGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V+L+G C  GE   +V EYMP G L + L R+    L     +++A+  A+G+ +L  
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE- 119

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG---YAAPEY 262
             +  ++RD  A N L+      K+SDFGL++     D         G +    + APE 
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPES 175

Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           L  G+ T+K DV+SFGV+L E+ + 
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  160 bits (407), Expect = 2e-46
 Identities = 90/295 (30%), Positives = 135/295 (45%), Gaps = 55/295 (18%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHH 144
           +GEG FG VYKG    +        G    +AVK LK +   +  K++L E   + +L H
Sbjct: 3   LGEGAFGEVYKGKLKGK-------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH 55

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP---------LPWTLRIKVAIG 195
           PN+V+L+G C + E   LV EYM  G L ++L  R +RP         L     +  AI 
Sbjct: 56  PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYL--RKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A+G+ +L    ++ ++RD  A N L+  +   K+SDFGL++     D          T 
Sbjct: 114 IAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTG 166

Query: 256 G-----YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           G     + APE L  G  T+K DV+SFGV+L E+ +          GA         PY 
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL---------GAT--------PYP 209

Query: 311 GDRRKLFRIMDIKLEGQYPQKGAYM---VAILALQCIS-EAKVRPSMSEVLSALE 361
           G       +++   +G    K  Y    +  L L C   + + RP+ SE++  LE
Sbjct: 210 G--LSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  139 bits (353), Expect = 1e-38
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 17/209 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           F     IG+GGFG VYK     H         G  +A+K +K E  +  ++ ++E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKAR---HKRT------GKEVAIKVIKLESKEKKEKIINEIQILK 52

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  HPN+VK  G  L  +   +V E+   GSL++ L +   + L  +    V     +GL
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGL 111

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTRGYAA 259
            +LH     +I+RD KA+NILL S+   KL DFGL+     T  R      ++GT  + A
Sbjct: 112 EYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWMA 165

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE +       K D++S G+  +EL  G+
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 1e-37
 Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLH 143
           LIG G FG VYKG ++  T        G  +A+K++  E    +  K  + E++ L  L 
Sbjct: 7   LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN+VK IG     ++  ++ EY   GSL   + + G  P P +L         +GL++L
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYL 115

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           HE  Q VI+RD KA+NIL   +   KL+DFG+  A    D +     V+GT  + APE +
Sbjct: 116 HE--QGVIHRDIKAANILTTKDGVVKLADFGV--ATKLNDVSKDDASVVGTPYWMAPEVI 171

Query: 264 ATGRLTAKCDVYSFGVVLLELLSGR 288
                +   D++S G  ++ELL+G 
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  136 bits (344), Expect = 4e-37
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 17/208 (8%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK--LKPEGFQGHKEWLSEVNYLGQLH 143
           L+G G FG VY   +D+ T        G ++AVK   L  +  +  +    E+  L  L 
Sbjct: 7   LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 144 HPNLVKLIGFCLDGE-NRLLVY-EYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           HPN+V+  G   D E N L ++ EY+  GSL + L + G   LP  +  K       GL+
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLA 115

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH     +++RD K +NIL+DS+   KL+DFG AK     +    +  V GT  + APE
Sbjct: 116 YLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRR 289
            +         D++S G  ++E+ +G+ 
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (328), Expect = 6e-35
 Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 26/208 (12%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
           + IG+G FG V  G              G  +AVK LK +     + +L+E + +  L H
Sbjct: 12  ATIGKGEFGDVMLG-----DYR------GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRH 59

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           PNLV+L+G  L G    +V EYM KGSL ++L  RG   +    ++  A+    G+ +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRGYAAPE 261
             E+  ++RD  A N+L+  +  AK+SDFGLAK    G    +  V         + APE
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPE 169

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS-GR 288
            L   + + K DV+SFG++L E+ S GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  129 bits (327), Expect = 1e-34
 Identities = 69/205 (33%), Positives = 100/205 (48%), Gaps = 14/205 (6%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHP 145
           +GEG FG V          +      G  +AVK L   G + H  ++  E+  L  L H 
Sbjct: 12  LGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 146 NLVKLIGFCLD--GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           N+VK  G C    G +  L+ EY+P GSL ++L R   +     L +  +    +G+ +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-LLFSSQICKGMDYL 125

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV--MGTRGYAAPE 261
               Q+ I+RD  A NIL++SE   K+SDFGLAK  P     +   +        Y APE
Sbjct: 126 GS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            L T + ++  DV+SFGV L EL +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 8e-31
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 22/207 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHH 144
            IG+G FG VYKG +               +AVK  +       K  +L E   L Q  H
Sbjct: 2   KIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           PN+VKLIG C+  +   +V E +P GSL   L ++  R L     +++++ AA G+ +L 
Sbjct: 52  PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLE 110

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR----GYAAP 260
              +  I+RD  A N L+      K+SDFG+++    G    + T   G +     + AP
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG----IYTVSDGLKQIPIKWTAP 164

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E L  GR T++ DV+S+G++L E  S 
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 3e-30
 Identities = 75/207 (36%), Positives = 102/207 (49%), Gaps = 22/207 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           +G+G FG V      + T        G + A+K LK +     KE    L+E N L +++
Sbjct: 1   LGKGSFGKVLLV-RKKDT--------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           HP +VKL  +    E +L LV EY P G L +HL + G             I  A  L +
Sbjct: 52  HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA--LEY 108

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTRGYAAPE 261
           LH     +IYRD K  NILLD++ + KL+DFGLAK     G RT+      GT  Y APE
Sbjct: 109 LHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN---TFCGTPEYLAPE 163

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            L         D +S GV+L E+L+G+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 7e-29
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 24/211 (11%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW--LSEVNYLGQ 141
           + +IG G FG V +G          +  +   +A+K LK  G    +    L+E + +GQ
Sbjct: 9   EKVIGGGEFGEVCRG----RLKLPGKKEI--DVAIKTLKA-GSSDKQRLDFLTEASIMGQ 61

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             HPN+++L G        +++ EYM  GSL+  L R           + +  G A G+ 
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMK 120

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG----- 256
           +L  +E   ++RD  A NIL++S    K+SDFGL++      R   S     T+G     
Sbjct: 121 YL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPI 172

Query: 257 -YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + APE +A  + T+  DV+SFG+V+ E++S
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 1e-28
 Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 25/208 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHP 145
           +G G FG V KG          + G  + +AVK LK E    G KE+L E + + QL HP
Sbjct: 3   LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----LPWTLRIKVAIGAARGLS 201
            +V+LIG C  GE  +LV E  P G L  +L +R   P         ++      A G++
Sbjct: 57  CIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMA 109

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYA 258
           +L    +  ++RD  A N+LL +   AK+SDFG+++A   G   + +T     R    + 
Sbjct: 110 YLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWY 165

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS 286
           APE +  G+ ++K DV+S+GV L E  S
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 3e-28
 Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G  +  T           +AVK LKP G    + +L E   + +L H  
Sbjct: 14  LGAGQFGEVWMGTWNGTT----------KVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDK 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L   C + E   +V EYM KGSL + L     + L     + +A   A G+++L   
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-- 120

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEYL 263
            +  I+RD  A NIL+      K++DFGLA+     D  + + +  G +    + APE  
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTARE--GAKFPIKWTAPEAA 176

Query: 264 ATGRLTAKCDVYSFGVVLLELLS-GR 288
             GR T K DV+SFG++L E+++ GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (285), Expect = 5e-28
 Identities = 91/363 (25%), Positives = 140/363 (38%), Gaps = 38/363 (10%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           ++R    +GEG FG VY                  ++A+K L  +     KE    L E+
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDR---------KLVALKVLAKKLESKSKEVERFLREI 48

Query: 137 NYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR-PLPWTLRIKVAI 194
             L  L H PN+VKL  F  D  +  LV EY+  GSLE+ L + G + PL  +  + +  
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAK----AGPTGDRTHVST 249
                L +LH   + +I+RD K  NILLD +    KL DFGLAK     G T     + +
Sbjct: 109 QILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 250 QVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA 306
             +GT GY APE L        ++  D++S G+ L ELL+G    +  +  +  +     
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL-- 224

Query: 307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPP 366
                   K+   +               +   A   + +  +       LS+   L   
Sbjct: 225 --------KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276

Query: 367 -RDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMKSPIL 425
                    SD   +  P   +P+R + P     L ++ +S         L     S  L
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336

Query: 426 KSP 428
              
Sbjct: 337 APN 339

Length = 384

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 6e-28
 Identities = 83/292 (28%), Positives = 145/292 (49%), Gaps = 43/292 (14%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +G G FG VYKG WI E         V + +A+K L+ E   + +KE L E   +  + H
Sbjct: 15  LGSGAFGTVYKGVWIPE------GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSL----ENHLFRRGARP-LPWTLRIKVAIGAARG 199
           P++V+L+G CL      L+ + MP G L     NH    G++  L W ++I      A+G
Sbjct: 69  PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           +S+L E  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        + A
Sbjct: 122 MSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
            E +     T K DV+S+GV + EL++ G +  +        +L++      G+R     
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-----KGERLPQPP 234

Query: 319 IMDIKLEGQYPQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLPPPRDP 369
           I  I +         YMV +   +C + +A+ RP+  E+++   ++   RDP
Sbjct: 235 ICTIDV---------YMVLV---KCWMIDAESRPTFKELINEFSKM--ARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  108 bits (270), Expect = 1e-26
 Identities = 90/291 (30%), Positives = 141/291 (48%), Gaps = 35/291 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           +GEG FG V       +  + A  G G ++AVK LK E  Q +   W  E+N L  L+H 
Sbjct: 12  LGEGHFGKV-----SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 146 NLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRG---ARPLPWTLRIKVAIGAARGL 200
           N+VK  G C +   +   L+ EY+P GSL ++L +     A+ L +  +I        G+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQI------CEGM 120

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAA 259
           ++LH   Q  I+RD  A N+LLD++   K+ DFGLAKA P G   + V         + A
Sbjct: 121 AYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF-- 317
            E L   + +   DV+SFGV L ELL        T   ++Q+     +  +G ++     
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELL--------THCDSKQSPPKKFEEMIGPKQGQMTV 230

Query: 318 -RIMDIKLEGQY---PQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQL 363
            R++++   G     P+     V IL   C  +EAK RP+   ++  L+++
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  106 bits (266), Expect = 2e-26
 Identities = 73/206 (35%), Positives = 113/206 (54%), Gaps = 25/206 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG FG V +G   E+T        G  +AVK +K +     + +L E   + +LHH N
Sbjct: 14  IGEGEFGAVLQG---EYT--------GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKN 60

Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  L   N L +V E M KG+L N L  RG   +     ++ ++  A G+ +L  
Sbjct: 61  LVRLLGVIL--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTRGYAAPEYLA 264
             +++++RD  A NIL+  +  AK+SDFGLA+ G  G D + +  +      + APE L 
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA 290
             + ++K DV+S+GV+L E+ S  RA
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (265), Expect = 3e-26
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 15/214 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHH 144
           IG+G FG V+K           R     V A+K++          +E + E   L +L  
Sbjct: 8   IGKGSFGVVFK---------VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
             +++     LD     +V EY   G L   L  +  RPLP     +  I    GL+ LH
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              +++++RD K+ N+ LD+  N K+ D G+AK     D T+ +  ++GT  Y +PE   
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCE 174

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA 298
                 K DV++ GVVL E  +G+   D    GA
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (265), Expect = 5e-26
 Identities = 66/209 (31%), Positives = 92/209 (44%), Gaps = 18/209 (8%)

Query: 87  IGEGGFGYVYKGW-IDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG VY    +D   L A +      I ++   P   +  KE   E+  L  L HP
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVK-----EIRIQDNDP---KTIKEIADEMKVLELLKHP 59

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           NLVK  G  +  E   +  EY   G+LE  L     R L   +     +    GL++LH 
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVM-GTRGYAAPEYL 263
               +++RD K +NI LD     KL DFG A              Q + GT  Y APE +
Sbjct: 118 --HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 264 ATGRLTAK---CDVYSFGVVLLELLSGRR 289
             G+        D++S G V+LE+ +G+R
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 7e-26
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 51/223 (22%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW------LSEVNYLG 140
           IGEG +G VYK         A     G ++A+KK++ E    +++       + E+  L 
Sbjct: 7   IGEGTYGQVYK---------ARNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQ 53

Query: 141 QLHHPNLVKLIGFCLDGE--NRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIG 195
           +L HPN+V+L          +  +V+EYM     G L++               +K    
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE-------------VKFTES 100

Query: 196 AAR--------GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
             +        GL +LH     +++RD K SNIL++++   KL+DFGLA+   T   +  
Sbjct: 101 QIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSAD 157

Query: 248 STQVMGTRGYAAPEYL--ATGRLTAKCDVYSFGVVLLELLSGR 288
            T  + T  Y  PE L  AT R   + D++S G +L EL  G+
Sbjct: 158 YTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  105 bits (265), Expect = 1e-25
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 35/222 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLS 134
            +     +GEG +  VYK   D+ T        G ++A+KK+K    +  K+      L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51

Query: 135 EVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPL------PWT 187
           E+  L +L HPN++ L+  F     N  LV+E+M    LE  + +  +  L       + 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKS-NINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYM 108

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           L         RGL +LH     +++RD K +N+L+ S+   KL+DFGLA++  + +R  +
Sbjct: 109 LMT------LRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KM 159

Query: 248 STQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           + QV+ TR Y APE L   R      D++S G +  ELL   
Sbjct: 160 THQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 1e-25
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHP 145
           +GEG FG VYKG                 +A+K LK     +  +E+  E   +  L HP
Sbjct: 13  LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------GARPLPWTLRIK 191
           N+V L+G C   +   +++EY+  G L   L R                   L  +  + 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +AI  A G+ +L  +    ++RD  A N L+      K+SDFGL++   + D   V ++ 
Sbjct: 129 IAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +    +  PE +  G+ T + D++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  104 bits (262), Expect = 1e-25
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVI--AVKKLKPEGFQG-HKEWLSEVNYLGQL 142
            +G+G FG V +G       E +  G G VI  AVK LK +       ++L E   +  L
Sbjct: 2   KLGDGSFGVVRRG-------EWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL 53

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H NL++L G  L     ++V E  P GSL + L +        +     A+  A G+ +
Sbjct: 54  DHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST-QVMGTRGYAAPE 261
           L    ++ I+RD  A NILL S+   K+ DFGL +A P  +  +V    +     + APE
Sbjct: 113 LES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            L T   +   DV+ FGV L E+ +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 21/214 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPG-VGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHH 144
           +GEG FG V+ G           P     ++AVK LK        K++  E   L    H
Sbjct: 13  LGEGAFGKVFLG-----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG----------ARPLPWTLR--IKV 192
            N+VK  G C +G+  ++V+EYM  G L   L   G          +     TL   +++
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A+  A G+ +L  A Q  ++RD    N L+  +   K+ DFG+++   T D   V    M
Sbjct: 128 AVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               +  PE +   + T + DV+SFGVVL E+ +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  103 bits (259), Expect = 3e-25
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 40/218 (18%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK--KLKPEGFQGH---KEWLSEVNYLG 140
           L+G G FG VY+G   +          G   AVK   L  +G  G    K+   E+  L 
Sbjct: 7   LLGSGSFGSVYEGLNLDD---------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS 57

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP----WTLRIKVAIGA 196
           +L HPN+V+ +G   + +N  +  E +P GSL   L + G+ P P    +T +I      
Sbjct: 58  KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------ 111

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM---- 252
             GL +LH  ++  ++RD K +NIL+D+    KL+DFG+AK         V         
Sbjct: 112 LLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSF 161

Query: 253 -GTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELLSGR 288
            G+  + APE +A  G      D++S G  +LE+ +G+
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++G  +  T           +AVK LKP G    K++L+E   + +L HP 
Sbjct: 14  LGAGQFGEVWEGLWNNTT----------PVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPK 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           L++L   C   E   +V E M  GSL  +L     R L     I +A   A G+++L   
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-- 120

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEYL 263
            Q  I+RD  A N+L+      K++DFGLA+     +  + + +  G +    + APE  
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPIKWTAPEAA 176

Query: 264 ATGRLTAKCDVYSFGVVLLELLS-GR 288
              R + K DV+SFG++L E+++ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  103 bits (259), Expect = 4e-25
 Identities = 86/314 (27%), Positives = 132/314 (42%), Gaps = 58/314 (18%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNY 138
           N      +GEG FG V K           R G   V AVK LK        ++ LSE N 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRL---KGRAGYTTV-AVKMLKENASSSELRDLLSEFNL 56

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL---------------------- 176
           L Q++HP+++KL G C      LL+ EY   GSL + L                      
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
                R L     I  A   +RG+ +L  AE ++++RD  A N+L+      K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 237 KAGPTGDRTHVSTQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV 291
           +     D     + V  ++G     + A E L     T + DV+SFGV+L E+++     
Sbjct: 175 R-----DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----- 224

Query: 292 DKTRVGAEQNLVDWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKV 349
               +G          PY G    +LF ++      + P+  +  +  L L C   E   
Sbjct: 225 ----LG--------GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDK 272

Query: 350 RPSMSEVLSALEQL 363
           RP+ +++   LE++
Sbjct: 273 RPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  102 bits (258), Expect = 5e-25
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 31/222 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK--LKPEGFQGHKEWLSEVN 137
            +     IG+G FG VY            R   G +  +K+  L     +  ++ L+EV 
Sbjct: 1   KYEIIKQIGKGSFGKVYL---------VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK 51

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLP------WTLR 189
            L +L+HPN++K      +     +V EY   G L   +   ++  +P P      W ++
Sbjct: 52  ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVS 248
           +         L +LH   +++++RD K  NI L S    KL DFG++K    T D     
Sbjct: 112 L------CLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAK 161

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           T V GT  Y +PE         K D++S G VL EL + +  
Sbjct: 162 TVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 7e-25
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPG-VGMVIAVKKLKP-EGFQGHKEWLSEVNYLGQLHH 144
           +G+G FG VY+G       +    G     +A+K +      +   E+L+E + + + + 
Sbjct: 14  LGQGSFGMVYEG-----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--------FRRGARPLPWTLRIKVAIGA 196
            ++V+L+G    G+  L+V E M KG L+++L           G  P      I++A   
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           A G+++L  A ++ ++RD  A N ++  +   K+ DFG+ +     D      + +    
Sbjct: 129 ADGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           + APE L  G  T K DV+SFGVVL E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (253), Expect = 2e-24
 Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 16/207 (7%)

Query: 81  FRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           F  +  +G G FG V++G W +            + +A+K LK +     +++  EV  L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQAL 56

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H +L+ L   C  GE   ++ E M KGSL   L     + LP    I +A   A G
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           +++L   EQ  I+RD  A NIL+  +   K++DFGLA+     +  ++S+       + A
Sbjct: 117 MAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTA 172

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLS 286
           PE  + G  + K DV+SFG++L E+ +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 2e-24
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP----EGFQGHKEWLSEV 136
           +     +GEG +G VYK   D+ T        G ++A+KK++     EG       L E+
Sbjct: 1   YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDNEEEGIP--STALREI 49

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL-FRRGARPLPWTLRIKVAIG 195
           + L +L HPN+VKL+          LV+EY     L+ +L  R G         I   + 
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL- 107

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
             RGL++ H    ++++RD K  NIL++ +   KL+DFGLA+A     RT+  T  + T 
Sbjct: 108 -LRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTL 162

Query: 256 GYAAPEYLATGRLTAKC-----DVYSFGVVLLELLSGR 288
            Y APE L    L +K      D++S G +  E+++G+
Sbjct: 163 WYRAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 87  IGEGGFGYV----YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL 142
           +G G FG V    ++G ID              +A+K ++ EG     +++ E   + +L
Sbjct: 12  LGSGQFGVVHLGKWRGKID--------------VAIKMIR-EGAMSEDDFIEEAKVMMKL 56

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL-FRRGARPLPWTLRIKVAIGAARGLS 201
            HPNLV+L G C       +V EYM  G L N+L  R+G     W L   +       + 
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAME 114

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYA 258
           +L       I+RD  A N L+  +   K+SDFGLA+     D  + S+Q  GT+    +A
Sbjct: 115 YLESN--GFIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQ--GTKFPVKWA 168

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
            PE     R ++K DV+SFGV++ E+ S 
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (253), Expect = 3e-24
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 13/212 (6%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           R+ +    +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  
Sbjct: 4   RHLKFIQQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58

Query: 139 LGQLHHPNLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
           L  L H N+VK  G C   G   L LV EY+P GSL ++L +   R     L +  A   
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQI 117

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            +G+ +L    ++ ++RD    NIL++SE   K+ DFGL K  P  D+ +   +  G   
Sbjct: 118 CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESP 174

Query: 257 --YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L   + +   DV+SFGVVL EL +
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 22/207 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP----EGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYK   D+ T        G ++A+KK+K     EG    K  L E+  L +L
Sbjct: 7   IGEGTYGVVYKAR-DKLT--------GEIVAIKKIKLRFESEGIP--KTALREIKLLKEL 55

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           +HPN++KL+       +  LV+E+M    L   L +   R LP +L         +GL+F
Sbjct: 56  NHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAF 113

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H     +++RD K  N+L+++E   KL+DFGLA++  +  R +  T  + TR Y APE 
Sbjct: 114 CHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPEL 169

Query: 263 LATGRL-TAKCDVYSFGVVLLELLSGR 288
           L   +  +   D++S G +  ELLS R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 22/215 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMV-IAVKKLKPEGF-QGHKEWLSEVNYLGQLH 143
            +G G FG VY+G       +   PG G + +AVK L+     Q  KE+L E + +   +
Sbjct: 2   FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-------LPWTLRIKVAIGA 196
           HPN+VKL+G CL  E + ++ E M  G L ++L  R AR        L     + + +  
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDV 115

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILL-----DSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           A+G  +L   +   I+RD  A N L+     D++   K+ DFGLA+     D      + 
Sbjct: 116 AKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +    + APE L  G+ T + DV+SFGV++ E+L+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK-LKPEGFQGHKEWLSEVNYLGQLH 143
           S +GEG  G V K  +            GM+ A+K           K+ L E+       
Sbjct: 7   SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57

Query: 144 HPNLVKLIGFCLDGENRLL--VYEYMPKGSLEN---HLFRRGARPLPWTLRIKVAIGAAR 198
            P +VK  G  LD  +  +    EY   GSL++    + +RG R     L  K+A    +
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVLK 116

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGY 257
           GLS+LH   +++I+RD K SNILL  +   KL DFG++ +   +   T       GT  Y
Sbjct: 117 GLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            APE +     +   DV+S G+ LLE+   R
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK--PEGFQGHKEWLSEVNYLGQL 142
            ++GEG +G V K               G ++A+KK K   +     K  L EV  L QL
Sbjct: 7   GVVGEGAYGVVLK---------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLE------NHLFRRGARPLPWTLRIKVAIG 195
            H N+V L       + RL LV+EY+ +  LE        L     R   W L       
Sbjct: 58  RHENIVNLKEAFRR-KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL------- 109

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
             + +++ H     +I+RD K  NIL+      KL DFG A+A      + ++  V  TR
Sbjct: 110 -LQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATR 165

Query: 256 GYAAPEYLATGRLTAK-CDVYSFGVVLLELLSGR 288
            Y APE L       K  DV++ G ++ ELL G 
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 38/282 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   ++          + +AVK LK +  +   E+L E   + ++ HPN
Sbjct: 14  LGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 121

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEYL 263
           ++  I+RD  A N L+      K++DFGL++   TGD     T   G +    + APE L
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGD---TYTAHAGAKFPIKWTAPESL 177

Query: 264 ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRIMDI 322
           A  + + K DV++FGV+L E+ +   +                 PY G D  +++ +++ 
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEK 220

Query: 323 KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               + P+     V  L   C       RPS +E+  A E +
Sbjct: 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 26/216 (12%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLH 143
           ++GEG FG V +G +      +   G  + +AVK +K +       +E+LSE   +    
Sbjct: 6   ILGEGEFGSVMEGQL------SQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 144 HPNLVKLIGFCLDGENR------LLVYEYMPKGSLENHLF--RRGARP--LPWTLRIKVA 193
           HPN++KLIG C +  +       +++  +M  G L + L   R G  P  LP    +K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD---RTHVSTQ 250
           +  A G+ +L  + +  I+RD  A N +L  +    ++DFGL+K   +GD   +  ++  
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK- 176

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            M  + + A E LA    T+K DV++FGV + E+ +
Sbjct: 177 -MPVK-WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 85/303 (28%), Positives = 146/303 (48%), Gaps = 47/303 (15%)

Query: 78  TRNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSE 135
               R   L+G G FG V+KG WI E         + + +A+K ++   G Q  +E    
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGD------SIKIPVAIKTIQDRSGRQTFQEITDH 59

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF-RRGA----RPLPWTLRI 190
           +  +G L H  +V+L+G C  G +  LV +  P GSL +H+   R +    R L W ++I
Sbjct: 60  MLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
                 A+G+ +L E   ++++R+  A NILL S+   +++DFG+A      D+ +  ++
Sbjct: 119 ------AKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
                 + A E +  GR T + DV+S+GV + E++S          GAE        PY 
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS---------YGAE--------PYA 213

Query: 311 GDRRKLFRIMDIKLEGQ---YPQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLP-- 364
           G R     + D+  +G+    PQ     V ++ ++C + +  VRP+  E+ +   ++   
Sbjct: 214 GMR--PHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271

Query: 365 PPR 367
           PPR
Sbjct: 272 PPR 274

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 92/286 (32%), Positives = 137/286 (47%), Gaps = 36/286 (12%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEVNYLGQLH 143
           +IG+G FG VY G  ID         G  +  AVK L +    +  +++L E   +    
Sbjct: 2   VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54

Query: 144 HPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG--AARGL 200
           HPN++ L+G CL  E   L+V  YM  G L N  F R     P T++  +  G   A+G+
Sbjct: 55  HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNP-TVKDLIGFGLQVAKGM 111

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTRGYA 258
            +L  A ++ ++RD  A N +LD  F  K++DFGLA+          H  T       + 
Sbjct: 112 EYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
           A E L T + T K DV+SFGV+L EL++ R A     V +    V     YL   R+L  
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITV-----YLLQGRRL-- 221

Query: 319 IMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSMSEVLSALEQL 363
                L+ +Y     Y V    L C   + ++RP+ SE++S +EQ+
Sbjct: 222 -----LQPEYCPDPLYEV---MLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 32/211 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G G  G V K           RP  G ++AVK ++ E      K+ L E++ L + + P
Sbjct: 9   LGAGNSGVVSKVLH--------RP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            +V   G   +  +  +  EYM  GSL+  + +     +P  +  K+A+   +GL++LHE
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM--------GTRGY 257
            + ++I+RD K SNIL++S    KL DFG            VS Q++        GT  Y
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            APE +     + K D++S G+ L+EL +GR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.4 bits (243), Expect = 7e-23
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEWLSEVNYLGQL 142
           IGEG  G V+K         A     G  +A+KK+       G     + L E+  L   
Sbjct: 8   IGEGAHGIVFK---------AKDRETGETVALKKVALRRLEGGIP--NQALREIKALQAC 56

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            HP +VKL+     G   +LV EYMP   L   L R   RPLP            +G+++
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           +H     +++RD K +N+L+ ++   K++DFGLA+     +    S QV  TR Y APE 
Sbjct: 115 MHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL 171

Query: 263 LATGR-LTAKCDVYSFGVVLLELLSGR 288
           L   R      D+++ G +  ELL+G 
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.6 bits (240), Expect = 7e-23
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 15/202 (7%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHH 144
           L+G+G FG V+KG     TL+   P     +AVK  K +  Q  K ++LSE   L Q  H
Sbjct: 2   LLGKGNFGEVFKG-----TLKDKTP-----VAVKTCKEDLPQELKIKFLSEARILKQYDH 51

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           PN+VKLIG C   +   +V E +P G   + L R+    L     +K A+ AA G+++L 
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE 110

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              +  I+RD  A N L+      K+SDFG+++    G  +    + +  + + APE L 
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALN 167

Query: 265 TGRLTAKCDVYSFGVVLLELLS 286
            GR +++ DV+S+G++L E  S
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 19/207 (9%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLH 143
            ++G+G  G VYK    + T        G + A+KK+      +  K+ L E+  L    
Sbjct: 7   KVLGQGSSGVVYKV-RHKPT--------GKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 144 HPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            P +VK  G F  +GE  + V EYM  GSL + L + G  P P    I  A    +GL +
Sbjct: 58  SPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYI--ARQILKGLDY 114

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPE 261
           LH  ++ +I+RD K SN+L++S+   K++DFG++K    T D+ +  T V GT  Y +PE
Sbjct: 115 LH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPE 170

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +     +   D++S G+ LLE   G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 37/226 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGV-----GMVIAVKKLKPEG-FQGHKEWLSEVNYLG 140
           IG+G FG V++         A  PG+       ++AVK LK E       ++  E   + 
Sbjct: 13  IGQGAFGRVFQ---------ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR------------------ 182
           +  HPN+VKL+G C  G+   L++EYM  G L   L  R  R                  
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 183 PLPWTLRIKVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
           PLP +   ++ I    A G+++L  +E++ ++RD    N L+      K++DFGL++   
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           + D    S        +  PE +   R T + DV+++GVVL E+ S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 33/210 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G VYK   D  T        G  +A+KK++    Q  +  ++E+  +    HPN
Sbjct: 27  IGEGASGEVYKA-TDRAT--------GKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL----ENHLFR----RGARPLPWTLRIKVAIGAAR 198
           +V      L G+   +V EYM  GSL      +  R    + A      L+         
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ--------- 127

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           GL +LH   Q VI+RD K+ NILL  + + KL+DFG A A  T +++  ++ V GT  + 
Sbjct: 128 GLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVV-GTPYWM 183

Query: 259 APEYLATGRL-TAKCDVYSFGVVLLELLSG 287
           APE +   +    K D++S G++ +E+  G
Sbjct: 184 APE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +A+K LK +G    + +L+E N + QL HP 
Sbjct: 14  LGAGQFGEVWMGYYNGHT----------KVAIKSLK-QGSMSPEAFLAEANLMKQLQHPR 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     I +A   A G++F+   
Sbjct: 63  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER- 120

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG------YAAP 260
            +  I+RD +A+NIL+      K++DFGLA       R     +     G      + AP
Sbjct: 121 -KNYIHRDLRAANILVSETLCCKIADFGLA-------RLIEDNEYTAREGAKFPIKWTAP 172

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLS-GR 288
           E +  G  T K DV+SFG++L E+++ GR
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWL-SEVNYLGQLHH 144
           IG+G FG V K           R   G ++  K++         K+ L SEVN L +L H
Sbjct: 8   IGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58

Query: 145 PNLVKLIGFCLDGENRLL--VYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIGAARGL 200
           PN+V+     +D  N+ L  V EY   G L   +   ++  + +      ++       L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 201 SFLH---EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
              H   +    V++RD K +NI LD+  N KL DFGLAK    G  +  +   +GT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYY 176

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            +PE L       K D++S G ++ EL +  
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 42/281 (14%)

Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   + +L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       +V EYM  G L N+L   G R  P  L +++      G+++L  
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE- 117

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
             +Q I+RD  A N L+D +   K+SDFGL++     D  + S+  +G++    ++ PE 
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEV 172

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
           L   + ++K DV++FGV++ E+ S G+   ++         V+     +    +L+R   
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVE----KVSQGLRLYR--- 222

Query: 322 IKLEGQYPQKGAYMVAILALQCISE-AKVRPSMSEVLSALE 361
                  P   +  V  +   C  E A+ RP+  ++LS++E
Sbjct: 223 -------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.4 bits (237), Expect = 4e-22
 Identities = 70/204 (34%), Positives = 102/204 (50%), Gaps = 12/204 (5%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQLHHP 145
           +GEG FG V     D    E      G  +AVK LKPE    H   L  E+  L  L+H 
Sbjct: 12  LGEGHFGKVELCRYDP---EGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 146 NLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           N+VK  G C +       L+ E++P GSL+ +L R   + +    ++K A+   +G+ +L
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL 125

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEY 262
               +Q ++RD  A N+L++SE   K+ DFGL KA  T    + V   +     + APE 
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 95.4 bits (237), Expect = 6e-22
 Identities = 82/303 (27%), Positives = 140/303 (46%), Gaps = 42/303 (13%)

Query: 87  IGEGGFGYVYKGWIDE-HTLEA------ARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNY 138
           +GEG FG V+   +     L         R G  +++AVK L+P+  +  + ++L EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------GARPL 184
           L +L  PN+++L+G C+D +   ++ EYM  G L   L                  A  L
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 185 P---WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
           P   ++  + VA+  A G+ +L  +    ++RD    N L+      K++DFG+++    
Sbjct: 133 PAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190

Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
           GD   +  + +    + A E +  G+ T   DV++FGV L E+L   +      +  EQ 
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ- 249

Query: 302 LVDWAKPYLGDRRK---LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL 357
           +++ A  +  D+ +   LFR          PQ G Y    L LQC S + + RPS S++ 
Sbjct: 250 VIENAGEFFRDQGRQVYLFR------PPPCPQ-GLYE---LMLQCWSRDCRERPSFSDIH 299

Query: 358 SAL 360
           + L
Sbjct: 300 AFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 7e-22
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN-- 137
           +F+    +G+G +G VYK           R       A+K++   G    KE    VN  
Sbjct: 1   DFKVLKKLGKGSYGSVYK---------VKRLSDNQFYALKEVDL-GSMSQKEREDAVNEI 50

Query: 138 -YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA--RPLPWTLRIKVAI 194
             L  ++HPN++      LDG    +V EY P G L   + +R    + +P     ++ I
Sbjct: 51  RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              RGL  LHE  Q++++RD K++NILL +    K+ D G++K      +    TQ+ GT
Sbjct: 111 QLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQI-GT 164

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             Y APE       + K D++S G +L E+ +  
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.2 bits (234), Expect = 9e-22
 Identities = 67/215 (31%), Positives = 117/215 (54%), Gaps = 22/215 (10%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMV-IAVKKLKPEGFQGH--KEWLSEVNYLG 140
           + +IG G FG V +G +         PG   + +A+K LK  G+     +++LSE + +G
Sbjct: 9   EEVIGAGEFGEVCRGRLKL-------PGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMG 60

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           Q  HPN++ L G        +++ E+M  G+L++ L +   +     L + +  G A G+
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGIAAGM 119

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTR--- 255
            +L  +E   ++RD  A NIL++S    K+SDFGL++     T D T+ S+  +G +   
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPI 175

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
            + APE +A  + T+  DV+S+G+V+ E++S G R
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.1 bits (234), Expect = 9e-22
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 33/220 (15%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK--LKPEGFQGHKEWL--------SE 135
           LIG+G +G VY        L       G ++AVK+  L       H            SE
Sbjct: 8   LIGKGTYGRVYLA------LNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVY-EYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           +  L  L H N+V+ +GF    E  L ++ EY+P GS+ +   R   R     +R     
Sbjct: 59  IETLKDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVR-FFTE 115

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
               GL++LH   + +++RD KA N+L+D++   K+SDFG++K     D  + + Q M  
Sbjct: 116 QVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSM 170

Query: 255 RG---YAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRR 289
           +G   + APE + +     +AK D++S G V+LE+ +GRR
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 17/214 (7%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-----------VAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C +     LV+E+M  G L ++L  +  +    TL + + +    G+++L  
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMAYLES 118

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           +   VI+RD  A N L+      K+SDFG+ +     D+   ST       +++PE  + 
Sbjct: 119 S--NVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSF 175

Query: 266 GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE 299
            + ++K DV+SFGV++ E+ S  +   + R  +E
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 67/211 (31%), Positives = 115/211 (54%), Gaps = 20/211 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMV-IAVKKLKPEGF--QGHKEWLSEVNYLGQL 142
           +IG G FG V++G +         PG   V +A+K LKP G+  +  +++LSE + +GQ 
Sbjct: 12  VIGAGEFGEVFRGILK-------MPGRKEVAVAIKTLKP-GYTEKQRQDFLSEASIMGQF 63

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H N+++L G     +  +++ EYM  G+L+ +L         + L + +  G A G+ +
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKY 122

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRGYAA 259
           L  ++   ++RD  A NIL++S    K+SDFGL++     P G  T    ++     + A
Sbjct: 123 L--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           PE +A  + T+  DV+SFG+V+ E++S G R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 49/238 (20%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY- 138
           +F+   +IGEG F  V     ++ T            A+K L        K+    V Y 
Sbjct: 2   DFKFGKIIGEGSFSTVVLAK-EKET--------NKEYAIKILDKRQLIKEKK----VKYV 48

Query: 139 ------LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
                 L +L  HP ++KL     D EN   V EY P G L  ++ + G+     T    
Sbjct: 49  KIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY- 107

Query: 192 VAIGAAR---GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               AA     L +LH   + +I+RD K  NILLD + + K++DFG AK          +
Sbjct: 108 ----AAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 249 TQVM------------------GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
                                 GT  Y +PE L         D+++ G ++ ++L+G+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 21/212 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPG--VGMVIAVKKLKPEGFQGHKE--WLSEVNYLGQL 142
           +G G FG VY+G      L   R G  V + +AVK L PE      E  +L E   + + 
Sbjct: 14  LGHGAFGEVYEG------LYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKF 66

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR---RGARPLPWTLR--IKVAIGAA 197
           +H N+V+LIG   +   R ++ E M  G L++ L     R  RP   T++  +  A   A
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGT 254
           +G  +L E     I+RD  A N LL  +     AK++DFG+A+            + M  
Sbjct: 127 KGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             +  PE    G  T+K DV+SFGV+L E+ S
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.8 bits (241), Expect = 2e-21
 Identities = 87/304 (28%), Positives = 139/304 (45%), Gaps = 44/304 (14%)

Query: 67  KAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK---- 122
           K+ T +++ ++ +    +++I  G  G  YKG   ++         GM   VK++     
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKN---------GMQFVVKEINDVNS 728

Query: 123 -PEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
            P          SE+  +G+L HPN+VKLIG C   +   L++EY+   +L   L     
Sbjct: 729 IPS---------SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----- 774

Query: 182 RPLPWTLRIKVAIGAARGLSFLH-EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
           R L W  R K+AIG A+ L FLH      V+  +     I++D +    L    L     
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ 300
           T  +  +S+       Y APE   T  +T K D+Y FG++L+ELL+G+   D    G   
Sbjct: 834 TDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHG 886

Query: 301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAI--LALQCIS-EAKVRPSMSEVL 357
           ++V+WA+ Y      L   +D  + G        +V +  LAL C + +   RP  ++VL
Sbjct: 887 SIVEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945

Query: 358 SALE 361
             LE
Sbjct: 946 KTLE 949

Length = 968

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 72/213 (33%), Positives = 98/213 (46%), Gaps = 31/213 (14%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP---------EGFQGHKEWLSEV 136
           ++G+G FG V         L A   G   + AVK LK          E     K  L+  
Sbjct: 2   VLGKGSFGKV---------LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
                  HP L +L   C   ++RL  V EY+  G L  H+ R G    P        I 
Sbjct: 53  G-----KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI- 105

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
              GL FLHE  + +IYRD K  N+LLDSE + K++DFG+ K G  G  T  ++   GT 
Sbjct: 106 -VLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTP 160

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            Y APE L+        D ++ GV+L E+L+G+
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 68/205 (33%), Positives = 107/205 (52%), Gaps = 24/205 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V  G   ++         G  +AVK +K +     + +L+E + + QL H N
Sbjct: 14  IGKGEFGDVMLG---DYR--------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60

Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYLA 264
                ++RD  A N+L+  +  AK+SDFGL K A  T D   +  +      + APE L 
Sbjct: 121 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172

Query: 265 TGRLTAKCDVYSFGVVLLELLS-GR 288
             + + K DV+SFG++L E+ S GR
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 74/226 (32%), Positives = 116/226 (51%), Gaps = 42/226 (18%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL 142
           + +IGEG FG V +  I        + G+ M  A+K LK    +  H+++  E+  L +L
Sbjct: 7   EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 143 -HHPNLVKLIGFCLDGENRLLVY---EYMPKGSLENHLFRRGARPL---PWTLR------ 189
            HHPN++ L+G C   ENR  +Y   EY P G+L +  F R +R L   P   +      
Sbjct: 60  GHHPNIINLLGAC---ENRGYLYIAIEYAPYGNLLD--FLRKSRVLETDPAFAKEHGTAS 114

Query: 190 -------IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
                  ++ A   A G+ +L  +E+Q I+RD  A N+L+     +K++DFGL++    G
Sbjct: 115 TLTSQQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----G 168

Query: 243 DRTHVSTQVMGTRG--YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +  +V  + MG     + A E L     T K DV+SFGV+L E++S
Sbjct: 169 EEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           F     +GEG +G VYK  I + T        G V+A+K +  E     +E + E++ L 
Sbjct: 5   FDILEKLGEGSYGSVYKA-IHKET--------GQVVAIKVVPVEE--DLQEIIKEISILK 53

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           Q   P +VK  G      +  +V EY   GS+ + + +   + L       +     +GL
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH    + I+RD KA NILL+ E  AKL+DFG+  +G   D       V+GT  + AP
Sbjct: 113 EYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAP 168

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E +       K D++S G+  +E+  G+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 81/293 (27%), Positives = 131/293 (44%), Gaps = 33/293 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N +  + +G G FG V+         E     V +V A++K K E  Q   E+  E++  
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLV-LVKALQKTKDENLQ--SEFRRELDMF 62

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF-----RRGARPLPWTLRIKVAI 194
            +L H N+V+L+G C + E   ++ EY   G L+  L          +P P + + KVA+
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 195 GA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
               A G+  L  A  + ++RD  A N L+ S+   K+S   L+K     +   +   ++
Sbjct: 123 CTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY--L 310
             R + APE +     + K DV+SFGV++ E+ +            E        P+  L
Sbjct: 181 PLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGEL-------PFYGL 222

Query: 311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQ 362
            D   L R+   KLE   P+     +  L  +C     K RPS SE++SAL +
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 28/218 (12%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLS----E 135
           +LIG G FG VY G      + A+    G ++AVK+++            +  L     E
Sbjct: 6   ALIGSGSFGSVYLG------MNASS---GELMAVKQVELPSVSASSKDRKRSMLDALARE 56

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           +  L +L H N+V+ +G  LD ++  +  EY+P GS+   L   GA     TL       
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQ 114

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-----AGPTGDRTHVSTQ 250
             +GL++LH   + +I+RD K +NIL+D++   K+SDFG++K     +  T         
Sbjct: 115 ILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA-RPS 171

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           + G+  + APE +     T K D++S G +++E+L+G+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 73/224 (32%), Positives = 114/224 (50%), Gaps = 42/224 (18%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-H 143
           +IGEG FG V K  I        + G+ M  A+K++K    +  H+++  E+  L +L H
Sbjct: 2   VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54

Query: 144 HPNLVKLIGFCLDGENRLLVY---EYMPKGSLENHLFRRGARPL---PWTLR-------- 189
           HPN++ L+G C   E+R  +Y   EY P G+L +  F R +R L   P            
Sbjct: 55  HPNIINLLGAC---EHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTL 109

Query: 190 -----IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
                +  A   ARG+ +L  +++Q I+RD  A NIL+   + AK++DFGL++    G  
Sbjct: 110 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 163

Query: 245 THVSTQVMGTRG--YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +V  + MG     + A E L     T   DV+S+GV+L E++S
Sbjct: 164 VYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 69/221 (31%), Positives = 97/221 (43%), Gaps = 43/221 (19%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYL 139
           F     IG+G FG VYK  ID+ T          V+A+K +  E  +   E +  E+ +L
Sbjct: 3   FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI---GA 196
            Q   P + K  G  L G    ++ EY   GS    L + G   L  T    +A      
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG--KLDET---YIAFILREV 107

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV----- 251
             GL +LHE  +  I+RD KA+NILL  E + KL+DFG            VS Q+     
Sbjct: 108 LLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFG------------VSGQLTSTMS 153

Query: 252 -----MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                +GT  + APE +       K D++S G+  +EL  G
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 27/205 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           IG G FG VY    + HT E        V+AVKK+   G Q +++W   + EV +L QL 
Sbjct: 29  IGHGSFGAVYFA-TNSHTNE--------VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN ++  G  L      LV EY   GS  + L     +PL       +  GA +GL++L
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAPEY 262
           H     +I+RD KA NILL      KL+DFG A K+ P       +   +GT  + APE 
Sbjct: 138 HS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEV 188

Query: 263 LAT---GRLTAKCDVYSFGVVLLEL 284
           +     G+   K DV+S G+  +EL
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 20/214 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+    + + L   +    M++AVK LK       K++  E   L  L H +
Sbjct: 13  LGEGAFGKVFLA--ECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------ARP------LPWTLRIKV 192
           +VK  G C DG+  ++V+EYM  G L   L   G         +P      L  +  + +
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A   A G+ +L  A Q  ++RD    N L+ +    K+ DFG+++   + D   V    M
Sbjct: 129 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               +  PE +   + T + DV+SFGV+L E+ +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARP-GVGMVIAVKKLK------PEGFQGHKEWLSEVNY 138
            +G G F   Y           AR    G ++AVK++        E  +  +    E+  
Sbjct: 7   QLGTGAFSSCY----------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRL 56

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           + +L+HP++++++G   +  +  L  E+M  GS+ + L + G       + I       R
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLR 114

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLA-KAGPTGDRT-HVSTQVMGTR 255
           GLS+LHE   Q+I+RD K +N+L+DS     +++DFG A +    G        Q++GT 
Sbjct: 115 GLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            + APE L   +    CDV+S G V++E+ + +
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 33/220 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVN 137
             + + +IG G FG V  G +    L   R    + +A+K LK  G+  +  +++LSE +
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRL---KLPGKRE---IPVAIKTLKA-GYTEKQRRDFLSEAS 57

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI--G 195
            +GQ  HPN++ L G     +  ++V EYM  GSL+  L +   +   +T+   V +  G
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FTVIQLVGMLRG 114

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVM 252
            A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++     P    T       
Sbjct: 115 IASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT------- 165

Query: 253 GTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            TRG      + APE +A  + T+  DV+S+G+V+ E++S
Sbjct: 166 -TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 29/218 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWLSEV 136
           +F    +IG+G FG V    I +            + A+K   K K       +  L+E 
Sbjct: 1   HFELLRVIGKGAFGKV---CIVQKR------DTKKMFAMKYMNKQKCVEKGSVRNVLNER 51

Query: 137 NYLGQLHHPNLVKL-IGFCLDGENRLLVYEYMPKGSLENHLFRRG----ARPLPWTLRIK 191
             L +L+HP LV L   F  D EN  LV + +  G L  HL ++      +   W   I 
Sbjct: 52  RILQELNHPFLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIV 110

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A      L +LH   + +I+RD K  NILLD + +  ++DF +A        T   T  
Sbjct: 111 LA------LEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TST 159

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
            GT GY APE L     +   D +S GV   E L G+R
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 19/206 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLH 143
           +G+GGFG V                 G + A KKL  +     +G +  L+E   L ++ 
Sbjct: 1   LGKGGFGEVCA---------CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
              +V L  +  + ++ L LV   M  G L+ H++  G    P    I  A     GL  
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           LH+  ++++YRD K  N+LLD   N ++SD GLA     G +        GT GY APE 
Sbjct: 111 LHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEV 165

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGR 288
           L         D ++ G  L E+++GR
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 19/217 (8%)

Query: 87  IGEGGFGYVY-------KGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNY 138
           +GEG FG V+       + + ++   E       +++AVK L+P+      +++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR---------GARPLPWTLR 189
           L +L  PN+ +L+G C       ++ EYM  G L   L +           ++ L ++  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           + +A   A G+ +L       ++RD    N L+   +  K++DFG+++   + D   V  
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +      + A E +  G+ T K DV++FGV L E+L+
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+         E  +    M++AVK LK       +++  E   L  L H +
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDK----MLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFR------------RGARPLPWTL--RIKV 192
           +V+  G C +G   L+V+EYM  G L N   R                P   TL   + +
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D   V  + M
Sbjct: 128 ASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               +  PE +   + T + D++SFGVVL E+ +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 51/302 (16%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-H 143
           +IGEG FG V K  I        + G+ M  A+K++K    +  H+++  E+  L +L H
Sbjct: 14  VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR--------------RGARPLPWTLR 189
           HPN++ L+G C       L  EY P G+L + L +                A  L     
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           +  A   ARG+ +L  +++Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179

Query: 250 QVMGTRG--YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK 307
           + MG     + A E L     T   DV+S+GV+L E++S         +G          
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 222

Query: 308 PYLGDR-RKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKV-RPSMSEVLSALEQLPP 365
           PY G    +L+  +      + P      V  L  QC  E    RPS +++L +L ++  
Sbjct: 223 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282

Query: 366 PR 367
            R
Sbjct: 283 ER 284

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 60/183 (32%), Positives = 89/183 (48%), Gaps = 11/183 (6%)

Query: 113 GMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGS 171
              +A+K++  E  Q    E   EV  + Q +HPN+VK     + G+   LV  Y+  GS
Sbjct: 26  NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85

Query: 172 LEN---HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA 228
           L +     + RG   L   +   V     +GL +LH      I+RD KA NILL  + + 
Sbjct: 86  LLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSV 141

Query: 229 KLSDFGL-AKAGPTGDRTH-VSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELL 285
           K++DFG+ A     GDRT  V    +GT  + APE +        K D++SFG+  +EL 
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201

Query: 286 SGR 288
           +G 
Sbjct: 202 TGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLSEVNYLGQLHHP 145
           +GE  FG +YKG +    ++ A+     ++A+K LK     Q   E+  E + + +LHHP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP---------------LPWTLRI 190
           N+V L+G     +   +++EY+ +G L   L  R                   L     +
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +AI  A G+ +L  +    +++D  A NIL+  + + K+SD GL++   + D   V  +
Sbjct: 128 HIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +    +  PE +  G+ ++  D++SFGVVL E+ S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK--PEGFQGHKEWLS--- 134
           N+R   L+G+G FG VY  + D  T        G  +AVK++   P+  +  KE  +   
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-DVDT--------GRELAVKQVPFDPDSPETKKEVNALEC 53

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  L  L H  +V+  G   D E   +  EYMP GS+++ L   GA  L  T+  K   
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTR 111

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK------AGPTGDRTHVS 248
               G+ +LH     +++RD K +NIL DS  N KL DFG +K      +  TG ++   
Sbjct: 112 QILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--- 166

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             V GT  + +PE ++      K DV+S G  ++E+L+
Sbjct: 167 --VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V +     + L  ++    M +AVK LKP      +E L SE+  +  L +H
Sbjct: 43  LGAGAFGKVVEA--TAYGL--SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
            N+V L+G C  G   L++ EY   G L N L R+    L     +  +   A+G++FL 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA------ 258
            A +  I+RD  A N+LL      K+ DFGLA+     D  + S  V   +G A      
Sbjct: 158 -ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYV--VKGNARLPVKW 209

Query: 259 -APEYLATGRLTAKCDVYSFGVVLLELLS 286
            APE +     T + DV+S+G++L E+ S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 37/211 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G +G VYK   D  T        G ++A+K +K E     +    E++ L +  HPN
Sbjct: 11  IGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V   G  L  +   +V EY   GSL++ +++    PL       V     +GL++LHE 
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE- 119

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV----------MGTRG 256
               I+RD K +NILL  + + KL+DFG            VS Q+          +GT  
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSFIGTPY 166

Query: 257 YAAPEYLA---TGRLTAKCDVYSFGVVLLEL 284
           + APE  A    G    KCD+++ G+  +EL
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ +  T           +AVK LKP G    + +L E N +  L H  
Sbjct: 14  LGAGQFGEVWMGYYNNST----------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L       E   ++ EYM KGSL + L       +     I  +   A G++++   
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER- 121

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+N+L+      K++DFGLA+     + T         + + APE +  G
Sbjct: 122 -KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFG 179

Query: 267 RLTAKCDVYSFGVVLLELLS 286
             T K DV+SFG++L E+++
Sbjct: 180 SFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 85.9 bits (212), Expect = 6e-19
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 21/210 (10%)

Query: 87  IGEGGFGYVYKGWI--DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
           +GEG FG V +G +  D+  L+ A   + + I  +          +++LSE   + +  H
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-------SEMEDFLSEAVCMKEFDH 59

Query: 145 PNLVKLIGFCLDGENR------LLVYEYMPKGSLENHLF--RRGARP--LPWTLRIKVAI 194
           PN+++LIG CL           +++  +M  G L + L   R G  P  LP  + +K   
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
             A G+ +L  + +  I+RD  A N +L+   N  ++DFGL+K    GD           
Sbjct: 120 DIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
             + A E LA    T K DV+SFGV + E+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.7 bits (212), Expect = 6e-19
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL------KPEGFQGHKEWLSEVNYL 139
           ++G+G +G VY G  ++          G +IAVK++           + +++   EV+ L
Sbjct: 7   VLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L H N+V+ +G CLD     +  E++P GS+ + L R G  P P   +    I    G
Sbjct: 57  KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDG 114

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK----AGPTGDRTHVSTQVMGTR 255
           +++LH     V++RD K +N++L      KL DFG A+     G  G  +++   + GT 
Sbjct: 115 VAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            + APE +       K D++S G  + E+ +G+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 85.4 bits (211), Expect = 8e-19
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHH 144
           +G G FG V KG       ++ +      +AVK LK +        E L E N + QL +
Sbjct: 3   LGSGNFGTVKKGMY--KMKKSEKT-----VAVKILKNDNNDPALKDELLREANVMQQLDN 55

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           P +V++IG C + E+ +LV E    G L  + F +  + +      ++    + G+ +L 
Sbjct: 56  PYIVRMIGIC-EAESWMLVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT--RGYAAPEY 262
           E     ++RD  A N+LL ++  AK+SDFGL+KA    D  +   +  G     + APE 
Sbjct: 113 E--TNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKTHGKWPVKWYAPEC 169

Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           +   + ++K DV+SFGV++ E  S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.1 bits (221), Expect = 8e-19
 Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 17/185 (9%)

Query: 118 VKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLI--GFCLDGENRLL-VYEYMPKGSLEN 174
           ++   PE       +  E     +L+HPN+V L+  G    G   L  V+EY+P  +L  
Sbjct: 11  LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVPGRTLRE 68

Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLS 231
            L   GA P   T R+ + +     L+  H   Q +++RD K  NI++       +AK+ 
Sbjct: 69  VLAADGALPAGETGRLMLQV--LDALACAHN--QGIVHRDLKPQNIMVSQTGVRPHAKVL 124

Query: 232 DFGLAKAGP-TGD----RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           DFG+    P   D        +T+V+GT  Y APE L    +T   D+Y++G++ LE L+
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184

Query: 287 GRRAV 291
           G+R V
Sbjct: 185 GQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 12/205 (5%)

Query: 83  PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQ 141
               IGEG FG VY+G               + +AVK  K       +E +L E   + Q
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             HP++VKLIG   +     +V E  P G L ++L       L     I  +   +  L+
Sbjct: 64  FDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALA 121

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +L    ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE
Sbjct: 122 YLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPE 178

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   R T+  DV+ FGV + E+L 
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 72/222 (32%), Positives = 109/222 (49%), Gaps = 46/222 (20%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLSEVNYLGQL- 142
           +G+G +G V+K  ID  T          V+A+KK+  + F+     +    E+ +L +L 
Sbjct: 15  LGKGAYGIVWKA-IDRRT--------KEVVALKKIF-DAFRNATDAQRTFREIMFLQELG 64

Query: 143 HHPNLVKLIGFCLDGENRL---LVYEYMP--------KGSLEN-HLFRRGARPLPWTLRI 190
            HPN+VKL+   +  EN     LV+EYM            LE+ H      R + + L  
Sbjct: 65  DHPNIVKLLNV-IKAENDKDIYLVFEYMETDLHAVIRANILEDVH-----KRYIMYQL-- 116

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH---V 247
                  + L ++H     VI+RD K SNILL+S+   KL+DFGLA++    +      V
Sbjct: 117 ------LKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 248 STQVMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
            T  + TR Y APE L  + R T   D++S G +L E+L G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V+ G      L A    V +    + L P+      ++L E   L Q  HPN
Sbjct: 3   IGRGNFGEVFSG-----RLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPN 54

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V+LIG C   +   +V E +  G     L   G R     L I++   AA G+ +L   
Sbjct: 55  IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-IQMVENAAAGMEYLE-- 111

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR----GYAAPEY 262
            +  I+RD  A N L+  +   K+SDFG+++    G    V     G +     + APE 
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG----VYASTGGMKQIPVKWTAPEA 167

Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L  GR +++ DV+SFG++L E  S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLSEVNYLGQLH 143
           I +G +G V+          A +   G + A+K +K           + L+E + L Q  
Sbjct: 1   ISKGAYGRVFL---------AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ 51

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-IGAARGLS 201
            P +VKL  +   G+  L LV EY+P G L + L   G+       RI +A I  A  L 
Sbjct: 52  SPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-RIYIAEIVLA--LE 107

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS------TQVMGTR 255
           +LH     +I+RD K  NIL+DS  + KL+DFGL+K G    + +++       +++GT 
Sbjct: 108 YLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            Y APE +     +   D +S G +L E L G
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+         E  +    +++AVK LK       K++  E   L  L H +
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDK----ILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIG 195
           +VK  G C++G+  ++V+EYM  G L   L   G              L  +  + +A  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+ +L  A Q  ++RD    N L+      K+ DFG+++   + D   V    M   
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +  PE +   + T + DV+S GVVL E+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 24/218 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 1   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 49

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 50  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V  T
Sbjct: 108 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 163

Query: 255 RGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 76/209 (36%), Positives = 101/209 (48%), Gaps = 35/209 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           IG G FG VY    D  T E        V+A+KK+   G Q +++W   + EV +L QL 
Sbjct: 23  IGHGSFGAVYFAR-DVRTNE--------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGS----LENHLFRRGARPLPWTLRIKVAIGAARG 199
           HPN ++  G  L      LV EY   GS    LE H      +PL       +  GA +G
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH-----KKPLQEVEIAAICHGALQG 127

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYA 258
           L++LH  E+  I+RD KA NILL      KL+DFG A    P       +   +GT  + 
Sbjct: 128 LAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWM 178

Query: 259 APEY-LAT--GRLTAKCDVYSFGVVLLEL 284
           APE  LA   G+   K DV+S G+  +EL
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 57/160 (35%), Positives = 82/160 (51%), Gaps = 19/160 (11%)

Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  + HP LV L G   D  N  LV EY+P G L +HL + G  P P       
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            +  A  L +LH  +  ++YRD K  N+LLDS+   K++DFG AK      RT+    + 
Sbjct: 109 QVVLA--LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LC 159

Query: 253 GTRGYAAPEYLATGRLTAK-----CDVYSFGVVLLELLSG 287
           GT     PEYLA   + +K      D ++ G+++ E+L+G
Sbjct: 160 GT-----PEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 46/219 (21%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-----LSEVNYLGQ 141
           +G+G FG VY    ++ T E        ++A+KK+K    +    W     L EV  L +
Sbjct: 7   LGDGTFGSVYLA-RNKETGE--------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53

Query: 142 L-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP------WTLRIKVAI 194
           L  HPN+VKL     + +    V+EYM +G+L   +  R  +P           +I    
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI---- 108

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR----THVSTQ 250
              +GL+ +H+      +RD K  N+L+      K++DFGLA+      R     +VS  
Sbjct: 109 --LQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVS-- 160

Query: 251 VMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
              TR Y APE  L +   ++  D+++ G ++ EL + R
Sbjct: 161 ---TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 21/209 (10%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           +  +G G FG V+    ++HT           +AVK +KP G    + +L+E N +  L 
Sbjct: 11  EKKLGAGQFGEVWMATYNKHT----------KVAVKTMKP-GSMSVEAFLAEANVMKTLQ 59

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           H  LVKL    +  E   ++ E+M KGSL + L        P    I  +   A G++F+
Sbjct: 60  HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAP 260
            +  +  I+RD +A+NIL+ +    K++DFGLA+     D  + + +  G +    + AP
Sbjct: 119 EQ--RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAP 172

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           E +  G  T K DV+SFG++L+E+++  R
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 85/280 (30%), Positives = 129/280 (46%), Gaps = 40/280 (14%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G  + +T           +AVK LKP G    + +L E   + +L H  
Sbjct: 14  LGNGQFGEVWMGTWNGNT----------KVAVKTLKP-GTMSPESFLEEAQIMKKLRHDK 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   +V EYM KGSL + L     R L     + +A   A G++++   
Sbjct: 63  LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER- 120

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEYL 263
               I+RD +++NIL+      K++DFGLA+     D  + + Q  G +    + APE  
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEAA 175

Query: 264 ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRIMDI 322
             GR T K DV+SFG++L EL      V K RV           PY G + R++   ++ 
Sbjct: 176 LYGRFTIKSDVWSFGILLTEL------VTKGRV-----------PYPGMNNREVLEQVER 218

Query: 323 KLEGQYPQKGAYMVAILALQCI-SEAKVRPSMSEVLSALE 361
                 PQ     +  L LQC   + + RP+   + S LE
Sbjct: 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 50/160 (31%), Positives = 91/160 (56%), Gaps = 9/160 (5%)

Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR 189
           K+ L E+  + +   P +V   G  L+  N  +  E+M  GSL+  ++++G  P+P  + 
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG-PIPVEIL 105

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VS 248
            K+A+    GL++L+    ++++RD K SNIL++S    KL DFG+     +G+  + ++
Sbjct: 106 GKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIA 159

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
              +GT  Y +PE +  G+ T K DV+S G+ ++EL  G+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.0 bits (205), Expect = 5e-18
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW--LSEVN 137
            +    ++G G FG V+        L   +    +VI +K++  E     +     +E  
Sbjct: 1   KYEKIRVVGRGAFGIVH--------LCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQ 51

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP--WTLRIKVAIG 195
            L  L HPN+++     L+ +  ++V EY P G+L  ++ +R    L     L   V I 
Sbjct: 52  VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI- 110

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGT 254
               L+  H   + +++RD K  NILLD      K+ DFG++K      ++   T V+GT
Sbjct: 111 ---LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGT 164

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD 292
             Y +PE         K D+++ G VL EL S +RA +
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLH 143
           +G+GGFG V    +            G + A KKL  +  +   G K  L E   L +++
Sbjct: 1   LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            P +V L  +  + +  L LV   M  G L+ H++  G R L     I  +     G+  
Sbjct: 52  SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           LH  +  ++YRD K  N+LLD + N +LSD GLA     G      TQ  GT GY APE 
Sbjct: 111 LHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEI 165

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGR 288
           L     +   D ++ G  + E+++GR
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 73/234 (31%), Positives = 104/234 (44%), Gaps = 40/234 (17%)

Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           L + T  F    +IGEG +G VYK    + T        G ++A+K +        +E  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIE-DEEEEIK 50

Query: 134 SEVNYLGQL-HHPNLVKLIGFCLD-----GENRL-LVYEYMPKGS---LENHLFRRGAR- 182
            E N L +  +HPN+    G  +       +++L LV E    GS   L   L ++G R 
Sbjct: 51  EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110

Query: 183 PLPWT---LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKA 238
              W    LR        RGL++LHE   +VI+RD K  NILL      KL DFG+ A+ 
Sbjct: 111 KEEWIAYILR-----ETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163

Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSG 287
             T  R +      GT  + APE +A          A+ DV+S G+  +EL  G
Sbjct: 164 DSTLGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.2 bits (205), Expect = 7e-18
 Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 17/202 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHHP 145
           IG+G FG VYKG ID  T E        V+A+K +  E  +   E +  E+  L Q   P
Sbjct: 12  IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + +  G  L G    ++ EY+  GS  + L + G  PL  T    +     +GL +LH 
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLHS 119

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             ++ I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 266 GRLTAKCDVYSFGVVLLELLSG 287
                K D++S G+  +EL  G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLH 143
           ++G+G FG V +  +          G    +AVK LK + F     +E+L E   + +  
Sbjct: 6   MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 144 HPNLVKLIGFCLDGENR------LLVYEYMPKGSLENHLF--RRGARP--LPWTLRIKVA 193
           HPN++KLIG  L    +      +++  +M  G L   L   R G  P  LP    ++  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           I  A G+ +L  + +  I+RD  A N +L+      ++DFGL+K   +GD          
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + A E LA    T   DV++FGV + E+++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 56/216 (25%), Positives = 107/216 (49%), Gaps = 18/216 (8%)

Query: 87  IGEGGFGYVYKGWID--EHTLEAARP---GVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLG 140
           +GEG FG V+    +     L    P   G  +++AVK L+ +  +    ++L E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-------ARPLPWTLR---I 190
           +L +PN+++L+G C+  +   ++ EYM  G L   L +R        A  +P       +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +A+  A G+ +L  A    ++RD    N L+ + +  K++DFG+++   +GD   +  +
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +    + A E +  G+ T   DV++FGV L E+ +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R D  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTT----------KVAIKTLKP-GTMMPEAFLQEAQIM 55

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV L    +  E   +V E+M KGSL + L     + L     + +A   A G
Sbjct: 56  KKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---G 256
           ++++       I+RD +A+NIL+      K++DFGLA+     D  + + Q  G +    
Sbjct: 115 MAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQ--GAKFPIK 168

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           + APE    GR T K DV+SFG++L EL++  R
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 87/293 (29%), Positives = 130/293 (44%), Gaps = 49/293 (16%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS---EV 136
           N+R   L+G+G FG VY  +  +   E A   V       +  PE  +  KE  +   E+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQV-------QFDPESPETSKEVSALECEI 55

Query: 137 NYLGQLHHPNLVKLIGFCLD-GENRLLVY-EYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
             L  L H  +V+  G   D  E  L ++ EYMP GS+++ L   GA  L  ++  K   
Sbjct: 56  QLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTR 113

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK------AGPTGDRTHVS 248
               G+S+LH     +++RD K +NIL DS  N KL DFG +K         TG R+   
Sbjct: 114 QILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--- 168

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP 308
             V GT  + +PE ++      K DV+S G  ++E+L+                    KP
Sbjct: 169 --VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-------------------EKP 207

Query: 309 YLGDRRKLFRIMDIKLEGQYPQKGAYMV--AILALQCI-SEAKVRPSMSEVLS 358
              +   +  I  I  +   PQ  +++   A   L CI  EA+ RPS  E+L 
Sbjct: 208 PWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 69/208 (33%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLGQ 141
           +G GGFG V         ++          A+K +K       G Q H    SE   L +
Sbjct: 1   LGVGGFGRVEL-------VKVKSKNR--TFALKCVKKRHIVETGQQEHI--FSEKEILEE 49

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            +HP +VKL     D +   ++ EY   G L   L  RG     +T R  +A        
Sbjct: 50  CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA-CVVLAFE 107

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH   + +IYRD K  N+LLDS    KL DFG AK   +G +T       GT  Y APE
Sbjct: 108 YLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPE 162

Query: 262 Y-LATGRLTAKCDVYSFGVVLLELLSGR 288
             L  G   +  D +S G++L ELL+GR
Sbjct: 163 IILNKGYDFS-VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 23/213 (10%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK--KLKPEGFQGHKEWLSEVNY 138
           ++   LIG G +G VY+G    H         G V+A+K   L             EV  
Sbjct: 3   YQRLELIGRGAYGAVYRGK---HVP------TGRVVALKIINLDTPDDDVSDIQ-REVAL 52

Query: 139 LGQLHH---PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           L QL     PN+ K  G  L G    ++ EY   GS+   L + G     +   I   + 
Sbjct: 53  LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A  L ++H+    VI+RD KA+NIL+ +  N KL DFG+A A    + +  ST V GT 
Sbjct: 112 VA--LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTFV-GTP 165

Query: 256 GYAAPEYLATGRL-TAKCDVYSFGVVLLELLSG 287
            + APE +  G+    K D++S G+ + E+ +G
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 70/205 (34%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           IG G FG VY    D  T E        V+A+KK+   G Q +++W   + EV +L ++ 
Sbjct: 33  IGHGSFGAVYFAR-DVRTNE--------VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN ++  G  L      LV EY   GS  + L     +PL       +  GA +GL++L
Sbjct: 84  HPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEY 262
           H     +I+RD KA NILL      KL+DFG A  A P       +   +GT  + APE 
Sbjct: 142 HS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEV 192

Query: 263 LAT---GRLTAKCDVYSFGVVLLEL 284
           +     G+   K DV+S G+  +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 68/227 (29%), Positives = 101/227 (44%), Gaps = 38/227 (16%)

Query: 84  DSLIGEGGFGYVYKG---WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYL 139
              +GEG FG V K     +D              +AVK LK +   +   + +SE+  +
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNET-------STVAVKMLKDDATEKDLSDLVSEMEMM 69

Query: 140 GQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR----------GARPLPWTL 188
             +  H N++ L+G C       +V EY   G+L + L  R            RP   TL
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 189 RIK----VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
             K     A   ARG+ FL  A ++ I+RD  A N+L+  +   K++DFGLA+     D 
Sbjct: 130 TQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DI 182

Query: 245 THVSTQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            H+      T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 39/284 (13%)

Query: 80  NFRPDSLIGEGGFG--YVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
           ++ P  ++G+G FG   +Y+   D+  +      V   + + +L     +  ++ L+E+ 
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLV------VWKEVNLTRLSE---KERRDALNEIV 51

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            L  L HPN++      +D    L+  EY   G+L + + R+  +     + +       
Sbjct: 52  ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
             +S++H+A   +++RD K  NI L      KL DFG++K    G    ++  V+GT  Y
Sbjct: 112 SAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYY 167

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
            +PE     +   K D+++ G VL ELL+ +R  D T      NLV              
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLV-------------V 211

Query: 318 RIMDIKLEGQY-PQKGAYMVAILAL--QCIS-EAKVRPSMSEVL 357
           +I+    +G Y P    Y   +++L    +  + + RP+  EVL
Sbjct: 212 KIV----QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 59/189 (31%), Positives = 97/189 (51%), Gaps = 32/189 (16%)

Query: 113 GMVIAVK----KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYM 167
           G+++A K    ++KP       + + E+  L + + P +V   G F  DGE  + + E+M
Sbjct: 26  GLIMARKLIHLEIKPAI---RNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM-EHM 81

Query: 168 PKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN 227
             GSL+     + A  +P  +  K++I   RGL++L E + ++++RD K SNIL++S   
Sbjct: 82  DGGSLD--QVLKKAGRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGE 138

Query: 228 AKLSDFGLAKAGPTGDRTHVSTQVM--------GTRGYAAPEYLATGRLTAKCDVYSFGV 279
            KL DFG            VS Q++        GTR Y +PE L     T + D++S G+
Sbjct: 139 IKLCDFG------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186

Query: 280 VLLELLSGR 288
            L+E+  GR
Sbjct: 187 SLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 55

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 56  KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---G 256
           ++++       ++RD +A+NIL+      K++DFGLA+     D  + + Q  G +    
Sbjct: 115 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIK 168

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           + APE    GR T K DV+SFG++L EL +  R
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 63/174 (36%), Positives = 90/174 (51%), Gaps = 28/174 (16%)

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLP------WTLRIKVAIGA 196
           HP LV L   C   E+RL  V E++  G L  H+ R+  R LP      ++  I +A   
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLA--- 108

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTR 255
              L+FLHE  + +IYRD K  N+LLD+E + KL+D+G+ K G   GD T   +   GT 
Sbjct: 109 ---LNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTP 160

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA----EQNLVDW 305
            Y APE L         D ++ GV++ E+++GR   D   VG     +QN  D+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI--VGMSDNPDQNTEDY 212

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 19/217 (8%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           ELK+   +F   S +G G  G V K       L  AR  + +     ++KP       + 
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL-----EIKP---AIRNQI 50

Query: 133 LSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L  + A+ +P  +  K
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KEAKRIPEEILGK 107

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           V+I   RGL++L E + Q+++RD K SNIL++S    KL DFG++  G   D   ++   
Sbjct: 108 VSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +GTR Y +PE L     + + D++S G+ L+EL  GR
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 61/213 (28%), Positives = 112/213 (52%), Gaps = 22/213 (10%)

Query: 81  FRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNY 138
           F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E   
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAYV 62

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL----ENHLFRRGARPL-PWTLRIKVA 193
           +  + +P++ +L+G CL    +L + + MP G L      H    G++ L  W ++I   
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
              A+G+++L E  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +     
Sbjct: 119 ---AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + A E +     T + DV+S+GV + EL++
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 71/245 (28%), Positives = 107/245 (43%), Gaps = 59/245 (24%)

Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEW 132
             R++     +GEG FG VYK         A +   G V+A+KK+    + +GF      
Sbjct: 6   KLRDYEILGKLGEGTFGEVYK---------ARQIKTGRVVALKKILMHNEKDGF--PITA 54

Query: 133 LSEVNYLGQLHHPNLVKLIGFCLD-----GENRLLVYEYMP------KGSLENHLFRRGA 181
           L E+  L +L HPN+V LI   ++        R  VY   P       G LEN       
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP------ 108

Query: 182 RPLPWTLRIKVAIGAAR--------GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
                   +K+     +        G+++LHE    +++RD KA+NIL+D++   K++DF
Sbjct: 109 -------SVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADF 159

Query: 234 GLAK---------AGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLE 283
           GLA+          G  G  T   T ++ TR Y  PE L   R  T   D++  G V  E
Sbjct: 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219

Query: 284 LLSGR 288
           + + R
Sbjct: 220 MFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 59/222 (26%), Positives = 109/222 (49%), Gaps = 20/222 (9%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE- 131
           EL N +   + + ++G G FG + +G +    L + R    + +A+  L+       +  
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLK---LPSKRE---LPVAIHTLRAGCSDKQRRG 52

Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           +L+E   LGQ  H N+V+L G    G   ++V EYM  G+L++ L R+    L     + 
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMG 111

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +  G A G+ +L  +E   +++   A  +L++S+   K+S F   +     D++      
Sbjct: 112 MLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIYTT 165

Query: 252 MGTRG---YAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           M  +    +AAPE +     ++  DV+SFG+V+ E++S G R
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 5e-17
 Identities = 61/208 (29%), Positives = 113/208 (54%), Gaps = 22/208 (10%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEVNYLGQLH 143
           ++G G FG VYKG W+ E         V + +A+K L +  G + + E++ E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGET------VKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR----GARPL-PWTLRIKVAIGAAR 198
           HP+LV+L+G CL    +L V + MP G L +++       G++ L  W ++I      A+
Sbjct: 68  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+ +L E  +++++RD  A N+L+ S  + K++DFGLA+     ++ + +        + 
Sbjct: 121 GMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS 286
           A E +   + T + DV+S+GV + EL++
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL--KPEGFQGHKEWLSEVNYLGQLHH 144
           IGEG +G V+K    E          G ++A+KK     +     K  L E+  L QL H
Sbjct: 9   IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 145 PNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           PNLV LI      + +L LV+EY     L  +   +  R +P  L  K+     + ++F 
Sbjct: 60  PNLVNLIE-VFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAAPE 261
           H+     I+RD K  NIL+  +   KL DFG A+   GP  D     T  + TR Y APE
Sbjct: 117 HK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATRWYRAPE 170

Query: 262 YL-ATGRLTAKCDVYSFGVVLLELLSG 287
            L    +     DV++ G V  ELL+G
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 21/217 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK--PEGFQGHKEWLS--- 134
           N+R   L+G+G FG VY  + D  T        G  +AVK+++  PE  +  KE  +   
Sbjct: 3   NWRLGKLLGQGAFGRVYLCY-DADT--------GRELAVKQVQFDPESPETSKEVNALEC 53

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           E+  L  L H  +V+  G   D   R L    E+MP GS+++ L   GA     T +   
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ-V 251
            I    G+S+LH     +++RD K +NIL DS  N KL DFG +K   T   +    + V
Sbjct: 114 QI--LEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            GT  + +PE ++      K D++S G  ++E+L+ +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 83/298 (27%), Positives = 141/298 (47%), Gaps = 51/298 (17%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLH 143
           ++G G FG VYKG WI +         V + +A+K L+     + +KE L E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGE------NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF----RRGARPL-PWTLRIKVAIGAAR 198
            P + +L+G CL    +L V + MP G L +++     R G++ L  W ++I      A+
Sbjct: 68  SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AK 120

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+S+L E   ++++RD  A N+L+ S  + K++DFGLA+     +  + +        + 
Sbjct: 121 GMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
           A E +   R T + DV+S+GV + EL++          G        AKPY G   +   
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT---------FG--------AKPYDGIPAR--E 219

Query: 319 IMDIKLEGQ-YPQ-----KGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPA 370
           I D+  +G+  PQ        YM+ +      SE   RP   E++    ++   RDP+
Sbjct: 220 IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSEC--RPRFRELVDEFSRM--ARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 71/215 (33%), Positives = 94/215 (43%), Gaps = 26/215 (12%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVN 137
           FR  +++G G FG V         L A     G + A+K LK        E    + E  
Sbjct: 1   FRCLAVLGRGHFGKV---------LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR 51

Query: 138 YL---GQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
                    HP LV L   C   E+ +  V EY   G L  H+        P    +  A
Sbjct: 52  IFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRA--VFYA 107

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP-TGDRTHVSTQVM 252
                GL +LHE   +++YRD K  N+LLD+E   K++DFGL K G   GDRT  ST   
Sbjct: 108 ACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FC 162

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  + APE L     T   D +  GV++ E+L G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK---EWLS 134
             NF+ +  IG+G F  VYK         A     G V+A+KK++       K   + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYK---------AICLLDGRVVALKKVQIFEMMDAKARQDCLK 51

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLP----WTL 188
           E++ L QL HPN++K +   ++     +V E    G L   +  F++  R +P    W  
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +++       L  +H   +++++RD K +N+ + +    KL D GL +      +T  +
Sbjct: 112 FVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAA 163

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
             ++GT  Y +PE +       K D++S G +L E+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 71/244 (29%), Positives = 98/244 (40%), Gaps = 55/244 (22%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-----GFQGHKEWLS 134
           +F    +IG G FG V+    D+ T        G V A+K L+           H    +
Sbjct: 2   DFEVIKVIGRGAFGEVWLVR-DKDT--------GQVYAMKVLRKSDMIKRNQIAH--VRA 50

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT----LRI 190
           E + L     P +VKL     D E+  LV EYMP G L N L R+   P          +
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP-TGDRTHVST 249
            +A+ +   L F+H        RD K  NIL+D++ + KL+DFGL K      DR +   
Sbjct: 111 VLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 250 Q--------------------------VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE 283
                                       +GT  Y APE L       +CD +S GV+L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 284 LLSG 287
           +L G
Sbjct: 223 MLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 40/217 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           I EG +G VY+   D+ T        G ++A+KKLK    +  KE      L E+N L +
Sbjct: 13  IEEGTYGVVYRA-RDKKT--------GEIVALKKLK---MEKEKEGFPITSLREINILLK 60

Query: 142 LHHPNLVKL----IGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTL-RIK-V 192
           L HPN+V +    +G  LD     +V EY+    K  +E           P+    +K +
Sbjct: 61  LQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETM-------KQPFLQSEVKCL 111

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            +    G++ LH  +  +++RD K SN+LL++    K+ DFGLA+    G      TQ++
Sbjct: 112 MLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLV 167

Query: 253 GTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
            T  Y APE  L     +   D++S G +  ELL+ +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 70/205 (34%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           IG G FG VY    D    E        V+A+KK+   G Q +++W   + EV +L +L 
Sbjct: 23  IGHGSFGAVYFAR-DVRNSE--------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN ++  G  L      LV EY   GS  + L     +PL       V  GA +GL++L
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEY 262
           H     +I+RD KA NILL      KL DFG A    P       +   +GT  + APE 
Sbjct: 132 HS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEV 182

Query: 263 LAT---GRLTAKCDVYSFGVVLLEL 284
           +     G+   K DV+S G+  +EL
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 74/255 (29%), Positives = 123/255 (48%), Gaps = 32/255 (12%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-LSEVNY 138
           NF+    +GEG +  VYKG  +  T        G ++A+K++  +  +G     + E++ 
Sbjct: 1   NFKQLEKLGEGTYATVYKG-RNRTT--------GEIVALKEIHLDAEEGTPSTAIREISL 51

Query: 139 LGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGAR-PLPWTLRIKVAIGA 196
           + +L H N+V+L    +  EN+L LV+EYM K  L+ ++   G R  L            
Sbjct: 52  MKELKHENIVRLHD-VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            +G++F HE   +V++RD K  N+L++     KL+DFGLA+A      T  +  V  T  
Sbjct: 110 LKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165

Query: 257 YAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
           Y AP+ L   R  +   D++S G ++ E+++G R +       +Q L            K
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLL------------K 212

Query: 316 LFRIMDIKLEGQYPQ 330
           +FRIM    E  +P 
Sbjct: 213 IFRIMGTPTESTWPG 227

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 60/161 (37%), Positives = 85/161 (52%), Gaps = 12/161 (7%)

Query: 143 HHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           +HP LV L   C   E+RL  V EY+  G L  H+ R+  R LP       +   +  L+
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 110

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTRGYAAP 260
           +LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G   GD T   +   GT  Y AP
Sbjct: 111 YLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 165

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
           E L         D ++ GV++ E+++GR   D   VG+  N
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI--VGSSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 19/217 (8%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
           +F    ++G+G FG V         + A R G   + A+K LK +      +    + E 
Sbjct: 1   DFNFLMVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L     P  +  +  C    +RL  V EY+  G L  H+ + G    P  +     I 
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI- 110

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            + GL FLH   + +IYRD K  N++LDSE + K++DFG+ K       T  +    GT 
Sbjct: 111 -SVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTP 165

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD 292
            Y APE +A        D +++GV+L E+L+G+   D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 24/209 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYKG    +         G ++A+KK++     EG       + E++ L +L
Sbjct: 8   IGEGTYGVVYKG---RNKK------TGQIVAMKKIRLESEEEGVPSTA--IREISLLKEL 56

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFR-RGARPLPWTLRIKVAIGAARGL 200
            HPN+V L    +  E+RL L++E++    L+ +L      + +   L         +G+
Sbjct: 57  QHPNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            F H   ++V++RD K  N+L+D++   KL+DFGLA+A   G    V T  + T  Y AP
Sbjct: 115 LFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEVVTLWYRAP 170

Query: 261 EYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           E L  + R +   D++S G +  E+ + +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +  E  +   E +  E+  L Q   P
Sbjct: 12  IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L G    ++ EY+  GS  + L R G  P        +     +GL +LH 
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAG--PFDEFQIATMLKEILKGLDYLHS 119

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 120 EKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175

Query: 266 GRLTAKCDVYSFGVVLLELLSG 287
               +K D++S G+  +EL  G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 37/222 (16%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLG 140
             IGEG +G VYK   D+ T        G ++A+KK++     EGF      + E+  L 
Sbjct: 13  GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFP--ITAIREIKILR 61

Query: 141 QLHHPNLVKL----------IGFCLDGENRLLVYEYMPK---GSLENHLFRRGARPLPWT 187
           QL+H N+V L          + F  D     LV+EYM     G LE+ L       +   
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           ++  +      GL++ H+  +  ++RD K SNILL+++   KL+DFGLA+   + +    
Sbjct: 122 MKQLL-----EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 248 STQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
           + +V+ T  Y  PE  L   R     DV+S G +L EL + +
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQ 141
            ++G+G FG V         + A R G   + A+K LK +      +    + E   L  
Sbjct: 6   MVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56

Query: 142 LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
              P  +  +  C    +RL  V EY+  G L  H+ + G    P  +     I  A GL
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI--AIGL 114

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            FLH   + +IYRD K  N++LD+E + K++DFG+ K    G +T  +    GT  Y AP
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAP 170

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVD 292
           E +A        D ++FGV+L E+L+G+   D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQG-HKEWLSEVNYLGQL 142
           + IGEG +G VYK   D +T        G  +A+KK++ P   +G     L E+  L QL
Sbjct: 5   AEIGEGAYGTVYKA-RDLNT--------GRFVALKKVRVPLSEEGIPLSTLREIALLKQL 55

Query: 143 ---HHPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
               HPN+V+L+  C     D E +L LV+E++ +  L  +L +     LP    IK  +
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLP-PETIKDLM 113

Query: 195 GA-ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
               RG+ FLH    ++++RD K  NIL+ S+   K++DFGLA+           T V+ 
Sbjct: 114 RQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVV 168

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
           T  Y APE L         D++S G +  EL
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 70/206 (33%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQ-L 142
           IG+G FG V           A     G   AVK L+ +     KE    ++E N L + +
Sbjct: 3   IGKGSFGKVL---------LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HP LV L  +     ++L  V +Y+  G L  HL R  + P P        I +A G  
Sbjct: 54  KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG-- 110

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH     +IYRD K  NILLDS+ +  L+DFGL K G    +T  ++   GT  Y APE
Sbjct: 111 YLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPE 166

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSG 287
            L         D +  G VL E+L G
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 76/295 (25%), Positives = 137/295 (46%), Gaps = 50/295 (16%)

Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 65

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L+  I+
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQ 123

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 124 MAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 224

Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ 362
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++++
Sbjct: 225 MSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 51/217 (23%), Positives = 105/217 (48%), Gaps = 19/217 (8%)

Query: 87  IGEGGFGYVY-------KGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNY 138
           +GEG FG V+       + ++D+           +++AVK L+ +  +  + ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR---------GARPLPWTLR 189
           + +L  PN+++L+  C+  +   ++ EYM  G L   L R              + ++  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I +A   A G+ +L  +    ++RD    N L+   +  K++DFG+++   +GD   +  
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           + +    + + E +  G+ T   DV++FGV L E+L+
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V     D+ T        G  +AVKK+     Q  +   +EV  +    HPN
Sbjct: 27  IGEGSTGIVCIAT-DKST--------GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFR-RGARPLPWTLRIKVAIGAARGLSFLHE 205
           +V++    L G+   +V E++  G+L + +   R       T    V +   + LSFLH 
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----VCLAVLKALSFLHA 133

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             Q VI+RD K+ +ILL S+   KLSDFG                ++GT  + APE ++ 
Sbjct: 134 --QGVIHRDIKSDSILLTSDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPEVISR 189

Query: 266 GRLTAKCDVYSFGVVLLELLSG 287
                + D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 78/228 (34%), Positives = 104/228 (45%), Gaps = 29/228 (12%)

Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           L + T  +     IG+G +G VYK               G + AVK L P      +E  
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYK---------VTNKKDGSLAAVKILDPIS-DVDEEIE 66

Query: 134 SEVNYLGQL-HHPNLVKLIGFC-----LDGENRLLVYEYMPKGS---LENHLFRRGARPL 184
           +E N L  L +HPN+VK  G       L G    LV E    GS   L   L   G R L
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-L 125

Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
              +   +  GA  GL  LH    ++I+RD K +NILL +E   KL DFG++ A  T  R
Sbjct: 126 DEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTR 182

Query: 245 THVSTQVMGTRGYAAPEYLATGR-----LTAKCDVYSFGVVLLELLSG 287
              +T V GT  + APE +A  +       A+CDV+S G+  +EL  G
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 62/238 (26%), Positives = 94/238 (39%), Gaps = 46/238 (19%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-----EVNYLGQ 141
           IG G +G VYK               G   A+KK K +  Q     +S     E+  L +
Sbjct: 8   IGRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQY--TGISQSACREIALLRE 58

Query: 142 LHHPNLVKLIGFCLDGENRL--LVYEYMPKGSLE--NHLFRRGARPLPWTLRIKVAI-GA 196
           L H N+V L+   L+  ++   L+++Y      +      +     +P    +K  +   
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP-PSMVKSLLWQI 117

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNA----KLSDFGLA-------KAGPTGDRT 245
             G+ +LH     V++RD K +NIL+  E       K+ D GLA       K     D  
Sbjct: 118 LNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP- 174

Query: 246 HVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLS------GRRAVDKTRV 296
                V+ T  Y APE L   R  T   D+++ G +  ELL+      GR A  K   
Sbjct: 175 -----VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 30/211 (14%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL--KPEGFQGHKEWLSEVNYLGQLH 143
           L+GEG +G V K    E          G ++A+KK     +     K  + E+  L QL 
Sbjct: 8   LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLEN-HLFRRGARPLPWTLRIKVAIGAARGLSF 202
           H NLV LI      +   LV+E++    L++   +  G   L  +   K      RG+ F
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEF 115

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAAP 260
            H     +I+RD K  NIL+      KL DFG A+  A P G+   V T  + TR Y AP
Sbjct: 116 CH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATRWYRAP 169

Query: 261 EYLAT----GRLTAKCDVYSFGVVLLELLSG 287
           E L      GR     D+++ G ++ E+L+G
Sbjct: 170 ELLVGDTKYGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------------PWTLR- 189
            N++ L+G C       ++ EY  KG+L  +L  R  RP                 T + 
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 190 -IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 139 LVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.8 bits (191), Expect = 9e-16
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +   +   + +SE+  +  +  H
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                L +  
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYL--RARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  A   ARG+ +L  A Q+ I+RD  A N+L+  +   K++DFGLA+     D    +
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV+L E+ +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 25/209 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-----LSEVNYLGQ 141
           IGEG +G VYK   D+ T        G ++A+KK++ E      E      + E++ L +
Sbjct: 7   IGEGTYGVVYKA-RDKLT--------GEIVALKKIRLET---EDEGVPSTAIREISLLKE 54

Query: 142 LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           L+HPN+V+L+   +  EN+L LV+E++    L+ ++       L   L         +G+
Sbjct: 55  LNHPNIVRLLDV-VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           ++ H    +V++RD K  N+L+D E   KL+DFGLA+A     RT+  T  + T  Y AP
Sbjct: 113 AYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYRAP 168

Query: 261 EYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           E L   R  +   D++S G +  E+++ R
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 80  NFRPDSLIGEGGFGYVY--KGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
           +      +G G FG V+  +  I EH        +  VI +K+   +     K  L EV+
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEVS 59

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
                 HP +++L     D     ++ EY+P G L ++L  R +     +  +  A    
Sbjct: 60  ------HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIV 111

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
             L +LH   ++++YRD K  NILLD E + KL+DFG AK     DRT     + GT  Y
Sbjct: 112 CALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPEY 164

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE + +       D ++ G+++ E+L G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 29/220 (13%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH----KEWLSEV 136
           +     IG G +G V    +D+ T        G  +A+KK+    F       K  L E+
Sbjct: 2   YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKI-SNVFD-DLIDAKRILREI 50

Query: 137 NYLGQLHHPNLVKLIGFCLDGENR-----LLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
             L  L H N++ L+               +V E M   +  + + +   +PL     I+
Sbjct: 51  KLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSP-QPLT-DDHIQ 106

Query: 192 VAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVST 249
             +    RGL +LH A   VI+RD K SNIL++S  + K+ DFGLA+   P  D     T
Sbjct: 107 YFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 250 QVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
           + + TR Y APE  L++ R T   D++S G +  ELL+ +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 28/224 (12%)

Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH 129
           T   + +  + +     IG+G  G VY          A     G  +A+K++  +  Q  
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYT---------AIDVATGQEVAIKQMNLQQ-QPK 59

Query: 130 KEWL-SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL 188
           KE + +E+  + +  HPN+V  +   L G+   +V EY+  GSL + +          T 
Sbjct: 60  KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TC 111

Query: 189 RIKVAIGAA-----RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
             +  I A      + L FLH    QVI+RD K+ NILL  + + KL+DFG   A  T +
Sbjct: 112 MDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPE 168

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           ++  ST V GT  + APE +       K D++S G++ +E++ G
Sbjct: 169 QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG VYK         A     G+  A K ++ E  +  ++++ E++ L +  HPN
Sbjct: 13  LGDGAFGKVYK---------AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 147 LVKLIGFCLDGENRLLVY-EYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           +V L       EN+L +  E+   G+L++ +     R L       V       L+FLH 
Sbjct: 64  IVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS 121

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              +VI+RD KA NILL  + + KL+DFG+ AK   T  +       +GT  + APE +A
Sbjct: 122 --HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVA 176

Query: 265 --TGRLTA---KCDVYSFGVVLLELLSGR 288
             T +      K D++S G+ L+EL    
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 72/316 (22%), Positives = 122/316 (38%), Gaps = 67/316 (21%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLSEV 136
            ++P   IG G +G V           A     G  +A+KK+ P  F      K  L E+
Sbjct: 6   RYKPIENIGSGAYGVV---------CSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLREL 55

Query: 137 NYLGQLHHPNLVKLIGFCL----DGENRLLVYEYM---------PKGSLENHLFRRGARP 183
             L    H N++ +         D ++  +V + M             L     R     
Sbjct: 56  KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115

Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG- 242
           L             RGL ++H A   VI+RD K SN+L++ +   ++ DFG+A+   +  
Sbjct: 116 L------------LRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161

Query: 243 -DRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAV--DKTRVGA 298
            +  +  T+ + TR Y APE L +    T   D++S G +  E+L GRR +   K  V  
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQ 220

Query: 299 EQNLVDWAKPYLG------------DR-RKLF----RIMDIKLEGQYPQKGAYMVAILAL 341
            + ++      LG            DR RK      R   +     +P+     + +L+ 
Sbjct: 221 LKLILS----VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276

Query: 342 QCISEAKVRPSMSEVL 357
               + + R ++ + L
Sbjct: 277 MLQFDPEERITVEQAL 292

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           IG G FG V  G       +A        + VK+L+          +L EV    +L+HP
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKAR-------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR-RGAR---PLPWTLRIKVAIGAARGLS 201
           N+++ +G C++    LLV E+ P G L+N+L   RG          L+ ++A   A GL 
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ-RMACEVASGLL 114

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH+A+   I+ D    N  L ++ + K+ D+GLA      D             + APE
Sbjct: 115 WLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172

Query: 262 Y-------LATGRLTAKCDVYSFGVVLLEL 284
                   L     T K +++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 56/230 (24%), Positives = 88/230 (38%), Gaps = 28/230 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE----WLSEVNYLGQL 142
           I +G FG VY          A +   G   A+K LK        +           + Q 
Sbjct: 4   ISKGAFGSVYL---------AKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG 54

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
             P + KL       +   LV EY+  G   + +   G  P  W  +    +    G+  
Sbjct: 55  ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV--VLGVED 112

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           LH+  + +I+RD K  N+L+D   + KL+DFGL++ G        + + +GT  Y APE 
Sbjct: 113 LHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPET 164

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGRR-----AVDKTRVGAEQNLVDWAK 307
           +         D +S G V+ E L G         D          ++W +
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/160 (35%), Positives = 81/160 (50%), Gaps = 11/160 (6%)

Query: 150 LIGF--CLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           L+G   C    +RL LV EY+  G L  H+ R+  R LP       A      L+FLHE 
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE- 114

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTRGYAAPEYLAT 265
            + +IYRD K  N+LLD++ + KL+D+G+ K G   GD T   +   GT  Y APE L  
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG 170

Query: 266 GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW 305
                  D ++ GV++ E+++GR   D      + N  D+
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G               + +A+K +  EG    ++++ E   + +L HP 
Sbjct: 12  LGSGQFGVVHLGKWRAQ----------IKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L G C   +   +V E+M  G L N+L +R  +     L + +      G+ +L   
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-LSMCQDVCEGMEYLE-- 117

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEYL 263
               I+RD  A N L+ S    K+SDFG+ +     D  + S+   G +    ++ PE  
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSS--GAKFPVKWSPPEVF 173

Query: 264 ATGRLTAKCDVYSFGVVLLELLS 286
              + ++K DV+SFGV++ E+ +
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 42/218 (19%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGFQGHKE-------WLSEVNY 138
           IGEG +G VY+          AR    G ++A+KK++ +      E        L E+  
Sbjct: 15  IGEGTYGIVYR----------ARDTTSGEIVALKKVRMD-----NERDGIPISSLREITL 59

Query: 139 LGQLHHPNLVKL----IGFCLDGENRLLVYEYMPK--GSLENHLFRRGARPLPWTLRIK- 191
           L  L HPN+V+L    +G  LD  +  LV EY  +   SL +++      P     ++K 
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNM----PTPFS-ESQVKC 112

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           + +   RGL +LHE    +I+RD K SN+LL  +   K++DFGLA+    G      T  
Sbjct: 113 LMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPK 168

Query: 252 MGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           + T  Y APE L      T   D+++ G +L ELL+ +
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 21/215 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL--KPEGFQGHKEWLS--- 134
           N+R   L+G G FG VY  + D  T        G  +AVK++   P+  +  KE  +   
Sbjct: 3   NWRLGKLLGRGAFGEVYLCY-DADT--------GRELAVKQVPFDPDSQETSKEVNALEC 53

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           E+  L  L H  +V+  G   D E + L    EYMP GS+++ L   GA     T R   
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ-V 251
            I   +G+S+LH     +++RD K +NIL DS  N KL DFG +K   T   +    + V
Sbjct: 114 QI--LQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            GT  + +PE ++      K DV+S    ++E+L+
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 53/151 (35%), Positives = 74/151 (49%), Gaps = 18/151 (11%)

Query: 144 HPNLVKLIGFCL--DGENRLLVYEYMPKGSLENHLFRRG----ARPLPWTLRIKVAIGAA 197
           HP L  L  FC     E+   V EY+  G L  H+   G    AR   +   I       
Sbjct: 55  HPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC----- 107

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            GL FLH+  + +IYRD K  N+LLD + + K++DFG+ K    G+    ++   GT  Y
Sbjct: 108 -GLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            APE L   +     D +SFGV+L E+L G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLG-Q 141
           ++G+G FG V         + A   G   V A+K LK +      +    ++E   L   
Sbjct: 2   VLGKGSFGKV---------MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52

Query: 142 LHHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
             HP L  L   C   ++RL  V EY+  G L   + R  +R          A      L
Sbjct: 53  AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLAL 109

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            FLH     VIYRD K  NILLD+E + KL+DFG+ K G     T  +T   GT  Y AP
Sbjct: 110 MFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAP 165

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L         D ++ GV++ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQLHHP 145
           +G G FG V KG    + +   +  V    A+K LK E  +    E + E   + QL +P
Sbjct: 3   LGSGNFGCVKKG---VYKMRKKQIDV----AIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR-PLPWTLRIKVAIGAARGLSFLH 204
            +V++IG C + E  +LV E    G L  + F  G +  +  +  +++    + G+ +L 
Sbjct: 56  YIVRMIGVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT--RGYAAPEY 262
              +  ++RD  A N+LL ++  AK+SDFGL+KA    D ++   +  G     + APE 
Sbjct: 113 G--KNFVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLKWYAPEC 169

Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           +   + +++ DV+S+G+ + E  S
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +  E  +   E +  E+  L Q   P
Sbjct: 12  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L      ++ EY+  GS  + L   G  PL  T    +     +GL +LH 
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 119

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL      KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 266 GRLTAKCDVYSFGVVLLELLSG 287
               +K D++S G+  +EL  G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 36/215 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYK   D  T E         IA+KK++     EG       + E++ L ++
Sbjct: 10  IGEGTYGVVYKAR-DRVTNE--------TIALKKIRLEQEDEGVPSTA--IREISLLKEM 58

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHL-----FRRGARPLPWTLRIKVAI-G 195
            H N+V+L    +  E RL LV+EY+    L+ H+     F +  R       IK  +  
Sbjct: 59  QHGNIVRLQD-VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPR------LIKTYLYQ 110

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 254
             RG+++ H    +V++RD K  N+L+D   NA KL+DFGLA+A     RT   T  + T
Sbjct: 111 ILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVT 166

Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGR 288
             Y APE L   R  +   D++S G +  E+++ +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 45/223 (20%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLSEVNYLGQ 141
           S IGEG +G V      + T        G+ +A+KK+ P  F+     +  L E+  L +
Sbjct: 11  SYIGEGAYGMVCSA-THKPT--------GVKVAIKKISP--FEHQTFCQRTLREIKILRR 59

Query: 142 LHHPNLVKL--IGFCLDGENRLLVY---EYMPKGSLENHLFRRGARPLPWTLR------- 189
             H N++ +  I      E+   VY   E M     E  L++         ++       
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYK--------LIKTQHLSND 106

Query: 190 -IKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTH 246
            I+  +    RGL ++H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T 
Sbjct: 107 HIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164

Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKC-DVYSFGVVLLELLSGR 288
             T+ + TR Y APE +   +   K  D++S G +L E+LS R
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 68/215 (31%), Positives = 91/215 (42%), Gaps = 35/215 (16%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP---------EGFQGHKEWLSEV 136
           ++G+G FG V+          A   G     A+K LK          E     K  LS  
Sbjct: 2   MLGKGSFGKVFL---------AELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
                  HP L  L       EN   V EY+  G L  H+       LP     +    A
Sbjct: 53  -----WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----RATFYA 102

Query: 197 AR---GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           A    GL FLH   + ++YRD K  NILLD++ + K++DFG+ K    GD    +    G
Sbjct: 103 AEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCG 158

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y APE L   +     D +SFGV+L E+L G+
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 8e-15
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 26/206 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G V+          A     G  +A+K++  +     +  ++E+  + +L +PN
Sbjct: 27  IGQGASGTVFT---------AIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALE 129

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH    QVI+RD K+ N+LL  + + KL+DFG   A  T +++  ST V GT  + APE
Sbjct: 130 FLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPE 185

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSG 287
            +       K D++S G++ +E++ G
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 69/221 (31%), Positives = 117/221 (52%), Gaps = 27/221 (12%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K         + +P  G+++A K    ++KP     
Sbjct: 1   ELKD--DDFEKISELGAGNGGVVFK--------VSHKPS-GLIMARKLIHLEIKP---AI 46

Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 103

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 104 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 158

Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 26/205 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +G G  G VYK         A       ++AVK +  +   +  K+ +SE+  L +   P
Sbjct: 9   LGHGNGGTVYK---------AYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59

Query: 146 NLVKLIG-FCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
            ++   G F +  ENR+ +  E+M  GSL+ +      R +P  +  ++A+   +GL++L
Sbjct: 60  YIIGFYGAFFV--ENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYL 111

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
                ++++RD K SN+L+++    KL DFG++    T     ++   +GT  Y APE +
Sbjct: 112 WSL--KILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERI 165

Query: 264 ATGRLTAKCDVYSFGVVLLELLSGR 288
           +  +     DV+S G+  +EL  GR
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 21/215 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +GE  FG VYKG    H    A       +A+K LK +      +E+  E     +L HP
Sbjct: 13  LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA----------RPLPWTLR----IK 191
           N+V L+G     +   +++ Y     L   L  R            + +  TL     + 
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +    A G+ FL  +   V+++D    N+L+  + N K+SD GL +     D   +    
Sbjct: 129 IVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +    + +PE +  G+ +   D++S+GVVL E+ S
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 41/214 (19%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY-------L 139
           +G+GG+G V+          A +   G ++A+K++K          L+EV +       L
Sbjct: 9   VGQGGYGQVFL---------AKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVA 193
                  LVKL+    D E   L  EY+P G     L   G      AR   +   +  A
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF--YMAEMFEA 113

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           + A   L ++H        RD K  N L+D+  + KL+DFGL+K   T      +  V+G
Sbjct: 114 VDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVG 160

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           +  Y APE L         D +S G +L E L G
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 19/211 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G   +  +          +AVK + +    +   E+L+E + +      
Sbjct: 14  LGQGSFGMVYEGNARD--IIKGEAETR--VAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 128 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + APE L  G  T   D++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 72/210 (34%), Positives = 92/210 (43%), Gaps = 27/210 (12%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVN-YLGQ 141
           +IG+G FG V         L A R   G   AVK L+ +     KE    ++E N  L  
Sbjct: 2   VIGKGSFGKV---------LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR----RGARPLPWTLRIKVAIGAA 197
           L HP LV L       E    V +Y+  G L  HL R       R   +   +  AIG  
Sbjct: 53  LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG-- 110

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
               +LH     +IYRD K  NILLDS+ +  L+DFGL K G   + T  ++   GT  Y
Sbjct: 111 ----YLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEY 162

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE L         D +  G VL E+L G
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 46/131 (35%), Positives = 64/131 (48%), Gaps = 13/131 (9%)

Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA-ARGLSFLHEAEQQVIYRDFKASNI 220
           L+ +Y+  G L  HL++R          ++V I      L  LH+    +IYRD K  NI
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLHQ--LGIIYRDIKLENI 136

Query: 221 LLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAAPEYLATGRL--TAKCDVYS 276
           LLDSE +  L+DFGL+K       +R +      GT  Y APE +  G        D +S
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193

Query: 277 FGVVLLELLSG 287
            GV+  ELL+G
Sbjct: 194 LGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQLH 143
           +G G FG V           A   G G   A+K LK       K+      E + L +L 
Sbjct: 26  LGTGSFGRVRI---------AKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA--IGAARGL 200
           HP +V ++    D ENR+  + E++  G L  HL + G  P        VA    A   L
Sbjct: 77  HPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHLRKAGRFP------NDVAKFYHAELVL 129

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           +F +   + +IYRD K  N+LLD++ + K++DFG AK  P  DRT     + GT  Y AP
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAP 184

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E + +       D ++ GV+L E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 34/223 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 26  LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                L +  
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+ 
Sbjct: 142 LVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 194

Query: 249 TQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVN 137
           FR   ++G+GGFG V    +            G + A KKL+ +  +   G    L+E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52

Query: 138 YLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L +++   +V L  +  + ++ L LV   M  G L+ H++  G         +  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
             GL  LH+  ++++YRD K  NILLD   + ++SD GLA   P G    +  +V GT G
Sbjct: 112 CCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +   R T   D ++ G +L E+++G+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 70/207 (33%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVN-YLGQ 141
           +IG+G FG V         L A R   G   AVK L+ +     KE    ++E N  L  
Sbjct: 2   VIGKGSFGKV---------LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA-ARGL 200
           + HP LV L       E    V +++  G L  HL R  + P P   R +      A  L
Sbjct: 53  VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH     ++YRD K  NILLDS+ +  L+DFGL K G     T  +T   GT  Y AP
Sbjct: 110 GYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAP 165

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E +         D +  G VL E+L G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HH 144
           +GEG FG V +   + + ++ +RP   + +AVK LK     +   + +SE+  +  +  H
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L   L  R  RP                L +  
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFL--RARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  A   ARG+ +L    ++ I+RD  A N+L+  +   K++DFGLA+     D    +
Sbjct: 136 LVSCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +       + APE L     T + DV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 22/211 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
            IG G FG V K               G ++AVK+++     +  K  L +++ + +   
Sbjct: 11  EIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 145 -PNLVKLIGFCLDGENRLLVYEYMPKGSLEN---HLFRRGARPLPWTLRIKVAIGAARGL 200
            P +VK  G      +  +  E M   SL+    +++      +P  +  K+A+   + L
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           ++L E E ++I+RD K SNILLD   N KL DFG+  +G   D     T+  G R Y AP
Sbjct: 121 NYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSI-AKTRDAGCRPYMAP 176

Query: 261 EYLATGRLTA---KCDVYSFGVVLLELLSGR 288
           E +          + DV+S G+ L E+ +G+
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 31/225 (13%)

Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           T  E+ N   + +P   +G G FG V     D+ T        G  +A+KK+ KP  F  
Sbjct: 4   TVFEITNRYVDLQP---VGMGAFGLVCSAR-DQLT--------GQNVAIKKIMKP--FST 49

Query: 129 ---HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPL 184
               K    E+  L  L H N++ L   F    E+   V E +  G+  + L    +RPL
Sbjct: 50  PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT--SRPL 105

Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
                        RGL ++H A   V++RD K SNIL++   + K+ DFGLA+      +
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARI-----Q 158

Query: 245 THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGR 288
               T  + TR Y APE + T  +   + D++S G +  E+L G+
Sbjct: 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 65/207 (31%), Positives = 86/207 (41%), Gaps = 20/207 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           L+G+G FG V         +       G   A+K LK E      E    L+E   L   
Sbjct: 2   LLGKGTFGKV---------ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HP L  L  +     +RL  V EY   G L  HL R               I +A  L 
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LG 109

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH     V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y APE
Sbjct: 110 YLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE 165

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            L         D +  GVV+ E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLH 143
             IG G  G VYK               G V+AVK+++  G  + +K  L +++ + + H
Sbjct: 21  GEIGSGTCGQVYK---------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH 71

Query: 144 H-PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
             P +VK  G+ +   +  +  E M   +  + L +R   P+P  +  K+ +   + L +
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           L E +  VI+RD K SNILLD+  N KL DFG+  +G   D +   T+  G   Y APE 
Sbjct: 130 LKE-KHGVIHRDVKPSNILLDASGNVKLCDFGI--SGRLVD-SKAKTRSAGCAAYMAPER 185

Query: 263 L----ATGRLTAKCDVYSFGVVLLELLSGR 288
           +       +   + DV+S G+ L+EL +G+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 24/209 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G V+K   +  T E        ++A+K+++     EG       L E+  L +L
Sbjct: 8   IGEGTYGTVFKA-KNRETHE--------IVALKRVRLDDDDEGVPSSA--LREICLLKEL 56

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            H N+V+L    L  + +L LV+EY  +  L+ +         P  ++        +GL+
Sbjct: 57  KHKNIVRLYD-VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVK-SFMFQLLKGLA 113

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           F H     V++RD K  N+L++     KL+DFGLA+A     R + S +V+ T  Y  P+
Sbjct: 114 FCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPPD 169

Query: 262 YLATGRL-TAKCDVYSFGVVLLELLSGRR 289
            L   +L +   D++S G +  EL +  R
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 82/318 (25%), Positives = 131/318 (41%), Gaps = 49/318 (15%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL----- 133
           + +   + IGEG +G V+K           + G G  +A+K+++    Q  +E +     
Sbjct: 1   QQYECVAEIGEGAYGKVFKA-------RDLKNG-GRFVALKRVR---VQTGEEGMPLSTI 49

Query: 134 SEVNYLGQLH---HPNLVKLIGFCL----DGENRL-LVYEYMPKGSLENHLFRRGARPLP 185
            EV  L  L    HPN+V+L   C     D E +L LV+E++ +  L  +L +     +P
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108

Query: 186 WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT 245
                 +     RGL FLH    +V++RD K  NIL+ S    KL+DFGLA+        
Sbjct: 109 TETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 163

Query: 246 HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW 305
              T V+ T  Y APE L         D++S G +  E+   R+ + +     +Q     
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ----- 217

Query: 306 AKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISE-AKVRPSMSE-----VLSA 359
               LG   K+  ++ +  E  +P+  A        +      K    + E     +L  
Sbjct: 218 ----LG---KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 270

Query: 360 LEQLPPPRDPASPSNSDP 377
           L   P  R  A  + S P
Sbjct: 271 LTFNPAKRISAYSALSHP 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           ++G+G FG V    + E          G + AVK LK +      +    ++E   L   
Sbjct: 2   VLGKGSFGKVMLARLKES---------GRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52

Query: 143 H-HPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHL--FRR--GARPLPWTLRIKVAIGA 196
             HP L +L   C    +RL  V E++  G L  H+   RR   AR   +   I  A   
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--- 108

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
              L FLH+  + +IYRD K  N+LLD E + KL+DFG+ K G    +T  ++   GT  
Sbjct: 109 ---LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPD 161

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           Y APE L         D ++ GV+L E+L G
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 50/148 (33%), Positives = 73/148 (49%), Gaps = 12/148 (8%)

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR---GL 200
           +P L  L       E+   V E++  G L  H+  +G   L      +    AA    GL
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGL 109

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            FLH   + +IYRD K  N++LD + + K++DFG+ K    GD    ++   GT  Y AP
Sbjct: 110 QFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAP 165

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L   + T   D +SFGV+L E+L G+
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 24/209 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           L+G+G FG V         +       G   A+K L+ E      E    ++E   L   
Sbjct: 2   LLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA--ARG 199
            HP L  L  +     +RL  V EY   G L  HL    +R   +T       GA     
Sbjct: 53  RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSA 107

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y A
Sbjct: 108 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L         D +  GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 36/255 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEV 136
           NFR +  IG G F  VY+         A     G+ +A+KK++       +   + + E+
Sbjct: 3   NFRIEKKIGRGQFSEVYR---------ATCLLDGVPVALKKVQIFDLMDAKARADCIKEI 53

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAI 194
           + L QL+HPN++K     ++     +V E    G L   +  F++  R +P     K  +
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
                L  +H   ++V++RD K +N+ + +    KL D GL +   +  +T  +  ++GT
Sbjct: 114 QLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR 314
             Y +PE +       K D++S G +L E+             A Q+      P+ GD+ 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKM 211

Query: 315 KLFRIMDIKLEGQYP 329
            L+ +     +  YP
Sbjct: 212 NLYSLCKKIEQCDYP 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           ++G+G FG V         + A R G   + A+K LK +      +    + E   L   
Sbjct: 7   VLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             P  +  +  C    +RL  V EY+  G L   + + G    P  +     I  A GL 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI--AIGLF 115

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH   + +IYRD K  N++LDSE + K++DFG+ K       T  +    GT  Y APE
Sbjct: 116 FLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPE 171

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +A        D ++FGV+L E+L+G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 74/250 (29%), Positives = 117/250 (46%), Gaps = 35/250 (14%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS--EVNYLGQLH 143
           ++G+G FG V+         +   P  G + A+K LK    +      +  E + L +++
Sbjct: 3   VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLR-IKVAIGA-ARGL 200
           HP +VKL  +    E +L L+ +++  G L    F R ++ + +T   +K  +   A  L
Sbjct: 57  HPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
             LH     +IYRD K  NILLD E + KL+DFGL+K     ++   S    GT  Y AP
Sbjct: 112 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 167

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR------------RAVDKTRVGAEQNLVDWAKP 308
           E +     T   D +SFGV++ E+L+G               + K ++G  Q L   A+ 
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 309 YLGDRRKLFR 318
            L   R LF+
Sbjct: 228 LL---RALFK 234

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 32/209 (15%)

Query: 87  IGEGGFGYVY--KGWID-EHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           IGEG FG +Y  K   D EH           VI    L     +  +    EV  L ++ 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHC----------VIKEIDLTKMPVKEKEASKKEVILLAKMK 57

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFR-RGA-----RPLPWTLRIKVAIGA 196
           HPN+V           RL +V EY   G L   + R RG      + L W ++I      
Sbjct: 58  HPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------ 110

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           + GL  +H+  +++++RD K+ NI L      AKL DFG+A+     D   ++   +GT 
Sbjct: 111 SLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTP 166

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
            Y +PE         K D++S G VL EL
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 66/207 (31%), Positives = 91/207 (43%), Gaps = 20/207 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           L+G+G FG V         +       G   A+K LK E      E    L+E   L   
Sbjct: 2   LLGKGTFGKV---------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HP L  L  +    ++RL  V EY+  G L  HL R        T      I +A  L 
Sbjct: 53  RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LD 109

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH    +++YRD K  N++LD + + K++DFGL K G T   T  +    GT  Y APE
Sbjct: 110 YLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            L         D +  GVV+ E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYL---G 140
           IG+G FG VY         +  +     + A+K L  +     KE    + E N L    
Sbjct: 1   IGKGTFGQVY---------QVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51

Query: 141 QLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
               P +V L  F    ++ L LV +YM  G L  HL + G        R K  I A   
Sbjct: 52  LDESPFIVGL-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYI-AELV 106

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L+  H  +  ++YRD K  NILLD+  +  L DFGL+KA  T ++T  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 260 PEYLATGR-LTAKCDVYSFGVVLLELLSG 287
           PE L   +  T   D +S GV++ E+  G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 41/219 (18%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMV-IAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
           ++G+G +G VY          AAR     V IA+K++     +  +    E+     L H
Sbjct: 15  VLGKGTYGIVY----------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH 64

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP--------WTLRIKVAIGA 196
            N+V+ +G   +     +  E +P GSL   L R    PL         +T +I      
Sbjct: 65  RNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQI------ 117

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFG----LAKAGPTGDRTHVSTQV 251
             GL +LH  + Q+++RD K  N+L+++     K+SDFG    LA   P       +   
Sbjct: 118 LEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETF 169

Query: 252 MGTRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGR 288
            GT  Y APE +  G     A  D++S G  ++E+ +G+
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 19/212 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVN 137
           FR   ++G+GGFG V    +            G + A K+L+ +  +   G    L+E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52

Query: 138 YLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L +++   +V L  +  + ++ L LV   M  G L+ H++  G         +  A   
Sbjct: 53  ILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
             GL  LH   +  +YRD K  NILLD   + ++SD GLA   P G+        +GT G
Sbjct: 112 LCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVG 166

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE L   R T   D +  G ++ E++ G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG VYK         A     G++ A K +  +  +  ++++ E++ L    HPN
Sbjct: 13  LGDGAFGKVYK---------AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +VKL+       N  ++ E+   G+++  +     RPL       V       L++LHE 
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE- 121

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTRGYAAPEYL-- 263
             ++I+RD KA NIL   + + KL+DFG+ AK   T  R       +GT  + APE +  
Sbjct: 122 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVMC 177

Query: 264 ATGR---LTAKCDVYSFGVVLLEL 284
            T +      K DV+S G+ L+E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 31/229 (13%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS---EVNYLGQL 142
           +G+G F  +YKG    +  L+   PG  + + +K L       H++ L+     + + QL
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-LPWTLRIKVAIGAARGLS 201
            H +LVKL G C+  EN ++V EY+  G L+  L R      L W L   VA   A  L 
Sbjct: 59  SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALH 115

Query: 202 FLHEAEQQVIYRDFKASNILL----DSEFN---AKLSDFGLAK-AGPTGDRTHVSTQVMG 253
           +L   ++++++ +    NIL+     +E      KLSD G+        +R      +  
Sbjct: 116 YLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI-- 171

Query: 254 TRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ 300
                APE +  G+  LT   D +SFG  LLE+ S       T   +E+
Sbjct: 172 -----APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-LSEVNYLGQLH 143
           L+ EG FG ++ G  IDE      +PG    + VK +K    +      L E   L  L 
Sbjct: 13  LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66

Query: 144 HPNLVKLIGFCL-DGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLR----IKVAIGA 196
           H N++ ++  C+ DGE   ++Y YM  G+L+  L   R G    P  L     + +AI  
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPT-----GDRTHVSTQ 250
           A G+S+LH+    VI++D  A N ++D E   K++D  L++   P      GD  +   +
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            M      A E L     ++  DV+SFGV+L EL++
Sbjct: 185 WM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 74/235 (31%), Positives = 103/235 (43%), Gaps = 29/235 (12%)

Query: 67  KAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF 126
           K   F    + +  +     IG+G +G V+K               G   AVK L P   
Sbjct: 6   KTIIFDSFPDPSDTWEIIETIGKGTYGKVFK---------VLNKKNGSKAAVKILDPI-H 55

Query: 127 QGHKEWLSEVNYLGQLH-HPNLVKLIGF-----CLDGENRLLVYEYMPKGS---LENHLF 177
              +E  +E N L  L  HPN+VK  G        +G+   LV E    GS   L     
Sbjct: 56  DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115

Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           +RG R +   +   +   A  GL  LH    + I+RD K +NILL +E   KL DFG++ 
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVS- 171

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGR-----LTAKCDVYSFGVVLLELLSG 287
           A  T  R   +T V GT  + APE +A  +       A+CDV+S G+  +EL  G
Sbjct: 172 AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 32/215 (14%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------QGHKEWLSEVNY 138
            ++G+GG+G V++        +      G + A+K LK            H +  +E N 
Sbjct: 2   KVLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53

Query: 139 LGQLHHPNLVKLI-GFCLDGENRLLVYEYMPKGSLENHLFRRGA----RPLPWTLRIKVA 193
           L  + HP +V LI  F   G+   L+ EY+  G L  HL R G         +   I +A
Sbjct: 54  LEAVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG-PTGDRTHVSTQVM 252
           +         H  +Q +IYRD K  NILLD++ + KL+DFGL K     G  TH      
Sbjct: 113 LE--------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FC 161

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE L         D +S G ++ ++L+G
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 66/207 (31%), Positives = 89/207 (42%), Gaps = 19/207 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           L+G+G FG V         +       G   A+K LK E      E    L+E   L   
Sbjct: 2   LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HP L  L  +     +RL  V EY   G L  HL R               I +A  L 
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LD 109

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y APE
Sbjct: 110 YLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 166

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            L         D +  GVV+ E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL---- 142
           IGEG F  V K    +          G   A+K +K + F+     L +VN L ++    
Sbjct: 7   IGEGTFSEVLKA---QSRKT------GKYYAIKCMK-KHFKS----LEQVNNLREIQALR 52

Query: 143 ---HHPNLVKLIGFCLDGE-NRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI-GA 196
               HPN+++LI    D +  RL LV+E M     E  L +   RPLP   R+K  +   
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLP-EKRVKSYMYQL 109

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            + L  +H     + +RD K  NIL+  +   KL+DFG  +           T+ + TR 
Sbjct: 110 LKSLDHMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRW 163

Query: 257 YAAPEYLAT-GRLTAKCDVYSFGVVLLELLS 286
           Y APE L T G    K D+++ G V  E+LS
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 32/209 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V     ++HT        G  +AVKK+     Q  +   +EV  +   HH N
Sbjct: 30  IGEGSTGIVCIA-TEKHT--------GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V +    L G+   +V E++  G+L + +   R     +       V +   R LS+LH
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH 135

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTRGYA 258
              Q VI+RD K+ +ILL S+   KLSDFG            VS +V      +GT  + 
Sbjct: 136 N--QGVIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKSLVGTPYWM 185

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           APE ++      + D++S G++++E++ G
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 19/228 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVN 137
           FR   ++G+GGFG V    +            G + A KKL+ +  +   G    L+E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52

Query: 138 YLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L +++   +V L  +  + ++ L LV   M  G L+ H++  G         I  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL 111

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
             GL  L    ++++YRD K  NILLD   + ++SD GLA   P G+   V  +V GT G
Sbjct: 112 CCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVG 166

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD 304
           Y APE +   + T   D +  G ++ E++ G+    K +   ++  VD
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 68.6 bits (167), Expect = 7e-13
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A+K++  +     +  ++E+  + +  +PN
Sbjct: 27  IGQGASGTVYT---------AIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALD 129

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH    QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  + APE
Sbjct: 130 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPE 185

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSG 287
            +       K D++S G++ +E++ G
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 44/220 (20%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL------KPEGFQGHKEWLSEVNYLG 140
           +G+GGFG V                 G + A KKL      K +G++G    + E   L 
Sbjct: 1   LGKGGFGEVSA---------CQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILA 48

Query: 141 QLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFR--------RGARPLPWTLRIK 191
           ++H   +V L  +    +  L LV   M  G L  H++            R   +T +I 
Sbjct: 49  KVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI- 106

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAGPTGDRTHVS 248
                  GL  LH+  +++IYRD K  N+LLD++ N ++SD GLA   K G +  + +  
Sbjct: 107 -----ISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA- 158

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT G+ APE L         D ++ GV L E+++ R
Sbjct: 159 ----GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVN 137
           FR   ++G+GGFG V    +            G + A KKL+ +  +   G    L+E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52

Query: 138 YLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L +++   +V L  +  + ++ L LV   M  G L+ H++  G         +  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
             GL  LH   ++++YRD K  NILLD   + ++SD GLA   P G+   +  +V GT G
Sbjct: 112 TCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVG 166

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +   R T   D +  G ++ E++ G+
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 27/207 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG VYK         A     G + A K ++ +  +  ++++ E+  L   +HP 
Sbjct: 20  LGDGAFGKVYK---------AKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 147 LVKLIG-FCLDGENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFL 203
           +VKL+G F  DG+  +++ E+ P G+++  +    RG       +  +  + A   L +L
Sbjct: 71  IVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA---LQYL 126

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           H    ++I+RD KA N+LL  + + KL+DFG+ AK   T  R       +GT  + APE 
Sbjct: 127 HS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEV 181

Query: 263 LATGRLTA-----KCDVYSFGVVLLEL 284
           +    +       K D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 7/154 (4%)

Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L E   L  ++HP+++++    + G    +V  +     L  +L +R +RPLP    + +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALII 162

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
                 GL +LH   Q++I+RD K  NI ++      + D G A+  P      +   + 
Sbjct: 163 EKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LA 217

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           GT    APE LA  +  +K D++S G+VL E+L+
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 27/216 (12%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHK-EWLSEVNY 138
           + P + IG G +G VYK         A  P  G  +A+K ++      G     + EV  
Sbjct: 2   YEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL 52

Query: 139 LGQLH---HPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
           L +L    HPN+V+L+  C     D E ++ LV+E++ +  L  +L +     LP     
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK 111

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS-T 249
            +     RGL FLH     +++RD K  NIL+ S    KL+DFGLA+         ++ T
Sbjct: 112 DLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALT 165

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
            V+ T  Y APE L         D++S G +  E+ 
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 28/207 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 28  IGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALE 130

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTRGYAAP 260
           FLH    QVI+RD K+ NILL  + + KL+DFG  A+  P   +    + ++GT  + AP
Sbjct: 131 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 185

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E +       K D++S G++ +E++ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL---KPEGFQGHKE-------WLSE 135
            +G G FG VYK  + +            ++A+K++    P   +  +E        +SE
Sbjct: 7   HLGSGAFGCVYK--VRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 136 VNYLG-QLHHPNLVKLIGFCLDGENRLLVYEYM---PKGSLENHLFRRGAR---PLPWTL 188
           V  +  QL HPN+V+     L+ +   +V + +   P G   N L  +  R      W +
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +++ +     L +LH+ E+++++RD   +NI+L  +    ++DFGLAK           
Sbjct: 119 FVQMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKL 170

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
           T V+GT  Y+ PE +       K DV++FG +L ++
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 19/214 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLSEVN 137
             PD  IG G FG V+             P  G  +A+KK+ P  FQ     K    E+ 
Sbjct: 2   VEPDRPIGYGAFGVVW---------SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELK 51

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL-RIKVAI-G 195
            L    H N++  +              Y+    +++ L +    P P +   +KV +  
Sbjct: 52  MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ 111

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
             RGL +LH A   +++RD K  N+L++S    K+ DFGLA+     +  H++ +V+ T+
Sbjct: 112 ILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQ 168

Query: 256 GYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGR 288
            Y APE L   R  T+  D++S G +  ELL  R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 65/209 (31%), Positives = 93/209 (44%), Gaps = 28/209 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQLH 143
           IG+G FG V         ++  +     + A+K ++        E    L+E   L Q++
Sbjct: 1   IGKGSFGKV---------MQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN 51

Query: 144 HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRG----ARPLPWTLRIKVAIGAAR 198
            P +V L  F      +L LV  ++  G L +HL R G    +R   +T  +  A     
Sbjct: 52  CPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA----- 105

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            L  LH+    VIYRD K  NILLD + +  L DFGL K     D    +    GT  Y 
Sbjct: 106 -LENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYL 160

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           APE L     T   D ++ GV+L E+L+G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 36/226 (15%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS---- 134
           ++F   SL+G G FG V      +   E A    G + A+K +K       +E +S    
Sbjct: 1   KDFDVKSLVGRGHFGEV------QVVREKA---TGDIYAMKVMKKSVL-LAQETVSFFEE 50

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL------ 188
           E + L   + P + +L     D +N  LV EY P G L + L  R        +      
Sbjct: 51  ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA 109

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            + +AI +   + ++H        RD K  N+L+D   + KL+DFG A A  T ++   S
Sbjct: 110 ELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNS 160

Query: 249 TQVMGTRGYAAPEYLAT------GRLTAKCDVYSFGVVLLELLSGR 288
              +GT  Y APE L T      G    +CD +S GV+  E++ GR
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY    D+  +   R  V   I V +L P E  Q ++E       L +L HP
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHP 62

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIGAARGLSFL 203
            +VK     L+ +   ++ EY     L+  L   +   + L      +  I    G+ ++
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H+  +++++RD KA NI L +    K+ DFG+++         ++T   GT  Y +PE L
Sbjct: 123 HQ--RRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177

Query: 264 ATGRLTAKCDVYSFGVVLLEL 284
                 +K D++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 63/293 (21%), Positives = 123/293 (41%), Gaps = 39/293 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKG--WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
           NF+ +  IG G F  VY+    +D   +   +  +  ++  K          ++ + E++
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--------ARQDCVKEID 54

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIG 195
            L QL+HPN++K +   ++     +V E    G L   +  F++  R +P     K  + 
Sbjct: 55  LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
               +  +H   ++V++RD K +N+ + +    KL D GL +   +  +T  +  ++GT 
Sbjct: 115 LCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTP 170

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            Y +PE +       K D++S G +L E+ +                     P+ GD+  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA------------------LQSPFYGDKMN 212

Query: 316 LFRIMDIKLEGQYP----QKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           LF +     +  YP    +  +  +  L   CI  +   RP +  V    +Q+
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 30/245 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHP 145
           +GEG +  V+KG                ++A+K+++ E  +G     + EV+ L  L H 
Sbjct: 13  LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V L           LV+EY+    L+ +L   G       ++I       RGLS+ H+
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK 121

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE-YLA 264
             +++++RD K  N+L++ +   KL+DFGLA+A     +T+ S +V+ T  Y  P+  L 
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLG 177

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKL 324
           +   +   D++  G +L E+ +GR     + V  E +L+             FR++    
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI-------------FRLLGTPT 224

Query: 325 EGQYP 329
           E  +P
Sbjct: 225 EETWP 229

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 24/223 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNY-LGQLHH 144
           +G G +G V K               G ++AVK+++     Q  K  L +++  +  +  
Sbjct: 9   LGRGAYGVVDK---------MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLEN---HLFRRGARPLPWTLRIKVAIGAARGLS 201
           P  V   G  L  E  + +   +   SL+     ++ +G   +P  +  K+A+   + L 
Sbjct: 60  PYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLT-IPEDILGKIAVSIVKALE 117

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH  +  VI+RD K SN+L++     KL DFG+  +G   D +   T   G + Y APE
Sbjct: 118 YLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVD-SVAKTIDAGCKPYMAPE 173

Query: 262 YLATGRLTA----KCDVYSFGVVLLELLSGRRAVDKTRVGAEQ 300
            +           K DV+S G+ ++EL +GR   D  +   +Q
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 19/149 (12%)

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP----WTLRIKVAIGAARGL 200
           PN+V L  + +  ++  LV ++   G L +H+ +    P      W   + VA+ A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG-LAKAGPTGDRTHVSTQVMGTRGYAA 259
             LH   + ++ RD   +NILLD   + +L+ F   ++   + D   V         Y A
Sbjct: 101 --LHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------NMYCA 150

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE       T  CD +S G +L ELL+G+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 42/241 (17%)

Query: 76  NATRNFRP-DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHK 130
           + +  +    + +GEG +G V K   D  T        G ++A+KK+K           +
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDVTKDR 55

Query: 131 EW----------LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG 180
           +           L E+  + ++ H N++ L+   ++G+   LV + M    L+  + R+ 
Sbjct: 56  QLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI 114

Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--- 237
                    I + I    GL+ LH+     ++RD   +NI ++S+   K++DFGLA+   
Sbjct: 115 RLTESQVKCILLQI--LNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADFGLARRYG 170

Query: 238 ----AGPTGDRTHVS-----TQVMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSG 287
               +        +      T  + T  Y APE L    +     D++S G +  ELL+G
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Query: 288 R 288
           +
Sbjct: 231 K 231

Length = 335

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V           A     G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 28  IGEGSTGIV---------CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L G+   +V E++  G+L + +   R     +       V +   + LS LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL  +   KLSDFG                ++GT  + APE ++
Sbjct: 134 A--QGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPELIS 189

Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 69/207 (33%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVN-YLGQ 141
           +IG+G FG V         L A         AVK L+ +     KE    +SE N  L  
Sbjct: 2   VIGKGSFGKV---------LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 52

Query: 142 LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           + HP LV L  F     ++L  V +Y+  G L  HL R      P        I +A  L
Sbjct: 53  VKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--L 109

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH     ++YRD K  NILLDS+ +  L+DFGL K     + T  ++   GT  Y AP
Sbjct: 110 GYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAP 165

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E L         D +  G VL E+L G
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 25/179 (13%)

Query: 135 EVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           E+  L  ++HPN+VK    F  +GE ++L+ E+M  GSLE      G           VA
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLE------GTHIADEQFLADVA 174

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 252
                G+++LH   + +++RD K SN+L++S  N K++DFG+++    T D  + S   +
Sbjct: 175 RQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---V 229

Query: 253 GTRGYAAPEYLAT----GRLTAKC-DVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA 306
           GT  Y +PE + T    G       D++S GV +LE   GR      R G      DWA
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWA 282

Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 52/232 (22%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP--EGFQGHKEWLSEVNY 138
           ++   +IG+G +G V    ID HT        G  +A+KK+    E        L E+  
Sbjct: 2   YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKL 52

Query: 139 LGQLHHPNLVKLIGFCLDGENR-----LLVYEYMPKG-----------SLENHLFRRGAR 182
           L  L HP++V++    L    R      +V+E M              + E+H F     
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF----- 107

Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---- 238
                          R L ++H A   V +RD K  NIL +++   K+ DFGLA+     
Sbjct: 108 ---------FLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156

Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGR 288
            PT       T  + TR Y APE   +   + T   D++S G +  E+L+G+
Sbjct: 157 TPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 17/219 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHP 145
           +GEG +  V+KG                ++A+K+++ E  +G     + EV+ L  L H 
Sbjct: 14  LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V L       ++  LV+EY+ K  L+ ++   G       ++I +     RGL++ H 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHR 122

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE-YLA 264
             ++V++RD K  N+L++     KL+DFGLA+A     +T+ S +V+ T  Y  P+  L 
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLG 178

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
           +   + + D++  G +  E+ SGR     + V  E +L+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 47/135 (34%), Positives = 61/135 (45%), Gaps = 20/135 (14%)

Query: 162 LVYEYMPKGSLENHLFRRGARPLPW----TLRIKVAIGAARGLSFLHEAEQQVIYRDFKA 217
           +V EYMP G L N L      P  W    T  + +A+ A   + F+H        RD K 
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKP 170

Query: 218 SNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTA----KC 272
            N+LLD   + KL+DFG   K    G      T V GT  Y +PE L +         +C
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228

Query: 273 DVYSFGVVLLELLSG 287
           D +S GV L E+L G
Sbjct: 229 DWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 26/223 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG FG   K  + +   E  +  V   I + K+ P   +  +E   EV  L  + HPN
Sbjct: 8   IGEGSFG---KAILVKSK-EDGKQYVIKEINISKMSP---KEREESRKEVAVLSNMKHPN 60

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP------WTLRIKVAIGAARGL 200
           +V+      +  N  +V +Y   G L   +  +     P      W ++I +A+      
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
              H  ++++++RD K+ NI L  +   KL DFG+A+         ++   +GT  Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSP 170

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
           E         K D+++ G VL E+ + + A +    G  +NLV
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 64/252 (25%), Positives = 95/252 (37%), Gaps = 56/252 (22%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG----HKEWLSEVNYLGQ 141
           LIG+GG G VY  +          P     +A+KK++ E         K +L E      
Sbjct: 9   LIGKGGMGEVYLAY---------DPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAAD 58

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMP--KGSLENHLFR--RGARPLPWTLRIKVAIGAA 197
           L HP +V +   C DG+    VY  MP  +G     L +       L   L  K ++GA 
Sbjct: 59  LIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 198 RGLSFLHEAEQQVIY--------RDFKASNILLDSEFNAKLSDFGLA------------- 236
             LS  H+    + Y        RD K  NILL       + D+G A             
Sbjct: 116 --LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 237 KAGPTGDRTHVST---QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS------- 286
                       T   +++GT  Y APE L     +   D+Y+ GV+L ++L+       
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233

Query: 287 --GRRAVDKTRV 296
             GR+   +  +
Sbjct: 234 KKGRKISYRDVI 245

Length = 932

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 38/93 (40%), Positives = 55/93 (59%), Gaps = 6/93 (6%)

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           RGL ++H A   V++RD K SN+LL++  + K+ DFGLA+   T ++    T+ + TR Y
Sbjct: 119 RGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 258 AAPE-YLATGRLTAKCDVYSFGVVLLELLSGRR 289
            APE  L     T   DV+S G +  ELL GR+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 17/221 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHP 145
           +GEG +  VYKG         +R   G ++A+K +  +  +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKG--------ISRIN-GQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V L       E    V+EYM    L  ++ +      P+ +R+       RGL+++H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL-A 264
             Q +++RD K  N+L+      KL+DFGLA+A     +T+ S  V  T  Y  P+ L  
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW 305
               ++  D++  G + +E+L G+ A        EQ    W
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 24/162 (14%)

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L+  H   + +I+RD K++NILL S    KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
           PE       + K D++S GV+L ELL+ +R                  P+  D   +  +
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKR------------------PF--DGENMEEV 253

Query: 320 MDIKLEGQY----PQKGAYMVAILALQCISEAKVRPSMSEVL 357
           M   L G+Y    P     M  I+     S+ K RPS S++L
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 7/157 (4%)

Query: 134 SEVNYLGQLHHPNLVKLI-GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
            E++ L  + H  ++ LI  +      +  V   MPK   +   +   + PLP    I +
Sbjct: 135 REIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
                  L++LH   + +I+RD K  NI LD   NA L DFG A        T       
Sbjct: 191 QRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           GT    +PE LA     AK D++S G+VL E+     
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 20/214 (9%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           +N   ++     +G G +G VYK         A     G + AVK +K E          
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYK---------ARNLHTGELAAVKIIKLEPGDDFSLIQQ 55

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  + +  H N+V   G  L  E   +  EY   GSL++     G  PL       V  
Sbjct: 56  EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCR 113

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMG 253
              +GL++LH   +  ++RD K +NILL    + KL+DFG+ AK   T  +       +G
Sbjct: 114 ETLQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIG 168

Query: 254 TRGYAAPEYLA---TGRLTAKCDVYSFGVVLLEL 284
           T  + APE  A    G     CD+++ G+  +EL
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 68/260 (26%), Positives = 104/260 (40%), Gaps = 78/260 (30%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWL----S 134
           +F    +IG G FG V    + +          G + A+KKL K E  +  KE +    +
Sbjct: 2   DFESIKVIGRGAFGEVR--LVQKKD-------TGHIYAMKKLRKSEMLE--KEQVAHVRA 50

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV-- 192
           E + L +  +P +VKL     D     L+ EY+P G +   L ++       T   +   
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD------TFTEEETR 104

Query: 193 --------AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL--------- 235
                   AI +   L ++H        RD K  N+LLD++ + KLSDFGL         
Sbjct: 105 FYIAETILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Query: 236 -------AKAGPTGDRTHVSTQ--------------------VMGTRGYAAPE-YLATGR 267
                  + A P+     +S                       +GT  Y APE +L TG 
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG- 215

Query: 268 LTAKCDVYSFGVVLLELLSG 287
              +CD +S GV++ E+L G
Sbjct: 216 YNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHP 145
           +GEG +  VYKG                ++A+K+++ E  +G     + EV+ L  L H 
Sbjct: 14  LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V L       ++  LV+EY+ K  L+ +L   G       +++ +     RGL++ H 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR 122

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE-YLA 264
             ++V++RD K  N+L++     KL+DFGLA+A     +T+ S +V+ T  Y  P+  L 
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILLG 178

Query: 265 TGRLTAKCDVYSFGVVLLELLSGR 288
           +   + + D++  G +  E+ +GR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 20/214 (9%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           +N   +F     IG G +G VYK         A     G + A+K +K E  +       
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYK---------ARNVNTGELAAIKVIKLEPGEDFAVVQQ 55

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  +    H N+V   G  L  +   +  E+   GSL++     G  PL  +    V+ 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSR 113

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMG 253
              +GL +LH   +  ++RD K +NILL    + KL+DFG+ A+   T  +       +G
Sbjct: 114 ETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIG 168

Query: 254 TRGYAAPEYLATGR---LTAKCDVYSFGVVLLEL 284
           T  + APE  A  R       CD+++ G+  +EL
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 26/213 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V  G ++     A        + VK+L+     Q   ++L E      L H 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQ-------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR------PLPWTLRIKVAIGAARG 199
           NL++ +G C +    LLV E+ P G L+ +L  R  R      P P TL+ ++A   A G
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L  LH  +   I+ D    N LL ++   K+ D+GL+      D      Q+     + A
Sbjct: 113 LLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170

Query: 260 PEYL--ATGRL-----TAKCDVYSFGVVLLELL 285
           PE +    G L     T + +V+S GV + EL 
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 49/151 (32%), Positives = 66/151 (43%), Gaps = 18/151 (11%)

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW----TLRIKVAIGAARGL 200
           P +V+L     D +   +V EYMP G L N L      P  W    T  + +A+ A   +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
             +H        RD K  N+LLD   + KL+DFG              T V GT  Y +P
Sbjct: 162 GLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212

Query: 261 EYLAT----GRLTAKCDVYSFGVVLLELLSG 287
           E L +    G    +CD +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 40/218 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEWLSEVNYLGQL 142
           IG+G FG V+K         A       ++A+KK+    + EGF      L E+  L  L
Sbjct: 20  IGQGTFGEVFK---------ARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLL 68

Query: 143 HHPNLVKLIGFC---LDGENR-----LLVYEYMP---KGSLENHLFRRGARPLPWTL-RI 190
            H N+V LI  C       NR      LV+E+      G L N   +       +TL  I
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-------FTLSEI 121

Query: 191 KVAIGA-ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHV 247
           K  +     GL ++H    ++++RD KA+NIL+  +   KL+DFGLA+A       + + 
Sbjct: 122 KKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 248 STQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLEL 284
            T  + T  Y  PE L   R      D++  G ++ E+
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 36/217 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHP 145
           +G+G +G VYK               G+ +A+K+++ E  +    + + E++ L +   P
Sbjct: 9   LGKGNYGSVYK---------VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59

Query: 146 NLVKLIG-FCLDGENRLLVY---EYMPKGSLEN---HLFRRGARPLPWTLRIKVAIGAAR 198
            +V   G F ++G     VY   EYM  GSL+            P     RI  A+   +
Sbjct: 60  YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV--VK 113

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD-RTHVSTQVMGTRGY 257
           GL FL E E  +I+RD K +N+L++     KL DFG+     +G+    ++   +G + Y
Sbjct: 114 GLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSY 167

Query: 258 AAPEYL----ATGRLT--AKCDVYSFGVVLLELLSGR 288
            APE +         T   + DV+S G+ +LE+  GR
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 25/235 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V     ++H+        G  +AVK +     Q  +   +EV  +    H N
Sbjct: 29  IGEGSTGIVCIAR-EKHS--------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V++    L GE   ++ E++  G+L + +       L       V     + L +LH  
Sbjct: 80  VVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHS- 135

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFG----LAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            Q VI+RD K+ +ILL  +   KLSDFG    ++K  P          ++GT  + APE 
Sbjct: 136 -QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEV 188

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGRRA-VDKTRVGAEQNLVDWAKPYLGDRRKL 316
           ++      + D++S G++++E++ G       + V A + L D   P L +  K+
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGT 254
            GL ++H A   V++RD K  N+L++++   K+ DFGLA+     P  +   + T+ + T
Sbjct: 116 CGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172

Query: 255 RGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
           R Y APE  L+    T   DV+S G +L ELL  +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 7/90 (7%)

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           GL  +H   + V+YRD K +NILLD   + ++SD GLA    +  + H S   +GT GY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162

Query: 259 APEYLATG-RLTAKCDVYSFGVVLLELLSG 287
           APE L  G    +  D +S G +L +LL G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 67/276 (24%), Positives = 103/276 (37%), Gaps = 78/276 (28%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQ----GHKEWLSEVNYLGQ 141
           IG G FG V    +        +     + A+K L K +        H +  +E + L +
Sbjct: 9   IGIGAFGEV---CL------VRKVDTNALYAMKTLRKADVLMRNQAAHVK--AERDILAE 57

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP----WTLRIKVAIGAA 197
             +  +VKL     D +N   V +Y+P G + + L R G         +   +  AI + 
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR-THVST------- 249
             + F+H        RD K  NIL+D + + KL+DFGL     TG R TH S        
Sbjct: 118 HKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSKYYQKGDH 165

Query: 250 -------------------------------------QVMGTRGYAAPEYLATGRLTAKC 272
                                                 ++GT  Y APE L     T  C
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225

Query: 273 DVYSFGVVLLELLSGRRA-VDKTRVGAEQNLVDWAK 307
           D +S GV+L E+L G+   +  T    +  +++W  
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHP 145
           +GEG +  VYKG    +         G ++A+K ++ +  +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGKSKVN---------GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V L       E   LV+EY+    L  ++ +      P  +++ +     RGLS++H+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             + +++RD K  N+L+      KL+DFGLA+A      T+ S +V+ T  Y  P+ L  
Sbjct: 122 --RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWYRPPDVLLG 177

Query: 266 GRLTAKC-DVYSFGVVLLELLSGRRA 290
               + C D++  G + +E++ G  A
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-----LSEVNYLGQ 141
           +GEG +  VYKG   + T        G ++A+K+++ E    H+E      + E + L  
Sbjct: 13  LGEGSYATVYKG-RSKLT--------GQLVALKEIRLE----HEEGAPFTAIREASLLKD 59

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           L H N+V L       +   LV+EY+    L+ ++   G       +R+       RGL+
Sbjct: 60  LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLA 117

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           + H+  ++V++RD K  N+L+      KL+DFGLA+A     +T+ S +V+ T  Y  P+
Sbjct: 118 YCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPD 173

Query: 262 YL-ATGRLTAKCDVYSFGVVLLELLSGR 288
            L  +   +   D++  G +  E+ +GR
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 24/209 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL 142
           +IG GGFG VY            +   G + A+K L  +     QG    L+E   L  +
Sbjct: 1   IIGRGGFGEVYG---------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51

Query: 143 HHPN--LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
              +   +  + +     ++L  + + M  G L  HL + G     ++ +          
Sbjct: 52  STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV----FSEKEMRFYATEII 107

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L   H   + V+YRD K +NILLD   + ++SD GLA    +  + H S   +GT GY A
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMA 163

Query: 260 PEYLATGR-LTAKCDVYSFGVVLLELLSG 287
           PE L  G    +  D +S G +L +LL G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 28/227 (12%)

Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           L++    F    L+G G +G VYKG    H         G + A+K +   G +  +E  
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTGDE-EEEIK 50

Query: 134 SEVNYLGQL-HHPNLVKLIGFCLD------GENRLLVYEYMPKGSLENHLFRRGARPLPW 186
            E+N L +  HH N+    G  +        +   LV E+   GS+ + +       L  
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT- 245
                +     RGLS LH+   +VI+RD K  N+LL      KL DFG++      DRT 
Sbjct: 111 EWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTV 165

Query: 246 HVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSG 287
                 +GT  + APE +A           K D++S G+  +E+  G
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHH 144
           ++GEG FG   +  + +H     +       A+K+++ P+     ++   E   L ++ H
Sbjct: 7   VVGEGSFG---RALLVQHVNSDQK------YAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57

Query: 145 PNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           PN+V       + +  L +V EY   G L   +  +  +  P    ++  +    G+  +
Sbjct: 58  PNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAAPE 261
           HE  ++V++RD K+ NI L      KL DFG A+    P     +  T V GT  Y  PE
Sbjct: 117 HE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPPE 170

Query: 262 YLATGRLTAKCDVYSFGVVLLEL 284
                    K D++S G +L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V    I          GV  V+ VK+LK     +   E+L + +    L HP
Sbjct: 3   IGNGWFGKVLLSEI------YTDTGVARVV-VKELKANASSKEQNEFLQQGDPYRILQHP 55

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHL-----FRRGARPLPWTLRIKVAIGAARGL 200
           N+++ +G C++    LLV+EY   G L+++L      RR ++ L   L  ++A   A G+
Sbjct: 56  NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGV 112

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           + +H  +   ++ D    N  L S+   K+ D+G+  +    D             + AP
Sbjct: 113 THMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170

Query: 261 EY-------LATGRLTAKCDVYSFGVVLLELL 285
           E        L T   T   +V++ GV L EL 
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 50/151 (33%), Positives = 66/151 (43%), Gaps = 18/151 (11%)

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW----TLRIKVAIGAARGL 200
           P +V+L     D     +V EYMP G L N L      P  W    T  + +A+ A   +
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            F+H        RD K  N+LLD   + KL+DFG              T V GT  Y +P
Sbjct: 162 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 212

Query: 261 EYLAT----GRLTAKCDVYSFGVVLLELLSG 287
           E L +    G    +CD +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG--H-KEWLSEV 136
           ++  S +G G +G V           A     G  +A+KKL +P  FQ   H K    E+
Sbjct: 17  YQNLSPVGSGAYGQVCS---------AFDTKTGRKVAIKKLSRP--FQSAIHAKRTYREL 65

Query: 137 NYLGQLHHPNLVKLIG-FCLDGENR-----LLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
             L  + H N++ L+  F             LV   M  G+  N++ +   + L     I
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC--QKLS-DDHI 120

Query: 191 KVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           +  +    RGL ++H A   +I+RD K SNI ++ +   K+ DFGLA+   T D     T
Sbjct: 121 QFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEM---T 173

Query: 250 QVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
             + TR Y APE  L         D++S G ++ ELL+G+
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 47/146 (32%), Positives = 70/146 (47%), Gaps = 9/146 (6%)

Query: 145 PNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           P LV L  +    + +L L+ +Y+  G L  HL +R          +++  G    L+  
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIV-LALE 119

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H  +  +IYRD K  NILLDS  +  L+DFGL+K     D    +    GT  Y AP+ +
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIV 178

Query: 264 ATGRL--TAKCDVYSFGVVLLELLSG 287
             G        D +S GV++ ELL+G
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 37/237 (15%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           ++  ++++  ++IG G FG VY         EA        +A+KK+  +    ++E L 
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVY---------EAICIDTSEKVAIKKVLQDPQYKNRELLI 112

Query: 135 EVNYLGQLHHPNLVKLIGF----CL--DGENRLL--VYEYMPKGSLENHL--FRRGARPL 184
             N    L+H N++ L  +    C   + +N  L  V E++P+ ++  ++  + R    L
Sbjct: 113 MKN----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGD 243
           P  L    +    R L+++H   + + +RD K  N+L+D   +  KL DFG AK    G 
Sbjct: 168 PLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225

Query: 244 RTHVSTQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLE------LLSGRRAVDK 293
           R   S   + +R Y APE  L     T   D++S G ++ E      + SG+ +VD+
Sbjct: 226 R---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Length = 440

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 18/206 (8%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEW-LSEVNYLGQLH 143
           ++GEG +G V K    E T E        ++A+KK K  E  +  KE  L E+  L  L 
Sbjct: 8   VVGEGAYGVVLKCRHKE-TKE--------IVAIKKFKDSEENEEVKETTLRELKMLRTLK 58

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLEN-HLFRRGARPLPWTLRIKVAIGAARGLSF 202
             N+V+L           LV+EY+ K  LE       G  P      I   I A   + +
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA---IHW 115

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H+ +  +++RD K  N+L+      KL DFG A+    G   +  T+ + TR Y +PE 
Sbjct: 116 CHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGR 288
           L         D++S G +L EL  G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK----LKPEGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYK         A     G ++A+KK    +  EG       L E++ L  L
Sbjct: 9   IGEGTYGKVYK---------ARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57

Query: 143 HH-PNLVKLIGFCLDGENR-----LLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVA 193
                +V+L+      E        LV+EY+    K  ++++  R   RPLP        
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN-GRGPGRPLPAKTIKSFM 116

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAG--PTGDRTHVSTQ 250
               +G++  H+    V++RD K  N+L+D +    K++D GL +A   P    TH   +
Sbjct: 117 YQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---E 171

Query: 251 VMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSG 287
           ++ T  Y APE L      +   D++S G +  E+   
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 2/157 (1%)

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           SE++ L    H  +VK        +  LL+ EY   G L   + +R    LP+    +V 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172

Query: 194 IGAARGLSFLHEAE-QQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           +   + +  L E   +++++RD K++NI L      KL DFG +K         V++   
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           GT  Y APE     R + K D++S GV+L ELL+  R
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 41/199 (20%)

Query: 116 IAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL-------------- 161
           +AVKK+     Q  K  L E+  + +L H N+VK+        + L              
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 162 LVYEYMP--------KGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIY 212
           +V EYM         +G L E H     AR   + L         RGL ++H A   V++
Sbjct: 93  IVQEYMETDLANVLEQGPLSEEH-----ARLFMYQL--------LRGLKYIHSA--NVLH 137

Query: 213 RDFKASNILLDSE-FNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LT 269
           RD K +N+ +++E    K+ DFGLA+   P        ++ + T+ Y +P  L +    T
Sbjct: 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYT 197

Query: 270 AKCDVYSFGVVLLELLSGR 288
              D+++ G +  E+L+G+
Sbjct: 198 KAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP------EGFQGHKEWL 133
           NF    ++G G +G V+         +      G + A+K L+            H    
Sbjct: 1   NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           +E N L  +     +  + +    E +L L+ +Y+  G +  HL++R          ++ 
Sbjct: 53  TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRF 109

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
             G    L+  H  +  ++YRD K  NILLDSE +  L+DFGL+K   + ++   +    
Sbjct: 110 YSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFC 167

Query: 253 GTRGYAAPEYLATGRLTAKC-DVYSFGVVLLELLSG 287
           GT  Y APE +       K  D +S G+++ ELL+G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G +G V         +     G   VI    L+    +  K    E   L QL HPN
Sbjct: 8   VGKGSYGEV-------SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 147 LVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V       +GE+ LL  V  +   G L + L  +  + LP    ++  +  A  L +LH
Sbjct: 61  IV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
           E  + +++RD K  N+ L      K+ D G+A+     ++  +++ ++GT  Y +PE  +
Sbjct: 120 E--KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELFS 175

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA 290
                 K DV++ G  + E+ + + A
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 49/155 (31%), Positives = 69/155 (44%), Gaps = 9/155 (5%)

Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
            SE   L  ++HP  V L G   D     LV E++  G     L RR  R   +   +  
Sbjct: 79  FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKR---FPNDVGC 134

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
              A   L F +     ++YRD K  N+LLD +   K++DFG AK   T  RT+    + 
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT---LC 189

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE L         D ++ G+ + E+L G
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + TR Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 183

Query: 258 AAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
            APE +          D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 48/236 (20%)

Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           T  E+ +  R+ +    +G G +G V    +D  T        G  +A+KKL +P  FQ 
Sbjct: 9   TIWEVPDRYRDLKQ---VGSGAYGTVCSA-LDRRT--------GAKVAIKKLYRP--FQS 54

Query: 129 H---KEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRL-LVYEYMPK--GSLENHLF 177
               K    E+  L  + H N++ L+        LD  +   LV  +M    G L  H  
Sbjct: 55  ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE- 113

Query: 178 RRGARPLPWTLRIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
           +          RI+  +    +GL ++H A   +I+RD K  N+ ++ +   K+ DFGLA
Sbjct: 114 KLSED------RIQFLVYQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 237 KAGPTGDRTHVSTQVMG---TRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
           +           +++ G   TR Y APE  L     T   D++S G ++ E+L+G+
Sbjct: 166 R--------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 18/184 (9%)

Query: 112 VGMVIAVKKL-KPEGFQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLV 163
           +G+ +AVKKL +P   Q H K    E+  L  ++H N++ L+          + ++  LV
Sbjct: 45  LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD 223
            E M     +          + + L   +      G+  LH A   +I+RD K SNI++ 
Sbjct: 105 MELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVK 157

Query: 224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE 283
           S+   K+ DFGLA+   T     + T  + TR Y APE +         D++S G ++ E
Sbjct: 158 SDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 284 LLSG 287
           L+ G
Sbjct: 215 LVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 53/204 (25%), Positives = 80/204 (39%), Gaps = 57/204 (27%)

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP----WTLR 189
           +E + L +  +  +VKL     D +N   V +Y+P G + + L R    P      +   
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE 109

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA----------- 238
           + +AI +   + F+H        RD K  NIL+D + + KL+DFGL              
Sbjct: 110 LTLAIESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161

Query: 239 ----------GPT-----------GDRTHVSTQ-------------VMGTRGYAAPEYLA 264
                      P+           GDR     Q             ++GT  Y APE L 
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221

Query: 265 TGRLTAKCDVYSFGVVLLELLSGR 288
               T  CD +S GV+L E+L G+
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 58/222 (26%)

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP----WTLR 189
           +E + L +  +  +V+L     D +N   V +Y+P G + + L R G  P      +   
Sbjct: 50  AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL---------AKAGP 240
           +  A+ +   + F+H        RD K  NIL+D + + KL+DFGL         +K   
Sbjct: 110 LTCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161

Query: 241 TGD---------------------------------RTH---VSTQVMGTRGYAAPEYLA 264
           +GD                                 R H   ++  ++GT  Y APE L 
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221

Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA-VDKTRVGAEQNLVDW 305
               T  CD +S GV+L E+L G+   + +T +  +  +++W
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 87  IGEGGFGYVYKGWIDE--HTLEAARPGVGMVIAVKKLK--PEGFQGHKEWLSEVNYLGQL 142
           +G+G F  ++KG   E     E  +  V + +  K  +   E F          + + QL
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF------FEAASMMSQL 56

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLS 201
            H +LV   G C+ G+  ++V EY+  GSL+ +L +      + W L  +VA   A  L 
Sbjct: 57  SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL--EVAKQLAWALH 114

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNA--------KLSDFGLAKAGPTGDRTHVSTQVMG 253
           FL   ++ + + +  A N+LL  E +         KLSD G++        T +  +++ 
Sbjct: 115 FLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-------TVLPKEILL 165

Query: 254 TR-GYAAPEYLATGR-LTAKCDVYSFGVVLLELLSG 287
            R  +  PE +   + L+   D +SFG  L E+ SG
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+    G    ++  V+ TR Y 
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV-TRYYR 184

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           APE +         D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 47/178 (26%), Positives = 68/178 (38%), Gaps = 45/178 (25%)

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT----LRIKVAIGAARGLSF 202
           +VK+     D  N  L+ E++P G +   L ++       T        +AI A   L F
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---------------GPTGD---- 243
           +H        RD K  N+LLD++ + KLSDFGL                   P  D    
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 244 --------------RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                         R  ++   +GT  Y APE          CD +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 39/158 (24%), Positives = 73/158 (46%), Gaps = 6/158 (3%)

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           +E + L  ++HP++++L G     +   L+   +P+   + + +    R +     + + 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
               R + +LHE   ++I+RD KA NI ++   +  L DFG A   P     +      G
Sbjct: 189 RSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV 291
           T    APE LA        D++S G+VL E+ +   ++
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 35/171 (20%)

Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP-- 185
           G  +W++ ++Y  Q              D  N  LV +Y   G L   L +   R LP  
Sbjct: 58  GDNQWITTLHYAFQ--------------DENNLYLVMDYYVGGDLLTLLSKFEDR-LPED 102

Query: 186 ----WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
               +   + +AI +   L ++H        RD K  NIL+D   + +L+DFG +     
Sbjct: 103 MARFYLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLM 153

Query: 242 GDRTHVSTQVMGTRGYAAPEYL-----ATGRLTAKCDVYSFGVVLLELLSG 287
            D T  S+  +GT  Y +PE L       G+   +CD +S GV + E+L G
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 64/238 (26%), Positives = 99/238 (41%), Gaps = 32/238 (13%)

Query: 65  NLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE 124
           +L     S L++    F    ++G G +G VYKG    H         G + A+K +   
Sbjct: 2   SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVT 52

Query: 125 GFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLF 177
             +  +E   E+N L +  HH N+    G  +        +   LV E+   GS+ + + 
Sbjct: 53  EDE-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK 111

Query: 178 RRGARPLP--WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
                 L   W   I   I   RGL+ LH    +VI+RD K  N+LL      KL DFG+
Sbjct: 112 NTKGNALKEDWIAYICREI--LRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGV 167

Query: 236 AKAGPTGDRT-HVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSG 287
           +      DRT       +GT  + APE +A           + D++S G+  +E+  G
Sbjct: 168 SA---QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 62/250 (24%), Positives = 91/250 (36%), Gaps = 61/250 (24%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-----GHKEWLS 134
           +F    +IG G FG V             +   G V A+K L+          GH    +
Sbjct: 2   DFESLKVIGRGAFGEVRL---------VQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT----LRI 190
           E + L +     +VK+     D  N  L+ E++P G +   L ++       T       
Sbjct: 51  ERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAET 110

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT----- 245
            +AI +   L F+H        RD K  N+LLDS+ + KLSDFGL        RT     
Sbjct: 111 VLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 246 ----------------------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
                                        ++   +GT  Y APE          CD +S 
Sbjct: 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 278 GVVLLELLSG 287
           GV++ E+L G
Sbjct: 223 GVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 49/172 (28%), Positives = 73/172 (42%), Gaps = 37/172 (21%)

Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP-- 185
           G + W++ ++Y  Q              D  N  LV +Y   G L   L +   R LP  
Sbjct: 58  GDRRWITNLHYAFQ--------------DENNLYLVMDYYVGGDLLTLLSKFEDR-LPED 102

Query: 186 ----WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG-LAKAGP 240
               +   + +AI +   L ++H        RD K  N+LLD   + +L+DFG   +   
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLA 154

Query: 241 TGDRTHVSTQVMGTRGYAAPEYL-----ATGRLTAKCDVYSFGVVLLELLSG 287
            G  T  S   +GT  Y +PE L       GR   +CD +S GV + E+L G
Sbjct: 155 DG--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 42/139 (30%), Positives = 61/139 (43%), Gaps = 17/139 (12%)

Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V EY+  G     L   GA P+    R+  A      L +LH     +++RD K  N+L
Sbjct: 78  MVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVLALEYLHN--YGIVHRDLKPDNLL 133

Query: 222 LDSEFNAKLSDFGLAKAG-------------PTGDRTHVSTQVMGTRGYAAPEYLATGRL 268
           + S  + KL+DFGL+K G                 R  +  QV GT  Y APE +     
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193

Query: 269 TAKCDVYSFGVVLLELLSG 287
               D ++ G++L E L G
Sbjct: 194 GKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 40/217 (18%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGH---KEWLSEVNYLGQ 141
            +G G +G V    ID+ T E         +A+KKL +P  FQ     K    E+  L  
Sbjct: 22  QVGSGAYGSVCSA-IDKRTGEK--------VAIKKLSRP--FQSEIFAKRAYRELTLLKH 70

Query: 142 LHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           + H N++ L+          + ++  LV  YM     +  L +    PL       +   
Sbjct: 71  MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQ 125

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG-- 253
              GL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+        H   ++ G  
Sbjct: 126 MLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYV 175

Query: 254 -TRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
            TR Y APE  L         D++S G ++ E+L+G+
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 14/160 (8%)

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL----LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
           E+  L ++   N++K+ GF +D  + L    L+ EY  +G L   L     + L +  ++
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKL 125

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +AI   +GL  L++   +  Y++  + + L+   +  K+   GL K   +    +V+  
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184

Query: 251 VMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGR 288
           V     Y + + L       T K D+YS GVVL E+ +G+
Sbjct: 185 V-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 43/112 (38%), Positives = 57/112 (50%), Gaps = 18/112 (16%)

Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-AKLSDFGLAK---A 238
           PL     I  +   ARG+ FL  A ++ I+RD  A NILL SE N  K+ DFGLA+    
Sbjct: 169 PLTLEDLISYSFQVARGMEFL--ASRKCIHRDLAARNILL-SENNVVKICDFGLARDIYK 225

Query: 239 GP----TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            P     GD   +  + M      APE +     T + DV+SFGV+L E+ S
Sbjct: 226 DPDYVRKGD-ARLPLKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T   + + T  + TR Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           APE +         D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 41/167 (24%), Positives = 64/167 (38%), Gaps = 23/167 (13%)

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGS----LENHLFRRGARPLPWTLRI 190
           E+    QL HPN++  +   +      +V   M  GS    L+ H F  G   LP     
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEG---LPELAIA 104

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA--------KAGPTG 242
            +       L ++H   +  I+R  KAS+ILL  +    LS    +        +     
Sbjct: 105 FILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 243 DRTHVSTQVMGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSG 287
           D    S + +    + +PE L         K D+YS G+   EL +G
Sbjct: 163 DFPKSSVKNL---PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 11/108 (10%)

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T   + + T  + TR Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185

Query: 259 APEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVDKTRVGAEQ 300
           APE +         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 253
           ARG+ FL  A ++ I+RD  A NILL      K+ DFGLA+     P   R   +   + 
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL- 240

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + APE +     T + DV+SFGV+L E+ S
Sbjct: 241 --KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           RGL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+     D     T  + TR Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181

Query: 258 AAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
            APE  L         D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           A+G+SFL  A +  I+RD  A NILL      K+ DFGLA+         V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           + APE +     T + DV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 6/86 (6%)

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL--- 263
           +   ++RD K  N+LLD   + +L+DFG +      D T  S+  +GT  Y +PE L   
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178

Query: 264 --ATGRLTAKCDVYSFGVVLLELLSG 287
               G+   +CD +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 63/262 (24%), Positives = 91/262 (34%), Gaps = 73/262 (27%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEV-- 136
           +F    +IG+G FG V             +   G + A+K L K E F+  K+ L+ V  
Sbjct: 2   DFHTVKVIGKGAFGEVRL---------VQKKDTGKIYAMKTLLKSEMFK--KDQLAHVKA 50

Query: 137 --NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT----LRI 190
             + L +   P +V L     D +   L+ E++P G L   L +        T       
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL--------------- 235
            +AI A   L F+H        RD K  NIL+D   + KLSDFGL               
Sbjct: 111 VLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 236 ------AKAGPTGDRTHVSTQV------------------------MGTRGYAAPEYLAT 265
                  K       +     +                        +GT  Y APE    
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 266 GRLTAKCDVYSFGVVLLELLSG 287
                +CD +S G ++ E L G
Sbjct: 223 QGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 16/116 (13%)

Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
              + PL     ++ +   A+G+ FL  A +  I+RD  A N+LL     AK+ DFGLA+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 238 AGPTGDRTHVSTQVMGTRGYA-------APEYLATGRLTAKCDVYSFGVVLLELLS 286
                D  + S  V+  +G A       APE +     T + DV+S+G++L E+ S
Sbjct: 261 -----DIMNDSNYVV--KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 16/130 (12%)

Query: 164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD 223
           Y+      ++N L   G+  L     +      ARG+ FL  A +  ++RD  A N+LL 
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271

Query: 224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG-------YAAPEYLATGRLTAKCDVYS 276
                K+ DFGLA+     D  H S  V  ++G       + APE +     T   DV+S
Sbjct: 272 QGKIVKICDFGLAR-----DIMHDSNYV--SKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324

Query: 277 FGVVLLELLS 286
           +G++L E+ S
Sbjct: 325 YGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 253
           A+G+ FL  A ++ I+RD  A NILL      K+ DFGLA+     P   R   +   + 
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + APE +     T + DV+SFGV+L E+ S
Sbjct: 246 --KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 78/329 (23%), Positives = 136/329 (41%), Gaps = 60/329 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G+VYK    +   E          A+K+++  G         E+  L +L HPN
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKE-------YALKQIEGTGIS--MSACREIALLRELKHPN 59

Query: 147 LVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARP------LPWTLRIKVAIGAAR 198
           ++ L    L   +R   L+++Y          F R ++       LP ++   +      
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSE----FNAKLSDFGLAK-----AGPTGDRTHVST 249
           G+ +LH     V++RD K +NIL+  E       K++D G A+       P  D      
Sbjct: 120 GIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----D 173

Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP 308
            V+ T  Y APE L   R  T   D+++ G +  ELL+             Q  +  + P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH-----CRQEDIKTSNP 228

Query: 309 YLGDR-RKLFRIM---------DIKLEGQYP------QKGAYMVAILALQCISEAKVRPS 352
           +  D+  ++F +M         DI+   +YP      ++  Y  + L ++ + + KV+P 
Sbjct: 229 FHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSL-IKYMEKHKVKPD 287

Query: 353 MSEVLSALEQL----PPPRDPASPSNSDP 377
            S+V   L++L    P  R  +  +  DP
Sbjct: 288 -SKVFLLLQKLLTMDPTKRITSEQALQDP 315

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 63/248 (25%), Positives = 93/248 (37%), Gaps = 57/248 (22%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSE 135
           ++F+   L+G+G  G V+        L   + G G + A+K L  +      +    L+E
Sbjct: 1   KHFKKIKLLGKGDVGRVF--------LVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTE 51

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVA 193
              L  L HP L  L           LV +Y P G L   L +R  G       L  +VA
Sbjct: 52  QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKC-----LSEEVA 105

Query: 194 ------IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
                 +  A  L +LH     ++YRD K  NILL    +  LSDF L+K          
Sbjct: 106 RFYAAEVLLA--LEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161

Query: 248 ---------------------------STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVV 280
                                      S   +GT  Y APE ++     +  D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221

Query: 281 LLELLSGR 288
           L E+L G 
Sbjct: 222 LYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 42/234 (17%)

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR-RGARPLPWTLRIKVAIGAA 197
           + Q+ H +L  + G C+ G   ++V E++  G L+  L + +G  P+ W  +I VA   A
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127

Query: 198 RGLSFLHEAEQQVIYRDFKASNILL--------DSEFNAKLSDFGLAKAGPTGDRTHVST 249
             LS+L   ++ +++ +  A NILL         S F  KLSD G++        T +S 
Sbjct: 128 SALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVS-------FTALSR 177

Query: 250 QVMGTR-GYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK 307
           +    R  + APE +  G  L+   D +SFG  LLE+        K R  +E+       
Sbjct: 178 EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE------ 231

Query: 308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL 360
                     R  + K   + P+     +A L  QC++ E   RPS   +L  L
Sbjct: 232 ----------RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 6/95 (6%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V    ++       +    M +AVK LKP      +E L SE+  L  L +H
Sbjct: 43  LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR 179
            N+V L+G C  G   L++ EY   G L N L R+
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 16/100 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL-SEVNYLG 140
           +G G FG V         +EA   G+G     + +AVK LK       +E L SE+  L 
Sbjct: 46  LGAGAFGKV---------VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS 96

Query: 141 QL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR 179
            L  H N+V L+G C  G   L++ EY   G L N L ++
Sbjct: 97  HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 9/157 (5%)

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLV---YEYMPKGSLENHLFRRGARPLPW-TLR 189
           +E+  LG+L+H N++K+        N  ++   Y++     + +  F    RPL   T  
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRA 271

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I   +  A  + ++H+  +++I+RD K  NI L+ +    L DFG A      +R     
Sbjct: 272 IMKQLLCA--VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK-EREAFDY 326

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             +GT    +PE LA        D++S G++LL++LS
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 8/151 (5%)

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPK--GSLENHLFRRGARPLPWTLRIKV 192
           E   L +L HP ++ L+   + G    LV   +PK    L  +L  R  RPL       V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGAR-LRPLGLAQVTAV 265

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A      + ++H   + +I+RD K  N+L++   +  L DFG A        T     + 
Sbjct: 266 ARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLE 283
           GT    APE LA    T   D++S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 62/258 (24%), Positives = 102/258 (39%), Gaps = 49/258 (18%)

Query: 87  IGEGGFGYVYK-----GWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G G +G+VYK     G  D         G G+ ++  +              E+  L +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54

Query: 142 LHHPNLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARP------LPWTLRIKVA 193
           L HPN++ L    L   +R   L+++Y          F R ++       LP  +   + 
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSE----FNAKLSDFGLAK-----AGPTGDR 244
                G+ +LH     V++RD K +NIL+  E       K++D G A+       P  D 
Sbjct: 115 YQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 245 THVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
                 V+ T  Y APE L   R  T   D+++ G +  ELL+             Q  +
Sbjct: 173 ----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH-----CRQEDI 223

Query: 304 DWAKPYLGDR-RKLFRIM 320
             + PY  D+  ++F +M
Sbjct: 224 KTSNPYHHDQLDRIFNVM 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 25/156 (16%)

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF-RRGARPL--PWTLRIKVAIGAA 197
           Q+ H ++V L G C+     ++V E++  G L+  LF  R +  L  PW  + KVA   A
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPW--KFKVAKQLA 115

Query: 198 RGLSFLHEAEQQVIYRDFKASNILL-----DSEFNA--KLSDFGLAKAGPTGDRTHVSTQ 250
             LS+L   ++ +++ +    NILL     D E     KLSD G+    P    T +S Q
Sbjct: 116 SALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PI---TVLSRQ 166

Query: 251 VMGTR-GYAAPEYLATGR-LTAKCDVYSFGVVLLEL 284
               R  + APE +   + L+   D +SFG  L E+
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 16/97 (16%)

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           A G+ FL  A +  ++RD  A N+L+      K+ DFGLA+     D    S  +  ++G
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYI--SKG 299

Query: 257 -------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T   DV+SFG++L E+ +
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 0.001
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 31/187 (16%)

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFR--RGARPLPWTLRI 190
           EVN + +L H N+V+ I   L+  N+ L  + E+   G L  ++ +  +    +     +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 191 KVAIGAARGLSFLHEAE-----QQVIYRDFKASNILLDSEFN-----------------A 228
            +       L++ H  +     ++V++RD K  NI L +                    A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL--ATGRLTAKCDVYSFGVVLLELLS 286
           K+ DFGL+K        H     +GT  Y +PE L   T     K D+++ G ++ EL S
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 287 GRRAVDK 293
           G+    K
Sbjct: 239 GKTPFHK 245

Length = 1021

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 15/155 (9%)

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN++        G    ++  +M  GS  + L       +   L   +  GA RGL++L
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSD----FGLAKAGPTG----DRTHVSTQVMGTR 255
           H+     I+R+ KAS+IL+  +    LS     + L + G       D    ST V+   
Sbjct: 118 HQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-- 173

Query: 256 GYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGR 288
            + +PE L         K D+YS G+   EL +GR
Sbjct: 174 -WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 6/95 (6%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-H 143
           ++G G FG V +G    + L  ++P   M +AVK LKP      K+ L SE+  +  L  
Sbjct: 44  ILGSGAFGKVVEG--TAYGLSRSQPV--MKVAVKMLKPTARSSEKQALMSELKIMTHLGP 99

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           H N+V L+G C       ++ EY   G L N+L +
Sbjct: 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 4/79 (5%)

Query: 159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKAS 218
           N  LV EY+  G +++ L   G       + +K     A  L +LH     +I+RD K  
Sbjct: 78  NVYLVMEYLIGGDVKSLLHIYGYFDEE--MAVKYISEVALALDYLHR--HGIIHRDLKPD 133

Query: 219 NILLDSEFNAKLSDFGLAK 237
           N+L+ +E + KL+DFGL+K
Sbjct: 134 NMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	441
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
smart00090	237	RIO RIO-like kinase.	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG3087	229	consensus Serine/threonine protein kinase [General	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.97
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
PRK09902	216	hypothetical protein; Provisional	98.89
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.89
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.76
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.68
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.67
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.63
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.54
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.47
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.39
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.35
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.2
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.09
PRK10593	297	hypothetical protein; Provisional	97.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.89
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.84
PRK05231	319	homoserine kinase; Provisional	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.78
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.77
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.71
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.66
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.52
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.5
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.42
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.24
PLN02236	344	choline kinase	97.16
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.12
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.11
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.07
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.9
PLN02756	418	S-methyl-5-thioribose kinase	96.78
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.66
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.6
PRK12396	409	5-methylribose kinase; Reviewed	96.52
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.5
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.33
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.23
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.14
KOG2270	520	consensus Serine/threonine protein kinase involved	96.09
PRK11768	325	serine/threonine protein kinase; Provisional	95.66
PRK06148	1013	hypothetical protein; Provisional	95.56
COG2334	331	Putative homoserine kinase type II (protein kinase	95.54
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.36
PTZ00384	383	choline kinase; Provisional	94.61
PTZ00296	442	choline kinase; Provisional	94.19

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-53  Score=409.05  Aligned_cols=288  Identities=57%  Similarity=0.980  Sum_probs=247.4

Q ss_pred             CCccccHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCC
Q 013557           65 NLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH  144 (441)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  144 (441)
                      ....|++.++..++++|.-.++||+|+||.||+|...+          +..||||++.........+|.+|+.+|.+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H  130 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH  130 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence            57789999999999999999999999999999998875          46899998876543314569999999999999


Q ss_pred             CCcccEEEEEEcCC-eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcC-CCeEEeccCCCcEEE
Q 013557          145 PNLVKLIGFCLDGE-NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAE-QQVIYRDFKASNILL  222 (441)
Q Consensus       145 pnIv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-~~ivH~Dlkp~Nill  222 (441)
                      ||+|+|+|||.+.+ ..+||+||+++|+|.++|+.....+++|..+++|+.++|+||+|||... ..|||||||++||||
T Consensus       131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            99999999999998 5999999999999999997655437999999999999999999999842 269999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeec-cCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQV-MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                      |+++++||+|||+|+..... ... .... .||.+|+|||++..+..+.++|||||||+|+||+||+.+.+........+
T Consensus       211 D~~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             CCCCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            99999999999999765431 111 1222 89999999999999999999999999999999999999988766556667


Q ss_pred             hhhhhccccccchhhhhhhccccc-CCCch-hHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLE-GQYPQ-KGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~-~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ++.|+.+..... .+.+++|+.+. ..++. .....+..++.+|++ +|++||+|.+|++.|+.+..
T Consensus       289 l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  289 LVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            899987776654 78899999887 55554 566678889999999 89999999999999965443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-51  Score=379.77  Aligned_cols=252  Identities=26%  Similarity=0.354  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-------HHHHHHHHHHHhcCCCCCccc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-------HKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      ..+.|.+.+.||+|+||.|-+|+.         +.+|+.||||++++.....       ...+.+|++||++|+|||||+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e---------~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~  240 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYE---------KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR  240 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEE---------cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence            557789999999999999999654         4578999999997653322       234679999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---C
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---F  226 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~  226 (441)
                      ++++|+..+..||||||++||+|.+++..++.  +.+.....++.|++.|+.|||+  +||+||||||+|||+..+   .
T Consensus       241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             EeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcce
Confidence            99999999999999999999999999987764  7788889999999999999999  999999999999999766   6


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC---CchhhhHHHhHHHHHHHhCCCCCCccccccchhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL---TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~  303 (441)
                      .+||+|||+|+...   ...+.++.|||+.|.|||++.++.+   ..++|||||||+||-+|+|.+||.....+.     
T Consensus       317 llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----  388 (475)
T KOG0615|consen  317 LLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----  388 (475)
T ss_pred             EEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----
Confidence            79999999999754   3346788999999999999987653   347899999999999999999997544322     


Q ss_pred             hhhccccccchhhhhhhcccccCC---CchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQ---YPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                                 .+.+.+...-...   .-....+....|+..++. ||++||++.|+|++-
T Consensus       389 -----------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  389 -----------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             -----------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence                       1111111111111   112233445566666776 999999999998763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=384.81  Aligned_cols=255  Identities=35%  Similarity=0.566  Sum_probs=211.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccE-EEEEEcCCCCccc--HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMV-IAVKKLKPEGFQG--HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++.+.+.||.|+||+||+|.|.           |.. ||||++.......  .+.|.+|+.+|.+|+|||||+++|+|.+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3445566999999999999987           344 9999998654332  4589999999999999999999999998


Q ss_pred             CC-eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC-eEEeccCCCcEEECCCC-cEEEccc
Q 013557          157 GE-NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ-VIYRDFKASNILLDSEF-NAKLSDF  233 (441)
Q Consensus       157 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-ivH~Dlkp~Nill~~~~-~~kl~DF  233 (441)
                      .. ..++||||+++|+|.+++.......+++..++.++.+|++||.|||+  .+ ||||||||+|||++.++ ++||+||
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCC
Confidence            88 79999999999999999987545579999999999999999999999  77 99999999999999998 9999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhh--cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA--TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |+++......  ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||......              
T Consensus       189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--------------  252 (362)
T KOG0192|consen  189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--------------  252 (362)
T ss_pred             ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--------------
Confidence            9998644321  2233468999999999999  568999999999999999999999999754321              


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                        .....+.....+...|..+...+..|+..||. ||+.||++.+|+..|+.+..
T Consensus       253 --~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  253 --QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             --HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence              11122222334444555567778888888999 99999999999999986654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-50  Score=371.17  Aligned_cols=202  Identities=33%  Similarity=0.523  Sum_probs=180.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..+|.+.+.||.|+||+||+|+++.         .+..||||.+.+..  ....+.+..|+.+|+.++|||||.+++++.
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~   79 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE   79 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence            4689999999999999999987654         46789999998763  334455789999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC------CcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE------FNAK  229 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~------~~~k  229 (441)
                      .++..|||||||.||+|.+||.+++  .+++..++.++.||+.||++||+  ++||||||||.||||+..      -.+|
T Consensus        80 ~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   80 DDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEE
Confidence            9999999999999999999998776  49999999999999999999998  999999999999999775      4589


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |+|||+|+....+.   ...+.+|++.|||||+++.++|+.|+|+||+|+|||+|++|+.||+...
T Consensus       156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            99999999876543   3457899999999999999999999999999999999999999998443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-50  Score=369.25  Aligned_cols=242  Identities=29%  Similarity=0.385  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|+++++||+|+||+||+++..         .+++.+|+|++++....   +.+....|..||.+++||+||+++..|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~---------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF   94 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKK---------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF   94 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEc---------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence            468999999999999999996543         46889999999876433   345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+...+|||+||+.||.|+-+|.+.+.  +++..+..++.+|+.||.|||+  +|||||||||+|||||.+|+++|+|||
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccc
Confidence            999999999999999999999987664  9999999999999999999999  999999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++......  ....+++||+.|||||++.+..|+.++|+||||+++||||+|.+||...+.....              
T Consensus       171 L~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~--------------  234 (357)
T KOG0598|consen  171 LCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY--------------  234 (357)
T ss_pred             cchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH--------------
Confidence            999643322  2345689999999999999999999999999999999999999999754422111              


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP  351 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP  351 (441)
                        ..+.. .-....|.........++..++. ||++|.
T Consensus       235 --~~I~~-~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  235 --DKILK-GKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --HHHhc-CcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              11111 11122344344555666666666 999995

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=366.98  Aligned_cols=253  Identities=30%  Similarity=0.440  Sum_probs=206.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .+.+.++.||+|..|+||++.         |+.+++.+|+|++.... ....+++.+|+++++..+|||||.+|+.|..+
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~---------Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVR---------HKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEE---------EcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            345567899999999999955         44568899999995443 33456789999999999999999999999999


Q ss_pred             C-eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 E-NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      . ..+|+||||++|+|.+++...+  .+++...-.++.+|++||.|||. .++||||||||+|||++..|.+||||||.+
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEecccccc
Confidence            8 4999999999999999986654  49999999999999999999995 389999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ......    ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.....           ++...-..+
T Consensus       227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-----------~~~~~~~Ll  291 (364)
T KOG0581|consen  227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-----------PYLDIFELL  291 (364)
T ss_pred             HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-----------CCCCHHHHH
Confidence            865433    44678999999999999999999999999999999999999999975311           011111122


Q ss_pred             hhhhcccccCCCchh-HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQK-GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+.+ ......|.. .......++.+|++ ||.+||+++|++++
T Consensus       292 ~~Iv~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  292 CAIVD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHhc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            22333 222334443 56667778888888 99999999999876

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-49  Score=385.30  Aligned_cols=248  Identities=30%  Similarity=0.456  Sum_probs=208.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..|...++||+|||+.||++..         ..+|..||+|++.+...   ...+.+.+|++|.+.|+|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~---------~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARD---------LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEE---------cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            5799999999999999999654         33588999999976432   34567899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.++.|||+|+|..++|..++.++  +++++.+++.++.||+.||.|||+  ++|+|||||..|+||+++.+|||+|||+
T Consensus        89 Ds~nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGL  164 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGL  164 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccce
Confidence            999999999999999999988644  469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |........  ...+.||||.|+|||++.+...+..+||||+||++|-||+|++||+........+              
T Consensus       165 At~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~--------------  228 (592)
T KOG0575|consen  165 ATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN--------------  228 (592)
T ss_pred             eeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH--------------
Confidence            988664432  2457899999999999999999999999999999999999999998543221111              


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        .+.  ......|.........|+..++. +|.+||++++|+..
T Consensus       229 --~Ik--~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  229 --KIK--LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --HHH--hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              111  11123455555666777778887 99999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-50  Score=354.60  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEE-EEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIG-FCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~  155 (441)
                      .+|++++.||+|.||+||++.         +..+|..+|.|.+.-...  ...+++..|+.+|++|+|||||++++ .|.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~---------~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~   89 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQ---------CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI   89 (375)
T ss_pred             HHHHHHHHHcCCcchheEEee---------eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence            468889999999999999964         344688899999874332  23456899999999999999999998 444


Q ss_pred             cCCe-eEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHh--cCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DGEN-RLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHE--AEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~~~-~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~--~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ++.. ++||||+|.+|+|...|..  ...+.+++..+|+++.|++.||.+||+  ...-|+||||||.||+|+.+|.+||
T Consensus        90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence            4444 8999999999999998863  345679999999999999999999998  3334999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||+++.....  .......+|||.||+||.+.+.+|+.+||||||||++|||..-++||.+.+.      ..      
T Consensus       170 GDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~------  235 (375)
T KOG0591|consen  170 GDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS------  235 (375)
T ss_pred             ccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH------
Confidence            999999986442  3344578999999999999999999999999999999999999999975421      11      


Q ss_pred             ccchhhhhhhcccccCCCc-hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          311 GDRRKLFRIMDIKLEGQYP-QKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~-~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                           +-..+........| ......+..|+.+|+. ||+.||+.-.++..+
T Consensus       236 -----L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  236 -----LCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             -----HHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                 11111112112233 5567778899999999 999999865555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=368.30  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=209.2

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKL  150 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l  150 (441)
                      +...++|.+++.||.|+|++|++|+         ++.+++.+|||++.+...   ...+.+..|-.+|.+| .||.|++|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~---------~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL  139 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAR---------EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL  139 (604)
T ss_pred             cCChhhcchhheeccccceeEEEee---------ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence            3456799999999999999999964         444788999999976533   2344577899999999 79999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      +..|.++..+|+|+||+++|+|.++|.+.+  .|++..++.++.+|+.||+|||+  +|||||||||+|||||.+|++||
T Consensus       140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikI  215 (604)
T KOG0592|consen  140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKI  215 (604)
T ss_pred             EEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEE
Confidence            999999999999999999999999998776  49999999999999999999999  99999999999999999999999


Q ss_pred             cccCCcccCCCCCcc---------cee--eeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccc
Q 013557          231 SDFGLAKAGPTGDRT---------HVS--TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE  299 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~  299 (441)
                      +|||.|+.+......         ...  ..++||..|.+||++..+..++.+|||+||||||+||.|++||...+.   
T Consensus       216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---  292 (604)
T KOG0592|consen  216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---  292 (604)
T ss_pred             eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---
Confidence            999999875432221         111  458999999999999999999999999999999999999999975431   


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                               +    ..+.++++  +.-.+|....+.+..|+..++. ||.+|++.++|-++
T Consensus       293 ---------y----liFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  293 ---------Y----LIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ---------H----HHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                     1    11222222  2223455445667777777777 99999999998654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=370.17  Aligned_cols=256  Identities=31%  Similarity=0.457  Sum_probs=219.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.+.+.+.||+|.||+||.|+++.+          ..||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..+.
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            3455678999999999999999853          36899998765 345678899999999999999999999999988


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..||||||++.|+|.++|....+..+...+.+.++.|||+||+||++  +++|||||...|||++++..+||+|||+|+.
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccc
Confidence            99999999999999999988666779999999999999999999999  9999999999999999999999999999995


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .....+. ......-...|.|||.+..+.++.+||||||||+||||+| |+.|+....                 ..++.
T Consensus       353 ~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~  414 (468)
T KOG0197|consen  353 IGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVL  414 (468)
T ss_pred             cCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHH
Confidence            4443332 2222223568999999999999999999999999999999 888876432                 24455


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      +.++..-+-..|..++..+..|+..||. +|++|||++.+...|+.+..
T Consensus       415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            6666667777889999999999999999 99999999999999886543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3e-47  Score=341.21  Aligned_cols=262  Identities=28%  Similarity=0.363  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +.|+.+.++|+|+||+||+         ++++.+|+.||||++.....  ...+-.++|++.|++|+|+|+|.++++|..
T Consensus         2 ekYE~LgkvGEGSYGvV~K---------Crnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMK---------CRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             cHHhhhhccccCcceEEEE---------eccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            4688889999999999999         56667899999999975432  123346899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ...++||+|||+. ++.+-|.+.. .+++...+..++.|++.|+.|||+  +++|||||||+||||+.+|.+||||||+|
T Consensus        73 krklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFA  148 (396)
T KOG0593|consen   73 KRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFA  148 (396)
T ss_pred             cceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhh
Confidence            9999999999977 5555565543 459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +.....  ....+..+.|.+|.|||.+.| .+|+..+||||+||++.||++|.+.|.+......  +.......-....+
T Consensus       149 R~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly~I~ktLG~L~pr  224 (396)
T KOG0593|consen  149 RTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LYLIRKTLGNLIPR  224 (396)
T ss_pred             HhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HHHHHHHHcccCHH
Confidence            976521  123346678999999999988 6899999999999999999999999975543221  11111111001111


Q ss_pred             hhhhhcc----------------cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          316 LFRIMDI----------------KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       316 l~~~~~~----------------~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      ...++..                .++..+|.... .+..++..|++ ||.+|++.++++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~-~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISN-VLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchH-HHHHHHHHHhcCCccccccHHHHhc
Confidence            1111110                12223343333 66778899999 9999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=350.52  Aligned_cols=256  Identities=29%  Similarity=0.465  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|...+.||+|+||.||++....         +|...|||.+........+.+.+|+.+|.+|+|||||++++.....
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~   86 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR   86 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence            3467788999999999999986653         3678999998765333356688999999999999999999974444


Q ss_pred             C--eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEcccC
Q 013557          158 E--NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDFG  234 (441)
Q Consensus       158 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg  234 (441)
                      .  .+++.|||+++|+|.+++.+.++ .+++..++.+..||++||+|||+  +|||||||||+|||++. ++.+||+|||
T Consensus        87 ~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   87 ENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             cCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCc
Confidence            4  68999999999999999988776 79999999999999999999998  99999999999999999 7999999999


Q ss_pred             CcccCCC-CCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          235 LAKAGPT-GDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       235 ~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      +++.... ...........||+.|||||++..+ ....++|||||||++.||+||++||... ...              
T Consensus       164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~--------------  228 (313)
T KOG0198|consen  164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE--------------  228 (313)
T ss_pred             cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch--------------
Confidence            9986543 1111223357899999999999853 3445999999999999999999999743 000              


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ...+..+.........|.........++..|+. +|+.|||++++|++.
T Consensus       229 ~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  229 AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            011112221122224566666777888888888 999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-46  Score=331.57  Aligned_cols=236  Identities=28%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .+|++++.||.|+||.|.+++.+         ..+..+|+|++++...-   ..+...+|..+|+.+.||+++++++.|.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k---------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~  114 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREK---------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK  114 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEc---------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence            47899999999999999996544         45889999999876443   3455788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+.+||||||++||.|+.++.+.+  .+++..++.++.||+.||+|||+  ++|++|||||+|||||.+|.+||+|||+
T Consensus       115 d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  115 DNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccc
Confidence            9999999999999999999996654  49999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+.....     .-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||......                ..
T Consensus       191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~i  249 (355)
T KOG0616|consen  191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QI  249 (355)
T ss_pred             eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HH
Confidence            9875432     35789999999999999999999999999999999999999999754321                11


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR  350 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~R  350 (441)
                      ...|+...  -.+|......+..|+..+++ |-.+|
T Consensus       250 Y~KI~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  250 YEKILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            11222211  23566656666677777776 76666

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-45  Score=354.62  Aligned_cols=251  Identities=27%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC----Cc-ccHHHHHHHHHHHhcCC-CCCccc
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE----GF-QGHKEWLSEVNYLGQLH-HPNLVK  149 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~  149 (441)
                      ...++|++.+.||+|+||+|++|....         ++..||+|++...    .. ...+.+.+|+.++++++ ||||++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~   84 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR   84 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence            345789999999999999999976543         4678999987664    12 23445668999999998 999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNA  228 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~  228 (441)
                      +++++......|+||||+.||+|++++...+  .+.+..+..++.|++.|++|||+  +||+||||||+|||+|.+ +++
T Consensus        85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   85 LLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             EEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCE
Confidence            9999999999999999999999999998743  58899999999999999999999  899999999999999999 999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC-CC-chhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LT-AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      ||+|||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....         
T Consensus       161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---------  229 (370)
T KOG0583|consen  161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---------  229 (370)
T ss_pred             EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---------
Confidence            999999999763  1223456789999999999999877 85 7899999999999999999999863211         


Q ss_pred             ccccccchhhhhhhcccccCCCchhH-HHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKG-AYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              .+...+... .-.+|... ...+..|+..|+. +|..|+++.+|++.
T Consensus       230 --------~l~~ki~~~-~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  230 --------NLYRKIRKG-EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             --------HHHHHHhcC-CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                    111111111 11233333 4555666666666 99999999999943

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=353.50  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++++.||+|+||.||++         ..+.+|.++|+|++++....   ..+.++.|-.+|...++++||+|+..|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             cccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            468999999999999999995         44557999999999876443   355688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+++||||||++||++..+|.+.+  .+++..+..++.+++.|++.+|+  .|+|||||||+|+|||..|++||+|||
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeecccc
Confidence            99999999999999999999997766  59999999999999999999998  999999999999999999999999999


Q ss_pred             CcccCCC----------------------CCccc-----------------------eeeeccCCCCcCchhhhhcCCCC
Q 013557          235 LAKAGPT----------------------GDRTH-----------------------VSTQVMGTRGYAAPEYLATGRLT  269 (441)
Q Consensus       235 ~a~~~~~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~  269 (441)
                      ++.-...                      .+...                       .....+|||.|||||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9842110                      00000                       01135799999999999999999


Q ss_pred             chhhhHHHhHHHHHHHhCCCCCCccccc-cchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCC
Q 013557          270 AKCDVYSFGVVLLELLSGRRAVDKTRVG-AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAK  348 (441)
Q Consensus       270 ~~sDvwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~  348 (441)
                      ..+|+||||||+||||.|.+||...... ...++..|...+...               ...........|+..|+.||+
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~d~~  431 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLCDPE  431 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhcCHH
Confidence            9999999999999999999999755432 234445554322110               011112445666777777999


Q ss_pred             CCCC---HHHHH
Q 013557          349 VRPS---MSEVL  357 (441)
Q Consensus       349 ~RPs---~~evl  357 (441)
                      .|.-   ++||-
T Consensus       432 ~RLG~~G~~EIK  443 (550)
T KOG0605|consen  432 NRLGSKGAEEIK  443 (550)
T ss_pred             HhcCcccHHHHh
Confidence            9964   66664

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-46  Score=352.36  Aligned_cols=264  Identities=26%  Similarity=0.335  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .+.|+.++.||+|+||.||+|+         +..+|+.||+|+++.+.  ........+||.||++|+||||++|.+...
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr---------~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKAR---------DLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEee---------ecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            3568888999999999999954         44578999999998664  333456789999999999999999999987


Q ss_pred             cC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          156 DG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       156 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.  ..+|||+|||+. +|..++.. ..-.|++.++..++.|++.||+|||+  +||+|||||.+|||||.+|.+||+||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccc
Confidence            76  689999999977 89887754 33469999999999999999999999  99999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-h--------
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-V--------  303 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~--------  303 (441)
                      |+|+++....... .+..+-|.+|.|||.+.|. .|+.++|+||.||||.||++|++.|.+.......+. .        
T Consensus       263 GLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  263 GLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             cceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            9999765544332 3455679999999999875 699999999999999999999999975543222211 1        


Q ss_pred             -hhhccccccchhhhhhhc------ccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          304 -DWAKPYLGDRRKLFRIMD------IKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       304 -~~~~~~~~~~~~l~~~~~------~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                       .|....+.    ...++.      ..+.+.+.......+.+|..++.-||.+|.|+.+.|+.
T Consensus       342 ~~W~~~kLP----~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  342 DYWPVSKLP----HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hccccccCC----cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             12210000    001110      11112222333444555555555599999999998854

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.7e-45  Score=354.79  Aligned_cols=265  Identities=28%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..    ......+..||||+++.... .....+.+|+.+|..+ +||||++++++|.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFG----IDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEec----cCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4689999999999999999987532    11223456899999975432 2345688999999999 8999999999887


Q ss_pred             cCC-eeEEEEEeCCCCCHHHHHHhcC------------------------------------------------------
Q 013557          156 DGE-NRLLVYEYMPKGSLENHLFRRG------------------------------------------------------  180 (441)
Q Consensus       156 ~~~-~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  180 (441)
                      ..+ ..++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            644 5789999999999999986532                                                      


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCC
Q 013557          181 ------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT  254 (441)
Q Consensus       181 ------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt  254 (441)
                            ..++++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++...............++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                  1247788899999999999999998  89999999999999999999999999999864332221122234567


Q ss_pred             CCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHH
Q 013557          255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGA  333 (441)
Q Consensus       255 ~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  333 (441)
                      ..|+|||++.+..++.++|||||||++|||++ |..||........  ..              ..+........+....
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~  303 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC--------------QRLKDGTRMRAPENAT  303 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH--------------HHHhcCCCCCCCCCCC
Confidence            88999999998899999999999999999997 9999975432110  00              0000001111122334


Q ss_pred             HHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          334 YMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       334 ~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ..+..|+..|+. ||++||++.+|++.|+.+.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            456778888888 9999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.4e-45  Score=321.48  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .+|..++.||+|.||.||+|+..         .+|+.||||+++.....+  ....++|++.|+.++|+||+.++++|.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~---------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDT---------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEec---------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            46888899999999999997644         468899999998654332  3457899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+...||+||++. +|+..|..+ ...++..++..|+.++++||+|||+  +.|+||||||.|+||+.+|.+||+|||++
T Consensus        73 ~~~l~lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLA  148 (318)
T KOG0659|consen   73 KSNLSLVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLA  148 (318)
T ss_pred             CCceEEEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccch
Confidence            9999999999976 999988554 4579999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh--hhhhccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL--VDWAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~--~~~~~~~~~~~  313 (441)
                      +.+...+...  ...+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|.+....+....  .....|...+.
T Consensus       149 r~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W  226 (318)
T KOG0659|consen  149 RFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW  226 (318)
T ss_pred             hccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence            9866544332  22367899999999887 4699999999999999999999988865443222111  11222322222


Q ss_pred             hhhhhhhcc---------cccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHHh
Q 013557          314 RKLFRIMDI---------KLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSAL  360 (441)
Q Consensus       314 ~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~L  360 (441)
                      ..+..+.+.         ....-++......+.++..+..-||.+|.++.|.+++-
T Consensus       227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence            222222211         11223444555555555555555999999999998773

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=347.19  Aligned_cols=267  Identities=25%  Similarity=0.349  Sum_probs=204.3

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHH-HHHHHHHHhcCC-CCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLH-HPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-hpnIv~l~~~  153 (441)
                      ...++|.+.+.||.|+||.||+|...         .++..||||+++.......+. -++|++.|++|+ ||||+++.++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~---------~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Ev   77 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSK---------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEV   77 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeec---------CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence            35678999999999999999997554         357789999998765443222 378999999998 9999999999


Q ss_pred             EEcCC-eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          154 CLDGE-NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       154 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      +.+.+ .+|+|||||+. +|++++..+ .+.|++..+..|+.||+.||+|+|.  +|++||||||+|||+..+..+||+|
T Consensus        78 i~d~~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   78 IRDNDRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             hhccCceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecc
Confidence            98887 99999999965 999999877 6789999999999999999999998  9999999999999999888999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhh-cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh----c
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA----K  307 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~----~  307 (441)
                      ||+||......   ..+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|.+....+  .+....    .
T Consensus       154 FGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~VLGt  228 (538)
T KOG0661|consen  154 FGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEVLGT  228 (538)
T ss_pred             cccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHHhCC
Confidence            99999754433   234567899999999985 5678999999999999999999999998665322  222111    1


Q ss_pred             ccccc---chhhhhhhcccccC--------CCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHHh
Q 013557          308 PYLGD---RRKLFRIMDIKLEG--------QYPQKGAYMVAILALQCISEAKVRPSMSEVLSAL  360 (441)
Q Consensus       308 ~~~~~---~~~l~~~~~~~~~~--------~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~L  360 (441)
                      |....   ...+...+.-.+..        -.+....+.+..|..+|.-||++|||+.+.+++-
T Consensus       229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            11111   11122222222211        1233333344444444444999999999998873

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-45  Score=357.88  Aligned_cols=247  Identities=26%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .+-|++++.||.|+-|.|.+|         ++..+|+..|||++.+...   .....+.+|+-||+.+.|||++++|+++
T Consensus        11 iGpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw   81 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW   81 (786)
T ss_pred             ccceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee
Confidence            345889999999999999984         5556799999999976521   1233467899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      ++..++|+|.||++||.|++++.+++  ++++.++..++.||+.|+.|||.  .+|+||||||+|+|||..+++||+|||
T Consensus        82 e~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   82 ENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             ccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccc
Confidence            99999999999999999999998877  49999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      +|..-..+.   .-.+-||+|.|.|||++.|.+| +.++||||+|||||.||||+.||++.++.                
T Consensus       158 MAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir----------------  218 (786)
T KOG0588|consen  158 MASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR----------------  218 (786)
T ss_pred             eeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH----------------
Confidence            998654443   3346799999999999999998 56899999999999999999999855432                


Q ss_pred             hhhhhhhcccccC--CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          314 RKLFRIMDIKLEG--QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       314 ~~l~~~~~~~~~~--~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                          .++.+.-.+  +.|......+..|+..++. ||+.|.|++||+++.
T Consensus       219 ----~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  219 ----VLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ----HHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                112222222  2355556667777888887 999999999999873

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=337.75  Aligned_cols=262  Identities=25%  Similarity=0.307  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .+.|++...||.|..++||+|++..         .+..||||++..+.... ...+.+|+..|+.++||||++++..|..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            4689999999999999999987654         46799999998765544 4778999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      +..+++||.||.+|++.+++...-...+++..+..|+.++++||.|||.  +|.||||||+.||||+.+|.|||+|||.+
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999988777779999999999999999999998  99999999999999999999999999987


Q ss_pred             ccCCC-CCcccee-eeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          237 KAGPT-GDRTHVS-TQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       237 ~~~~~-~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      -.... +...... .++.||+.|||||++..  ..|+.|+||||||+++.||.+|..||.....-....+.-...+....
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            64332 2222222 56789999999999643  46999999999999999999999999865421111000000000000


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                          ...++    .+...........++..|++ ||.+|||+++++.
T Consensus       254 ----t~~~~----~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 ----TSGLD----KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ----cccCC----hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                00000    00011112245566677777 9999999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-45  Score=339.85  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=205.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHH---HHHHHHHHHhcCCCCCcccEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK---EWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      +...+|++.+.||+|.||+|-+|+         +...|+.||||.+++....+.+   .+.+|++||..|+||||+.++.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~---------e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE  120 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAY---------EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE  120 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehh---------hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhh
Confidence            456789999999999999999854         3446899999999887665544   4789999999999999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      +|++.+...|||||..+|.|+||+.+.+.  +++.++..++.||..|+.|||.  ++++|||||.+|||+|+|+++||+|
T Consensus       121 VFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  121 VFENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             hhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeec
Confidence            99999999999999999999999987764  9999999999999999999998  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      ||++.++....   +..++||++-|.+||++.|.+| ++.+|-|||||+||-|+.|..||++.+...             
T Consensus       197 FGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------------  260 (668)
T KOG0611|consen  197 FGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------------  260 (668)
T ss_pred             cchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------------
Confidence            99998765543   4467899999999999999988 689999999999999999999998654321             


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                          +.+.+..... .-|........+|..++..+|++|.|+.+|..+
T Consensus       261 ----lvrQIs~GaY-rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  261 ----LVRQISRGAY-REPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ----HHHHhhcccc-cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                1111111110 112233333334444444599999999998754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-44  Score=333.86  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++++.||.|.-|+||++..+         +++..+|+|++.+.....   ..+...|-+||+.++||.++.||..|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~---------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELR---------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEec---------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            457888999999999999997654         346789999998765433   34567899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      +.+...|+|||||+||+|..+++++..+-+++..++.++.+++.||+|||.  .|||+|||||+||||.++|++-|+||.
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecc
Confidence            999999999999999999999999988889999999999999999999998  999999999999999999999999999


Q ss_pred             CcccCCC---------------------------------CCcc---------------------ceeeeccCCCCcCch
Q 013557          235 LAKAGPT---------------------------------GDRT---------------------HVSTQVMGTRGYAAP  260 (441)
Q Consensus       235 ~a~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aP  260 (441)
                      ++.....                                 ....                     .....++||-.|+||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            8753210                                 0000                     012246799999999


Q ss_pred             hhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHH
Q 013557          261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILA  340 (441)
Q Consensus       261 E~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~  340 (441)
                      |++.|...+.++|+|+|||++||||.|..||.+.+.                ...+.+++...+.-.........+..|+
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLI  368 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLI  368 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence            999999999999999999999999999999986542                2334444444332211123344556666


Q ss_pred             HHHhc-CCCCCCC----HHHHHHH
Q 013557          341 LQCIS-EAKVRPS----MSEVLSA  359 (441)
Q Consensus       341 ~~c~~-~P~~RPs----~~evl~~  359 (441)
                      +.++. ||.+|..    ++||-++
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHhccChhhhhccccchHHhhcC
Confidence            66666 9999988    7777543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.4e-45  Score=349.65  Aligned_cols=247  Identities=29%  Similarity=0.398  Sum_probs=203.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|.+.+.||+|.||.||||+-         +.+.+.||+|.+.+...  .+.+.+.+|++|++.|+||||+.++++|++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrr---------K~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRR---------KYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeeccc---------ccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            5789999999999999999754         44678999999876543  345668999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ..++++|.||+.| +|+.+|...+.  ++++.+..++.+++.||.|||+  ++|+|||+||.|||++.+|.+|++|||+|
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~A  147 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLA  147 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhh
Confidence            9999999999977 99999976654  9999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      +....  .+...+.+.|||.|||||+..++.|+..+|+||||||+|||++|++||-...+                 ..+
T Consensus       148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----------------~~L  208 (808)
T KOG0597|consen  148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----------------TQL  208 (808)
T ss_pred             hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------------HHH
Confidence            97544  44566778899999999999999999999999999999999999999953221                 111


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+.+.... ..+|.........+...++. ||..|.+..+++.+
T Consensus       209 v~~I~~d~-v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  209 VKSILKDP-VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHhcCC-CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            12222111 12344444444555555555 99999999998754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=351.50  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=209.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ..|.....||+|+.|.||.+.         ...++..||||++........+-+++|+.+|+.++|+|||.+++.|...+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~---------~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVAR---------KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhcchhhhccccccceeeee---------eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            468888999999999999854         44567789999998877677777999999999999999999999999899


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .+++||||++||+|.|.+....   +++.++..|+.+++.||+|||.  +||+|||||.+|||++.+|.+||+|||++..
T Consensus       344 eLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             eeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeec
Confidence            9999999999999999886544   8999999999999999999998  9999999999999999999999999999987


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  ...+.+|||.|||||+.....|++++||||||++++||+-|++||-.....                +.+..
T Consensus       419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----------------rAlyL  480 (550)
T KOG0578|consen  419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------------RALYL  480 (550)
T ss_pred             cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----------------HHHHH
Confidence            544332  345778999999999999999999999999999999999999998532210                11111


Q ss_pred             hhcc-cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDI-KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~-~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +.+. ...-..+......+..+...|+. |+++|+++.|+|++
T Consensus       481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            1111 11223455556677788888888 99999999999976

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=354.87  Aligned_cols=243  Identities=28%  Similarity=0.414  Sum_probs=200.1

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      ..++|+++++||+|.||+|+++..+         .++..+|||.+++...   .+.+..+.|.+|+... +||.++.++.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k---------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELK---------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEc---------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence            4578999999999999999996544         4678999999998754   3455678899998887 5999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .|.+.+++|+||||+.||++..++.   ...+++..+..|+..|+.||+|||+  +||||||||.+|||||.+|++||+|
T Consensus       437 ~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  437 CFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             ccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecc
Confidence            9999999999999999999655432   2349999999999999999999998  9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||+++......  ....+++|||.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+.+               
T Consensus       512 FGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------  574 (694)
T KOG0694|consen  512 FGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------  574 (694)
T ss_pred             cccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------
Confidence            99999754322  2456899999999999999999999999999999999999999999865422               


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                        +++..+. .....+|.........|+..++. +|++|.-+
T Consensus       575 --e~FdsI~-~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 --EVFDSIV-NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHHHHHh-cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              2222111 12234566666666666666666 99999865

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=348.75  Aligned_cols=265  Identities=27%  Similarity=0.433  Sum_probs=208.8

Q ss_pred             HHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCccc
Q 013557           72 SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      .++..-.+...+...||+|.||+||+|.|..            .||||+++....  ...+.|.+|+.++++-+|-||+-
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence            4444556778889999999999999999874            599999986644  34567999999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      +.|+|..+.. .||..||+|.+|+.+|+-.. ..|.....+.|+.||+.||.|||.  ++|||||||..||++.+++.||
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEE
Confidence            9999998877 99999999999999997554 348999999999999999999999  9999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      |+|||++..-.............|...|||||+++.   .+|++.+||||||+++|||+||..||.....+  +.+..-.
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmVG  606 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMVG  606 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEec
Confidence            999999965322211112233457889999999975   36899999999999999999999999733221  1111111


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      +.+...        +   ....-..+...+..|...||. ++++||.+.+|+..|+.+..
T Consensus       607 rG~l~p--------d---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGYLMP--------D---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccccCc--------c---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111100        0   001123445677888899998 99999999999998887655

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-43  Score=348.64  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..    ..+...+..||||+++.... ...+.+.+|+.+|..+ +||||++++++|.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYG----LFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEec----cccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            4579999999999999999987532    12233466899999975432 3345688999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC-------------------------------------------------------
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG-------------------------------------------------------  180 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  180 (441)
                      +....++||||+++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999986432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCC
Q 013557          181 ------------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG  242 (441)
Q Consensus       181 ------------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~  242 (441)
                                        ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              1247888899999999999999998  89999999999999999999999999999865433


Q ss_pred             CccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       243 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....              .+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~--------------~~~  331 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK--------------MIK  331 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH--------------HHH
Confidence            22222223345678999999999999999999999999999998 888886432111  1111              111


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      .......+......+..|+..|+. ||++||++.+|++.|++
T Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            111111122233456678888888 99999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7e-43  Score=335.89  Aligned_cols=272  Identities=26%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccc-------cccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCccc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLE-------AARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      .++|++.+.||+|+||.||+|.+......       ......+..||+|.+...... ...++.+|+++|.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            35799999999999999999986542210       112334568999998765322 3456889999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-----------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIY  212 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH  212 (441)
                      +++++.+.+..++||||+++++|.+++.....                 ..+++..++.++.||+.||.|||+  .+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence            99999999999999999999999999864321                 236778899999999999999998  89999


Q ss_pred             eccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh--CCCC
Q 013557          213 RDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS--GRRA  290 (441)
Q Consensus       213 ~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~p  290 (441)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543332222233456789999999998899999999999999999987  5567


Q ss_pred             CCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          291 VDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       291 f~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      |......   ............       .........+......+..|+..|+. +|++||++.+|.+.|+
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRD-------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhh-------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7543211   111111100000       00001111222334566788888988 9999999999998885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=346.10  Aligned_cols=237  Identities=29%  Similarity=0.493  Sum_probs=199.3

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ++-||.|+.|.||+|.++           +..||||+++.-.       ..+|+-|++|+|+||+.+.|+|.....+|||
T Consensus       129 LeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             hhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            467999999999999876           4579999986422       2478889999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      ||||..|.|++.|..  .++++......|..+|+.||.|||.  +.|||||||.-||||..+..|||+|||.++..... 
T Consensus       191 MEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             eeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            999999999999954  4469999999999999999999999  78999999999999999999999999999875432 


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                        ...-.++||..|||||++++.+.++|+|||||||+|||||||..||.+.+..    .+.|.            .-...
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwG------------VGsNs  327 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWG------------VGSNS  327 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEe------------ccCCc
Confidence              2334678999999999999999999999999999999999999998643211    11111            01112


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      +.-..|..+++-+.+|++.||+ .|..||++++|+.+|+
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            2234567777888999999999 8999999999998876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.8e-44  Score=360.41  Aligned_cols=266  Identities=28%  Similarity=0.452  Sum_probs=221.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..+.++.+.||+|+||+||+|.....    .-....+.||||.++..... ...+|.+|+++|..|+|||||+++|+|.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            35667789999999999999876542    12234678999999987665 66789999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC--------CCC----CCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG--------ARP----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~~----~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      ++-.|||+|||..|+|.++|..+.        ..+    ++..+.+.|+.||+.||+||-+  +.+|||||-..|+||.+
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceecc
Confidence            999999999999999999996432        223    8889999999999999999998  88999999999999999


Q ss_pred             CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhh
Q 013557          225 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~  303 (441)
                      +..|||+|||+++.....++........-..+||+||.+..++|+.+||||||||+|||+++ |+.|+.+...+      
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------  712 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------  712 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------
Confidence            99999999999997666665554434444679999999999999999999999999999998 88888644322      


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                                 ++.+.+...-.-..|..++..+..|+..||+ .|++||++.||-..|+.+...
T Consensus       713 -----------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 -----------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -----------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                       1222222222245788888999999999999 899999999999999876543

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.3e-43  Score=347.58  Aligned_cols=264  Identities=27%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+...    .....+..||||+++.... .....+.+|+.+|+.+ +|+||++++++|.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            35799999999999999999875421    1223456799999976432 2345688999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC-------------------------------------------------------
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG-------------------------------------------------------  180 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  180 (441)
                      +....++||||+++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999985421                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccce
Q 013557          181 -------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV  247 (441)
Q Consensus       181 -------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~  247 (441)
                                   ..++++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++..........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                         1247888899999999999999998  8999999999999999999999999999976433222222


Q ss_pred             eeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcccccC
Q 013557          248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEG  326 (441)
Q Consensus       248 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  326 (441)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......                .+...+......
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~~  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQM  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccCc
Confidence            223345678999999998899999999999999999997 999996432111                011111111111


Q ss_pred             CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          327 QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       327 ~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ..+......+..++..|+. +|++||++.+|++.|+++
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1222223456778888888 999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-44  Score=342.90  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=210.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|..++++|+|+||.+++         +.++..+..+++|++......  ..+...+|+.++++++|||||.+.+.|++
T Consensus         4 ~~Ye~~~~iG~GafG~a~l---------vrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~   74 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALL---------VRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE   74 (426)
T ss_pred             chhhhhhhcCccccchhhh---------hhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence            5799999999999999998         455556779999998765433  23457899999999999999999999998


Q ss_pred             CCe-eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          157 GEN-RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       157 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ++. .+|||+||+||+|.+.|.+..+.-++++.++.|+.|++.|+.|||+  +.|+|||||+.||+++.++.|||+|||+
T Consensus        75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhh
Confidence            888 9999999999999999988777779999999999999999999997  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+......  ....+.+||+.||+||.+.+.+|+.|+|||||||++|||++-+++|...+...                -
T Consensus       153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------L  214 (426)
T KOG0589|consen  153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------L  214 (426)
T ss_pred             hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----------------H
Confidence            99865543  23457899999999999999999999999999999999999999998544221                1


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +..++. ......|......+..|+..|+. +|..||++.++|.+
T Consensus       215 i~ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  215 ILKINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            111111 22223455556667778888887 99999999999865

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.3e-43  Score=333.12  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=199.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .|++.+.||+|+||.||+|....         ++..||+|.+......   ....+.+|+.+|.+++|+||+++++++.+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~   71 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence            37788999999999999976543         4778999998654322   23457789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999998876555568999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........             +
T Consensus       150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-------------~  213 (285)
T cd05631         150 VQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-------------V  213 (285)
T ss_pred             EEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-------------H
Confidence            7643222   12345789999999999999999999999999999999999999975432111000             0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                      ...+. .....++......+..|+..|+. ||++||+     ++++++.
T Consensus       214 ~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         214 DRRVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            00000 11112233334556678888888 9999997     7888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-42  Score=328.58  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=196.2

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEEEEc----C
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGFCLD----G  157 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~  157 (441)
                      ..||+|++|.||+|.+.           ++.||||.++......   .+.+.+|+.+|.+++||||+++++++.+    .
T Consensus        26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            67999999999998764           6689999997654333   4567899999999999999999999876    3


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++|+|.+++....  .+++...+.++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence            46899999999999999996543  588999999999999999999972 488999999999999999999999999988


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.......   +..           
T Consensus       172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~-----------  232 (283)
T PHA02988        172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD-----------  232 (283)
T ss_pred             hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH-----------
Confidence            543221     23468899999999976  689999999999999999999999997543211   101           


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                        .+.........+......+..++..||. ||++||++.||++.|+++.
T Consensus       233 --~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        233 --LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              0111111112232345567788889998 9999999999999998654

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.5e-42  Score=328.25  Aligned_cols=261  Identities=27%  Similarity=0.464  Sum_probs=206.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||+|......    .......+++|.++.... .....+.+|+.++.+++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            47889999999999999998765321    123456899999875432 2345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      ...+++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+  ++++|+||||+||+++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~  158 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVG  158 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEc
Confidence            999999999999999999975421              357889999999999999999998  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhh
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNL  302 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~  302 (441)
                      .++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......    
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----  234 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----  234 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence            999999999999976433332222334457889999999988899999999999999999998 999986433211    


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                                   +...+........+......+..|+..|+. +|++||++.+|+++|+.
T Consensus       235 -------------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 -------------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                         111111111112233445667788899998 99999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.6e-43  Score=317.18  Aligned_cols=268  Identities=23%  Similarity=0.274  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|+.++.|++|+||.||+|         +++.++..||+|+++.+....  --..++|+.+|.+++|||||.+-.+.
T Consensus        74 sv~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVV  144 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVV  144 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEE
Confidence            3457888999999999999995         556678999999998654221  12357999999999999999999886


Q ss_pred             E--cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          155 L--DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       155 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .  +-+..|||||||+. +|..++.... ++|...++..++.|+++||+|||.  +.|+|||||++|+|+...|.+||+|
T Consensus       145 vG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaD  220 (419)
T KOG0663|consen  145 VGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIAD  220 (419)
T ss_pred             eccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecc
Confidence            6  44679999999977 9999886544 679999999999999999999998  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhh-hccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDW-AKPY  309 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~-~~~~  309 (441)
                      ||+|+.+...-  ...+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.|||++++.|.+...-...+. ... ..|.
T Consensus       221 FGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  221 FGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS  298 (419)
T ss_pred             cchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence            99999865432  234556789999999999875 589999999999999999999999976543222111 111 1111


Q ss_pred             cccchh-----------hhhhhcccccCCCchh-HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          310 LGDRRK-----------LFRIMDIKLEGQYPQK-GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~-----------l~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ......           +.......++..++.. ..+.-..|...++. ||++|-|+.+.|++
T Consensus       299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            111111           1111111223333333 23444556666666 99999999998876

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-43  Score=308.04  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=209.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|.||.||+|+.+.         ++..||+|++.+...   .-.+.+.+|++|-..|+||||++++++|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            3589999999999999999976554         467899999876532   2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....||++||..+|+|+..|.......+++.....+..|++.||.|+|.  ++++||||||+|+|++..+.+||+|||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCC
Confidence            999999999999999999999987777779999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      .+......    ...+.+||..|.+||...+..++..+|+|++|++.||+|.|.+||+....+                .
T Consensus       170 wsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------e  229 (281)
T KOG0580|consen  170 WSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------E  229 (281)
T ss_pred             ceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------H
Confidence            99865422    345789999999999999999999999999999999999999999744311                1


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...++..  ..-.+|......+..++..|+. +|.+|.+..|+++.
T Consensus       230 tYkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  230 TYKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1112111  1223455566667778888887 99999999999865

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=350.89  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=206.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEE-E
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGF-C  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~-~  154 (441)
                      ...++++.+.|.+|||+.||+|....         .|..||+|++-.......+.+.+|+++|++|+ |+|||.++|. .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~  105 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSA  105 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence            34578889999999999999976543         34789999987776677788999999999996 9999999993 2


Q ss_pred             Ec------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          155 LD------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       155 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ..      .-..+|.||||.||.|-|++..+....|++.++++|+.++++|+.+||.....|||||||-+||||..+|+.
T Consensus       106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence            21      135689999999999999998776666999999999999999999999966679999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceee-------eccCCCCcCchhhh---hcCCCCchhhhHHHhHHHHHHHhCCCCCCcccccc
Q 013557          229 KLSDFGLAKAGPTGDRTHVST-------QVMGTRGYAAPEYL---ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA  298 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~-------~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~  298 (441)
                      ||||||.+.............       ...-|+.|+|||++   .+..+++|+|||||||+||-|+....||+..+.  
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--  263 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--  263 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence            999999986422111000000       12368999999987   467899999999999999999999999985432  


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCCC
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPR  367 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~~  367 (441)
                                        ..|+.....-.........+..|++.||+ +|.+||++-+|++.+-.++...
T Consensus       264 ------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                              12222222111123455667778888888 9999999999999887665543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-42  Score=337.18  Aligned_cols=242  Identities=27%  Similarity=0.349  Sum_probs=193.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      +.||+|+||.||++...         ..++.+|+|+++....   .....+.+|+.+|++++||||+++++++.+.+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREK---------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            47999999999997543         3478899999875422   23355788999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++++|.+++....  .+++..+..++.||+.||+|||+  +||+||||||+|||++.++.+||+|||+++....
T Consensus        72 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            9999999999999986644  58999999999999999999998  8999999999999999999999999999875322


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..             .+..
T Consensus       148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~-------------~~~~  209 (323)
T cd05571         148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE-------------LILM  209 (323)
T ss_pred             CC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HH-------------HHHc
Confidence            11  122346799999999999999999999999999999999999999964322110   00             0000


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      .  ...++......+..++..|+. ||++||     ++.+++++
T Consensus       210 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         210 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            0  012233334456677778887 999999     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=328.04  Aligned_cols=257  Identities=27%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--------------ccHHHHHHHHHHHh
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--------------QGHKEWLSEVNYLG  140 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~  140 (441)
                      .+..++|++.+.||+|.||.|.+|+..         .+++.||||++.+...              ...+.+.+|+.||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~---------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK  163 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDE---------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK  163 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeec---------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence            456689999999999999999997654         3578999999975422              12357899999999


Q ss_pred             cCCCCCcccEEEEEEc--CCeeEEEEEeCCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCC
Q 013557          141 QLHHPNLVKLIGFCLD--GENRLLVYEYMPKGSLENHLFRRGARP-LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKA  217 (441)
Q Consensus       141 ~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp  217 (441)
                      +|.|||||+|+++..+  .+.+|||+|||..|.+...   ....+ +.+.++++|+.+++.||+|||.  +|||||||||
T Consensus       164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKP  238 (576)
T KOG0585|consen  164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKP  238 (576)
T ss_pred             hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccch
Confidence            9999999999999875  4688999999998887542   23334 8999999999999999999998  9999999999


Q ss_pred             CcEEECCCCcEEEcccCCcccCCCCC---ccceeeeccCCCCcCchhhhhcCC----CCchhhhHHHhHHHHHHHhCCCC
Q 013557          218 SNILLDSEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTRGYAAPEYLATGR----LTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       218 ~Nill~~~~~~kl~DFg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~p  290 (441)
                      +|+||+.+|++||+|||.+.....+.   .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.|
T Consensus       239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            99999999999999999998652221   111122368999999999998743    35688999999999999999999


Q ss_pred             CCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          291 VDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       291 f~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      |.....-                .....|+...+.-....+....+.+|++.++. ||+.|.+..+|..+..
T Consensus       319 F~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  319 FFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             cccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            9643211                11112222222211112235566777777776 9999999999876654

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.3e-42  Score=322.86  Aligned_cols=259  Identities=24%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|++...      ...+..+|+|.++.... .....+.+|+.++.+++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLP------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecC------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            45799999999999999999976431      22467899999976532 234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+  .+++||||||+|||++.++.+||+|||.+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            999999999999999999987643 358999999999999999999998  89999999999999999999999999987


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||.......   ....          
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----------  220 (266)
T cd05064         155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----------  220 (266)
T ss_pred             ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----------
Confidence            65322111 11112345678999999999999999999999999999775 999996433211   1110          


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                          +........+......+..++..|+. +|++||++++|++.|.++
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         221 ----VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                00011111233344567778888888 999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.1e-42  Score=341.54  Aligned_cols=265  Identities=26%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      .++|++.++||+|+||.||+|....    ..+...+..||||+++.... ...+.+.+|+++|+++. ||||++++++|.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYG----LSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcc----cCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            5689999999999999999987642    12223456799999975433 23456889999999996 999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC-------------------------------------------------------
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG-------------------------------------------------------  180 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  180 (441)
                      +....||||||+++|+|.++|..+.                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999999986531                                                       


Q ss_pred             ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          181 ---------------------------------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       181 ---------------------------------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                                                             ...+++..++.++.||+.||.|||+  .+|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nil  269 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEE
Confidence                                                   1247788889999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ 
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-  348 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-  348 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence            99999999999999976433222222233457788999999998899999999999999999997 9999864321110 


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                       .              ...+........+......+..++..|+. +|++||++.+|.+.|+++.
T Consensus       349 -~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 -F--------------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -H--------------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             0              00011111111222334556778888888 9999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.8e-42  Score=325.76  Aligned_cols=260  Identities=26%  Similarity=0.439  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|.+.+.||+|+||.||+|.....    .....+..+|||.++..... ....+.+|+++|++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            5688899999999999999876431    11234678999999765443 346789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      ...++||||+++++|.+++...+            ...+++..+..++.|++.||.|||+  ++++||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~  158 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCC
Confidence            99999999999999999997543            2347888999999999999999998  899999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhh
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~  304 (441)
                      +.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ...
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~  235 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE  235 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH
Confidence            9999999999875433222222233456788999999999999999999999999999998 999986433211   111


Q ss_pred             hhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          305 WAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       305 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      .              +........+......+..++..|+. +|++||++.||++.|+
T Consensus       236 ~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 C--------------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H--------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1              00111111222334556778888887 9999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=335.41  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=206.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..|+..++||+|.||.||+|...         .+++.||+|++..+... ..+++.+|+.+|..++++||.++|+.|..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~---------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g   83 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDN---------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG   83 (467)
T ss_pred             cccccchhccccccceeeeeeec---------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence            45777899999999999997654         46789999999876443 467889999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ..++++|||+.||++.+.+....  .+.+..+..++++++.||.|||.  .+.+|||||+.|||+..+|.+||+|||.+-
T Consensus        84 ~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   84 TKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAG  159 (467)
T ss_pred             ccHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceee
Confidence            99999999999999999885433  35888888999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ........  ..+++||+.|||||++.+..|+.++||||||+++|||.+|.+|+.....                 .++.
T Consensus       160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------------mrvl  220 (467)
T KOG0201|consen  160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------------MRVL  220 (467)
T ss_pred             eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------------ceEE
Confidence            75443322  3678999999999999988999999999999999999999999975432                 1111


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      -++.+.............+..++.+|+. +|+.||++.+++.
T Consensus       221 flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  221 FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2222222333334455667788899998 9999999999874

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=332.43  Aligned_cols=245  Identities=23%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|...         .+++.+|+|++.....   ...+.+.+|+.+|++++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            47899999999999999997654         3477899999865322   23456788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....++||||+++++|.+++....  .+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCc
Confidence            9999999999999999999996654  58999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .            
T Consensus       148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~------------  207 (291)
T cd05612         148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---Y------------  207 (291)
T ss_pred             chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H------------
Confidence            9864322     1245799999999999988899999999999999999999999974321110   0            


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                       ..+...  ...++......+..|+..|+. ||.+||+     +.+++++
T Consensus       208 -~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         208 -EKILAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -HHHHhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             011110  011233334456678888887 9999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-42  Score=350.24  Aligned_cols=252  Identities=22%  Similarity=0.265  Sum_probs=199.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      .|.+.+.||+|+||.||+|.....        .+..||+|.+..........+.+|+.+|+.++||||++++++|...+.
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            489999999999999999754321        145788888765544445567889999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          160 RLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      .||||||++||+|.+++...  ...++++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            99999999999999988643  33468999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .             +.
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~-------------~~  281 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I-------------MQ  281 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---H-------------HH
Confidence            6543332223345679999999999999999999999999999999999999996432110   0             01


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      .++.... ...+......+..++..|+. +|++||++.+++.
T Consensus       282 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        282 QVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1111000 11122233456677777887 9999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.7e-42  Score=333.07  Aligned_cols=201  Identities=30%  Similarity=0.426  Sum_probs=174.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||++...         .++..+|+|.+..... .....+.+|+++|++++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            468999999999999999997654         3477899999876432 234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence            999999999999999999986544  48899999999999999999997 246999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         152 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            754322    123457899999999999989999999999999999999999999644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.7e-42  Score=326.57  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|.+.+.||+|+||.||+|.....    .....+..+++|.+........+.+.+|+.++++++|+||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            4688899999999999999875431    122345678999987765555667899999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      ..++||||+++++|.+++.....              ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEcc
Confidence            99999999999999999965431              247899999999999999999998  89999999999999999


Q ss_pred             CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhh
Q 013557          225 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~  303 (441)
                      ++.+||+|||++................++..|+|||++.+..++.++|||||||++|||+| |+.||........   .
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~  235 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---I  235 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H
Confidence            99999999999976433322222233456789999999998899999999999999999999 9999864432111   1


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ..              +........+......+..++..|+. +|++||++.+|++.|+++..
T Consensus       236 ~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         236 EC--------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HH--------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            10              01011111122233456678888887 99999999999999987744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.3e-42  Score=329.95  Aligned_cols=261  Identities=24%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .+|++.+.||+|+||.||+|.+....     ......||+|.++.... ...+++.+|+.+++.++||||+++++++...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCC-----CccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            57999999999999999999865321     12244699999875432 3356788999999999999999999998764


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                       ..++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccccc
Confidence             5789999999999999987643 348899999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...............++..|+|||++.+..++.++|||||||++|||++ |+.||+......                 +
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----------------~  220 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I  220 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence            6543322211222334678999999999999999999999999999998 999987432111                 0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ..++........+......+..++..|+. +|.+||++.+|+..|.++..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            11111111111122333456678888887 99999999999999886644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.2e-42  Score=333.03  Aligned_cols=255  Identities=25%  Similarity=0.315  Sum_probs=196.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC----cccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG----FQGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      +|++.+.||+|+||.||++...      .....+..+|+|++....    ....+.+..|+.+|..+ +|+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKV------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEc------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            5888999999999999998653      223457899999986432    12234577899999999 599999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+++|+|.+++..+.  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999999999986654  48999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      +++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...........           
T Consensus       151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-----------  218 (332)
T cd05614         151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-----------  218 (332)
T ss_pred             CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-----------
Confidence            99754322211 12345799999999999865 478899999999999999999999964322111100           


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                        +...+. ......+......+..++..|+. ||++||     ++++++++
T Consensus       219 --~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         219 --VSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --HHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              000000 01112233334556677888887 999999     67787765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-42  Score=337.06  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|....         +++.+|+|+++....   ...+.+.+|+.+|++++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            578999999999999999976543         477899999865321   23456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..|+||||+.+++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~  164 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGF  164 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccC
Confidence            9999999999999999999997654  48899999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .             
T Consensus       165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~-------------  223 (329)
T PTZ00263        165 AKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---I-------------  223 (329)
T ss_pred             ceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---H-------------
Confidence            9864322     124579999999999999999999999999999999999999996432110   0             


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                      ...+....  ...+......+..|+..|+. ||++|++     +++++.+
T Consensus       224 ~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        224 YEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            00111100  11222233456677888887 9999986     6777755

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-42  Score=339.10  Aligned_cols=203  Identities=28%  Similarity=0.386  Sum_probs=173.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||++...         .+++.+|+|+++....   .....+.+|+.++.+++|+||+++++.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKK---------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            47899999999999999997543         3577899999875321   22345788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....|+||||++||+|.+++.+..  .+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGl  147 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGL  147 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccC
Confidence            9999999999999999999997654  58999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHH
Q 013557          236 AKAGPTGDRT---------------------------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLL  282 (441)
Q Consensus       236 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~  282 (441)
                      ++........                                 ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence            8753221100                                 0112357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCcc
Q 013557          283 ELLSGRRAVDKT  294 (441)
Q Consensus       283 elltg~~pf~~~  294 (441)
                      ||++|+.||...
T Consensus       228 ell~G~~Pf~~~  239 (363)
T cd05628         228 EMLIGYPPFCSE  239 (363)
T ss_pred             HHHhCCCCCCCC
Confidence            999999999744

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=358.40  Aligned_cols=266  Identities=29%  Similarity=0.415  Sum_probs=214.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC-CcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..+..+.+.||+|+||.||.|.......    ......||||.+++. ..++..+|++|..+|+.++|||||+++|++.+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~----~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPG----SVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCC----CccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            3456677899999999999998765221    111457999999765 34556789999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG-----ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      ....+|++|||+||+|..+|.+..     ...++....+.++.+||+|+.||++  +++|||||..+|+||+....+||+
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEc
Confidence            999999999999999999997541     3458899999999999999999998  999999999999999999999999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      |||+|+.....++........-...|||||.+..+.++.|+|||||||+|||++| |..||.....              
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------------  910 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------------  910 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------------
Confidence            9999995444443332222233468999999999999999999999999999999 7888864321              


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                         ..+.......-+-..|..++..+..|+..||+ +|++||++..|++.+..+...
T Consensus       911 ---~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  911 ---FEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ---HHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence               11111111112445677888888899999999 999999999999988766544

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=336.78  Aligned_cols=252  Identities=26%  Similarity=0.342  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|....         ++..||||+++....   .....+.+|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            478999999999999999976543         467899999875422   23456788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcC
Confidence            9999999999999999999996544  48999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~  314 (441)
                      +.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+..|....     
T Consensus       148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  217 (333)
T cd05600         148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----  217 (333)
T ss_pred             Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc-----
Confidence            975432     22346799999999999999999999999999999999999999975432211 1111111000     


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            ...............+..++..|+. +|++||++.+++++
T Consensus       218 ------~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         218 ------QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  0000000001123345566677777 78999999999876

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.3e-42  Score=330.91  Aligned_cols=242  Identities=26%  Similarity=0.333  Sum_probs=192.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      +.||+|+||.||++...         ..+..||+|+++....   .....+.+|+++++.++||||++++++|...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            47999999999997543         3577899999875422   23445778999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++|+|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  147 (323)
T cd05595          72 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence            9999999999999886544  58999999999999999999998  8999999999999999999999999999875322


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..+..
T Consensus       148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----------------~~~~~  209 (323)
T cd05595         148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----------------ELILM  209 (323)
T ss_pred             CC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHhc
Confidence            11  1123457999999999999999999999999999999999999999643321110                00000


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      ..  ...+......+..++..|+. ||++|+     ++.+++++
T Consensus       210 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         210 EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            00  11233334456677788887 999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-41  Score=324.36  Aligned_cols=265  Identities=27%  Similarity=0.442  Sum_probs=206.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|.+.+.||+|+||.||++....    ......+..+++|.+..........+.+|+.+|++++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~----~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYN----LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEecc----CCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4679999999999999999986532    112234567999998766545566789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      +..++||||+++++|.+++....           ...+++..++.++.|++.||+|||+  ++++||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCC
Confidence            99999999999999999986443           1248999999999999999999998  8999999999999999999


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDW  305 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~  305 (441)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........   .. 
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~-  233 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE-  233 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-
Confidence            999999999975433222112223345778999999998889999999999999999998 8999864432110   00 


Q ss_pred             hccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          306 AKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       306 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                  .+..... ...+......+..|+..|+. +|.+||++.+|++.|+++..
T Consensus       234 ------------~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         234 ------------CITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             ------------HHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                        0000000 01111223446778888888 99999999999999987653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-42  Score=322.68  Aligned_cols=254  Identities=36%  Similarity=0.561  Sum_probs=196.7

Q ss_pred             CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           83 PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        83 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      +.+.||.|.||.||+|.+..     .....+..|+||.++.... ...+.+.+|++++++++||||+++++++.+....+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence            35789999999999998863     2334577899999976433 33678999999999999999999999999888899


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++|+|.++|.......+++..+..|+.||+.||.|||+  ++++|+||+++||+++.++.+||+|||++.....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence            99999999999999988755679999999999999999999999  8999999999999999999999999999987532


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...........+...|+|||.+.+..++.++||||||+++|||++ |+.||......                 .+...+
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----------------~~~~~~  218 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----------------EIIEKL  218 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----------------HHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------cccccc
Confidence            222222233456778999999998889999999999999999999 67887643211                 111111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ........+......+..++.+||. +|++||++.+|++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  219 KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1122222344445567788999998 999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-41  Score=322.48  Aligned_cols=262  Identities=24%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|.+...    .....+..+|+|++.... ......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            457899999999999999999876431    122345789999986532 223456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA--------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +....++||||+++++|.+++.....        ..+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCC
Confidence            99999999999999999999865321        235788899999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~  306 (441)
                      +||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||......   ....+ 
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~-  233 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF-  233 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-
Confidence            99999999875433222111122345788999999998899999999999999999999 68888643211   11110 


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                                  +.. ......+......+..++.+|++ +|++||++.|+++.|+
T Consensus       234 ------------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 ------------VME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ------------HHc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                        000 00111223334456778888888 9999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-42  Score=338.68  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=192.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|.+.+.||+|+||.||++...         .+++.||||++.....   .....+.+|+++|++++||||++++++|.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK---------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            47899999999999999997544         3577899999865321   23456788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....|+||||++||+|.+++....  .+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999999986543  58899999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------------------------ceeeeccCCCCcCchhhhhcCCCCc
Q 013557          236 AKAGPTGDRT---------------------------------------------HVSTQVMGTRGYAAPEYLATGRLTA  270 (441)
Q Consensus       236 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  270 (441)
                      ++........                                             ......+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            8632110000                                             0001246999999999999989999


Q ss_pred             hhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhhhhccccccchhhhhhhcccccCCCch--hHHHHHHHHHHHHhcCC
Q 013557          271 KCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQ--KGAYMVAILALQCISEA  347 (441)
Q Consensus       271 ~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~l~~~c~~~P  347 (441)
                      ++|||||||++|||++|..||........ .....|...                 ...+.  .....+..++..|+.+|
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~p~~~~~s~~~~dli~~lL~~~  290 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET-----------------LYFPDDIHLSVEAEDLIRRLITNA  290 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc-----------------cCCCCCCCCCHHHHHHHHHHhcCH
Confidence            99999999999999999999964332110 011111000                 00111  12234556666777766


Q ss_pred             CC---CCCHHHHHHH
Q 013557          348 KV---RPSMSEVLSA  359 (441)
Q Consensus       348 ~~---RPs~~evl~~  359 (441)
                      .+   |+++.+++++
T Consensus       291 ~~r~~r~~~~~~l~h  305 (377)
T cd05629         291 ENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhcCCCCCHHHHhcC
Confidence            55   5699998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-41  Score=322.60  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||+|.+..     .....+..+++|.+..... .....+.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            468889999999999999987532     1223467899999975432 2335688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG---------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ...|+||||+++++|.+++....               ...+++..++.++.|++.||.|||+  ++|+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili  157 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILI  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEE
Confidence            99999999999999999986432               1247888999999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQN  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~  301 (441)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   .
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~  234 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E  234 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999976533322222334456778999999988889999999999999999998 98898643211   1


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ..              +.+........+......+..++..|+. +|++||++.+|++.|..
T Consensus       235 ~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VI--------------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH--------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11              1111111111222333456677788888 99999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.2e-42  Score=332.73  Aligned_cols=265  Identities=28%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|....    ..+..+++.||+|+++.... ...+.+.+|+.++.++ +|+||++++++|.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFG----IEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccc----cccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            3579999999999999999986432    11223467899999875432 2345678899999999 7999999999876


Q ss_pred             c-CCeeEEEEEeCCCCCHHHHHHhcCC-----------------------------------------------------
Q 013557          156 D-GENRLLVYEYMPKGSLENHLFRRGA-----------------------------------------------------  181 (441)
Q Consensus       156 ~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  181 (441)
                      . +...+++|||+++++|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 4568899999999999999864321                                                     


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCC
Q 013557          182 ------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR  255 (441)
Q Consensus       182 ------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~  255 (441)
                            ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++...............++.
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                  257899999999999999999998  899999999999999999999999999998653322211222345677


Q ss_pred             CcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHH
Q 013557          256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAY  334 (441)
Q Consensus       256 ~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  334 (441)
                      .|+|||++.+..++.++|||||||++|||++ |..||.......  .              +...+........+.....
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~  303 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E--------------FCRRLKEGTRMRAPEYATP  303 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H--------------HHHHHhccCCCCCCccCCH
Confidence            8999999999999999999999999999998 999986432111  0              0011111111111222334


Q ss_pred             HHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          335 MVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       335 ~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      .+..++..|++ +|++||++.||+++|+++.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            56677778887 9999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=338.27  Aligned_cols=264  Identities=31%  Similarity=0.428  Sum_probs=211.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++-.+.++||+|+||+||+|.+....     ......||||..+...   .....++++|+++|++++|||||+++|++.
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~-----~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKN-----GFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecC-----CceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            45566799999999999999876421     1011228999998532   345678999999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ...-+++|||+|.||+|.++|.++.. .++..+.+.++.+.+.||+|||+  ++++||||-.+|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999987664 59999999999999999999999  9999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++.......  ......-...|+|||.+..+-|++++|||||||++||+++ |..||.+......               
T Consensus       309 s~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---------------  371 (474)
T KOG0194|consen  309 SRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---------------  371 (474)
T ss_pred             ccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---------------
Confidence            986431111  0101123578999999999999999999999999999999 8888875432111               


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRD  368 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~~~  368 (441)
                       ...+.....+...+...+..+..++..|+. +|++||+|.++.+.|+.+.....
T Consensus       372 -~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  372 -KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence             111112233344556677788888889998 99999999999999987665543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=319.67  Aligned_cols=269  Identities=25%  Similarity=0.328  Sum_probs=205.8

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCC--CCcccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP--EGFQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .+...|...+.||+|+||.|+.+..         +.+|..||||++..  ......++..+|+++|+.++|+||+.++++
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~---------~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di   89 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKD---------KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI   89 (359)
T ss_pred             eccceecccccccCcceeeEEEEEE---------cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence            4456777789999999999998654         44678999999973  333456778999999999999999999998


Q ss_pred             EEc-----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          154 CLD-----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       154 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      +.-     -+..|+|+|++ +.+|...|..+.  .++...+..++.|+++||+|+|+  -+|+||||||+|+|++.+..+
T Consensus        90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             cccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCE
Confidence            864     35789999999 559999885443  49999999999999999999999  799999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+|+...........+..+.|.+|.|||++.. ..|+.+.||||+|||+.|||+|++.|.+.+.-....+.-..-
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            9999999997644333334466778999999999864 579999999999999999999999998665433322221111


Q ss_pred             cccccchh--------hhhhhc-------ccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          308 PYLGDRRK--------LFRIMD-------IKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~--------l~~~~~-------~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                      +.. ....        ....+.       ......+|......+.+|.+++.-||.+|+|++|.|++
T Consensus       245 GtP-~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  245 GTP-SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCC-CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            100 0000        111111       11222345555666777777766799999999999876

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6e-42  Score=334.22  Aligned_cols=247  Identities=24%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|.+.+.||+|+||.||+|.+...        .+..+|+|.+....   ......+.+|+.+++.++||||+++++++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            35799999999999999999865431        13579999886432   22345678899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....|+||||+.+|+|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCC
Confidence            99999999999999999999997654  48999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........               
T Consensus       177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---------------  236 (340)
T PTZ00426        177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---------------  236 (340)
T ss_pred             CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---------------
Confidence            99764321     2345799999999999988899999999999999999999999974321100               


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                       ...+....  ..+|......+..++..|+. +|++|+     ++++++++
T Consensus       237 -~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        237 -YQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -HHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             00111100  11233333445677788887 999995     88888765

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-41  Score=319.01  Aligned_cols=255  Identities=29%  Similarity=0.458  Sum_probs=206.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|.+.+.||.|+||.||+|....          +..+++|.+..........+..|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            4578999999999999999987653          567999999877655667789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..++.++.|++.||.|||+  ++|+|+||||+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchh
Confidence            999999999999999999977665678999999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........  .....++..|++||++.+..++.++||||||+++|+|++ |+.||.......   ..             
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~-------------  214 (261)
T cd05148         153 LIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VY-------------  214 (261)
T ss_pred             hcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HH-------------
Confidence            65332211  123345778999999988889999999999999999998 899986433111   11             


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                       ..+........+......+..++.+|+. +|.+||++.+|++.|+.+
T Consensus       215 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         215 -DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -HHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             1111111112233334456677788887 999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.9e-41  Score=317.67  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .+|.+.+.||+|+||.||+|.+..         .+..+++|.+.... .....+.+|++++++++|+||+++++++..+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            458888999999999999987653         36689999987543 34567889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++.......+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            99999999999999999976655568999999999999999999998  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   .              .
T Consensus       154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~--------------~  215 (263)
T cd05052         154 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V--------------Y  215 (263)
T ss_pred             cccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H--------------H
Confidence            5432211 1112234668999999998899999999999999999998 999986432211   1              1


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ..+........+......+..++..|+. +|++||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         216 ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            1111111122233334567778888888 999999999999999754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.8e-42  Score=331.41  Aligned_cols=242  Identities=26%  Similarity=0.342  Sum_probs=192.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      +.||+|+||.||++...         ..+..+|+|++.....   .....+.+|+++|+.++||||+++++++.+.+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREK---------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            47999999999997543         3577899999875422   23456788999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++|+|.+++....  .+++.++..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        72 lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          72 FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            9999999999999886543  58999999999999999999998  8999999999999999999999999999875322


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........                 ..+.
T Consensus       148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-----------------~~~~  208 (328)
T cd05593         148 DA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----------------ELIL  208 (328)
T ss_pred             cc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-----------------HHhc
Confidence            11  1223457999999999999889999999999999999999999999643221100                 0000


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      . .....+......+..++..|+. ||++|+     ++.+++++
T Consensus       209 ~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         209 M-EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             c-CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            0 0011233334455667777877 999997     88998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=339.38  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=195.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|...         ..++.||||+++...   ......+.+|+.+|..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK---------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            47999999999999999997654         347789999987532   123345778999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  147 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGL  147 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeeccc
Confidence            9999999999999999999987654  48999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccc------------------------------------eeeeccCCCCcCchhhhhcCCCCchhhhHHHhH
Q 013557          236 AKAGPTGDRTH------------------------------------VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGV  279 (441)
Q Consensus       236 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~  279 (441)
                      +..........                                    .....+||+.|+|||++.+..++.++|||||||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  227 (364)
T cd05599         148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV  227 (364)
T ss_pred             ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence            86532111000                                    011246999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccccccc-hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCC---HHH
Q 013557          280 VLLELLSGRRAVDKTRVGAE-QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPS---MSE  355 (441)
Q Consensus       280 il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs---~~e  355 (441)
                      ++|||++|..||........ .....|....             ....  .......+..++..|+.+|.+|++   +.+
T Consensus       228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~-------------~~~~--~~~~s~~~~~li~~ll~~p~~R~~~~~~~~  292 (364)
T cd05599         228 IMYEMLVGYPPFCSDNPQETYRKIINWKETL-------------QFPD--EVPLSPEAKDLIKRLCCEAERRLGNNGVNE  292 (364)
T ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHcCCCcc-------------CCCC--CCCCCHHHHHHHHHHccCHhhcCCCCCHHH
Confidence            99999999999975432111 1111111100             0000  001123445566667779999987   888


Q ss_pred             HHHH
Q 013557          356 VLSA  359 (441)
Q Consensus       356 vl~~  359 (441)
                      ++++
T Consensus       293 ll~h  296 (364)
T cd05599         293 IKSH  296 (364)
T ss_pred             HhcC
Confidence            8765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-41  Score=317.47  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....          +..+++|.+.... ...+.+.+|+.++++++|+||+++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3579999999999999999986542          4568999887543 3356789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccce
Confidence            999999999999999999976655568999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ ......++..|+|||++.+..++.++|||||||++|+|+| |..||.......   .....          
T Consensus       152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----------  217 (261)
T cd05072         152 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----------  217 (261)
T ss_pred             ecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----------
Confidence            65332211 1122345678999999998889999999999999999998 999986432111   11110          


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                          ...............+..++..|+. +|++||++++|++.|+.+
T Consensus       218 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         218 ----QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                0000001111223446677888887 999999999999999853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=339.04  Aligned_cols=251  Identities=29%  Similarity=0.415  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|.+.+.||+|+||.||+|...         .+++.||||+++....   .....+..|+++|..++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK---------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            47999999999999999997654         3477899999875421   23456788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCC
Confidence            999999999999999999999765  358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCC---------------------------ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCC
Q 013557          236 AKAGPTGD---------------------------RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR  288 (441)
Q Consensus       236 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~  288 (441)
                      +.......                           .........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  227 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF  227 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence            97643322                           001123457999999999999999999999999999999999999


Q ss_pred             CCCCccccccc-hhhhhhhccccccchhhhhhhcccccCCCchh--HHHHHHHHHHHHhcCCCCCCC-HHHHHHH
Q 013557          289 RAVDKTRVGAE-QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQK--GAYMVAILALQCISEAKVRPS-MSEVLSA  359 (441)
Q Consensus       289 ~pf~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~l~~~c~~~P~~RPs-~~evl~~  359 (441)
                      .||........ ..+..|..               ..  ..+..  ....+..|+.+|+.+|.+||+ +.+++++
T Consensus       228 ~Pf~~~~~~~~~~~i~~~~~---------------~~--~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h  285 (350)
T cd05573         228 PPFYSDTLQETYNKIINWKE---------------SL--RFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCHHHHHHHHhccCC---------------cc--cCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence            99975432111 01111100               00  11111  234556677778889999999 9999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.7e-41  Score=323.64  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|....    ......+..+|+|.++.... ...+.+.+|+.+++++ +|+||+++++++.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYG----LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEec----CCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            4579999999999999999987532    12234466899999876432 2345688999999999 7999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ..+..++||||+.+++|.+++.......+++.++..++.|++.||.|||+  ++|+|+||||+|||++.++.+||+|||+
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999999976554458999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........  .            
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~------------  253 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F------------  253 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H------------
Confidence            986543322112223456788999999998899999999999999999998 9999864332110  0            


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        ...+........+......+..++..|+. +|++||++.+|++.|+++
T Consensus       254 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 --YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              01111111111122223456778888887 999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.7e-41  Score=320.06  Aligned_cols=261  Identities=25%  Similarity=0.407  Sum_probs=204.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|.+.+.||+|+||.||++....    ......+..+++|.+..........+.+|+++++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEec----CCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4578889999999999999986432    122334668999998876655567899999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGA-------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      ...++||||+++++|.+++.....             ..+++..++.++.|++.||+|||+  .+++||||||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQ  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcC
Confidence            999999999999999999865431             247889999999999999999998  89999999999999999


Q ss_pred             CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhh
Q 013557          225 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~  303 (441)
                      ++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.........   
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---  234 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---  234 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---
Confidence            99999999999875433222112223345788999999998899999999999999999998 89998643211110   


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                                    ..+........+......+..|+.+|+. ||.+||++.+|++.|+
T Consensus       235 --------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 --------------ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --------------HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                          0000011111122233456788888888 9999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.2e-41  Score=321.92  Aligned_cols=261  Identities=25%  Similarity=0.381  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .+|++.+.||+|+||.||+|.....    .....+..+|+|+++..... ..+.+.+|+.++..++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            3577889999999999999976532    12234678999999755322 235678899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      ...++++||+.+++|.+++....              ...+++..++.++.|++.||.|||+  ++|+||||||+|||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~  158 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVF  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEec
Confidence            99999999999999999985321              1347888899999999999999998  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhh
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNL  302 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~  302 (441)
                      +++.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||......   ..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~  235 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV  235 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999886543332222334456789999999998899999999999999999998 88888643211   11


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      .              +.+........+......+..|+..|++ +|++||++++|+..|+.
T Consensus       236 ~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 I--------------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H--------------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1              1111111112334455667788899998 99999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=315.87  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....          +..+|+|.++... ...+.+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE   73 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence            4578999999999999999986532          4579999987653 3456788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++.......+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence            999999999999999999976555568999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ .......+..|+|||++.+..++.++||||||+++|+|++ |+.||.......                 +
T Consensus       152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~  213 (261)
T cd05068         152 VIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----------------V  213 (261)
T ss_pred             EccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------H
Confidence            65422111 1111223457999999998899999999999999999999 999986432111                 0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ...+........+......+..++..|+. +|++||++.+|++.|+.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         214 LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            01111111111222233456677778887 999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.2e-41  Score=321.26  Aligned_cols=262  Identities=29%  Similarity=0.394  Sum_probs=203.5

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +|++.+.||+|+||.||+|....    .........+++|.+..... .....+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFR----LKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEec----CCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            57889999999999999997643    11122345789998875532 23456889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccC
Q 013557          159 NRLLVYEYMPKGSLENHLFRRG----------------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFK  216 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlk  216 (441)
                      ..++||||+.+++|.+++....                      ...+++..++.++.|++.||+|||+  .+|+|||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dik  154 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLA  154 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhh
Confidence            9999999999999999986421                      1347889999999999999999998  899999999


Q ss_pred             CCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccc
Q 013557          217 ASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTR  295 (441)
Q Consensus       217 p~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~  295 (441)
                      |+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999975433221111223345778999999988889999999999999999998 999986432


Q ss_pred             cccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ..   .+.              ..+........+......+..++..|+. +|++||++.++++.|+++.
T Consensus       235 ~~---~~~--------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 PE---RLF--------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HH---HHH--------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            11   111              1111111122233334456678888988 9999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-42  Score=340.60  Aligned_cols=204  Identities=28%  Similarity=0.359  Sum_probs=172.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|...         .+++.+|||++.....   .....+.+|+++|++++|+||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV---------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ   71 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            47999999999999999997543         3478899999865321   23455788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence            9999999999999999999996644  48899999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCC-----------------------------------------ccceeeeccCCCCcCchhhhhcCCCCchhhh
Q 013557          236 AKAGPTGD-----------------------------------------RTHVSTQVMGTRGYAAPEYLATGRLTAKCDV  274 (441)
Q Consensus       236 a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv  274 (441)
                      +.......                                         ........+||+.|+|||++.+..++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            75221000                                         0000123579999999999999999999999


Q ss_pred             HHHhHHHHHHHhCCCCCCccc
Q 013557          275 YSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       275 wSlG~il~elltg~~pf~~~~  295 (441)
                      |||||++|||++|+.||....
T Consensus       228 wSlGvilyell~G~~Pf~~~~  248 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             eeccceeeehhhCCCCCCCCC
Confidence            999999999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-41  Score=315.94  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+...      ......++||.++..... ...++.+|+.++++++|+||+++++++.+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLP------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccC------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            35799999999999999999987532      123457999998754332 34568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++..... .+++..++.++.|++.||.|||+  ++|+|+||||+|||++.++.++|+|||++
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchh
Confidence            9999999999999999999976543 58999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~----------  220 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKA----------  220 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHH----------
Confidence            87542222111222345678999999998899999999999999999998 99998543211   11111          


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                          +........+......+..++..|+. +|++||++.+|++.|+++
T Consensus       221 ----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         221 ----VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                00000111122334556788888988 999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-41  Score=337.48  Aligned_cols=202  Identities=28%  Similarity=0.367  Sum_probs=172.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .|.+.+.||+|+||+||+|...         .++..+|||++.....   .....+.+|+++|++++|+||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV---------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            6888999999999999997654         3477899999975432   234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..|+||||++||+|.+++....  .+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~  148 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLC  148 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence            999999999999999999986644  48899999999999999999998  89999999999999999999999999997


Q ss_pred             ccCCCCCc---------------------------------------------cceeeeccCCCCcCchhhhhcCCCCch
Q 013557          237 KAGPTGDR---------------------------------------------THVSTQVMGTRGYAAPEYLATGRLTAK  271 (441)
Q Consensus       237 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~  271 (441)
                      +.......                                             .......+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (381)
T cd05626         149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL  228 (381)
T ss_pred             cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence            53210000                                             000123579999999999998899999


Q ss_pred             hhhHHHhHHHHHHHhCCCCCCcc
Q 013557          272 CDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       272 sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +|||||||++|||+||+.||...
T Consensus       229 ~DiwSlG~il~elltG~~Pf~~~  251 (381)
T cd05626         229 CDWWSVGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             cceeehhhHHHHHHhCCCCCcCC
Confidence            99999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-41  Score=323.18  Aligned_cols=267  Identities=22%  Similarity=0.285  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|....         ++..+|+|+++....  ...+.+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            479999999999999999976543         467899999875422  234567899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||++++.|..+. .. ...+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~-~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  147 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLE-EM-PNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFA  147 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence            99999999999987665543 32 2358999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhhccccccc--
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWAKPYLGDR--  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~--  313 (441)
                      ......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+.....  
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07848         148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK  226 (287)
T ss_pred             ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence            865332211 123456899999999999889999999999999999999999999754321111 1111111100000  


Q ss_pred             -----hhhhhhhcccc------cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 -----RKLFRIMDIKL------EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 -----~~l~~~~~~~~------~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           ...........      ...+.......+..|+..|+. ||++||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                 00000000000      000111123456778888888 99999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.6e-41  Score=323.87  Aligned_cols=202  Identities=26%  Similarity=0.369  Sum_probs=170.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         ..+..+|||+++.... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            468999999999999999997654         2477899999875432 223457789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  150 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLA  150 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence            999999999995 58888886543 358899999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         151 RAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             eeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7532221  11234568999999999875 45788999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=325.28  Aligned_cols=250  Identities=25%  Similarity=0.352  Sum_probs=212.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccH--HHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      +..-|.+.+.||+|.|++|.+         +.+..+|..||||++.+......  ..+++|++.|+.++|||||++|++.
T Consensus        16 IAGLYDLekTlG~GHFAVVKL---------ArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi   86 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKL---------ARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI   86 (864)
T ss_pred             eeeeehhhhhhcCCceehhhh---------hhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence            456789999999999999987         56677899999999987655443  4588999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEccc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDF  233 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DF  233 (441)
                      .....+|||+|+-++|+|+|||.++.. .+.+..+.+++.||+.|+.|||+  ..+|||||||+||.+-+ -|-+||.||
T Consensus        87 DTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   87 DTQTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             cccceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeec
Confidence            999999999999999999999987754 59999999999999999999998  88999999999998765 588999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCC-chhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT-AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      |++..+.++...   .+.+|+..|-|||++.|..|+ +++||||||||||-|++|+.||...+                +
T Consensus       164 GFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------D  224 (864)
T KOG4717|consen  164 GFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------D  224 (864)
T ss_pred             cccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------c
Confidence            999877666543   467999999999999999986 58999999999999999999997543                2


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...+..+||-.  ...|......+..|+..++. ||++|.+.+||...
T Consensus       225 SETLTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  225 SETLTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhhhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            34455555532  23466677777777777776 99999999998754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.2e-41  Score=314.63  Aligned_cols=250  Identities=25%  Similarity=0.420  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||.||+|.+..          +..+|+|.+.... .....+.+|+.+|++++||||+++++++.+..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            468889999999999999987643          3468999886543 33567889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~  149 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRY  149 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccc
Confidence            99999999999999999865432 48899999999999999999998  8999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......   ......           
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i-----------  214 (256)
T cd05114         150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI-----------  214 (256)
T ss_pred             cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-----------
Confidence            4322211 1122235668999999998889999999999999999999 89998643211   111110           


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                         ........+......+..++..|+. +|++||++.++++.|
T Consensus       215 ---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         215 ---SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---HCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               0000111122233456778888888 999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.5e-41  Score=318.25  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=199.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||+||+|.+....     ......+++|.+..... ....++..|+.++++++||||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEG-----DSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCC-----CceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            47888999999999999999774321     11223588888864422 22356778888999999999999999875 4


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++++||+++|+|.+++.... ..+++..+..++.||+.||.|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence            56789999999999999997543 358999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...............++..|+|||++.++.++.++|||||||++|||++ |+.||.........                
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~----------------  221 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP----------------  221 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----------------
Confidence            6543332222234457789999999998899999999999999999998 99998644321111                


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       .++........+......+..++..|+. +|++||++.|+++.|..+..
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         222 -DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             1111111111122223345567778887 99999999999999886543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.6e-42  Score=339.27  Aligned_cols=202  Identities=28%  Similarity=0.376  Sum_probs=171.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +|++.+.||+|+||.||+|...         .++..+|+|++.....   .....+.+|+++|+.++|+||+++++.|.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV---------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            6888999999999999997654         3477899999875422   234567889999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....|+||||+++|+|.+++.+..  .+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla  148 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC  148 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCC
Confidence            999999999999999999986653  48899999999999999999998  89999999999999999999999999997


Q ss_pred             ccCCCCC---------------------------------------------ccceeeeccCCCCcCchhhhhcCCCCch
Q 013557          237 KAGPTGD---------------------------------------------RTHVSTQVMGTRGYAAPEYLATGRLTAK  271 (441)
Q Consensus       237 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~  271 (441)
                      .......                                             ........+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (382)
T cd05625         149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  228 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence            5321000                                             0001123579999999999999999999


Q ss_pred             hhhHHHhHHHHHHHhCCCCCCcc
Q 013557          272 CDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       272 sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +|||||||++|||++|+.||...
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         229 CDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             eeEEechHHHHHHHhCCCCCCCC
Confidence            99999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=329.17  Aligned_cols=250  Identities=25%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCC-CCCcccEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLH-HPNLVKLI  151 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~l~  151 (441)
                      .....|.+.+.||+|.||.||++.         ++.+|..+|+|.+.+....   ....+.+|+.+|+++. |||||.++
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~---------~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~  102 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCR---------EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLK  102 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEE---------ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEE
Confidence            445689999999999999999954         4456889999999876553   3457899999999998 99999999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC----Cc
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE----FN  227 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~----~~  227 (441)
                      ++|++....++|||++.||.|++.|...  . +++..+..++.|++.++.|||+  .||+||||||+|+|+...    +.
T Consensus       103 ~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  103 DAFEDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             EEEEcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCc
Confidence            9999999999999999999999999877  2 9999999999999999999999  999999999999999643    47


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      +|++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.||+|.+||..........      
T Consensus       178 ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------  248 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------  248 (382)
T ss_pred             EEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------
Confidence            99999999998655   234567899999999999998999999999999999999999999997544221111      


Q ss_pred             cccccchhhhhhhcc---cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLGDRRKLFRIMDI---KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                .+...   ...+.++.. ...+..++..++. ||.+|+++.+++++
T Consensus       249 ----------~i~~~~~~f~~~~w~~i-s~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 ----------AILRGDFDFTSEPWDDI-SESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----------HHHcCCCCCCCCCcccc-CHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                      11111   111222333 4455666666666 99999999999985

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=328.59  Aligned_cols=240  Identities=28%  Similarity=0.349  Sum_probs=190.0

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||+|+||.||+|....         ++..||+|+++...   ......+.+|+.+|.+++||||+++++++.+.+..|+|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            7999999999976543         46789999986432   22345678899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++|+|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus        72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  147 (312)
T cd05585          72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD  147 (312)
T ss_pred             EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence            99999999999997644  48999999999999999999998  899999999999999999999999999997532221


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .          ...++.. 
T Consensus       148 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~----------~~~~~~~-  208 (312)
T cd05585         148 --DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------M----------YRKILQE-  208 (312)
T ss_pred             --CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------H----------HHHHHcC-
Confidence              12234679999999999999999999999999999999999999997432111      0          0011110 


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCC---HHHHHHH
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPS---MSEVLSA  359 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs---~~evl~~  359 (441)
                       ...++......+..++..|+. ||++||+   +.+++.+
T Consensus       209 -~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         209 -PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence             111233334456677788888 9999985   5555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-41  Score=327.57  Aligned_cols=201  Identities=29%  Similarity=0.447  Sum_probs=173.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||++...         ..+..+|+|.+..... .....+.+|+++|+.++|+||++++++|.+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            468999999999999999997654         3467899998875422 234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++....  .+++..+..++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~  151 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence            999999999999999999996544  48899999999999999999997 247999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ......    ......||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       152 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         152 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            754221    123456899999999999888999999999999999999999999744

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-41  Score=322.35  Aligned_cols=202  Identities=26%  Similarity=0.394  Sum_probs=171.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||.|+||.||+|...         .++..||+|.++.... .....+.+|+.++++++||||+++++++.++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            57999999999999999997654         3477899999875432 2344677899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+  +||+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~  151 (288)
T cd07871          76 RCLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR  151 (288)
T ss_pred             CeEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCccee
Confidence            999999999975 9999886543 347899999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      .......  ......|++.|+|||++.+ ..++.++|||||||++|+|+||+.||....
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         152 AKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             eccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5432221  1234568999999999875 468999999999999999999999997554

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=346.36  Aligned_cols=257  Identities=26%  Similarity=0.302  Sum_probs=201.4

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      ....++|++.+.||+|+||+||+|...         .+++.||||++.....  .....+.+|+.+|..++|+||+++++
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~   98 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRV---------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE   98 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEc---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence            345679999999999999999997643         3477899999865432  23456788999999999999999988


Q ss_pred             EEEcCC--------eeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          153 FCLDGE--------NRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       153 ~~~~~~--------~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      .+...+        ..++||||+++|+|.+++..+  ....+++..+..++.|++.||+|||+  ++|+||||||+|||+
T Consensus        99 ~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl  176 (496)
T PTZ00283         99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILL  176 (496)
T ss_pred             ceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE
Confidence            765332        368999999999999998653  23468999999999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~---  253 (496)
T PTZ00283        177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---  253 (496)
T ss_pred             eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---
Confidence            99999999999999865433222233456799999999999999999999999999999999999999974332110   


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                   +..++. ......+......+..|+..|+. +|++||++.+++++
T Consensus       254 -------------~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 -------------MHKTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -------------HHHHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                         001111 00111223334556778888887 99999999999864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.3e-41  Score=328.28  Aligned_cols=248  Identities=25%  Similarity=0.343  Sum_probs=190.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||+|....         +++.||||++...... ....+.+|+++|+.++|+||+++++++.+.
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            467778999999999999976543         4678999998654322 245688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+..      ...+..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       145 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~  216 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSR  216 (353)
T ss_pred             CeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999986532      35677888999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ......  .......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+..        
T Consensus       217 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--------  286 (353)
T PLN00034        217 ILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC--------  286 (353)
T ss_pred             eccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------
Confidence            643221  11234579999999998743     234568999999999999999999997322111111100        


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           . +........+......+..|+..|+. ||++||++.||+++
T Consensus       287 -----~-~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        287 -----A-ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----H-HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0 00011111222334456777888887 99999999999876

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-41  Score=327.49  Aligned_cols=245  Identities=26%  Similarity=0.371  Sum_probs=190.3

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHH---hcCCCCCcccEEEEE
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYL---GQLHHPNLVKLIGFC  154 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~  154 (441)
                      |++.+.||+|+||.||+|....         ++..||||+++...   ....+.+.+|++++   +.++||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            6788999999999999976543         47789999987542   12234566676655   567899999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....|+||||+++++|..++..   ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCccc
Confidence            999999999999999999988753   248999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........              
T Consensus       147 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~--------------  210 (324)
T cd05589         147 LCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF--------------  210 (324)
T ss_pred             CCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH--------------
Confidence            987532211  1223567999999999999999999999999999999999999999744321100              


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                        ..+....  ..++......+..++..|+. ||.+||     ++.++++.
T Consensus       211 --~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         211 --DSIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             --HHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence              0111100  11233333445667777777 999999     56666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5e-41  Score=333.65  Aligned_cols=264  Identities=23%  Similarity=0.382  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|.+..    ..+...+..||+|+++..... ..+.+.+|+++|.++. ||||+++++++.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHG----LSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcC----CCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4578889999999999999998753    122334668999999765322 2346889999999997 999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC------------------------------------------------------
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA------------------------------------------------------  181 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  181 (441)
                      .....++||||+.+|+|.+++.+...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999965321                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          182 ------------------------------------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       182 ------------------------------------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                                                                ..+++..++.++.||+.||.|||+  .+|+||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcce
Confidence                                                      236777889999999999999998  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCcccccc
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGA  298 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~  298 (441)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999975432221112223457889999999998889999999999999999998 888986432111


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                      .+...+........+......+..|+..|+. +|.+||++.+|++.|+++
T Consensus       350 ----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 ----------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                            0111111111112233344567778888888 999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.4e-41  Score=327.98  Aligned_cols=252  Identities=25%  Similarity=0.317  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|.+.+.||+|+||.||++...         ..+..+|+|+++....   .....+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK---------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            47899999999999999997544         3477899999875422   23455788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..++||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCC
Confidence            9999999999999999999997653 358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhh------cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLA------TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      +......... ......||+.|+|||++.      +..++.++|||||||++|+|++|+.||........          
T Consensus       149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------  217 (330)
T cd05601         149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT----------  217 (330)
T ss_pred             CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH----------
Confidence            9765432221 223457999999999987      45678999999999999999999999974332110          


Q ss_pred             cccchhhhhhhcccccCCCch--hHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQ--KGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                            +..++.......++.  .....+..|+..|+.+|++||++.+++.+
T Consensus       218 ------~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~t~~~l~~h  263 (330)
T cd05601         218 ------YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCH  263 (330)
T ss_pred             ------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCCCHHHHhCC
Confidence                  001111000001111  12334556667777899999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=317.61  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.....    .....+..+++|.+..... .....+.+|+.+|+.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            45789999999999999999876531    1123457899999865432 334568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG--------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ....++||||+++++|.+++....        ...+++..++.++.|++.||.|||+  .+++||||||+|||++.++.+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCE
Confidence            999999999999999999996532        1246888999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.......   ...   
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~---  232 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK---  232 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH---
Confidence            9999999876433322222233456789999999988889999999999999999998 899986432211   111   


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                                 .+........+......+..++..|+. +|++||++.+|++.|+
T Consensus       233 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 -----------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                       111111112233334567788888888 9999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-41  Score=326.32  Aligned_cols=246  Identities=28%  Similarity=0.372  Sum_probs=193.3

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      .+.||+|+||.||+++...      ....++.+|+|+++....    .....+..|+.+|+.++||||++++++|.+++.
T Consensus         1 ~~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   74 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK   74 (323)
T ss_pred             CceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence            3689999999999986532      223578899999865321    223456789999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .|+||||+++++|.+++....  .+.+..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          75 LYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            999999999999999986654  47888999999999999999998  89999999999999999999999999998753


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                .+..+
T Consensus       151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------------~~~~~  212 (323)
T cd05584         151 IHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------------TIDKI  212 (323)
T ss_pred             ccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------------HHHHH
Confidence            2221  12234579999999999998889999999999999999999999997433110                01111


Q ss_pred             hcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      ....  ...+......+..++..|+. +|++||     ++.++++.
T Consensus       213 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         213 LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            1111  11233334456677788887 999999     78887764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1e-40  Score=316.41  Aligned_cols=261  Identities=26%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.+...    .....+..+++|.+...... ....+.+|+.++++++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            46799999999999999999876531    11124668999988754322 23568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC---cE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGA-----RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF---NA  228 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~---~~  228 (441)
                      ....++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+  ++++||||||+||+++.++   .+
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcce
Confidence            9999999999999999999976432     248999999999999999999998  8999999999999998764   59


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........        
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--------  230 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--------  230 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence            9999999986532221111112234568999999998899999999999999999997 9999874332111        


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                               ...+........+......+..++..|+. +|++||++.+|++.|+
T Consensus       231 ---------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 ---------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                     11111111112233333456678888888 9999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=317.11  Aligned_cols=271  Identities=32%  Similarity=0.472  Sum_probs=203.2

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC--
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG--  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  157 (441)
                      |.+.+.||+|+||+||++.++     ......+..+|+|.++.... .....+.+|+++|++++||||+++++++...  
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ceeceecccCCCcEEEEeeEc-----cccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            488999999999999987654     22334577899999876532 2345688999999999999999999987653  


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++...   .+++.+++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccc
Confidence            4689999999999999998653   38999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|+||..||........ ....+..... ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhh
Confidence            654322111 11123456679999999888899999999999999999999999864322111 1111111000 00111


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ...++.......+......+..++..|+. +|++||++++|++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            12222222222233445567788888888 999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6e-41  Score=320.03  Aligned_cols=267  Identities=26%  Similarity=0.326  Sum_probs=193.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcC---CCCCcccEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQL---HHPNLVKLIGF  153 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~  153 (441)
                      ++|++.+.||+|+||.||+|....        ..+..+|+|.++.....  ....+.+|+.+++.+   +||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            479999999999999999986532        12567999988654322  234456777777665   69999999998


Q ss_pred             EE-----cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          154 CL-----DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       154 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      |.     .....++||||+. ++|.+++.......+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCE
Confidence            85     3456899999996 599999977655668999999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccccc-chhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA-EQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~  307 (441)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|++||....... .........
T Consensus       150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~  226 (290)
T cd07862         150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  226 (290)
T ss_pred             EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            999999997643321   2234578999999999998899999999999999999999999997543211 111111110


Q ss_pred             ccc-ccchhhh----hhhcccccC---CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYL-GDRRKLF----RIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~-~~~~~l~----~~~~~~~~~---~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ... .......    ..+......   .........+..|+..|+. +|++||++.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000 0000000    000000000   0001123345667777777 99999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.1e-41  Score=321.03  Aligned_cols=264  Identities=27%  Similarity=0.416  Sum_probs=204.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|......    .......+|+|.+..... ....++.+|+.++.++ +|+||+++++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD----NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCC----CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4567999999999999999998765311    123356899999875422 2345688999999999 799999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcE
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRR--------------GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI  220 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Ni  220 (441)
                      ......++||||+++|+|.+++..+              ....+++..++.++.|++.||.|||+  ++|+||||||+||
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Ni  163 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNV  163 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeE
Confidence            9999999999999999999998652              23458899999999999999999998  8999999999999


Q ss_pred             EECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccc
Q 013557          221 LLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAE  299 (441)
Q Consensus       221 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~  299 (441)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            999999999999999986543222111222345678999999988899999999999999999998 888886432211 


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                      +...+........+......+..|+..|+. +|++||++.+|++.|+.+
T Consensus       243 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 ----------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                            111111111111223334456677888887 999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8e-41  Score=322.05  Aligned_cols=267  Identities=25%  Similarity=0.393  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|......  .........+|+|.++... ......+.+|+.+++.+ +|+||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            367999999999999999998754211  1111234579999997643 23345688899999999 7999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      .....++||||+.+++|.+++.....              ..+++.+++.++.|++.||+|||+  ++++||||||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nil  172 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL  172 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheE
Confidence            99999999999999999999976431              247889999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--  250 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--  250 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence            99999999999999875432221111112234568999999998889999999999999999998 888886432111  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                     +...+........+......+..|+..|+. +|++||++.+|++.|+++.+
T Consensus       251 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         251 ---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ---------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                           111111111112233334566678888888 99999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-41  Score=328.86  Aligned_cols=243  Identities=27%  Similarity=0.345  Sum_probs=191.5

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      +.||+|+||.||++...         .++..+|+|+++....   .....+..|++++..++||||+++++++.+.+..|
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            47999999999997543         3577899999875422   23455778999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++|+|.+++....  .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9999999999999886544  58999999999999999999996 26999999999999999999999999999875322


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.........                 ..+.
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-----------------~~i~  209 (325)
T cd05594         149 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----------------ELIL  209 (325)
T ss_pred             CC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-----------------HHHh
Confidence            11  1223457999999999999999999999999999999999999999643321110                 0000


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      . ....++......+..++..|+. ||++|+     ++.+++++
T Consensus       210 ~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         210 M-EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             c-CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            0 0011222333445667777777 999996     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-41  Score=333.96  Aligned_cols=252  Identities=25%  Similarity=0.306  Sum_probs=194.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||++....         +++.+|+|++....   ......+.+|+.+++.++||||++++++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            35789999999999999999976543         47789999986422   1233457789999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+++..|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEec
Confidence            99999999999999999999998543   38899999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCC----CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR----LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |++........ .......||+.|+|||++.+..    ++.++|||||||++|+|++|+.||.......           
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----------  254 (370)
T cd05621         187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----------  254 (370)
T ss_pred             ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----------
Confidence            99986432221 1123567999999999997643    7889999999999999999999997443211           


Q ss_pred             cccchhhhhhhcccccCCCch--hHHHHHHHHHHHHhcCC-C--CCCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQ--KGAYMVAILALQCISEA-K--VRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~l~~~c~~~P-~--~RPs~~evl~~  359 (441)
                           ....++........+.  ........++..|+.++ .  .|+++.|++++
T Consensus       255 -----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         255 -----TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 0111111111111121  22344556667777643 3  38899999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=320.16  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=199.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +|++.++||+|+||+||++...         .++..||+|++......   ....+.+|+.++++++|+||+++++.+.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            4888999999999999997653         24678999998654322   23456789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++|+|.+++.......+++..+..++.|++.||.|||+  .+|+||||||+||++++++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999998876555569999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........   .....|++.|+|||++.+..++.++|||||||++|||++|+.||.........             ..+
T Consensus       150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~  213 (285)
T cd05605         150 VEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEV  213 (285)
T ss_pred             eecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHH
Confidence            76433221   23457899999999999888999999999999999999999999743221100             000


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      ...+. .....++......+..|+..|+. ||++||     ++++++++
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         214 ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            01111 11112233344556778888888 999999     78888665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-40  Score=311.79  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=198.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||.||+|.+..          +..+|+|.+.... .....+.+|+.++++++||||+++++++.+..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            468889999999999999986543          3359999887543 33567899999999999999999999999988


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+.+++|.+++..... .+++..++.++.||+.||.|||+  .+++|+||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~  149 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY  149 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCcccee
Confidence            99999999999999999865443 58999999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......++..|++||++.+..++.++|||||||++|+|++ |..||.......   ...             
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~-------------  212 (256)
T cd05113         150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE-------------  212 (256)
T ss_pred             cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH-------------
Confidence            4332211 1112345678999999998889999999999999999999 999986432111   000             


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      .+.. ......+......+..++..|+. +|++||++.+|++.|+
T Consensus       213 ~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         213 KVSQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0000 11111122234556778888887 9999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.2e-41  Score=325.84  Aligned_cols=241  Identities=27%  Similarity=0.376  Sum_probs=189.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCC-CCcccEEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHH-PNLVKLIGFCL  155 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~  155 (441)
                      +|++.+.||+|+||.||+|....         +++.||||+++...   ....+.+..|.+++..++| ++|+.+++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            58899999999999999976543         46789999987542   2234567889999999976 46888999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGM  147 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCc
Confidence            9999999999999999999986544  48899999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......   ..            
T Consensus       148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~------------  210 (324)
T cd05587         148 CKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF------------  210 (324)
T ss_pred             ceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH------------
Confidence            87532211  12345679999999999999999999999999999999999999997443211   00            


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                       ..+..  ....++......+..++..|+. +|.+|++.
T Consensus       211 -~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         211 -QSIME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -HHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             01111  0111233333445566777777 99999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-40  Score=314.81  Aligned_cols=276  Identities=27%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc--
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  156 (441)
                      .+|++.+.||+|+||.||+|....     .+...+..|++|.+........+.+.+|++++++++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            578999999999999999986542     2334577899999987655556778999999999999999999998754  


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  +||+||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCccc
Confidence            346899999999999999986543 348999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCcccee-eeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVS-TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +........... ....++..|+|||++.+..++.++|||||||++|||++|..++.............. .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYH  234 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHH
Confidence            865432211111 112234569999999988999999999999999999999876543211100000000 000000011


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      +.+.+........+......+..|+..|+. +|++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111222111111223334567788888888 999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-40  Score=319.51  Aligned_cols=267  Identities=25%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      ..+|.+.+.||+|+||.||+|.+....  ......+..+++|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            467889999999999999998753210  0112235679999987543 23456788999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      .....++||||+.+++|.+++.....              ..+++..++.++.||+.||.|||+  +||+||||||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEE
Confidence            99999999999999999999976421              347888899999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence            99999999999999986543222222223345678999999998889999999999999999998 788886432111  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                     +...+........+......+..++..|+. +|++||++.+|++.|+++..
T Consensus       248 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         248 ---------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ---------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                           111111111111223334556678888888 99999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.2e-41  Score=326.54  Aligned_cols=202  Identities=26%  Similarity=0.420  Sum_probs=167.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||+|...         .++..||||++....  ......+.+|+.+|++++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT---------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            5888999999999999997654         347789999986432  22345688999999999999999999987643


Q ss_pred             -----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          158 -----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       158 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                           ...|+||||+. ++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          72 SRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             CCCCCceEEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEcc
Confidence                 35799999995 69999886544  48999999999999999999998  8999999999999999999999999


Q ss_pred             cCCcccCCCCCc-cceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          233 FGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       233 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+++....... ........||+.|+|||++.+  ..++.++|||||||++|||+||+.||....
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999975432211 111234579999999999876  678999999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.8e-41  Score=323.41  Aligned_cols=242  Identities=26%  Similarity=0.322  Sum_probs=191.0

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      ++.||+|+||.||++...      .....+..+|+|+++....  .....+..|+++|++++||||+++++++.+....|
T Consensus         1 l~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY   74 (318)
T ss_pred             CceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence            367999999999997642      2234578999999875422  22345678999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++++|.+++.+..  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        75 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          75 LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            9999999999999986543  48999999999999999999998  8999999999999999999999999999876433


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .             +..+..
T Consensus       151 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~-------------~~~i~~  212 (318)
T cd05582         151 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---T-------------MTMILK  212 (318)
T ss_pred             CC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---H-------------HHHHHc
Confidence            21  12234679999999999998889999999999999999999999997432110   0             001111


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSE  355 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~e  355 (441)
                      .  ....+......+..|+..|+. ||++||++.+
T Consensus       213 ~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         213 A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0  011233334456677788887 9999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-40  Score=310.04  Aligned_cols=248  Identities=28%  Similarity=0.410  Sum_probs=193.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|....         .++.+|+|.+..... .....+.+|++++++++|+||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            469999999999976543         367899998865432 2345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        72 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  148 (252)
T cd05084          72 MELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV  148 (252)
T ss_pred             EeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCccccccc
Confidence            99999999999986543 358999999999999999999998  899999999999999999999999999987543221


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI  322 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  322 (441)
                      .........++..|+|||.+.++.++.++|||||||++|+|++ |..||.......                 ....+..
T Consensus       149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~  211 (252)
T cd05084         149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQ  211 (252)
T ss_pred             ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHc
Confidence            1111111123457999999998899999999999999999998 888886432111                 0111111


Q ss_pred             cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          323 KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      ......+......+..++..|+. +|++||++.+|++.|.
T Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            11112233334456778888888 9999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.7e-41  Score=324.95  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=191.8

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      ++||+|+||.||+|....         .+..||+|+++....   .....+..|..++..+ +||||++++++|.+....
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            479999999999976543         477899999975422   2334578899999998 799999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++.+..  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  147 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI  147 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence            99999999999999886543  59999999999999999999998  899999999999999999999999999987422


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccccc--chhhhhhhccccccchhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA--EQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+......  ......          .+.+
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----------~~~~  215 (329)
T cd05588         148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED----------YLFQ  215 (329)
T ss_pred             cCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH----------HHHH
Confidence            111  12234679999999999999999999999999999999999999997432211  000000          0111


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC------HHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS------MSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs------~~evl~~  359 (441)
                      .+... ....|......+..++..|+. ||.+|++      +++++++
T Consensus       216 ~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         216 VILEK-QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HHHcC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            11111 112233334455667777887 9999997      5676644

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-41  Score=311.80  Aligned_cols=204  Identities=29%  Similarity=0.416  Sum_probs=173.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCC-cccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPN-LVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~  155 (441)
                      ..|...+.||+|+||+||+|...         .+|+.||+|+++.+...  .-....+|+.+|++|+|+| |+.+++++.
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~---------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~   81 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSK---------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH   81 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEe---------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence            45666778999999999997654         35789999999765432  2345689999999999999 999999998


Q ss_pred             cCC------eeEEEEEeCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 DGE------NRLLVYEYMPKGSLENHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~~~------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +.+      .+++|+||++. +|.+++.....  ..++...+..++.||+.||+|||+  ++|+||||||.||||+.+|.
T Consensus        82 ~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   82 TSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             ecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCc
Confidence            877      88999999955 99999976553  357888999999999999999999  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      +||+|||+|+.......  ..+..++|.+|.|||++.+. .|+...||||+|||++||++++..|.+...
T Consensus       159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            99999999996543322  23456789999999999886 689999999999999999999999976553

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.1e-41  Score=330.18  Aligned_cols=200  Identities=27%  Similarity=0.356  Sum_probs=174.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-C-----CCcccEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-H-----PNLVKLIG  152 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~  152 (441)
                      .+|.++++||+|+||.|.+++.         .++++.||||++++.. .-..+...|+.+|..|+ |     -|+|++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d---------~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYD---------HKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEEEEEEEecccccceeEEEEe---------cCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            3788899999999999999654         4568899999998763 33455678999999996 4     38999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC--cEEE
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF--NAKL  230 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~--~~kl  230 (441)
                      +|...++.|||+|.+ ..+|+++|..+...+++...++.++.||+.||.+||+  .+|||+||||+||||.+.+  .+||
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeE
Confidence            999999999999999 4599999999998999999999999999999999998  8999999999999997643  6999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      +|||.|......-     .+.+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+.
T Consensus       333 IDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  333 IDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             EecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            9999998743322     145678899999999999999999999999999999999998876653

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-40  Score=317.29  Aligned_cols=272  Identities=24%  Similarity=0.401  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccc-------cccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCccc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLE-------AARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      ..+|++.+.||+|+||.||+|........       ..+...+..+|+|.+..... .....+.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            35799999999999999999876542211       22334456799999876533 23556889999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRG---------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI  220 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Ni  220 (441)
                      +++++..+...++||||+++++|.+++....         ...+++..++.++.|++.||.|||+  ++|+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence            9999999999999999999999999996543         1258999999999999999999998  8999999999999


Q ss_pred             EECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh--CCCCCCcccccc
Q 013557          221 LLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS--GRRAVDKTRVGA  298 (441)
Q Consensus       221 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~pf~~~~~~~  298 (441)
                      +++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999876443332222334456789999999998889999999999999999998  67777543211 


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                        ............       .........+......+..|+..|+. +|++||++.+|++.|+
T Consensus       241 --~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 --QVIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              111111000000       00000011122223456778888887 9999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-40  Score=327.53  Aligned_cols=202  Identities=26%  Similarity=0.254  Sum_probs=172.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ...+|++.+.||+|+||.||++....       ...+..|++|.+...     ....+|+++|++++||||+++++++..
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~  157 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW  157 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence            34689999999999999999975432       234678999988653     234579999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....|+|||++. ++|.+++...  ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccc
Confidence            999999999995 6899988433  358999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +...............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            76544333222335679999999999999999999999999999999999999996543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=310.05  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .+|++.+.||+|+||.||+|.+..          +..+++|.+.... .....+.+|+.++++++|+||+++++++.+..
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            358899999999999999986542          3468999886543 23456888999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++..+.. .+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCccccee
Confidence            99999999999999999876543 58999999999999999999998  8999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........   .              
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~--------------  211 (256)
T cd05059         150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V--------------  211 (256)
T ss_pred             ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H--------------
Confidence            4322111 1111223457999999998899999999999999999999 8999864322110   0              


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ..+........+......+..++..|+. +|++||++.++++.|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0011111112233345567788888888 999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-41  Score=332.23  Aligned_cols=252  Identities=25%  Similarity=0.294  Sum_probs=195.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||++...         .++..+|+|+++...   ......+.+|+.+|+.++||||++++++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHK---------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3468999999999999999997654         347789999986432   1233457789999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.++...|+||||++||+|.+++...   .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~Df  186 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF  186 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEec
Confidence            99999999999999999999988543   37889999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcC----CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG----RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......           
T Consensus       187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----------  254 (370)
T cd05596         187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----------  254 (370)
T ss_pred             cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----------
Confidence            99976432211 112345799999999998753    47889999999999999999999997543210           


Q ss_pred             cccchhhhhhhcccccCCCch--hHHHHHHHHHHHHhc-CCCC--CCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQ--KGAYMVAILALQCIS-EAKV--RPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~l~~~c~~-~P~~--RPs~~evl~~  359 (441)
                           ....++.......++.  .....+..++..|+. +|++  |+++.+++++
T Consensus       255 -----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         255 -----TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 0111111110011121  223455667777777 7876  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=311.98  Aligned_cols=258  Identities=27%  Similarity=0.460  Sum_probs=197.8

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      |.+.+.||+|+||.||+|.....      ...+..+|+|+++....  .....+.+|+++++.++|+||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD------DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC------CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            67889999999999999876432      12356799999875432  23456889999999999999999999886655


Q ss_pred             e------eEEEEEeCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          159 N------RLLVYEYMPKGSLENHLFRR----GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       159 ~------~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      .      .++||||+++++|..++...    ....+++..++.++.|++.||.|||+  .+++||||||+||++++++.+
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~  152 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTV  152 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeE
Confidence            4      79999999999999988543    22358999999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   ....+. 
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~-  228 (273)
T cd05035         153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL-  228 (273)
T ss_pred             EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-
Confidence            9999999986543322111122335678999999988889999999999999999999 88888643211   111110 


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                   ........+......+..++..|+. +|++||++.||++.|+++
T Consensus       229 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 -------------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -------------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                         0011111222333456667777888 999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-40  Score=322.56  Aligned_cols=241  Identities=26%  Similarity=0.369  Sum_probs=188.2

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||.||+|....         ++..||+|.++....   ...+.+..|..++..+ +||||+++++++......
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            479999999999976543         467899999875421   2234456677777654 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||++||+|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            99999999999999986544  48999999999999999999998  899999999999999999999999999997543


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                 ..+
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-----------------~~i  208 (316)
T cd05592         148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-----------------DSI  208 (316)
T ss_pred             CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHH
Confidence            222  1233567999999999999889999999999999999999999999754321100                 000


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH-HHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS-EVLS  358 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~-evl~  358 (441)
                      . ......+......+..++..|+. +|++||++. ++++
T Consensus       209 ~-~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         209 L-NDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             H-cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            0 01112233334455677788887 999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-40  Score=315.14  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|.....    .....+..+|+|.++.... .....+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            357899999999999999999876531    1122355799999865432 23345788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG--------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +....++||||+++|+|.+++....        ...++...+..++.|++.||.|||+  ++|+||||||+|||++.++.
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCc
Confidence            9999999999999999999996532        1235677889999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~  306 (441)
                      +||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......   ...  
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~--  232 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK--  232 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999885433222211222345678999999998899999999999999999999 788886432111   111  


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                 .+.... ....+......+..++..|+. +|++||++.++++.|...
T Consensus       233 -----------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 -----------FVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -----------HHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                       000100 011122334567788888888 999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.4e-40  Score=309.80  Aligned_cols=253  Identities=30%  Similarity=0.445  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....          +..+|+|.++.... ..+.+.+|+.++++++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            3579999999999999999986542          45689999876543 3567899999999999999999999875 4


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..++.++.+++.||.|||+  ++|+||||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeee
Confidence            568999999999999999976555568999999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ..             
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~-------------  213 (260)
T cd05070         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VL-------------  213 (260)
T ss_pred             eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HH-------------
Confidence            64332211 1122345678999999988889999999999999999999 888986432111   10             


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                       ..+........+......+..|+..|+. +|++||++.++.+.|++
T Consensus       214 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         214 -EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -HHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             1111111112233334567778888887 99999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=304.40  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=197.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      +.++|.+.+.||+|.|+.||+         +.+..+|+.+|+|+++-..+  .+.+++.+|++|.+.|+||||+++++.+
T Consensus         9 f~d~y~l~e~igkG~FSvVrR---------c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti   79 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   79 (355)
T ss_pred             cchhhhHHHHHccCchHHHHH---------HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence            457789999999999999997         55666788888888764432  3567788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---CcEEEc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLS  231 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~~kl~  231 (441)
                      .+....|||+|+++|++|..-|..+.  .+++..+-.++.||+++|.|||.  ++|||||+||+|+|+...   .-+||+
T Consensus        80 ~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   80 QEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             cccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeec
Confidence            99999999999999999988777663  37888999999999999999998  999999999999999543   349999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||++.....+.   ......|||+|||||+++..+|+..+|||+.|||||-||.|.+||.+...               
T Consensus       156 ~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---------------  217 (355)
T KOG0033|consen  156 DFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------------  217 (355)
T ss_pred             ccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---------------
Confidence            999998766332   33567899999999999999999999999999999999999999975321               


Q ss_pred             cchhhhhhhccc---ccC-CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          312 DRRKLFRIMDIK---LEG-QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       312 ~~~~l~~~~~~~---~~~-~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                        ..+.+.+...   ..+ .++.... ....|++.++. ||.+|.|+.|.|+
T Consensus       218 --~rlye~I~~g~yd~~~~~w~~is~-~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  218 --HRLYEQIKAGAYDYPSPEWDTVTP-EAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --HHHHHHHhccccCCCCcccCcCCH-HHHHHHHHHhccChhhhccHHHHhC
Confidence              1111111111   111 2233333 34455555555 9999999999764

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-40  Score=320.99  Aligned_cols=237  Identities=29%  Similarity=0.382  Sum_probs=183.7

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHH-HHhcCCCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVN-YLGQLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||+||+|...         .+++.||+|++.....   .....+..|.. +++.++||||+++++.+.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK---------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            47999999999997654         3477899999865322   12334555555 46788999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~  147 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence            99999999999999986544  58999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........                ...++
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----------------~~~i~  209 (323)
T cd05575         148 EHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----------------YDNIL  209 (323)
T ss_pred             cCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----------------HHHHH
Confidence            221  122345799999999999999999999999999999999999999974321110                00111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS  354 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~  354 (441)
                      ....  ..+......+..++..|+. ||++||++.
T Consensus       210 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         210 NKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1111  1111223445667777777 999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=317.33  Aligned_cols=272  Identities=22%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCccc-----ccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTL-----EAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLI  151 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~  151 (441)
                      .++|++.+.||+|+||.||++.......     ..........||+|.++.... .....+.+|+++|++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3589999999999999999986643210     011122344689999976532 2345688999999999999999999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGA----------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +++......++||||+++++|.+++.....          ..+++..++.++.|++.||.|||+  ++++||||||+||+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEE
Confidence            999999999999999999999999865321          236888999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh--CCCCCCccccccc
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS--GRRAVDKTRVGAE  299 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~pf~~~~~~~~  299 (441)
                      ++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976433322222223345778999999998899999999999999999998  5667764322110


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                        .......+.        ..........+......+..|+..|+. +|++||++.+|++.|.
T Consensus       242 --~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 --IENTGEFFR--------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHhhh--------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              000000000        000000011122233567788888888 9999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-40  Score=308.41  Aligned_cols=250  Identities=31%  Similarity=0.515  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||.|+||.||+|...           ++.+++|.++.... ..+.+.+|+.++++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            457899999999999999998643           56799999987643 466789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||.++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~  150 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAK  150 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEccccccc
Confidence            999999999999999999977665569999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ......     ....++..|+|||++.++.++.++||||||+++|+|++ |..||.......   +..            
T Consensus       151 ~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~------------  210 (256)
T cd05039         151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP------------  210 (256)
T ss_pred             cccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH------------
Confidence            653211     12234668999999988889999999999999999997 999986432211   111            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        .+........+......+..++..|+. +|++||++.++++.|+.+
T Consensus       211 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         211 --HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              000011111122223455667777887 999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-40  Score=325.15  Aligned_cols=265  Identities=27%  Similarity=0.378  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..    ......++.||||+++.... .....+.+|+.+|.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeecc----CCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            3579999999999999999987532    12334577899999976432 2345688999999999 6899999999876


Q ss_pred             cC-CeeEEEEEeCCCCCHHHHHHhcC------------------------------------------------------
Q 013557          156 DG-ENRLLVYEYMPKGSLENHLFRRG------------------------------------------------------  180 (441)
Q Consensus       156 ~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  180 (441)
                      .. ...++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 46789999999999999986432                                                      


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceee
Q 013557          181 -----------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST  249 (441)
Q Consensus       181 -----------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~  249 (441)
                                 ...+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++.............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                       1236788889999999999999998  899999999999999999999999999987643222111122


Q ss_pred             eccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCC
Q 013557          250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQY  328 (441)
Q Consensus       250 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  328 (441)
                      ...++..|+|||++.+..++.++||||||+++|+|++ |..||........  ..              ..+........
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~--------------~~~~~~~~~~~  303 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC--------------RRLKEGTRMRA  303 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH--------------HHHhccCCCCC
Confidence            3345678999999988899999999999999999997 8999864322110  00              00000111111


Q ss_pred             chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          329 PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       329 ~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      +......+..++..|++ +|++||++.+|++.|+.+.
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11222345667777887 9999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-40  Score=324.19  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=191.0

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||.||+|....         +++.+|+|+++....   .....+..|+.++.++ +||||+++++++.+....
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            479999999999976543         477899999876422   2334577899888877 799999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~  147 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  147 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence            99999999999999886543  58999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........        ......+...+
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--------~~~~~~~~~~i  217 (329)
T cd05618         148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTEDYLFQVI  217 (329)
T ss_pred             CCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc--------cccHHHHHHHH
Confidence            211  12234679999999999999999999999999999999999999996322111000        00000011111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH------HHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM------SEVLSA  359 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~------~evl~~  359 (441)
                      .. .....|......+..|+..|+. ||++||++      .+++++
T Consensus       218 ~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         218 LE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             hc-CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            10 1112333444556677788887 99999984      566543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.9e-40  Score=312.74  Aligned_cols=262  Identities=24%  Similarity=0.411  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||+||+|.+.....     .....||+|.++.... .....+.+|+.+++.++|+||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGE-----NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCC-----ccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            3578899999999999999997653211     1234689999875433 234568899999999999999999999875


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      . ..+++|||+++|+|.+++..+. ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        81 ~-~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          81 S-TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             C-CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCce
Confidence            4 5789999999999999986543 358999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||+......   +..           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~-----------  222 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD-----------  222 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-----------
Confidence            86543222111112234678999999998899999999999999999998 899986432111   111           


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                         .+........+......+..++..|+. ||++||++.++++.|+.+..
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         223 ---LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ---HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence               111111111122233445677788887 99999999999999886644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.3e-41  Score=323.82  Aligned_cols=236  Identities=28%  Similarity=0.395  Sum_probs=186.7

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||.||+|....         ++..||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            479999999999976543         47789999987532   22345577888888877 699999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~  147 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  147 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence            99999999999999886554  48999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...             .+.
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~-------------~i~  209 (320)
T cd05590         148 FNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE-------------AIL  209 (320)
T ss_pred             cCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH-------------HHh
Confidence            211  12234579999999999998899999999999999999999999997443211   000             011


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                      ..  ....+......+..++..|+. ||++||++
T Consensus       210 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         210 ND--EVVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            00  011222233455667777877 99999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.7e-40  Score=310.74  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=194.4

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC-
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG-  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  157 (441)
                      |.+.+.||+|+||.||+|.+....       ....+|+|.++...  ....+.+.+|+.+++.++|+||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            457789999999999998765421       12368999886542  23356688999999999999999999987532 


Q ss_pred             -----CeeEEEEEeCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          158 -----ENRLLVYEYMPKGSLENHLFRR----GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       158 -----~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                           ...++||||+.+|+|.+++...    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~  151 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNV  151 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCE
Confidence                 2468999999999999987432    22348899999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............+++.|++||++.+..++.++||||||+++|||++ |+.||......   .....  
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~--  226 (272)
T cd05075         152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDY--  226 (272)
T ss_pred             EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence            9999999986543322111222346778999999998899999999999999999999 78888643211   11110  


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                  +........+......+..++..|+. +|++||++.+|++.|+.+
T Consensus       227 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 ------------LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                        00000001122233446777888887 999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.5e-40  Score=308.26  Aligned_cols=248  Identities=30%  Similarity=0.469  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE-cC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL-DG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~  157 (441)
                      ++|.+.+.||+|+||.||+|...           +..+++|.++...  ..+.+.+|+.++++++|+|++++++++. +.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            57899999999999999997543           5578999986542  3567889999999999999999999754 55


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..++.++.|++.||+|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccce
Confidence            678999999999999999977665568999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ......     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......   .+..            
T Consensus       151 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~------------  210 (256)
T cd05082         151 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP------------  210 (256)
T ss_pred             eccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH------------
Confidence            533221     12334668999999998889999999999999999998 99998643211   1111            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        .+........+......+..++..|+. +|++||++.++++.|+.+
T Consensus       211 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         211 --RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              111111112223334556677888887 999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-41  Score=331.63  Aligned_cols=203  Identities=27%  Similarity=0.388  Sum_probs=173.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||++...         .++..+|+|+++...   ......+.+|+.++..++|+||+++++.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            46889999999999999997654         347789999986432   123456788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||++||+|.+++.+..  .+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccC
Confidence            9999999999999999999986544  48999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHH
Q 013557          236 AKAGPTGDRT---------------------------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLL  282 (441)
Q Consensus       236 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~  282 (441)
                      +.........                                 ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            8743211100                                 0012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCcc
Q 013557          283 ELLSGRRAVDKT  294 (441)
Q Consensus       283 elltg~~pf~~~  294 (441)
                      ||++|+.||...
T Consensus       228 el~tG~~Pf~~~  239 (360)
T cd05627         228 EMLIGYPPFCSE  239 (360)
T ss_pred             ecccCCCCCCCC
Confidence            999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.6e-40  Score=310.67  Aligned_cols=258  Identities=22%  Similarity=0.326  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|+...         .+..+|||.++...   ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            579999999999999999986543         36789999876432   223346789999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+||
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECcc
Confidence            999999999999999999988532  23458899999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++........  ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||........ ...          
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~----------  217 (267)
T cd08228         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC----------  217 (267)
T ss_pred             ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH----------
Confidence            99876433221  11234688899999999988899999999999999999999999864322110 000          


Q ss_pred             hhhhhhhcc-cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          314 RKLFRIMDI-KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       314 ~~l~~~~~~-~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                          ..+.. .............+..++..|+. +|++||++.+|++.++++.
T Consensus       218 ----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         218 ----QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----HHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                00000 01111112233557778888888 9999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-40  Score=323.66  Aligned_cols=241  Identities=27%  Similarity=0.372  Sum_probs=190.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      +|++.+.||+|+||.||+|...         .++..+|+|+++....   ...+.+..|..++..+ +|++|+.+++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            5888999999999999997654         3467899999875422   2234567788888877 5899999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~  147 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCC
Confidence            9999999999999999999986554  48999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......   +.            
T Consensus       148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~------------  210 (323)
T cd05616         148 CKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF------------  210 (323)
T ss_pred             ceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HH------------
Confidence            87532211  12234679999999999999999999999999999999999999997543211   10            


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                       ..+....  ..+|......+..++..|+. +|++|++.
T Consensus       211 -~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         211 -QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -HHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             1111111  11233333455667777777 99999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-40  Score=308.97  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.++||+|+||.||+|....          +..+|+|.+.... .....+.+|+.++++++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   72 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG----------HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q   72 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC----------CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence            4679999999999999999986532          5679999987554 34567889999999999999999999864 5


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+.+++|.+++.......+++.++..++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCccee
Confidence            578999999999999999876665678999999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ..             
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~-------------  213 (260)
T cd05067         151 LIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI-------------  213 (260)
T ss_pred             ecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH-------------
Confidence            65422211 1123345778999999998889999999999999999999 999996433111   00             


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                       ..+........+......+..++..|+. +|++||+++++++.|+.
T Consensus       214 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         214 -QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             0011111111222233457778888887 99999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=296.91  Aligned_cols=265  Identities=25%  Similarity=0.355  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ...++|++.+.||.|||+.||++.         ...++..+|+|++.....++.+..++|++..++++|||+++++++..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~---------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l   88 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVK---------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL   88 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeec---------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence            456799999999999999999964         34457889999998887778888999999999999999999998765


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      .+     ...||++.|+..|+|.+.+...  .+..+++.+++.|+.+|++||++||+....++||||||.|||+.+.+.+
T Consensus        89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~  168 (302)
T KOG2345|consen   89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP  168 (302)
T ss_pred             HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence            43     3489999999999999999754  3346999999999999999999999843449999999999999999999


Q ss_pred             EEcccCCcccCCCCCccce-------eeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCcccccc
Q 013557          229 KLSDFGLAKAGPTGDRTHV-------STQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA  298 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~  298 (441)
                      +|.|||.+......-....       ......|..|.|||.+.-   ...++++|||||||+||+|+.|..||+......
T Consensus       169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G  248 (302)
T KOG2345|consen  169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG  248 (302)
T ss_pred             EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence            9999999876432211110       012346889999999863   457899999999999999999999997432110


Q ss_pred             chhhhhhhccccccchhhhh-hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          299 EQNLVDWAKPYLGDRRKLFR-IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                                     ..+.- +......-.......+.+..++..|++ ||.+||++.+++..++.+.
T Consensus       249 ---------------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 ---------------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                           11100 000001001111245667778888888 9999999999999988653

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.3e-40  Score=316.31  Aligned_cols=258  Identities=29%  Similarity=0.438  Sum_probs=198.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|......       ....+++|.++... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            67999999999999999998765321       12347888876432 23345688999999999 79999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ....++||||+++++|.+++....              ...+++..++.++.|++.||+|||+  ++|+||||||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill  152 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLV  152 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEE
Confidence            999999999999999999996532              1248889999999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQN  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~  301 (441)
                      +.++.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---  226 (297)
T cd05089         153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---  226 (297)
T ss_pred             CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            999999999999986422110   0111123557999999988889999999999999999997 999996433211   


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      +              ...+........+......+..|+.+|+. +|.+||++++|++.|+.+..
T Consensus       227 ~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         227 L--------------YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             H--------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0              01111111111222233456678888888 99999999999999876544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-40  Score=323.35  Aligned_cols=242  Identities=27%  Similarity=0.357  Sum_probs=189.8

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      ++||+|+||.||+|...         .++..+|+|+++...   ......+..|.+++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            46999999999997654         346789999987542   12334577899998876 799999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus        72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999999886544  48999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ..             ..+.
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~-------------~~i~  209 (321)
T cd05591         148 LNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF-------------ESIL  209 (321)
T ss_pred             cCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH-------------HHHH
Confidence            222  12234579999999999998899999999999999999999999997443211   10             0111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCC-------CHHHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-------SMSEVLSA  359 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-------s~~evl~~  359 (441)
                      ...  ...+......+..++..|+. +|++|+       ++.+++++
T Consensus       210 ~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         210 HDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            100  11222223445566777777 999999       77777755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=325.47  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCC-CCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLH-HPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  153 (441)
                      ..+.|++++.||+||.+.||++....          ...+|+|++....  .....-|.+|+.+|.+|+ |.+||.++||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY  428 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY  428 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence            34679999999999999999976543          3467777765432  233456899999999995 9999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      -..++.+|||||+- ..+|..+|..+......| .++.+..||+.|+.++|.  .||||.||||.|+|+-. |.+||+||
T Consensus       429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDF  503 (677)
T KOG0596|consen  429 EVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDF  503 (677)
T ss_pred             eccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeee
Confidence            99999999999996 459999998776544444 788999999999999998  89999999999999864 58999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCC-----------CCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-----------LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      |+|.........-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||..         
T Consensus       504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------  574 (677)
T KOG0596|consen  504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------  574 (677)
T ss_pred             chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------
Confidence            9999876655444556779999999999986322           46789999999999999999999963         


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHH-HHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYM-VAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            +......+..++++.....+|...... +..++++|+. ||++||++.|+|+.
T Consensus       575 ------~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  575 ------IINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  222334566777766655666655444 8889999999 99999999999876

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-40  Score=321.66  Aligned_cols=241  Identities=27%  Similarity=0.389  Sum_probs=188.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      ++||+|+||.||+|....         ++..||+|.++...   ......+..|..++..+ +||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            479999999999976543         47789999987542   12344567788888765 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+.+|+|.+++....  .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV  147 (316)
T ss_pred             EEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence            99999999999999986643  48899999999999999999998  899999999999999999999999999987432


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.              +.+
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~--------------~~~  208 (316)
T cd05620         148 FGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF--------------ESI  208 (316)
T ss_pred             cCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH--------------HHH
Confidence            221  12345679999999999999999999999999999999999999997443211   10              100


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH-HHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS-EVLS  358 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~-evl~  358 (441)
                      ... ....+......+..++..|+. ||++||++. ++++
T Consensus       209 ~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         209 RVD-TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             HhC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            000 111222233445667777887 999999984 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-40  Score=330.26  Aligned_cols=194  Identities=22%  Similarity=0.269  Sum_probs=167.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|.+.+.||+|+||.||++...         .+++.||+|....      ..+.+|+++|++|+||||++++++|...
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~---------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~  155 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDN---------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN  155 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEEC---------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence            368999999999999999996543         3577899997542      3467899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++|||++. ++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       156 ~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        156 KFTCLILPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             CeeEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence            99999999995 68998886543  48899999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       231 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        231 FPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            5322111 12234679999999999999999999999999999999999998764

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-40  Score=313.96  Aligned_cols=247  Identities=27%  Similarity=0.374  Sum_probs=191.0

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||+|+||.||++...         ..++.+|+|.+......   ....+..|++++++++||||+++++++.+....++|
T Consensus         1 lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVK---------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEc---------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            799999999997554         34778999998643221   223456799999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||++|++|.+++.......+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~  149 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK  149 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence            999999999999876666678999999999999999999998  899999999999999999999999999987643322


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  ...          ........
T Consensus       150 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~----------~~~~~~~~  214 (277)
T cd05607         150 ---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EEL----------KRRTLEDE  214 (277)
T ss_pred             ---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHH----------HHHhhccc
Confidence               223456899999999999888999999999999999999999999643221110  000          00111101


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ... ........+..|+..|+. +|++||+++|+++.+
T Consensus       215 ~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            100 011223345677777887 999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.9e-40  Score=309.29  Aligned_cols=252  Identities=29%  Similarity=0.410  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||.||+|.+..          ...+++|+++... ...+.+.+|++++++++|+||+++++++. ..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~   73 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE   73 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CC
Confidence            579999999999999999986543          2358999997643 23567889999999999999999999875 45


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++.......+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||.++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceee
Confidence            68999999999999999976544568999999999999999999998  8999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|+| |..||.........                 
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-----------------  213 (262)
T cd05071         152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----------------  213 (262)
T ss_pred             ccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-----------------
Confidence            4332211 1123346778999999988899999999999999999999 88888643211100                 


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ..+........+......+..|+..|+. +|++||++.++++.|+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         214 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            0000000011122233456678888888 99999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.4e-40  Score=310.72  Aligned_cols=256  Identities=25%  Similarity=0.311  Sum_probs=190.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.+..       ...+..+++|.++.... .....+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            469999999999987542       12356799999876543 2334688899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          164 YEYMPKGSLENHLFRRG---ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |||+++|+|.+++....   ....++..+..++.|++.||+|||+  .+++|+||||+||+++.++.+||+|||+++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999996532   2245677888999999999999998  899999999999999999999999999987543


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcC-------CCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccccc
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATG-------RLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ............|+..|+|||++.+.       .++.++||||||+++|||++ |+.||........   ..+.  ... 
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~--~~~-  225 (269)
T cd05087         152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT--VRE-  225 (269)
T ss_pred             CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH--hhc-
Confidence            32221112234578899999998642       35789999999999999996 9999964322111   0000  000 


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHHhh
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALE  361 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~L~  361 (441)
                        .......    ..........+..++.+|+.+|++||+++||+..|+
T Consensus       226 --~~~~~~~----~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 --QQLKLPK----PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             --ccCCCCC----CccCCCCChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence              0000001    111112234466688889889999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.7e-40  Score=308.52  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC-CcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +|++.+.||.|+||.||++...         .++..+++|.++.. .....+.+.+|+.+++.++|+||+++++.+.+..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV---------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc---------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence            5888999999999999997543         34778999988643 2234566888999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++.......+++..++.++.|++.||.|||+  ++|+|+||||+||+++.++.++|+|||++..
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  149 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL  149 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCccee
Confidence            99999999999999999876555568999999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      .....  .......|+..|+|||++.+..++.++|+||||+++|+|++|..||........  .              ..
T Consensus       150 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~--------------~~  211 (255)
T cd08219         150 LTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--I--------------LK  211 (255)
T ss_pred             ecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--H--------------HH
Confidence            43221  122345689999999999988899999999999999999999999974321110  0              00


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +.. ......+......+..++..|+. +|++||++.+|+..
T Consensus       212 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         212 VCQ-GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             Hhc-CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            000 00011122233445667777887 99999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-41  Score=299.97  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----c----cHHHHHHHHHHHhcC-CC
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----Q----GHKEWLSEVNYLGQL-HH  144 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l-~h  144 (441)
                      .+...++|...+.||+|..+.|.+         +.++.++..+|+|++.....    .    -.+.-++|+.||+++ .|
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrR---------ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GH   82 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRR---------CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGH   82 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhh---------hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCC
Confidence            456778899999999999999987         55566788899998853221    1    123457899999999 69


Q ss_pred             CCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       145 pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      |+|+++.++|+.+...|+|+|.++.|.|+|+|...-  .++++....|+.|+++|++|||.  ++||||||||+|||+|+
T Consensus        83 P~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   83 PYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDD  158 (411)
T ss_pred             CcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeecc
Confidence            999999999999999999999999999999996654  59999999999999999999998  89999999999999999


Q ss_pred             CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc------CCCCchhhhHHHhHHHHHHHhCCCCCCcccccc
Q 013557          225 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA  298 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~  298 (441)
                      +.++||+|||++.....+..   .+..||||+|+|||.+..      ..|+..+|+||+|||+|-||.|.+||--...- 
T Consensus       159 n~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-  234 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-  234 (411)
T ss_pred             ccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-
Confidence            99999999999998777654   357899999999999853      35788999999999999999999998521100 


Q ss_pred             chhhhhhhccccccchhhhhhhccccc--CCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLE--GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                     --+..++.....  ...-.+....+..|+..|++ ||.+|-|++|.|.+
T Consensus       235 ---------------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  235 ---------------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ---------------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                           011111111111  11112334456778888888 99999999999865

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-40  Score=320.83  Aligned_cols=240  Identities=28%  Similarity=0.351  Sum_probs=183.9

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHH-HHhcCCCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVN-YLGQLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||+||+|....         .+..+|+|++.....   .....+..|.. +++.++|+||+++++++.+.+..
T Consensus         1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            479999999999976543         467899999865321   12234444544 46788999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++++|.+++....  .+.+..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          72 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            99999999999999986544  47888899999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ..             ..+.
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~-------------~~i~  209 (325)
T cd05602         148 EHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MY-------------DNIL  209 (325)
T ss_pred             cCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HH-------------HHHH
Confidence            211  12335679999999999999999999999999999999999999996433211   00             0111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                      ....  ..+......+..++..|++ +|.+||++.+.+
T Consensus       210 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         210 NKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             hCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1111  1122223445666677776 999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.8e-40  Score=310.38  Aligned_cols=256  Identities=25%  Similarity=0.309  Sum_probs=189.0

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.....       .....+++|.+..... .....+.+|+.+++.++|+||+++++.+.+....++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence            3699999999999865321       2245789998765432 2235678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          164 YEYMPKGSLENHLFRRGA---RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |||+++|+|.+++.....   ...++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccc
Confidence            999999999999976432   234677889999999999999998  899999999999999999999999999987533


Q ss_pred             CCCccceeeeccCCCCcCchhhhhc-------CCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccccc
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLAT-------GRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ............++..|+|||++..       ..++.++|||||||++|||++ |..||.......  .+.....     
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~-----  224 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQVVR-----  224 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhh-----
Confidence            3221111223346778999999753       356789999999999999999 778886432110  0000000     


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHHhh
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALE  361 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~L~  361 (441)
                           ...........+.........++.+|+.||++||++++|++.|.
T Consensus       225 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 -----EQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLT  268 (269)
T ss_pred             -----ccCccCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence                 00000011112223344556678888899999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6e-40  Score=314.29  Aligned_cols=271  Identities=23%  Similarity=0.400  Sum_probs=201.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCccccc-------ccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEA-------ARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      ++|++.+.||+|+||.||++.........       ........+|+|.++.... ....++.+|+.+|+.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999997543211000       1223355799999976432 234578899999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGA---------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      ++++.+.+..++||||+++++|.+++.....         ..+++..+..++.|++.||+|||+  .+++||||||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Nil  162 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheEE
Confidence            9999999999999999999999999875432         236778899999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh--CCCCCCccccccc
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS--GRRAVDKTRVGAE  299 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~pf~~~~~~~~  299 (441)
                      ++.++.++|+|||+++...............++..|++||+..++.++.++|||||||++|||++  |..||........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999976433222112223345678999999888899999999999999999998  6778864322110


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                         ......+...       .........+......+..|+..|++ +|++||++.+|++.|+
T Consensus       243 ---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         243 ---IENTGEFFRD-------QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHHHHHHhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               0000000000       00000001122233567788888988 9999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5e-40  Score=320.06  Aligned_cols=203  Identities=26%  Similarity=0.322  Sum_probs=171.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||++....         .+..+|+|++.....   .....+..|+.++..++|+||+.+++++.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            478999999999999999976543         467899999864211   22344778999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecch
Confidence            9999999999999999999997543 358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +........ .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            875432211 1223357999999999986     346889999999999999999999999743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.5e-40  Score=317.28  Aligned_cols=267  Identities=25%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|......  .........+|+|.++.... .....+.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            357889999999999999998653210  11123356789999875432 3345688999999999 6999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +....++||||+++|+|.+++....              ...+++..+..++.|++.||.|||+  +||+||||||+|||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nil  166 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVL  166 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEE
Confidence            9999999999999999999996532              1348889999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++ |..||.......  
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999986433221111112234567999999998899999999999999999999 888886432211  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       +.              ..+........+......+..++..|+. +|++||++.++++.|+++..
T Consensus       245 -~~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 -LF--------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -HH--------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence             11              1111111111223333455678888888 99999999999999986643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-40  Score=319.77  Aligned_cols=241  Identities=27%  Similarity=0.403  Sum_probs=187.8

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||+||+|....         .+..||||+++...   ......+..|..++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            479999999999976543         46789999987542   12334566788888765 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      ++||||+++|+|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENM  147 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence            99999999999999986543  48899999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...              +
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~--------------i  208 (316)
T cd05619         148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQS--------------I  208 (316)
T ss_pred             CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHH--------------H
Confidence            2211  2234679999999999998899999999999999999999999997543211   1110              0


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH-HHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS-EVLS  358 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~-evl~  358 (441)
                      ... ...++......+..++..|+. +|++||++. ++++
T Consensus       209 ~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         209 RMD-NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HhC-CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            000 011222233445566777777 999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-40  Score=329.05  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=196.6

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccE
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      +....++|++.+.||+|+||.||++...         .+++.+|+|++.....   .....+.+|+.+++.++||||+++
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEEC---------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3345689999999999999999997554         3577899999864221   223457789999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ++.+.+....|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999988543   38889999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC----CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR----LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      +|||+++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||........       
T Consensus       184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------  255 (371)
T cd05622         184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------  255 (371)
T ss_pred             EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-------
Confidence            99999976432211 1223567999999999997543    78899999999999999999999975432110       


Q ss_pred             ccccccchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhcCCCC---CCCHHHHHHHh
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCISEAKV---RPSMSEVLSAL  360 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~~P~~---RPs~~evl~~L  360 (441)
                               ...++.......++  ......+..++..|+.+|..   |+++.+|+++.
T Consensus       256 ---------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         256 ---------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---------HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                     01111100000111  12344556677777775443   78999988764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-40  Score=314.17  Aligned_cols=246  Identities=26%  Similarity=0.389  Sum_probs=190.6

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||+|+||+||++...         .+++.+|+|.+......   ..+.+..|+++|+.++|+||+++.+++......++|
T Consensus         1 lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMR---------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEc---------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            799999999997543         34778999998654322   234567899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          164 YEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      |||+++|+|.+++...  ....+++..++.++.||+.||.|||+  ++|+||||||+||+++.++.+||+|||++.....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            9999999999887542  23458999999999999999999998  8999999999999999999999999999875433


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  ..          ...+..
T Consensus       150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~----------~~~~~~  215 (280)
T cd05608         150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--EL----------KQRILN  215 (280)
T ss_pred             CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HH----------HHhhcc
Confidence            221  1234578999999999999999999999999999999999999997433211100  00          000000


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      .  ....+......+..++..|+. +|++||     ++++++++
T Consensus       216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         216 D--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             c--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            0  011223334456677788887 999999     66777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7e-40  Score=333.30  Aligned_cols=204  Identities=22%  Similarity=0.380  Sum_probs=165.3

Q ss_pred             HHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCC------CC
Q 013557           73 ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH------PN  146 (441)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pn  146 (441)
                      ++....++|++.++||+|+||+||+|+...         .+..||||+++... .....+..|+.+++.++|      .+
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~  192 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFP  192 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcc
Confidence            344456889999999999999999976543         46789999986432 223345567777766654      45


Q ss_pred             cccEEEEEEcC-CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          147 LVKLIGFCLDG-ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       147 Iv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      |++++++|..+ ...|+|||++ +++|.+++.+..  .+++..+..++.||+.||+|||+ ..|||||||||+|||++.+
T Consensus       193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETS  268 (467)
T ss_pred             eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecC
Confidence            88898888764 5789999988 779999887654  58999999999999999999996 1499999999999999876


Q ss_pred             C----------------cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCC
Q 013557          226 F----------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR  289 (441)
Q Consensus       226 ~----------------~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~  289 (441)
                      +                .+||+|||.+.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~  343 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL  343 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            5                499999998764221     1235679999999999999999999999999999999999999


Q ss_pred             CCCccc
Q 013557          290 AVDKTR  295 (441)
Q Consensus       290 pf~~~~  295 (441)
                      ||+...
T Consensus       344 pf~~~~  349 (467)
T PTZ00284        344 LYDTHD  349 (467)
T ss_pred             CCCCCC
Confidence            997544

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.7e-40  Score=320.82  Aligned_cols=203  Identities=25%  Similarity=0.301  Sum_probs=172.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||++...         ..++.+|+|.+....   ......+.+|+.++..++|+||+.+++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            47999999999999999997654         346789999986532   122344778999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||++||+|.+++.+.. ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~  148 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGS  148 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccc
Confidence            9999999999999999999997643 358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +........ .......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||...
T Consensus       149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         149 CLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            876433221 11233579999999999875     46788999999999999999999999643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-40  Score=314.70  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=197.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .|++.+.||+|+||.||++...         .+++.+|+|.+.......   ...+.+|+.++++++|+||+.+++.+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            3778899999999999997654         347789999986543222   2446789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++.......+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            9999999999999999999876655569999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........             .
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-------------~  213 (285)
T cd05630         150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-------------V  213 (285)
T ss_pred             eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-------------H
Confidence            75432221   1234789999999999998999999999999999999999999974321110000             0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                      ..... ......+......+..|+..|+. ||++||+     ++|++++
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         214 ERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             Hhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            00000 00111222233445677778888 9999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.6e-40  Score=307.13  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.+.+.||+|+||.||+|....         .+..+++|.+....  ......+.+|++++++++||||+++++++.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47888999999999999986643         36789999886432  23456688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++.......+++..++.++.+++.||.|||+  .+++|+||||+||+++.++.++|+|||+++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~  149 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAK  149 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccce
Confidence            999999999999999999977655678999999999999999999998  899999999999999999999999999988


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .......  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...             
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-------------  211 (256)
T cd08529         150 LLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL-------------  211 (256)
T ss_pred             eccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH-------------
Confidence            6543221  2234568899999999999889999999999999999999999997443110   000             


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+.. ......+......+..++..|+. +|++||++.++++.
T Consensus       212 ~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         212 KIIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            0010 11111222334456778888887 99999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-40  Score=306.77  Aligned_cols=254  Identities=30%  Similarity=0.447  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....          +..++||.+.... ....++.+|+.++++++|+||+++++++.+.
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE   73 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence            4689999999999999999986543          4568999987543 3456789999999999999999999999998


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..+..++.+++.||.|||+  ++++|+||||+||+++.++.+||+|||++.
T Consensus        74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccce
Confidence            999999999999999999977665668999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......  .+..            
T Consensus       152 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~------------  216 (261)
T cd05034         152 LIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQ------------  216 (261)
T ss_pred             eccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------
Confidence            6432111 11112234678999999998889999999999999999999 999986432111  0000            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                         +........+......+..++..|+. +|++||+++++++.|+.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 ---VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               00011111122223456677777887 99999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.2e-40  Score=318.41  Aligned_cols=237  Identities=30%  Similarity=0.385  Sum_probs=183.5

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHH-HHhcCCCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVN-YLGQLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~  160 (441)
                      ++||+|+||.||+|...         ..+..+|+|++.....   .....+..|.. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            47999999999997654         3477899999865322   12334555554 57889999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            99999999999999886543  48899999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .             ...+.
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~-------------~~~i~  209 (321)
T cd05603         148 EPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---M-------------YDNIL  209 (321)
T ss_pred             CCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---H-------------HHHHh
Confidence            211  12234579999999999998899999999999999999999999996543111   0             00111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS  354 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~  354 (441)
                      ...  ...+......+..++..|++ +|.+||++.
T Consensus       210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         210 HKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            111  11222333455667777777 999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.9e-40  Score=307.42  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|....         ++..+++|.++....   .....+.+|++++++++|+||+++++++.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            579999999999999999986542         467899998864322   23457889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+..++||||+++++|.+++...  ....+++.+++.++.+++.||.|||+  .||+||||||+||+++.++.++|+||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEecc
Confidence            999999999999999999988642  23458999999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++........  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......    ...        
T Consensus       151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~--------  216 (267)
T cd08224         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSL--------  216 (267)
T ss_pred             ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HHH--------
Confidence            99876433221  1234568899999999998889999999999999999999999986433111    000        


Q ss_pred             hhhhhhhcccccCCCch-hHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          314 RKLFRIMDIKLEGQYPQ-KGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~-~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                         ...+........+. .....+..++..|+. +|++||++.+|++.|+++.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         217 ---CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---HhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               00000000111111 233456677888888 9999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-39  Score=305.67  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=193.2

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      .||+|+||.||+|.+..       ...+..+|+|+++....  ...+.+.+|+.+++.++|+||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            68999999999986542       23467899999875432  23456889999999999999999999875 4577999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++......
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          74 MELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            99999999999986543  58999999999999999999998  899999999999999999999999999998653322


Q ss_pred             ccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          244 RTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       244 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......   .              ...+.
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~--------------~~~i~  212 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V--------------TQMIE  212 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H--------------HHHHH
Confidence            111 1112234678999999988889999999999999999998 999997432211   1              11111


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      .......+......+..++..|+. +|++||++.+|.+.|++
T Consensus       213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            111122333344556778888888 99999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.1e-40  Score=312.01  Aligned_cols=262  Identities=27%  Similarity=0.419  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|....    ......+..+|+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPG----LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcc----cCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            4679999999999999999987542    11123467899999876532 234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG--------------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFK  216 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlk  216 (441)
                      +...++||||+++++|.+++....                    ...+++..++.++.|++.||.|||+  ++++|||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~  157 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLA  157 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeeccccc
Confidence            999999999999999999996432                    1247788899999999999999998  899999999


Q ss_pred             CCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccc
Q 013557          217 ASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTR  295 (441)
Q Consensus       217 p~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~  295 (441)
                      |+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999875432221111222345678999999998899999999999999999998 888885332


Q ss_pred             cccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ...   ...             .+.+.... ..+......+..++..|++ +|++||++.||++.|++
T Consensus       238 ~~~---~~~-------------~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEE---VIY-------------YVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHH---HHH-------------HHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            111   111             00010110 1122233456667788887 99999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.9e-40  Score=319.74  Aligned_cols=242  Identities=28%  Similarity=0.414  Sum_probs=191.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||+||+|....         ++..+|||+++...   ......+..|..++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            479999999999976543         46789999987542   22345567899999888 699999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++++|.+++....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  147 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI  147 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence            99999999999999886654  48999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...             .+.
T Consensus       148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~-------------~i~  209 (318)
T cd05570         148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ-------------SIL  209 (318)
T ss_pred             cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH-------------HHH
Confidence            2111  1234578999999999999999999999999999999999999997433111   000             000


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH-----HHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM-----SEVLSA  359 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~-----~evl~~  359 (441)
                      ...  ...+......+..|+..|+. ||++||++     .++++.
T Consensus       210 ~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         210 EDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             cCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            000  11222334456677788887 99999999     777654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=307.89  Aligned_cols=252  Identities=30%  Similarity=0.403  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-----ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-----QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ++|.+.+.||+|+||.||+|...         ..+..+++|.+.....     .....+.+|++++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV---------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc---------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            57999999999999999997643         2467899998764321     123467889999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.++...++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+|+||||+|+||+++.++.++|+||
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~df  148 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDF  148 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeec
Confidence            999999999999999999999986544  48899999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          234 GLAKAGPTGDRTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       234 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      |+++......... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........             
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------  215 (263)
T cd06625         149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-------------  215 (263)
T ss_pred             ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-------------
Confidence            9987543221111 11234678899999999988899999999999999999999999864321100             


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .............+......+..++..|+. +|++||++.++++.
T Consensus       216 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         216 ---IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               001111111122333344456677778887 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.9e-40  Score=316.72  Aligned_cols=260  Identities=30%  Similarity=0.442  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+....       ....+++|.++.... .....+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            468899999999999999998764321       123568887764322 2345688899999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +.+..++||||+++++|.+++....              ...+++..++.++.|++.||+|||+  +|++||||||+|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nil  156 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNIL  156 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEE
Confidence            9999999999999999999996543              1247899999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||+| |..||.......  
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  231 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--  231 (303)
T ss_pred             ecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--
Confidence            9999999999999986421111   1111234667999999988889999999999999999998 999986432211  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                       ...              .+........+......+..|+..|+. +|++||++.++++.|+++...
T Consensus       232 -~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         232 -LYE--------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             -HHH--------------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             000              000011111122223446678888888 999999999999998765443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-39  Score=307.35  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|...+.||+|+||.||+|.....      ......+++|.++... ....+.+..|++++++++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMP------GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            35788899999999999999876431      1123479999987542 2334568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+  .+++|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccc
Confidence            999999999999999999986543 358999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCcccee-eeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRTHVS-TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ............ .....+..|+|||++.+..++.++|||||||++|||++ |+.||......   ..            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~------------  219 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EV------------  219 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH------------
Confidence            764332211111 11223457999999998889999999999999999997 99998643211   01            


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        ...+........+......+..++.+|+. +|++||++.+|++.|+++
T Consensus       220 --~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         220 --MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              11111111111122233456677788887 999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-40  Score=309.02  Aligned_cols=259  Identities=26%  Similarity=0.452  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..|++.+.||+|+||.||+|.+....      ..+..|+||.++... ......+..|+.+++.++||||+++++++.++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCC------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence            35788999999999999998765321      124579999987642 23356789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCcccc
Confidence            99999999999999999986543 358999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceee-ecc--CCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccc
Q 013557          238 AGPTGDRTHVST-QVM--GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       238 ~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ............ ...  .+..|+|||++.+..++.++|||||||++|||++ |..||......   ....+..      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~------  225 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE------  225 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH------
Confidence            543322111111 111  2457999999998899999999999999999886 99998643321   1111110      


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                              .......+......+..++..|+. +|.+||++.+|+..|+.+
T Consensus       226 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 --------QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    001111122233456678888888 999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-39  Score=304.98  Aligned_cols=252  Identities=29%  Similarity=0.422  Sum_probs=198.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||.||+|....          +..+++|.+.... ...+.+.+|+.++++++|+||+++++++. ..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            568899999999999999986543          3358999886543 33467889999999999999999999875 45


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~  151 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARL  151 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceE
Confidence            68999999999999999976655568999999999999999999998  8999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|+| |..||.......   ...+            
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~------------  215 (260)
T cd05069         152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQ------------  215 (260)
T ss_pred             ccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH------------
Confidence            4332211 1122345678999999988889999999999999999999 899986432111   1110            


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                        +........+......+..++..|+. +|++||++++|++.|+.
T Consensus       216 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         216 --VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              11011111222334566778888888 99999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.8e-40  Score=308.76  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|....         .+..++||.+.....   ....++.+|+.+++.++|+||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            478899999999999999976543         367899998764322   23356889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.++|+||
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcc
Confidence            999999999999999999988642  23458999999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++........  ......|+..|+|||++.+..++.++||||||+++|+|++|..||........    .+..      
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~------  218 (267)
T cd08229         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK------  218 (267)
T ss_pred             hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh------
Confidence            99876433221  12345688999999999988899999999999999999999999864322110    0000      


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                          .+.........+......+..++..|+. +|++||++.+|++.+.++.
T Consensus       219 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         219 ----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ----hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                0000001111122334567778888887 9999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=317.38  Aligned_cols=203  Identities=27%  Similarity=0.327  Sum_probs=171.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||++....         .++.||+|++....   ....+.+.+|+.++..++|+||+.+++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            479999999999999999976543         46789999986421   123345788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCc
Confidence            9999999999999999999996533 358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +......... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...
T Consensus       149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            8754332211 1223469999999999973     45788999999999999999999999743

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=325.20  Aligned_cols=245  Identities=25%  Similarity=0.391  Sum_probs=199.9

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYE  165 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  165 (441)
                      +||+|.||+||.|+...         +...+|||-+........+-+..|+.+-++|+|.|||+++|.+.+++.+-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            69999999999876543         456799999987766667778899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEcccCCcccCCCC
Q 013557          166 YMPKGSLENHLFRRGARPL--PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDFGLAKAGPTG  242 (441)
Q Consensus       166 ~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg~a~~~~~~  242 (441)
                      .++||+|.+++.. ...++  .+...-.+.+||++||.|||.  +.|||||||-+|||++. .|.+||+|||-++....-
T Consensus       653 qVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             cCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            9999999998854 33456  778888999999999999998  89999999999999976 588999999999864332


Q ss_pred             CccceeeeccCCCCcCchhhhhcC--CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          243 DRTHVSTQVMGTRGYAAPEYLATG--RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       243 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      .  ....++.||..|||||++..+  .|+.++|||||||++.||.||++||-..+...               ..++..-
T Consensus       730 n--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------AAMFkVG  792 (1226)
T KOG4279|consen  730 N--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------AAMFKVG  792 (1226)
T ss_pred             C--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------Hhhhhhc
Confidence            2  123467899999999999865  58999999999999999999999995332110               1111111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      --......|.........++..|.. +|.+||++.++|+.
T Consensus       793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            1123345677777788889999998 99999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-39  Score=309.52  Aligned_cols=263  Identities=25%  Similarity=0.378  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.+...     ....+..+++|++.... ......+.+|+.+|++++|+||+++++++..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            56899999999999999999976531     12235679999887542 2335568899999999999999999998765


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRRGA------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                       ....++++||+++++|.+++.....      ..+++..++.++.|++.||+|||+  ++++||||||+||+++.++.+|
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEE
Confidence             5678999999999999999865422      458999999999999999999998  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||......   .+..+.. 
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~-  233 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK-  233 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH-
Confidence            999999986533322222223446778999999998889999999999999999999 99999743211   1111110 


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                                   .......+......+..++..|+. +|++||++.++++.|+.+.
T Consensus       234 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 -------------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -------------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                         000101111223445678888887 9999999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-40  Score=321.75  Aligned_cols=240  Identities=29%  Similarity=0.366  Sum_probs=183.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHH-HHhcCCCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVN-YLGQLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||+|+||+||+|...         .++..+|+|++.....   .....+..|.. +++.++||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK---------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            46999999999997643         3477899999865421   22344556655 46778999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  +||+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~  147 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence            99999999999999886543  58999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........                ...++
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----------------~~~~~  209 (325)
T cd05604         148 AQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----------------YDNIL  209 (325)
T ss_pred             CCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----------------HHHHH
Confidence            211  122346799999999999999999999999999999999999999974332110                00111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                      .... ...+. ....+..++..|+. +|++||++.+.+
T Consensus       210 ~~~~-~~~~~-~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         210 HKPL-VLRPG-ASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             cCCc-cCCCC-CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            1111 11122 22334456666666 999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.8e-40  Score=318.89  Aligned_cols=241  Identities=27%  Similarity=0.377  Sum_probs=188.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      +|++.+.||+|+||.||+|...         .++..||+|+++...   ....+.+..|..++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            4778899999999999997543         357789999987532   123455778999998885 678889999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||+++|+|.+++....  .+++.+++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~  147 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEecccc
Confidence            9999999999999999999986544  48999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .             
T Consensus       148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~-------------  209 (323)
T cd05615         148 CKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L-------------  209 (323)
T ss_pred             ccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H-------------
Confidence            87532221  12234579999999999999899999999999999999999999997543211   0             


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                      ...++...  ..++......+..++..|+. +|.+|++.
T Consensus       210 ~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         210 FQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            01111111  11222233345556677776 99999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-39  Score=304.48  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=197.9

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.+...      ......+|||.+..... ...+.+.+|+.++++++|+||+++++++.+ ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            4689999999999876431      12234699999987766 456678999999999999999999999888 889999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.......+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||+++......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccc
Confidence            999999999999976553568999999999999999999998  899999999999999999999999999998654322


Q ss_pred             ccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          244 RTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       244 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.......   ....             +..
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~-------------~~~  215 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKK-------------IDK  215 (257)
T ss_pred             cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HHh
Confidence            111 1123457789999999998899999999999999999998 999986432211   0000             000


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      .......+......+..++..|+. +|++||++.+|++.|.
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            000111122233456678888888 9999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-39  Score=306.47  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=200.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .+|++.+.||+|+||.||+|.+...      ...+..+|+|.++.... .....+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP------GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC------CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            5788999999999999999875421      11244799999875432 2345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+  ++++||||||+|||++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence            99999999999999999997654 358999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccce-eeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          238 AGPTGDRTHV-STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       238 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      .......... .....++..|+|||++.+..++.++|+||||+++|++++ |..||.......   .....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---------  222 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---------  222 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH---------
Confidence            6543221111 111223568999999998899999999999999999886 999986433211   11100         


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                          .. ......+......+..++..|+. +|.+||++.++++.|+.+
T Consensus       223 ----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 ----EE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----hC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                00 00111122223456778888888 999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=303.67  Aligned_cols=252  Identities=32%  Similarity=0.504  Sum_probs=195.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.+...      ...+..+|+|.+...... ..+.+.+|+.+++.+.|+||+++++++. ....++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK------SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeecc------CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence            4799999999999876432      113468999999866442 3456889999999999999999999876 4568999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||.  .+++|+||||+|||++.++.+||+|||+++......
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            99999999999997654  58999999999999999999998  899999999999999999999999999998653322


Q ss_pred             ccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          244 RTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       244 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....+.              .
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~--------------~  212 (257)
T cd05060         150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML--------------E  212 (257)
T ss_pred             cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH--------------H
Confidence            111 1111224568999999998899999999999999999998 9999964321   1111111              1


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      .......+......+..++.+|+. +|++||++.+|++.|+.+.
T Consensus       213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            011111233334556678888888 9999999999999998653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.1e-40  Score=319.30  Aligned_cols=243  Identities=27%  Similarity=0.373  Sum_probs=188.0

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  160 (441)
                      ++||+|+||.||+|....         .++.+|+|+++....   ...+.+.+|+.++.++ +|+||+.+++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            479999999999976543         467899999976432   2334578899999888 699999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~  147 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL  147 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence            99999999999999886544  48999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............          ..+...+
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~----------~~~~~~~  215 (327)
T cd05617         148 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE----------DYLFQVI  215 (327)
T ss_pred             CCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH----------HHHHHHH
Confidence            211  1234567999999999999999999999999999999999999999643221111110          0111111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                      ... ....|......+..++..|+. ||++|+++
T Consensus       216 ~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         216 LEK-PIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HhC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            111 112233333445667777777 99999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.7e-40  Score=311.87  Aligned_cols=252  Identities=28%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .|+..+.||+|+||+||+|.+..         +++.+|+|.+......   ....+.+|+++|++++|+||+.+++.+.+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence            36778899999999999976543         4778999998654322   23346789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..++||||+++++|.+++.......+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            9999999999999999998876655569999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......   ......|+..|+|||++.+..++.++|||||||++|+|++|..||.............            
T Consensus       150 ~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~------------  214 (285)
T cd05632         150 VKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD------------  214 (285)
T ss_pred             eecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence            7543221   1234578999999999998899999999999999999999999997432211100000            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                       .... .....++......+..|+..|+. +|++||+     +.+++..
T Consensus       215 -~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         215 -RRVL-ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -Hhhh-ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             0000 00011222233445677788887 9999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-39  Score=309.78  Aligned_cols=273  Identities=29%  Similarity=0.421  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +.|.+.+.||+|+||.||++.+..     .....+..+|+|.++... ......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            457889999999999999987542     234457889999987553 23345688999999999999999999998775


Q ss_pred             --CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          158 --ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       158 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                        ...++||||++|++|.+++.+.. ..+++..++.++.|++.||+|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcc
Confidence              57899999999999999986543 358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc--
Q 013557          236 AKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD--  312 (441)
Q Consensus       236 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  312 (441)
                      ++........ .......++..|+|||++.+..++.++|||||||++|+|+|++.|+.......    .....+....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~~~~~~  231 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPTHGQMT  231 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh----hhhccccccccc
Confidence            9865432211 11223456778999999988889999999999999999999877643211100    0000000000  


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .......+........+......+..|+..|++ +|++||++.+|++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000111111111111122334556778888887 999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-39  Score=309.28  Aligned_cols=275  Identities=29%  Similarity=0.386  Sum_probs=206.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEc-
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLD-  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  156 (441)
                      ++|.+.+.||+|+||.||+|.+...     ....+..+|||.++..... ....+.+|+++++.++|+||+++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL-----GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC-----CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            4678889999999999999976532     1335778999999866443 45678999999999999999999999887 


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                       ....++||||+++++|.+++..... .+++..+..++.|++.||+|||+  ++++|+||||+||+++.++.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence             5678999999999999999965443 48999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +.......... ......++..|++||.+.+..++.++||||||+++|||++|..||............. .. ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~-~~~~~~  233 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQ-GQMIVT  233 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-cc-ccccHH
Confidence            98754222111 1112344567999999988889999999999999999999999986432211000000 00 000011


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .+...+........+......+..|+.+|+. +|++||++.||+++|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1122222221112223333557778888888 999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1e-39  Score=307.68  Aligned_cols=255  Identities=26%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....         .+..+|+|++..........+.+|+.++++++||||+++++++...
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~   78 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR   78 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence            4579999999999999999986542         4678999998765444556678999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.
T Consensus        79 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          79 EKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccce
Confidence            99999999999999999986543  58999999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      .......  ......|+..|+|||++.   ...++.++|||||||++|||++|+.||........  ...+....     
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~~~~-----  225 (267)
T cd06646         155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMSKSN-----  225 (267)
T ss_pred             eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeeecCC-----
Confidence            6432211  122356889999999984   34578899999999999999999999853321100  00000000     


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                          .......  ........+..++..|+. +|++||++++|++.|
T Consensus       226 ----~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 ----FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                0000000  011123455677788887 999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=306.33  Aligned_cols=242  Identities=27%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccH---HHHHHHHHHHhcCCCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..++|..+++||+|.||+|.+         ++.+.+++.+|+|+++++-.-..   ..-+.|-++|+..+||.+..+...
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL---------~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs  236 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVIL---------CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS  236 (516)
T ss_pred             ccchhhHHHHhcCCccceEEE---------EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence            347899999999999999998         55666799999999998754333   345779999999999999999989


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |...+.+|+||||+.||.|+-+|.+..  .+++...+.+-.+|+.||.|||+  ++||+||||.+|+|+|.+|++||+||
T Consensus       237 FQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  237 FQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             hccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeec
Confidence            999999999999999999999886644  58999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++..-  .......++||||.|+|||++....|+.++|+|.+||++|||++|+.||...+                 .
T Consensus       313 GLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------------h  373 (516)
T KOG0690|consen  313 GLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------------H  373 (516)
T ss_pred             ccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------------h
Confidence            9998632  22335678999999999999999999999999999999999999999995322                 2


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP  351 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP  351 (441)
                      ..+++++... .-.+|.........|...++. ||++|.
T Consensus       374 ~kLFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  374 EKLFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hHHHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            3333433321 123555544455555555555 999984

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-39  Score=313.15  Aligned_cols=266  Identities=24%  Similarity=0.357  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||++...         .++..+++|.+..... .....+.+|++++++++||||++++++|.++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR---------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc---------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            47899999999999999997544         3467899998875422 2345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence            9999999999999999999655  358999999999999999999997 2589999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc-----
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD-----  312 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  312 (441)
                      .....    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....................     
T Consensus       149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         149 QLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             ccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence            54322    123457899999999998888999999999999999999999999644321111111100000000     


Q ss_pred             -----------chhhhhhhcccc---cCCCch-hHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          313 -----------RRKLFRIMDIKL---EGQYPQ-KGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       313 -----------~~~l~~~~~~~~---~~~~~~-~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                                 .....+..+...   ....+. .....+..++..|+. +|++||++.+|++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                       000001111000   001111 123346678888887 999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=307.32  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=201.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .+|++.+.||+|+||.||+|.+..+.     ......+++|.+..... .....+.+|+.++++++|+||+++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEG-----EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCC-----CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            57889999999999999999765321     11234689998876543 234568899999999999999999999887 


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence            788999999999999999876433 48999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...............++..|+|||.+....++.++||||||+++|||++ |+.||+......   .              
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~--------------  220 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---I--------------  220 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---H--------------
Confidence            6543322111112224568999999988889999999999999999998 999997543211   1              


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ...+........+......+..++..|+. +|++||++.++++.|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11111111111222233445666777776 9999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=303.59  Aligned_cols=252  Identities=32%  Similarity=0.498  Sum_probs=200.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-HHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|......      ..+..+++|.++...... .+.+.+|++++..++|+||+++++++.+....++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence            47999999999998765321      236689999998664433 56788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          164 YEYMPKGSLENHLFRRG-------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      |||+++++|.+++....       ...+++..++.++.|++.||+|||+  ++++|+||||+||+++.++.+||+|||.+
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccc
Confidence            99999999999997642       2468999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ................++..|+|||++.+..++.++||||||+++|+|++ |..||......   ....           
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~-----------  218 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE-----------  218 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH-----------
Confidence            87554332222334567889999999988889999999999999999999 69999754211   1111           


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                         .+........+......+..++..|+. +|++||++.++++.|+
T Consensus       219 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         219 ---YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               111011112233334556677778887 9999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.6e-41  Score=309.43  Aligned_cols=267  Identities=27%  Similarity=0.360  Sum_probs=194.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      -.|.-.+++|.|+||.||+|...+.         +..||||+...+..    .--+|+++|+.+.|||||++..+|....
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~---------~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRET---------EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSST   90 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCC---------CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence            3577789999999999999987653         66899999865432    2237999999999999999998886432


Q ss_pred             -----eeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcEEE
Q 013557          159 -----NRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKL  230 (441)
Q Consensus       159 -----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~kl  230 (441)
                           ...+||||++. +|.+++...  .+..++...+.-+..||++||.|||+  .||+||||||.|+|+|.+ |.+||
T Consensus        91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEe
Confidence                 44689999976 999988642  34568888999999999999999999  899999999999999987 89999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      +|||.|+....+...   .....|..|+|||.+.| ..|+.+.||||.||++.||+-|++.|.+.....  .++...+-+
T Consensus       168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~l  242 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVL  242 (364)
T ss_pred             ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHh
Confidence            999999976555432   34556889999999987 469999999999999999999999998654322  222221111


Q ss_pred             ccc-chhhh------------hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH--hhcCCCC
Q 013557          310 LGD-RRKLF------------RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA--LEQLPPP  366 (441)
Q Consensus       310 ~~~-~~~l~------------~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~--L~~l~~~  366 (441)
                      -.. .+.+.            .+....+...+..........|+..++. +|.+|.++.|++.+  ++.+..+
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            100 01110            1111011111122223344455566666 99999999999865  4444444

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-39  Score=302.71  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=192.6

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVY  164 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  164 (441)
                      .||+|+||.||+|.+..       ...+..+|+|++...... ..+.+.+|+.++++++|+||+++++++. ....++||
T Consensus         2 ~ig~G~~g~v~~~~~~~-------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKM-------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEec-------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence            48999999999987542       123557999998765332 2456889999999999999999999875 45789999


Q ss_pred             EeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCc
Q 013557          165 EYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR  244 (441)
Q Consensus       165 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~  244 (441)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++++||||||+|||++.++.+||+|||++........
T Consensus        74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            9999999999986433 358999999999999999999998  8999999999999999999999999999975433221


Q ss_pred             cce-eeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcc
Q 013557          245 THV-STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI  322 (441)
Q Consensus       245 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  322 (441)
                      ... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......                 +...+..
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~  213 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----------------VMSFIEQ  213 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHHHHHC
Confidence            111 111223578999999988889999999999999999996 999996432111                 1111111


Q ss_pred             cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          323 KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ......+......+..++..|+. +|++||++.+|.+.|+.
T Consensus       214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            11122333445566678888888 99999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-39  Score=316.33  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      .+|++.+.||+|+||.||+|......  .........+|+|.++.... ...+.+.+|+.+++++ +|+||++++++|.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            47899999999999999998754211  01112244789998875432 2346788999999999 79999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ....++||||+++|+|.+++..+.              ...+++..++.++.|++.||.|||+  ++|+||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nill  167 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLV  167 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEE
Confidence            999999999999999999997542              1247888999999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQN  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~  301 (441)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence            9999999999999976433221111122234567999999998899999999999999999998 8888864321111  


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                     ...+........+......+..++..|+. +|++||++.+|++.|+++..
T Consensus       246 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         246 ---------------FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ---------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                           01111111111222333456678888888 99999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-39  Score=311.45  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|.+.+.||+|+||.||+|...         ..+..+++|.+..........+.+|+.+++.++|+||+++++.+...
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~   89 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEEC---------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence            468999999999999999998643         24678999998776555667788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++...   .+++.++..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccch
Confidence            9999999999999999988543   37899999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .......  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  ....+..          
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~~----------  230 (296)
T cd06654         165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIAT----------  230 (296)
T ss_pred             hcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHhc----------
Confidence            5433221  1223468899999999998889999999999999999999999996433211  0000000          


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         ........+......+..++..|+. +|++||++.+|++.
T Consensus       231 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 ---NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence               0000001122233445667777887 99999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.4e-39  Score=306.50  Aligned_cols=260  Identities=26%  Similarity=0.384  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||.|+||.||+|+....    ........+++|.+...... ....+.+|++++++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            5788999999999999999987542    22344668999988764433 346789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGA-------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ...++||||+++++|.+++.....       ..+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.++|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEE
Confidence            999999999999999999975542       158999999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      +|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....   
T Consensus       159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~---  231 (275)
T cd05046         159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL---  231 (275)
T ss_pred             cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH---
Confidence            99999875322211 11223356778999999988889999999999999999999 788885332111   11110   


Q ss_pred             cccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                                .........+......+..++..|+. +|++||++.+++..|.
T Consensus       232 ----------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 ----------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ----------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                      00011111122333466778888887 9999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=305.21  Aligned_cols=250  Identities=31%  Similarity=0.464  Sum_probs=191.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCeeEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  162 (441)
                      ++||+|+||.||+|......       ....+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            46899999999998765321       12357888887533 23345788999999999 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          163 VYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ||||+++++|.+++..+.              ...+++.+++.++.|++.||+|||+  ++++||||||+|||++.++.+
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~  151 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA  151 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeE
Confidence            999999999999986532              1247899999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   
T Consensus       152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---  222 (270)
T cd05047         152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---  222 (270)
T ss_pred             EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---
Confidence            999999986321110   1111233567999999988889999999999999999997 999986432111   110   


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                 .+........+......+..|+..|+. +|.+||++.+++..|+++
T Consensus       223 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         223 -----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -----------HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                       011111111122223456678888888 999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=332.63  Aligned_cols=260  Identities=27%  Similarity=0.482  Sum_probs=218.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ...|.++||.|.||+||+|+++...      +....||||.++....+ ...+|+.|+.||.+++||||++|.|+.....
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pg------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPG------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             heEEEEEEecccccceecccccCCC------CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            4566799999999999999887532      23568999999876443 3567999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      -..||.|||++|+|..+|..+.++ |+..+...++.+|+.||+||-+  .++|||||...|||++.+..+|++|||+++.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsd--m~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhh--cCchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999999887765 9999999999999999999998  9999999999999999999999999999997


Q ss_pred             CCCCCccceeeeccC--CCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          239 GPTGDRTHVSTQVMG--TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       239 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ..+..... .++.-|  ...|.|||.+...+++.+|||||+|+++||.++ |.+||-+..                 ..+
T Consensus       781 ledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQd  842 (996)
T KOG0196|consen  781 LEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQD  842 (996)
T ss_pred             cccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hHH
Confidence            65443221 122222  468999999999999999999999999999876 999875332                 133


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      +...+....+-..|.+++..+.+|++.||+ |-.+||.+.+|+..|+++...
T Consensus       843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            444444455556788899999999999999 999999999999999987553

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-39  Score=310.40  Aligned_cols=200  Identities=30%  Similarity=0.425  Sum_probs=166.5

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcC---CCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQL---HHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~  154 (441)
                      +|++.+.||+|+||.||+|...         .+++.+|+|.++.....  ....+.+|+.+++.+   +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP---------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC---------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            5889999999999999997654         35778999998754222  223456777777665   699999999987


Q ss_pred             Ec-----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          155 LD-----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       155 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ..     ....++||||+.+ +|.+++.......+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+|
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             ccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEE
Confidence            64     3457999999975 89998876655568999999999999999999998  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      |+|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|++||...
T Consensus       149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         149 LADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             ECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            99999998643322   123356899999999999889999999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-39  Score=327.53  Aligned_cols=195  Identities=25%  Similarity=0.288  Sum_probs=167.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|.+.+.||+|+||.||+|....         .++.||||....      ..+.+|+++|++|+|+||+++++++...
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            4579999999999999999976543         467899996432      2356899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++|||++. ++|.+++.... ..+++.+++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++
T Consensus       233 ~~~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        233 GLTCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             CEEEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence            99999999995 69999886543 359999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      ...............||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus       309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            653322222223467999999999999999999999999999999999988654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=299.93  Aligned_cols=247  Identities=31%  Similarity=0.473  Sum_probs=194.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ++||+|+||.||++....          ++.+++|.+...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence            479999999999976432          668999998765443 455788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.... ..+++..+..++.+++.+|.|||+  ++++||||||+|||++.++.+||+|||++.......
T Consensus        71 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (251)
T cd05041          71 MELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI  147 (251)
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence            99999999999986543 358899999999999999999998  899999999999999999999999999987543221


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI  322 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  322 (441)
                      .........++..|+|||++.++.++.++|||||||++|+|+| |..||.........                 ..+..
T Consensus       148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~~~  210 (251)
T cd05041         148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIES  210 (251)
T ss_pred             ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHHhc
Confidence            1111112234567999999988899999999999999999999 88888643321111                 11111


Q ss_pred             cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          323 KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      ......+......+..++..|+. +|++||++.||++.|+
T Consensus       211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11111233334567778888887 9999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.1e-40  Score=329.67  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=188.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....         .+..||||++....    ....+|+.+|+.++|+||+++++++...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~  131 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE  131 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence            4689999999999999999986543         46789999885432    2345799999999999999999886432


Q ss_pred             --------CeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-
Q 013557          158 --------ENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-  226 (441)
Q Consensus       158 --------~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-  226 (441)
                              ..+++||||+++ +|.+++..  .....+++..++.++.||+.||.|||+  ++|+||||||+|||++.++ 
T Consensus       132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~  208 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTH  208 (440)
T ss_pred             ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCC
Confidence                    246799999975 78777753  234568999999999999999999998  8999999999999999765 


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVD  304 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~  304 (441)
                      .+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||........ .....
T Consensus       209 ~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  285 (440)
T PTZ00036        209 TLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ  285 (440)
T ss_pred             ceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            699999999986543221   2245789999999998764 689999999999999999999999975432111 01111


Q ss_pred             hh-ccccccch----hhhh-----hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          305 WA-KPYLGDRR----KLFR-----IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       305 ~~-~~~~~~~~----~l~~-----~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .. .+......    ....     .....+...+|......+..|+..|+. +|.+||++.|++++
T Consensus       286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00 00000000    0000     000001111222223445667777777 99999999999865

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-39  Score=307.55  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=196.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      .+.+.|++.+.||+|+||.||+|....         .++.+|+|.+.... .....+.+|+.++.++ +|+||+++++++
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   72 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   72 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence            356789999999999999999986543         46789999986543 3456788999999998 699999999998


Q ss_pred             EcC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          155 LDG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       155 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ...      ...++||||+.+++|.+++.......+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCE
Confidence            753      468999999999999999976555568999999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhh
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~  303 (441)
                      ||+|||++.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||............
T Consensus       151 ~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         151 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             EEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            999999987543221  1223457899999999986     345788999999999999999999999643211110000


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                      ................+..|+..|+. +|.+||++.+++..
T Consensus       229 ----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 ----------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----------------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                            00000000111222345677788887 99999999999753

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.4e-39  Score=302.32  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....          +..+++|.+.... .....+.+|+.++++++|+||+++++++.+ 
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   72 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-   72 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence            4679999999999999999986543          3468999887543 235678899999999999999999999887 


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...+++|||+++++|.+++.......+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCccee
Confidence            788999999999999999977655568899999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ ......++..|+|||++.+..++.++|+|||||++|+++| |+.||.......   ...+.          
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----------  216 (260)
T cd05073         151 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----------  216 (260)
T ss_pred             eccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----------
Confidence            64332211 1122345678999999998889999999999999999999 899986432111   11100          


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                          ........+......+..++..|+. +|++||++.++++.|+.
T Consensus       217 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         217 ----ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0000011112223445667777887 99999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-40  Score=317.77  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ...+.++||.|-||.||+|.+....     ++....||||..+.+. ..+.+.|+.|..+|++++||||++++|+|.+. 
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            3445678999999999999886532     3345579999998753 44567799999999999999999999998765 


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      -.+||||+++-|.|..||..+.. .++......++.||+.||.|||+  +.+|||||...|||+....-+||+|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchhhh
Confidence            67999999999999999977654 58999999999999999999999  8999999999999999999999999999998


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .....+.... ...-...|||||-+.-..++.++|||-|||.+||+|. |..||.+....                 .+.
T Consensus       541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----------------DVI  602 (974)
T KOG4257|consen  541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----------------DVI  602 (974)
T ss_pred             ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----------------ceE
Confidence            7776655443 2233678999999998999999999999999999987 99999643211                 111


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      -.+....+...|+.++..+..|+..||. +|.+||.+.+|...|..+
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            2222344455677888888899999999 999999999998777643

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-39  Score=340.87  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.++||+|+||.||+|...         ..++.||+|+++.....   ..+++.+|++++++++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~---------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP---------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC---------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            57999999999999999997653         34778999998754222   2456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG---------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      +.+..++||||++|++|.+++....         ...+++..++.++.||+.||+|||+  ++|+||||||+|||++.++
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCC
Confidence            9999999999999999999986421         1235667788999999999999998  8999999999999999999


Q ss_pred             cEEEcccCCcccCCCCCc----------------cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCC
Q 013557          227 NAKLSDFGLAKAGPTGDR----------------THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      .+||+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            999999999976421100                0011235699999999999999999999999999999999999999


Q ss_pred             CCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-CHHHHHHHhhcCC
Q 013557          291 VDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-SMSEVLSALEQLP  364 (441)
Q Consensus       291 f~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-s~~evl~~L~~l~  364 (441)
                      |.........    +.. ..         ........ .......+..++..|+. ||++|+ +++++++.|+...
T Consensus       231 F~~~~~~ki~----~~~-~i---------~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        231 YRRKKGRKIS----YRD-VI---------LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             CCCcchhhhh----hhh-hc---------cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            9642211000    000 00         00000000 01122345566777777 999996 5677777776543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.6e-39  Score=298.63  Aligned_cols=246  Identities=31%  Similarity=0.456  Sum_probs=192.2

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ++||+|+||.||+|....          +..+|+|.++..... ....+.+|+++++.++||||+++++++......++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~----------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD----------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEecC----------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            469999999999986432          567999998765432 234688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.... ..+.+..+..++.+++.+|.|||+  ++++||||||+||+++.++.+||+|||++.......
T Consensus        71 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (250)
T cd05085          71 MELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI  147 (250)
T ss_pred             EECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence            99999999999886543 358899999999999999999998  899999999999999999999999999987533221


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhhcc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI  322 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  322 (441)
                      .. ......++..|+|||++.++.++.++||||||+++|++++ |..||........   ..              .+..
T Consensus       148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~--------------~~~~  209 (250)
T cd05085         148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---RE--------------QVEK  209 (250)
T ss_pred             cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HH--------------HHHc
Confidence            11 1112234678999999998889999999999999999998 9999864321110   00              0000


Q ss_pred             cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          323 KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      ......+......+..++..|+. +|++||++.++++.|.
T Consensus       210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11111222334556778888887 9999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=318.79  Aligned_cols=263  Identities=27%  Similarity=0.454  Sum_probs=215.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccH-HHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .....+.+.||+|-||+|.++....          +..||||+++....... .+|.+|+++|.+|+||||++++++|..
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            3567888999999999999975542          57899999998766554 789999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++.+++|+||+++|+|..++.++....+.......|+.||+.||+||.+  .++|||||.+.|+|+|.++++||+|||++
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCcccc
Confidence            9999999999999999999988765445666778899999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh--CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS--GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +-...++........+-...|||+|.+..++++.++|||+||+++||+++  ...||.....+   ..++....+.... 
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~-  760 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQ-  760 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCC-
Confidence            97777777766666777889999999999999999999999999999866  67788643221   1111111111111 


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                            ........|..+...+..|+..||. |-++||++++|-..|.+
T Consensus       761 ------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  761 ------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence                  1111223456666667799999999 99999999999888764

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-39  Score=320.49  Aligned_cols=200  Identities=28%  Similarity=0.354  Sum_probs=168.0

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||.||++...         ..+..+|+|++....  ......+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   88 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDT---------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV   88 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEc---------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            34578999999999999999997543         347789999986542  2334567899999999999999999999


Q ss_pred             EEcCC------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          154 CLDGE------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       154 ~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +....      ..|+||||+.+ +|.+.+..    .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~  161 (359)
T cd07876          89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  161 (359)
T ss_pred             eccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCC
Confidence            86543      57999999965 67776632    37888999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       162 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         162 LKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             EEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999997543221   123457899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.9e-39  Score=304.82  Aligned_cols=255  Identities=27%  Similarity=0.444  Sum_probs=195.8

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.+....   .....+..+++|.+.... ......+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            46999999999998765421   112234678999886543 23456788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-----cEEEccc
Q 013557          164 YEYMPKGSLENHLFRRG-----ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-----NAKLSDF  233 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-----~~kl~DF  233 (441)
                      |||+++++|.+++....     ...+++.+++.++.|++.||.|||+  .+++|+||||+||+++.++     .++|+||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            99999999999996532     2347889999999999999999998  8999999999999999877     8999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      |+++...............++..|+|||++.++.++.++|||||||++|+|++ |+.||......   ......      
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~------  226 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV------  226 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH------
Confidence            99875433322222223356788999999999999999999999999999998 99998633211   111110      


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                              ........+......+..++..|+. +|.+||++.+|++.|+
T Consensus       227 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 --------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    0001111222334556778888887 9999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.9e-39  Score=303.49  Aligned_cols=256  Identities=23%  Similarity=0.319  Sum_probs=187.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.....       .....+++|.++... ....+.+.+|+.+++.++||||+++++.|.+....|+|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv   73 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV   73 (268)
T ss_pred             CcCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence            3699999999999864321       123456788776543 23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          164 YEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      |||+++|+|.+++.+..  ....++..+..++.||+.||+|||+  .+++||||||+|||++.++.+||+|||++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            99999999999997542  2346677788999999999999998  8999999999999999999999999999864322


Q ss_pred             CCccceeeeccCCCCcCchhhhhc-------CCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLAT-------GRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ...........|+..|+|||++..       ..++.++|||||||++|||++ |..||........  ......      
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~------  223 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV--LNHVIK------  223 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHh------
Confidence            221122234568899999999753       235779999999999999997 4667753321100  000000      


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHHhh
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALE  361 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~L~  361 (441)
                      .......+    ...+......+..++.+|+.+|++||++++|++.|.
T Consensus       224 ~~~~~~~~----~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         224 DQQVKLFK----PQLELPYSERWYEVLQFCWLSPEKRATAEEVHRLLT  267 (268)
T ss_pred             hcccccCC----CccCCCCcHHHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence            00001111    111222334556677889999999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.3e-39  Score=301.98  Aligned_cols=245  Identities=33%  Similarity=0.517  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|.+.+.||+|+||.||+|..           .+..+|+|.++...  ....+.+|+.++++++||||+++++++... 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-   71 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence            4689999999999999998643           25679999986542  345788999999999999999999998654 


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+.+++|.+++.......+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++..
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCcccee
Confidence            57999999999999999977665568999999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .....     .....+..|+|||++.++.++.++|+|||||++|+|++ |+.||.........                 
T Consensus       150 ~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----------------  207 (254)
T cd05083         150 GSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-----------------  207 (254)
T ss_pred             ccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-----------------
Confidence            33211     12234568999999988899999999999999999998 99998644321110                 


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      ..+........+......+..++..|+. +|++||++.+|++.|+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         208 ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             HHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            1111111111122233456678888888 9999999999999886

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.6e-39  Score=309.97  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=198.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|+..+.||+|+||.||+|.+.....     .....+|+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGE-----TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCC-----cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            3578889999999999999987653211     12346899988765332 23467899999999999999999999875


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      . ..++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccc
Confidence            4 5679999999999999986543 348899999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ...+.         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~---------  224 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL---------  224 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---------
Confidence            86543222111222345778999999998899999999999999999997 899986432111   11111         


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                           ........+......+..++..|+. +|++||++.++++.|+.+..
T Consensus       225 -----~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         225 -----EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             -----HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 1000001112223345667777776 99999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.1e-39  Score=302.41  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=197.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc-
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD-  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  156 (441)
                      +|++.+.||+|++|.||++...         ..++.+++|.+.....  ...+.+.+|++++++++|+|++++++.+.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR---------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc---------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            5889999999999999997653         2466899999865432  234567889999999999999999998764 


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      +...|+||||+++++|.+++.......+++.+++.++.+++.||.+||+  .+++||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccce
Confidence            4467999999999999999977655668999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......  .......|++.|+|||++.+..++.++||||||+++|+|++|+.||+.......                .
T Consensus       150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----------------~  211 (257)
T cd08223         150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----------------V  211 (257)
T ss_pred             EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----------------H
Confidence            7643221  122345689999999999998999999999999999999999999874321110                0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+.. ......+......+..++..|+. +|++||++.+++.+
T Consensus       212 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         212 YRIIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000 00111222333456677788887 99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-39  Score=312.47  Aligned_cols=203  Identities=26%  Similarity=0.411  Sum_probs=170.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|.+.+.||+|+||.||+|+..         ..+..+|+|.++..... ....+.+|+.++++++|+||+++++++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            57999999999999999997654         24678999998754322 234577899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  152 (309)
T cd07872          77 KSLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR  152 (309)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccce
Confidence            999999999975 8988886543 348899999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      .......  ......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||.....
T Consensus       153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  210 (309)
T cd07872         153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV  210 (309)
T ss_pred             ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            5332211  1223467899999999865 4588999999999999999999999975543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-39  Score=339.64  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=193.4

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      ....++|.+.+.||+|+||+||+|...         ..+..+|+|.+.....  .....+..|+.+|+.|+||||+++++
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk---------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d   79 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHK---------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID   79 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEEC---------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence            345678999999999999999997654         3467899998875432  23456889999999999999999999


Q ss_pred             EEEc--CCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCeEEeccCCCcEEEC
Q 013557          153 FCLD--GENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAE-----QQVIYRDFKASNILLD  223 (441)
Q Consensus       153 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~-----~~ivH~Dlkp~Nill~  223 (441)
                      +|.+  ...+||||||+++++|.++|...  ....+++..++.|+.||+.||.|||+..     .+||||||||+||||+
T Consensus        80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            8854  45789999999999999998653  2246999999999999999999999732     3599999999999996


Q ss_pred             C-----------------CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHH
Q 013557          224 S-----------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLEL  284 (441)
Q Consensus       224 ~-----------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~el  284 (441)
                      .                 .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||+|
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            4                 2348999999998643322   2234579999999999864  4588999999999999999


Q ss_pred             HhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          285 LSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       285 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      +||+.||......  ..              +...+........ ......+..|+..|+. +|.+||++.+++.
T Consensus       237 LTGk~PF~~~~~~--~q--------------li~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        237 CSGKTPFHKANNF--SQ--------------LISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHCCCCCCcCCcH--HH--------------HHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999999643210  00              0111110000001 1122345667778887 9999999999984

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5e-39  Score=302.99  Aligned_cols=252  Identities=29%  Similarity=0.385  Sum_probs=194.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-----ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-----QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .+|.+.+.||+|+||.||+|...         ..+..+++|.+.....     .....+.+|+.++++++|+||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV---------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc---------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            47999999999999999997543         3467899998864321     223457889999999999999999998


Q ss_pred             EEc--CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          154 CLD--GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       154 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +.+  ....+++|||+++++|.+++....  .+++...+.++.|++.||+|||+  .+|+||||||+||+++.++.+||+
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEc
Confidence            875  357889999999999999996544  48899999999999999999998  899999999999999999999999


Q ss_pred             ccCCcccCCCCCc-cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          232 DFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       232 DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      |||+++....... ........++..|+|||++.+..++.++|||||||++|+|++|+.||......             
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------------  215 (266)
T cd06651         149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------------  215 (266)
T ss_pred             cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------------
Confidence            9999875432111 11112345889999999999888999999999999999999999999643210             


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                         ...............+......+..++.+|..+|++||+++||+++
T Consensus       216 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         216 ---AAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---HHHHHHhcCCCCCCCchhcCHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0011111111112233333445556665555699999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-39  Score=306.23  Aligned_cols=248  Identities=25%  Similarity=0.414  Sum_probs=188.1

Q ss_pred             eeeecCceEEEEEEecCcc---------------cccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccE
Q 013557           86 LIGEGGFGYVYKGWIDEHT---------------LEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~---------------~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      .||+|+||.||+|.+....               ...........|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999864211               0112233445789999876554445678889999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----  226 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----  226 (441)
                      ++++.+....++||||+++|+|..++.... ..+++..+..++.||+.||+|||+  ++|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCcccC
Confidence            999999999999999999999999886533 358899999999999999999998  8999999999999997643    


Q ss_pred             ---cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHH-hCCCCCCccccccchh
Q 013557          227 ---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELL-SGRRAVDKTRVGAEQN  301 (441)
Q Consensus       227 ---~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell-tg~~pf~~~~~~~~~~  301 (441)
                         .+||+|||++......      ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||..........
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               3899999988643221      12357788999999875 56899999999999999994 6899986432211110


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                                       ......  ..+......+..++..|+. +|++||++.+|++.|.
T Consensus       233 -----------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 -----------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                             000000  0111112245667778887 9999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-39  Score=321.95  Aligned_cols=201  Identities=28%  Similarity=0.392  Sum_probs=168.6

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||+|...         .++..||||++....  ....+.+.+|+++|+.++|+||+++++++...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP---------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC---------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            5788999999999999997643         347789999986532  22345688999999999999999999999877


Q ss_pred             C-----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          158 E-----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       158 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .     ..|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~D  146 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICD  146 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEecc
Confidence            6     7899999996 5888887543  358999999999999999999998  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            999986433221 122334678999999999874 47899999999999999999999997544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.9e-39  Score=300.45  Aligned_cols=250  Identities=26%  Similarity=0.444  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .+|++.+.||+|+||.||+|.+..          +..+++|.+.... .....+.+|++++++++||||+++++++....
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            468889999999999999986542          4578999887543 33467889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++.... ..+++..++.++.+++.+|+|||+  .+++|+||||+||+++.++.+||+|||++..
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  149 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRF  149 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceee
Confidence            9999999999999999986543 358899999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ...... .......++..|+|||++.++.++.++||||||+++|||++ |+.||.......   ..              
T Consensus       150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~--------------  211 (256)
T cd05112         150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VV--------------  211 (256)
T ss_pred             cccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH--------------
Confidence            432211 11122335678999999998899999999999999999998 999986433111   00              


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ..+........+......+..|+..|+. +|++||++.++++.|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         212 ETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0000011111122233567778888988 999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-39  Score=309.34  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ...+|.+.+.||+|+||.||+|...         ..+..||+|.+........+.+.+|+.+++.++|+||+++++++..
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDI---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV   87 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEEC---------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4478999999999999999997643         2467899999976655556678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++.+.   .+++.++..++.|++.||.|||+  .+++||||||+|||++.++.++|+|||++
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          88 GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             CCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccc
Confidence            99999999999999999998543   37899999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.........  .....         
T Consensus       163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~~~~---------  229 (297)
T cd06656         163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIAT---------  229 (297)
T ss_pred             eEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--eeecc---------
Confidence            75433221  123456889999999999888999999999999999999999999643221100  00000         


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ........+......+..++..|+. +|++||++.+|++.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 ----NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000011122233445667788887 99999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-39  Score=304.50  Aligned_cols=253  Identities=30%  Similarity=0.483  Sum_probs=195.9

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHH--HHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK--EWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      |++.+.||+|+||+||++...         ..+..+|+|.+.........  ...+|+.++++++|+||+++++++.+..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK---------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET---------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEEC---------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence            677899999999999997654         35678999999876544332  2356999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++|||++.+++|.+++....  .+++..+..++.|+++||++||+  .+|+|+||||+||+++.++.++|+|||.+..
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             cccccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc
Confidence            9999999999999999997433  48999999999999999999999  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhh-cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ..  ..........++..|+|||++. +..++.++||||||+++|+|++|..||..............         ...
T Consensus       148 ~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~---------~~~  216 (260)
T PF00069_consen  148 LS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK---------ILK  216 (260)
T ss_dssp             ST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH---------HHH
T ss_pred             cc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh---------ccc
Confidence            31  1122334567899999999998 78899999999999999999999999985521111111100         000


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .......  .........+..++..|+. ||++||++.++++.
T Consensus       217 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  217 RPLPSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             THHHHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000  0011112566677777777 99999999999753

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.3e-39  Score=317.50  Aligned_cols=200  Identities=25%  Similarity=0.318  Sum_probs=168.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+++..         ..++.+|||++....  ......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~   92 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF   92 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEEC---------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence            4578999999999999999997643         346789999987542  23345678999999999999999999987


Q ss_pred             EcC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          155 LDG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       155 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ...      ...|+||||+++ +|.+++..    .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875          93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             cccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcE
Confidence            543      357999999965 78777742    37888999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999998643221   2234578999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-39  Score=319.66  Aligned_cols=201  Identities=24%  Similarity=0.311  Sum_probs=168.8

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||.||++...         ..++.+|||++.....  .....+.+|+.+++.++||||++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   84 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV   84 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEec---------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence            35679999999999999999997543         3477899999875422  234567889999999999999999998


Q ss_pred             EEcC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          154 CLDG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       154 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +...      ...|+||||+++ +|.+++..    .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~  157 (355)
T cd07874          85 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             eeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCC
Confidence            8643      357999999965 77776632    37889999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +||+|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       158 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         158 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             EEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999998643221   1234578999999999999899999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-39  Score=305.76  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=192.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.++||+|+||.||+|...         ..+..+|+|.+.... ......+.+|++++++++||||+++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHL---------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            36888999999999999997543         346789999986542 22345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|..+.      .+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             CEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            9999999999999996542      37888899999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-hhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-LVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~l  316 (441)
                      ......    .....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...+          .
T Consensus       144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~  209 (279)
T cd06619         144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL----------L  209 (279)
T ss_pred             eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH----------H
Confidence            543221    234578999999999998899999999999999999999999996432111100 0000          0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ..+................+..++..|++ +|++||+++|+++..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            00000000000011122345566777777 999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.2e-39  Score=300.83  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=199.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||.|+||.||.+...         ..+..+++|.+....  .....++.+|+++|++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            5889999999999999986543         347789999876542  23345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.......+++..+..++.|++.+|.|||+  .+++|+||+|+||+++.++.+||+|||++.
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~  149 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISK  149 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceE
Confidence            999999999999999999977645568999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||+......                ...
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~  211 (256)
T cd08221         150 ILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------------LVV  211 (256)
T ss_pred             Ecccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHH
Confidence            6433221  2234568999999999988888999999999999999999999986432110                000


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      .+...... ..+......+..++..|+. +|++||++.++++.+
T Consensus       212 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         212 KIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11111111 1112223445567777887 999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.2e-39  Score=301.41  Aligned_cols=250  Identities=27%  Similarity=0.456  Sum_probs=196.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---------HHHHHHHHHHHhcCCCCCcccE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---------HKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      +|.+.+.||+|+||.||+|...         ..+..+++|.+.......         .+.+.+|+.++++++||||+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   71 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA---------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY   71 (267)
T ss_pred             CccccceeecCCCeEEEEEEec---------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            4788999999999999997643         236789999886543221         2457889999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ++++.+....++||||+++++|.+++....  .+++..+..++.|++.||+|||+  .+++||||+|+||+++.++.+||
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l  147 (267)
T cd06628          72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKI  147 (267)
T ss_pred             EEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEe
Confidence            999999999999999999999999996543  58899999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCcc----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          231 SDFGLAKAGPTGDRT----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      +|||+++........    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......         
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------  218 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---------  218 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---------
Confidence            999998765421110    1112345889999999999888999999999999999999999999743210         


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             ..+..+.. ......+......+..++..|++ +|++||++.+|++.
T Consensus       219 -------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         219 -------QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -------HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                   00111111 11112233334556677788888 99999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-39  Score=313.90  Aligned_cols=193  Identities=25%  Similarity=0.352  Sum_probs=164.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ...+|++.+.||+|+||.||+|....         .+..||+|+....      ....|+.+|++++|+||+++++++.+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~  128 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS  128 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence            34689999999999999999976543         3668999986443      23469999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++|||++. ++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a  204 (357)
T PHA03209        129 GAITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAA  204 (357)
T ss_pred             CCeeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccc
Confidence            999999999995 58999886543 458999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      +......   ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        205 QFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            7532211   123456999999999999999999999999999999999865544

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.7e-39  Score=306.49  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=196.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      .|++.+.||+|+||.||+|....         .+..+++|.+..........+.+|+++++.++|+||+++++++.....
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~   76 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN   76 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence            36788999999999999976543         466889999876655556778899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .++||||+++++|.+++.... .++++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccc
Confidence            999999999999998876533 368999999999999999999998  89999999999999999999999999998754


Q ss_pred             CCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ....  .......|+..|+|||++.     +..++.++|||||||++|+|++|+.||......  ..........     
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~-----  224 (282)
T cd06643         154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSE-----  224 (282)
T ss_pred             cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhcC-----
Confidence            3221  1123456899999999984     345778999999999999999999998643211  1111110000     


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                              ......+......+..++..|+. +|.+||++.+++++-
T Consensus       225 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         225 --------PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             --------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                    00001122233456777888887 999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.9e-39  Score=301.76  Aligned_cols=252  Identities=29%  Similarity=0.387  Sum_probs=194.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-----cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-----FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ++|++.+.||+|+||.||+|....         ++..|+||.+....     ....+.+.+|+.++++++|+||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            578999999999999999976543         46789999875321     1224567889999999999999999998


Q ss_pred             EEcC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          154 CLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       154 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +.+.  ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEEC
Confidence            8763  46789999999999999986553  47888999999999999999998  899999999999999999999999


Q ss_pred             ccCCcccCCCCCc-cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          232 DFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       232 DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      |||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.......            
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------  216 (265)
T cd06652         149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------------  216 (265)
T ss_pred             cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------------
Confidence            9999875432111 111223468899999999988889999999999999999999999996432110            


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                          ..............+......+..++.+|+.+|++||++++|++.
T Consensus       217 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~~  261 (265)
T cd06652         217 ----AIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLRH  261 (265)
T ss_pred             ----HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHhcC
Confidence                001111111112233344445566667777899999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.7e-39  Score=306.84  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||.|+||.||+|....         .+..+++|.+........+.+.+|+.+++.++|+||+++++.+..+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD   81 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence            3679999999999999999976543         4678999999876655667788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|..++.+.. ..+++..+..++.|++.+|.|||+  .+++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccce
Confidence            99999999999999988875543 358999999999999999999998  899999999999999999999999999887


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ......  .......++..|+|||++.     ...++.++|||||||++|+|++|..||......  .....+....   
T Consensus       159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~---  231 (292)
T cd06644         159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSE---  231 (292)
T ss_pred             eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHhcCC---
Confidence            532211  1123456889999999985     345688999999999999999999998643211  0011110000   


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                ......+......+..++..|+. +|++||++.+|++.
T Consensus       232 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         232 ----------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ----------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                      00001122223345667788887 99999999999764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.9e-39  Score=300.78  Aligned_cols=249  Identities=21%  Similarity=0.343  Sum_probs=189.0

Q ss_pred             CeeeecCceEEEEEEecCcccc---cccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLE---AARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      +.||+|+||.||+|++......   .........+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999986432110   0111234568999887655445567888999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc-------EEEcccC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-------AKLSDFG  234 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~-------~kl~DFg  234 (441)
                      +||||+++++|..++.... ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            9999999999988876543 358999999999999999999998  89999999999999987654       8999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhh-cCCCCchhhhHHHhHHHHHHH-hCCCCCCccccccchhhhhhhcccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELL-SGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ++......      ....++..|+|||++. +..++.++|||||||++|||+ +|..||...........          
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----------  221 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF----------  221 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----------
Confidence            98754221      2345788999999987 466899999999999999998 58888764321111000          


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                             .......  .......+..|+..|++ ||++||++.+|++.|+
T Consensus       222 -------~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 -------YEGQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -------HhcCccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                   0000000  11112345677888888 9999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-38  Score=299.69  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=189.4

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEE-cCCeeEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL-DGENRLL  162 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~l  162 (441)
                      +.||+|+||.||+|.+...      ......+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecC------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            4689999999999876431      1235679999985432 234567889999999999999999999775 4556899


Q ss_pred             EEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCC
Q 013557          163 VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG  242 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~  242 (441)
                      ||||+.+++|.+++..... ...+..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++.....
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            9999999999999865432 36778889999999999999998  89999999999999999999999999998754321


Q ss_pred             Cccc--eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhC-CCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          243 DRTH--VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG-RRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       243 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      ....  ......++..|+|||++.+..++.++|||||||++|||++| .+||......   ....+.             
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~-------------  215 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL-------------  215 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-------------
Confidence            1110  11233457789999999888999999999999999999995 5556432211   111110             


Q ss_pred             hcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                       ........+......+..++..|+. +|++||++.+|++.|+++
T Consensus       216 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         216 -LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -hcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             0000001112223456678888888 999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=308.23  Aligned_cols=254  Identities=25%  Similarity=0.330  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|....         .+..+|+|.+......   ..+.+..|+++++.++|+||+++++.+.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            468899999999999999975542         4778999999765433   3456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....|+||||+.+++|.+++.......+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecch
Confidence            99999999999999999999876555679999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCC
Q 013557          236 AKAGPTGDRT---------------------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR  288 (441)
Q Consensus       236 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~  288 (441)
                      +.........                           .......||..|+|||++.+..++.++||||||+++|+|++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            8753221100                           0112346889999999999888999999999999999999999


Q ss_pred             CCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC----HHHHHHH
Q 013557          289 RAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS----MSEVLSA  359 (441)
Q Consensus       289 ~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs----~~evl~~  359 (441)
                      .||.......                .+..+................+..++..|+. +|++||+    +++++..
T Consensus       230 ~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         230 TPFKGSNRDE----------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCCCCchHH----------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            9996443211                0111111111100111134556777777877 9999999    6666653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.2e-39  Score=308.48  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .+|++.+.||.|+||.||+|...         ..++.+++|.+........+.+.+|+.+++.++|+||+++++++....
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDV---------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEc---------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            46999999999999999997543         347789999987665555677889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++...   .+++.++..++.+++.||.|||+  .+++||||||+||+++.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~  164 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ  164 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence            999999999999999988543   48999999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........  .....           
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~~~~-----------  229 (296)
T cd06655         165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIAT-----------  229 (296)
T ss_pred             cccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-----------
Confidence            433221  123356889999999999888999999999999999999999999754321110  00000           


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ........+......+..++..|+. +|++||++.+|+..
T Consensus       230 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         230 --NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              0000001122223445667788887 99999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.7e-39  Score=304.77  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=196.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|.+.+.||+|+||.||+|...         ..+..+|+|.++.........+.+|+.+++.++||||+++++.+...
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNV---------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEc---------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            357888999999999999997554         34678999998766544556678899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++...+  .+++.+++.++.|++.||.|||+  .|++|+||||+||+++.++.+||+|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeee
Confidence            99999999999999999986554  58999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ......  .......|+..|+|||++.   ...++.++|||||||++|+|++|..||........  .........    
T Consensus       155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~~----  226 (267)
T cd06645         155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSNF----  226 (267)
T ss_pred             EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhccCC----
Confidence            543211  1223457899999999984   45688999999999999999999999854321110  000000000    


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           .......  .......+..++..|+. +|++||++.+|+++
T Consensus       227 -----~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         227 -----QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -----CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                 0000000  00112345667777887 99999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-39  Score=327.89  Aligned_cols=210  Identities=21%  Similarity=0.276  Sum_probs=161.7

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccC----------CCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARP----------GVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP  145 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp  145 (441)
                      ...++|++.+.||+|+||+||++.++.........          .....++.|.+... ......+.+|+.+|++++|+
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCC
Confidence            45679999999999999999998654322111000          00011122222211 12345578999999999999


Q ss_pred             CcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA---RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       146 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ||+++++++.+.+..|+|+|++. ++|.+++.....   .......+..++.||+.||+|||+  ++|+||||||+|||+
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl  300 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFL  300 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence            99999999999999999999985 588888754321   123456778899999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCC
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      +.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999986543221 122346799999999999999999999999999999999998754

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=300.24  Aligned_cols=249  Identities=27%  Similarity=0.449  Sum_probs=195.0

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc------ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      +|.+.+.||+|+||.||+|...          .+..+|+|.+.....      .....+.+|+++|++++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            5888999999999999998643          266899998864321      122457889999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+....++||||+++++|.+++.+..  .+++..+..++.|++.||+|||+  .+|+|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df  146 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDF  146 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccc
Confidence            999999999999999999999996544  48899999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCC----CccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          234 GLAKAGPTG----DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       234 g~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |++......    ..........|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ..      
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~------  218 (265)
T cd06631         147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MF------  218 (265)
T ss_pred             hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HH------
Confidence            998753211    111112245689999999999988899999999999999999999999964321110  00      


Q ss_pred             cccchhhhhhhcc-cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          310 LGDRRKLFRIMDI-KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       310 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                              .+... ......+......+..++..|+. +|++||++.++++
T Consensus       219 --------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         219 --------YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --------HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    00000 00111222334456677788887 9999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-38  Score=301.35  Aligned_cols=259  Identities=25%  Similarity=0.350  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.+....      .....++||...... ....+.+.+|+.++++++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            356888999999999999999764321      123468999887654 3345678899999999999999999998875


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       ...++||||+++++|.+++.... ..+++..++.++.+++.||+|||+  .+++|+||||+||+++.++.+||+|||++
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCcee
Confidence             45789999999999999996543 358999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.........   ...         
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~---------  221 (270)
T cd05056         155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI---------  221 (270)
T ss_pred             eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH---------
Confidence            764332211 1112234568999999988889999999999999999986 99999644321110   000         


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                           ........+......+..++..|+. +|.+||++.++++.|+.+.
T Consensus       222 -----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         222 -----ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 0000111122333456667777887 9999999999999998654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-40  Score=317.85  Aligned_cols=240  Identities=27%  Similarity=0.331  Sum_probs=182.0

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcC---CCCCcccEEEEEEcCCee
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQL---HHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~  160 (441)
                      ||+|+||+||+|...         ..+..||||++......   ....+..|..++..+   +||||+++++++.+....
T Consensus         1 lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKK---------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEEC---------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            799999999997654         34778999998643221   223455677777655   699999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             EEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            99999999999999986544  48999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      ....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........                .+
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~----------------~i  209 (330)
T cd05586         148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR----------------NI  209 (330)
T ss_pred             CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH----------------HH
Confidence            2221  22356799999999999764 48999999999999999999999996433211000                00


Q ss_pred             hcccccCCCc-hhHHHHHHHHHHHHhc-CCCCCC----CHHHHHHH
Q 013557          320 MDIKLEGQYP-QKGAYMVAILALQCIS-EAKVRP----SMSEVLSA  359 (441)
Q Consensus       320 ~~~~~~~~~~-~~~~~~~~~l~~~c~~-~P~~RP----s~~evl~~  359 (441)
                      .....  ..+ ......+..++..|+. +|++||    ++.+++++
T Consensus       210 ~~~~~--~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         210 AFGKV--RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             HcCCC--CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            00000  011 1123345567777777 999998    46666543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-39  Score=302.71  Aligned_cols=248  Identities=27%  Similarity=0.354  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||.|+||.||+|....         .+..+++|.+.... ......+.+|+++++.++|+||+++++++.++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence            468899999999999999986543         47789999987543 23345678999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++|+||+++++|.+++...   .+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||+++
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          72 SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccce
Confidence            9999999999999999998654   58999999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ......  .......|+..|+|||++.+..++.++||||||+++|+|+||+.||.........                 
T Consensus       147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-----------------  207 (274)
T cd06609         147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-----------------  207 (274)
T ss_pred             eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-----------------
Confidence            654321  1123456888999999999888999999999999999999999999743311100                 


Q ss_pred             hhhcccccCCCchh-HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQK-GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~-~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+........+.. ....+..++..|+. +|++||+++++++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         208 FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00000011111111 23345567777776 99999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=299.52  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||.|+||.||+|....         .+..+++|.+........+.+.+|+.++++++||||+++++++.+..
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            578999999999999999976542         35679999987665556677899999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.+||+|||++..
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchh
Confidence            9999999999999999886542 358999999999999999999998  8999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcC---CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATG---RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      .....  .......++..|+|||++.+.   .++.++||||||+++|+|+||+.||........  .......       
T Consensus       151 ~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~~-------  219 (262)
T cd06613         151 LTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISKS-------  219 (262)
T ss_pred             hhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc-------
Confidence            43221  112345688899999999776   789999999999999999999999974331110  0000000       


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .+. ......+......+..++.+|+. +|.+||++.+|+.+
T Consensus       220 ---~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         220 ---NFP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ---cCC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               000 00001122223446678888887 99999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.8e-38  Score=307.07  Aligned_cols=199  Identities=25%  Similarity=0.347  Sum_probs=160.9

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc--CCeeE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--GENRL  161 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~  161 (441)
                      .++||+|+||.||+|....       ...+..+|+|.+....  ....+.+|+.+|++++||||+++++++..  ....+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence            4689999999999987542       1246789999987543  23456789999999999999999998864  45689


Q ss_pred             EEEEeCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE----CCCCcEEE
Q 013557          162 LVYEYMPKGSLENHLFRRG-------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL----DSEFNAKL  230 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill----~~~~~~kl  230 (441)
                      +||||+. ++|.+++....       ...+++..+..++.||+.||.|||+  ++|+||||||+|||+    +.++.+||
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            9999985 58988875321       2358899999999999999999998  899999999999999    45678999


Q ss_pred             cccCCcccCCCCCc-cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          231 SDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       231 ~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +|||+++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99999986432211 1112345789999999999874 5899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-39  Score=302.86  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=188.9

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVY  164 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  164 (441)
                      +.||+|+||.||+|.......  ........+++|.+........+.+..|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999987643210  001224468888886654444567889999999999999999999999989999999


Q ss_pred             EeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--------EEEcccCCc
Q 013557          165 EYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--------AKLSDFGLA  236 (441)
Q Consensus       165 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--------~kl~DFg~a  236 (441)
                      ||+++|+|.+++..+.. .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.        ++++|||++
T Consensus        79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999999865543 58999999999999999999998  89999999999999987764        699999988


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCC-CCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR-RAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ......      ....++..|+|||++.+. .++.++|||||||++|+|++|. .||.........              
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--------------  215 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--------------  215 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--------------
Confidence            653321      234678899999999864 5789999999999999999995 555432211100              


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                         .....  ....+......+..|+..|++ +|++||++++|++.|+
T Consensus       216 ---~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 ---QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00000  111222223456677888888 9999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-38  Score=296.75  Aligned_cols=255  Identities=31%  Similarity=0.503  Sum_probs=198.7

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      +.+.+.||.|+||.||++.+....     ...+..+|+|.++..... ....+..|+.++..++|+||+++++++.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS-----GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC-----CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            457789999999999998765421     123478999999765433 45678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .+++|||+++++|.+++.......+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceec
Confidence            9999999999999999876544338999999999999999999998  89999999999999999999999999999865


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ........ ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....             
T Consensus       154 ~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-------------  216 (258)
T smart00219      154 YDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY-------------  216 (258)
T ss_pred             cccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------
Confidence            43321111 12236789999999988889999999999999999998 788886422111   1110             


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                       +........+......+..++..|+. +|++||++.++++.|
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 -LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             00001111122233455667778887 999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-38  Score=300.33  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++++.....||+|+||.||+|....         .+..+++|.+........+.+.+|+.++++++|+||+++++++..
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE   76 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence            44556666789999999999986543         366899999877665666788999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEccc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPL--PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDF  233 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DF  233 (441)
                      ++..++||||+++++|.+++.... ..+  ++..+..++.||+.||.|||+  ++|+||||||+||+++. ++.++|+||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          77 NGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecc
Confidence            999999999999999999987542 234  788889999999999999998  89999999999999986 678999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCC--CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |++........  ......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||........   ..+..    
T Consensus       154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~----  224 (268)
T cd06624         154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV----  224 (268)
T ss_pred             hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh----
Confidence            99875432221  122345889999999987643  78899999999999999999999864321100   00000    


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              .........+......+..++..|+. +|++||++.+|++.
T Consensus       225 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 --------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --------hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                    00011112233344556778889998 99999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-38  Score=299.65  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=196.0

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      |.+.+.||+|+||.||+|.+..      ....+..+|||++.....  ...+++.+|+++|++++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            6778999999999999987643      223477899999876432  23456889999999999999999999886532


Q ss_pred             ------eeEEEEEeCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          159 ------NRLLVYEYMPKGSLENHLFRRG----ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       159 ------~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                            ..++++||+.+|+|.+++....    ...+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~  152 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTV  152 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCE
Confidence                  2478999999999998875321    1247889999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |+.||.....   ..+..+..
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~  229 (273)
T cd05074         153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI  229 (273)
T ss_pred             EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Confidence            9999999886433222111223345678999999998889999999999999999999 8888864321   11111110


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .              ......+......+..++..|+. +|++||++.++++.|+.+
T Consensus       230 ~--------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 K--------------GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             c--------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0              00001112223456777888887 999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-39  Score=315.49  Aligned_cols=199  Identities=25%  Similarity=0.381  Sum_probs=167.8

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|.+.+.||+|+||.||+|...         .++..||||++.....  .....+.+|+.+|++++|+||++++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDT---------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEEC---------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence            45678999999999999999997543         3467899999875422  233557789999999999999999998


Q ss_pred             EEcC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          154 CLDG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       154 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +...      ...|++||++ +++|.+++..   ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~  156 (343)
T cd07878          83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCE  156 (343)
T ss_pred             hcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCC
Confidence            7543      3568999988 7799887743   248999999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       157 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         157 LRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             EEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            999999999864322     234578999999999976 56899999999999999999999999654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-38  Score=309.54  Aligned_cols=200  Identities=20%  Similarity=0.248  Sum_probs=165.7

Q ss_pred             CCCeeeec--CceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           83 PDSLIGEG--GFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        83 ~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.++||+|  +|++||++...         .++..||+|+++....  ...+.+.+|+.+++.++||||++++++|..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK---------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeec---------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            56789999  68899996544         4578999999976532  22345778999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++|+|.+++..+....+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.++++||+....
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence            99999999999999999976555568999999999999999999998  8999999999999999999999999986543


Q ss_pred             CCCCCc-c----ceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCc
Q 013557          239 GPTGDR-T----HVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDK  293 (441)
Q Consensus       239 ~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~  293 (441)
                      ...... .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            211110 0    01122356778999999976  4589999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-39  Score=304.53  Aligned_cols=253  Identities=26%  Similarity=0.384  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||.|+||.||+|....         .+..+++|.+........+.+.+|++++++++|+||+++++++.+.
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE   74 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence            3579999999999999999986543         3678999998766555566788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccch
Confidence            99999999999999999886543 358999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      .......  ......|++.|++||++..     ..++.++||||||+++|+|++|+.||......  .....+...   .
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---~  224 (280)
T cd06611         152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKILKS---E  224 (280)
T ss_pred             hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHhcC---C
Confidence            5432221  1234568999999999853     34677999999999999999999999743211  111111000   0


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                ......+......+..++..|+. +|.+||++.+|++.
T Consensus       225 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 ----------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                      00001122223445667778887 99999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-40  Score=316.74  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=218.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .+.....+||-|.||.||.|.|+.+         ...||||.++.+. ...++|+.|+.+|+.++|||+|+|+++|..+.
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            4555567899999999999999875         3469999998654 56889999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      -+|||.|||..|+|.|||.+-+...++....+.++.||..||+||..  +++|||||...|+|+.++..+|++|||++++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999999988777778888899999999999999998  8999999999999999999999999999998


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .....++. .....-...|.|||-+....++.++|||+|||+|||+.| |..||.+.+.                 ..+.
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----------------SqVY  476 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVY  476 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----------------HHHH
Confidence            65443321 111122568999999999999999999999999999988 8888864332                 3345


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .++.+..+-+.|+.+...+..|++.||+ .|.+||+++||-+.++.+
T Consensus       477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            5666667777899999999999999999 999999999998877754

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-38  Score=297.09  Aligned_cols=250  Identities=27%  Similarity=0.367  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||.|+||.||+|.+..         .+..+++|.+.....  ...+.+|++++++++|+||+++++++.+..
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            679999999999999999987653         356899999875532  677899999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..|+++||+.+++|.+++.... ..+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++..
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~  148 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQ  148 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchh
Confidence            9999999999999999986433 468999999999999999999998  8999999999999999999999999999886


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.........  ....           .
T Consensus       149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~~~-----------~  213 (256)
T cd06612         149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FMIP-----------N  213 (256)
T ss_pred             cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hhhc-----------c
Confidence            543221  223455889999999999889999999999999999999999999743211100  0000           0


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..  ......+......+..++..|+. +|++||++.+|++.
T Consensus       214 ~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         214 KP--PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CC--CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            00  00001112223345667777887 99999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.1e-39  Score=305.03  Aligned_cols=262  Identities=27%  Similarity=0.382  Sum_probs=198.2

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcc
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLV  148 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  148 (441)
                      .++.+....++|++.+.||+|+||.||+|....         .+..+++|++.... .....+.+|+.++.++ +|+||+
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~   78 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVV   78 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCee
Confidence            344556678899999999999999999976543         46789999886532 2235677899999999 699999


Q ss_pred             cEEEEEE-----cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          149 KLIGFCL-----DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       149 ~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      ++++++.     .+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+  .+|+||||||+||+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil  156 (286)
T cd06638          79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEE
Confidence            9999874     345789999999999999987532  23458899999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ++.++.+||+|||+++.......  ......|++.|+|||++..     ..++.++|||||||++|+|++|+.||.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999999999876433221  1233468999999999853     4578899999999999999999999864321


Q ss_pred             ccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      .  ..+.....           ..  ......+......+..|+..|+. +|++||++.||++.+
T Consensus       235 ~--~~~~~~~~-----------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         235 M--RALFKIPR-----------NP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             h--HHHhhccc-----------cC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            1  00000000           00  00001122223346667777887 999999999998764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-38  Score=300.23  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..|...+.||.|+||.||+|....         .+..+|+|.+.... ......+.+|+.++++++|+||+++++++.+.
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG   74 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            457788999999999999986543         36789999887543 23456688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++..   .++++.++..++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~  149 (277)
T cd06640          75 TKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccce
Confidence            999999999999999998854   248899999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .......  ......++..|+|||++.+..++.++|+|||||++|||++|..||.........                 
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------  210 (277)
T cd06640         150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------  210 (277)
T ss_pred             eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------
Confidence            6433221  123346888999999999888999999999999999999999998643211100                 


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+........+......+..++..|+. +|++||++.+++..
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            0001011112233445567788888998 99999999999866

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-38  Score=296.85  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=198.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||++....         .+..+++|.+.....  .....+.+|+++|++++|+||+++++.+...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            58889999999999999976543         467899999865432  2355688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEcccCCc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDFGLA  236 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFg~a  236 (441)
                      ...++||||+++++|.+++.......+++..+..++.+++.+|.|||+  ++++|+||||+||+++.++ .+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~  149 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGIS  149 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence            999999999999999999977655668999999999999999999998  8999999999999998654 5899999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||+......   .             .
T Consensus       150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~-------------~  210 (256)
T cd08220         150 KILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L-------------V  210 (256)
T ss_pred             eecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H-------------H
Confidence            86533221   123568899999999998888999999999999999999999996543211   0             0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+.. ......+......+..++..|+. +|++||++.|++..
T Consensus       211 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         211 LKIMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            01111 01111222234456677788887 99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=315.88  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--HHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .....|.+.+.||+|.|++|.+|++..         ++..||||.+.+.....  .+.+.+|+++|+.|+|||||+++.+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v  123 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV  123 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            446789999999999999999976543         57889999998764433  3458899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      .+....+|+||||+.+|.+++++.+++.  +.+..+..++.|++.|++|||+  ++|+|||||.+||||+.+.++||+||
T Consensus       124 ~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  124 IETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeecc
Confidence            9999999999999999999999988775  6668899999999999999999  99999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      |++..+..+   ....+++|++.|.|||++.+..| ++++|+||+|++||-|+.|..||++......+.           
T Consensus       200 gfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-----------  265 (596)
T KOG0586|consen  200 GFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-----------  265 (596)
T ss_pred             ccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-----------
Confidence            999876533   34567899999999999998876 679999999999999999999998654322111           


Q ss_pred             chhhhhhhcccccC--CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          313 RRKLFRIMDIKLEG--QYPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       313 ~~~l~~~~~~~~~~--~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                               ..+.+  ..|.........|++.++. +|.+|+++++|.
T Consensus       266 ---------rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim  304 (596)
T KOG0586|consen  266 ---------RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM  304 (596)
T ss_pred             ---------hheeeeecccceeechhHHHHHHhhccCccccCCHHHhh
Confidence                     01111  1122222334455555554 888888888874

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.7e-38  Score=295.32  Aligned_cols=247  Identities=26%  Similarity=0.435  Sum_probs=188.8

Q ss_pred             CeeeecCceEEEEEEecCcccc-cccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLE-AARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.||+|+||.||+|.+...... .........+++|.+...... ...+.+|+.+|++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4699999999999987642210 011222346788887655433 6778899999999999999999999888 778999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-------cEEEcccCCc
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-------NAKLSDFGLA  236 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-------~~kl~DFg~a  236 (441)
                      |||+++++|.+++..... .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999876543 58999999999999999999998  8999999999999999887       7999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC--CCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG--RLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      .....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||..........  .+.       
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~--~~~-------  220 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER--FYQ-------  220 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH--HHh-------
Confidence            86432      1233567789999999876  78999999999999999999 577775432111110  000       


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                             .   ....+......+..++..|+. +|.+||++.+|++.|+
T Consensus       221 -------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -------D---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------c---CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   0   000111111456677788887 9999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-38  Score=297.58  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||++....         .++.+++|.+....  ......+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            58889999999999999976543         46789999886432  23345788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+.+++|.+++.......+++.+++.++.|++.||.|||+  .+++|+||+|+|||++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~  149 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIAR  149 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence            999999999999999999876555568999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .......  ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.......                .+.
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~  211 (256)
T cd08218         150 VLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------------LVL  211 (256)
T ss_pred             ecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----------------HHH
Confidence            6433221  1223468889999999998889999999999999999999999986432110                001


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .++... ....+......+..++..|+. +|++||++.+|++.
T Consensus       212 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         212 KIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111101 111222334456677788887 99999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-38  Score=302.85  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcc
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLV  148 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  148 (441)
                      ++.++....+.|++.+.||.|+||.||+|....         .+..+|+|.+.... .....+..|+.+++++ +|+||+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~   76 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIA   76 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEE
Confidence            445555677899999999999999999986543         46789999886543 2345678899999998 699999


Q ss_pred             cEEEEEEc------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          149 KLIGFCLD------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       149 ~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ++++++..      ....|+||||+.+|+|.+++.......+++..+..++.|++.||.|||+  .+|+|+||||+||++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili  154 (282)
T cd06636          77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLL  154 (282)
T ss_pred             EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE
Confidence            99999853      4578999999999999999976555568899999999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccc
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG  297 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~  297 (441)
                      +.++.++|+|||++........  ......|+..|+|||++.     +..++.++|||||||++|+|++|+.||......
T Consensus       155 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~  232 (282)
T cd06636         155 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM  232 (282)
T ss_pred             CCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence            9999999999999875432111  123456899999999986     345788999999999999999999999643211


Q ss_pred             cchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...                ..+................+..++..|+. +|.+||++.||++.
T Consensus       233 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         233 RAL----------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhh----------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            100                00000000000111223456677888888 99999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-38  Score=301.33  Aligned_cols=201  Identities=29%  Similarity=0.430  Sum_probs=169.0

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||+|....         .+..||+|+++....  .....+.+|+.++++++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            58889999999999999986543         367899999865422  2345678899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ...++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccce
Confidence            99999999997 58988886533 2568999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .......  .......+++.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            7543221  112234578899999998754 4788999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2e-38  Score=304.42  Aligned_cols=202  Identities=26%  Similarity=0.399  Sum_probs=170.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|.+.+.||.|+||.||+|...         .++..||+|.++.... .....+.+|+.++++++|+||+++++++.+.
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            57999999999999999997654         2467899999865432 2334677899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.+||+|||++.
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  152 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR  152 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence            99999999997 59999886543 358899999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      .......  ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||....
T Consensus       153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         153 AKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             ccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5332211  12234578899999998754 57889999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=309.19  Aligned_cols=247  Identities=27%  Similarity=0.381  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      +.|+.-++||+||||.||-.         ....+|+.+|.|.+.+....   .....+.|-.||.+++.+.||.+-..|+
T Consensus       185 n~F~~~RvlGkGGFGEV~ac---------qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCAC---------QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             cceeeeEEEecccccceeEE---------EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            57888899999999999974         34456889999988654332   2234678999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+.+||||..|.||+|.-+|...+...+++..++.++.+|+.||++||+  .+||+|||||+|||+|+.|+++|+|+|+
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccce
Confidence            99999999999999999999988887889999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |.....+..   .+..+||.+|||||++.++.|+...|+|||||+||||+.|+.||.........             .+
T Consensus       334 Avei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eE  397 (591)
T KOG0986|consen  334 AVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EE  397 (591)
T ss_pred             EEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HH
Confidence            998766543   23458999999999999999999999999999999999999999754332211             11


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                      +.+... .....++....+....|..+++. ||++|...
T Consensus       398 vdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  398 VDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            111111 22334556666677778888887 99887543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-38  Score=301.70  Aligned_cols=263  Identities=25%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||+||++....         .+..+|+|++.... ....+.+.+|+++++.++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN   74 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence            3578899999999999999976543         46789999876543 2334678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++...+  .+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          75 ENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            999999999999999999886543  58999999999999999999996 258999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......    .....|+..|+|||++.+..++.++|||||||++|+|+||+.||...........     ........+
T Consensus       152 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-----~~~~~~~~~  222 (284)
T cd06620         152 GELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-----DPMGILDLL  222 (284)
T ss_pred             cchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-----hhhHHHHHH
Confidence            6532211    1245689999999999888899999999999999999999999975432110000     000000001


Q ss_pred             hhhhcccccCCCc-hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          317 FRIMDIKLEGQYP-QKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       317 ~~~~~~~~~~~~~-~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ..++... ....+ ......+..|+..|+. +|++||++.|++++..-
T Consensus       223 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         223 QQIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             HHHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            1111100 01111 1123456677778887 99999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.7e-38  Score=295.89  Aligned_cols=250  Identities=25%  Similarity=0.350  Sum_probs=197.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc-
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD-  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  156 (441)
                      +|++.+.||.|+||.||++....         .+..+++|.+.....  ...+.+..|++++++++|+||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            58889999999999999975443         467899998865432  234568889999999999999999998764 


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhH-----hcCCCeEEeccCCCcEEECCCCcE
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLH-----EAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH-----~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                       ....+++|||+++++|.+++...  ....+++..++.++.|++.||.|||     +  .+++|+||||+||+++.++.+
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--~~i~h~dl~p~nili~~~~~~  149 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG--NTVLHRDLKPANIFLDANNNV  149 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc--CcceecCCCHHHEEEecCCCE
Confidence             45679999999999999998653  2346899999999999999999999     6  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      ||+|||++........  ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||......   ....    
T Consensus       150 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~----  220 (265)
T cd08217         150 KLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS----  220 (265)
T ss_pred             EEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH----
Confidence            9999999986543321  123456899999999999888999999999999999999999999754311   1111    


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                .+........+......+..++..|+. +|++||++.+|+++
T Consensus       221 ----------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         221 ----------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                      111111112233334556677788887 99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-38  Score=302.09  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=195.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .|...+.||+|+||.||+|....         .+..+|+|.++... ....+.+.+|+.++++++|+||+++++++....
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            45667889999999999986543         36689999987543 233456889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEcccccccc
Confidence            99999999999999998853   348899999999999999999998  8999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........   ..              
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~--------------  211 (277)
T cd06642         151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF--------------  211 (277)
T ss_pred             ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh--------------
Confidence            433221  12234688899999999988899999999999999999999999863321100   00              


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+........+......+..++..|+. +|++||++.+|+.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            000001111122233456677788887 99999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=335.49  Aligned_cols=254  Identities=26%  Similarity=0.293  Sum_probs=206.1

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      -..++|.++++||+|+||.|.+++.         +.++++||.|++++...   ....-|..|-++|..-+.+.|+.++.
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~---------k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRH---------KSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEe---------eccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            3457999999999999999998554         45688999999987432   23445888999999999999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .|.++.++|+||||++||+|..++.+..  .+++..++.|+..|+.||+-||+  .|+|||||||+|||||..|++||+|
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999999997776  59999999999999999999999  9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhh----c-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA----T-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||.+-..... ....+...+|||.|++||++.    + +.|+..+|+||+||++||||.|..||.....      +    
T Consensus       219 FGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------v----  287 (1317)
T KOG0612|consen  219 FGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------V----  287 (1317)
T ss_pred             chhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------H----
Confidence            9988654322 223345678999999999996    2 5699999999999999999999999963221      1    


Q ss_pred             cccccchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhcCCCCCCC---HHHHHHH
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCISEAKVRPS---MSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~~P~~RPs---~~evl~~  359 (441)
                            .....|++-.-.-.+|  .........|+..++.+|+.|..   ++++-.+
T Consensus       288 ------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  288 ------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhC
Confidence                  1112233222222344  23456677889999999998877   8887654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-38  Score=296.56  Aligned_cols=257  Identities=27%  Similarity=0.359  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||.|+||+||+|....         .+..+++|++..... .....+.+|+++|+.++|+||+++++.+...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence            479999999999999999986543         366899999865432 3456789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ...++|||++++++|.+++..... ..+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||++
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            999999999999999999976433 468999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCcc--ceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          237 KAGPTGDRT--HVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      .........  .......|+..|+|||++... .++.++|+|||||++|+|++|+.||......  .........   . 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~---~-  223 (267)
T cd06610         150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN---D-  223 (267)
T ss_pred             HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC---C-
Confidence            765443222  122345689999999999877 7899999999999999999999999643221  111111110   0 


Q ss_pred             hhhhhhhcccccCCC-chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQY-PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~-~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             ........ .......+..++..|+. +|++||++.+|++.
T Consensus       224 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 -------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   00000000 11223455677777887 99999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.5e-38  Score=303.44  Aligned_cols=199  Identities=25%  Similarity=0.358  Sum_probs=160.3

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc--CCeeE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--GENRL  161 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~  161 (441)
                      ...||+|+||.||+|.....       ..+..+|+|.+....  ....+.+|+.+|++++||||+++++++..  +...+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVW   76 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC-------CccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence            36899999999999875431       235689999987543  23457789999999999999999998853  56789


Q ss_pred             EEEEeCCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE----CCCCcEEE
Q 013557          162 LVYEYMPKGSLENHLFRR-------GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL----DSEFNAKL  230 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill----~~~~~~kl  230 (441)
                      +||||+.+ +|.+++...       ....+++..+..++.||+.||.|||+  .+|+||||||+|||+    +.++.+||
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          77 LLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence            99999864 888877532       12348889999999999999999998  899999999999999    55678999


Q ss_pred             cccCCcccCCCCCcc-ceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          231 SDFGLAKAGPTGDRT-HVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999999864332211 112345689999999999764 5799999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-38  Score=301.35  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=196.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||++....         .+..+|+|.++... ......+.+|++++++++|+||+++++.+...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            468899999999999999976542         46789999886542 22345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ...++||||+++++|..++.... ...+++..+..++.+++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999999999999998886531 2358999999999999999999996 258999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCC------CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGR------LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      ......    ......|+..|+|||++.+..      ++.++|||||||++|+|++|+.||.........          
T Consensus       151 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----------  216 (286)
T cd06622         151 GNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF----------  216 (286)
T ss_pred             ccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH----------
Confidence            754322    122346888999999986543      478999999999999999999999643211100          


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         ..+..+... .....+......+..++..|+. +|++||++.++++.
T Consensus       217 ---~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         217 ---AQLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ---HHHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence               001111111 1112233344556677788887 99999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=297.08  Aligned_cols=248  Identities=27%  Similarity=0.371  Sum_probs=202.5

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      -|.+..+||+|.||.||+         +.++..|+.+|||++.-+  .+.+++..|+.||+++..|++|++|+.|.....
T Consensus        34 VFDi~~KLGEGSYGSV~K---------AIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD  102 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHK---------AIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD  102 (502)
T ss_pred             HHHHHHHhcCCcchHHHH---------HHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence            366778999999999998         455567999999999765  467889999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      +++|||||--|++.|.+..+ ++++.+.++..++...++||+|||.  ..-+|||||..|||++.+|.+||+|||.+-.+
T Consensus       103 LWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~--~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHD--LKKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHH--HHHHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999999987554 4579999999999999999999998  77899999999999999999999999999765


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      .+.  -....++.||+.|||||++..-.|+.++||||||++..||..|++||.+...-.                .++-+
T Consensus       180 TDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMI  241 (502)
T KOG0574|consen  180 TDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMI  241 (502)
T ss_pred             hhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEec
Confidence            432  223457899999999999999999999999999999999999999986432100                00000


Q ss_pred             hc-ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          320 MD-IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       320 ~~-~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      -. +...-..|..-......+++.|+. .|++|-|+.+++++
T Consensus       242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            00 011112244445556677777776 99999999998764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=316.25  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=212.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +..+.++||+|.||.|++|.|...      .++-..||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ .
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~p------sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQP------SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCC------CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            455678999999999999999752      223457999999877655 56789999999999999999999999887 6


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ...||||+++.|+|.+.|.+.....|.......++.||+.||.||.+  +++|||||...|+|+-....|||+|||+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceec
Confidence            78899999999999999988555678889999999999999999998  9999999999999999998999999999998


Q ss_pred             CCCCCccceeee-ccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          239 GPTGDRTHVSTQ-VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       239 ~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      +...+....+.. ..-...|+|||.++...++.++|||+|||+||||+| |+.||.+-..                 ..+
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qI  324 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQI  324 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHH
Confidence            765554433322 223568999999999999999999999999999999 6778754321                 223


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+.+|...+-..|..+.+.+..+++.||. +|++||++..|.+.
T Consensus       325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            44445555556788999999999999999 99999999999743

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-38  Score=296.37  Aligned_cols=254  Identities=25%  Similarity=0.434  Sum_probs=197.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc------ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      +|+..+.||+|+||.||+|...         .++..+|+|.+.....      ...+.+.+|++++++++|+||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDV---------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEEc---------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            5888999999999999997543         3467899999865321      124568899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEcc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSD  232 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  232 (441)
                      +.+.+..++||||+++++|.+++.+..  ++++..+..++.|++.||.|||+  +|++|+||||+||+++.++ .+||+|
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~d  147 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIAD  147 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcc
Confidence            999999999999999999999986543  58899999999999999999998  8999999999999998876 599999


Q ss_pred             cCCcccCCCCCc--cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          233 FGLAKAGPTGDR--THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       233 Fg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      ||.+........  ........|+..|+|||++.+..++.++||||||+++|+|++|..||..........         
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---------  218 (268)
T cd06630         148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---------  218 (268)
T ss_pred             cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---------
Confidence            999876433211  111223568899999999988889999999999999999999999996432211100         


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ..............+......+..++..|+. +|.+||++.++++.
T Consensus       219 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         219 ----LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ----HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                0111111111122333444556667778887 99999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.5e-38  Score=293.39  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=196.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-----ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-----QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      +|+..+.||+|+||.||+|....         .+..+++|.+.....     ...+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            47888999999999999986542         366899998764321     2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~  147 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFG  147 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCc
Confidence            99999999999999999999986543  48899999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ++.......   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.....  ......+        
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~--------  214 (258)
T cd06632         148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKI--------  214 (258)
T ss_pred             cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHH--------
Confidence            987643322   123456899999999987766 89999999999999999999999974331  1111110        


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            .........+......+..++..|+. +|++||++.+++..
T Consensus       215 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         215 ------GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                  00001111223334455667778887 99999999999754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.8e-38  Score=300.88  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=196.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|.+.+.||+|+||.||++....         .++.+|+|.+.....   .....+.+|+++|++++||||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            478999999999999999976543         467899999865422   23456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+|+|+||+|+|||++.++.+||+|||+
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence            9999999999999999999986653  58999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +......     .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ..            
T Consensus       148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~------------  207 (290)
T cd05580         148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IY------------  207 (290)
T ss_pred             ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH------------
Confidence            9865432     234568999999999988888999999999999999999999996433110   00            


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                       ..+...  ....+......+..++..|+. +|.+|+     +++|+++.
T Consensus       208 -~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         208 -EKILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -HHHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence             001100  011222233455667777887 999998     77777644

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-38  Score=296.65  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=192.3

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc----------cHHHHHHHHHHHhcCCCCCccc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ----------GHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      +|.+.+.||.|+||.||+|....         .+..+|+|.++.....          ..+.+.+|+.+++.++|+||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   72 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ   72 (272)
T ss_pred             ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence            57889999999999999986432         4678999987532111          1235778999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      +++++......++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~  148 (272)
T cd06629          73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICK  148 (272)
T ss_pred             EEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEE
Confidence            9999999999999999999999999986653  58999999999999999999998  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC--CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      |+|||+++...............|+..|+|||++....  ++.++|+||||+++|+|++|..||.......  .......
T Consensus       149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~  226 (272)
T cd06629         149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLGN  226 (272)
T ss_pred             EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhhc
Confidence            99999987643221111123456889999999987654  7889999999999999999999986332110  0000000


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            .....    .............+..++..|+. +|++||++.+|+++
T Consensus       227 ------~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 ------KRSAP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ------cccCC----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                  00000    00001111123445556677776 99999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.8e-38  Score=294.48  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=196.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC----------cccHHHHHHHHHHHhc-CCCCCcc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG----------FQGHKEWLSEVNYLGQ-LHHPNLV  148 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv  148 (441)
                      +|.+.+.||+|+||.||+|....+        .+..+++|.+....          .....++.+|+.++.+ ++|+||+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            488899999999999999876531        35689999875321          1223457788888875 6999999


Q ss_pred             cEEEEEEcCCeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          149 KLIGFCLDGENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       149 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      ++++++.+.+..++||||+++++|.+++..  .....+++..++.++.|++.+|.|||+ ..+++|+||||+||+++.++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence            999999999999999999999999998853  233458999999999999999999995 26899999999999999999


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||++.......   ......|+..|++||++.+..++.++||||||+++|+|++|+.||.........   .  
T Consensus       152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~--  223 (269)
T cd08528         152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---T--  223 (269)
T ss_pred             cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---H--
Confidence            99999999998644322   223456899999999999888999999999999999999999998643211100   0  


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                                 .+................+..++..|+. ||++||++.|+.++++
T Consensus       224 -----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 -----------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -----------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                       0000000000011223456677778887 9999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-38  Score=303.19  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=194.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.|.....||+|+||.||++...         ..+..+|||.+........+.+.+|+.+++.++|+||+++++.+...+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   92 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD   92 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence            34444577999999999997543         246789999987655455567889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++...   .+++..++.++.||+.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            999999999999999987432   48899999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  ......|+..|+|||++.+..++.++||||||+++|||++|+.||........  ...           +..
T Consensus       168 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~-----------~~~  232 (292)
T cd06658         168 VSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRR-----------IRD  232 (292)
T ss_pred             cccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----------HHh
Confidence            432211  12345689999999999888899999999999999999999999864321110  000           000


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+......  .......+..++..|+. +|.+||+++++++.
T Consensus       233 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         233 NLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            01111111  11122345566677776 99999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=298.31  Aligned_cols=253  Identities=28%  Similarity=0.379  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .+++|++.+.||+|+||.||+|....         .+..+++|.+..... ....+.+|+.+++++ +|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            46899999999999999999976542         467899999876543 346788999999999 6999999999987


Q ss_pred             cCC------eeEEEEEeCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 DGE------NRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~~~------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +..      ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCe
Confidence            644      4899999999999999886533  4568999999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      +||+|||++.......  .......|+..|+|||++..     ..++.++|||||||++|+|++|+.||......  ...
T Consensus       152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~  227 (275)
T cd06608         152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL  227 (275)
T ss_pred             EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH
Confidence            9999999987543221  12234568999999999854     34678999999999999999999999643211  111


Q ss_pred             hhhhccccccchhhhhhhcccc-cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKL-EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..              +..... ....+......+..++..|+. ||++||++.+|++.
T Consensus       228 ~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         228 FK--------------IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HH--------------hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11              000000 001122233456678888887 99999999999763

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-38  Score=298.34  Aligned_cols=201  Identities=26%  Similarity=0.423  Sum_probs=169.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||+|....         .+..||||.+...... ....+.+|++++++++|+||+++++++.+.
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            679999999999999999986542         4678999998654322 234567899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        76 ~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  151 (291)
T cd07844          76 KTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLAR  151 (291)
T ss_pred             CeEEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECcccccc
Confidence            999999999975 99998865543 68999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .......  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus       152 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         152 AKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             ccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            5322111  1123356889999999875 45889999999999999999999999644

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.2e-38  Score=301.66  Aligned_cols=255  Identities=23%  Similarity=0.301  Sum_probs=195.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||++...         ..++.|++|.+.....   .....+.+|+++++.++||||+++++.+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHK---------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEEC---------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            47899999999999999997654         3467899999875532   22346788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..++||||++|++|.+++....  .+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCC
Confidence            9999999999999999999996543  58999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCcc-------------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          236 AKAGPTGDRT-------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       236 a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      ++........             .......|+..|+|||++.+..++.++|||||||++|||++|..||.......   +
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~  224 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L  224 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            8742111000             01112457889999999988889999999999999999999999996432110   0


Q ss_pred             hhhhccccccchhhhhhhccccc-CCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLE-GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ..             ........ ..........+..++..|+. +|++||++.++++.|+.
T Consensus       225 ~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         225 FG-------------QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HH-------------HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00             00000000 00011223345677777777 99999997777766653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-37  Score=298.82  Aligned_cols=265  Identities=25%  Similarity=0.316  Sum_probs=193.6

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-----cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-----GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      +|.+.+.||+|+||.||+|....         .+..|+||.++.....     ....+..|++++++++|+||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            47888999999999999986543         3678999999765432     234567899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+ +++|.+++.... ..+++..++.++.||++||.|||+  ++|+|+||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg  147 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFG  147 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccce
Confidence            9999999999999 889999986544 358999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhhhh-ccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVDWA-KPYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~-~~~~~  311 (441)
                      ++........  ......++..|+|||++.+ ..++.++|||||||++|+|++|.++|........ ....... .+...
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (298)
T cd07841         148 LARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE  225 (298)
T ss_pred             eeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence            9976433221  1223356788999999865 4578999999999999999999888764332110 0010000 00000


Q ss_pred             cc---hhhhhhhcccccCCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DR---RKLFRIMDIKLEGQY-----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~---~~l~~~~~~~~~~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..   ..+............     .......+..++..|+. +|++||++.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00   000000000000000     11123345567777777 99999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.2e-38  Score=299.99  Aligned_cols=261  Identities=29%  Similarity=0.392  Sum_probs=197.4

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcc
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLV  148 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  148 (441)
                      ...++....++|.+.+.||+|+||.||+|....         .+..+|+|.+.... .....+.+|+.++.++ +||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~   82 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVV   82 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeE
Confidence            344555678899999999999999999976543         47789999986542 2345677899999999 799999


Q ss_pred             cEEEEEEcC-----CeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          149 KLIGFCLDG-----ENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       149 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      ++++++...     ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+  .+++||||||+||+
T Consensus        83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nil  160 (291)
T cd06639          83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEE
Confidence            999998753     3589999999999999988542  23458999999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC-----CCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-----LTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ++.++.+||+|||++........  ......|+..|+|||++....     ++.++|||||||++|+|++|+.||.....
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            99999999999999876433221  112346889999999986433     67899999999999999999999864321


Q ss_pred             ccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ...+..+....             ......+......+..++..|++ +|++||++.+++++
T Consensus       239 --~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         239 --VKTLFKIPRNP-------------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --HHHHHHHhcCC-------------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              11111111000             00000111222346667777777 99999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.5e-38  Score=297.06  Aligned_cols=202  Identities=33%  Similarity=0.433  Sum_probs=170.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|....         .+..+|+|++.....  ...+.+.+|+.++++++|+||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            478999999999999999976542         467899998864322  223557899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||++++.|..++...  ..+++..+..++.|++.+|.|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFA  147 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccc
Confidence            99999999999998887766433  248999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ........  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            86543221  1223457889999999876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=316.17  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=199.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.|.|+..||.|+||.||+|..++         ++...|-|++........++|+-|++||..+.||+||+|++.|+.++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            457778899999999999976554         34456778887666677889999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .++|+.|||.||.....+..-+ .++++.++.-++.|++.||.|||+  ++|||||||..|||++.+|.++|+|||.+..
T Consensus       103 kLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeeccccccc
Confidence            9999999999999988876654 469999999999999999999999  8999999999999999999999999998864


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ....  ......++|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...+.  ..             
T Consensus       180 n~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MR-------------  242 (1187)
T KOG0579|consen  180 NKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MR-------------  242 (1187)
T ss_pred             chhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HH-------------
Confidence            3211  11234689999999999975     46899999999999999999999998653221  11             


Q ss_pred             hhhhhhhcccc-cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKL-EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       .+..+..... .--.|..-..-...+...|+. +|..||++.+++++
T Consensus       243 -VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  243 -VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence             1111111111 011233444455666677776 99999999998754

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-38  Score=301.87  Aligned_cols=248  Identities=23%  Similarity=0.302  Sum_probs=193.6

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCee
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  160 (441)
                      |.....||+|+||.||+|...         ..+..+++|.+........+.+.+|+.++..++||||+++++++..+...
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            444567999999999997543         24678999998765445566788999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      ++||||+++++|.+++...   .+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++....
T Consensus        94 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            9999999999999977442   48999999999999999999998  899999999999999999999999999987543


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  +...... .          
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~----------  233 (297)
T cd06659         169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRDS-P----------  233 (297)
T ss_pred             cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhcc-C----------
Confidence            2211  12345689999999999988899999999999999999999999964321111  0000000 0          


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      . .. ..........+..++..|+. +|++||++.+|++.
T Consensus       234 ~-~~-~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         234 P-PK-LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             C-CC-ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0 00 00011122345567777777 99999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.2e-38  Score=299.94  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|.+.+.||+|+||.||+|....         .+..+++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   88 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG   88 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence            4689999999999999999986432         3567999998755445556788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++|+||+++++|.+++.+.   .+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence            9999999999999999998643   37899999999999999999998  899999999999999999999999999887


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .......  ......|++.|++||.+.+..++.++|||||||++|+|++|+.||.........  .....          
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~~~~----------  229 (293)
T cd06647         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIAT----------  229 (293)
T ss_pred             ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--eehhc----------
Confidence            5433221  123346889999999998888999999999999999999999999744321110  00000          


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         ........+......+..++..|+. +|++||++.+++.+
T Consensus       230 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 ---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000001122223456677788887 99999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.1e-38  Score=298.81  Aligned_cols=198  Identities=26%  Similarity=0.377  Sum_probs=166.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||+|....         .|..+++|.++....  .....+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            58889999999999999976543         467899999865422  1234577899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  147 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLAR  147 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence            99999999996 48888876543 358999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      .......  ......++..|+|||++.+.. ++.++|||||||++|+|+||..||.
T Consensus       148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            5432221  122346788999999987654 7899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.2e-38  Score=297.51  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=189.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHH-HhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNY-LGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++.... .....+..|+.+ ++.++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV---------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc---------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            47889999999999999997654         3478999999876532 233456667765 556689999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEEECCCCcEEEccc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +...|+||||++ ++|.+++...  ....+++..++.++.|++.||+|||+  + +++||||||+||+++.++.+||+||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999996 5888887542  23468999999999999999999998  6 8999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhc----CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT----GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |++.......   ......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||....... .         
T Consensus       149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~---------  215 (283)
T cd06617         149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-Q---------  215 (283)
T ss_pred             cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-H---------
Confidence            9987643221   1223468899999999865    456889999999999999999999996422110 0         


Q ss_pred             cccchhhhhhhcccccCCCc-hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYP-QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           .+...+.... ...+ ......+..++..|+. +|++||++.+|++.
T Consensus       216 -----~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         216 -----QLKQVVEEPS-PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -----HHHHHHhcCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0111111000 0111 1122345667777777 99999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=291.57  Aligned_cols=252  Identities=27%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC-----CcccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-----GFQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .+|++.+.||+|+||.||+|...         .++..+++|.+...     .......+.+|+.++++++|+||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   72 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA---------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC   72 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc---------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            57999999999999999997643         34778999987432     12234568899999999999999999999


Q ss_pred             EEcC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          154 CLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       154 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +.+.  ...++||||+++++|.+++....  .+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             EEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEC
Confidence            8764  46889999999999999986544  48899999999999999999998  899999999999999999999999


Q ss_pred             ccCCcccCCCCCc-cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          232 DFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       232 DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      |||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||......             
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------  215 (264)
T cd06653         149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------------  215 (264)
T ss_pred             ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------------
Confidence            9999975432111 01112356899999999999888999999999999999999999999643211             


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                         ..+..+.........|......+..++..|+.++..||++.+++.+
T Consensus       216 ---~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~~  261 (264)
T cd06653         216 ---AAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRH  261 (264)
T ss_pred             ---HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhcC
Confidence               1111111111222345555567888888999888999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=288.26  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=198.0

Q ss_pred             HHhcCCCCC-CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           76 NATRNFRPD-SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      .++++|.+. ++||-|-.|.|..         +.++.++..+|+|++...     ...++|+++--.. .|||||.++++
T Consensus        58 ~itedY~is~qvLG~GinGkV~~---------C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidV  123 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQ---------CVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDV  123 (400)
T ss_pred             cchhhheehhhhhccccCCceEE---------EEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehh
Confidence            467788875 6899999999986         455567889999998643     3456788876555 69999999998


Q ss_pred             EEc----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---C
Q 013557          154 CLD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---F  226 (441)
Q Consensus       154 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~  226 (441)
                      |++    ...+.+|||.++||.|+..|..++.+.+++.++-.|+.||+.|+.|||+  .+|.||||||+|+|....   .
T Consensus       124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             hhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCc
Confidence            764    4567899999999999999999999999999999999999999999999  899999999999999654   4


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||+|+.....   ....+.+-||.|.|||++....|+..+|+||+||++|-||+|.+||-...-..        
T Consensus       202 ~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------  270 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------  270 (400)
T ss_pred             ceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--------
Confidence            6999999999864322   12345678999999999998999999999999999999999999995332110        


Q ss_pred             ccccccchhhhhhhcccccCCCc----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYP----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           ....+..-+... .-.+|    ....+....++++++. +|.+|.|++++++.
T Consensus       271 -----ispgMk~rI~~g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  271 -----ISPGMKRRIRTG-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -----CChhHHhHhhcc-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                 001111111100 11222    2345667778888888 99999999999865

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.1e-38  Score=297.18  Aligned_cols=201  Identities=29%  Similarity=0.451  Sum_probs=171.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||+|....         .+..+++|++.....  .....+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            58899999999999999976543         367899999876542  2345788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+ +++|.+++.... ..+++.+++.++.||+.||.|||+  .+++|+||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~  147 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLAR  147 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence            9999999999 999999986544 469999999999999999999998  899999999999999999999999999988


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ....... .......|+..|+|||++.+. .++.++||||||+++|+|++|.++|...
T Consensus       148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            6543321 112334689999999998654 4689999999999999999998888643

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=298.39  Aligned_cols=267  Identities=27%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|....         ++..|++|.++....  .....+.+|++++++++|+||+++++++.+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            368999999999999999976543         367899999875422  234668899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||++++.|..++...  ..+++..+..++.||+.||.|||+  .+++|+||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence            99999999999886666554332  348999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhhccccc---
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWAKPYLG---  311 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~~~---  311 (441)
                      ........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... .........   
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07833         148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ  226 (288)
T ss_pred             cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence            86544332 122345678999999999887 789999999999999999999999974432111100 000000000   


Q ss_pred             ----cchh-----hhhhhc-ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 ----DRRK-----LFRIMD-IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ----~~~~-----l~~~~~-~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ....     +..... ......++......+..++..|+. +|++||++++|+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                0000     000000 000111223334567778888887 99999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.2e-37  Score=290.92  Aligned_cols=250  Identities=29%  Similarity=0.419  Sum_probs=195.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.+.+.||+|+||.||+|....         .+..+++|.++.....  ..+.+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            58889999999999999986543         3678999998765443  456788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++|+||+++++|.+++....  .+++..+..++.+++.||.|||+  .+|+|+||+|+||+++.++.+||+|||++.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~  147 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV  147 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccccccc
Confidence            99999999999999999986543  47889999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccce--eeeccCCCCcCchhhhhcCC---CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          238 AGPTGDRTHV--STQVMGTRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       238 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ..........  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||........  . .+       
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~-~~-------  217 (264)
T cd06626         148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I-MF-------  217 (264)
T ss_pred             ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H-HH-------
Confidence            6543322111  12356788999999998766   88999999999999999999999964321100  0 00       


Q ss_pred             chhhhhhhcccccCCCchhH--HHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKG--AYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~--~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                           .+.. ......+...  ...+..++..|++ +|++||++.+++.
T Consensus       218 -----~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         218 -----HVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -----HHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 0000 0011112211  3445567778887 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.8e-38  Score=293.91  Aligned_cols=254  Identities=28%  Similarity=0.403  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||.|+||.||++...         ..++.+++|.+..... .....+.+|++++++++||||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            46888899999999999997654         3467899999876532 3345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~  149 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG  149 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence            99999999999999999986543 468999999999999999999997 3689999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ......    .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ .....          +.
T Consensus       150 ~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~----------~~  214 (265)
T cd06605         150 QLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFEL----------LQ  214 (265)
T ss_pred             hhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHH----------HH
Confidence            542211    1125688999999999988999999999999999999999999964421110 00000          01


Q ss_pred             hhhcccccCCCchh-HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQK-GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~-~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .++... ....+.. ....+..++..|+. +|++||++.+++..
T Consensus       215 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         215 YIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHhcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111111 0111111 33445677778887 99999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-37  Score=293.50  Aligned_cols=256  Identities=27%  Similarity=0.341  Sum_probs=197.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|+..+.||.|++|.||+|....         .++.+|+|.+..... .....+.+|++++++++||||++++++|.+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            468888999999999999976543         467899999875433 2345688999999999999999999988653


Q ss_pred             --CeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          158 --ENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       158 --~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                        ...++||||+++++|.+++..  .....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeec
Confidence              478999999999999998753  223458899999999999999999998  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccc--ccchhhhhhhccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV--GAEQNLVDWAKPYLG  311 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~  311 (441)
                      |++.......    .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....  ........+..... 
T Consensus       150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  224 (287)
T cd06621         150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-  224 (287)
T ss_pred             cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-
Confidence            9987543221    1234578899999999988999999999999999999999999975432  11111111111100 


Q ss_pred             cchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                               ...+.....  ......+..++..|+. +|.+||++.||++.
T Consensus       225 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 ---------NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ---------chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                     000000001  1123456788899998 99999999999875

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.7e-37  Score=292.97  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=195.6

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      -|++.+.||.|+||.||+|....         .+..+|+|.+..... .....+.+|+.++.+++|+||+++++++.++.
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence            47788999999999999986543         367899998764432 23456888999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++++|.+++...   .+++..+..++.|++.+|.|||+  .+++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06641          76 KLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence            999999999999999988532   48899999999999999999998  8999999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......   ...              
T Consensus       151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~--------------  211 (277)
T cd06641         151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLF--------------  211 (277)
T ss_pred             cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHH--------------
Confidence            433221  1233568889999999988888999999999999999999999986432110   000              


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+........+......+..++..|+. +|.+||++.+++.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         212 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000000111122233456677888887 99999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-37  Score=289.14  Aligned_cols=253  Identities=27%  Similarity=0.395  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|++|.||+|....         ++..++||++..... .....+.+|+.++.+++|+||+++++++...
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            478899999999999999976543         477899999876644 3456789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++...  ..+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~  148 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISK  148 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999999765  4589999999999999999999962 689999999999999999999999999988


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ........  .....++..|+|||.+.+..++.++|+||||+++|+|+||+.||.............             
T Consensus       149 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------------  213 (264)
T cd06623         149 VLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------------  213 (264)
T ss_pred             ecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-------------
Confidence            64332211  124467889999999998889999999999999999999999997543211111111             


Q ss_pred             hhhcccccCCCchh-HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          318 RIMDIKLEGQYPQK-GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       318 ~~~~~~~~~~~~~~-~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+.. ......+.. ....+..++..|+. +|++||++.++++.
T Consensus       214 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         214 AICD-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHhc-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111 111111222 33456667777777 99999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.7e-38  Score=298.68  Aligned_cols=266  Identities=27%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|.+..         .++.+|+|.+......  ..+.+.+|+++++.++||||+++++++.+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            468899999999999999986543         3678999988654322  24567889999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      +...++||||+++++|.++.....  .+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~  147 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFA  147 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeee
Confidence            999999999999988888764432  48999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhhhhccccccch
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~  314 (441)
                      .......  .......++..|+|||++.+ ..++.++||||||+++|||++|++||........ .....+.........
T Consensus       148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07846         148 RTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ  225 (286)
T ss_pred             eeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence            7643322  12233567889999999875 3478899999999999999999999864332110 111111111100000


Q ss_pred             hhh---hhhcccccC---------CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLF---RIMDIKLEG---------QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~---~~~~~~~~~---------~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...   .++......         .........+..++..|+. +|++||++.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000   000000000         0011223456778888887 99999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=310.24  Aligned_cols=244  Identities=30%  Similarity=0.406  Sum_probs=192.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .|.-++.||.|+||.||-|+         +..+...||||++.-.+-+   ...+++.|+..|.+|+|||++.+-++|..
T Consensus        27 lf~dLrEIGHGSFGAVYfAr---------d~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr   97 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR   97 (948)
T ss_pred             HHHHHHHhcCCccceeEEee---------ccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence            35557889999999999854         4446779999998755433   34678999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      +...+||||||-| +-.|++.-. .+++.+..+..|+.+.+.||.|||+  .+.||||||..|||+++.|.|||+|||.+
T Consensus        98 e~TaWLVMEYClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen   98 EHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             cchHHHHHHHHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccch
Confidence            9999999999955 777876433 3469999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ....+      ...++|||.|||||++.   .+.|+-++||||||++..||.-.++|+...+  ...-+...        
T Consensus       174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHI--------  237 (948)
T KOG0577|consen  174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHI--------  237 (948)
T ss_pred             hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHH--------
Confidence            76433      24679999999999985   5789999999999999999999999864322  11111111        


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                            ......--....-......++..|++ -|.+|||.++++.
T Consensus       238 ------AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  238 ------AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  11111111123334555667778887 8999999999753

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-37  Score=295.79  Aligned_cols=203  Identities=26%  Similarity=0.385  Sum_probs=169.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|....         .+..+++|.+....... ...+.+|+.+++.++|+||+++++++.+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            5789999999999999999976542         36789999986543222 3456789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      +...++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccc
Confidence            999999999995 68888775443 357888899999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +.......  ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            75332211  12234578999999998754 57889999999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.6e-38  Score=294.28  Aligned_cols=247  Identities=25%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +|++.+.||.|+||.||+|...         .++..+++|.+.....   ...+.+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            5888999999999999997654         3477899999875432   235678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+.+++|.+++...  .++++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~  147 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIA  147 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccc
Confidence            99999999999999999998665  358999999999999999999998  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.............            
T Consensus       148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------  212 (258)
T cd05578         148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA------------  212 (258)
T ss_pred             cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH------------
Confidence            7654332   1234568889999999988889999999999999999999999997544221111111            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH--HHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM--SEVL  357 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~--~evl  357 (441)
                        .... .....+......+..++..|+. +|.+||++  +|++
T Consensus       213 --~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 --KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              1110 1112233334556677777887 99999999  6665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=292.65  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=194.3

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCC---CCCcccEEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLH---HPNLVKLIGFCL  155 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~  155 (441)
                      .|++.+.||+|+||.||+|.+..         .+..+++|.++... ......+.+|+.++++++   |+|++++++++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            57888999999999999986542         46789999986542 234556888999999986   999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....++||||+++++|.+++...   .+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||+
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGV  147 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence            999999999999999999988543   58999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +........  ......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||........   .....       
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~-------  215 (277)
T cd06917         148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIP-------  215 (277)
T ss_pred             eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccc-------
Confidence            876543321  12345689999999998754 468899999999999999999999974321110   00000       


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         ......+.   .......+..++..|+. +|++||++.+++..
T Consensus       216 ---~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 ---KSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ---cCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence               00000010   11123456677788887 99999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.8e-38  Score=296.86  Aligned_cols=201  Identities=31%  Similarity=0.466  Sum_probs=169.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||.|+||.||+|...         .++..++||+++....  .....+.+|++++++++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            5888999999999999997654         3467899998875432  2235688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+. ++|.+++.......+++..+..++.|++.||+|||+  .+++|+||+|+||+++.++.+||+|||++.
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~  148 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR  148 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence            99999999995 589998876655678999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .......  ......++..|+|||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus       149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            5432211  122345788999999887644 588999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.9e-37  Score=290.22  Aligned_cols=250  Identities=23%  Similarity=0.347  Sum_probs=196.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.+.+.||+|+||.||+|....         .+..+|+|.+.....  ...+.+.+|+.+++.++|+||+++++.+.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            57888999999999999986643         466799999865422  2345678999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc-EEEcccCCc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-AKLSDFGLA  236 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~-~kl~DFg~a  236 (441)
                      ...++|+||+++++|.+++.......+++..+..++.|++.||.|||+  .+++|+||||+||+++.++. +||+|||.+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~  149 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIA  149 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccc
Confidence            999999999999999999977655568999999999999999999998  89999999999999998864 699999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......  .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......      +          +
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~----------~  211 (257)
T cd08225         150 RQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------L----------V  211 (257)
T ss_pred             hhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------H----------H
Confidence            7643322  12233468999999999988889999999999999999999999986432110      0          0


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .......... .+......+..++..|+. +|++||++.+|+..
T Consensus       212 ~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         212 LKICQGYFAP-ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHhcccCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0111111111 111222345566677776 99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-38  Score=310.44  Aligned_cols=243  Identities=25%  Similarity=0.408  Sum_probs=193.4

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC----CcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE----GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +...+||+|+|-+||+|.....         |..||.-.++..    .....++|..|+.+|+.|+|+||+++++.+.+.
T Consensus        43 k~~evLGrGafKtVYka~De~~---------giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEE---------GIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             ehhhhcccccceeeeecccccc---------chhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            5567899999999999876543         445554443322    223457899999999999999999999998876


Q ss_pred             Ce--eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcEEEcccC
Q 013557          158 EN--RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFG  234 (441)
Q Consensus       158 ~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFg  234 (441)
                      ..  ..+|+|.+..|+|..|+.+...  +....+..|+.||++||.|||+++..|+|||||.+||+|+.+ |.|||+|+|
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence            55  7889999999999999977664  888999999999999999999988899999999999999876 889999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +|.......    ....+|||.|||||+.. ..|++.+||||||+.++||+|+..||..=.                   
T Consensus       192 LAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------------------  247 (632)
T KOG0584|consen  192 LATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------------------  247 (632)
T ss_pred             HHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------------------
Confidence            998743322    23478999999999987 799999999999999999999999985210                   


Q ss_pred             hhhhhhcccccCCCchh----HHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQK----GAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~----~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                      .-..|..+...+..|..    ....+..++..|+....+||++.|+|..
T Consensus       248 n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  248 NPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSERLSAKELLKD  296 (632)
T ss_pred             CHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhccCHHHHhhC
Confidence            01122222222333322    2345778889999888899999999865

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.4e-37  Score=287.20  Aligned_cols=252  Identities=28%  Similarity=0.423  Sum_probs=201.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.+.+.||+|++|.||+|....         .+..+++|.+.....  ...+.+.+|+.++++++|+||+++++.+.+.
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47888999999999999986653         467899999876542  3456788999999999999999999999988


Q ss_pred             --CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          158 --ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       158 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                        ...++||||+++++|.+++....  .+++..++.++.|++.+|.|||+  .+++|+||+|+||+++.++.++|+|||.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccccc
Confidence              89999999999999999987654  68999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +................++..|++||.+.+..++.++||||||+++|+|++|..||..... ....              
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~--------------  212 (260)
T cd06606         148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAA--------------  212 (260)
T ss_pred             EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHH--------------
Confidence            8865443321112345688999999999888899999999999999999999999975431 0000              


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +..+.........+......+..++..|+. +|++||++.+++..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            001111111122333334567777788887 99999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.8e-37  Score=286.96  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.+.+.||.|+||.||++....         .+..+++|.+.....  .....+.+|+++++.++|+|++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            58889999999999999976543         467899999876543  3456688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ...++||||+++++|.+++....  ...+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccc
Confidence            99999999999999999987643  3569999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +.......  .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||+......   .             
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~-------------  211 (258)
T cd08215         150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L-------------  211 (258)
T ss_pred             eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H-------------
Confidence            87643322  12334578899999999988889999999999999999999999986443110   0             


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ............+......+..++..|+. +|++||++.++++.
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         212 -ALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00000011112232334556777888887 99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.5e-37  Score=292.81  Aligned_cols=249  Identities=25%  Similarity=0.332  Sum_probs=195.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      +|...+.||+|++|.||+|....         .+..+++|++........+.+.+|+.+++.++|+||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            45556899999999999976542         367899998865544455668899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .++|+||+++++|.+++..   ..+++..+..++.|++.||.|||+  ++|+||||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            9999999999999999865   248999999999999999999998  89999999999999999999999999988754


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      ....  .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........   ..          +...
T Consensus       166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~----------~~~~  230 (285)
T cd06648         166 SKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KR----------IRDN  230 (285)
T ss_pred             ccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HH----------HHhc
Confidence            3221  1123356899999999998888999999999999999999999998643211100   00          0000


Q ss_pred             hcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .....  ..+......+..++..|+. +|++||++.++++.
T Consensus       231 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         231 LPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            00000  0111123456677788887 99999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=276.35  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=191.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      ++...+..||.|..|.|++.++..         +|..+|||.+..... +..++++..++++... .+|+||+.+|+|..
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            445567889999999999976553         578999999977543 4456788888887766 49999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      +...++.||.+.  .-.+.|.++...++++..+-++...++.||.||-. .++|+|||+||+|||+|+.|++||||||++
T Consensus       163 n~dV~IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  163 NTDVFICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             CchHHHHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeeccccc
Confidence            999999999983  34444555566789999999999999999999987 589999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      -......   ..+...|.+.|||||.+.-   ..|+.++||||||++|+||.||+.||.....+-+              
T Consensus       240 GrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--------------  302 (391)
T KOG0983|consen  240 GRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--------------  302 (391)
T ss_pred             ceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--------------
Confidence            7644332   2345579999999999863   4689999999999999999999999986443221              


Q ss_pred             hhhhhhhcccccCCCch--hHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQ--KGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~--~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       .+..+++... ...+.  ........+...|+. |+.+||...+++++
T Consensus       303 -~ltkvln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  303 -VLTKVLNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -HHHHHHhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence             1112222111 11111  122334455566666 99999999998865

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.2e-37  Score=285.02  Aligned_cols=248  Identities=29%  Similarity=0.423  Sum_probs=199.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      +|.+.+.||+|++|.||++....         .+..+++|++..........+.+|+.++++++|+||+++++++.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            47888999999999999976543         467899999987655456778999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .++++||+++++|.+++.... ..+++..+..++.|++.+|.+||.  .+++||||+|+||+++.++.++|+|||.+...
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  148 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL  148 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence            999999999999999986653 458999999999999999999998  89999999999999999999999999998765


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      .....   .....|+..|++||++.+..++.++||||||+++|+|++|+.||..........                ..
T Consensus       149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~  209 (253)
T cd05122         149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF----------------KI  209 (253)
T ss_pred             ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH----------------HH
Confidence            44321   234568899999999988888999999999999999999999987442111000                00


Q ss_pred             hcccccCCC--chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          320 MDIKLEGQY--PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       320 ~~~~~~~~~--~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .. ......  +......+..++..|+. +|++||++.++++.
T Consensus       210 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         210 AT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             Hh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00 000001  11113456677778887 99999999999764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.1e-37  Score=291.76  Aligned_cols=245  Identities=29%  Similarity=0.409  Sum_probs=189.6

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||+|+||+||++...         ..+..+++|.+.....   .....+..|+++|++++||||+++++.+...+..|+|
T Consensus         1 lg~g~~g~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVK---------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEc---------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            689999999997543         3477899998865322   2234567899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.......+++..++.++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~  149 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK  149 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence            999999999999977665569999999999999999999998  899999999999999999999999999987543211


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                         ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........             +..... .
T Consensus       150 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~-~  212 (277)
T cd05577         150 ---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------------LKRRTL-E  212 (277)
T ss_pred             ---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------------HHhccc-c
Confidence               12234678899999999888899999999999999999999999964432111000             000000 0


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      .....+......+..++..|++ +|.+||     ++.+++++
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            0111222234455677777777 999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.4e-37  Score=301.92  Aligned_cols=199  Identities=26%  Similarity=0.343  Sum_probs=168.1

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|...         .++..+|+|.+....  ......+.+|+.++++++|+||++++++|
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDT---------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEEC---------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            4678999999999999999997544         347789999986432  23345677899999999999999999988


Q ss_pred             EcC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          155 LDG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       155 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ...      ...|+||||+.+ +|.+++...    ++...+..++.|++.||+|||+  .||+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             ccCCCccccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCE
Confidence            643      357999999964 888877432    7889999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ||+|||+++......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       158 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         158 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             EEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            999999998643322   122346789999999999999999999999999999999999999644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.4e-37  Score=294.68  Aligned_cols=266  Identities=24%  Similarity=0.312  Sum_probs=194.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||.|+||.||+|....         .+..+++|.++.....  ....+.+|+.++.+++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   75 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG   75 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence            579999999999999999986543         4678999998754322  22356789999999999999999999887


Q ss_pred             C--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          157 G--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       157 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .  ...|+||||+.+ +|.+++..... .+++..++.++.|++.||+|||+  .+++|+||||+||+++.++.+||+|||
T Consensus        76 ~~~~~~~lv~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          76 SNLDKIYMVMEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             cCCCcEEEEehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecC
Confidence            7  899999999975 99998865443 58999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhhhh-ccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVDWA-KPYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~-~~~~~  311 (441)
                      ++........  ......+++.|+|||++.+. .++.++||||||+++|+|++|..||........ ....... .+...
T Consensus       152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (293)
T cd07843         152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK  229 (293)
T ss_pred             ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence            9886543221  12234578899999998764 468899999999999999999999974432111 1111000 00000


Q ss_pred             cc-----------hhhhhhhcccccCCCchh-HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DR-----------RKLFRIMDIKLEGQYPQK-GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~-----------~~l~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..           ..........+...++.. ....+..++..|+. +|++||++.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00           000000000111222222 24455667777887 99999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-37  Score=296.46  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=190.0

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCC-CCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  157 (441)
                      +|...+.||+|+||.||++...         ..+..+|+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            5666788999999999997654         3477899999875432 33456889999999996 99999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          158 ENRLLVYEYMPKGSLENHL---FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      ...+++|||+.. +|.++.   .......+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||
T Consensus        76 ~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          76 GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             CcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecc
Confidence            999999999854 665543   33334568999999999999999999996 2599999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcC---CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG---RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      +++......   ......|+..|+|||++.+.   .++.++|||||||++|+|++|+.||..... ..........   .
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~---~  226 (288)
T cd06616         154 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVK---G  226 (288)
T ss_pred             hhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcC---C
Confidence            987543221   11234688999999999866   689999999999999999999999974321 0000000000   0


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .        ...+....+......+..|+..|+. +|++||++.+|+..
T Consensus       227 ~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 D--------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             C--------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0        0011111112233456677788887 99999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.7e-37  Score=291.59  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ...++|++.+.||+|+||.||+|.+..         .+..+++|.+..... ....+.+|+++++.++|+||+++++.+.
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~   85 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL   85 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence            356789999999999999999986643         367899999876543 4567889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      .....++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          86 VGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccch
Confidence            9999999999999999999997654 359999999999999999999998  8999999999999999999999999998


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +........  ......++..|++||++.+..++.++|+|||||++|+|++|+.||........  ...           
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~-----------  227 (286)
T cd06614         163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFL-----------  227 (286)
T ss_pred             hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----------
Confidence            865432211  12334578899999999888899999999999999999999999864322110  000           


Q ss_pred             hhhhhcccccC-CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEG-QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~-~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         +....... ..+......+..++..|+. +|.+||++.+|++.
T Consensus       228 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         228 ---ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ---HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               00000000 0111123456678888888 99999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=295.13  Aligned_cols=206  Identities=25%  Similarity=0.345  Sum_probs=169.5

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +|++.+.||+|+||.||+|.....       ..+..||+|.+....   ......+.+|+.+++.++||||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence            478889999999999999876431       247789999998632   2334567889999999999999999999998


Q ss_pred             C--CeeEEEEEeCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC----CCc
Q 013557          157 G--ENRLLVYEYMPKGSLENHLFRRG---ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS----EFN  227 (441)
Q Consensus       157 ~--~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~----~~~  227 (441)
                      .  ...++||||+++ +|.+++....   ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.    ++.
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~  150 (316)
T cd07842          74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGV  150 (316)
T ss_pred             CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccce
Confidence            8  889999999965 7877774322   2368899999999999999999998  89999999999999999    899


Q ss_pred             EEEcccCCcccCCCCCc-cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 AKLSDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99999999986433221 1112345678999999998764 57899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.9e-37  Score=292.09  Aligned_cols=263  Identities=17%  Similarity=0.179  Sum_probs=184.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccH-----------HHHHHHHHHHhcCCCCC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-----------KEWLSEVNYLGQLHHPN  146 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpn  146 (441)
                      .++|++.++||+|+||.||+|.+....      ..+..+++|+.........           .....+...+..+.|+|
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDH------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG   84 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCc------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence            468999999999999999998765321      1134566775433221110           11233445566778999


Q ss_pred             cccEEEEEEcCC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          147 LVKLIGFCLDGE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       147 Iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      |+++++.+....    ..+++||++. .++.+.+....  ..++..+..++.|++.||+|||+  .+|+||||||+|||+
T Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill  159 (294)
T PHA02882         85 IPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMV  159 (294)
T ss_pred             CCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence            999998765443    3478888874 47777664432  36788899999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccc
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG  297 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~  297 (441)
                      +.++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999764321111     1112346999999999999999999999999999999999999999754221


Q ss_pred             cchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      ..  ......-     ..+..+.....   ........+..++..|+. +|++||++.+|++.|+
T Consensus       240 ~~--~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GN--LIHAAKC-----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hH--HHHHhHH-----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11  1100000     00001111000   011224567788899998 9999999999998763

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.2e-37  Score=290.98  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=182.1

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHH---HhcCCCCCcccEEEEEEcCCe
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNY---LGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      +||+|+||.||++...         ..+..+|+|.+......   ....+.+|..+   +...+|+||+.+++++...+.
T Consensus         1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            4899999999997643         34778999988654321   12223444433   334479999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||++...
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~  147 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence            999999999999999886554  48999999999999999999998  89999999999999999999999999998754


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ....    .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||..........+...             
T Consensus       148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------------  210 (279)
T cd05633         148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-------------  210 (279)
T ss_pred             cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-------------
Confidence            3221    123468999999999864 5688999999999999999999999974432111111100             


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                       .. ......+......+..++..|+. +|++||     ++++++++
T Consensus       211 -~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         211 -TL-TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -hh-cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             00 01111222333455666677777 999999     59998876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.8e-37  Score=293.91  Aligned_cols=248  Identities=29%  Similarity=0.410  Sum_probs=192.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ...|.+.+.||+|+||.||+|....         .+..|++|.+.....   .....+.+|+.+++.++||||++++++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~   84 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY   84 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3569999999999999999986543         367899998864322   2335688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+  .+|+||||+|+||+++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          85 LREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecC
Confidence            99999999999996 57877775433 358999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      ++......      ....|+..|+|||++.   ...++.++||||||+++|||+||+.||.........           
T Consensus       161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-----------  223 (307)
T cd06607         161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------  223 (307)
T ss_pred             cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-----------
Confidence            98754322      2346788999999874   356888999999999999999999998643211100           


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                           ..+.........+......+..++..|+. +|++||++.+|+.+.
T Consensus       224 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         224 -----YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -----HHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                 00000000001111223456777788887 999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=310.65  Aligned_cols=202  Identities=32%  Similarity=0.481  Sum_probs=172.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC-
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG-  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  157 (441)
                      .+...+.||+|+||.||+|+.+         .+|+.||||.++.... ...+.+.+|+++|++|+|+|||+++++-++. 
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnk---------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~   84 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNK---------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF   84 (732)
T ss_pred             ceeehhhhcCCccceeeeeccc---------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence            3455688999999999997644         4689999999987543 3456688999999999999999999985443 


Q ss_pred             -----CeeEEEEEeCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC--CC--c
Q 013557          158 -----ENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS--EF--N  227 (441)
Q Consensus       158 -----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~--~~--~  227 (441)
                           ....+|||||.||+|+.++.+- +..++++.+.+.++.+++.||.|||+  +||+||||||.||++-.  +|  .
T Consensus        85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceE
Confidence                 3568999999999999999643 34579999999999999999999998  99999999999999843  34  3


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      .||+|||.|+....+.   ....+.||..|++||++.. +.|+..+|.|||||++|++.||..||....
T Consensus       163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            7999999999865544   5678899999999999984 789999999999999999999999996444

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=292.71  Aligned_cols=241  Identities=29%  Similarity=0.408  Sum_probs=195.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      ..+|.++.+||+|+||+|.+         +.++++...+|||+++++-.-.   .+--+.|-++|... +-|.++.++.+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlL---------aerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLL---------AERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ecccceEEEeccCccceeee---------ecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            45788999999999999998         4556678899999998764322   23345678888877 57899999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |.+.+.+|+||||+.||+|--.|.+.+.  +.+..+..++.+|+-||-|||+  +||++||||.+|||+|.+|++||+||
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeec
Confidence            9999999999999999999888877664  7888899999999999999998  99999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++..-....  ..++++|||.|+|||++..++|+.++|+||+||+|||||.|++||++.+.+.               
T Consensus       495 GmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---------------  557 (683)
T KOG0696|consen  495 GMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------  557 (683)
T ss_pred             ccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---------------
Confidence            99987544332  3568999999999999999999999999999999999999999998654321               


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP  351 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP  351 (441)
                       .+..+++...  .+|.........+....+- .|.+|.
T Consensus       558 -lF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  558 -LFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -HHHHHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence             1223333222  3555555555555555554 888774

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.9e-36  Score=292.94  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=194.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      +.|...+.||+|+||.||+|....         .+..+++|.+.....   .....+.+|++++++++|+|++++++++.
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL   95 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            347788999999999999976543         367899999864322   23356888999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ++...++||||+.| +|.+++... ..++++.++..++.|++.||.|||+  ++|+||||+|+||+++.++.+||+|||+
T Consensus        96 ~~~~~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          96 REHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCC
Confidence            99999999999975 888877543 3458999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      +......      ....|+..|+|||++.   ++.++.++|||||||++|+|++|+.||.......  .           
T Consensus       172 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~-----------  232 (317)
T cd06635         172 ASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A-----------  232 (317)
T ss_pred             ccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--H-----------
Confidence            8754321      2346889999999974   4568899999999999999999999986432110  0           


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                         +..+................+..++..|++ +|.+||++.+|++.+..+
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         233 ---LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ---HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence               001111011111112233456778888888 999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.4e-37  Score=286.66  Aligned_cols=243  Identities=27%  Similarity=0.342  Sum_probs=193.1

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||.|+||.||+|....         .+..+++|.+.....   ...+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus         1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            7999999999976542         467899999865432   2345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.+..  .+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~  147 (262)
T cd05572          72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ  147 (262)
T ss_pred             EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence            99999999999996543  48999999999999999999998  899999999999999999999999999998654332


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                         ......|+..|++||++.+..++.++|+||||+++|+|++|..||.....+...              ....+....
T Consensus       148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~  210 (262)
T cd05572         148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME--------------IYNDILKGN  210 (262)
T ss_pred             ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH--------------HHHHHhccC
Confidence               122346889999999998888999999999999999999999999754321100              011111111


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                      ....++......+..++..|+. +|++||+     ++|+++.
T Consensus       211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            1223343334566777888887 9999999     7777663

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.7e-37  Score=285.73  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=197.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||+|+||.||++...         ..+..+++|.+.....  .....+.+|++++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL---------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC---------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            5888999999999999997543         3467899999875432  2345678899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ...++||||+++++|.+++.+..  ...+++..++.++.|++.||.|||+  .|++|+||+|+||+++.++.+||+|||+
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccc
Confidence            99999999999999999986532  2458999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +......    ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||........   .            
T Consensus       150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~------------  210 (256)
T cd08530         150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---R------------  210 (256)
T ss_pred             hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H------------
Confidence            9865433    12234688999999999988899999999999999999999999975432110   0            


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ...........+......+..++..|+. +|++||++.++++.
T Consensus       211 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         211 --YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              0000011111222334456777778887 99999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-36  Score=285.89  Aligned_cols=251  Identities=22%  Similarity=0.273  Sum_probs=190.1

Q ss_pred             HHHHHHHhcCCCCCCee--eecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCc
Q 013557           71 FSELKNATRNFRPDSLI--GEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNL  147 (441)
Q Consensus        71 ~~~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  147 (441)
                      ..++....++|.+.+.+  |+|+||.||++...         ..+..+++|.+........     |+.+...+ +|+||
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~i   71 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK---------PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNF   71 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEc---------CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCE
Confidence            44556667788888877  99999999996543         3477899999875432221     23222223 69999


Q ss_pred             ccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-
Q 013557          148 VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-  226 (441)
Q Consensus       148 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-  226 (441)
                      +++++.|...+..++||||+++++|.+++..+.  .+++..++.++.|++.||.|||+  .+++||||||+||+++.++ 
T Consensus        72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~  147 (267)
T PHA03390         72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKD  147 (267)
T ss_pred             EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCC
Confidence            999999999999999999999999999996654  68999999999999999999998  8999999999999999998 


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .++|+|||++......      ....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.
T Consensus       148 ~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~  220 (267)
T PHA03390        148 RIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL  220 (267)
T ss_pred             eEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH
Confidence            9999999998754322      23458899999999998899999999999999999999999997332211 1111111


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-HHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-MSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-~~evl~~  359 (441)
                                 .......  ..+......+..++..|++ +|.+||+ ++++++.
T Consensus       221 -----------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        221 -----------KRQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -----------HhhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                       0011000  1122233445666677777 9999995 6888753

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.7e-37  Score=296.42  Aligned_cols=199  Identities=24%  Similarity=0.310  Sum_probs=162.0

Q ss_pred             Ceeeec--CceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCee
Q 013557           85 SLIGEG--GFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  160 (441)
                      ..||+|  +||+||++...         ..++.||+|++.....  ...+.+.+|+.+++.++||||++++++|..++..
T Consensus         4 ~~ig~g~~~~~~v~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT---------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEc---------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence            456666  89999996543         3578999999875432  2345688899999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      ++||||+.+++|.+++.......+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.++++||+.+....
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~  152 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLV  152 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence            999999999999999977655568999999999999999999998  899999999999999999999999997653221


Q ss_pred             CCCc-cc----eeeeccCCCCcCchhhhhcC--CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          241 TGDR-TH----VSTQVMGTRGYAAPEYLATG--RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       241 ~~~~-~~----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .... ..    ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            1110 00    00112346679999999764  4789999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=282.36  Aligned_cols=247  Identities=31%  Similarity=0.498  Sum_probs=198.4

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.+.+.||+|++|.||+|....         .+..+++|.+.....  .....+.+|++++.+++|+|++++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            58889999999999999976543         367899999977654  3456788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.+|.|||+  .||+||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  147 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVAT  147 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccce
Confidence            9999999999999999998665  358999999999999999999998  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ........  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  .......            
T Consensus       148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~~~------------  211 (254)
T cd06627         148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALFRI------------  211 (254)
T ss_pred             ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHH------------
Confidence            65433221  2345688999999999888889999999999999999999999864321  0000000            


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                        .. ......+......+..++..|+. +|++||++.+++.
T Consensus       212 --~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         212 --VQ-DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --hc-cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              00 01111222334556677777777 9999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-38  Score=282.39  Aligned_cols=267  Identities=27%  Similarity=0.365  Sum_probs=196.7

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcc
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLV  148 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv  148 (441)
                      +|.++-+.++     +.||+|+|+.|-.+         ....++..+|||++.+.......++.+|++++.+.+ |+||+
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nil  139 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNIL  139 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHH
Confidence            3555555444     57999999999764         344568889999998886667788999999999995 99999


Q ss_pred             cEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc-
Q 013557          149 KLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-  227 (441)
Q Consensus       149 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~-  227 (441)
                      .+++||+++..+|||||.+.||.|..+|.++..  +++.++..+..+|+.||+|||.  +||.||||||+|||...... 
T Consensus       140 qLiefFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  140 QLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             HHHHHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCc
Confidence            999999999999999999999999999987664  9999999999999999999998  99999999999999976544 


Q ss_pred             --EEEcccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 --AKLSDFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 --~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                        +||+||.+..-.......     ....+.+|+..|||||+..     ...|+.++|.||||||||-||.|.+||-+.-
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence              899999887532221111     1122467999999999864     2358899999999999999999999996442


Q ss_pred             cccchhhhhhh--ccccccchhhhhhhcccccCCCchhH----HHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          296 VGAEQNLVDWA--KPYLGDRRKLFRIMDIKLEGQYPQKG----AYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       296 ~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~----~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...    -.|-  .+-..-...+++-+...- -.+|+..    ......|+..++. ++.+|.++.+++++
T Consensus       296 g~d----CGWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  296 GAD----CGWDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             CCc----CCccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            211    0111  111111122333332111 1233322    2333445555555 99999999988763

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=298.38  Aligned_cols=266  Identities=25%  Similarity=0.332  Sum_probs=191.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|.+.+.||+|+||.||+|...         .++..||+|.+.... ......+.+|+.++++++|+||+++++++.
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHK---------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIR   73 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEc---------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence            3578999999999999999997654         347789999986432 223456788999999999999999999876


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..     ...|+||||+.+ +|.+++..   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          74 PPSFESFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             cccccccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEE
Confidence            44     357999999965 88887743   248999999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCc-cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          231 SDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       231 ~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      +|||++........ ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||........  ...+...
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~  225 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGV  225 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHH
Confidence            99999875432211 111223568999999998765 4688999999999999999999999964432110  0000000


Q ss_pred             cc-ccchhhhhhhccc-------ccC--CCc-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YL-GDRRKLFRIMDIK-------LEG--QYP-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~-~~~~~l~~~~~~~-------~~~--~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .. .....+..+....       ...  ..+     ......+..++..|+. +|++||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00 0000000000000       000  000     0112345677888887 99999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=289.23  Aligned_cols=200  Identities=29%  Similarity=0.427  Sum_probs=168.8

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      |++.+.||.|++|.||+|....         .+..+++|++.....  .....+.+|+++++.++|+||+++++++.+..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6788999999999999986543         467899999875432  22356788999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||++ ++|.+++.......+++..++.++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~  148 (283)
T cd07835          72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARA  148 (283)
T ss_pred             eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence            9999999995 699999876654568999999999999999999998  8999999999999999999999999999975


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ......  ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       149 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         149 FGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             cCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            432211  11233568899999988654 5788999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-36  Score=293.21  Aligned_cols=202  Identities=31%  Similarity=0.430  Sum_probs=167.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|....         ++..||+|.++.....  ....+.+|+.++++++|+||+++++++.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV   76 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence            4689999999999999999976543         4778999998644322  1234568999999999999999999987


Q ss_pred             cC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          156 DG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       156 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.  +..++||||+.+ +|.+++.... ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          77 GKHLDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             cCCCCeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcc
Confidence            55  568999999965 8988886543 458999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      |++........  ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         153 GLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             ceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99986543221  1122345788999999875 45789999999999999999999999744

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-36  Score=288.64  Aligned_cols=202  Identities=28%  Similarity=0.454  Sum_probs=169.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +|++.+.||.|++|.||+|....         ++..+|||.++..... ....+.+|+.++++++|+||+++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence            58889999999999999976543         4778999998765322 3456778999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            99999999975 8999886543 2458999999999999999999998  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      .......  ......++..|++||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5432211  11234578899999998664 46889999999999999999999997543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-36  Score=292.62  Aligned_cols=206  Identities=27%  Similarity=0.372  Sum_probs=167.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|...         .++..+|||.+......  ....+.+|+.++++++||||+++++++
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   80 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC   80 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence            3457999999999999999997644         34778999988643222  233467899999999999999999998


Q ss_pred             EcCC--------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          155 LDGE--------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       155 ~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      ....        ..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+  ++++|+||||+||+++.++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~  156 (310)
T cd07865          81 RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDG  156 (310)
T ss_pred             ecccccccCCCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCC
Confidence            7654        45999999964 8888875543 358999999999999999999998  8999999999999999999


Q ss_pred             cEEEcccCCcccCCCCCcc--ceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          227 NAKLSDFGLAKAGPTGDRT--HVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      .+||+|||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999764332211  111234578899999998764 47889999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-36  Score=290.18  Aligned_cols=202  Identities=27%  Similarity=0.378  Sum_probs=168.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|++|.||+|....         .++.+++|.+.....  .....+.+|++++++++|+||+++++++.+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            578999999999999999976542         467899999865432  223567889999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEcccCC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDFGL  235 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg~  235 (441)
                      ....++||||++ ++|.+++.......+++..+..++.||+.||+|||+  ++++|+||+|+||+++. ++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~  149 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGL  149 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEccccc
Confidence            999999999995 588888866555557888899999999999999998  89999999999999985 45799999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +.......  .......+++.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        150 ARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             ccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            97543221  112234578899999998764 5789999999999999999999999643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=334.28  Aligned_cols=262  Identities=32%  Similarity=0.523  Sum_probs=200.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ....|...++||+|+||.||+|....         .+..||||+++.....    ...|+++|++++||||++++++|.+
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            34568888999999999999986543         3678999998654321    1346889999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA-EQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      ....|+||||+++|+|.+++.     .+++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||.
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            999999999999999999984     278999999999999999999942 3799999999999999998887775 655


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ......      .....||+.|+|||++.+..++.++|||||||++|||+||+.||+... ........|.+..... ..
T Consensus       829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~-~~  900 (968)
T PLN00113        829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD-CH  900 (968)
T ss_pred             cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCc-cc
Confidence            443211      112367899999999999999999999999999999999999996432 2233445555432211 12


Q ss_pred             hhhhhcccccCC--CchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          316 LFRIMDIKLEGQ--YPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       316 l~~~~~~~~~~~--~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ....++..+...  .+......+..++..|+. +|++||+|+||++.|+++..
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            223333333222  222334446678888998 99999999999999987644

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-36  Score=289.78  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=190.6

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ...||+|+||.||+|....         .+..+|||++..........+.+|+.+++.++|+||+++++++...+..++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            4679999999999976543         4778999998655444556788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++...   .+++..+..++.|++.+|+|||+  .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            9999999999977432   47899999999999999999998  899999999999999999999999999887543221


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                      .  ......|+..|++||++.+..++.++|+||||+++|+|++|..||.............             ..+...
T Consensus       171 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-------------~~~~~~  235 (292)
T cd06657         171 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------------DNLPPK  235 (292)
T ss_pred             c--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hhCCcc
Confidence            1  1234568899999999988888999999999999999999999986432111100000             000000


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +.  ........+..++..|+. +|.+||++.+++++
T Consensus       236 ~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         236 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            00  011112234556677777 99999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-36  Score=290.18  Aligned_cols=202  Identities=27%  Similarity=0.372  Sum_probs=166.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|....         ++..||+|.++....  .....+.+|+.+++.+. |+||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            478999999999999999986543         467899998765422  22356788999999995 699999999988


Q ss_pred             cCCe-----eEEEEEeCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CC
Q 013557          156 DGEN-----RLLVYEYMPKGSLENHLFRRG---ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EF  226 (441)
Q Consensus       156 ~~~~-----~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~  226 (441)
                      ..+.     .|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||+  ++|+||||||+||+++. ++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~  148 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKG  148 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCC
Confidence            7665     8999999986 8999886543   2458999999999999999999998  89999999999999998 88


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .+||+|||+++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus       149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999875432211  1122356889999999865 45789999999999999999999999643

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.7e-36  Score=285.44  Aligned_cols=242  Identities=26%  Similarity=0.361  Sum_probs=181.6

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHH---HHHhcCCCCCcccEEEEEEcCCe
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEV---NYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      +||+|+||.||+|...         ..++.||+|.+.......   ...+..|.   .+++...||||+.+++++.+.+.
T Consensus         1 ~ig~g~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEe---------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            4899999999997543         347789999986543221   11233343   34555689999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .++||||+.|++|.+++....  .+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++...
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~  147 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence            999999999999999886543  58999999999999999999998  89999999999999999999999999998754


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ....    .....|+..|+|||++.++ .++.++|||||||++|+|++|+.||...........              ..
T Consensus       148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--------------~~  209 (278)
T cd05606         148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------------DR  209 (278)
T ss_pred             CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--------------HH
Confidence            3221    1234689999999999754 689999999999999999999999975422111100              00


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      ... ......+......+..++..|+. +|.+||     ++.++++.
T Consensus       210 ~~~-~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         210 MTL-TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             Hhh-ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            000 00111222223445566666776 999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-36  Score=286.02  Aligned_cols=198  Identities=31%  Similarity=0.396  Sum_probs=163.5

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCC-CCCcccEEEEEEcC-
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDG-  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~-  157 (441)
                      |++.+.||+|+||.||+|....         .+..+|+|+++.... .......+|+.++.++. |+||+++++++.+. 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            6778999999999999976543         467899999875422 22234567999999995 99999999999987 


Q ss_pred             -CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 -ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+  .+++||||||+||+++. +.+||+|||++
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~  146 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSC  146 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccc
Confidence             88999999996 58888886543 358999999999999999999998  89999999999999999 99999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +.......   .....++..|+|||++.. +.++.++|||||||++|||++|..||....
T Consensus       147 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         147 RGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             cccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            86433221   123457899999998754 457889999999999999999999997543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-36  Score=284.79  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=191.1

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||.|+||.||++....         ++..+++|.+.....   .....+.+|++++++++|+||+++++.+......|+|
T Consensus         1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            6899999999976543         467899999876543   3345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++.+..  .+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~  147 (265)
T cd05579          72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR  147 (265)
T ss_pred             EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence            99999999999987654  58999999999999999999998  899999999999999999999999999987543321


Q ss_pred             c------cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          244 R------THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       244 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      .      ........++..|++||.+.+..++.++||||||+++|+|++|+.||........   ..             
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~-------------  211 (265)
T cd05579         148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQ-------------  211 (265)
T ss_pred             ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------
Confidence            1      0122345678899999999888889999999999999999999999974431110   00             


Q ss_pred             hhhcccccCCCchhH--HHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          318 RIMDIKLEGQYPQKG--AYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~--~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      .+....  ...+...  ...+..++..|+. +|++||++.++.+.|+
T Consensus       212 ~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         212 NILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHhcCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            000000  0112221  3455677777777 9999999966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.1e-36  Score=286.11  Aligned_cols=255  Identities=26%  Similarity=0.324  Sum_probs=194.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      +|++.+.||+|+||.||++....      ....+..+|+|.++....    ...+.+.+|+.+|.++ +|+||+.+++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            58889999999999999986532      123477899999875322    2235678899999999 599999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      ..+...++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999999999997654  48899999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcC--CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG--RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ++......... ......|+..|+|||++.+.  .++.++||||||+++|+|++|..||........  ...        
T Consensus       151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~--------  219 (290)
T cd05613         151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAE--------  219 (290)
T ss_pred             cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHH--------
Confidence            99764332211 12245689999999998753  467899999999999999999999863221100  000        


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                         +...+... ....+......+..++..|+. +|++||     ++.++++.
T Consensus       220 ---~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         220 ---ISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---HHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence               00111000 111233344566778888888 999997     66777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=330.16  Aligned_cols=255  Identities=28%  Similarity=0.370  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..+-++.-...||.|.||.||.|...         .+|...|+|-++....  .....+.+|..+|..|+|||+|+++|+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~---------~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNL---------DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecC---------CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce
Confidence            34557777889999999999986543         4577889997764322  223457789999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      -.+.+..+|.||||++|+|.+.+....  -.++.....+..|++.|+.|||+  +|||||||||+||+++.+|.+|++||
T Consensus      1303 EvHRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             eecHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecc
Confidence            999999999999999999999885433  36777778899999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCc--cceeeeccCCCCcCchhhhhcC---CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          234 GLAKAGPTGDR--THVSTQVMGTRGYAAPEYLATG---RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       234 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      |.|........  .......+||+.|||||++.+.   .-..+.|||||||++.||+||++||...+.            
T Consensus      1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------------ 1446 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------------ 1446 (1509)
T ss_pred             cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------------
Confidence            99987544321  1122356899999999999864   356789999999999999999999863221            


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ...+..-+...-..+.|......-..++..|+. ||+.|-++.|+++.
T Consensus      1447 ----e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 ----EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                111111111122234455555666777888887 99999999888876

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=282.44  Aligned_cols=243  Identities=24%  Similarity=0.268  Sum_probs=184.0

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHh-cCCCCCcccEEEEEEcCCee
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLG-QLHHPNLVKLIGFCLDGENR  160 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~  160 (441)
                      +.||.|+||.||+|....         .++.+|+|.++.....   ....+..|..++. .++|+||+++++++.+.+..
T Consensus         2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            579999999999976532         4678999998754321   1233455555544 45899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                      |+||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+++...
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            99999999999999986543  58999999999999999999998  899999999999999999999999999987532


Q ss_pred             CCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       241 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      .      .....|+..|++||.+.+..++.++||||||+++|+|++|..||.........  ......            
T Consensus       149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~------------  208 (260)
T cd05611         149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF--DNILSR------------  208 (260)
T ss_pred             c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhc------------
Confidence            2      22346889999999998888899999999999999999999999643321100  000000            


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      ...............+..++..|+. +|++||++.++.+.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0000111111233456677777777 999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-36  Score=295.88  Aligned_cols=268  Identities=27%  Similarity=0.380  Sum_probs=193.3

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--CcccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GFQGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      ...++|.+.+.||+|+||.||+|....         .+..+|+|++...  .......+.+|+.+++++ +|+||+++++
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~   74 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN   74 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence            346789999999999999999986542         3678999988543  222345577899999999 9999999999


Q ss_pred             EEEcC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          153 FCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       153 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      +|...  ...++||||+. ++|.+++...   .+.+..++.++.||+.||.|||+  .+|+||||||+||+++.++.+||
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl  148 (337)
T cd07852          75 VIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKL  148 (337)
T ss_pred             eeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEE
Confidence            88643  46899999997 5999988553   58899999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCcc---ceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-hhhh
Q 013557          231 SDFGLAKAGPTGDRT---HVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-LVDW  305 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-~~~~  305 (441)
                      +|||++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ....
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~  228 (337)
T cd07852         149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV  228 (337)
T ss_pred             eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999864332211   12234568999999998765 457889999999999999999999996443221110 0010


Q ss_pred             hcccccc-c-----hhhhhhhccc-------ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          306 AKPYLGD-R-----RKLFRIMDIK-------LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       306 ~~~~~~~-~-----~~l~~~~~~~-------~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ....... .     .....++...       .....+. ....+..++..|++ +|++||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccC-CCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000 0     0000000000       0001111 23445667777777 99999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.1e-36  Score=289.42  Aligned_cols=200  Identities=22%  Similarity=0.227  Sum_probs=163.3

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--CcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      .+.+.+|.|+++.||++.           .+++.+|||+++..  .......+.+|+++++.++|+||+++++++.+.+.
T Consensus         5 ~i~~~~~~~~~v~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   73 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHK-----------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE   73 (314)
T ss_pred             hhhHhhcCCceEEEEEec-----------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence            344555555666565532           24778999998754  23345678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .+++|||+++++|.+++.......+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||.+...
T Consensus        74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceee
Confidence            9999999999999999987655568999999999999999999998  89999999999999999999999999988643


Q ss_pred             CCCCc-----cceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          240 PTGDR-----THVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       240 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .....     ........++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            22111     111223457788999999876  35889999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.1e-37  Score=278.73  Aligned_cols=210  Identities=26%  Similarity=0.347  Sum_probs=171.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..|++...||+|+||.||+|.-.+..     ..-...+|||+++.+..  .......+|+.+++.|+|+||+.+..+|.+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n-----~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTN-----DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCC-----cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            57999999999999999998543211     11144799999986522  223456789999999999999999998877


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC----CcE
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRRG---ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE----FNA  228 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~----~~~  228 (441)
                       +...+|++||.+. +|...|..+.   ...++...+..|+.||+.|+.|||+  +-|+||||||.|||+..+    |.|
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCee
Confidence             7889999999987 9999886432   2468899999999999999999999  889999999999999877    899


Q ss_pred             EEcccCCcccCCCCCccc-eeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          229 KLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ||+|||+++.+...-... ....++-|.+|.|||.+.|. .|+.+.||||+|||+.||||-++.|.....
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            999999999754322211 22345679999999999875 699999999999999999999999975543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-36  Score=286.41  Aligned_cols=250  Identities=27%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCC-CCCcccEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLH-HPNLVKLIGFC  154 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  154 (441)
                      ++|.+.+.||+|+||.||+|....         .+..+++|++.....   .....+.+|+.++++++ |+||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            478999999999999999986543         477899999875322   23456788999999998 99999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++|||++++++|.+++.+..  .+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCc
Confidence            99999999999999999999997654  59999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCcc------------------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          235 LAKAGPTGDRT------------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       235 ~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ++.........                  .......|+..|+|||++.+..++.++||||||+++|++++|+.||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            98754332210                  122334678999999999888899999999999999999999999974431


Q ss_pred             ccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH----HHHHHH
Q 013557          297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM----SEVLSA  359 (441)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~----~evl~~  359 (441)
                      ..                .+..+.  ......+......+..++..|+. +|.+||++    ++++..
T Consensus       228 ~~----------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         228 YL----------------TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HH----------------HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            10                000111  01112233334556777788887 99999999    777643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-36  Score=294.25  Aligned_cols=265  Identities=24%  Similarity=0.332  Sum_probs=193.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|...         .++..||||.+....  ......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS---------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec---------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            467999999999999999997643         357789999987532  223456778999999999999999999876


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..     ...|+||||+. ++|.+++....  .+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEE
Confidence            44     34799999995 68999886543  58999999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhhcc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWAKP  308 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~~  308 (441)
                      +|||+++......  .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... ......
T Consensus       150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  227 (337)
T cd07858         150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS  227 (337)
T ss_pred             CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999998653322  12234567889999999865 4688999999999999999999999965432111100 000000


Q ss_pred             ccc------cchhhhhhhcc-------cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLG------DRRKLFRIMDI-------KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~------~~~~l~~~~~~-------~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...      ........+..       ......+ .....+..++..|+. +|++||+++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP-HANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHHHHcc-cCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000      00000000000       0000111 123445677888887 99999999999977

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.3e-36  Score=293.45  Aligned_cols=268  Identities=22%  Similarity=0.304  Sum_probs=194.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|...         .++..|++|++....  ......+.+|+.+|++++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   74 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDT---------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR   74 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence            378999999999999999997544         347789999987542  233456788999999999999999999876


Q ss_pred             c----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          156 D----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       156 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      .    ....++||||+. ++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+||+++.++.+||+
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          75 PPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             ccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEec
Confidence            3    356899999995 58999885443  48999999999999999999998  899999999999999999999999


Q ss_pred             ccCCcccCCCCCc--cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh--h
Q 013557          232 DFGLAKAGPTGDR--THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--A  306 (441)
Q Consensus       232 DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~--~  306 (441)
                      |||++........  ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..............  .
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            9999875432221  111234578999999999865 4588999999999999999999999965432211110000  0


Q ss_pred             ccccc-----cchhhhhhhcccc-cCCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLG-----DRRKLFRIMDIKL-EGQY-----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~-----~~~~l~~~~~~~~-~~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+...     ....+.+...... ....     .......+..++..|++ +|++||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000     0000111111000 0000     01123446667777777 99999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.8e-36  Score=284.54  Aligned_cols=258  Identities=25%  Similarity=0.326  Sum_probs=195.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      +|++.+.||+|+||.||++....      ....+..+|||.++....    .....+.+|+.++.++ +|+||+++++.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            47888999999999999986432      223467899999865321    2234578899999999 599999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      ......++||||+++++|.+++....  .+++..+..++.|++.+|.|||+  .+++||||||+||+++.++.++|+|||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECc
Confidence            99999999999999999999986543  58899999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCC--CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      +++........ ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||........  ...+..     
T Consensus       151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~-----  222 (288)
T cd05583         151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISR-----  222 (288)
T ss_pred             ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHH-----
Confidence            98764332211 122346899999999987654  78899999999999999999999863221100  000000     


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                           .... . ....+......+..++..|+. +|++||++.++.+.|+.
T Consensus       223 -----~~~~-~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 -----RILK-S-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----HHHc-c-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 0000 0 011222233445667777777 99999999888777753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=283.84  Aligned_cols=271  Identities=28%  Similarity=0.411  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhc--CCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ--LHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~  156 (441)
                      ....+.++||+|.||.||+|.+.           ++.||||++..   ++.+.|..|-+|.+.  ++|+||+++++.-..
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence            34566788999999999998765           46899999974   456678888888665  489999999988655


Q ss_pred             CC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHh-------cCCCeEEeccCCCcEEECCC
Q 013557          157 GE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE-------AEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       157 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~-------~~~~ivH~Dlkp~Nill~~~  225 (441)
                      ..    .++||+||.+.|+|.+||..+.   ++|....+++..+++||+|||+       ++..|+|||||..|||+..+
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence            44    7899999999999999997765   8999999999999999999997       23579999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC-CC-----chhhhHHHhHHHHHHHhCCCCCCccccccc
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LT-----AKCDVYSFGVVLLELLSGRRAVDKTRVGAE  299 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlG~il~elltg~~pf~~~~~~~~  299 (441)
                      +.+.|+|||+|..+..+....-.-..+||.+|||||++.+.- +.     .+.||||+|.+||||+++..-++.......
T Consensus       353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y  432 (534)
T KOG3653|consen  353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY  432 (534)
T ss_pred             CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence            999999999998765544433344578999999999998642 22     268999999999999998765532221111


Q ss_pred             hhhhhhhccccccchhhhhh-hcccccCCCch-----hHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          300 QNLVDWAKPYLGDRRKLFRI-MDIKLEGQYPQ-----KGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~-----~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      +-..+..-...+..+++.+. +.+..+..++.     .....+...+..||. |++.|.|+.=+.+++.++.-.
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            11111000000011111111 11112222222     334556778889998 999999999988888766543

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.2e-36  Score=286.57  Aligned_cols=205  Identities=30%  Similarity=0.386  Sum_probs=168.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||.||+|....         .+..+++|.++....  .....+.+|++++++++||||++++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~   74 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI   74 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence            456789999999999999999987643         367899999865432  223457789999999999999999999


Q ss_pred             EEcCC----------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          154 CLDGE----------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       154 ~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      +.+..          ..++||||+++ +|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||||+||+++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~  150 (302)
T cd07864          75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLN  150 (302)
T ss_pred             ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEC
Confidence            87654          78999999976 787777544 3358999999999999999999998  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +++.+||+|||++......... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999765432211 11223467889999988653 5788999999999999999999999744

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-36  Score=283.76  Aligned_cols=264  Identities=27%  Similarity=0.353  Sum_probs=195.6

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      |.+.+.||.|++|.||+|...         ..+..+++|.++.....  ....+.+|+.+|++++|+||+++++++....
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK---------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcC---------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            677889999999999997653         24778999998765333  3456788999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||.+..
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~  147 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARS  147 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence            99999999975 8988886644 468999999999999999999998  8999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhh-hhccccccchh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVD-WAKPYLGDRRK  315 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~-~~~~~~~~~~~  315 (441)
                      .....  .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......... .... ...+.......
T Consensus       148 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd05118         148 FGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK  225 (283)
T ss_pred             cCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence            54332  112234578899999999876 7899999999999999999999999654321110 0000 00000000000


Q ss_pred             hhh---hhccccc-------CCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFR---IMDIKLE-------GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~---~~~~~~~-------~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +..   .......       ..........+..++..|+. +|.+||++.+++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            000   0000000       00011234456678888888 99999999999764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=285.73  Aligned_cols=201  Identities=29%  Similarity=0.418  Sum_probs=168.8

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC-
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG-  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  157 (441)
                      |++.+.||.|+||.||+|....         .+..+++|.+....  ......+.+|+.+++.++|+|++++++++.+. 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6778999999999999986543         36789999997653  23345688999999999999999999999888 


Q ss_pred             -CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 -ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       ...++||||+++ +|.+++.... ..+++..++.++.||+.||+|||+  .+++|+||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~  147 (287)
T cd07840          72 KGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLA  147 (287)
T ss_pred             CCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccce
Confidence             899999999975 8988886543 368999999999999999999998  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            865433211 1223456888999998765 457899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.9e-36  Score=286.14  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=189.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..         .++.+|||.++.... .....+..|+.++.++ .|+||+++++++.
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            4678999999999999999986643         367899999875432 2334567788777777 4999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ ..+|+||||+|+||+++.++.+||+|||+
T Consensus        85 ~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          85 TDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             cCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            9999999999985 47877765533 368999999999999999999996 25899999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCC----CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR----LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      +........   .....++..|+|||++.+..    ++.++||||||+++|+|++|+.||...... ...+.        
T Consensus       162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~--------  229 (296)
T cd06618         162 SGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLT--------  229 (296)
T ss_pred             chhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHH--------
Confidence            875432211   12335788999999987553    788999999999999999999999642211 00000        


Q ss_pred             cchhhhhhhcccccC-CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEG-QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            .++...... .........+..++..|+. +|++||++.++++.
T Consensus       230 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 ------KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ------HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  111100000 0011123446677788887 99999999999866

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-36  Score=292.80  Aligned_cols=271  Identities=27%  Similarity=0.347  Sum_probs=198.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|++.+.||.|+||.||+|....         .+..++||++....  ....+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            58899999999999999976542         36789999987643  23456788999999999999999999998877


Q ss_pred             C-----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          158 E-----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       158 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .     ..|+||||+. ++|.+++....  .+++..++.++.|++.||.|||+  .||+||||||+|||++.++.++|+|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcc
Confidence            5     7899999997 48998886543  69999999999999999999998  8999999999999999999999999


Q ss_pred             cCCcccCCCCCc-cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhhccc
Q 013557          233 FGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWAKPY  309 (441)
Q Consensus       233 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~  309 (441)
                      ||++........ ........++..|+|||++.+. .++.++||||||+++|+|++|+.||........... .......
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  226 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP  226 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence            999986543321 0112334678899999999887 789999999999999999999999975542211110 1100000


Q ss_pred             cc------cchhhhhhhcc-------cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH--hhcCCC
Q 013557          310 LG------DRRKLFRIMDI-------KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA--LEQLPP  365 (441)
Q Consensus       310 ~~------~~~~l~~~~~~-------~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~--L~~l~~  365 (441)
                      ..      ........+..       ......+. ....+..++..|+. +|.+||++++++..  ++++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhccc-CCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            00      00000000000       00000111 23345667777777 99999999999975  444333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=278.80  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=197.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      -++|+++++||+|+|++|.++         ..+++.+.+|+|+++++-..+   +.-...|-.+.... +||.+|.++.+
T Consensus       249 l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             cccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence            468999999999999999874         445578899999998764433   33456787887777 79999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |.++..+++|.||++||+|-=++.+..  .++++.+..+..+|+.||.|||+  +||++||||.+|||+|.+|++||+|+
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeeccc
Confidence            999999999999999999977775544  49999999999999999999999  99999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++..-..  .....+++|||.|.|||++++..|+..+|+|+|||+++||+.|+.||+....+.         +..+.+
T Consensus       396 gmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n---------~d~nte  464 (593)
T KOG0695|consen  396 GMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN---------PDMNTE  464 (593)
T ss_pred             chhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC---------cccchh
Confidence            999864322  224568899999999999999999999999999999999999999998654332         112222


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP  351 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP  351 (441)
                      ..++.++.... ...|........-+.+..+. ||++|.
T Consensus       465 dylfqvilekq-iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  465 DYLFQVILEKQ-IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHHHHhhhc-ccccceeehhhHHHHHHhhcCCcHHhc
Confidence            33333333211 12343334444555666666 898874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=282.39  Aligned_cols=262  Identities=26%  Similarity=0.296  Sum_probs=190.7

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcC---CCCCcccEEEEEE
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQL---HHPNLVKLIGFCL  155 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~~  155 (441)
                      |++.+.||+|+||.||+|....         .+..+|+|.++.....  ....+.+|+.+++++   +|+||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6778999999999999987643         3678999999754222  123466788777666   5999999999998


Q ss_pred             cCCe-----eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DGEN-----RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..+.     .+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.+||
T Consensus        72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEE
Confidence            8776     9999999965 89998876554468999999999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||++........   .....++..|+|||++.+..++.++|||||||++|+|++|..||.......  .+..+.....
T Consensus       149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~  223 (287)
T cd07838         149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIG  223 (287)
T ss_pred             eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcC
Confidence            99999876533221   123357889999999998899999999999999999999999987543211  1111100000


Q ss_pred             c--------cchhhhhhhcccccC---CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 G--------DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~--------~~~~l~~~~~~~~~~---~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .        ...............   .........+..++..|+. ||++||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0        000000000000000   0011223445667788887 99999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-35  Score=285.83  Aligned_cols=248  Identities=29%  Similarity=0.387  Sum_probs=191.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      +.|...+.||+|+||.||+|....         .+..+++|.+.....   ....++.+|+++++.++|+|++++++++.
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   85 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence            447778899999999999986543         366899998864322   23456788999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      .....++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          86 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             cCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCccc
Confidence            9999999999996 58888775433 358999999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      +......      ....|+..|+|||++.   ...++.++|||||||++|+|++|+.||.......  ....+.      
T Consensus       162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~------  227 (308)
T cd06634         162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA------  227 (308)
T ss_pred             ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHHh------
Confidence            8754321      2346889999999985   3567889999999999999999999986432110  000000      


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                              ...............+..|+..|+. +|++||++.++++...
T Consensus       228 --------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         228 --------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             --------hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                    0000111122234456778888887 9999999999987743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.5e-36  Score=290.65  Aligned_cols=204  Identities=26%  Similarity=0.392  Sum_probs=166.7

Q ss_pred             hcCCC-CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--------------HHHHHHHHHHHhcC
Q 013557           78 TRNFR-PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--------------HKEWLSEVNYLGQL  142 (441)
Q Consensus        78 ~~~y~-~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l  142 (441)
                      .++|. +.+.||.|+||+||+|...         ..++.||||+++......              ...+.+|+++++.+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   77 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI   77 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence            45675 4578999999999997643         247789999986543221              12467899999999


Q ss_pred             CCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       143 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      +|+||+++++++...+..++||||+. ++|.+++....  .+++..+..++.|++.||.|||+  .+|+|+||||+||++
T Consensus        78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill  152 (335)
T PTZ00024         78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFI  152 (335)
T ss_pred             CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEE
Confidence            99999999999999999999999996 59999886543  48999999999999999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCC------------ccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCC
Q 013557          223 DSEFNAKLSDFGLAKAGPTGD------------RTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRR  289 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~  289 (441)
                      +.++.+||+|||++.......            .........++..|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999987543110            01111223568899999998764 46889999999999999999999


Q ss_pred             CCCccc
Q 013557          290 AVDKTR  295 (441)
Q Consensus       290 pf~~~~  295 (441)
                      ||....
T Consensus       233 p~~~~~  238 (335)
T PTZ00024        233 LFPGEN  238 (335)
T ss_pred             CCCCCC
Confidence            997543

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.5e-35  Score=284.68  Aligned_cols=244  Identities=30%  Similarity=0.428  Sum_probs=188.9

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      |...+.||+|+||.||+|....         .+..+++|.+.....   .....+.+|+++++.++|+|++++++++.+.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            6677889999999999976532         467899999864332   2235678899999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...|+||||+. ++|.+++.... .++++..+..++.|++.+|.|||+  .|++|+||+|+||+++.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~  169 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSAS  169 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCc
Confidence            99999999996 58888775443 458999999999999999999998  899999999999999999999999999886


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ....      .....|+..|+|||++.   +..++.++|||||||++|+|++|..||.........              
T Consensus       170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~--------------  229 (313)
T cd06633         170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------------  229 (313)
T ss_pred             ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH--------------
Confidence            4322      12456889999999984   456888999999999999999999998643211100              


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ..+................+..++..|++ +|++||++.+++..
T Consensus       230 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         230 --YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00000000000111122345677888887 99999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.9e-36  Score=279.69  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCC---CC--cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP---EG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      +|.+.+.||+|+||.||++.....         +..+++|.++.   ..  ......+..|+.++++++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            588899999999999999865431         22344444432   11  12234567899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .+....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+  .+++|+||||+||+++. +.+||+|
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecc
Confidence            9999999999999999999988642  33468999999999999999999998  89999999999999975 5699999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||++........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......   .          
T Consensus       149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~----------  213 (260)
T cd08222         149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---V----------  213 (260)
T ss_pred             cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---H----------
Confidence            999876433221  2234568899999999988888999999999999999999999986332110   0          


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         ...+.. ......+......+..++..|+. +|++||++.++++.
T Consensus       214 ---~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         214 ---VLRIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ---HHHHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence               001111 11111233334456667777777 99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=283.80  Aligned_cols=263  Identities=26%  Similarity=0.394  Sum_probs=193.1

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCC-CCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  158 (441)
                      |.+.+.||+|+||.||+|....         .+..++||.+...... ......+|+..+.+++ |+||+++++++.+++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6788999999999999987643         3668999998654322 2234567999999998 999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+ +++|.+++.......+++..+..++.|++.+|.|||+  ++++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~  148 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLARE  148 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence            999999999 7899999877654568999999999999999999998  8999999999999999999999999999976


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhhccccc----c
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWAKPYLG----D  312 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~----~  312 (441)
                      .....   ......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||......... ....+......    .
T Consensus       149 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07830         149 IRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE  225 (283)
T ss_pred             ccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence            43321   1123467889999998854 45789999999999999999999999654321110 00010000000    0


Q ss_pred             chhhhhhhccc--------ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIK--------LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~--------~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...+...+...        .....+.. ...+..++..|+. +|++||++.|++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         226 GYKLASKLGFRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             HhhhhccccccccccccccHHHHcccC-CHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000        00001111 3446677788887 99999999999754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-35  Score=289.18  Aligned_cols=204  Identities=25%  Similarity=0.338  Sum_probs=163.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      +|++.+.||+|+||.||++.....       ..+..+|+|.+.....  ...+.+.+|+.+++++ +|+||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            478889999999999999865431       1156899999865322  2245678899999999 59999999987543


Q ss_pred             C----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          157 G----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       157 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .    ...+++|||+. ++|.+++...  ..+++..++.++.||+.||.|||+  .||+||||||+|||++.++.+||+|
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCc
Confidence            2    45788999985 6899988543  358999999999999999999998  8999999999999999999999999


Q ss_pred             cCCcccCCCCCcc--ceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          233 FGLAKAGPTGDRT--HVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       233 Fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            9999754322111  11223568999999998865 468999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-36  Score=287.58  Aligned_cols=205  Identities=30%  Similarity=0.435  Sum_probs=165.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||.|+||.||+|....         .+..+++|++......  ....+.+|++++++++|+||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            4789999999999999999976543         4678999988643222  2345678999999999999999999875


Q ss_pred             cCC--------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 DGE--------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +..        ..++||||+.+ +|.+.+.... ..+++..+..++.|+++||.|||+  ++|+|+||||+||+++.++.
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGI  153 (311)
T ss_pred             cccccccccCceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence            433        46999999965 7877775433 359999999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCcc---------ceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 AKLSDFGLAKAGPTGDRT---------HVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +||+|||+++........         .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999754322111         111234578899999988654 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-35  Score=290.06  Aligned_cols=205  Identities=27%  Similarity=0.388  Sum_probs=170.2

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCc
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNL  147 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI  147 (441)
                      ...++..+.++|.+.+.||+|+||.||+|...         .++..||+|++.....  ...+.+.+|+.++++++|+||
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i   78 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV   78 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEc---------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc
Confidence            34456678899999999999999999997543         2477899999875422  224567889999999999999


Q ss_pred             ccEEEEEEcC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          148 VKLIGFCLDG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       148 v~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +++++++...      ...|++++++ +++|.+++...   .+++..+..++.|++.||+|||+  .+|+||||||+||+
T Consensus        79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl  152 (345)
T cd07877          79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLA  152 (345)
T ss_pred             cceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEE
Confidence            9999987643      3468888887 78998877543   48999999999999999999998  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ++.++.+||+|||+++.....     .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             EcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999998754221     223467899999999876 46889999999999999999999999643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-36  Score=294.77  Aligned_cols=204  Identities=29%  Similarity=0.392  Sum_probs=171.0

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      -|..++.||-|+||+|.+++-.+         +...+|.|.+++....   ....+..|-+||...+.+.||+||..|.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            45556789999999999965332         3557899998765432   23446789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+.+|+||+|++||++-.+|.+.+-  |.+..++.++.++..|++++|.  .|+|||||||+|||||.+|++||+|||++
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeecccc
Confidence            9999999999999999999987764  8899999999999999999998  99999999999999999999999999998


Q ss_pred             cc---------CCCCCccc-------------------------------eeeeccCCCCcCchhhhhcCCCCchhhhHH
Q 013557          237 KA---------GPTGDRTH-------------------------------VSTQVMGTRGYAAPEYLATGRLTAKCDVYS  276 (441)
Q Consensus       237 ~~---------~~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS  276 (441)
                      .=         +..++...                               .....+||+.|+|||++....|+..+|+||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            52         11111000                               011357999999999999999999999999


Q ss_pred             HhHHHHHHHhCCCCCCcccc
Q 013557          277 FGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       277 lG~il~elltg~~pf~~~~~  296 (441)
                      .|||||||+.|+.||-....
T Consensus       857 ~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCC
Confidence            99999999999999965443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-35  Score=312.37  Aligned_cols=147  Identities=30%  Similarity=0.386  Sum_probs=130.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|.+.+.||+|+||.||+|....         .++.||||+++.....   ....+..|+.+++.++|+||+++++++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   73 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL   73 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence            3679999999999999999986543         4678999998754322   235678899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      ......||||||+.|++|.+++....  .+++..++.++.||+.||+|||.  ++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          74 QSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             EECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            99999999999999999999986544  48899999999999999999998  899999999999999999999999999


Q ss_pred             Ccc
Q 013557          235 LAK  237 (441)
Q Consensus       235 ~a~  237 (441)
                      +++
T Consensus       150 ls~  152 (669)
T cd05610         150 LSK  152 (669)
T ss_pred             CCc
Confidence            886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=290.65  Aligned_cols=196  Identities=25%  Similarity=0.403  Sum_probs=163.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|...         .++..+|||++.....  .....+.+|+.+++.++|+||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDK---------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeC---------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            478999999999999999997653         3477899999865321  22345789999999999999999999987


Q ss_pred             cC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ..      ...++||||+.. +|.+++    ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             ccccCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEE
Confidence            54      346999999964 777654    2248999999999999999999998  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      |+|||+++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999998764321     123457889999999876 46889999999999999999999999754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=297.71  Aligned_cols=241  Identities=26%  Similarity=0.305  Sum_probs=194.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      +...|.+...+|.|+|+.|..+         .+..+++..++|++.+..    .+..+|+.++... +||||+++.+.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             cchhhccccccCCCCccceeee---------eccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence            4678999999999999999874         445567889999997652    2233578777666 7999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE-CCCCcEEEcccC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL-DSEFNAKLSDFG  234 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill-~~~~~~kl~DFg  234 (441)
                      +..+.|+|||.+.|+.|.+.+....   ....++..|+.+|+.|+.|||+  +|+|||||||+|||+ +..++++|+|||
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEec
Confidence            9999999999999999999886544   2337778899999999999998  999999999999999 588999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      .++.....     ..+.+-|..|.|||++....|++++||||||++||+||+|+.||.....+                 
T Consensus       462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------  519 (612)
T KOG0603|consen  462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------  519 (612)
T ss_pred             hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------
Confidence            99875443     22345688999999999999999999999999999999999999744322                 


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        .+++.....+.+..........|+.+|++ ||.+||+|.++...
T Consensus       520 --~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  520 --IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence              11222222222334455667788899998 99999999999765

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.1e-36  Score=292.02  Aligned_cols=203  Identities=25%  Similarity=0.369  Sum_probs=165.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|.+.+.||.|+||.||+|...         .++..|++|++........+.+.+|++++++++||||+++++++...
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~---------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS---------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC---------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            368999999999999999997654         34778999998766555667788999999999999999999776543


Q ss_pred             --------------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          158 --------------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       158 --------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                                    ...|+||||+. ++|.+++...   .+++..++.++.||+.||.|||+  .||+||||||+||+++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~  148 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFIN  148 (342)
T ss_pred             ccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEc
Confidence                          35789999996 5898887532   48899999999999999999998  8999999999999998


Q ss_pred             C-CCcEEEcccCCcccCCCCCc-cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          224 S-EFNAKLSDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       224 ~-~~~~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      . ++.+||+|||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5 55789999999875422111 111123357889999998754 467889999999999999999999996543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=302.06  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=211.4

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      .+..++||+|+||+||+|.|-..     ......+||||++.... .....+++.|+-+|.+|+|||+++++++|.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe-----ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE-----GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC-----CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            44568999999999999988653     23346689999986543 344677999999999999999999999998765 


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      +-||++|+++|.|.|++..+. ..+..+..+.|..||++||.|||.  +.+|||||-..|||+....++||.|||+++..
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            789999999999999997654 358899999999999999999998  89999999999999999999999999999986


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      .............-.+.|||=|.++...|+.++|||||||++||++| |..|++.....                 ++..
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~d  911 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPD  911 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhH
Confidence            65443322222334678999999999999999999999999999998 99998755432                 2333


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ++....+-..|+.+...+..++..||. |++.||+++++.+.+.+.
T Consensus       912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            333344445688888889999999998 899999999998887643

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=288.55  Aligned_cols=200  Identities=25%  Similarity=0.359  Sum_probs=167.4

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      ....++|.+.+.||+|+||.||+|...         .++..||||++.....  .....+.+|+.+|++++|+||+++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDR---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD   81 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEEC---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceee
Confidence            345788999999999999999997543         3477899999864322  22345789999999999999999999


Q ss_pred             EEEcCC------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          153 FCLDGE------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       153 ~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      ++....      ..++||||+ +++|.+++..   ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~  155 (343)
T cd07880          82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDC  155 (343)
T ss_pred             eecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCC
Confidence            987553      458999998 7799888753   248999999999999999999998  8999999999999999999


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .+||+|||++......     .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       156 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         156 ELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             CEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999764321     123467889999999876 45889999999999999999999999744

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.2e-35  Score=288.75  Aligned_cols=266  Identities=25%  Similarity=0.330  Sum_probs=193.2

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEE
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLI  151 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~  151 (441)
                      +..++++|.+.+.||.|+||.||+|...         .++..+|+|++.....  ...+.+.+|+.+++.++||||++++
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   75 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQ---------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS   75 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEEC---------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEe
Confidence            3456789999999999999999997544         3577899998764322  2345678899999999999999999


Q ss_pred             EEEEc-CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          152 GFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       152 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ++|.. ....++||||+ +++|.+++...   .+++..+..++.|++.||.|||+  .+|+||||+|+||+++.++.+||
T Consensus        76 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          76 DIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             eeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEe
Confidence            98865 56789999998 56898887532   47888899999999999999998  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hhhhhhhcc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QNLVDWAKP  308 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~  308 (441)
                      +|||++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..+..+...
T Consensus       150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  224 (328)
T cd07856         150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT  224 (328)
T ss_pred             CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998753221     123457889999999865 5689999999999999999999999964432110 000111000


Q ss_pred             cccc------chhhhhhhcc-cccCCCc-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGD------RRKLFRIMDI-KLEGQYP-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~------~~~l~~~~~~-~~~~~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ....      .......+.. ......+     ......+..++..|+. +|++||++.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000      0000000000 0000111     1123455667777887 99999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=291.08  Aligned_cols=196  Identities=29%  Similarity=0.429  Sum_probs=170.6

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  161 (441)
                      .++||.|.||+||-|.         +.++|+.||||++.+..+.  ....+++|+.||+++.||.||.+...|++.+..|
T Consensus       569 devLGSGQFG~VYgg~---------hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGK---------HRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecce---------ecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            5899999999999865         4457999999999876543  3456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---CcEEEcccCCccc
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGLAKA  238 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~~kl~DFg~a~~  238 (441)
                      +|||.+.| +..+.|.......+++.....++.||+.||.|||-  ++|+|.||||+|||+...   -.+||||||+|+.
T Consensus       640 VVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  640 VVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             EEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceee
Confidence            99999955 66665555445569999999999999999999998  999999999999999654   4699999999998


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      .....   +.+..+|||.|+|||+++++.|...-|+||+|||+|--|+|..||+..
T Consensus       717 IgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  717 IGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             cchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence            65433   456789999999999999999999999999999999999999999743

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.3e-36  Score=313.13  Aligned_cols=253  Identities=29%  Similarity=0.384  Sum_probs=183.0

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ...++|+.+++||+||||.||+++         .+-+|+.||||++.... ......+.+|+..|++|+|||||+++..+
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVR---------NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVR---------NKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEe---------ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            345678889999999999999954         44568999999997653 22345588999999999999999998433


Q ss_pred             EcC-----------------------------------------------------------------------------
Q 013557          155 LDG-----------------------------------------------------------------------------  157 (441)
Q Consensus       155 ~~~-----------------------------------------------------------------------------  157 (441)
                      .+.                                                                             
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            110                                                                             


Q ss_pred             ------------------------------------------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 013557          158 ------------------------------------------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG  195 (441)
Q Consensus       158 ------------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~  195 (441)
                                                                ..+||-||||+..+|.+++.++... -.....++++.+
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFre  705 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFRE  705 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHH
Confidence                                                      1247899999987777776555421 146778999999


Q ss_pred             HHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC----C------------CCccceeeeccCCCCcCc
Q 013557          196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP----T------------GDRTHVSTQVMGTRGYAA  259 (441)
Q Consensus       196 i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~----~------------~~~~~~~~~~~gt~~y~a  259 (441)
                      |++||.|+|+  .|||||||||.||++|.++.|||+|||++....    .            +......+..+||.-|+|
T Consensus       706 IlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  706 ILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            9999999998  899999999999999999999999999997621    0            111112345689999999


Q ss_pred             hhhhhcCC---CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccccc--CCCchhHHH
Q 013557          260 PEYLATGR---LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLE--GQYPQKGAY  334 (441)
Q Consensus       260 PE~~~~~~---~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~  334 (441)
                      ||++.+..   |+.|+|+||||+||+||+.   ||....   + +..           .+..+-+..+.  ..+....-.
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---E-Ra~-----------iL~~LR~g~iP~~~~f~~~~~~  845 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---E-RAS-----------ILTNLRKGSIPEPADFFDPEHP  845 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH---H-HHH-----------HHHhcccCCCCCCcccccccch
Confidence            99997654   9999999999999999986   354221   0 000           00011111111  112222233


Q ss_pred             HHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          335 MVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       335 ~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      ....++.++++ ||.+|||+.|+|.
T Consensus       846 ~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  846 EEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhh
Confidence            34556666776 9999999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=293.29  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .+++++..||-|+||.|-++.....         ...+|+|++++...   ...+.+..|-+||..++.|.||++|..|.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr  490 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR  490 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence            4667788999999999998765532         22478888876544   33456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....|+.||-|-||.|...|..++  .|.......++..+++|++|||+  +|||+|||||+|+|+|.+|.+||.|||+
T Consensus       491 d~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  491 DSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             cchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhh
Confidence            9999999999999999999997665  48999999999999999999999  9999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+....+..+   -+++|||.|.|||++.+...+.++|.||||+++||||+|.+||...+.-..-+             .
T Consensus       567 AKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-------------~  630 (732)
T KOG0614|consen  567 AKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-------------L  630 (732)
T ss_pred             HHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-------------H
Confidence            9987665543   46899999999999999999999999999999999999999998554211100             0


Q ss_pred             hhhhhcccccCCCchhHHHH-HHHHHHHHhcCCCCCCC-----HHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYM-VAILALQCISEAKVRPS-----MSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~-~~~l~~~c~~~P~~RPs-----~~evl~~  359 (441)
                      +..-++   .-.+|...... ..++...|-++|.+|..     +.+|-.+
T Consensus       631 ILkGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  631 ILKGID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             HHhhhh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            111111   12334444444 44455666669988865     5666544

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=276.91  Aligned_cols=200  Identities=31%  Similarity=0.473  Sum_probs=169.3

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      |++.+.||+|+||.||+|....         .+..+++|.+....  ......+..|+.++++++|+||+++++++.+..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            5677899999999999976543         47789999987653  223456788999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+. ++|.+++.... ..+++..++.++.+++.||.|||+  .+|+||||+|+||+++.++.+||+|||+++.
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~  147 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARA  147 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence            9999999997 59999997653 358999999999999999999998  8999999999999999999999999999876


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ......  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            433221  12234567889999998776 78999999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=272.27  Aligned_cols=236  Identities=30%  Similarity=0.390  Sum_probs=187.7

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      ||+|+||.||++....         .+..+++|.+......   ....+..|++++++++|+||+++++.+..+...++|
T Consensus         1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            6999999999976542         4678999998765332   345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD  243 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~  243 (441)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  147 (250)
T cd05123          72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG  147 (250)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence            99999999999996554  48999999999999999999998  899999999999999999999999999987643321


Q ss_pred             ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       244 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                        .......++..|++||.+.+...+.++|+||||+++|+|++|+.||.......   ..             ..+..  
T Consensus       148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~-------------~~~~~--  207 (250)
T cd05123         148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY-------------EKILK--  207 (250)
T ss_pred             --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH-------------HHHhc--
Confidence              12234568889999999988888999999999999999999999996443210   00             00000  


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHH
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSE  355 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~e  355 (441)
                      .....+......+..++..|+. ||++||++.+
T Consensus       208 ~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         208 DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1112233334455667777887 9999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-35  Score=290.07  Aligned_cols=199  Identities=27%  Similarity=0.396  Sum_probs=167.9

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|.+.+.||+|+||.||+|....         .+..+|+|++....  ......+.+|+.+++.++|+||++++++
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV   82 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHH
Confidence            456789999999999999999986643         46789999986532  2233567789999999999999999988


Q ss_pred             EEcCCe------eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          154 CLDGEN------RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       154 ~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +.....      .++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+  .||+||||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~  156 (343)
T cd07851          83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCE  156 (343)
T ss_pred             hhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCC
Confidence            766554      89999998 6799998854   348999999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +||+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999864332     223467889999999865 36788999999999999999999999644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=247.34  Aligned_cols=265  Identities=24%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +|.-.++||+|.||+||+|+..         .+...||+|.++.+...  -....++|+-+|+.|+|.|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfkarn~---------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccC---------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            4566788999999999997544         35779999998754322  234578999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ..+-+|+|||. .+|..+...-++ .++.+.+..++.|+++||.|+|+  ++++||||||.|.||+.+|.+||+|||+++
T Consensus        74 kkltlvfe~cd-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglar  149 (292)
T KOG0662|consen   74 KKLTLVFEFCD-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLAR  149 (292)
T ss_pred             ceeEEeHHHhh-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhh
Confidence            99999999995 489888755443 58999999999999999999999  899999999999999999999999999999


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhh--hccccccc
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDW--AKPYLGDR  313 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~--~~~~~~~~  313 (441)
                      .+...-.  -....+-|.+|.+|.++.|.. |+...|+||-|||+.|+.. |++.|.+.+.+....-+-|  ..+...+.
T Consensus       150 afgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             hcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence            7544321  122345689999999998765 7889999999999999976 7777876665443222111  11222222


Q ss_pred             hhhhhhhcccccCCCchh---------HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQK---------GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~---------~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+..+-|......+|..         ....-..|...++. +|..|.++++.++.
T Consensus       228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            333333333322223221         11112334444555 89999999887654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=276.17  Aligned_cols=209  Identities=25%  Similarity=0.382  Sum_probs=175.2

Q ss_pred             ccHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC--CCC
Q 013557           69 FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH--HPN  146 (441)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpn  146 (441)
                      +.+.......++|.+..++|+|+||.|-..+..+         .+..||||+++... .-.+..+-|+++|.++.  .|+
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~  148 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPN  148 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCC
Confidence            3444444568999999999999999999865443         36789999997642 22344567999999993  232


Q ss_pred             ----cccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          147 ----LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       147 ----Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                          +|.+.++|...++.|||+|.+ |.+++|+|..++..+++...+..++.|++++++|||+  .+++|.||||+|||+
T Consensus       149 g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILf  225 (415)
T KOG0671|consen  149 GKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILF  225 (415)
T ss_pred             CceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEE
Confidence                678888899999999999998 7799999999999999999999999999999999998  899999999999998


Q ss_pred             C--------------------CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHH
Q 013557          223 D--------------------SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLL  282 (441)
Q Consensus       223 ~--------------------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~  282 (441)
                      .                    .+..++|+|||.|++....     ...++.|..|.|||++.+-+++..+||||+||||+
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV  300 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence            2                    1335899999999863322     24567899999999999999999999999999999


Q ss_pred             HHHhCCCCCCccc
Q 013557          283 ELLSGRRAVDKTR  295 (441)
Q Consensus       283 elltg~~pf~~~~  295 (441)
                      ||.||...|....
T Consensus       301 ElytG~~LFqtHe  313 (415)
T KOG0671|consen  301 ELYTGETLFQTHE  313 (415)
T ss_pred             EeeccceecccCC
Confidence            9999999997554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=300.43  Aligned_cols=265  Identities=27%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      ..++..+.+.||.|.||.|++|........  .......||||.++..... +.+.+..|+++|+.+ .|+||+.++++|
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~--~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKA--LLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccc--cccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            344556777999999999999976532111  0123668999999865443 456789999999999 699999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcE
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRG------------A--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI  220 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Ni  220 (441)
                      ......++|+||+..|+|.+++..+.            .  ..++....+.++.||+.|++||++  .++|||||-..||
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARNV  449 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhhE
Confidence            99999999999999999999997655            0  138889999999999999999998  8999999999999


Q ss_pred             EECCCCcEEEcccCCcccCCCCCccceeeeccC--CCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccc
Q 013557          221 LLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG--TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVG  297 (441)
Q Consensus       221 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~  297 (441)
                      |+..+..+||+|||+++........... .-.|  ...|||||.+....|+.++|||||||+|||++| |..||..... 
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            9999999999999999965443332211 1122  345999999999999999999999999999999 7888864210 


Q ss_pred             cchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                       .              ..+.+.+...-+...|..+...+..+++.||+ +|++||++.++.+.|+.
T Consensus       528 -~--------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  528 -T--------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             -H--------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence             1              12222333344445677777788899999999 99999999999999876

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=271.10  Aligned_cols=252  Identities=27%  Similarity=0.381  Sum_probs=184.8

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCeeE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENRL  161 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  161 (441)
                      +..||.|+||+|++         ..++..|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..+
T Consensus        69 lg~iG~G~fG~V~K---------M~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNK---------MLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             HHHhcCCcchhhhh---------hhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            57899999999998         55666799999999987655 4556788898875554 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          162 LVYEYMPKGSLENHL---FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       162 lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      +.||+++ .+|..+.   ..-....+++..+-.|...++.||.||-. ...|||||+||+|||+|..|.+||||||++-.
T Consensus       140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            9999994 4665543   22233458888888999999999999987 47899999999999999999999999999875


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ....-   ..+.-.|...|||||.+..  ..|+.+|||||||++|||+.||+.|+..+....++ +..   ....+...+
T Consensus       218 Lv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq-l~~---Vv~gdpp~l  290 (361)
T KOG1006|consen  218 LVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ-LCQ---VVIGDPPIL  290 (361)
T ss_pred             HHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-HHH---HHcCCCCee
Confidence            43321   1233468899999999863  45899999999999999999999998755431111 100   000110000


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~evl~~  359 (441)
                      ..      ....-.....+...+..|+.+|-..||...++.+.
T Consensus       291 ~~------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LF------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cC------cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            00      00011123444555555555699999999998654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-34  Score=268.61  Aligned_cols=219  Identities=22%  Similarity=0.240  Sum_probs=172.0

Q ss_pred             cCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCC
Q 013557           90 GGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPK  169 (441)
Q Consensus        90 G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  169 (441)
                      |.||.||++..         ..+++.+|+|.++...     .+.+|...+....||||+++++++.+.+..++||||+++
T Consensus         4 g~~~~v~~~~~---------~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMD---------TRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEE---------ccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            88999999654         3457889999997643     223455555666799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceee
Q 013557          170 GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST  249 (441)
Q Consensus       170 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~  249 (441)
                      ++|.+++.+..  .+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||.+......     ..
T Consensus        70 ~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~  140 (237)
T cd05576          70 GKLWSHISKFL--NIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD  140 (237)
T ss_pred             CCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence            99999986654  48999999999999999999998  89999999999999999999999999987654322     12


Q ss_pred             eccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCc
Q 013557          250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYP  329 (441)
Q Consensus       250 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  329 (441)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.||.......            .      .    ......+
T Consensus       141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~------~----~~~~~~~  198 (237)
T cd05576         141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N------T----HTTLNIP  198 (237)
T ss_pred             cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c------c----ccccCCc
Confidence            3346778999999988889999999999999999999998875321100            0      0    0000112


Q ss_pred             hhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          330 QKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       330 ~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                      ......+..++..|++ ||++||++
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCC
Confidence            2233445667777887 99999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=269.14  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=193.2

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhc--CCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ--LHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~  153 (441)
                      ...++..+.+.||+|.||+||+|.|+           |..||||++...   +.+.+.+|.+|.+.  |+|+||+.+++.
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaa  273 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAA  273 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-----------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhc
Confidence            34577888999999999999999997           678999999753   45678889998876  499999999987


Q ss_pred             EEcC----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc------CCCeEEeccCCCcEEEC
Q 013557          154 CLDG----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA------EQQVIYRDFKASNILLD  223 (441)
Q Consensus       154 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------~~~ivH~Dlkp~Nill~  223 (441)
                      -..+    .+++||.+|-+.|+|+|||.++   .++....++++..++.||++||..      +..|.|||||..|||+.
T Consensus       274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             cccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            5433    2679999999999999999764   489999999999999999999962      24699999999999999


Q ss_pred             CCCcEEEcccCCcccCCCC--CccceeeeccCCCCcCchhhhhcCC----C--CchhhhHHHhHHHHHHHhCC-------
Q 013557          224 SEFNAKLSDFGLAKAGPTG--DRTHVSTQVMGTRGYAAPEYLATGR----L--TAKCDVYSFGVVLLELLSGR-------  288 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlG~il~elltg~-------  288 (441)
                      .+|.+.|+|+|+|......  ......+..+||-+|||||++...-    +  -..+||||||.++||+....       
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            9999999999999753222  1122234568999999999996532    1  23589999999999997643       


Q ss_pred             ---CCCCccccccchhhhhhhccccccchhhhhhhc----ccccCCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHH
Q 013557          289 ---RAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD----IKLEGQY-----PQKGAYMVAILALQCIS-EAKVRPSMSE  355 (441)
Q Consensus       289 ---~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----~~~~~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~e  355 (441)
                         .||.+.-.               ......++.+    ..++...     .......+..|++.||. +|..|-|+-.
T Consensus       431 ey~~Pyyd~Vp---------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr  495 (513)
T KOG2052|consen  431 EYQLPYYDVVP---------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR  495 (513)
T ss_pred             hhcCCcccCCC---------------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence               33321110               0011111111    1111111     23445567889999999 9999999999


Q ss_pred             HHHHhhcCC
Q 013557          356 VLSALEQLP  364 (441)
Q Consensus       356 vl~~L~~l~  364 (441)
                      |-..|.++.
T Consensus       496 iKKtl~~l~  504 (513)
T KOG2052|consen  496 IKKTLAKLS  504 (513)
T ss_pred             HHHHHHHHh
Confidence            988887665

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=274.48  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=191.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-ccc------HHHHHHHHHHHhcCCCCCcccE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQG------HKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~------~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      .++|.++.+||+|||++||+|+.-         .-.+.||||+-.... +.+      .+...+|.+|-+.|.||.||++
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl---------~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl  532 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDL---------TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL  532 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhccc---------chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence            357888899999999999997643         236789999864321 111      2345789999999999999999


Q ss_pred             EEEEE-cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---CC
Q 013557          151 IGFCL-DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EF  226 (441)
Q Consensus       151 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~~  226 (441)
                      |++|. +.+.+|-|+|||+|.+|.=||..+.  .+++.++..|+.||+.||.||......|||-||||.|||+-.   .|
T Consensus       533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence            99986 5678899999999999988886654  489999999999999999999987779999999999999954   47


Q ss_pred             cEEEcccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcC----CCCchhhhHHHhHHHHHHHhCCCCCCccccc
Q 013557          227 NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATG----RLTAKCDVYSFGVVLLELLSGRRAVDKTRVG  297 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltg~~pf~~~~~~  297 (441)
                      .+||+|||+++........     .......||.+|++||.+.-+    .++.++||||+|||+|++|.|+.||......
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            8999999999976554333     234456899999999988643    4688999999999999999999999744321


Q ss_pred             cchhhhhhhccccccchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                        +++....           .++. ...-.+|  .........+++.|+. .-++|-...++.
T Consensus       691 --QdILqeN-----------TIlk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 --QDILQEN-----------TILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             --HHHHhhh-----------chhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence              1111100           0111 1111222  2233455677888888 567788776664

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=288.76  Aligned_cols=254  Identities=27%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      .-+.-|++.++||+|.+|.||+++.         .++++..|+|+..... ...+++..|.++|+.+ .|||++.++++|
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~---------~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRH---------VKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEee---------eecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3456789999999999999999643         4467889999987654 3345677889999988 699999999998


Q ss_pred             E-----cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          155 L-----DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       155 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      .     .++.++||||||.||+..|++..-.+..+.|..+..|++.++.||.+||.  +.++|||||-.|||++.++.||
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEE
Confidence            6     35789999999999999999977667779999999999999999999998  8899999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-----CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhh
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-----RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~  304 (441)
                      |+|||.+......-  ....+.+|||.|||||++...     .|+..+|+||||++..||--|.+|+-+...-.      
T Consensus       164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------  235 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------  235 (953)
T ss_pred             Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------
Confidence            99999998643322  223467899999999999643     46789999999999999999999985432110      


Q ss_pred             hhccccccchhhhhhh-cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          305 WAKPYLGDRRKLFRIM-DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       305 ~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                .++.+. .+...-..|..-......++..|+. |-++||++.+++++
T Consensus       236 ----------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 ----------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                      011110 0111112233334445556666665 99999999998753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=261.33  Aligned_cols=269  Identities=23%  Similarity=0.312  Sum_probs=219.0

Q ss_pred             HHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCccc
Q 013557           71 FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      ..++.....++++..++-+|.||.||.|.|.+.    +.....+.+.+|.++....+ ....++.|.-.|..+.|||+..
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~  351 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS  351 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence            445555667889999999999999999988752    33334556778888755332 3456889999999999999999


Q ss_pred             EEEEEEc-CCeeEEEEEeCCCCCHHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          150 LIGFCLD-GENRLLVYEYMPKGSLENHLFR------RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       150 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      +.+++.+ ...+++++.+..-|+|..++..      +..+.++..+...++.|++.|++|||+  +++||.||...|.+|
T Consensus       352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVI  429 (563)
T ss_pred             eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhccee
Confidence            9998764 4577888999988999999961      233567888899999999999999999  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQN  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~  301 (441)
                      |+...+||+|=.+++...+.++............||++|.+.+..|+.++|||||||++|||+| |+.|+-..+.     
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-----  504 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-----  504 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-----
Confidence            9999999999999998777777776666667889999999999999999999999999999999 8888753321     


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                                  .++...+...-+-..|..+++.+..++.+||. +|++||+++++..-|..
T Consensus       505 ------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  505 ------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                        12223333344445577788889999999999 99999999999887754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-35  Score=258.02  Aligned_cols=272  Identities=24%  Similarity=0.322  Sum_probs=192.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +.|.-..+||+|.||+||+|.         .+..++.||+|++-.++  ..--...++|+++|..|.|+|++.++++|..
T Consensus        17 ~~yek~~kigqGtfgeVFkAr---------~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t   87 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKAR---------SKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHh---------hcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence            456667889999999999854         44567788888764322  2223456899999999999999999887653


Q ss_pred             --------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          157 --------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       157 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                              ...+|+||.+|+. +|..++.... ..++...+.+++.++..||.|+|+  ..|+|||+|++|+||+.+|.+
T Consensus        88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             ccCCcccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceE
Confidence                    3458999999977 8999885442 458999999999999999999998  889999999999999999999


Q ss_pred             EEcccCCcccCCCCCccce--eeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh
Q 013557          229 KLSDFGLAKAGPTGDRTHV--STQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW  305 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~  305 (441)
                      ||+|||+++.+...+....  .+..+-|.+|++||.+.| ..|+++.|||+-|||+.||+||.+.|.+........++..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            9999999986544332221  223456999999999987 4699999999999999999999998876543332222211


Q ss_pred             h-----cccccc--chhhhhhhccc--ccCCC--------chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          306 A-----KPYLGD--RRKLFRIMDIK--LEGQY--------PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       306 ~-----~~~~~~--~~~l~~~~~~~--~~~~~--------~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .     +...++  .-.+...+...  ..+.+        |-........|+..++. ||.+|+++.+++.+.-..
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            0     000011  01122222111  00000        11111233445555555 999999999998775433

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.6e-33  Score=290.09  Aligned_cols=204  Identities=21%  Similarity=0.279  Sum_probs=144.1

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEE---
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGF---  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~---  153 (441)
                      ..++|.+.+.||+|+||.||+|++.....     ..+..||||++.....  .+.+..|  .+....+.++..++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            45789999999999999999998754211     2367899998865321  1111111  1222222233222211   


Q ss_pred             ---EEcCCeeEEEEEeCCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHhHhcCCCeEE
Q 013557          154 ---CLDGENRLLVYEYMPKGSLENHLFRRGAR------------------PLPWTLRIKVAIGAARGLSFLHEAEQQVIY  212 (441)
Q Consensus       154 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH  212 (441)
                         ..+....++||||+.+++|.+++......                  ......+..++.||+.||+|||+  ++|+|
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiH  278 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVH  278 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence               24566889999999999999998654311                  01233456799999999999998  89999


Q ss_pred             eccCCCcEEECC-CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC----------------------CCC
Q 013557          213 RDFKASNILLDS-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG----------------------RLT  269 (441)
Q Consensus       213 ~Dlkp~Nill~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~  269 (441)
                      |||||+|||++. ++.+||+|||+++....... .......|++.|+|||++...                      .++
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            999999999986 57899999999985433221 123456789999999976432                      234


Q ss_pred             chhhhHHHhHHHHHHHhCCCCCC
Q 013557          270 AKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       270 ~~sDvwSlG~il~elltg~~pf~  292 (441)
                      .++|||||||+||||+++..+++
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCc
Confidence            56799999999999999877654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.5e-32  Score=253.54  Aligned_cols=236  Identities=31%  Similarity=0.422  Sum_probs=187.7

Q ss_pred             CceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-HHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCC
Q 013557           91 GFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPK  169 (441)
Q Consensus        91 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  169 (441)
                      +||.||+|....         .+..+++|++....... .+.+.+|++.+++++|+||+++++++......+++|||+.+
T Consensus         1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            589999987643         46789999998765444 67889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceee
Q 013557          170 GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST  249 (441)
Q Consensus       170 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~  249 (441)
                      ++|.+++.....  +++..++.++.+++.+|.+||+  .+++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        72 ~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~  144 (244)
T smart00220       72 GDLFDLLKKRGR--LSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT  144 (244)
T ss_pred             CCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence            999999865443  8899999999999999999998  899999999999999999999999999998654332   223


Q ss_pred             eccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCc
Q 013557          250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYP  329 (441)
Q Consensus       250 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  329 (441)
                      ...++..|++||++.+..++.++||||||+++|+|++|..||.....  ......              .+.........
T Consensus       145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~--------------~~~~~~~~~~~  208 (244)
T smart00220      145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFK--------------KIGKPKPPFPP  208 (244)
T ss_pred             cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHH--------------HHhccCCCCcc
Confidence            45688899999999888899999999999999999999999864211  111111              11111100000


Q ss_pred             hh--HHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          330 QK--GAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       330 ~~--~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      ..  ....+..++..|+. +|++||++.++++
T Consensus       209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00  23455667777887 9999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=241.24  Aligned_cols=206  Identities=25%  Similarity=0.374  Sum_probs=167.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      ...++...+..||+|+||.|-+         ..+...|+..|+|.++..- .+..++.++|+++..+. .+|.+|+++|.
T Consensus        43 V~ad~L~~i~elGrGayG~vek---------mrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa  113 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEK---------MRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA  113 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhh---------eeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence            3345566678899999999976         3445568999999987542 34456788999987766 79999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      ...+...++.||.++- +|..+-.+  ..+..+++..+-+|+..+++||.|||+ +..++|||+||+||||+.+|++|+|
T Consensus       114 ~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  114 LFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             hhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEc
Confidence            9999999999999954 77665432  233468999999999999999999998 4799999999999999999999999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhc----CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT----GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |||++-.+.+.-   ..+...|.-.|||||.+..    ..|+.++||||||+++.||.+++.||+.+.
T Consensus       192 DFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  192 DFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            999997654322   1122468889999999863    368999999999999999999999998544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=275.94  Aligned_cols=212  Identities=19%  Similarity=0.274  Sum_probs=154.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCccc-------ccccCCCccEEEEEEcCCCCcccHHH--------------HHHHH
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTL-------EAARPGVGMVIAVKKLKPEGFQGHKE--------------WLSEV  136 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~E~  136 (441)
                      .++|++.++||+|+||.||+|.......       .......++.||||+++.......++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            5689999999999999999997532110       11223446789999987543222222              33466


Q ss_pred             HHHhcCCCCCc-----ccEEEEEEc--------CCeeEEEEEeCCCCCHHHHHHhcCC----------------------
Q 013557          137 NYLGQLHHPNL-----VKLIGFCLD--------GENRLLVYEYMPKGSLENHLFRRGA----------------------  181 (441)
Q Consensus       137 ~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~----------------------  181 (441)
                      ..+.+++|.++     ++++++|..        ....+|||||+++++|.+++.....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766544     667776653        3568999999999999999864211                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchh
Q 013557          182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE  261 (441)
Q Consensus       182 ~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE  261 (441)
                      ..+++..+..++.|++.+|.|||+  .+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChh
Confidence            124567788999999999999998  899999999999999999999999999997543322111 11223578999999


Q ss_pred             hhhcCC--------------------CC--chhhhHHHhHHHHHHHhCCC-CCC
Q 013557          262 YLATGR--------------------LT--AKCDVYSFGVVLLELLSGRR-AVD  292 (441)
Q Consensus       262 ~~~~~~--------------------~~--~~sDvwSlG~il~elltg~~-pf~  292 (441)
                      ++....                    |+  .+.||||+||++|+|++|.. ||.
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            985432                    11  24799999999999999975 664

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=272.95  Aligned_cols=198  Identities=25%  Similarity=0.329  Sum_probs=169.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--------HHHHHHHHHHHhcCC---CCC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--------HKEWLSEVNYLGQLH---HPN  146 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---hpn  146 (441)
                      ..+|..++.||.|+||.|+++.++++         ...|+||.+.++..-.        .-.+-.|+.||..|+   |+|
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N  630 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN  630 (772)
T ss_pred             cccceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence            45789999999999999999776653         5579999987753311        112456999999997   999


Q ss_pred             cccEEEEEEcCCeeEEEEEeC-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          147 LVKLIGFCLDGENRLLVYEYM-PKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       147 Iv~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      |++++++|++++.+||+||-- +|-+|+++|..+.  .+++.++..|+.|++.|+++||+  .||||||||-+||.++.+
T Consensus       631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             hhhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecC
Confidence            999999999999999999974 6779999997655  48999999999999999999998  999999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCC
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      |-+||+|||.+.+...+.    ...++||..|.|||++.|..| +..-|||+||++||-++....||-
T Consensus       707 g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999997754432    346789999999999999887 556899999999999999988863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-31  Score=252.64  Aligned_cols=132  Identities=24%  Similarity=0.388  Sum_probs=115.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-----C---CCcccE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-----H---PNLVKL  150 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l  150 (441)
                      .+|.+.++||.|.|++||+++...         ..+.||+|+.+... .-.+..+.||++|++++     |   .+||+|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            789999999999999999987654         36789999997542 23455688999999883     3   369999


Q ss_pred             EEEEE----cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          151 IGFCL----DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       151 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ++.|.    ++.+.|||+|++ |.+|..+|.....+.++...+..|+.||+.||.|||. +.||||.||||+|||+
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLL  221 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeee
Confidence            99987    467999999999 7799999999888999999999999999999999998 5899999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-33  Score=277.32  Aligned_cols=244  Identities=28%  Similarity=0.413  Sum_probs=181.6

Q ss_pred             CCCCCeeeecCce-EEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCC
Q 013557           81 FRPDSLIGEGGFG-YVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGE  158 (441)
Q Consensus        81 y~~~~~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  158 (441)
                      |.-.+++|.|+.| .||+|.+.           ++.||||.+-.+.   .....+|+..|+.- +|||||++++.-.+.+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            3345678999887 57899876           6789999986543   23456899999988 5999999999988999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---C--CcEEEc
Q 013557          159 NRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---E--FNAKLS  231 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~--~~~kl~  231 (441)
                      ..||..|.|.. +|.|++...  ..........+.++.|++.||++||+  .+||||||||.||||+.   +  ..++|+
T Consensus       577 F~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  577 FLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             eEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEec
Confidence            99999999965 999999763  11111114567889999999999999  89999999999999976   3  468999


Q ss_pred             ccCCcccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhC-CCCCCccccccchhhhhhhccc
Q 013557          232 DFGLAKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG-RRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       232 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |||+++....+... ....+..||-+|+|||++....-+.++|||||||++|+.++| .+||......... ..      
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-Il------  726 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-IL------  726 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-hh------
Confidence            99999976543321 113356799999999999988888899999999999999996 8999754321110 00      


Q ss_pred             cccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                       .....+..     +   .+.... ....|+..++. +|..||++.+|+.
T Consensus       727 -~~~~~L~~-----L---~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 -TGNYTLVH-----L---EPLPDC-EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -cCccceee-----e---ccCchH-HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             00000000     0   011111 56677777777 9999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=6.3e-32  Score=233.91  Aligned_cols=197  Identities=22%  Similarity=0.341  Sum_probs=163.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      ..++|++.+.+|+|.|++||.|....         ++..++||++++.   ..+.+.+|++||..|. ||||++++++..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~  103 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVK  103 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence            45789999999999999999976432         3568999999875   3556788999999996 999999999987


Q ss_pred             cC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcEEEcc
Q 013557          156 DG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSD  232 (441)
Q Consensus       156 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~kl~D  232 (441)
                      +.  ..+.||+||+.+.+...+.     ..++...+..++.+++.||.|||+  .||+|||+||.|++||.. -.++|+|
T Consensus       104 Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  104 DPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             CccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeee
Confidence            64  4678999999887765543     247788899999999999999999  999999999999999975 4699999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +|+|.++..+....   -.+.+..|--||.+-. ..|+..-|+|||||+|..|+..+.||....
T Consensus       177 WGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  177 WGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             cchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            99999876654332   2345677889998864 568999999999999999999999996443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.7e-31  Score=253.66  Aligned_cols=220  Identities=22%  Similarity=0.255  Sum_probs=177.8

Q ss_pred             cccCCCCCccccHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHH
Q 013557           59 DILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY  138 (441)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~  138 (441)
                      .|-....+..+.+.  +...++|.+....|+|-|++|.+|.         +...|..||||++..+... .+.=+.|++|
T Consensus       414 NWdDaEGYYrv~ig--E~LD~RY~V~~~~GkGvFs~Vvra~---------D~~r~~~vAiKIIRnNE~M-~KtGl~Elei  481 (752)
T KOG0670|consen  414 NWDDAEGYYRVRIG--ELLDSRYEVQGYTGKGVFSTVVRAR---------DQARGQEVAIKIIRNNEVM-HKTGLKELEI  481 (752)
T ss_pred             CcccccceEEEehh--hhhcceeEEEeccccceeeeeeecc---------ccCCCCeeEEEEeecchHH-hhhhhHHHHH
Confidence            33333444444444  3456899999999999999999854         4445779999999876433 3344689999


Q ss_pred             HhcCC------CCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeE
Q 013557          139 LGQLH------HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVI  211 (441)
Q Consensus       139 l~~l~------hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~iv  211 (441)
                      |++|+      .-|+++++-.|...+++|||+|-+ ..+|.++|.+.+. ..+....+..++.|+..||..|-.  .||+
T Consensus       482 LkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~--c~vl  558 (752)
T KOG0670|consen  482 LKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK--CGVL  558 (752)
T ss_pred             HHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh--cCee
Confidence            99995      247999999999999999999998 5699999987654 468889999999999999999998  8999


Q ss_pred             EeccCCCcEEECCC-CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCC
Q 013557          212 YRDFKASNILLDSE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       212 H~Dlkp~Nill~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      |.||||+|||+++. ..+||||||.|........+    ...-+..|.|||++.|..|+...|+||+||+||||.||+..
T Consensus       559 HaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  559 HADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             ecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence            99999999999886 45899999999875443322    22345679999999999999999999999999999999999


Q ss_pred             CCccccc
Q 013557          291 VDKTRVG  297 (441)
Q Consensus       291 f~~~~~~  297 (441)
                      |.+....
T Consensus       635 FpG~TNN  641 (752)
T KOG0670|consen  635 FPGRTNN  641 (752)
T ss_pred             cCCCCcH
Confidence            9765433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=244.04  Aligned_cols=202  Identities=28%  Similarity=0.452  Sum_probs=166.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--CcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +.+..+.||-|+||.||.         +.+..+|+.|++|++...  +....+++.+|++.|..++|.|++..+++..-.
T Consensus        54 Di~PDRPIGYGAFGVVWs---------VTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp  124 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWS---------VTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA  124 (449)
T ss_pred             cCCCCCcccccceeEEEe---------ccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence            566789999999999997         556677999999998653  223456789999999999999999988875432


Q ss_pred             -----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          158 -----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       158 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                           +..|++.|.+.. +|...|.  ..+.++...+.-++.||++||+|||+  .+|+||||||.|.|++.|..+||+|
T Consensus       125 h~dfFqEiYV~TELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICD  199 (449)
T KOG0664|consen  125 NPSFFQELYVLTELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICD  199 (449)
T ss_pred             CchHHHHHHHHHHHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecc
Confidence                 245788888854 8887774  34568888899999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ||+++.....+.. ..+..+-|..|.|||++.|. .|+.+.||||+|||+.|||..+..|...+.
T Consensus       200 FGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  200 FGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             cccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            9999976554433 23445668899999999874 689999999999999999999998875543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.4e-29  Score=225.49  Aligned_cols=210  Identities=37%  Similarity=0.553  Sum_probs=176.7

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYE  165 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  165 (441)
                      ||+|.+|.||++....         .+..+++|++...... ....+.+|+++++.++|++|+++++++......+++||
T Consensus         1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence            6899999999986543         3678999999866432 24678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEcccCCcccCCCCCc
Q 013557          166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDFGLAKAGPTGDR  244 (441)
Q Consensus       166 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg~a~~~~~~~~  244 (441)
                      ++.+++|.+++.... ..+++..++.++.+++.+|.+||+  .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus        72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~  148 (215)
T cd00180          72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS  148 (215)
T ss_pred             cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence            999999999986653 358999999999999999999998  89999999999999999 89999999999976433221


Q ss_pred             cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhccc
Q 013557          245 THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK  323 (441)
Q Consensus       245 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  323 (441)
                        ......+...|++||.+... .++.+.|+|+||+++++|                                       
T Consensus       149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------  187 (215)
T cd00180         149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------  187 (215)
T ss_pred             --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence              12234578899999999877 788999999999999998                                       


Q ss_pred             ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          324 LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       324 ~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                ..+..++..|+. +|++||++.++++.
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                      234455566666 99999999999865

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.9e-29  Score=230.61  Aligned_cols=200  Identities=36%  Similarity=0.481  Sum_probs=171.5

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      |.+.+.||.|++|.||+|....         .+..+++|.+...... ..+.+.+|++.+++++|+|++++++++.....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence            5678899999999999986643         3668999999876544 56778899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      .++++|++++++|.+++...... +++..+..++.+++.+|.+||+  .+++|+||+|.||+++.++.++|+|||.+...
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~  148 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFI  148 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence            99999999999999998664422 7899999999999999999998  89999999999999999999999999998865


Q ss_pred             CCCCccceeeeccCCCCcCchhhh-hcCCCCchhhhHHHhHHHHHHHhCCCCCCc
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGRRAVDK  293 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltg~~pf~~  293 (441)
                      ..... .......++..|++||.+ ....++.++|+|+||+++|+|++|+.||+.
T Consensus       149 ~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      149 HRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            43320 012345678899999998 666778899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-31  Score=237.96  Aligned_cols=196  Identities=27%  Similarity=0.349  Sum_probs=162.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--CcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..+|.-++.+|.|.- .|..         +.+...++.||+|++...  .....++..+|..++..++|+||++++.+|.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~---------a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft   85 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVA---------AFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT   85 (369)
T ss_pred             eeeeeeecccCCCCc-eEEe---------cchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence            356777888999988 4443         344556788999988654  2234566789999999999999999999986


Q ss_pred             c------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 D------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      -      ....|+|||++. .+|...+.-    .++-+.+..++.|++.|++|||+  .||+||||||+||++..+..+|
T Consensus        86 P~~~l~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lK  158 (369)
T KOG0665|consen   86 PQKTLEEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLK  158 (369)
T ss_pred             ccccHHHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhhee
Confidence            3      346799999995 599998862    26677889999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDK  293 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~  293 (441)
                      |.|||+++.....   -..+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+
T Consensus       159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            9999999863332   134456789999999999998899999999999999999999998873

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-31  Score=232.10  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=183.7

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEE-
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGF-  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-  153 (441)
                      ...+.|.+.+.||+|.||.+-++         .++.....+++|-+... ....++|.+|...--.| .|.||+.-+++ 
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va   90 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA   90 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence            34577999999999999999985         45556778999998765 34578899999887677 48999988874 


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-C-CcEEEc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-E-FNAKLS  231 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~-~~~kl~  231 (441)
                      |...+.++++|||++.|+|..-+...   ++.+.....++.|++.||.|+|+  +++||||||.+||||-. + -++|||
T Consensus        91 Fqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   91 FQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             hhcCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEee
Confidence            67778889999999999998877543   48899999999999999999999  99999999999999943 3 479999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-----CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-----RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      |||+.+....     .....--+..|.+||+....     ...+.+|||.||+++|.+|||+.||..... .....+.|.
T Consensus       166 DFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~  239 (378)
T KOG1345|consen  166 DFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWE  239 (378)
T ss_pred             ecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHH
Confidence            9999875332     12223346789999987532     246789999999999999999999984432 233333333


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCCCCHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSE  355 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~RPs~~e  355 (441)
                      +-.....        ..+...+......++..+.+.+..++++|--..+
T Consensus       240 ~w~~rk~--------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  240 QWLKRKN--------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             HHhcccC--------ccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence            2211110        1222333334444555555555557888744433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=260.05  Aligned_cols=248  Identities=26%  Similarity=0.346  Sum_probs=198.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|.++.++|.|+||.||++         +++..+...|+|+++.+...+..-+.+|+-+++..+||||+.+++.+...
T Consensus        14 ~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             ccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            468999999999999999995         45556888999999988777777788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++.||||.||+|.+.-+  ...++++.++...++..+++|+|||+  .|-+|||||-.|||+++.|.+||.|||.+-
T Consensus        85 dklwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             cCcEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchh
Confidence            99999999999999999653  34479999999999999999999998  899999999999999999999999999987


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhh---hcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYL---ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      .+...-  .....+.||+.|||||+.   +.+.|...+|||++|++..|+---++|......  .+              
T Consensus       161 qitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr--------------  222 (829)
T KOG0576|consen  161 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MR--------------  222 (829)
T ss_pred             hhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HH--------------
Confidence            644322  224568999999999986   457899999999999999999887776432111  00              


Q ss_pred             hhhhhhcccc----cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          315 KLFRIMDIKL----EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       315 ~l~~~~~~~~----~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                       ...++.+..    .-..+..-......+++.|+- +|++||+++.+|
T Consensus       223 -~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  223 -ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             -HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence             011111110    111123334566778888887 999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.1e-28  Score=229.69  Aligned_cols=207  Identities=28%  Similarity=0.371  Sum_probs=169.2

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      +....+.|...++||.|.|++||+++....      ....+.||+|.+...  ....++..|++.|..+ .+.||+++.+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchh
Confidence            345667899999999999999999876541      234778999999765  3456788999999999 5999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcEEEc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLS  231 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~kl~  231 (441)
                      ++..++...+||||++..+..++...     ++..++..++..++.||.++|.  +|||||||||+|+|.+.. +.-.|+
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEE
Confidence            99999999999999999888887632     6688999999999999999998  999999999999999865 678999


Q ss_pred             ccCCcccC-----------------CC--CCc---------------c--------ceeeeccCCCCcCchhhhhc-CCC
Q 013557          232 DFGLAKAG-----------------PT--GDR---------------T--------HVSTQVMGTRGYAAPEYLAT-GRL  268 (441)
Q Consensus       232 DFg~a~~~-----------------~~--~~~---------------~--------~~~~~~~gt~~y~aPE~~~~-~~~  268 (441)
                      |||+|...                 ..  +..               .        .......||++|.|||++.. ...
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            99998710                 00  000               0        00112469999999999875 456


Q ss_pred             CchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          269 TAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       269 ~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +.++||||.|||++-+++++.||-...
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             CCccceeeccceeehhhccccccccCc
Confidence            889999999999999999999996443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.3e-28  Score=265.62  Aligned_cols=196  Identities=21%  Similarity=0.233  Sum_probs=135.1

Q ss_pred             hcCCC-CCcccEEEEE-------EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeE
Q 013557          140 GQLHH-PNLVKLIGFC-------LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVI  211 (441)
Q Consensus       140 ~~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~iv  211 (441)
                      +.++| .||..++++|       .+...++++||++ +++|.++|... ...+++..++.++.||+.||.|||+  +||+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS--QGIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            45556 5788888877       3334677889987 66999999643 3459999999999999999999998  8999


Q ss_pred             EeccCCCcEEECCC-------------------CcEEEcccCCcccCCCCCc--------------cceeeeccCCCCcC
Q 013557          212 YRDFKASNILLDSE-------------------FNAKLSDFGLAKAGPTGDR--------------THVSTQVMGTRGYA  258 (441)
Q Consensus       212 H~Dlkp~Nill~~~-------------------~~~kl~DFg~a~~~~~~~~--------------~~~~~~~~gt~~y~  258 (441)
                      ||||||+||||+..                   +.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999653                   4456666666653210000              00011245899999


Q ss_pred             chhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHH
Q 013557          259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAI  338 (441)
Q Consensus       259 aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  338 (441)
                      |||++.+..|+.++|||||||+||||++|..|+......    ...+..          ..+    ......... ....
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~----------~~~----~~~~~~~~~-~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRH----------RVL----PPQILLNWP-KEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHH----------hhc----ChhhhhcCH-HHHH
Confidence            999999999999999999999999999998886521100    000000          000    000000111 2234


Q ss_pred             HHHHHhc-CCCCCCCHHHHHH
Q 013557          339 LALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       339 l~~~c~~-~P~~RPs~~evl~  358 (441)
                      ++..|+. +|.+||++.||++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            5566777 9999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.3e-26  Score=202.89  Aligned_cols=163  Identities=26%  Similarity=0.207  Sum_probs=121.1

Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceee
Q 013557          170 GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST  249 (441)
Q Consensus       170 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~  249 (441)
                      |+|.+++..++ .++++.+++.++.|++.||.|||+  .+      ||+|||++.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            68999997543 459999999999999999999998  55      999999999999999  9998764332       


Q ss_pred             eccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccC--C
Q 013557          250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEG--Q  327 (441)
Q Consensus       250 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~  327 (441)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...+..+...           +......  .
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~  130 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNG-----------MPADDPRDRS  130 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHH-----------hccCCccccc
Confidence            125899999999999999999999999999999999999999643210 0111111000           0000000  0


Q ss_pred             CchhHHH--HHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          328 YPQKGAY--MVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       328 ~~~~~~~--~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      .+.....  .+..++..|+. +|++||++.++++++..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1112222  46778888888 99999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-25  Score=217.00  Aligned_cols=262  Identities=21%  Similarity=0.185  Sum_probs=192.5

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCC----CCcccEEEEE-
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH----PNLVKLIGFC-  154 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-  154 (441)
                      +|.+.+.||+|+||.||+|......        ...+|+|............+..|+.+|..+..    .++..+++.. 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            8999999999999999998654321        34688888765433322356778999888863    5899999998 


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-----CcEE
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-----FNAK  229 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-----~~~k  229 (441)
                      ..+...|+||+.+ |.+|.++........++...+..++.|++.+|+++|+  .|++||||||+|+++...     ..++
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEE
Confidence            5788899999998 8899998766665679999999999999999999998  999999999999999765     3599


Q ss_pred             EcccCCcccCC--CCCcc---ce---eeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          230 LSDFGLAKAGP--TGDRT---HV---STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       230 l~DFg~a~~~~--~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                      |.|||+++...  .....   ..   .....||..|+++.++.+...+.+.|+||++.++.+++.|..||..........
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            99999998322  11110   01   124569999999999999999999999999999999999999996443221111


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      .             +......................+...+-. +...+|....+...|.+...
T Consensus       248 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  248 K-------------FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             H-------------HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0             001000011100122223344445555554 78889999999888765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.8e-26  Score=221.98  Aligned_cols=170  Identities=18%  Similarity=0.125  Sum_probs=129.0

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-----cccHHHHHHHHHHHhcCCCCCccc
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-----FQGHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      ....++|.+.+.||+|+||+||+|.+...        .+..+|||++....     ....+.+.+|+++|++|+|+||+.
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~   85 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP   85 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc
Confidence            45567899999999999999999875431        25568999865331     112456889999999999999985


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc-CCCcEEECCCCcE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF-KASNILLDSEFNA  228 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl-kp~Nill~~~~~~  228 (441)
                      .+..   ....||||||++|++|.. +.  .   ..   ...++.+++.+|.|||+  +||+|||| ||+|||++.++.+
T Consensus        86 ~l~~---~~~~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         86 QLLA---TGKDGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             EEEE---cCCcEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCE
Confidence            3322   245799999999999963 21  1   11   14678899999999998  89999999 9999999999999


Q ss_pred             EEcccCCcccCCCCCccce------eeeccCCCCcCchhhhhcC
Q 013557          229 KLSDFGLAKAGPTGDRTHV------STQVMGTRGYAAPEYLATG  266 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  266 (441)
                      ||+|||+++..........      .....+++.|+|||.+...
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999986543221111      1356788999999998643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.7e-23  Score=201.06  Aligned_cols=201  Identities=36%  Similarity=0.543  Sum_probs=168.7

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCC-CcccEEEEEEc
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHP-NLVKLIGFCLD  156 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp-nIv~l~~~~~~  156 (441)
                      |.+.+.||.|+||.||++...            ..+++|.+.......   ...+.+|+.++..+.|+ +|+++++++..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            677889999999999997654            468899887654432   56789999999999988 79999999987


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEcccC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDFG  234 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFg  234 (441)
                      ....+++++++.+++|.+++..... ..+.......++.|++.++.|+|+  .+++||||||+||+++..+ .++++|||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccC
Confidence            7778999999999999976654432 258899999999999999999998  8999999999999999988 79999999


Q ss_pred             CcccCCCCCccc----eeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          235 LAKAGPTGDRTH----VSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       235 ~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +++.........    ......||..|++||.+.+   ..+....|+||+|++++++++|..||....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            998543332211    2356789999999999987   578889999999999999999999976443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-24  Score=196.54  Aligned_cols=203  Identities=21%  Similarity=0.279  Sum_probs=168.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  157 (441)
                      -+|++.++||+|.||+++.|..--         .+..||||.-....  +.-.+..|.+..+.| ..++|..++.|..++
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             ccceeccccccCcceeeecccccc---------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            379999999999999999986432         37799999875542  344566788888888 578999999888888


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-----cEEEcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-----NAKLSD  232 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-----~~kl~D  232 (441)
                      -+..||||++ |.+|+|+..-- ++.|+.+.+..+++|++.-++|+|+  +.+|+|||||+|+||...+     .+.|+|
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEe
Confidence            8999999998 88999976433 3459999999999999999999999  8999999999999996543     489999


Q ss_pred             cCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          233 FGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       233 Fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ||+|+.+.+....     ...+...||..||+-....|.+.+.+.|+=|||-++.+.|-|..||.+...
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            9999976543221     123456799999999999999999999999999999999999999986543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.8e-25  Score=195.83  Aligned_cols=249  Identities=21%  Similarity=0.319  Sum_probs=192.6

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--CcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +..+..+|.+...|+.|+|+|..           ..+++|+++-.  .....++|..|.-.|+.+.||||+.+++.|...
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp  259 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP  259 (448)
T ss_pred             hhhhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence            34556778889999999999974           34666766533  223446788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc--ccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS--DFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~--DFg~  235 (441)
                      .++.++..|++.|+|+..++....-..+..++.+++.+|++|++|||+.+.-|.---|....++||++.+.+|.  |--+
T Consensus       260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence            99999999999999999998877666788899999999999999999975445555799999999999877664  4222


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCC---chhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT---AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      +..         .....-.|.||+||.+...+-+   .++|+|||++++|||.|...||.....-+              
T Consensus       340 sfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--------------  396 (448)
T KOG0195|consen  340 SFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--------------  396 (448)
T ss_pred             eee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh--------------
Confidence            221         1123457899999999876543   47999999999999999999997443110              


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                       - -..+....++...|......+..|+.-|.. ||.+||.+..|+-.|+++.
T Consensus       397 -c-gmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  397 -C-GMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -h-hhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             0 012222345556677777778888888888 9999999999998888653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.5e-25  Score=228.95  Aligned_cols=251  Identities=21%  Similarity=0.271  Sum_probs=180.4

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcC-----CCCcccH-HHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ....++|.|++|.|+......         ....++.|..+     ....... ..+..|+.+-..|.|+|++..+..+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~---------~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS---------DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             CccceeeecccCceEEEEecC---------CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence            567889999999777643322         12222333222     1111111 11556777888899999988877777


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....+-+||||++ +|+.++....  .+....+..++.|++.|+.|+|+  .||.|||||++|++++.+|.+||+|||.
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~  466 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGA  466 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCc
Confidence            66666666999999 9999997653  38888999999999999999999  9999999999999999999999999999


Q ss_pred             cccCCCCCcc--ceeeeccCCCCcCchhhhhcCCCCc-hhhhHHHhHHHHHHHhCCCCCCccccccchh----hhhhhcc
Q 013557          236 AKAGPTGDRT--HVSTQVMGTRGYAAPEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVDKTRVGAEQN----LVDWAKP  308 (441)
Q Consensus       236 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlG~il~elltg~~pf~~~~~~~~~~----~~~~~~~  308 (441)
                      +.........  .....++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||..........    ...|...
T Consensus       467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~  546 (601)
T KOG0590|consen  467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI  546 (601)
T ss_pred             ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc
Confidence            8764433322  4556788999999999999999987 5899999999999999999997544322210    0000000


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .    ...         ...-...+.....++.++++ +|.+|-++++|++.
T Consensus       547 ~----~~~---------~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  547 F----EGP---------NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             c----cCh---------HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0    000         00112223445667777887 99999999999854

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2e-24  Score=194.86  Aligned_cols=171  Identities=12%  Similarity=0.073  Sum_probs=132.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHH---------HHHHHHHHhcCCCCCc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---------WLSEVNYLGQLHHPNL  147 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnI  147 (441)
                      ..++|++.++||.|+||.||+...           .+..+|||.+++........         +.+|+..+.++.|++|
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI   97 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL   97 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence            568999999999999999998422           14469999997654333222         5789999999999999


Q ss_pred             ccEEEEEEcC--------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          148 VKLIGFCLDG--------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       148 v~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                      ..+.+++...        ...+|||||++|.+|.++..      +++    ....+++.+|..+|.  .|++|||+||+|
T Consensus        98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~N  165 (232)
T PRK10359         98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGN  165 (232)
T ss_pred             CcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHH
Confidence            9999886643        35789999999999988631      233    245689999999998  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHH
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL  285 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell  285 (441)
                      |+++.+| ++|+|||...........              -.++....|+.++|+|+||+++..+.
T Consensus       166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999988 999999988754221100              11344556778999999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-24  Score=189.06  Aligned_cols=205  Identities=22%  Similarity=0.254  Sum_probs=168.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||.|+||.+|.|...         ..|..||||+-+...  ....+..|.++...|+ ...|..+..++.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i---------~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISI---------TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeec---------cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence            4578999999999999999997543         357899999976542  3345678999999996 468888888889


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---CcEEEcc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSD  232 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~~kl~D  232 (441)
                      +.....+||+.+ |.+|+++..--. ..++...++.++-|++.-++|+|.  ++++||||||+|+|..-+   ..+.|+|
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEe
Confidence            999999999998 889999875332 348999999999999999999998  899999999999999654   4689999


Q ss_pred             cCCcccCCCCCc-----cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccc
Q 013557          233 FGLAKAGPTGDR-----THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV  296 (441)
Q Consensus       233 Fg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~  296 (441)
                      ||+|+.+.+...     ....+...||..|.+--...+...+.+.|+-|+|.+|.++.-|..||.+...
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            999986433211     1123456899999998888887888899999999999999999999986543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.1e-22  Score=181.27  Aligned_cols=138  Identities=16%  Similarity=0.161  Sum_probs=106.3

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--c-------H-----------------HHHHHHHH
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--G-------H-----------------KEWLSEVN  137 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~  137 (441)
                      ...||+|+||.||+|...          +|+.||||+++.....  .       .                 .....|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            578999999999997543          4789999998754211  1       0                 11235999


Q ss_pred             HHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCeEEeccC
Q 013557          138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL-HEAEQQVIYRDFK  216 (441)
Q Consensus       138 ~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~l-H~~~~~ivH~Dlk  216 (441)
                      +|.++.++++.....+...  ..+|||||++|++|...+...  ..++...+..++.|++.+|.++ |+  .||+|||||
T Consensus        72 ~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlk  145 (190)
T cd05147          72 NLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD--CRLVHADLS  145 (190)
T ss_pred             HHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCC
Confidence            9999988777444333222  238999999988776554332  3588999999999999999999 67  799999999


Q ss_pred             CCcEEECCCCcEEEcccCCccc
Q 013557          217 ASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       217 p~Nill~~~~~~kl~DFg~a~~  238 (441)
                      |+|||++ ++.++|+|||++..
T Consensus       146 P~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         146 EYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             HHHEEEE-CCcEEEEEcccccc
Confidence            9999998 47899999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.1e-21  Score=173.43  Aligned_cols=185  Identities=18%  Similarity=0.116  Sum_probs=138.1

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc----HHHHHHHHHHHhcCC-CCCcccEEEEEEc
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG----HKEWLSEVNYLGQLH-HPNLVKLIGFCLD  156 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  156 (441)
                      .+...|++|+||+||.+.-           .+..++.+.+.....-.    ...+.+|+++|++|. |++|++++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            3567899999999996432           35677777776543311    124789999999995 5889999886   


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc-CCCcEEECCCCcEEEcccCC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF-KASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl-kp~Nill~~~~~~kl~DFg~  235 (441)
                       ...+++|||+.|.+|...+..         ....++.|++.+|.++|+  .||+|||| ||+|||++.++.++|+|||+
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence             346999999999998764311         123577899999999998  89999999 79999999999999999999


Q ss_pred             cccCCCCCcc----c---e----eeeccCCCCcCchhhhhcC-CCC-chhhhHHHhHHHHHHHhCCCCCC
Q 013557          236 AKAGPTGDRT----H---V----STQVMGTRGYAAPEYLATG-RLT-AKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       236 a~~~~~~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~elltg~~pf~  292 (441)
                      +.........    .   .    ......++.|++|+...-. ..+ ...++++.|+-+|.++||..++-
T Consensus       139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            9854332210    0   0    0012368899999975432 223 57799999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-23  Score=206.44  Aligned_cols=228  Identities=27%  Similarity=0.329  Sum_probs=178.3

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--HHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  162 (441)
                      ++|+|+||.|+++.-      +.....+..++.|.+++.....  ......|..++...+ ||.+++++..+..+...++
T Consensus         1 vlg~g~~gkvfLvrk------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRK------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHH------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            479999999997532      3344457788888887653221  124556888888886 9999999999999999999


Q ss_pred             EEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCC
Q 013557          163 VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG  242 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~  242 (441)
                      +++|..||+|...+....  .+.+.....+...++-+++++|+  .+|+|||+|++||+++.+|++++.|||+++..-..
T Consensus        75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            999999999998886554  37888888899999999999998  99999999999999999999999999999864333


Q ss_pred             CccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcc
Q 013557          243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI  322 (441)
Q Consensus       243 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  322 (441)
                      ..      .+||..|||||++.  ....++|.||||++++||+||..||..                    ..+..++..
T Consensus       151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~  202 (612)
T KOG0603|consen  151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA  202 (612)
T ss_pred             hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh
Confidence            21      28999999999997  568899999999999999999999863                    112222221


Q ss_pred             cccCCCchhHHHHHHHHHHHHhc-CCCCCCCH
Q 013557          323 KLEGQYPQKGAYMVAILALQCIS-EAKVRPSM  353 (441)
Q Consensus       323 ~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~  353 (441)
                      .  ...|.........+...+.. +|..|--.
T Consensus       203 ~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 E--LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             c--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2  23455555666666666666 78877644

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=4.2e-23  Score=213.08  Aligned_cols=248  Identities=24%  Similarity=0.289  Sum_probs=176.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHH---HHHHHHhcCCCCCcccEEEEEE
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWL---SEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      +|...+.||.+.|=+|.+|..++          | .|+||++-+.. .-..+.+.   .|++ ...++|||.+.+..+-.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            67778999999999999987664          3 38888875443 22333443   4444 45568999999988877


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      .+...|||-+|+.+ +|+|+|..+..  +...+.+.|+.|++.||..+|.  .||+|||||.+||||+.-..+.|+||..
T Consensus        92 t~kAAylvRqyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             hhHHHHHHHHHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccc
Confidence            88888999999966 99999976653  7788889999999999999998  8999999999999999998999999987


Q ss_pred             cccC--CCC---CccceeeeccCCCCcCchhhhhcC----------C-CCchhhhHHHhHHHHHHHh-CCCCCCcccccc
Q 013557          236 AKAG--PTG---DRTHVSTQVMGTRGYAAPEYLATG----------R-LTAKCDVYSFGVVLLELLS-GRRAVDKTRVGA  298 (441)
Q Consensus       236 a~~~--~~~---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~  298 (441)
                      .+..  +..   +...+..+-..-..|+|||.+...          . .+++-||||+||+++||++ |+++|+..    
T Consensus       167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----  242 (1431)
T KOG1240|consen  167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----  242 (1431)
T ss_pred             cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence            6532  211   111122222334579999988541          1 5678999999999999988 68888632    


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                        .+..+...-..+...+.+    .++.       .-+..++..|++ ||.+|.+++++|+.-.
T Consensus       243 --QL~aYr~~~~~~~e~~Le----~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  243 --QLLAYRSGNADDPEQLLE----KIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             --HHHhHhccCccCHHHHHH----hCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence              222222211111111111    1111       134556677777 9999999999987643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.2e-21  Score=171.47  Aligned_cols=141  Identities=18%  Similarity=0.139  Sum_probs=108.9

Q ss_pred             CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--c------------------------HHHHHHHH
Q 013557           83 PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--G------------------------HKEWLSEV  136 (441)
Q Consensus        83 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~  136 (441)
                      +.+.||+|+||.||+|...          +|+.||||+++.....  .                        ...+..|.
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            3578999999999997543          4789999998764211  0                        11235789


Q ss_pred             HHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccC
Q 013557          137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFK  216 (441)
Q Consensus       137 ~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlk  216 (441)
                      +.+.++.|++|.....+...  ..+|||||++|+++.......  ..++......++.|++.+|.++|+ ..||+|||||
T Consensus        71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlk  145 (190)
T cd05145          71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLS  145 (190)
T ss_pred             HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCC
Confidence            99999999988555444333  248999999988654432222  247788899999999999999996 3699999999


Q ss_pred             CCcEEECCCCcEEEcccCCcccC
Q 013557          217 ASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       217 p~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      |+|||++ ++.++|+|||++...
T Consensus       146 P~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         146 EYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             hhhEEEE-CCCEEEEEcccceec
Confidence            9999999 789999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=7.4e-22  Score=207.42  Aligned_cols=196  Identities=22%  Similarity=0.255  Sum_probs=157.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC---CCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH---HPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~  153 (441)
                      ....|.|.+.||+|+||.||+|...+          ++.||+|+-++...-   +|.--.+++.+|+   -+.|..+...
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHH
Confidence            34578888999999999999976543          789999998775432   2222344455554   3355666666


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-------CC
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-------EF  226 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-------~~  226 (441)
                      +.-.+.-+||+||.+.|+|.|++.  ....+++..++.+..|+++.+++||.  .+|||+||||+|+||..       +.
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCccc
Confidence            666778899999999999999996  45569999999999999999999998  89999999999999942       34


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCC
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR  289 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~  289 (441)
                      .++|+|||.+.....-......+..++|-.+-.+|+..|..++.+.|.|.|+.++|-||.|+.
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            599999999875433222334567789999999999999999999999999999999999986

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.4e-20  Score=169.28  Aligned_cols=136  Identities=17%  Similarity=0.183  Sum_probs=105.1

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-----CCCCcccEEEEEEc
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-----HHPNLVKLIGFCLD  156 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~  156 (441)
                      .-.++||+|+||.||.  +.         .+... +||++........+.+.+|+.+++.+     .||||+++++++++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp---------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HP---------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             CCcceecCCCceEEEE--CC---------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            3457899999999995  21         12333 68888765444567789999999999     57999999999988


Q ss_pred             CC---e-eEEEEEe--CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHhHhcCCCeEEeccCCCcEEECC----C
Q 013557          157 GE---N-RLLVYEY--MPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL-SFLHEAEQQVIYRDFKASNILLDS----E  225 (441)
Q Consensus       157 ~~---~-~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L-~~lH~~~~~ivH~Dlkp~Nill~~----~  225 (441)
                      +.   . +.+||||  +.+++|.+++.+.   .+++.  ..++.+++.++ +|||+  ++|+||||||+|||++.    +
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCC
Confidence            74   3 3378999  5579999999553   25555  35677888777 99998  89999999999999974    3


Q ss_pred             CcEEEcccCCc
Q 013557          226 FNAKLSDFGLA  236 (441)
Q Consensus       226 ~~~kl~DFg~a  236 (441)
                      +.++|+||+.+
T Consensus       146 ~~~~LiDg~G~  156 (210)
T PRK10345        146 VIPVVCDNIGE  156 (210)
T ss_pred             CcEEEEECCCC
Confidence            47999995433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=8.5e-20  Score=169.69  Aligned_cols=233  Identities=21%  Similarity=0.248  Sum_probs=143.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCC----------C
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHH----------P  145 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------p  145 (441)
                      ..+...+.||.|+++.||.+..         ..+++.+|+|++....   ....+.+.+|.-....+.+          -
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d---------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~   82 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTD---------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHL   82 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH
T ss_pred             eEEEEccccccCCceEEEEEEE---------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhc
Confidence            3455678899999999998654         4568899999875432   1234556666554444322          1


Q ss_pred             CcccEEEEEE---------cC---C-----eeEEEEEeCCCCCHHHHHH---hcCCC--CCCHHHHHHHHHHHHHHHHHh
Q 013557          146 NLVKLIGFCL---------DG---E-----NRLLVYEYMPKGSLENHLF---RRGAR--PLPWTLRIKVAIGAARGLSFL  203 (441)
Q Consensus       146 nIv~l~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~--~~~~~~~~~i~~~i~~~L~~l  203 (441)
                      .++-.++...         ..   .     +.+++|+-+. ++|.+++.   .....  .+....+..+..|+++.+++|
T Consensus        83 r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L  161 (288)
T PF14531_consen   83 RFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL  161 (288)
T ss_dssp             -B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH
Confidence            2222222221         11   1     3367888874 58888764   22221  233445567779999999999


Q ss_pred             HhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC--------CCCchhhhH
Q 013557          204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG--------RLTAKCDVY  275 (441)
Q Consensus       204 H~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvw  275 (441)
                      |.  .|++|+||+|+|++++.+|.++|+||+........     ......+..|.+||.....        .++.+.|.|
T Consensus       162 h~--~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW  234 (288)
T PF14531_consen  162 HS--YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAW  234 (288)
T ss_dssp             HH--TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred             hh--cceEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence            99  89999999999999999999999999877653221     1113446789999987542        478899999


Q ss_pred             HHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCC
Q 013557          276 SFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR  350 (441)
Q Consensus       276 SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~R  350 (441)
                      +||+++|.|++|..||+..........                     ....+. ..++.+..|+..+++ +|++|
T Consensus       235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  235 QLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999984432111100                     112334 566778888888888 88877

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=8.2e-20  Score=170.55  Aligned_cols=195  Identities=19%  Similarity=0.255  Sum_probs=139.3

Q ss_pred             CCCCcccEEEEEEcC---------------------------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 013557          143 HHPNLVKLIGFCLDG---------------------------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG  195 (441)
Q Consensus       143 ~hpnIv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~  195 (441)
                      +|||||+++.+|.+.                           ..+|+||..++. +|..++..+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            699999999887542                           356999999865 9999997655   567778889999


Q ss_pred             HHHHHHHhHhcCCCeEEeccCCCcEEE--CCCC--cEEEcccCCcccCCCCCc----cceeeeccCCCCcCchhhhhcCC
Q 013557          196 AARGLSFLHEAEQQVIYRDFKASNILL--DSEF--NAKLSDFGLAKAGPTGDR----THVSTQVMGTRGYAAPEYLATGR  267 (441)
Q Consensus       196 i~~~L~~lH~~~~~ivH~Dlkp~Nill--~~~~--~~kl~DFg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~  267 (441)
                      +++|+.|||.  +||.|||+|.+|||+  |+++  .++|+|||++-......-    ....-..-|...-||||+....+
T Consensus       350 lLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999998  899999999999998  3333  589999998864222110    11112345778899999986422


Q ss_pred             ------CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHH
Q 013557          268 ------LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILAL  341 (441)
Q Consensus       268 ------~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~  341 (441)
                            ...++|.|+.|.+.||+++...||-..+. ...+...+.           +    ......|......+.+|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yq-----------e----~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQ-----------E----SQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhh-----------h----hhCCCCcccCChHHHHHHH
Confidence                  23589999999999999999999964221 111111111           1    1112345566667788888


Q ss_pred             HHhc-CCCCCCCHHHHHHH
Q 013557          342 QCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       342 ~c~~-~P~~RPs~~evl~~  359 (441)
                      .+++ ||.+|++..-..+.
T Consensus       492 ~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHhcCCccccCCccHHHhH
Confidence            8888 99999987654433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=8e-20  Score=180.30  Aligned_cols=215  Identities=27%  Similarity=0.408  Sum_probs=156.6

Q ss_pred             HhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCC
Q 013557          139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKAS  218 (441)
Q Consensus       139 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~  218 (441)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ....+++.-...+.++|+.||.|||... ...|+.|+..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence            4678999999999999999999999999999999999866 3456899999999999999999999842 2399999999


Q ss_pred             cEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC-------CCchhhhHHHhHHHHHHHhCCCCC
Q 013557          219 NILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-------LTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       219 Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      |.++|..+.+||+|||+.................-..-|.|||.+++..       .+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987653211111111112345699999998642       356799999999999999999999


Q ss_pred             Cccccccc-hhhhhhhccccccchhhhhhhcccccCCCc-h-hHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          292 DKTRVGAE-QNLVDWAKPYLGDRRKLFRIMDIKLEGQYP-Q-KGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       292 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~-~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      +....... ..++.+.+.  ..        ....+.... . .....+..++..||. +|+.||++++|...++.+..
T Consensus       159 ~~~~~~~~~~eii~~~~~--~~--------~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK--GG--------SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCChHHHHHHHHh--cC--------CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            85443222 112221111  00        000100000 0 222356778889998 89999999999888765433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.8e-19  Score=162.49  Aligned_cols=134  Identities=23%  Similarity=0.323  Sum_probs=111.9

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--------HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--------HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +.||+|++|.||+|.+.           +..+++|+........        ...+.+|+.++..+.|++|.....++.+
T Consensus         2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD   70 (211)
T ss_pred             cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence            67999999999998653           5568889865433211        2347789999999999998877777777


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||++|++|.+++....     . .+..++.+++.+|.++|+  .+++|+|++|+|||++ ++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence            788899999999999999885432     2 788899999999999998  8999999999999999 788999999988


Q ss_pred             cc
Q 013557          237 KA  238 (441)
Q Consensus       237 ~~  238 (441)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            65

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.1e-19  Score=159.91  Aligned_cols=130  Identities=22%  Similarity=0.352  Sum_probs=105.1

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--------cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--------GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +||+|+||.||+|.+.           +..+++|........        ...++.+|++++..++|+++.....++...
T Consensus         1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP   69 (199)
T ss_pred             CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence            4899999999998643           457888886543221        124567899999999988766555555666


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||++|++|.+++....   .      .++.+++.+|.+||+  .+++|+|++|+||+++ ++.++++|||++.
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence            77899999999999999874422   1      789999999999998  8999999999999999 7899999999987


Q ss_pred             c
Q 013557          238 A  238 (441)
Q Consensus       238 ~  238 (441)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            5

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=1.9e-19  Score=165.74  Aligned_cols=144  Identities=17%  Similarity=0.111  Sum_probs=110.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------------------------cHHHHH
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------------------------GHKEWL  133 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~  133 (441)
                      ...|.+.+.||+|+||.||+|..        +...|..||+|+++.....                        ....+.
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE   98 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence            34689999999999999999751        1224788999998754210                        012356


Q ss_pred             HHHHHHhcCCCCC--cccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC-e
Q 013557          134 SEVNYLGQLHHPN--LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ-V  210 (441)
Q Consensus       134 ~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-i  210 (441)
                      +|+.++.++.+.+  +.+++++   . ..++||||+.|.+|..++...  ..+....+..++.|++.+|.+||+  .| |
T Consensus        99 ~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~g~i  170 (237)
T smart00090       99 KEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK--EGEL  170 (237)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh--cCCE
Confidence            8999999997533  3444443   2 358999999998887654322  235666778999999999999998  88 9


Q ss_pred             EEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          211 IYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       211 vH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      +||||||+||+++ ++.++|+|||.+..
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            9999999999999 78999999998875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=4.5e-20  Score=190.75  Aligned_cols=168  Identities=30%  Similarity=0.420  Sum_probs=120.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ...+|+.+++|..|+||.||.+.+         +.+.+.+|+|+-+..      .+++-  ||.....|.+|        
T Consensus        81 ~e~df~~IklisngAygavylvrh---------~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv--------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRH---------KETRQRFAMKINKQN------LILRN--ILTFAGNPFVV--------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeec---------cccccchhhcccccc------hhhhc--cccccCCccee--------
Confidence            356899999999999999998544         445667888443221      11111  22222333333        


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                                   |+-...+..-+  +++...        +.+++|||+  .||+|||+||+|.+|+.-|++|++|||++
T Consensus       136 -------------gDc~tllk~~g--~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  136 -------------GDCATLLKNIG--PLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             -------------chhhhhcccCC--CCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhh
Confidence                         34444342222  233222        778999998  99999999999999999999999999998


Q ss_pred             ccCCCCCcc-------------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          237 KAGPTGDRT-------------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       237 ~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      +........             -..+..+||+.|.|||++....|+..+|+|++|+|+||.+-|+.||++.
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence            753211110             0123568999999999999999999999999999999999999999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=2.2e-20  Score=181.04  Aligned_cols=124  Identities=28%  Similarity=0.441  Sum_probs=106.3

Q ss_pred             CeeEEEEEeCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .++|+.|++|.-.+|.+||.++ .....++.....++.|++.+++|     ++.+|+|+||.||+...+..+||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence            3578999999999999999643 33457788899999999999999     68999999999999999999999999998


Q ss_pred             ccCCCCC----ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh
Q 013557          237 KAGPTGD----RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS  286 (441)
Q Consensus       237 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt  286 (441)
                      .......    .....+...||..||+||++.+..|+.++||||||+||+||++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7543322    1223446789999999999999999999999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=6.1e-19  Score=182.08  Aligned_cols=139  Identities=22%  Similarity=0.281  Sum_probs=111.2

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--Cc------ccHHHHHHHHHHHhcCCCCCc
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GF------QGHKEWLSEVNYLGQLHHPNL  147 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~hpnI  147 (441)
                      .....|...+.||+|+||.||+|.+...           .+++|+....  ..      ...+++.+|++++..++|++|
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i  398 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGV  398 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCC
Confidence            3345667889999999999999876432           2233322111  10      113457899999999999999


Q ss_pred             ccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          148 VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       148 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +....++.+....++||||++|++|.+++.          ....++.+++.+|.+||+  .+++||||||+|||+ .++.
T Consensus       399 ~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~  465 (535)
T PRK09605        399 PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDR  465 (535)
T ss_pred             CeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCc
Confidence            988877777778899999999999999874          356789999999999998  899999999999999 5779


Q ss_pred             EEEcccCCccc
Q 013557          228 AKLSDFGLAKA  238 (441)
Q Consensus       228 ~kl~DFg~a~~  238 (441)
                      ++|+|||+++.
T Consensus       466 ~~liDFGla~~  476 (535)
T PRK09605        466 LYLIDFGLGKY  476 (535)
T ss_pred             EEEEeCccccc
Confidence            99999999975

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.1e-18  Score=154.04  Aligned_cols=143  Identities=18%  Similarity=0.083  Sum_probs=108.9

Q ss_pred             HHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc----------------------cHH
Q 013557           73 ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ----------------------GHK  130 (441)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~  130 (441)
                      ++......|.+.+.||+|+||.||+|...          +++.+|||+++.....                      ...
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   78 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL   78 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence            33344445889999999999999997543          3778999986543200                      012


Q ss_pred             HHHHHHHHHhcCCCCC--cccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 013557          131 EWLSEVNYLGQLHHPN--LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ  208 (441)
Q Consensus       131 ~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~  208 (441)
                      .+..|+.++..+.|.+  ++.+++.    ...++||||++|++|.++...        .....++.+++.++.++|+  .
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~--~  144 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK--H  144 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH--C
Confidence            3567899999997774  4455442    355899999999998765321        2356788899999999998  8


Q ss_pred             CeEEeccCCCcEEECCCCcEEEcccCCcccC
Q 013557          209 QVIYRDFKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       209 ~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      +|+||||||+||+++.++.++|+|||++...
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.5e-16  Score=146.77  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=101.0

Q ss_pred             CCeee-ecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-------------ccHHHHHHHHHHHhcCCCCCc--
Q 013557           84 DSLIG-EGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-------------QGHKEWLSEVNYLGQLHHPNL--  147 (441)
Q Consensus        84 ~~~lG-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnI--  147 (441)
                      ...|| .|+.|+||.+...           +..++||.+.....             .....+.+|+.++.+|+|++|  
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~v  104 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPV  104 (239)
T ss_pred             CceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCC
Confidence            34677 7778888876443           45688887753211             123457889999999998875  


Q ss_pred             ccEEEEEEcCC----eeEEEEEeCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          148 VKLIGFCLDGE----NRLLVYEYMPK-GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       148 v~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      +..+++.....    ..++|||+++| .+|.+++...   .++...    +.+++.+|.+||+  .||+||||||+|||+
T Consensus       105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~--~GI~HrDlkp~NILv  175 (239)
T PRK01723        105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHD--AGVYHADLNAHNILL  175 (239)
T ss_pred             ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHH--CCCCCCCCCchhEEE
Confidence            66776644322    23599999997 6898887432   345443    5688999999998  899999999999999


Q ss_pred             CCCCcEEEcccCCccc
Q 013557          223 DSEFNAKLSDFGLAKA  238 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~  238 (441)
                      +.++.++|+|||.+..
T Consensus       176 ~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        176 DPDGKFWLIDFDRGEL  191 (239)
T ss_pred             cCCCCEEEEECCCccc
Confidence            9988999999998875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=2.9e-16  Score=133.97  Aligned_cols=134  Identities=19%  Similarity=0.094  Sum_probs=111.2

Q ss_pred             CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCC--CCcccEEEEEEcCCee
Q 013557           83 PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH--PNLVKLIGFCLDGENR  160 (441)
Q Consensus        83 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~  160 (441)
                      +.+.||+|.++.||++...           +..+++|.......  ...+.+|+.++..++|  .++++++.++...+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence            4578999999999997653           24689999866533  4568899999999976  5899999988888889


Q ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcC-CCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAE-QQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       161 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      +++|||+.++.+..+         +......++.+++.+|.++|... .+++|+||+|+||+++..+.++++|||.+..
T Consensus        69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999999998777553         45566778999999999999732 3799999999999999988999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3e-18  Score=176.72  Aligned_cols=207  Identities=27%  Similarity=0.300  Sum_probs=165.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLH-HPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  155 (441)
                      ..|.+.+.||+|+|+.|-.....        ......+|+|.+....  .........|..+-+.+. |.|++.+++...
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~--------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~   91 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNS--------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS   91 (601)
T ss_pred             ccccccccccccccchhhhhhhc--------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC
Confidence            45778888999999999764322        2234567777765543  222334456787778886 999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCeEEeccCCCcEEECCCC-cEEEccc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH-EAEQQVIYRDFKASNILLDSEF-NAKLSDF  233 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH-~~~~~ivH~Dlkp~Nill~~~~-~~kl~DF  233 (441)
                      +.+..++++++..|+++++.+........+...+..++.|+..++.|+| .  .++.|+||||+|.+++..+ .+++.||
T Consensus        92 ~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   92 SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCc
Confidence            9999999999999999999884333224667778889999999999999 6  8999999999999999999 9999999


Q ss_pred             CCcccCCC-CCccceeeeccC-CCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          234 GLAKAGPT-GDRTHVSTQVMG-TRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       234 g~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |+|..... ..........+| ++.|+|||...+. ...+..|+||+|+++.-+++|..|++...
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            99987655 444444456678 9999999999874 45778999999999999999999987544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=3.4e-16  Score=139.37  Aligned_cols=137  Identities=21%  Similarity=0.145  Sum_probs=96.3

Q ss_pred             CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHH----------------------HHHHHHH
Q 013557           83 PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKE----------------------WLSEVNY  138 (441)
Q Consensus        83 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~  138 (441)
                      +.+.||+|+||.||+|...          .+..||||+++.....  ....                      ...|...
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~   70 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN   70 (187)
T ss_pred             CCcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence            3578999999999997543          3678999988653221  1111                      1356666


Q ss_pred             HhcCCCC--CcccEEEEEEcCCeeEEEEEeCCCCCHHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc
Q 013557          139 LGQLHHP--NLVKLIGFCLDGENRLLVYEYMPKGSLENH-LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF  215 (441)
Q Consensus       139 l~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl  215 (441)
                      +.++.+.  .+.+.+++    ...++||||++++.+... +....   .. ..+..++.+++.++.++|. ..+|+||||
T Consensus        71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl  141 (187)
T cd05119          71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR-EAGLVHGDL  141 (187)
T ss_pred             HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCC
Confidence            6666443  24455443    246899999998543221 11111   11 5678899999999999996 368999999


Q ss_pred             CCCcEEECCCCcEEEcccCCcccC
Q 013557          216 KASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       216 kp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      ||+||+++ ++.++|+|||.+...
T Consensus       142 ~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         142 SEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ChhhEEEE-CCcEEEEECcccccc
Confidence            99999999 889999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=2.9e-14  Score=142.87  Aligned_cols=141  Identities=19%  Similarity=0.161  Sum_probs=96.1

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccH----------------------------------
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH----------------------------------  129 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------  129 (441)
                      .+.||.|++|.||+|++..          |+.||||+.++......                                  
T Consensus       122 ~~plasaSigQVh~A~l~~----------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~  191 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD----------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE  191 (437)
T ss_pred             CcceeeeehhheEEEEecC----------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence            4679999999999997653          77899999876421110                                  


Q ss_pred             ------HHHHHHHHHHhcC----CCCCcccEEEEE-EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH
Q 013557          130 ------KEWLSEVNYLGQL----HHPNLVKLIGFC-LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR  198 (441)
Q Consensus       130 ------~~~~~E~~~l~~l----~hpnIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~  198 (441)
                            -+|.+|+..+.++    +|.+-+.+-.++ ......+|||||++|++|.++...... ...   ...++..++.
T Consensus       192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~  267 (437)
T TIGR01982       192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLAR  267 (437)
T ss_pred             HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHH
Confidence                  0244455555554    222222222222 223457999999999999987643211 122   3345555555


Q ss_pred             -HHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCC
Q 013557          199 -GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP  240 (441)
Q Consensus       199 -~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~  240 (441)
                       .+..+|.  .|++|+|+||.||+++.++.++|+|||++....
T Consensus       268 ~~l~ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       268 SFLNQVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             4678887  899999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=4.9e-14  Score=139.60  Aligned_cols=203  Identities=28%  Similarity=0.273  Sum_probs=159.8

Q ss_pred             hcCCCCCCeeee--cCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           78 TRNFRPDSLIGE--GGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        78 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      ...|.+.+.+|.  |.+|.||.+...       ....+..+|+|.-+...  ......-.+|+...+++ .|+|.++.+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~-------~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCT-------NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCC-------cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence            346777889999  999999987542       14457788998844322  22333345677777777 4999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHhHhcCCCeEEeccCCCcEEECCC-Cc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSE-FN  227 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~----~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~  227 (441)
                      .++..+..|+-+|++ +.+|..+...... -++....+.++.+...    ||.++|+  .+++|-|+||.||++..+ ..
T Consensus       186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  186 AWEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             ccccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccce
Confidence            999999999999998 5688888765432 3778888999999999    9999999  899999999999999999 78


Q ss_pred             EEEcccCCcccCCCCCccce---eeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          228 AKLSDFGLAKAGPTGDRTHV---STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      .+++|||+............   .....|...|++||... +-++..+|||+||.++.+..+|.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            99999999987655442221   12336778899999985 578999999999999999999877653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=4.2e-13  Score=117.30  Aligned_cols=128  Identities=19%  Similarity=0.076  Sum_probs=94.0

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLL  162 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l  162 (441)
                      .+.|+.|.++.||++...           +..+++|+...... ....+..|+.++..+.+.++ .+++.+.  ....++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence            356889999999987543           55799999765431 12345689999998865454 4555543  334589


Q ss_pred             EEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC-----eEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          163 VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ-----VIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-----ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ||||++|.++.+.    .   .   ....++.+++++|..||+  .+     ++|+|++|+||+++ ++.++++|||.+.
T Consensus        69 v~e~i~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          69 ITEFIEGSELLTE----D---F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EEEecCCCccccc----c---c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9999999887643    0   1   123456789999999998  55     59999999999999 6689999999876


Q ss_pred             c
Q 013557          238 A  238 (441)
Q Consensus       238 ~  238 (441)
                      .
T Consensus       136 ~  136 (170)
T cd05151         136 M  136 (170)
T ss_pred             C
Confidence            4

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=8.2e-14  Score=127.87  Aligned_cols=153  Identities=25%  Similarity=0.350  Sum_probs=115.4

Q ss_pred             HHHhcCCCCCcccEEEEEEcCC-----eeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 013557          137 NYLGQLHHPNLVKLIGFCLDGE-----NRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQ  209 (441)
Q Consensus       137 ~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~  209 (441)
                      .-|-.+-|.|||+++.|+.+..     ...++.||+..|+|..+|.+.  ....+....-.+|+.||+.||.|||+.+..
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3445567999999999876543     468899999999999999753  334577888889999999999999999889


Q ss_pred             eEEeccCCCcEEECCCCcEEEcccC--CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhC
Q 013557          210 VIYRDFKASNILLDSEFNAKLSDFG--LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG  287 (441)
Q Consensus       210 ivH~Dlkp~Nill~~~~~~kl~DFg--~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg  287 (441)
                      |+|+++..+-|++..+|-+|++---  ..................+-++|.+||.-...+.+.++|||+||....+|-.|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888875311  11000000000011123467899999987666778899999999999999887


Q ss_pred             CC
Q 013557          288 RR  289 (441)
Q Consensus       288 ~~  289 (441)
                      ..
T Consensus       279 Ei  280 (458)
T KOG1266|consen  279 EI  280 (458)
T ss_pred             ee
Confidence            64

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.43  E-value=2.1e-12  Score=109.90  Aligned_cols=143  Identities=20%  Similarity=0.224  Sum_probs=111.1

Q ss_pred             CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--------HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           83 PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--------HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        83 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .+.+|-+|+-+.|+++.+.           |+.++||.-....+..        ..+..+|+++|.++.--.|.-..-+|
T Consensus        11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            5678999999999998765           6677777654433321        24578899999998755665555566


Q ss_pred             EcCCeeEEEEEeCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc---EEE
Q 013557          155 LDGENRLLVYEYMPK-GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKL  230 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~---~kl  230 (441)
                      .+...-.|+|||++| .++.+++...............++..|-+.+.-||.  .+|+|+||..+||++..++.   +.|
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~l  157 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPIL  157 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEE
Confidence            777788999999977 588898876655445555557899999999999998  89999999999999976543   589


Q ss_pred             cccCCccc
Q 013557          231 SDFGLAKA  238 (441)
Q Consensus       231 ~DFg~a~~  238 (441)
                      +|||++..
T Consensus       158 Idfgls~~  165 (229)
T KOG3087|consen  158 IDFGLSSV  165 (229)
T ss_pred             Eeecchhc
Confidence            99999865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=1.8e-12  Score=110.89  Aligned_cols=131  Identities=24%  Similarity=0.329  Sum_probs=101.4

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--------HHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--------HKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..+++|+-+.+|.+.+.           |..+++|.-.+..+..        ..+..+|+++|.++.--.|....=++.+
T Consensus         2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD   70 (204)
T ss_pred             chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            46889999999987543           4456777654443322        2346789999999876566555555667


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .....|+|||++|..|.+.+...         ...++..+-.-+.-||.  .||+|+||.++||++..++ +.++|||++
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg  138 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLG  138 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcc
Confidence            77889999999999999888554         25667778888899998  8999999999999998764 999999998


Q ss_pred             cc
Q 013557          237 KA  238 (441)
Q Consensus       237 ~~  238 (441)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            75

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=1.6e-13  Score=139.21  Aligned_cols=144  Identities=15%  Similarity=0.158  Sum_probs=93.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc------------------------------
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG------------------------------  128 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------  128 (441)
                      ..|.. +.||.|++|+||+|++.+         +|+.||||+.++.....                              
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~  189 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV  189 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence            35766 789999999999987653         37789999997642110                              


Q ss_pred             ----H------HHHHHHHHHHhcCC----CCCcccEEEEEEc-CCeeEEEEEeCCCCCHHHHH--HhcCC--CCCCHHHH
Q 013557          129 ----H------KEWLSEVNYLGQLH----HPNLVKLIGFCLD-GENRLLVYEYMPKGSLENHL--FRRGA--RPLPWTLR  189 (441)
Q Consensus       129 ----~------~~~~~E~~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~--~~~~~~~~  189 (441)
                          .      -++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.|.++.  ...+.  ..+....+
T Consensus       190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v  269 (537)
T PRK04750        190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV  269 (537)
T ss_pred             HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence                0      11344554444442    3333333333322 45678999999999998743  22221  01223333


Q ss_pred             HHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----cEEEcccCCcccCCC
Q 013557          190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----NAKLSDFGLAKAGPT  241 (441)
Q Consensus       190 ~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFg~a~~~~~  241 (441)
                      ..++.|+       ..  .|++|+|+||+||+++.+|    .++++|||++.....
T Consensus       270 ~~~~~Qi-------f~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        270 EVFFTQV-------FR--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH-------Hh--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3344443       33  7899999999999999888    999999999876533

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=6e-12  Score=111.38  Aligned_cols=144  Identities=13%  Similarity=0.088  Sum_probs=98.9

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--c-------------------c-HHHH----HHHHH
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--Q-------------------G-HKEW----LSEVN  137 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~-------------------~-~~~~----~~E~~  137 (441)
                      ...||.|.-+.||.|.....   ......+..+|||+.+....  .                   . ...+    .+|++
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~---~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r   78 (197)
T cd05146           2 NGCISTGKESVVLHANGGSN---ETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH   78 (197)
T ss_pred             CCccccCcceEEEEEecCcc---cccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence            45799999999999854321   00011356899998753210  0                   0 1122    37999


Q ss_pred             HHhcCC--CCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCeEEec
Q 013557          138 YLGQLH--HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL-HEAEQQVIYRD  214 (441)
Q Consensus       138 ~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~l-H~~~~~ivH~D  214 (441)
                      .|.++.  .-++..++++    ...+|||||+.+..+..-..+..  .++..+...+..+++.+|..+ |.  .||+|+|
T Consensus        79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGD  150 (197)
T cd05146          79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKE--CNLVHAD  150 (197)
T ss_pred             HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHh--CCeecCC
Confidence            999995  3566777765    45689999997654422111111  245566777889999999998 77  8999999


Q ss_pred             cCCCcEEECCCCcEEEcccCCcccC
Q 013557          215 FKASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       215 lkp~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      |++.|||++ ++.++|+|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 468999999988653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=3.7e-12  Score=127.62  Aligned_cols=164  Identities=18%  Similarity=0.202  Sum_probs=125.0

Q ss_pred             CccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHH
Q 013557          112 VGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK  191 (441)
Q Consensus       112 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  191 (441)
                      ++..+.|...+...........+-++.|+.|+||||+++++.++.+...|||+|.+.  .|..++.+.+     ...+..
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHHHH
Confidence            466777777765544334556778899999999999999999999999999999984  7887776544     566777


Q ss_pred             HHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCch
Q 013557          192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAK  271 (441)
Q Consensus       192 i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  271 (441)
                      .+.||+.||.|||. +.+++|++|.-+.|+++..|..||++|.++........  ......--..|..|+.+...  +-.
T Consensus       109 Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s--~~s  183 (690)
T KOG1243|consen  109 GLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS--EWS  183 (690)
T ss_pred             HHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--ccc
Confidence            88999999999996 48999999999999999999999999987754322111  00111112246677755322  245


Q ss_pred             hhhHHHhHHHHHHHhC
Q 013557          272 CDVYSFGVVLLELLSG  287 (441)
Q Consensus       272 sDvwSlG~il~elltg  287 (441)
                      .|.|-|||+++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            7999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.5e-12  Score=129.18  Aligned_cols=196  Identities=23%  Similarity=0.217  Sum_probs=148.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHH--HHHHHHHHhcC-CCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--WLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      ..+|.....||.|.|+.|+....        +...+..+++|.+.+.......+  -+.|+-+...+ .|.+++.++..+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~--------r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSK--------RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeee--------cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence            34677788999999999987532        22457789999887664444333  35677777777 588999988887


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcEEEccc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDF  233 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~kl~DF  233 (441)
                      ......|+-.|||+++++...+..  ...+.+...+.+..|++.++.++|+  ..++|+|+||+||++..+ +..+++||
T Consensus       336 ~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  336 SQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhcccc
Confidence            877888899999999998877632  2347778889999999999999998  899999999999999886 78899999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcC--chhhhhcCCCCchhhhHHHhHHHHHHHhCCCC
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYA--APEYLATGRLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      |+........     .......+++  +++.+....+..+.|+||||..+.+.++|...
T Consensus       412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            9886321111     1122333444  45555556788899999999999999999753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=4.5e-11  Score=109.08  Aligned_cols=141  Identities=20%  Similarity=0.265  Sum_probs=105.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCC--CCcccEEEEEEcCC---
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHH--PNLVKLIGFCLDGE---  158 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~---  158 (441)
                      +.|+.|.++.||++...+          |..+++|....... .....+..|+++++.+.+  .++.+++.+.....   
T Consensus         4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            568999999999975431          46799998765422 134567889999999965  44677887766532   


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc--------------------------------
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA--------------------------------  206 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--------------------------------  206 (441)
                      ..++||||++|.+|.+.+..   ..++..+...++.+++++|..||+.                                
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR  150 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence            56899999999888775421   2366677777777888888888742                                


Q ss_pred             ----------------------CCCeEEeccCCCcEEECC--CCcEEEcccCCccc
Q 013557          207 ----------------------EQQVIYRDFKASNILLDS--EFNAKLSDFGLAKA  238 (441)
Q Consensus       207 ----------------------~~~ivH~Dlkp~Nill~~--~~~~kl~DFg~a~~  238 (441)
                                            ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                  145799999999999998  56689999987764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.17  E-value=6.4e-12  Score=131.10  Aligned_cols=204  Identities=23%  Similarity=0.234  Sum_probs=145.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .+.+.+.+-+-+|.++.++.+         .-...+...++|......   ..+.+....+-.++..-.+|-++...--+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~  873 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF  873 (1205)
T ss_pred             CccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence            456777778889999999863         223334444555443221   11223333444444444556666555445


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .-....+||++|+.+++|...++..+  ..+.+-...+...+..++++||+  ..+.|+|++|.|+|+..+|+.++.|||
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccc
Confidence            55677899999999999999886554  46666677778888999999998  669999999999999999999999998


Q ss_pred             CcccCCCC----Cc-------------------------cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHH
Q 013557          235 LAKAGPTG----DR-------------------------THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL  285 (441)
Q Consensus       235 ~a~~~~~~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell  285 (441)
                      .......-    ..                         ........||+.|.+||.+.+......+|+|++|++++|.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            43221000    00                         00112356899999999999999999999999999999999


Q ss_pred             hCCCCCCcc
Q 013557          286 SGRRAVDKT  294 (441)
Q Consensus       286 tg~~pf~~~  294 (441)
                      +|.+||+..
T Consensus      1030 ~g~pp~na~ 1038 (1205)
T KOG0606|consen 1030 TGIPPFNAE 1038 (1205)
T ss_pred             cCCCCCCCc
Confidence            999999744

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=7.2e-10  Score=103.60  Aligned_cols=124  Identities=17%  Similarity=0.145  Sum_probs=91.7

Q ss_pred             ccEEEEEEcCCCCccc-----------HHHHHHHHHHHhcCCCCCc--ccEEEEEEc-----CCeeEEEEEeCCCC-CHH
Q 013557          113 GMVIAVKKLKPEGFQG-----------HKEWLSEVNYLGQLHHPNL--VKLIGFCLD-----GENRLLVYEYMPKG-SLE  173 (441)
Q Consensus       113 ~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnI--v~l~~~~~~-----~~~~~lv~e~~~~g-~L~  173 (441)
                      |+.+.||.........           ...+.+|...+.+|..-+|  +.++.+++.     ....+||||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            5678999775433211           1136789998888854444  445555543     23568999999886 799


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-------CCcEEEcccCCccc
Q 013557          174 NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-------EFNAKLSDFGLAKA  238 (441)
Q Consensus       174 ~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-------~~~~kl~DFg~a~~  238 (441)
                      +++......+........++.+++..+.-||.  .||+|+|++++|||++.       ++.+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            98854323345677788999999999999998  89999999999999975       46799999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=6e-09  Score=99.48  Aligned_cols=260  Identities=18%  Similarity=0.198  Sum_probs=156.2

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEE------E
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGF------C  154 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~------~  154 (441)
                      ...+.||+|+-+.+|..-.      +      ...+-|+..........+   .+..|... .||-+-.-+.+      .
T Consensus        14 ~~gr~LgqGgea~ly~l~e------~------~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G   78 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE------V------RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG   78 (637)
T ss_pred             CCCccccCCccceeeecch------h------hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC
Confidence            3567899999999995211      1      124556665443332222   22233333 56643321111      1


Q ss_pred             EcCC-eeEEEEEeCCCCC-HHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          155 LDGE-NRLLVYEYMPKGS-LENHLF----RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       155 ~~~~-~~~lv~e~~~~g~-L~~~l~----~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      -+.+ ..-+.|..+.|.. +.+++.    ++......|.-.+..+..++.+.+-||.  .|.+-+|++++|+|+.+++.+
T Consensus        79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V  156 (637)
T COG4248          79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKV  156 (637)
T ss_pred             CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceE
Confidence            1222 2557788877642 222221    2233447889999999999999999998  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhC-CCCCCccccccch--
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSG-RRAVDKTRVGAEQ--  300 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg-~~pf~~~~~~~~~--  300 (441)
                      +|+|=......   .........+|...|.+||.-.     +..-+...|.|.||+++++||.| ++||.+.......  
T Consensus       157 ~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~  233 (637)
T COG4248         157 VLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN  233 (637)
T ss_pred             EEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence            99985433221   2222344567899999999754     34557789999999999999997 9999744321110  


Q ss_pred             ----hhhhhhccccccchhhhhhhcccccCCCc-hhHHHHHHHHHHHHhcC---CCCCCCHHHHHHHhhcCCC
Q 013557          301 ----NLVDWAKPYLGDRRKLFRIMDIKLEGQYP-QKGAYMVAILALQCISE---AKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       301 ----~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~l~~~c~~~---P~~RPs~~evl~~L~~l~~  365 (441)
                          .+......+..+.   ..-.... ....| ......+..|...|..+   +.-||+++.++..|..+..
T Consensus       234 p~E~~Ia~g~f~ya~~~---~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         234 PLETDIAHGRFAYASDQ---RRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             cchhhhhcceeeechhc---cCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence                1100000000000   0000000 11111 22234566677777764   4579999999988876554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=3.4e-09  Score=93.53  Aligned_cols=96  Identities=21%  Similarity=0.213  Sum_probs=64.4

Q ss_pred             HHHHHHHHhcCCCC--CcccEEEEEEcCCeeEEEEEeCC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-hHhc
Q 013557          132 WLSEVNYLGQLHHP--NLVKLIGFCLDGENRLLVYEYMP--KGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF-LHEA  206 (441)
Q Consensus       132 ~~~E~~~l~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~-lH~~  206 (441)
                      ..+|.+.|.++..-  ++.+++++.    ..+|||||++  |..+..+. ...   ++......++.+++..+.. +|. 
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~-  125 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHK-  125 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHh-
Confidence            57899999999755  567777553    3479999998  65555433 222   1133456677777775555 566 


Q ss_pred             CCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                       .||+|+||.+.|||++++ .+.|+|||.+..
T Consensus       126 -~givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  126 -AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             -TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             -cCceecCCChhhEEeecc-eEEEEecCccee
Confidence             899999999999999988 999999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.97  E-value=1.9e-08  Score=98.42  Aligned_cols=169  Identities=21%  Similarity=0.250  Sum_probs=126.5

Q ss_pred             ceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE----cCCeeEEEEEeC
Q 013557           92 FGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL----DGENRLLVYEYM  167 (441)
Q Consensus        92 ~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lv~e~~  167 (441)
                      -.+.|+++..         .+|..|++|++.............-+++++++.|.|||.+.++|.    .+..+++|++|+
T Consensus       289 ~~Ttyk~~s~---------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  289 SITTYKATSN---------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             cceeEeeeec---------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            3567776543         357889999995443333333345688899999999999999876    355789999998


Q ss_pred             CC-CCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          168 PK-GSLENHLFRRG-------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       168 ~~-g~L~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      ++ ++|.++-....             +...++..+|.++.|+..||.++|+  .|+.-+-|.+.+||++.+.+++|...
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C  437 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGC  437 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecc
Confidence            76 67888654321             2346789999999999999999999  89999999999999999989999988


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCC
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      |+........         +       |-+.   --.+-|.=.||.+++.|.||..-
T Consensus       438 ~i~Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  438 GIMDVLQEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cceeeecCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            8765432221         0       1111   12356899999999999999653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=8.3e-09  Score=93.82  Aligned_cols=135  Identities=19%  Similarity=0.096  Sum_probs=94.9

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----------------------ccHHHHHHHHH
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----------------------QGHKEWLSEVN  137 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~  137 (441)
                      =+.+...||.|.-+.||.|....          |..+|||.-+....                      .......+|.+
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~----------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~  161 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPK----------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE  161 (304)
T ss_pred             HHhhccccccCccceEEEEECCC----------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence            45678999999999999986543          77899997542110                      01123578999


Q ss_pred             HHhcCCCC--CcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc
Q 013557          138 YLGQLHHP--NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF  215 (441)
Q Consensus       138 ~l~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl  215 (441)
                      +|.+|.-.  .+.+.+++    +...+|||+++|-.|...-       +..+..-.++..|++-+..+-.  .||||+|+
T Consensus       162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~--~GiVHGDl  228 (304)
T COG0478         162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR--RGIVHGDL  228 (304)
T ss_pred             HHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH--cCccccCC
Confidence            99999644  77777765    3568999999997775532       1222233344444444444434  79999999


Q ss_pred             CCCcEEECCCCcEEEcccCCcc
Q 013557          216 KASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       216 kp~Nill~~~~~~kl~DFg~a~  237 (441)
                      .+-||+++++|.++++||--+.
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             chheEEEecCCCEEEEeCcccc
Confidence            9999999999999999996554

>PRK09902 hypothetical protein; Provisional

Probab=98.89  E-value=2.6e-08  Score=88.53  Aligned_cols=138  Identities=18%  Similarity=0.138  Sum_probs=101.2

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC------cccHHHHHHHHHHHhcCCCCC--cccEEEEEE-c-
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG------FQGHKEWLSEVNYLGQLHHPN--LVKLIGFCL-D-  156 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~-~-  156 (441)
                      -|+||.+-|++..+.           |..+-+|+-....      ......|.+|+..|.+|..-+  +.++. ++. . 
T Consensus        26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k   93 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK   93 (216)
T ss_pred             cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence            466888888875433           3357777654211      124567899999999985333  44554 332 1 


Q ss_pred             ---CCeeEEEEEeCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--EEE
Q 013557          157 ---GENRLLVYEYMPK-GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--AKL  230 (441)
Q Consensus       157 ---~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--~kl  230 (441)
                         ...-+||+|-+.| .+|.+++......+.+......++.+++..+.-||+  .|+.|+|+.+.|||++.++.  +++
T Consensus        94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902         94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEE
Confidence               1246899998754 689988866554456788888999999999999998  89999999999999987777  999


Q ss_pred             cccCCccc
Q 013557          231 SDFGLAKA  238 (441)
Q Consensus       231 ~DFg~a~~  238 (441)
                      +||.-++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99976654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=3.6e-08  Score=89.06  Aligned_cols=105  Identities=21%  Similarity=0.216  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHhcCCCC--CcccEEEEEEcCC----eeEEEEEeCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 013557          130 KEWLSEVNYLGQLHHP--NLVKLIGFCLDGE----NRLLVYEYMPKG-SLENHLFRRGARPLPWTLRIKVAIGAARGLSF  202 (441)
Q Consensus       130 ~~~~~E~~~l~~l~hp--nIv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~  202 (441)
                      ....+|...+..|..-  ..++.+.+.+...    ..+||+|++++. +|.+++.....  .+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            4577888888888533  3466676665432    458999999884 79998865332  5666788999999999999


Q ss_pred             hHhcCCCeEEeccCCCcEEECCCC---cEEEcccCCccc
Q 013557          203 LHEAEQQVIYRDFKASNILLDSEF---NAKLSDFGLAKA  238 (441)
Q Consensus       203 lH~~~~~ivH~Dlkp~Nill~~~~---~~kl~DFg~a~~  238 (441)
                      ||.  .||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       134 lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            998  9999999999999999887   799999987764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.76  E-value=3.8e-08  Score=99.61  Aligned_cols=141  Identities=17%  Similarity=0.169  Sum_probs=91.7

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccH-----------------------------------
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-----------------------------------  129 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------------------  129 (441)
                      +.|+.++-|.||+|.++.          |+.||||+.++.-....                                   
T Consensus       131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            679999999999998764          78999999876422110                                   


Q ss_pred             -----HHHHHHHHHHhcCC-----CCCcccEEEEE-EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH
Q 013557          130 -----KEWLSEVNYLGQLH-----HPNLVKLIGFC-LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR  198 (441)
Q Consensus       130 -----~~~~~E~~~l~~l~-----hpnIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~  198 (441)
                           -++.+|..-+.+++     .+++ .+=.+| +-.....|+|||++|-.+.+...... ..++...+.....++. 
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f-  277 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF-  277 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH-
Confidence                 02345555555442     2332 121222 23456789999999999988743222 2355433333333222 


Q ss_pred             HHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       199 ~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                       +..+=.  .|++|.|.+|.||+++.+|++.+.|||+......
T Consensus       278 -~~q~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 -LRQLLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -HHHHHh--cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             122222  5899999999999999999999999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.68  E-value=4.3e-07  Score=83.14  Aligned_cols=138  Identities=14%  Similarity=0.149  Sum_probs=85.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC--cccEEEEEEcCCeeEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN--LVKLIGFCLDGENRLL  162 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~l  162 (441)
                      ..||+|..+.||+..             +..+++|......  ......+|.+++..+..-+  +.+++++....+...+
T Consensus         7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence            578999999999721             3357888876532  3455788999999986433  5778888888888899


Q ss_pred             EEEeCCCCC-HHHHH---------------------HhcCCCCCCHHHHHH-HHH----------HHHH-HHHHhH--hc
Q 013557          163 VYEYMPKGS-LENHL---------------------FRRGARPLPWTLRIK-VAI----------GAAR-GLSFLH--EA  206 (441)
Q Consensus       163 v~e~~~~g~-L~~~l---------------------~~~~~~~~~~~~~~~-i~~----------~i~~-~L~~lH--~~  206 (441)
                      |||+++|.+ +...+                     +.-............ +..          .+.. ...+|.  ..
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999999864 21111                     100000111111000 000          0001 112222  12


Q ss_pred             CCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34678999999999999888 99999987753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=1.1e-08  Score=103.37  Aligned_cols=151  Identities=19%  Similarity=0.268  Sum_probs=97.1

Q ss_pred             HHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccce-------eeeccCCCCcCchhhhhc
Q 013557          193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV-------STQVMGTRGYAAPEYLAT  265 (441)
Q Consensus       193 ~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  265 (441)
                      +.+++.||.|+|.+ -++||++|.|++|.++.++..||+.|+.+...........       ..-..-...|.|||++.+
T Consensus       105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            33445999999984 7999999999999999999999999998764332111000       001123568999999998


Q ss_pred             CCCCchhhhHHHhHHHHHHH-hCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHh
Q 013557          266 GRLTAKCDVYSFGVVLLELL-SGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI  344 (441)
Q Consensus       266 ~~~~~~sDvwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~  344 (441)
                      ...+.++|+|||||++|.+. .|+..+...+......     ....        ..+......-.....+....|.+...
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~--------~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRN--------LLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhc--------ccccccccccccCcHHHHHHHHHHhc
Confidence            88899999999999999999 5666554332111110     0000        00001111112233445555656656


Q ss_pred             cCCCCCCCHHHHH
Q 013557          345 SEAKVRPSMSEVL  357 (441)
Q Consensus       345 ~~P~~RPs~~evl  357 (441)
                      .+...||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            6899999887764

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.63  E-value=3.8e-07  Score=81.42  Aligned_cols=138  Identities=14%  Similarity=0.126  Sum_probs=90.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHH---------HHHHHHHHhcCCC---
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---------WLSEVNYLGQLHH---  144 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---  144 (441)
                      ..++|.+.+++-......|.+-..+           +..+++|..+.......+.         ..+++..+.+++.   
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~   97 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF   97 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence            4578888888888777777764332           6789999887654322222         2234444444432   


Q ss_pred             CCcccEEEEEE-----cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          145 PNLVKLIGFCL-----DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       145 pnIv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                      -.+..++.+.+     -....+|||||++|..|.+...      +++    .+...+..++.-+|.  .|++|+|.+|+|
T Consensus        98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgN  165 (229)
T PF06176_consen   98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGN  165 (229)
T ss_pred             cccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcCc
Confidence            22333332222     2234578999999988876531      222    234556778999998  899999999999


Q ss_pred             EEECCCCcEEEcccCCccc
Q 013557          220 ILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~  238 (441)
                      ++++.+ .++++||+..+.
T Consensus       166 Flv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  166 FLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEEECC-cEEEEECccccc
Confidence            999965 599999976653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.54  E-value=1e-06  Score=81.81  Aligned_cols=138  Identities=18%  Similarity=0.094  Sum_probs=82.7

Q ss_pred             eeecCc-eEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEEEE
Q 013557           87 IGEGGF-GYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLLVY  164 (441)
Q Consensus        87 lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  164 (441)
                      |..|.. ..||+....           +..++||+.....   ...+.+|+++++.+. +--+.+++++....+..++||
T Consensus         6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   71 (244)
T cd05150           6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT   71 (244)
T ss_pred             cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence            444555 788985321           2468888876543   334667999988883 444678888877766789999


Q ss_pred             EeCCCCCHHHHH-------------------HhcC--CCCCCHH--HHHHHHH--------------------HHHHHHH
Q 013557          165 EYMPKGSLENHL-------------------FRRG--ARPLPWT--LRIKVAI--------------------GAARGLS  201 (441)
Q Consensus       165 e~~~~g~L~~~l-------------------~~~~--~~~~~~~--~~~~i~~--------------------~i~~~L~  201 (441)
                      |+++|.+|....                   +.-.  ..++...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            999998776431                   0000  0011100  0000000                    0111112


Q ss_pred             HhHh-----cCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          202 FLHE-----AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       202 ~lH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .|-.     ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            2211     124589999999999999987788999987643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=7e-07  Score=76.33  Aligned_cols=130  Identities=15%  Similarity=0.134  Sum_probs=90.0

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCe
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGEN  159 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~  159 (441)
                      .+..+.|++|++|.||+|.+.           +..+|+|+-+.+.  ....+..|+++|..+.--++ .+++.+..    
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence            345678999999999999886           4478999877653  45668899999999986666 44554432    


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccC-CCcEEECCCCcEEEcccCCccc
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFK-ASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlk-p~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .++.|||+.|-.|.++-...     +...    ...+++.---|-.  .||-|+.|. |..++|-.++.+.|+||.-|..
T Consensus        87 ~~i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            24569999998887764221     2222    3334444333443  789999986 5555555555999999998874

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.47  E-value=1.7e-06  Score=78.13  Aligned_cols=153  Identities=20%  Similarity=0.163  Sum_probs=102.2

Q ss_pred             ccccHHHHHHHhcCCCCCCeee---ecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---------------
Q 013557           67 KAFTFSELKNATRNFRPDSLIG---EGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---------------  128 (441)
Q Consensus        67 ~~~~~~~~~~~~~~y~~~~~lG---~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------  128 (441)
                      ...+++.+....++..+..+.|   .|.-+.||+|...          .+..+|||+++......               
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~  102 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRN  102 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhc
Confidence            3456677777777877776655   5667789987532          36789999987432111               


Q ss_pred             ----HHH-----HHHHHHHHhcCC--CCCcccEEEEEEcCCeeEEEEEeCCCCC-HHHHHHhcCCCCCCHHHHHHHHHHH
Q 013557          129 ----HKE-----WLSEVNYLGQLH--HPNLVKLIGFCLDGENRLLVYEYMPKGS-LENHLFRRGARPLPWTLRIKVAIGA  196 (441)
Q Consensus       129 ----~~~-----~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~i~~~i  196 (441)
                          .+.     ..+|+.-|.++.  +-.+.+.+.+.    ...|||||+.... -.-.|.   ..++...+...+..++
T Consensus       103 ~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~  175 (268)
T COG1718         103 SRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDV  175 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHH
Confidence                111     256888888883  55566777664    3479999985431 111111   1123333566677777


Q ss_pred             HHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       197 ~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ++.+.-|-. ..++||+||..-|||+. ++.+.|+|||-|..
T Consensus       176 v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         176 VEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            777777764 26899999999999999 77999999998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.39  E-value=5.1e-06  Score=73.43  Aligned_cols=137  Identities=29%  Similarity=0.417  Sum_probs=97.1

Q ss_pred             CCCCCccccHHHHHHHhcCCCCCCeeeecCc-eEEEEEEecCcccccccCCCccEEEEEEcCCC---Cc-----------
Q 013557           62 SCPNLKAFTFSELKNATRNFRPDSLIGEGGF-GYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE---GF-----------  126 (441)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~-----------  126 (441)
                      ..+++..|+.     .+.+++.++.||.|.- |.||++.+.           |+.+|+|+++.-   ..           
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~   88 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHE   88 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccc
Confidence            5567777776     2378999999999999 999998775           668999993321   00           


Q ss_pred             -------ccHHHHHHHHHHHhcCC---CCCc--ccEEEEEEcC------------------CeeEEEEEeCCCCCHHHHH
Q 013557          127 -------QGHKEWLSEVNYLGQLH---HPNL--VKLIGFCLDG------------------ENRLLVYEYMPKGSLENHL  176 (441)
Q Consensus       127 -------~~~~~~~~E~~~l~~l~---hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l  176 (441)
                             .....|..|.+...+|+   +.++  |+.+||..-.                  ...-||.||++...     
T Consensus        89 ~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----  163 (207)
T PF13095_consen   89 TSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----  163 (207)
T ss_pred             cccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----
Confidence                   01124778998888774   4456  8899886321                  12357888776533     


Q ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       177 ~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                            .+....    +.+|.+-|..+|.  .||+-+|+++.|..     .-||+|||.+
T Consensus       164 ------~~~~~~----~~~~~~dl~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  164 ------PLQIRD----IPQMLRDLKILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ------ccchhH----HHHHHHHHHHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence                  123333    5567777888998  89999999999997     4589999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.38  E-value=1.3e-05  Score=71.35  Aligned_cols=132  Identities=22%  Similarity=0.292  Sum_probs=91.6

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC----------------cccHHHHHHHHHHHhcCC----
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG----------------FQGHKEWLSEVNYLGQLH----  143 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~----  143 (441)
                      ...||+|+.-.||.-  .          .+....||+.....                ....++..+|+.....+.    
T Consensus         6 ~~~i~~G~~R~cy~H--P----------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~   73 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P----------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG   73 (199)
T ss_pred             CcccccCCCceEEEC--C----------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence            467999999999961  1          12346788887665                112345566766655554    


Q ss_pred             --CCCcccEEEEEEcCCeeEEEEEeCCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc
Q 013557          144 --HPNLVKLIGFCLDGENRLLVYEYMPK------GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF  215 (441)
Q Consensus       144 --hpnIv~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl  215 (441)
                        +.+|.+++|+.+++...-+|+|.+.+      .+|.+++....   ++. .....+.+.   ..||-.  ..|+.+||
T Consensus        74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f---~~~l~~--~~Iv~~dl  144 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEF---KRYLLD--HHIVIRDL  144 (199)
T ss_pred             CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHH---HHHHHH--cCCeecCC
Confidence              78899999999999999999998743      47888884433   555 444444433   555655  78999999


Q ss_pred             CCCcEEECCC--C--cEEEcc-cCCc
Q 013557          216 KASNILLDSE--F--NAKLSD-FGLA  236 (441)
Q Consensus       216 kp~Nill~~~--~--~~kl~D-Fg~a  236 (441)
                      +|.||++...  +  .++|+| ||..
T Consensus       145 ~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CcccEEEEecCCCceEEEEEeCCCCc
Confidence            9999999543  2  588888 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=4.4e-06  Score=76.50  Aligned_cols=140  Identities=21%  Similarity=0.194  Sum_probs=81.4

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC--CcccEEEEEEc---CCe
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP--NLVKLIGFCLD---GEN  159 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~---~~~  159 (441)
                      +.|+.|..+.||+....           +..+++|.....  .....+.+|..+++.|...  .+.+++.+...   ...
T Consensus         3 ~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             ccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            57899999999986543           237899997654  3456677899998888533  35677764432   335


Q ss_pred             eEEEEEeCCCCCHHH----------------HH---Hhc--CCCCCCHHH---------HHHH------------HHHHH
Q 013557          160 RLLVYEYMPKGSLEN----------------HL---FRR--GARPLPWTL---------RIKV------------AIGAA  197 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~----------------~l---~~~--~~~~~~~~~---------~~~i------------~~~i~  197 (441)
                      .+++|++++|..+..                .+   +..  ...++....         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            689999999988877                11   111  111111100         0000            11122


Q ss_pred             H-HHHHhHh-----cCCCeEEeccCCCcEEEC-CCCcEEEcccCCcc
Q 013557          198 R-GLSFLHE-----AEQQVIYRDFKASNILLD-SEFNAKLSDFGLAK  237 (441)
Q Consensus       198 ~-~L~~lH~-----~~~~ivH~Dlkp~Nill~-~~~~~kl~DFg~a~  237 (441)
                      . .+..++.     ....++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2 2333332     236799999999999999 56667899998664

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=1.9e-06  Score=87.20  Aligned_cols=161  Identities=17%  Similarity=0.116  Sum_probs=100.1

Q ss_pred             CCCccccHHHHHHHhc---------CC--CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc----
Q 013557           64 PNLKAFTFSELKNATR---------NF--RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG----  128 (441)
Q Consensus        64 ~~~~~~~~~~~~~~~~---------~y--~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----  128 (441)
                      ++...++++|+....+         -|  --.+.||.-..|.||+|+.++          |..||||+-++.-...    
T Consensus       135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~D  204 (538)
T KOG1235|consen  135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLD  204 (538)
T ss_pred             ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHH
Confidence            4455667776654321         11  123679999999999988764          7789999987542111    


Q ss_pred             ---------------------------------HHHHHHHHHHHhc----CCCCC------cccEEEEEEcCCeeEEEEE
Q 013557          129 ---------------------------------HKEWLSEVNYLGQ----LHHPN------LVKLIGFCLDGENRLLVYE  165 (441)
Q Consensus       129 ---------------------------------~~~~~~E~~~l~~----l~hpn------Iv~l~~~~~~~~~~~lv~e  165 (441)
                                                       .-+|.+|++-..+    +.|-+      |.+++--  -.....|+||
T Consensus       205 l~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME  282 (538)
T KOG1235|consen  205 LRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTME  282 (538)
T ss_pred             HHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEE
Confidence                                             0023444443332    33444      3333322  2345789999


Q ss_pred             eCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC----CCcEEEcccCCcccCCC
Q 013557          166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS----EFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       166 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~----~~~~kl~DFg~a~~~~~  241 (441)
                      |++|..+.|.-.-. ...++...+...+.+...-+-+.    .|++|.|=+|.||+++.    ++.+.+.|||+......
T Consensus       283 ~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  283 YVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIFK----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHHh----cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            99998877753211 12366665555444443333332    58999999999999984    56799999999876544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=3.1e-08  Score=99.30  Aligned_cols=182  Identities=17%  Similarity=0.107  Sum_probs=126.4

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC-cccEEEEEEcCCeeEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN-LVKLIGFCLDGENRLL  162 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~l  162 (441)
                      ..-+++|++++++|.+-..          .+....+.+...     ....-++++|.+++||| .+..++-+..+....+
T Consensus       247 fh~fvK~altknpKkRpta----------eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTA----------EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             HHHHHHHHhcCCCccCCCh----------hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            3457889999999743211          122234444322     33456899999999999 6666666677778899


Q ss_pred             EEEeCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          163 VYEYMPKG-SLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       163 v~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +|+++.++ +-.+.+.. ....+...+...+...-+++|+++|+  ..-+|+|    ||+..+ +..++.||+....+..
T Consensus       312 ~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-cccccccccCCcccCc
Confidence            99999776 22111110 00113333445556666789999997  3458888    887765 5789999998876544


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      ..   ..+...+|+.++|||+..+..+....|+|++|+-..++--|-+|-
T Consensus       384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            33   345678999999999999999999999999999877887777664

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=8.3e-06  Score=75.25  Aligned_cols=73  Identities=15%  Similarity=0.163  Sum_probs=46.2

Q ss_pred             CeeeecCce-EEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC---CcccEEEEEEcC---
Q 013557           85 SLIGEGGFG-YVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP---NLVKLIGFCLDG---  157 (441)
Q Consensus        85 ~~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~---  157 (441)
                      +.|+.|+.. .||+.              +..+++|..+..  .....+.+|.++|..|...   -+.++++.....   
T Consensus         3 ~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~   66 (235)
T cd05155           3 EPVDSGGTDNATFRL--------------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY   66 (235)
T ss_pred             eeccCCCcccceEEc--------------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence            467777766 58862              224778876542  2345688899999888531   345555543322   


Q ss_pred             CeeEEEEEeCCCCCHH
Q 013557          158 ENRLLVYEYMPKGSLE  173 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~  173 (441)
                      ...+++|++++|.++.
T Consensus        67 ~~~~~l~~~i~G~~l~   82 (235)
T cd05155          67 PWPWSVYRWLEGETAT   82 (235)
T ss_pred             CcceEEEEeecCCCCC
Confidence            2358899999997763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=2.4e-05  Score=85.32  Aligned_cols=82  Identities=20%  Similarity=0.255  Sum_probs=56.5

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCC-CCCc--ccEEEEEEcC--
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLH-HPNL--VKLIGFCLDG--  157 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~--  157 (441)
                      .+.|+.|.+..+|+......       .....+++|+..... ......+.+|+++|+.|. |.++  .+++.+|.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            46788999999998644321       111357777765432 223456889999999995 6665  7888887664  


Q ss_pred             -CeeEEEEEeCCCCCH
Q 013557          158 -ENRLLVYEYMPKGSL  172 (441)
Q Consensus       158 -~~~~lv~e~~~~g~L  172 (441)
                       ...|+||||++|..+
T Consensus       116 ~G~~flVME~v~G~~~  131 (822)
T PLN02876        116 IGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCCceEEEEecCCccc
Confidence             467999999988643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.09  E-value=1.6e-05  Score=70.39  Aligned_cols=101  Identities=26%  Similarity=0.263  Sum_probs=78.0

Q ss_pred             HHHHHHhcCCC-CCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-Ce
Q 013557          134 SEVNYLGQLHH-PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR-RGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QV  210 (441)
Q Consensus       134 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~i  210 (441)
                      .|.-+|+.+++ +++++++|+|-    .++|.||+..+++.+.-.. ......+|..+.+|+.++++.+++++.... .+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888975 69999999983    4789999987666431000 011236899999999999999999986322 36


Q ss_pred             EEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          211 IYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       211 vH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .-.|++++|+-++++|++|++|.+.+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            6679999999999999999999986643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.96  E-value=0.00014  Score=69.58  Aligned_cols=76  Identities=12%  Similarity=-0.009  Sum_probs=53.9

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-C--CCcccEEEEEEcC---
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-H--PNLVKLIGFCLDG---  157 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~---  157 (441)
                      .+.||.|..+.||+....           +..+++|..+..  .....+..|...|+.|. +  -.+.++++++...   
T Consensus        19 ~~~i~~G~~~~vy~~~~~-----------~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~   85 (297)
T PRK10593         19 VECISEQPYAALWALYDS-----------QGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP   85 (297)
T ss_pred             eeecCCccceeEEEEEcC-----------CCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence            467999999999985322           124667775431  12356788999998884 2  3678889887543   


Q ss_pred             CeeEEEEEeCCCCCH
Q 013557          158 ENRLLVYEYMPKGSL  172 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L  172 (441)
                      +..+||||+++|.++
T Consensus        86 g~~~LVmE~i~G~~~  100 (297)
T PRK10593         86 GPDVLLLERLRGVSV  100 (297)
T ss_pred             CCeEEEEeccCCEec
Confidence            568999999998765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.89  E-value=9.2e-05  Score=70.73  Aligned_cols=141  Identities=18%  Similarity=0.103  Sum_probs=81.2

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC--cccEEEE------EE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN--LVKLIGF------CL  155 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~  155 (441)
                      .+.|..|....+|+....           +..+++|+...   .....+..|+.++..|.+.+  +.+++..      ..
T Consensus        19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            345667777889975332           23588898764   23445667888888874332  4444431      22


Q ss_pred             cCCeeEEEEEeCCCCCHHH----HH----------Hhc--CC-------CCCCHHHHH----------HHHHHHHHHHHH
Q 013557          156 DGENRLLVYEYMPKGSLEN----HL----------FRR--GA-------RPLPWTLRI----------KVAIGAARGLSF  202 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~----~l----------~~~--~~-------~~~~~~~~~----------~i~~~i~~~L~~  202 (441)
                      ..+..++|++|++|..+..    .+          +..  ..       ....+....          .....+..++.+
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            3456689999999876522    11          110  00       001111100          011112233444


Q ss_pred             hHh-----cCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          203 LHE-----AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       203 lH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      +..     ...+++|+|++|.|||++.++.+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            432     125799999999999999887778999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.84  E-value=0.00025  Score=76.47  Aligned_cols=195  Identities=22%  Similarity=0.250  Sum_probs=128.9

Q ss_pred             HHHHHHHHhcCCCCCcccEEEEEEcCCee----EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcC
Q 013557          132 WLSEVNYLGQLHHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAE  207 (441)
Q Consensus       132 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~  207 (441)
                      ...|...+.++.|+|++.++.+..+....    .+..|++..-++...+..-+  ..+....+.+..++.+||.|+|+  
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~--  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS--  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH--
Confidence            34567778888999999999886654332    23456777778877775444  47888899999999999999998  


Q ss_pred             CCeEEeccCCC---cEEECCCCcEEEc--ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCch--hhhHHHhHH
Q 013557          208 QQVIYRDFKAS---NILLDSEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAK--CDVYSFGVV  280 (441)
Q Consensus       208 ~~ivH~Dlkp~---Nill~~~~~~kl~--DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDvwSlG~i  280 (441)
                      ....|.-|..+   +...+..+.+.+.  ||+.+........   .....-+..|.++|......+..+  .|+|.+|..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence            45555555444   4445666667776  8988876544332   122334556788888766655554  699999999


Q ss_pred             HHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          281 LLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       281 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +..+..|..+-...                   .....+++.        ............|.. +.++|+++.+++..
T Consensus       382 ~~~~~~~~~i~~~~-------------------~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKS-------------------AVPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCcccccc-------------------cchhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            99999987642211                   011111111        111133444556665 89999999999876


Q ss_pred             h
Q 013557          360 L  360 (441)
Q Consensus       360 L  360 (441)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            4

>PRK05231 homoserine kinase; Provisional

Probab=97.81  E-value=0.00068  Score=65.50  Aligned_cols=156  Identities=14%  Similarity=0.066  Sum_probs=82.6

Q ss_pred             ccHHHHHHHhcCCCC-----CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC
Q 013557           69 FTFSELKNATRNFRP-----DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH  143 (441)
Q Consensus        69 ~~~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  143 (441)
                      .+..++...-..|.+     .+.|+.|....+|+....           +..+++|+...   .....+..|+.++..|.
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-----------~g~~vLK~~~~---~~~~~l~~~~~~l~~L~   72 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-----------QGEYVLTLFER---LTAEDLPFFLGLMQHLA   72 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC-----------CCcEEEEEecc---CChHHhHHHHHHHHHHH
Confidence            344555555556655     244666777788875432           22588898752   12334445666666653


Q ss_pred             CC--CcccEEE------EEEcCCeeEEEEEeCCCCCHH-----------HHH---Hhc--CC-------CCCCH-HHHHH
Q 013557          144 HP--NLVKLIG------FCLDGENRLLVYEYMPKGSLE-----------NHL---FRR--GA-------RPLPW-TLRIK  191 (441)
Q Consensus       144 hp--nIv~l~~------~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~--~~-------~~~~~-~~~~~  191 (441)
                      ..  .+.+++.      +....+..++++||++|..+.           ..+   +..  +.       ..+.+ .....
T Consensus        73 ~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~  152 (319)
T PRK05231         73 ARGVPVPAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAP  152 (319)
T ss_pred             HCCCCCCcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHH
Confidence            22  2334432      122355679999999986431           111   110  00       00111 11110


Q ss_pred             ------------HHHH-HHHHHHHhHh-----cCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          192 ------------VAIG-AARGLSFLHE-----AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       192 ------------i~~~-i~~~L~~lH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                                  .+.+ +...++.+..     ...+++|+|+++.|||++.+...-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        153 RLLPFLADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHhhccChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                        1111 1112222221     235899999999999999765568999987754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.78  E-value=0.00025  Score=65.21  Aligned_cols=75  Identities=17%  Similarity=0.079  Sum_probs=45.4

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC-cccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN-LVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv  163 (441)
                      +.|..|-...+|+.....+        .+..+++|+....... .-+..+|+.+++.+...+ .++++..+.    ..+|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence            4566777789998543210        1346888877643221 122346888888885333 455554432    2489


Q ss_pred             EEeCCCCCH
Q 013557          164 YEYMPKGSL  172 (441)
Q Consensus       164 ~e~~~~g~L  172 (441)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998766

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.77  E-value=0.00015  Score=67.76  Aligned_cols=136  Identities=17%  Similarity=0.099  Sum_probs=75.6

Q ss_pred             eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEEEEE
Q 013557           87 IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLLVYE  165 (441)
Q Consensus        87 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e  165 (441)
                      +..|-...+|+...           .+..+++|..........-+..+|..+++.+..-++ .+++..+.    .++|||
T Consensus         4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e   68 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVE   68 (256)
T ss_pred             CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence            45577778887532           245688887654322111134678999988854333 44554432    368999


Q ss_pred             eCCCCCHHHH----------H-------HhcC--CCCCCHHH-HHHHHHHH---------HHHHHHhHhc------CCCe
Q 013557          166 YMPKGSLENH----------L-------FRRG--ARPLPWTL-RIKVAIGA---------ARGLSFLHEA------EQQV  210 (441)
Q Consensus       166 ~~~~g~L~~~----------l-------~~~~--~~~~~~~~-~~~i~~~i---------~~~L~~lH~~------~~~i  210 (441)
                      |++|..+...          +       +...  ..++.... ...+..++         ...+..+-..      ...+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            9998765321          1       1111  11122221 11111111         1112222110      1358


Q ss_pred             EEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          211 IYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       211 vH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      +|+|+.|.||++++++ +.|+||+.+..
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999999876 78999987764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.71  E-value=3.4e-05  Score=72.32  Aligned_cols=134  Identities=17%  Similarity=0.087  Sum_probs=89.7

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--c------------------c--cHHHHHHHHH
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--F------------------Q--GHKEWLSEVN  137 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~------------------~--~~~~~~~E~~  137 (441)
                      =+.+.+.||-|.-+.||.+-..+          |...++|.-+...  +                  .  ..-...+|+.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa  162 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA  162 (465)
T ss_pred             hhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence            36678999999999999976543          5667777543210  0                  0  0112457888


Q ss_pred             HHhcCC-CC-CcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc
Q 013557          138 YLGQLH-HP-NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF  215 (441)
Q Consensus       138 ~l~~l~-hp-nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl  215 (441)
                      .|+.|. |- -+.+.+++    +..++|||++.|-.|...-.-     .....+.   ..+..-+.-|..  +|+||+|.
T Consensus       163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly---~~lm~~Iv~la~--~GlIHgDF  228 (465)
T KOG2268|consen  163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLY---DDLMGLIVRLAN--HGLIHGDF  228 (465)
T ss_pred             HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHH---HHHHHHHHHHHH--cCceeccc
Confidence            888884 32 35555554    456899999999888664211     2223333   333333455555  89999999


Q ss_pred             CCCcEEECCCCcEEEcccCCcc
Q 013557          216 KASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       216 kp~Nill~~~~~~kl~DFg~a~  237 (441)
                      .-=||++++++.++++||--..
T Consensus       229 NEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  229 NEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             chheeEEecCCCEEEeechHhh
Confidence            9999999999999999996443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.66  E-value=0.00074  Score=66.73  Aligned_cols=76  Identities=21%  Similarity=0.166  Sum_probs=52.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC------C-cccHHHHHHHHHHHhcCC---CCCcccEEEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE------G-FQGHKEWLSEVNYLGQLH---HPNLVKLIGFC  154 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~  154 (441)
                      +.||.|.+..||++....         .++.++||+-.+.      . ....++...|.+.|..+.   -.++++++.+ 
T Consensus        32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence            578999999999976532         1247899985421      1 123456778888888763   2457777766 


Q ss_pred             EcCCeeEEEEEeCCCCC
Q 013557          155 LDGENRLLVYEYMPKGS  171 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~  171 (441)
                       +....++||||+++..
T Consensus       102 -D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 -DEELAVTVMEDLSDHK  117 (401)
T ss_pred             -CCCCCEEEEecCCCcc
Confidence             4466789999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.52  E-value=0.0023  Score=61.48  Aligned_cols=154  Identities=15%  Similarity=0.084  Sum_probs=85.1

Q ss_pred             HHHHHHhcCCCC-----CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC-
Q 013557           72 SELKNATRNFRP-----DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP-  145 (441)
Q Consensus        72 ~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-  145 (441)
                      +++...-++|.+     .+.++.|....+|+....           +..+++|+.....  ....+..|+.++..|... 
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-----------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g   76 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-----------VGRYILTLYEKRV--KAEELPFFLALTTHLAARG   76 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeC-----------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCC
Confidence            444444445655     355667777889975322           2257788875421  234455677777777422 


Q ss_pred             -CcccEEEE------EEcCCeeEEEEEeCCCCCHH----H-------H---HHh--cCC-CC-------CCHHHHH----
Q 013557          146 -NLVKLIGF------CLDGENRLLVYEYMPKGSLE----N-------H---LFR--RGA-RP-------LPWTLRI----  190 (441)
Q Consensus       146 -nIv~l~~~------~~~~~~~~lv~e~~~~g~L~----~-------~---l~~--~~~-~~-------~~~~~~~----  190 (441)
                       .+.+++..      ....+..+++|||++|..+.    +       .   ++.  .+. .+       -.|....    
T Consensus        77 ~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~  156 (307)
T TIGR00938        77 LPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCF  156 (307)
T ss_pred             CCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhh
Confidence             24444432      12245678999999885431    1       0   111  000 00       0111000    


Q ss_pred             --------HHHHHHHHHHHHhHh-----cCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          191 --------KVAIGAARGLSFLHE-----AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       191 --------~i~~~i~~~L~~lH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                              .....+...++++..     ...+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       157 ~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       157 EAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                    001112334444432     236899999999999999887778999987653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.50  E-value=0.00074  Score=64.71  Aligned_cols=80  Identities=19%  Similarity=0.150  Sum_probs=47.4

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC-cccEEEEEEcCCeeEEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN-LVKLIGFCLDGENRLLVY  164 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~  164 (441)
                      .|..|-...+|+.......   ..+..+..+++|+..... ....+..+|.+++..+...+ ..+++.++..    .+|+
T Consensus         5 ~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           5 KISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            4555666688876432210   012235678999976542 22234567888888885333 3456655532    3689


Q ss_pred             EeCCCCCHH
Q 013557          165 EYMPKGSLE  173 (441)
Q Consensus       165 e~~~~g~L~  173 (441)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.42  E-value=3.1e-05  Score=85.13  Aligned_cols=174  Identities=14%  Similarity=0.041  Sum_probs=120.3

Q ss_pred             EEEEEcCCCCcccHHH-----HHHHHHHHhcCCCCCcccEEEEEE--cCCeeEEEEEeCCCCCHHHHHHhcCC--CCCCH
Q 013557          116 IAVKKLKPEGFQGHKE-----WLSEVNYLGQLHHPNLVKLIGFCL--DGENRLLVYEYMPKGSLENHLFRRGA--RPLPW  186 (441)
Q Consensus       116 vavK~~~~~~~~~~~~-----~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~  186 (441)
                      +.+|+.+.-.++...+     .+.|.+-++.+.|+++.....-..  +....+.+++++.+|.+++.|.+...  .++..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            3455555443333222     344555566678998876655433  23456889999999999999876432  22333


Q ss_pred             HHHHHHHHHHHHHHHHhHhc---CCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhh
Q 013557          187 TLRIKVAIGAARGLSFLHEA---EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL  263 (441)
Q Consensus       187 ~~~~~i~~~i~~~L~~lH~~---~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  263 (441)
                      .-+.....+.+.+..-+|+.   ..-.+|++||+-|.+|..+-++|++++|+.+...  ......+...+++.|+.+++.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHH
Confidence            33333333335556666652   2347899999999999999999999999998321  122234456788899999999


Q ss_pred             hcCCCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          264 ATGRLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       264 ~~~~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      ..-.++.++|+|..|+.+|++.-|..+|
T Consensus      1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            8888999999999999999998888765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.24  E-value=0.0029  Score=60.43  Aligned_cols=126  Identities=15%  Similarity=0.236  Sum_probs=72.1

Q ss_pred             ccEEEEEEcCC--CCcccHHHHHHHHHHHhcCCC--CCcccEEEEEEcCC--eeEEEEEeCCCCCHHHHHHhcC------
Q 013557          113 GMVIAVKKLKP--EGFQGHKEWLSEVNYLGQLHH--PNLVKLIGFCLDGE--NRLLVYEYMPKGSLENHLFRRG------  180 (441)
Q Consensus       113 ~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~------  180 (441)
                      ++.+++. ...  ..........+|+.+|+.+.-  --+...+++|.++.  ..|.||+|++|..+.+.+....      
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            5567777 321  222334556778888888743  23455667777666  7799999998843322110000      


Q ss_pred             ----------------------C--CCCCHHHHHHHHHHH--------------HHHHHHhHhc------CCCeEEeccC
Q 013557          181 ----------------------A--RPLPWTLRIKVAIGA--------------ARGLSFLHEA------EQQVIYRDFK  216 (441)
Q Consensus       181 ----------------------~--~~~~~~~~~~i~~~i--------------~~~L~~lH~~------~~~ivH~Dlk  216 (441)
                                            .  ......++..+..+.              ..-..+|+.+      ...++|+|++
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                                  0  000111111111111              1122333321      1359999999


Q ss_pred             CCcEEECCCCcEEEcccCCcccC
Q 013557          217 ASNILLDSEFNAKLSDFGLAKAG  239 (441)
Q Consensus       217 p~Nill~~~~~~kl~DFg~a~~~  239 (441)
                      +.||+++.++-+=++||+++...
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccC
Confidence            99999999888999999998764

>PLN02236 choline kinase

Probab=97.16  E-value=0.0048  Score=60.29  Aligned_cols=143  Identities=15%  Similarity=0.123  Sum_probs=79.7

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLLVY  164 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~  164 (441)
                      .|-.|-.-.+|+..+...     ....+..+++|+.......... -.+|..+++.+..-++ .++++.+...    .|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            344466678888654321     0112467889988654322222 2578999888854444 4666665332    589


Q ss_pred             EeCCCCCHHHH-------H----------HhcC---CC-CCCHHHHHHHHHHH-----------------HHHHHHh---
Q 013557          165 EYMPKGSLENH-------L----------FRRG---AR-PLPWTLRIKVAIGA-----------------ARGLSFL---  203 (441)
Q Consensus       165 e~~~~g~L~~~-------l----------~~~~---~~-~~~~~~~~~i~~~i-----------------~~~L~~l---  203 (441)
                      ||+++.+|...       +          +...   .. ...+..+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99988766421       0          1111   00 11122222332111                 1111111   


Q ss_pred             -Hh--cCCCeEEeccCCCcEEECC-CCcEEEcccCCccc
Q 013557          204 -HE--AEQQVIYRDFKASNILLDS-EFNAKLSDFGLAKA  238 (441)
Q Consensus       204 -H~--~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg~a~~  238 (441)
                       ..  ....++|+|+++.|||+++ ++.++|+||..+..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11  1247899999999999986 46799999987754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.12  E-value=0.002  Score=57.50  Aligned_cols=137  Identities=17%  Similarity=0.144  Sum_probs=84.5

Q ss_pred             EEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHH
Q 013557          116 IAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI  194 (441)
Q Consensus       116 vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  194 (441)
                      ..+|++..-... ....|..+.++++++.  .|+++..  .+...+-++.|+|.....           ..    ..++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~----~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-----------NF----SNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-----------ch----hHHHH
Confidence            456666544333 3455778899998885  5777763  244455688999843110           11    11122


Q ss_pred             HHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhh
Q 013557          195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDV  274 (441)
Q Consensus       195 ~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv  274 (441)
                      .=+.+|.-.|+...+.+|+|-.|+|||-|..|.+||.|=+....              .+..|.--|   ....+.++.+
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~  211 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEV  211 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHH
Confidence            22567888897668999999999999999999999999664321              011122211   1345667777


Q ss_pred             HHHhHHHHHHHhCC
Q 013557          275 YSFGVVLLELLSGR  288 (441)
Q Consensus       275 wSlG~il~elltg~  288 (441)
                      =+|=.-++++....
T Consensus       212 ~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  212 KVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHH
Confidence            66666666665543

The function of this family is unknown.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.11  E-value=0.004  Score=58.78  Aligned_cols=31  Identities=26%  Similarity=0.405  Sum_probs=25.7

Q ss_pred             CCeEEeccCCCcEEECCCCc-EEEcccCCccc
Q 013557          208 QQVIYRDFKASNILLDSEFN-AKLSDFGLAKA  238 (441)
Q Consensus       208 ~~ivH~Dlkp~Nill~~~~~-~kl~DFg~a~~  238 (441)
                      ..++|+|+++.|||++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.07  E-value=0.0086  Score=58.12  Aligned_cols=73  Identities=19%  Similarity=0.164  Sum_probs=47.0

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC-------CcccHHHHHHHHHHHhcCC--CC-CcccEEEEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-------GFQGHKEWLSEVNYLGQLH--HP-NLVKLIGFCL  155 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~  155 (441)
                      .||.|....||++....         .++.++||+-.+.       -.....+..-|...|+...  -| .+++++.  .
T Consensus         2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F   70 (370)
T ss_pred             cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence            47999999999976321         1256899975421       1223455667888887763  34 4555554  4


Q ss_pred             cCCeeEEEEEeCCC
Q 013557          156 DGENRLLVYEYMPK  169 (441)
Q Consensus       156 ~~~~~~lv~e~~~~  169 (441)
                      +.....+|||+++.
T Consensus        71 D~e~~~~vMEdL~~   84 (370)
T TIGR01767        71 DTEMAVTVMEDLSH   84 (370)
T ss_pred             ccccceehHhhCcc
Confidence            55667799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.90  E-value=0.0024  Score=62.01  Aligned_cols=133  Identities=21%  Similarity=0.150  Sum_probs=78.9

Q ss_pred             CeeeecCceEEEEEEecCccccc------ccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEE----
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEA------ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGF----  153 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~----  153 (441)
                      ..||.|+-+.||+|+.+..-.+.      .++...+.+|||+..+.....   +...+.||.-.. -.|++.-..+    
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~---ir~Dl~Il~f~Akl~~~vP~l~wL~l~  271 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQ---IRLDLGILGFGAKLINNVPDLSWLSLP  271 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHH---HHHHHHHHhhhhhhhhhcCccccccCc
Confidence            47999999999999876432222      235556789999987653222   222233332221 1111111100    


Q ss_pred             -----------------------------E-------------EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHH
Q 013557          154 -----------------------------C-------------LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK  191 (441)
Q Consensus       154 -----------------------------~-------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  191 (441)
                                                   |             .-.....||=+|..|-++..++...+   .+++.+..
T Consensus       272 ~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kk  348 (565)
T KOG1236|consen  272 LEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS---QPEALVKK  348 (565)
T ss_pred             chHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc---ChHHHHHH
Confidence                                         0             00122356667888888888885544   45556666


Q ss_pred             HHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       192 i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      ++.-.+.||..+--. .+.+|.|++|.||++.-
T Consensus       349 va~lg~~AllkMl~v-DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  349 VAKLGVNALLKMLIV-DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             HHHHHHHHHHHHHHh-hcceecccCCCcEEEEe
Confidence            666666666555432 58999999999999954

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.78  E-value=0.021  Score=56.48  Aligned_cols=73  Identities=15%  Similarity=0.140  Sum_probs=48.3

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-------ccHHHHHHHHHHHhcCC---CCCcccEEEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-------QGHKEWLSEVNYLGQLH---HPNLVKLIGF  153 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpnIv~l~~~  153 (441)
                      .+.||.|..-.||+....           +..++||+-.....       ....+...|...|+.+.   ..++.+++.+
T Consensus        37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            457899999999985432           23588988652111       13344455677776663   2478888887


Q ss_pred             EEcCCeeEEEEEeCCC
Q 013557          154 CLDGENRLLVYEYMPK  169 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~  169 (441)
                      +.  +..+++||++++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            66  456889999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.66  E-value=0.052  Score=52.10  Aligned_cols=30  Identities=23%  Similarity=0.335  Sum_probs=26.1

Q ss_pred             CCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          208 QQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       208 ~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .+++|+|+++.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            68999999999999987 6789999986653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.60  E-value=0.014  Score=55.99  Aligned_cols=105  Identities=15%  Similarity=0.153  Sum_probs=70.2

Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...|++|++- |++|.- +     ....++++..++.+.+..++-+.. +...-|||+.-.||||+ +|++.|+||-+++
T Consensus       299 ~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeee
Confidence            3556777764 545432 2     124678888899888887777775 46899999999999999 9999999999999


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhH
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGV  279 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~  279 (441)
                      ....+..       +-....--|-.+.| .-+.+-|||-+--
T Consensus       370 l~~~q~~-------isy~rldhp~lF~G-~dd~QFeIYrlMr  403 (488)
T COG5072         370 LSYSQGI-------ISYNRLDHPDLFNG-VDDYQFEIYRLMR  403 (488)
T ss_pred             cccCCce-------eeccccCchhhhcC-ccceeeeHHHHHH
Confidence            6433321       11122334555553 3366667775433

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.52  E-value=0.01  Score=58.38  Aligned_cols=75  Identities=20%  Similarity=0.244  Sum_probs=49.0

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC------CcccHHHHHHHHHHHhcCC--CC-CcccEEEEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE------GFQGHKEWLSEVNYLGQLH--HP-NLVKLIGFC  154 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~  154 (441)
                      .+.||.|.-..||++....         .+..++||+-.+.      -.-..++..-|.++|+.+.  -| .+++++.  
T Consensus        34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence            4578999999999976421         1346888875321      1234566777888888763  34 4556654  


Q ss_pred             EcCCeeEEEEEeCCC
Q 013557          155 LDGENRLLVYEYMPK  169 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~  169 (441)
                      .+.....+|||+++.
T Consensus       103 ~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVMNCCVMEDLSD  117 (409)
T ss_pred             ECcHHhhHHHHhCcc
Confidence            455567789998853

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.50  E-value=0.017  Score=54.67  Aligned_cols=73  Identities=19%  Similarity=0.202  Sum_probs=44.9

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC---CCCcccEEEEEEcCCee
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH---HPNLVKLIGFCLDGENR  160 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~  160 (441)
                      .+.|+-|....+|+..           ..+..+.||+-...   ....|..|..-|+.|.   --.+++++.+....+..
T Consensus        22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~   87 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA   87 (288)
T ss_dssp             EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred             eEecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence            4568888889999754           23667899987622   2345667888777773   34678999988877788


Q ss_pred             EEEEEeCCCC
Q 013557          161 LLVYEYMPKG  170 (441)
Q Consensus       161 ~lv~e~~~~g  170 (441)
                      ||||||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            9999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.33  E-value=0.15  Score=46.08  Aligned_cols=160  Identities=21%  Similarity=0.289  Sum_probs=90.6

Q ss_pred             ccEEEEEEcCCCCcccHHHHHHHHHHHhcC---CCCCcccEEEEEEcCCeeEEEEEeCCCCCHH--HH---------HHh
Q 013557          113 GMVIAVKKLKPEGFQGHKEWLSEVNYLGQL---HHPNLVKLIGFCLDGENRLLVYEYMPKGSLE--NH---------LFR  178 (441)
Q Consensus       113 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~--~~---------l~~  178 (441)
                      ...+.||.-...   ....|..|+.-|..|   +--++.+++.+..+..+.|+||||++-+.+.  ..         |+.
T Consensus        39 ~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~~~~GqqLA~LH~  115 (286)
T COG3001          39 TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSAFILGQQLARLHQ  115 (286)
T ss_pred             CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCCchhHHHHHHHHHHHHh
Confidence            346788875432   234566777766666   3456788888888999999999999876654  11         111


Q ss_pred             cCC----------------CCCCH---------HHHHHHHHHHHH--------------HHHHh---HhcCCCeEEeccC
Q 013557          179 RGA----------------RPLPW---------TLRIKVAIGAAR--------------GLSFL---HEAEQQVIYRDFK  216 (441)
Q Consensus       179 ~~~----------------~~~~~---------~~~~~i~~~i~~--------------~L~~l---H~~~~~ivH~Dlk  216 (441)
                      -+.                ++-+|         ++++-+..|+++              .+.-+   |+.....+|+||.
T Consensus       116 ~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~hqpqPsLlHGDLW  195 (286)
T COG3001         116 WGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADHQPQPSLLHGDLW  195 (286)
T ss_pred             hcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcCCCCcceeecccc
Confidence            000                11111         233334443332              22222   4334579999999


Q ss_pred             CCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc--------CCCCchhhhHHHhHHH
Q 013557          217 ASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT--------GRLTAKCDVYSFGVVL  281 (441)
Q Consensus       217 p~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il  281 (441)
                      ..|.++..+| ..+.|  =|....+.+.........|.   .+||...+        ..|..+-+||-|=.+|
T Consensus       196 ~gN~a~~~~G-Pv~fD--PA~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~G~~eRk~iYqLY~ll  262 (286)
T COG3001         196 SGNCAFGKDG-PVIFD--PACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPAGYLERKPIYQLYHLL  262 (286)
T ss_pred             cccccccCCC-Ceeec--cccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCCchHHHhHHHHHHHHH
Confidence            9999999998 77766  23333333322223333333   45666543        2345567787654333

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.23  E-value=0.052  Score=52.20  Aligned_cols=31  Identities=16%  Similarity=0.186  Sum_probs=28.1

Q ss_pred             CCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          208 QQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       208 ~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .+++|+|+.+.|||++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            5899999999999999998999999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.14  E-value=0.048  Score=52.93  Aligned_cols=142  Identities=17%  Similarity=0.206  Sum_probs=75.6

Q ss_pred             eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEEEE
Q 013557           86 LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLLVY  164 (441)
Q Consensus        86 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~  164 (441)
                      .|..|=.-.+|+......      ...+..+++|+....... .-+-.+|..+++.+..-++ .++++++..  .  +|.
T Consensus        21 ~l~gGlTN~~~~v~~~~~------~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~   89 (330)
T PLN02421         21 RISGGITNLLLKVSVKEE------NGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQ   89 (330)
T ss_pred             EeCCcccceEEEEEecCC------CCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC--c--Eee
Confidence            343455567887543221      011336888887653221 1122468888888865455 466666532  2  589


Q ss_pred             EeCCCCCHHH-------HH----------HhcC---CC-CCCHHHHHHHHHHH----------------------HHHHH
Q 013557          165 EYMPKGSLEN-------HL----------FRRG---AR-PLPWTLRIKVAIGA----------------------ARGLS  201 (441)
Q Consensus       165 e~~~~g~L~~-------~l----------~~~~---~~-~~~~~~~~~i~~~i----------------------~~~L~  201 (441)
                      +|++|.+|..       .+          +...   .. +..+..+..+..++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            9998766522       01          1111   00 11122222222221                      11111


Q ss_pred             H---hH-h--cCCCeEEeccCCCcEEECC-CCcEEEcccCCccc
Q 013557          202 F---LH-E--AEQQVIYRDFKASNILLDS-EFNAKLSDFGLAKA  238 (441)
Q Consensus       202 ~---lH-~--~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg~a~~  238 (441)
                      .   +. .  ...-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1   11 1  1124799999999999975 57899999987754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.09  E-value=0.034  Score=53.59  Aligned_cols=139  Identities=18%  Similarity=0.146  Sum_probs=88.4

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccH--------------------H----HHHHH
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGH--------------------K----EWLSE  135 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~--------------------~----~~~~E  135 (441)
                      .+...|..|.-+.||.+.-.          .|..+|||+++-...  .+.                    +    -...|
T Consensus       147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE  216 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE  216 (520)
T ss_pred             ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence            34567888889999987543          366799998763211  000                    0    12457


Q ss_pred             HHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE--NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       136 ~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~--~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      ++-|++|+.-.|...--+..  ....|||+|+- ++=+  -.|   ....++...+..+-.+++.-|.-|-+ ..++||.
T Consensus       217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHA  289 (520)
T KOG2270|consen  217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHA  289 (520)
T ss_pred             HHHHHHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHH-Hhceecc
Confidence            88888886555532221111  23479999983 2211  111   11236666677777777777776655 3689999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCccc
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ||.=-|+|+- +|.+.|+|-+-+..
T Consensus       290 DLSEfN~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  290 DLSEFNLLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             chhhhhheEE-CCEEEEEEcccccc
Confidence            9999999985 45899999887654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.66  E-value=0.68  Score=44.82  Aligned_cols=30  Identities=20%  Similarity=0.257  Sum_probs=24.9

Q ss_pred             CCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..+++|+|+.++|||++ + .+.|+||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            35799999999999995 4 578999987653

>PRK06148 hypothetical protein; Provisional

Probab=95.56  E-value=0.11  Score=58.27  Aligned_cols=32  Identities=41%  Similarity=0.440  Sum_probs=27.0

Q ss_pred             CCCeEEeccCCCcEEECCCC--cEE-EcccCCccc
Q 013557          207 EQQVIYRDFKASNILLDSEF--NAK-LSDFGLAKA  238 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~--~~k-l~DFg~a~~  238 (441)
                      ..++||+|+++.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46899999999999999875  565 999997764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.54  E-value=0.35  Score=46.76  Aligned_cols=121  Identities=25%  Similarity=0.339  Sum_probs=68.4

Q ss_pred             EEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc------ccEEE----EEEcCCeeEEEEEeCCCCCHHH-H---------
Q 013557          116 IAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL------VKLIG----FCLDGENRLLVYEYMPKGSLEN-H---------  175 (441)
Q Consensus       116 vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI------v~l~~----~~~~~~~~~lv~e~~~~g~L~~-~---------  175 (441)
                      +++|+....  ....++..|+..|..|.-.+|      ..+-|    ........+-|++|++|..+.. .         
T Consensus        51 ~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG  128 (331)
T COG2334          51 YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELG  128 (331)
T ss_pred             eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHH
Confidence            489988775  345566678888877732221      12211    1111136788999999987762 1         


Q ss_pred             -----HHh--cCC---C-----CCCHH-------------HHHHHHHHHHHHHHHhHh------cCCC--eEEeccCCCc
Q 013557          176 -----LFR--RGA---R-----PLPWT-------------LRIKVAIGAARGLSFLHE------AEQQ--VIYRDFKASN  219 (441)
Q Consensus       176 -----l~~--~~~---~-----~~~~~-------------~~~~i~~~i~~~L~~lH~------~~~~--ivH~Dlkp~N  219 (441)
                           |+.  ++.   .     ...|.             .......++...++.+.+      ...+  +||+|+.|.|
T Consensus       129 ~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~N  208 (331)
T COG2334         129 RMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN  208 (331)
T ss_pred             HHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccc
Confidence                 110  010   0     11221             001122333444444443      1123  9999999999


Q ss_pred             EEECCCCc-EEEcccCCccc
Q 013557          220 ILLDSEFN-AKLSDFGLAKA  238 (441)
Q Consensus       220 ill~~~~~-~kl~DFg~a~~  238 (441)
                      |+++.+.. +-++|||-+..
T Consensus       209 Vl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         209 VLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeEcCCCCeeeEEEcccccc
Confidence            99999875 88999987653

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.36  E-value=0.026  Score=56.64  Aligned_cols=51  Identities=29%  Similarity=0.378  Sum_probs=40.3

Q ss_pred             HHHHHHHHHHHhcCCCCCcccEEEEEEc-CCeeEEEEEeCCCCCHHHHHHhcC
Q 013557          129 HKEWLSEVNYLGQLHHPNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRG  180 (441)
Q Consensus       129 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~  180 (441)
                      ...++....+++.+.|+|...++++... .....+|||++ +.+|+|.+..+.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            4556778999999999999999987653 34578899998 669999886544

>PTZ00384 choline kinase; Provisional

Probab=94.61  E-value=0.3  Score=48.33  Aligned_cols=81  Identities=16%  Similarity=0.097  Sum_probs=44.1

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv  163 (441)
                      +.|..|-...+|++......   ...-..+.|.+....... ...-+-.+|+++++.|...++ .++++.+..    .+|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCC---CCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            34545777888987543211   000011224444432211 111112468999999965444 566666542    699


Q ss_pred             EEeCCCCCHH
Q 013557          164 YEYMPKGSLE  173 (441)
Q Consensus       164 ~e~~~~g~L~  173 (441)
                      .||++|.+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987664

>PTZ00296 choline kinase; Provisional

Probab=94.19  E-value=0.54  Score=47.51  Aligned_cols=82  Identities=12%  Similarity=0.062  Sum_probs=44.4

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv  163 (441)
                      +.|..|=.-.+|+........ ......++.|++++.......-. +-..|..+++.+..-+| .++++.+.    -..|
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            344445556677765432110 00111245788888755432211 22468888887754455 35666543    2468


Q ss_pred             EEeCCCCCH
Q 013557          164 YEYMPKGSL  172 (441)
Q Consensus       164 ~e~~~~g~L  172 (441)
                      .||++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            999988644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	441
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-57
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-56
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-50
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-49
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-48
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-47
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-46
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-23
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-19
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-19
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-19
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-19
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-19
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-19
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-18
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-16
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-16
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-15
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-15
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-15
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-15
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-15
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		5e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		9e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 195/325 (60%), Gaps = 20/325 (6%)
Query: 45  KRPSGNF-SMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           K+P  +F  +P  E   +    LK F+  EL+ A+ NF   +++G GGFG VYKG     
Sbjct: 3   KKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----- 57
Query: 104 TLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHPNLVKLIGFCLDGENRLL 162
                R   G ++AVK+LK E  QG + ++ +EV  +    H NL++L GFC+    RLL
Sbjct: 58  -----RLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 112
Query: 163 VYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHE-AEQQVIYRDFKASN 219
           VY YM  GS+ + L  R     PL W  R ++A+G+ARGL++LH+  + ++I+RD KA+N
Sbjct: 113 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 172
Query: 220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGV 279
           ILLD EF A + DFGLAK     D  HV   V GT G+ APEYL+TG+ + K DV+ +GV
Sbjct: 173 ILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 231
Query: 280 VLLELLSGRRAVDKTRVGAEQN--LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVA 337
           +LLEL++G+RA D  R+  + +  L+DW K  L + +KL  ++D+ L+G Y  +    + 
Sbjct: 232 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLI 290
Query: 338 ILALQCISEAKV-RPSMSEVLSALE 361
            +AL C   + + RP MSEV+  LE
Sbjct: 291 QVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  215 bits (548), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 130/318 (40%), Positives = 190/318 (59%), Gaps = 19/318 (5%)
Query: 51  FSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARP 110
           F +P  E   +    LK F+  EL+ A+ NF   +++G GGFG VYKG          R 
Sbjct: 2   FDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----------RL 51
Query: 111 GVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPK 169
             G ++AVK+LK E  QG + ++ +EV  +    H NL++L GFC+    RLLVY YM  
Sbjct: 52  ADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 170 GSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHE-AEQQVIYRDFKASNILLDSEF 226
           GS+ + L  R     PL W  R ++A+G+ARGL++LH+  + ++I+RD KA+NILLD EF
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A + DFGLAK     D  HV   V G  G+ APEYL+TG+ + K DV+ +GV+LLEL++
Sbjct: 172 EAVVGDFGLAKLMDYKD-XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
Query: 287 GRRAVDKTRVGAEQN--LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI 344
           G+RA D  R+  + +  L+DW K  L + +KL  ++D+ L+G Y  +    +  +AL C 
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCT 289
Query: 345 SEAKV-RPSMSEVLSALE 361
             + + RP MSEV+  LE
Sbjct: 290 QSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  194 bits (494), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 122/311 (39%), Positives = 182/311 (58%), Gaps = 21/311 (6%)
Query: 61  LSCPNLKAFTFSELKNATRNF--RPDSL----IGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           +S     +F+F ELKN T NF  RP S+    +GEGGFG VYKG+++  T+   +    +
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV 66
Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
            I  ++LK       +++  E+  + +  H NLV+L+GF  DG++  LVY YMP GSL +
Sbjct: 67  DITTEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 175 HL-FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
            L    G  PL W +R K+A GAA G++FLHE     I+RD K++NILLD  F AK+SDF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDF 177
Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDK 293
           GLA+A     +T + ++++GT  Y APE L  G +T K D+YSFGVVLLE+++G  AVD+
Sbjct: 178 GLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 294 TRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAK-VRPS 352
            R    Q L+D  +    + + +   +D K+          M ++ A QC+ E K  RP 
Sbjct: 237 HR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPD 293
Query: 353 MSEVLSALEQL 363
           + +V   L+++
Sbjct: 294 IKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 122/311 (39%), Positives = 181/311 (58%), Gaps = 21/311 (6%)
Query: 61  LSCPNLKAFTFSELKNATRNF--RPDSL----IGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           +S     +F+F ELKN T NF  RP S+    +GEGGFG VYKG+++  T+   +    +
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV 66
Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
            I  ++LK       +++  E+  + +  H NLV+L+GF  DG++  LVY YMP GSL +
Sbjct: 67  DITTEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 175 HL-FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
            L    G  PL W +R K+A GAA G++FLHE     I+RD K++NILLD  F AK+SDF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDF 177
Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDK 293
           GLA+A     +T +  +++GT  Y APE L  G +T K D+YSFGVVLLE+++G  AVD+
Sbjct: 178 GLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 294 TRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAK-VRPS 352
            R    Q L+D  +    + + +   +D K+          M ++ A QC+ E K  RP 
Sbjct: 237 HR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPD 293
Query: 353 MSEVLSALEQL 363
           + +V   L+++
Sbjct: 294 IKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 121/311 (38%), Positives = 180/311 (57%), Gaps = 21/311 (6%)
Query: 61  LSCPNLKAFTFSELKNATRNF--RPDSL----IGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           +S     +F+F ELKN T NF  RP S+    +GEGGFG VYKG+++  T+   +    +
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV 60
Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
            I  ++LK       +++  E+  + +  H NLV+L+GF  DG++  LVY YMP GSL +
Sbjct: 61  DITTEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 113
Query: 175 HL-FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
            L    G  PL W +R K+A GAA G++FLHE     I+RD K++NILLD  F AK+SDF
Sbjct: 114 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDF 171
Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDK 293
           GLA+A     +  +  +++GT  Y APE L  G +T K D+YSFGVVLLE+++G  AVD+
Sbjct: 172 GLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 230
Query: 294 TRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAK-VRPS 352
            R    Q L+D  +    + + +   +D K+          M ++ A QC+ E K  RP 
Sbjct: 231 HR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPD 287
Query: 353 MSEVLSALEQL 363
           + +V   L+++
Sbjct: 288 IKKVQQLLQEM 298

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 116/292 (39%), Positives = 168/292 (57%), Gaps = 16/292 (5%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           +L+ AT NF    LIG G FG VYKG + +          G  +A+K+  PE  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRI 190
            +E+  L    HP+LV LIGFC +    +L+Y+YM  G+L+ HL+        + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
           ++ IGAARGL +LH   + +I+RD K+ NILLD  F  K++DFG++K G   D+TH+   
Sbjct: 143 EICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           V GT GY  PEY   GRLT K DVYSFGVVL E+L  R A+ ++      NL +WA    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES- 259
Query: 311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE 361
            +  +L +I+D  L  +   +        A++C++  ++ RPSM +VL  LE
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 115/292 (39%), Positives = 167/292 (57%), Gaps = 16/292 (5%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           +L+ AT NF    LIG G FG VYKG + +          G  +A+K+  PE  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRI 190
            +E+  L    HP+LV LIGFC +    +L+Y+YM  G+L+ HL+        + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
           ++ IGAARGL +LH   + +I+RD K+ NILLD  F  K++DFG++K G    +TH+   
Sbjct: 143 EICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           V GT GY  PEY   GRLT K DVYSFGVVL E+L  R A+ ++      NL +WA    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES- 259
Query: 311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE 361
            +  +L +I+D  L  +   +        A++C++  ++ RPSM +VL  LE
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 104/235 (44%), Positives = 144/235 (61%), Gaps = 17/235 (7%)
Query: 68  AFTFSELKNATRNF--RPDSL----IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL 121
           +F+F ELKN T NF  RP S+     GEGGFG VYKG+++  T+   +    + I  ++L
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEEL 64
Query: 122 KPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL-FRRG 180
           K       +++  E+    +  H NLV+L+GF  DG++  LVY Y P GSL + L    G
Sbjct: 65  K-------QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG 117
Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
             PL W  R K+A GAA G++FLHE     I+RD K++NILLD  F AK+SDFGLA+A  
Sbjct: 118 TPPLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
              +    ++++GT  Y APE L  G +T K D+YSFGVVLLE+++G  AVD+ R
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK--EWLSEVNYLGQLHH 144
           IG G FG V++   + H         G  +AVK L  + F   +  E+L EV  + +L H
Sbjct: 45  IGAGSFGTVHRA--EWH---------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-LPWTLRIKVAIGAARGLSFL 203
           PN+V  +G      N  +V EY+ +GSL   L + GAR  L    R+ +A   A+G+++L
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H     +++RD K+ N+L+D ++  K+ DFGL++          S    GT  + APE L
Sbjct: 154 HNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVL 211
Query: 264 ATGRLTAKCDVYSFGVVLLEL 284
                  K DVYSFGV+L EL
Sbjct: 212 RDEPSNEKSDVYSFGVILWEL 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK--EWLSEVNYLGQLHH 144
           IG G FG V++   + H         G  +AVK L  + F   +  E+L EV  + +L H
Sbjct: 45  IGAGSFGTVHRA--EWH---------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-LPWTLRIKVAIGAARGLSFL 203
           PN+V  +G      N  +V EY+ +GSL   L + GAR  L    R+ +A   A+G+++L
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTRGYAAPEY 262
           H     +++R+ K+ N+L+D ++  K+ DFGL++   +   T +S++   GT  + APE 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS---TFLSSKSAAGTPEWMAPEV 210
Query: 263 LATGRLTAKCDVYSFGVVLLEL 284
           L       K DVYSFGV+L EL
Sbjct: 211 LRDEPSNEKSDVYSFGVILWEL 232

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/204 (36%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V       +  +    G G ++AVK LK + G Q    W  E++ L  L+H 
Sbjct: 22  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 146 NLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +++K  G C D GE  L LV EY+P GSL ++L R     +     +  A     G+++L
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEY 262
           H   Q  I+R+  A N+LLD++   K+ DFGLAKA P G   + V         + APE 
Sbjct: 134 HS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/204 (36%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V       +  +    G G ++AVK LK + G Q    W  E++ L  L+H 
Sbjct: 22  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 146 NLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +++K  G C D GE  L LV EY+P GSL ++L R     +     +  A     G+++L
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEY 262
           H   Q  I+R+  A N+LLD++   K+ DFGLAKA P G   + V         + APE 
Sbjct: 134 HA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 143/292 (48%), Gaps = 45/292 (15%)
Query: 79  RNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
           +    + ++G G FG V K  W  +             +A+K+++ E  +  K ++ E+ 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 54
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR---IKVAI 194
            L +++HPN+VKL G CL+     LV EY   GSL N L   GA PLP+      +   +
Sbjct: 55  QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCL 110
Query: 195 GAARGLSFLHEAE-QQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVM 252
             ++G+++LH  + + +I+RD K  N+LL +     K+ DFG A       +TH+ T   
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNK 165
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD 312
           G+  + APE       + KCDV+S+G++L E+++ R+  D+  +G     + WA  + G 
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAV-HNGT 222
Query: 313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           R  L + +   +E             L  +C S +   RPSM E++  +  L
Sbjct: 223 RPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           +GEG FG V       +  +    G G ++AVK LK +    H+  W  E++ L  L+H 
Sbjct: 39  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 146 NLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +++K  G C D G   L LV EY+P GSL ++L R     +     +  A     G+++L
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 150
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEY 262
           H   Q  I+RD  A N+LLD++   K+ DFGLAKA P G   + V         + APE 
Sbjct: 151 HA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 143/292 (48%), Gaps = 45/292 (15%)
Query: 79  RNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
           +    + ++G G FG V K  W  +             +A+K+++ E  +  K ++ E+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 53
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR---IKVAI 194
            L +++HPN+VKL G CL+     LV EY   GSL N L   GA PLP+      +   +
Sbjct: 54  QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCL 109
Query: 195 GAARGLSFLHEAE-QQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVM 252
             ++G+++LH  + + +I+RD K  N+LL +     K+ DFG A       +TH+ T   
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNK 164
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD 312
           G+  + APE       + KCDV+S+G++L E+++ R+  D+  +G     + WA  + G 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAV-HNGT 221
Query: 313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           R  L + +   +E             L  +C S +   RPSM E++  +  L
Sbjct: 222 RPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 33  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 145
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 146 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 254
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 255 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 40  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 93
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 94  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 152
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 153 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 261
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 262 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 94  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 206
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 207 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 315
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 316 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 137/289 (47%), Gaps = 38/289 (13%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 36  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 148
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 149 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA----EQNLVDWAKPYLGDRRK 315
            E L T + T K DV+SFGV+L EL+        TR GA    + N  D    YL   R+
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM--------TR-GAPPYPDVNTFD-ITVYLLQGRR 256
Query: 316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           L       L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 257 L-------LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 147
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 148 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 256
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 36  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 148
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 149 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 257
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 258 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 147
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A
Sbjct: 148 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 256
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 115/219 (52%), Gaps = 19/219 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG+GGFG V+KG  + + ++ A +    +++   + + E  +  +E+  EV  +  L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VKL G   +     +V E++P G L + L  + A P+ W++++++ +  A G+ ++  
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 206 AEQQVIYRDFKASNILLDS-----EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
               +++RD ++ NI L S        AK++DFGL++        H  + ++G   + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWMAP 195
Query: 261 EYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
           E +       T K D YSF ++L  +L+G    D+   G
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 114/232 (49%), Gaps = 38/232 (16%)
Query: 84  DSLIGEGGFGYVYKG-WI-DEHTLEAAR--PGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + +IG GGFG VY+  WI DE  ++AAR  P   +   ++ ++            E    
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVR-----------QEAKLF 60
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L HPN++ L G CL   N  LV E+   G L   L     + +P  + +  A+  ARG
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARG 117
Query: 200 LSFLH-EAEQQVIYRDFKASNILLDSEFN--------AKLSDFGLAKAGPTGDRTHVSTQ 250
           +++LH EA   +I+RD K+SNIL+  +           K++DFGLA+        H +T+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTK 171
Query: 251 VMGTRGYA--APEYLATGRLTAKCDVYSFGVVLLELLSGR---RAVDKTRVG 297
           +     YA  APE +     +   DV+S+GV+L ELL+G    R +D   V 
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHP 145
           +GEG FG V     D           G  +AVK LKPE    H  +   E+  L  L+H 
Sbjct: 29  LGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 146 NLVKLIGFCL-DGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           N+VK  G C  DG N + L+ E++P GSL+ +L  +    +    ++K A+   +G+ +L
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTRGYAAPEY 262
               +Q ++RD  A N+L++SE   K+ DFGL KA  T  +   V         + APE 
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 121/237 (51%), Gaps = 28/237 (11%)
Query: 66  LKAFTFSELKNATRNF---------RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
           +  FTF +   A R F         + + +IG G FG V  G +    L   R    + +
Sbjct: 11  IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHL---KLPGKRE---IFV 64
Query: 117 AVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           A+K LK  G+  +  +++LSE + +GQ  HPN++ L G        +++ E+M  GSL++
Sbjct: 65  AIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG 234
            L R+          + +  G A G+ +L  A+   ++RD  A NIL++S    K+SDFG
Sbjct: 124 FL-RQNDGQFTVIQLVGMLRGIAAGMKYL--ADMNYVHRDLAARNILVNSNLVCKVSDFG 180
Query: 235 LAK--AGPTGDRTHVSTQVMGTR---GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           L++     T D T+  T  +G +    + APE +   + T+  DV+S+G+V+ E++S
Sbjct: 181 LSRFLEDDTSDPTY--TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHP 145
           +GEG FG V     D           G  +AVK LKPE    H  +   E+  L  L+H 
Sbjct: 17  LGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 146 NLVKLIGFCL-DGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           N+VK  G C  DG N + L+ E++P GSL+ +L  +    +    ++K A+   +G+ +L
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTRGYAAPEY 262
               +Q ++RD  A N+L++SE   K+ DFGL KA  T  +   V         + APE 
Sbjct: 131 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG+GGFG V+KG  + + ++ A +    +++   + + E  +  +E+  EV  +  L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VKL G   +     +V E++P G L + L  + A P+ W++++++ +  A G+ ++  
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 206 AEQQVIYRDFKASNILLDS-----EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
               +++RD ++ NI L S        AK++DFG ++        H  + ++G   + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSVSGLLGNFQWMAP 195
Query: 261 EYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
           E +       T K D YSF ++L  +L+G    D+   G
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG+GGFG V+KG  + + ++ A +    +++   + + E  +  +E+  EV  +  L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VKL G   +     +V E++P G L + L  + A P+ W++++++ +  A G+ ++  
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 206 AEQQVIYRDFKASNILLDS-----EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
               +++RD ++ NI L S        AK++DF L++        H  + ++G   + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSVSGLLGNFQWMAP 195
Query: 261 EYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
           E +       T K D YSF ++L  +L+G    D+   G
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 130/254 (51%), Gaps = 34/254 (13%)
Query: 48  SGNFSMP--RTECD--ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           +G+  +P  RT  D      P      F++  +AT N   D ++G G FG V  G +   
Sbjct: 11  NGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL--- 66
Query: 104 TLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL 161
            L + +    + +A+K LK  G+  +  +++L E + +GQ  HPN+++L G     +  +
Sbjct: 67  KLPSKKE---ISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V EYM  GSL++ L +  A+     L + +  G A G+ +L  ++   ++RD  A NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNIL 179
Query: 222 LDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKC 272
           ++S    K+SDFGLA+     P    T        TRG      + +PE +A  + T+  
Sbjct: 180 INSNLVCKVSDFGLARVLEDDPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 273 DVYSFGVVLLELLS 286
           DV+S+G+VL E++S
Sbjct: 232 DVWSYGIVLWEVMS 245

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 152/312 (48%), Gaps = 37/312 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
             R   ++G G FG V+KG WI E   E+ +  V + +   K   + FQ   + +  +  
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEG--ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI-- 87
Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR-RGARPLPWTLRIKVAIGAA 197
            G L H ++V+L+G C  G +  LV +Y+P GSL +H+ + RGA  L   L +   +  A
Sbjct: 88  -GSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIA 143
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+ +L E    +++R+  A N+LL S    +++DFG+A   P  D+  + ++      +
Sbjct: 144 KGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
            A E +  G+ T + DV+S+GV + EL++          GAE        PY G R  L 
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMT---------FGAE--------PYAGLR--LA 242
Query: 318 RIMDIKLEGQ---YPQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLP--PPRDPAS 371
            + D+  +G+    PQ     V ++ ++C + +  +RP+  E+ +   ++   PPR    
Sbjct: 243 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 302
Query: 372 PSNSDPQVIYSP 383
              S P +   P
Sbjct: 303 KRESGPGIAPGP 314

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 27  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 134 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 191
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 30  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 78
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 79  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 136
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 137 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 194
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 29  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 77
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 78  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 135
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 136 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 193
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGR 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/204 (36%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V       +  +    G G ++AVK LK   G Q    W  E+  L  L+H 
Sbjct: 17  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 146 NLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           ++VK  G C D GE  + LV EY+P GSL ++L R         L    A     G+++L
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL---FAQQICEGMAYL 128
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEY 262
           H   Q  I+R   A N+LLD++   K+ DFGLAKA P G   + V         + APE 
Sbjct: 129 HA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 185
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 23  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 71
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 72  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 130 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 187
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 188 TFTIKSDVWSFGILLTEIVTHGR 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/204 (36%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V       +  +    G G ++AVK LK   G Q    W  E+  L  L+H 
Sbjct: 16  LGEGHFGKV-----SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 146 NLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           ++VK  G C D GE  + LV EY+P GSL ++L R         L    A     G+++L
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL---FAQQICEGMAYL 127
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTRGYAAPEY 262
           H   Q  I+R   A N+LLD++   K+ DFGLAKA P G   + V         + APE 
Sbjct: 128 HA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   +     DV+SFGV L ELL+
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 152/312 (48%), Gaps = 37/312 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
             R   ++G G FG V+KG WI E   E+ +  V + +   K   + FQ   + +  +  
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEG--ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI-- 69
Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR-RGARPLPWTLRIKVAIGAA 197
            G L H ++V+L+G C  G +  LV +Y+P GSL +H+ + RGA  L   L +   +  A
Sbjct: 70  -GSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIA 125
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+ +L E    +++R+  A N+LL S    +++DFG+A   P  D+  + ++      +
Sbjct: 126 KGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
            A E +  G+ T + DV+S+GV + EL++          GAE        PY G R  L 
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT---------FGAE--------PYAGLR--LA 224
Query: 318 RIMDIKLEGQ---YPQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLP--PPRDPAS 371
            + D+  +G+    PQ     V ++ ++C + +  +RP+  E+ +   ++   PPR    
Sbjct: 225 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 284
Query: 372 PSNSDPQVIYSP 383
              S P +   P
Sbjct: 285 KRESGPGIAPGP 296

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 34/254 (13%)
Query: 48  SGNFSMP--RTECD--ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           +G+  +P  RT  D      P      F++  +AT N   D ++G G FG V  G +   
Sbjct: 11  NGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL--- 66
Query: 104 TLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL 161
            L + +    + +A+K LK  G+  +  +++L E + +GQ  HPN+++L G     +  +
Sbjct: 67  KLPSKKE---ISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V EYM  GSL++ L +  A+     L + +  G A G+ +L  ++   ++RD  A NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNIL 179
Query: 222 LDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKC 272
           ++S    K+SDFGL++     P    T        TRG      + +PE +A  + T+  
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 273 DVYSFGVVLLELLS 286
           DV+S+G+VL E++S
Sbjct: 232 DVWSYGIVLWEVMS 245

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV+E+M  G L ++L  +       TL + + +    G+++L E
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 121
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           A   VI+RD  A N L+      K+SDFG+ +     D+   ST       +A+PE  + 
Sbjct: 122 A--SVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            R ++K DV+SFGV++ E+ S
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFS 199

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 31  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 79
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 80  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 137
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 138 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG 195
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 27  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 134 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG 191
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 134/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 34  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 146
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+          H  T       + A
Sbjct: 147 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 255
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 256 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 54  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 107
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 108 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 166
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 167 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 275
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 276 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 26  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 74
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 75  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 132
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 133 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG 190
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 191 TFTIKSDVWSFGILLTEIVTHGR 213

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 53  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 106
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 107 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 165
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 166 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 274
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 275 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 22  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 71  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 129 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 186
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 187 TFTIKSDVWSFGILLTEIVTHGR 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYG 185
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 34/254 (13%)
Query: 48  SGNFSMP--RTECD--ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           +G+  +P  RT  D      P      F++  +AT N   D ++G G FG V  G +   
Sbjct: 11  NGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL--- 66
Query: 104 TLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL 161
            L + +    + +A+K LK  G+  +  +++L E + +GQ  HPN+++L G     +  +
Sbjct: 67  KLPSKKE---ISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V EYM  GSL++ L +  A+     L + +  G A G+ +L  ++   ++RD  A NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL--SDMGFVHRDLAARNIL 179
Query: 222 LDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKC 272
           ++S    K+SDFGL++     P    T        TRG      + +PE +A  + T+  
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 273 DVYSFGVVLLELLS 286
           DV+S+G+VL E++S
Sbjct: 232 DVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 122/234 (52%), Gaps = 30/234 (12%)
Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           P      F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK 
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV 83
Query: 124 EGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
            G+  +  +++L E + +GQ  HPN+++L G     +  ++V EYM  GSL++ L +  A
Sbjct: 84  -GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--- 238
           +     L + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++    
Sbjct: 143 QFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 239 GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            P    T        TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 200 DPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 116/233 (49%), Gaps = 28/233 (12%)
Query: 69  FTFSELKNATRNF---------RPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAV 118
           FTF +   A R F         + + +IG G FG V  G           PG   + +A+
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSG-------RLKVPGKREICVAI 62
Query: 119 KKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL 176
           K LK  G+  +  +++LSE + +GQ  HPN++ L G     +  +++ EYM  GSL+  L
Sbjct: 63  KTLKA-GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 121
Query: 177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
            +   R     L + +  G   G+ +L  ++   ++RD  A NIL++S    K+SDFG++
Sbjct: 122 RKNDGRFTVIQL-VGMLRGIGSGMKYL--SDMSAVHRDLAARNILVNSNLVCKVSDFGMS 178
Query: 237 KAGPTGDRTHVSTQVMGTR---GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           +     D    +    G +    + APE +A  + T+  DV+S+G+V+ E++S
Sbjct: 179 RV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 16  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 64
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 65  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 122
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 123 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG 180
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 181 TFTIKSDVWSFGILLTEIVTHGR 203

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 34/254 (13%)
Query: 48  SGNFSMP--RTECD--ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           +G+  +P  RT  D      P      F++  +AT N   D ++G G FG V  G +   
Sbjct: 11  NGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL--- 66
Query: 104 TLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL 161
            L + +    + +A+K LK  G+  +  +++L E + +GQ  HPN+++L G     +  +
Sbjct: 67  KLPSKKE---ISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V EYM  GSL++ L +  A+     L + +  G A G+ +L  ++   ++RD  A NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNIL 179
Query: 222 LDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKC 272
           ++S    K+SDFGL++     P    T        TRG      + +PE +A  + T+  
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 273 DVYSFGVVLLELLS 286
           DV+S+G+VL E++S
Sbjct: 232 DVWSYGIVLWEVMS 245

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 147
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 148 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 256
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 30  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 142
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 143 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 251
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 252 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 27  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 80
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 81  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 139
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 140 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 248
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 249 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K +K EG     +++ E   + +L HP
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-----------VAIKTIK-EGSMSEDDFIEEAEVMMKLSHP 82
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV+E+M  G L ++L  +       TL + + +    G+++L E
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 141
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           A   VI+RD  A N L+      K+SDFG+ +     D+   ST       +A+PE  + 
Sbjct: 142 A--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 198
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            R ++K DV+SFGV++ E+ S
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFS 219

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 32  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 144
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 145 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 253
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 254 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 122/234 (52%), Gaps = 30/234 (12%)
Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           P      F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK 
Sbjct: 29  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV 81
Query: 124 EGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
            G+  +  +++L E + +GQ  HPN+++L G     +  ++V EYM  GSL++ L +  A
Sbjct: 82  -GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 140
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--- 238
           +     L + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++    
Sbjct: 141 QFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 197
Query: 239 GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            P    T        TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 198 DPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 122/234 (52%), Gaps = 30/234 (12%)
Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           P      F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK 
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV 83
Query: 124 EGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
            G+  +  +++L E + +GQ  HPN+++L G     +  ++V EYM  GSL++ L +  A
Sbjct: 84  -GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--- 238
           +     L + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++    
Sbjct: 143 QFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 239 GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            P    T        TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 200 DPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV+E+M  G L ++L  +       TL + + +    G+++L E
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 119
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           A   VI+RD  A N L+      K+SDFG+ +     D+   ST       +A+PE  + 
Sbjct: 120 A--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            R ++K DV+SFGV++ E+ S
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFS 197

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 147
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 148 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 256
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV+E+M  G L ++L  +       TL + + +    G+++L E
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 121
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           A   VI+RD  A N L+      K+SDFG+ +     D+   ST       +A+PE  + 
Sbjct: 122 A--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            R ++K DV+SFGV++ E+ S
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFS 199

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 34  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 146
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 147 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 255
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 256 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG 185
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 30/285 (10%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           + +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +   
Sbjct: 33  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 143 HHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 145
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAA 259
           +L  A ++ ++RD  A N +LD +F  K++DFGLA+     +    H  T       + A
Sbjct: 146 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
            E L T + T K DV+SFGV+L EL++ R A     V      V     YL   R+L   
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITV-----YLLQGRRL--- 254
Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               L+ +Y     Y V    L+C   +A++RPS SE++S +  +
Sbjct: 255 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 128/251 (50%), Gaps = 28/251 (11%)
Query: 48  SGNFSMP--RTECD--ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           +G+  +P  RT  D      P      F++  +AT N   D ++G G FG V  G +   
Sbjct: 11  NGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL--- 66
Query: 104 TLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL 161
            L + +    + +A+K LK  G+  +  +++L E + +GQ  HPN+++L G     +  +
Sbjct: 67  KLPSKKE---ISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V EYM  GSL++ L +  A+     L + +  G A G+ +L  ++   ++RD  A NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNIL 179
Query: 222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKCDVY 275
           ++S    K+SDFGL +          +     TRG      + +PE +A  + T+  DV+
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 276 SFGVVLLELLS 286
           S+G+VL E++S
Sbjct: 235 SYGIVLWEVMS 245

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV+E+M  G L ++L  +       TL + + +    G+++L E
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 124
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           A   VI+RD  A N L+      K+SDFG+ +     D+   ST       +A+PE  + 
Sbjct: 125 A--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 181
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            R ++K DV+SFGV++ E+ S
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFS 202

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 121/227 (53%), Gaps = 30/227 (13%)
Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QG 128
           F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK  G+  + 
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV-GYTEKQ 60
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL 188
            +++L E + +GQ  HPN+++L G     +  ++V EYM  GSL++ L +  A+     L
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 120
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRT 245
            + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++     P    T
Sbjct: 121 -VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 246 HVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 178 --------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 121/227 (53%), Gaps = 30/227 (13%)
Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QG 128
           F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK  G+  + 
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV-GYTEKQ 77
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL 188
            +++L E + +GQ  HPN+++L G     +  ++V EYM  GSL++ L +  A+     L
Sbjct: 78  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 137
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRT 245
            + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++     P    T
Sbjct: 138 -VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 246 HVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 195 --------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPEGF--QGHKEWLSEVNYLG 140
           + +IG G FG V +G      L+A  PG     +A+K LK  G+  +  +E+LSE + +G
Sbjct: 21  EEVIGAGEFGEVCRG-----RLKA--PGKKESCVAIKTLKG-GYTERQRREFLSEASIMG 72
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           Q  HPN+++L G   +    +++ E+M  G+L++ L R           + +  G A G+
Sbjct: 73  QFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGMLRGIASGM 131
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GY 257
            +L  AE   ++RD  A NIL++S    K+SDFGL++           T  +G +    +
Sbjct: 132 RYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            APE +A  + T+  D +S+G+V+ E++S
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+    ++HT           +AVK +KP G    + +L+E N +  L H  
Sbjct: 23  LGAGQFGEVWMATYNKHT----------KVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK 71
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LVKL    +  E   ++ E+M KGSL + L        P    I  +   A G++F+ + 
Sbjct: 72  LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+ +    K++DFGLA+     + T         + + APE +  G
Sbjct: 130 -RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFG 187
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L+E+++  R
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGR 210

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+    ++HT           +AVK +KP G    + +L+E N +  L H  
Sbjct: 196 LGAGQFGEVWMATYNKHT----------KVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK 244
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LVKL    +  E   ++ E+M KGSL + L        P    I  +   A G++F+ + 
Sbjct: 245 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ- 302
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+ +    K++DFGLA+     + T         + + APE +  G
Sbjct: 303 -RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFG 360
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L+E+++  R
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 17  LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 65
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 66  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 123
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+R+ +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 124 -RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG 181
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 17  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 129
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 187
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPEGF--QGHKEWLSEVNYLG 140
           + +IG G FG V +G      L+A  PG     +A+K LK  G+  +  +E+LSE + +G
Sbjct: 19  EEVIGAGEFGEVCRG-----RLKA--PGKKESCVAIKTLKG-GYTERQRREFLSEASIMG 70
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           Q  HPN+++L G   +    +++ E+M  G+L++ L R           + +  G A G+
Sbjct: 71  QFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGMLRGIASGM 129
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GY 257
            +L  AE   ++RD  A NIL++S    K+SDFGL++           T  +G +    +
Sbjct: 130 RYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            APE +A  + T+  D +S+G+V+ E++S
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 22  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 134
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 192
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 18  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 130
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 188
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 21  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 133
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 16  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 128
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 186
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 18  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 130
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPES 188
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 24  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 136
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 194
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 49  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 161
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 219
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 25  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 137
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 195
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 23  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 135
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 193
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 18  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 130
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 188
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV E+M  G L ++L  +       TL + + +    G+++L E
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
           A   VI+RD  A N L+      K+SDFG+ +     D+   ST       +A+PE  + 
Sbjct: 123 A--CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            R ++K DV+SFGV++ E+ S
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHH 144
           +IG G FG VYKG +   + +   P     +A+K LK    +  + ++L E   +GQ  H
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
            N+++L G     +  +++ EYM  G+L+  L  +        L + +  G A G+ +L 
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKYL- 163
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTRGYAAPEYL 263
            A    ++RD  A NIL++S    K+SDFGL++      + T+ ++       + APE +
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 264 ATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRIMD 321
           +  + T+  DV+SFG+V+ E+++ G R                  PY      ++ + ++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSNHEVMKAIN 264
Query: 322 IKLEGQYPQKGAYMVAILALQCISEAKV-RPSMSEVLSALEQLP-PPRDPASPSNSDPQV 379
                  P      +  L +QC  + +  RP  ++++S L++L   P    + ++ DP+V
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRV 324

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 36  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 148
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 206
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 129/254 (50%), Gaps = 34/254 (13%)
Query: 48  SGNFSMP--RTECD--ILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEH 103
           +G+  +P  RT  D      P      F++  +AT N   D ++G G FG V  G +   
Sbjct: 11  NGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL--- 66
Query: 104 TLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL 161
            L + +    + +A+K LK  G+  +  +++L E + +GQ  HPN+++L G     +  +
Sbjct: 67  KLPSKKE---ISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           +V E M  GSL++ L +  A+     L + +  G A G+ +L  ++   ++RD  A NIL
Sbjct: 123 IVTEXMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL--SDMGAVHRDLAARNIL 179
Query: 222 LDSEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKC 272
           ++S    K+SDFGL++     P    T        TRG      + +PE +A  + T+  
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 273 DVYSFGVVLLELLS 286
           DV+S+G+VL E++S
Sbjct: 232 DVWSYGIVLWEVMS 245

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G  G V+ G+ + HT           +AVK LK +G      +L+E N + QL H  
Sbjct: 21  LGAGQAGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   ++ EYM  GSL + L       L     + +A   A G++F+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+    + K++DFGLA+     + T         + + APE +  G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYG 185
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L E+++  R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+    ++HT           +AVK +KP G    + +L+E N +  L H  
Sbjct: 190 LGAGQFGEVWMATYNKHT----------KVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK 238
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LVKL    +  E   ++ E+M KGSL + L        P    I  +   A G++F+ + 
Sbjct: 239 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ- 296
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD +A+NIL+ +    K++DFGLA+ G                 + APE +  G
Sbjct: 297 -RNYIHRDLRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFG 344
Query: 267 RLTAKCDVYSFGVVLLELLSGRR 289
             T K DV+SFG++L+E+++  R
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 36  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 148
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 206
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+    + + L   +    M++AVK LK       K++  E   L  L H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--------------RRGARPLPWTLRIKV 192
           +VK  G C DG+  ++V+EYM  G L   L               R+    L  +  + +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A   A G+ +L  A Q  ++RD    N L+ +    K+ DFG+++   + D   V    M
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               +  PE +   + T + DV+SFGV+L E+ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 32/232 (13%)
Query: 79  RNFRPDSLI-----GEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           R FRP  LI     G+G FG           ++      G V+ +K+L     +  + +L
Sbjct: 5   RIFRPSDLIHGEVLGKGCFG---------QAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV  +  L HPN++K IG     +    + EY+  G+L   + +      PW+ R+  A
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFA 114
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA------KAGPTG----- 242
              A G+++LH     +I+RD  + N L+    N  ++DFGLA      K  P G     
Sbjct: 115 KDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 243 --DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD 292
             DR    T V+G   + APE +       K DV+SFG+VL E++ GR   D
Sbjct: 173 KPDRKKRYT-VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 21  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L     R     L ++      +G+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-LQYTSQICKGMEYL- 133
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 19  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 131
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+R+    NIL+++E   K+ DFGL K  P  D+ +   +  G     + APE 
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPES 189
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 121/234 (51%), Gaps = 30/234 (12%)
Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           P      F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK 
Sbjct: 31  PTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV 83
Query: 124 EGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
            G+  +  +++L E + +GQ  HPN+++L G     +  ++V E M  GSL++ L +  A
Sbjct: 84  -GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA 142
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--- 238
           +     L + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++    
Sbjct: 143 QFTVIQL-VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 239 GPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            P    T        TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 200 DPEAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 84  DSLIGEGGFGYVYKG-WIDE--HTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           D +IG+G FG VY G +ID+  + ++ A   +  +  ++++  E F      L E   + 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV--EAF------LREGLLMR 77
Query: 141 QLHHPNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            L+HPN++ LIG  L  E    ++  YM  G L   +      P    L I   +  ARG
Sbjct: 78  GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARG 136
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---- 255
           + +L  AEQ+ ++RD  A N +LD  F  K++DFGLA+     DR + S Q         
Sbjct: 137 MEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPV 192
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + A E L T R T K DV+SFGV+L ELL+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 120/227 (52%), Gaps = 30/227 (13%)
Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QG 128
           F++  +AT N   D ++G G FG V  G +    L + +    + +A+K LK  G+  + 
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRL---KLPSKKE---ISVAIKTLKV-GYTEKQ 60
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL 188
            +++L E + +GQ  HPN+++L G     +  ++V E M  GSL++ L +  A+     L
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 120
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRT 245
            + +  G A G+ +L  ++   ++RD  A NIL++S    K+SDFGL++     P    T
Sbjct: 121 -VGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 246 HVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   TRG      + +PE +A  + T+  DV+S+G+VL E++S
Sbjct: 178 --------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 4   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 53  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GLSF H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 111 QLLQGLSFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V     D       +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 21  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 147 LVKLIGFCLDG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C      N  L+ E++P GSL  +L +   R     L ++      +G+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-LQYTSQICKGMEYL- 133
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPEY 262
              ++ I+RD    NIL+++E   K+ DFGL K  P  D+     +  G     + APE 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           L   + +   DV+SFGVVL EL +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V  G              G  +AVK +K +     + +L+E + + QL H N
Sbjct: 201 IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 247
Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYLA 264
                ++RD  A N+L+  +  AK+SDFGL K A  T D   +  +      + APE L 
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 359
Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA 290
             + + K DV+SFG++L E+ S  R 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRV 385

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 116/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 49
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L++ +       +P  L   
Sbjct: 50  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKS 107
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 108 YLFQLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V  G              G  +AVK +K +     + +L+E + + QL H N
Sbjct: 14  IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60
Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYLA 264
                ++RD  A N+L+  +  AK+SDFGL K A  T D   +  +      + APE L 
Sbjct: 121 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172
Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA 290
             + + K DV+SFG++L E+ S  R 
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRV 198

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V  G              G  +AVK +K +     + +L+E + + QL H N
Sbjct: 29  IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 75
Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYLA 264
                ++RD  A N+L+  +  AK+SDFGL K A  T D   +  +      + APE L 
Sbjct: 136 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 187
Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA 290
             + + K DV+SFG++L E+ S  R 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRV 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG +G VYK         A     G ++A+K++  E     +E + E++ + Q   P+
Sbjct: 37  LGEGSYGSVYK---------AIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPH 85
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +VK  G      +  +V EY   GS+ + + R   + L       +     +GL +LH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            +  I+RD KA NILL++E +AKL+DFG+  AG   D       V+GT  + APE +   
Sbjct: 145 RK--IHRDIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 267 RLTAKCDVYSFGVVLLELLSGR 288
                 D++S G+  +E+  G+
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 112/212 (52%), Gaps = 19/212 (8%)
Query: 82  RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYL 139
           + + +IG G FG V  G +    L   R    + +A+K LK  G+  +  +++LSE + +
Sbjct: 10  KIEQVIGAGEFGEVCSGHL---KLPGKRE---IFVAIKTLK-SGYTEKQRRDFLSEASIM 62
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
           GQ  HPN++ L G        +++ E+M  GSL++ L R+          + +  G A G
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAG 121
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTR-- 255
           + +L  A+   ++R   A NIL++S    K+SDFGL++     T D T+  T  +G +  
Sbjct: 122 MKYL--ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSALGGKIP 177
Query: 256 -GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE +   + T+  DV+S+G+V+ E++S
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 4   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 53  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 3   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 52  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 116/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 50
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 51  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 108
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  
Sbjct: 109 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THE 164
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
           + T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 4   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 53  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 3   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 52  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 4   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 53  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 11  NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 60  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 117
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 118 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 11  NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 60  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 117
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 118 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 25/215 (11%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGF--QGHKEWLSEVN 137
            + + +IG G FG V  G           PG   + +A+K LK  G+  +  +++LSE +
Sbjct: 16  IKIEKVIGVGEFGEVCSG-------RLKVPGKREICVAIKTLKA-GYTDKQRRDFLSEAS 67
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +GQ  HPN++ L G     +  +++ EYM  GSL+  L +   R     L + +  G  
Sbjct: 68  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-VGMLRGIG 126
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG- 256
            G+ +L  ++   ++RD  A NIL++S    K+SDFG+++          +     TRG 
Sbjct: 127 SGMKYL--SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-----TRGG 179
Query: 257 -----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                + APE +A  + T+  DV+S+G+V+ E++S
Sbjct: 180 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 8   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 57  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 114
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 115 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 170
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGF--QGHKEWLSEVN 137
            + + +IG G FG V  G           PG   + +A+K LK  G+  +  +++LSE +
Sbjct: 10  IKIEKVIGVGEFGEVCSG-------RLKVPGKREICVAIKTLKA-GYTDKQRRDFLSEAS 61
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +GQ  HPN++ L G     +  +++ EYM  GSL+  L +   R     L + +  G  
Sbjct: 62  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-VGMLRGIG 120
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR-- 255
            G+ +L  ++   ++RD  A NIL++S    K+SDFG+++     D    +    G +  
Sbjct: 121 SGMKYL--SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGGKIP 176
Query: 256 -GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE +A  + T+  DV+S+G+V+ E++S
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 51
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++    L++ +       +P  L   
Sbjct: 52  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKS 109
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 110 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 52
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++    L++ +       +P  L   
Sbjct: 53  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKS 110
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 111 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 116 IAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           +A+K LK  G+  +  +++LSE + +GQ  HPN+++L G    G   ++V EYM  GSL+
Sbjct: 80  VAIKALKA-GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGL--SFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
             L     R       I   +G  RG+     + ++   ++RD  A N+L+DS    K+S
Sbjct: 139 TFL-----RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 232 DFGLAKAGPTG-DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           DFGL++      D  + +T       + APE +A    ++  DV+SFGVV+ E+L+
Sbjct: 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 49
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 50  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 107
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 108 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 49
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 50  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 107
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 108 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 118/227 (51%), Gaps = 16/227 (7%)
Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           PN     F++  +A+   + + +IG G FG V  G +    L   R    + +A+K LK 
Sbjct: 29  PNRAVHQFAKELDAS-CIKIERVIGAGEFGEVCSGRL---KLPGKRD---VAVAIKTLKV 81
Query: 124 EGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA 181
            G+  +  +++L E + +GQ  HPN+V L G    G+  ++V E+M  G+L+  L +   
Sbjct: 82  -GYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG 140
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
           +     L + +  G A G+ +L  A+   ++RD  A NIL++S    K+SDFGL++    
Sbjct: 141 QFTVIQL-VGMLRGIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-IE 196
Query: 242 GDRTHVSTQVMGT--RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            D   V T   G     + APE +   + T+  DV+S+G+V+ E++S
Sbjct: 197 DDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 49
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 50  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 107
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 108 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 50
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 51  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 108
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 109 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V  G              G  +AVK +K +     + +L+E + + QL H N
Sbjct: 20  IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 66
Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L  
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYLA 264
                ++RD  A N+L+  +  AK+SDFGL K A  T D   +  +      + APE L 
Sbjct: 127 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 178
Query: 265 TGRLTAKCDVYSFGVVLLELLSGRRA 290
               + K DV+SFG++L E+ S  R 
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRV 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 52
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 53  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 110
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 111 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 51
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 52  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 109
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 110 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 49
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 50  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 107
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 108 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 51
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 52  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 109
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 110 YLFQLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 51
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 52  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 109
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 110 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 3   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 52  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V  T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 52
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 53  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKS 110
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 111 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 3   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 52  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V  T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 52
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++    L+  +       +P  L   
Sbjct: 53  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKS 110
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 111 YLFQLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ +  T           +AVK LKP G    + +L E N +  L H  
Sbjct: 21  LGAGQFGEVWMGYYNNST----------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 69
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLH 204
           LV+L       E   ++ EYM KGSL + L     G   LP  +     I  A G++++ 
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 127
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              +  I+RD +A+N+L+      K++DFGLA+     + T         + + APE + 
Sbjct: 128 R--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAIN 184
Query: 265 TGRLTAKCDVYSFGVVLLELLS 286
            G  T K DV+SFG++L E+++
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVT 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           R+ +  S +G+G FG V     D           G ++AVK+L+  G    +++  E+  
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 139 LGQLHHPNLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
           L  LH   +VK  G     G   L LV EY+P G L + L R  AR L  +  +  +   
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 123
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR- 255
            +G+ +L    ++ ++RD  A NIL++SE + K++DFGLAK  P  D+ +   +  G   
Sbjct: 124 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 180
Query: 256 -GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L+    + + DV+SFGVVL EL +
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 19  LGGGQFGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYN 185
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 186 KFSIKSDVWAFGVLLWEI 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 50
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 51  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 108
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 109 YLFQLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 52
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 53  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 110
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 111 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 123
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V  +     
Sbjct: 124 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNY 138
           + +   +IGEG FG V K  I        + G+ M  A+K++K    +  H+++  E+  
Sbjct: 26  DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------GARP 183
           L +L HHPN++ L+G C       L  EY P G+L + L +                A  
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           L     +  A   ARG+ +L  +++Q I+RD  A NIL+   + AK++DFGL++    G 
Sbjct: 139 LSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQ 192
Query: 244 RTHVSTQVMGTR--GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             +V  + MG     + A E L     T   DV+S+GV+L E++S
Sbjct: 193 EVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 5   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 53
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 54  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 111
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 112 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNY 138
           + +   +IGEG FG V K  I        + G+ M  A+K++K    +  H+++  E+  
Sbjct: 16  DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 68
Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------GARP 183
           L +L HHPN++ L+G C       L  EY P G+L + L +                A  
Sbjct: 69  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           L     +  A   ARG+ +L  +++Q I+RD  A NIL+   + AK++DFGL++    G 
Sbjct: 129 LSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQ 182
Query: 244 RTHVSTQVMGTR--GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             +V  + MG     + A E L     T   DV+S+GV+L E++S
Sbjct: 183 EVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 3   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 52  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLF 109
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+KK++     EG       + E
Sbjct: 5   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 54  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 111
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V  T
Sbjct: 112 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 50
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++    L+  +       +P  L   
Sbjct: 51  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKS 108
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 109 YLFQLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK LK     PE FQ  +   +EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKILKVVDPTPEQFQAFR---NEVAVLR 87
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+ +  +N  +V ++    SL  HL  +  +   + L I +A   A+G+
Sbjct: 88  KTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGM 145
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L      K+ DFGLA        +    Q  G+  + AP
Sbjct: 146 DYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSG 287
           E +        + + DVYS+G+VL EL++G
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           R+ +  S +G+G FG V     D           G ++AVK+L+  G    +++  E+  
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 139 LGQLHHPNLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
           L  LH   +VK  G     G   L LV EY+P G L + L R  AR L  +  +  +   
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 124
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR- 255
            +G+ +L    ++ ++RD  A NIL++SE + K++DFGLAK  P  D+ +   +  G   
Sbjct: 125 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 181
Query: 256 -GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L+    + + DV+SFGVVL EL +
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 123
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V  +     
Sbjct: 124 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 40  LGGGQYGEVYVGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 89
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       +V EYMP G+L ++L       +   + + +A   +  + +L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE-- 147
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 206
Query: 267 RLTAKCDVYSFGVVLLEL 284
             + K DV++FGV+L E+
Sbjct: 207 TFSIKSDVWAFGVLLWEI 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 119
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V  +     
Sbjct: 120 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 94/178 (52%), Gaps = 15/178 (8%)
Query: 116 IAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           +A+K LK  G+  +  +++LSE + +GQ  HPN+++L G    G   ++V EYM  GSL+
Sbjct: 80  VAIKALKA-GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGL--SFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
             L     R       I   +G  RG+     + ++   ++RD  A N+L+DS    K+S
Sbjct: 139 TFL-----RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 232 DFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           DFGL++     D    +    G +    + APE +A    ++  DV+SFGVV+ E+L+
Sbjct: 194 DFGLSRV--LEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 129
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V  +     
Sbjct: 130 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 119
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V  +     
Sbjct: 120 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+         E  +    +++AVK LK       K++  E   L  L H +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDK----ILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIG 195
           +VK  G C++G+  ++V+EYM  G L   L   G              L  +  + +A  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+ +L  A Q  ++RD    N L+      K+ DFG+++   + D   V    M   
Sbjct: 137 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +  PE +   + T + DV+S GVVL E+ +
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 24/221 (10%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEW 132
           +  NF+    IGEG +G VYK         A     G V+A+KK++     EG       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTA-- 52
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L   
Sbjct: 53  IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKS 110
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+    V
Sbjct: 111 YLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 252 MGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             T  Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           R+ +  S +G+G FG V     D           G ++AVK+L+  G    +++  E+  
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 139 LGQLHHPNLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
           L  LH   +VK  G     G   L LV EY+P G L + L R  AR L  +  +  +   
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 136
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR- 255
            +G+ +L    ++ ++RD  A NIL++SE + K++DFGLAK  P  D+ +   +  G   
Sbjct: 137 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 193
Query: 256 -GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L+    + + DV+SFGVVL EL +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 63  CPNLKAFTFSELKNA----TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           CP  K  T    K+A      + R +  +G+G FG V+ G  +  T           +A+
Sbjct: 247 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAI 296
Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           K LKP G    + +L E   + +L H  LV+L     + E   +V EYM KGSL + L  
Sbjct: 297 KTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG 354
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              + L     + +A   A G++++       ++RD +A+NIL+      K++DFGLA+ 
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
               + T         + + APE    GR T K DV+SFG++L EL +  R
Sbjct: 413 IEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 19  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYN 185
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 186 KFSIKSDVWAFGVLLWEI 203

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 119/244 (48%), Gaps = 32/244 (13%)
Query: 53  MPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV 112
           MP T  D    PN     F++   A+     + +IG G FG V  G +    L   R   
Sbjct: 1   MPHTYED----PNQAVHEFAKEIEAS-CITIERVIGAGEFGEVCSGRL---KLPGKRE-- 50
Query: 113 GMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKG 170
            + +A+K LK  G+  +  +++L E + +GQ  HPN++ L G     +  ++V EYM  G
Sbjct: 51  -LPVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENG 108
Query: 171 SLENHLFRRGARPLPWTLRIKVAIGAARGLS--FLHEAEQQVIYRDFKASNILLDSEFNA 228
           SL+  L +   +       +   +G  RG+S    + ++   ++RD  A NIL++S    
Sbjct: 109 SLDTFLKKNDGQ-----FTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVC 163
Query: 229 KLSDFGLAKAGPTGDRTHVSTQVMGTRG------YAAPEYLATGRLTAKCDVYSFGVVLL 282
           K+SDFGL++          +     TRG      + APE +A  + T+  DV+S+G+V+ 
Sbjct: 164 KVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMW 218
Query: 283 ELLS 286
           E++S
Sbjct: 219 EVVS 222

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 114/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+ K++     EG       + E
Sbjct: 4   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALXKIRLDTETEGVPSTA--IRE 52
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 53  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 114/218 (52%), Gaps = 24/218 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSE 135
           NF+    IGEG +G VYK         A     G V+A+ K++     EG       + E
Sbjct: 3   NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALXKIRLDTETEGVPSTA--IRE 51
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           ++ L +L+HPN+VKL+   +  EN+L LV+E++ +  L+  +       +P  L      
Sbjct: 52  ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
              +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+  T  + T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 255 RGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             Y APE L   +  +   D++S G +  E+++ RRA+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 22  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYN 188
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 189 KFSIKSDVWAFGVLLWEI 206

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 119
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D   V  +     
Sbjct: 120 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP 177
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           R+ +  S +G+G FG V     +    +      G ++AVK+L+  G    +++  E+  
Sbjct: 7   RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 139 LGQLHHPNLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
           L  LH   +VK  G     G   L LV EY+P G L + L R  AR L  +  +  +   
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 120
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTR 255
            +G+ +L    ++ ++RD  A NIL++SE + K++DFGLAK  P   D   V        
Sbjct: 121 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + APE L+    + + DV+SFGVVL EL +
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V  G W  ++            +AVK +K EG     E+  E   + +L HP
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LVK  G C       +V EY+  G L N+L   G    P  L +++      G++FL  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-LEMCYDVCEGMAFL-- 120
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
              Q I+RD  A N L+D +   K+SDFG+ +     D  +VS+  +GT+    ++APE 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS--VGTKFPVKWSAPEV 176
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
               + ++K DV++FG+++ E+ S
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D      A  G  + +AVK LKP+     +   +++ E
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    ++ V E  P GSL + L +     L  TL  + A+ 
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQ 129
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT- 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D   V  +     
Sbjct: 130 VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP 187
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             + APE L T   +   D + FGV L E+ +
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYN 192
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 19/232 (8%)
Query: 63  CPNLKAFTFSELKNA----TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           CP  K  T    K+A      + R +  +G+G FG V+ G  +  T           +A+
Sbjct: 164 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAI 213
Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           K LKP G    + +L E   + +L H  LV+L    +  E   +V EYM KGSL + L  
Sbjct: 214 KTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG 271
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              + L     + +A   A G++++       ++RD +A+NIL+      K++DFGLA+ 
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
               + T         + + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 330 IEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 19/232 (8%)
Query: 63  CPNLKAFTFSELKNA----TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           CP  K  T    K+A      + R +  +G+G FG V+ G  +  T           +A+
Sbjct: 164 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAI 213
Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           K LKP G    + +L E   + +L H  LV+L    +  E   +V EYM KGSL + L  
Sbjct: 214 KTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG 271
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              + L     + +A   A G++++       ++RD +A+NIL+      K++DFGLA+ 
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
               + T         + + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 330 IEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+    + H L   +    M++AVK LK       +++  E   L  L H +
Sbjct: 26  LGEGAFGKVFLA--ECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIG 195
           +V+  G C +G   L+V+EYM  G L   L   G             P P  L   +A+ 
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +      ++ A    ++RD    N L+      K+ DFG+++   + D   V  + M   
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +  PE +   + T + DV+SFGVVL E+ +
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G  + +T           +A+K LKP G    + +L E   + +L H  
Sbjct: 17  LGNGQFGEVWMGTWNGNT----------KVAIKTLKP-GTMSPESFLEEAQIMKKLKHDK 65
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L    +  E   +V EYM KGSL + L     R L     + +A   A G++++   
Sbjct: 66  LVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER- 123
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
               I+RD +++NIL+ +    K++DFGLA+     + T         + + APE    G
Sbjct: 124 -MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYG 181
Query: 267 RLTAKCDVYSFGVVLLELLSGRRA 290
           R T K DV+SFG++L EL++  R 
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRV 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 19  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTFTAHAGAKFPIKWTAPESLAYN 185
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 186 KFSIKSDVWAFGVLLWEI 203

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+    + H L   +    M++AVK LK       +++  E   L  L H +
Sbjct: 20  LGEGAFGKVFLA--ECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIG 195
           +V+  G C +G   L+V+EYM  G L   L   G             P P  L   +A+ 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +      ++ A    ++RD    N L+      K+ DFG+++   + D   V  + M   
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +  PE +   + T + DV+SFGVVL E+ +
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 26  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 25  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 74
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 132
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 192 KFSIKSDVWAFGVLLWEI 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V+    + H L   +    M++AVK LK       +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIG 195
           +V+  G C +G   L+V+EYM  G L   L   G             P P  L   +A+ 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +      ++ A    ++RD    N L+      K+ DFG+++   + D   V  + M   
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +  PE +   + T + DV+SFGVVL E+ +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 57
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 58  KKLRHEKLVQLYAV-VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 116
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 117 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTA 173
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 174 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 204

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNY 138
           + +   +IGEG FG V K  I        + G+ M  A+K++K    +  H+++  E+  
Sbjct: 23  DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 75
Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------GARP 183
           L +L HHPN++ L+G C       L  EY P G+L + L +                A  
Sbjct: 76  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           L     +  A   ARG+ +L  +++Q I+R+  A NIL+   + AK++DFGL++    G 
Sbjct: 136 LSSQQLLHFAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQ 189
Query: 244 RTHVSTQVMGTR--GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             +V  + MG     + A E L     T   DV+S+GV+L E++S
Sbjct: 190 EVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 228 LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 277
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+R+  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 267 RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRIMDIKLE 325
           + + K DV++FGV+L E+ +   +                 PY G D  +++ +++    
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYR 437
Query: 326 GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
            + P+     V  L   C       RPS +E+  A E +
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 19/232 (8%)
Query: 63  CPNLKAFTFSELKNA----TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           CP  K  T    K+A      + R +  +G+G FG V+ G  +  T           +A+
Sbjct: 164 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAI 213
Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           K LKP G    + +L E   + +L H  LV+L    +  E   +V EYM KGSL + L  
Sbjct: 214 KTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKG 271
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              + L     + +A   A G++++       ++RD +A+NIL+      K++DFGLA+ 
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
               + T         + + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 330 IEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL- 133
           N +    +G G FG V         +EA   G+G     + +AVK LK       KE L 
Sbjct: 39  NLQFGKTLGAGAFGKV---------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 89
Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------ARPL 184
           SE+  +  L  H N+V L+G C  G   L++ EY   G L N L R+          RPL
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
                +  +   A+G++FL  A +  I+RD  A N+LL +   AK+ DFGLA+       
Sbjct: 150 ELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207
Query: 245 THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             V         + APE +     T + DV+S+G++L E+ S
Sbjct: 208 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 23  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 190 KFSIKSDVWAFGVLLWEI 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 21  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 23  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 190 KFSIKSDVWAFGVLLWEI 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 34  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 83
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 141
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 200
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 201 KFSIKSDVWAFGVLLWEI 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 22  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAPAGAKFPIKWTAPESLAYN 188
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 189 KFSIKSDVWAFGVLLWEI 206

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL- 133
           N +    +G G FG V         +EA   G+G     + +AVK LK       KE L 
Sbjct: 47  NLQFGKTLGAGAFGKV---------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------ARPL 184
           SE+  +  L  H N+V L+G C  G   L++ EY   G L N L R+          RPL
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
                +  +   A+G++FL  A +  I+RD  A N+LL +   AK+ DFGLA+       
Sbjct: 158 ELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215
Query: 245 THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             V         + APE +     T + DV+S+G++L E+ S
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 65  NLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKL-K 122
            L+    +ELK          ++G G FG VYKG W+ E         V + +A+K L +
Sbjct: 31  QLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGE------TVKIPVAIKILNE 77
Query: 123 PEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             G + + E++ E   +  + HP+LV+L+G CL    +L V + MP G L  ++      
Sbjct: 78  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDN 136
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            +   L +   +  A+G+ +L E  +++++RD  A N+L+ S  + K++DFGLA+     
Sbjct: 137 -IGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 193
Query: 243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           ++ + +        + A E +   + T + DV+S+GV + EL++
Sbjct: 194 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 23  LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+RD  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAPAGAKFPIKWTAPESLAYN 189
Query: 267 RLTAKCDVYSFGVVLLEL 284
           + + K DV++FGV+L E+
Sbjct: 190 KFSIKSDVWAFGVLLWEI 207

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V+ G+ +  T           +AVK LKP G    + +L E N +  L H  
Sbjct: 20  LGAGQFGEVWMGYYNNST----------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 68
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           LV+L       E   ++ E+M KGSL + L     G   LP  +     I  A G++++ 
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 126
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              +  I+RD +A+N+L+      K++DFGLA+     + T         + + APE + 
Sbjct: 127 R--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAIN 183
Query: 265 TGRLTAKCDVYSFGVVLLELLS 286
            G  T K +V+SFG++L E+++
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVT 205

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 60
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 61  KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---G 256
           ++++       ++RD +A+NIL+      K++DFGLA+     D  + + Q  G +    
Sbjct: 120 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIK 173
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 207

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G VY+G   +++L          +AVK LK +  +  +E+L E   + ++ HPN
Sbjct: 267 LGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 316
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L   
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 374
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++  I+R+  A N L+      K++DFGL++   TGD             + APE LA  
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 433
Query: 267 RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRIMDIKLE 325
           + + K DV++FGV+L E+ +   +                 PY G D  +++ +++    
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYR 476
Query: 326 GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
            + P+     V  L   C       RPS +E+  A E +
Sbjct: 477 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 58
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 59  KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---G 256
           ++++       ++RD +A+NIL+      K++DFGLA+     D  + + Q  G +    
Sbjct: 118 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIK 171
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEVNYLGQLH 143
           ++G G FG VYKG W+ E         V + +A+K L +  G + + E++ E   +  + 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGE------TVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HP+LV+L+G CL    +L V + MP G L  ++       +   L +   +  A+G+ +L
Sbjct: 76  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAKGMMYL 133
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
            E  +++++RD  A N+L+ S  + K++DFGLA+     ++ + +        + A E +
Sbjct: 134 EE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 264 ATGRLTAKCDVYSFGVVLLELLS 286
              + T + DV+S+GV + EL++
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 56
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 57  KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 115
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 116 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 172
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 203

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G GG   VY   + E T+   +  +  +    + K E     K +  EV+   QL H N
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETL---KRFEREVHNSSQLSHQN 72
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V +I    + +   LV EY+   +L  ++   G  PL     I        G+   H+ 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
             ++++RD K  NIL+DS    K+ DFG+AKA      T  +  V+GT  Y +PE  A G
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQ-AKG 186
Query: 267 RLTAKC-DVYSFGVVLLELLSGR 288
             T +C D+YS G+VL E+L G 
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 72  SELKNATRNFRPD-------SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE 124
            EL+N   +   D        ++GEG FG V +G + +        G  + +AVK +K +
Sbjct: 20  EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQED------GTSLKVAVKTMKLD 73
Query: 125 GFQGHK--EWLSEVNYLGQLHHPNLVKLIGFCLDGENR-----LLVYEYMPKGSLENHL- 176
                +  E+LSE   +    HPN+++L+G C++  ++     +++  +M  G L  +L 
Sbjct: 74  NSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL 133
Query: 177 ---FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
                 G + +P    +K  +  A G+ +L  + +  ++RD  A N +L  +    ++DF
Sbjct: 134 YSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADF 191
Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
           GL+K   +GD             + A E LA    T+K DV++FGV + E+
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V K    +H     RP  G+++A K    ++KP     
Sbjct: 12  ELKD--DDFERISELGAGNGGVVTKV---QH-----RPS-GLIMARKLIHLEIKP---AI 57
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L  + A+ +P  
Sbjct: 58  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KEAKRIPEE 114
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   RGL++L E + Q+++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 115 ILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 169
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y APE L     + + D++S G+ L+EL  GR
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 33/213 (15%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 20  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 63
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--IKVAIGAAR 198
           +  H N++  +G+    +   +V ++    SL +HL    A    + ++  I +A   AR
Sbjct: 64  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTAR 119
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+ +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + 
Sbjct: 120 GMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 177
Query: 259 APEYL---ATGRLTAKCDVYSFGVVLLELLSGR 288
           APE +    +   + + DVY+FG+VL EL++G+
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 19/232 (8%)
Query: 63  CPNLKAFTFSELKNA----TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAV 118
           CP  K  T    K+A      + R +  +G+G FG V+ G  +  T           +A+
Sbjct: 165 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAI 214
Query: 119 KKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
           K LKP G    + +L E   + +L H  LV+L    +  E   +V EYM KGSL + L  
Sbjct: 215 KTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG 272
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              + L     + +A   A G++++       ++RD +A+NIL+      K++DFGL + 
Sbjct: 273 EMGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLGRL 330
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
               + T         + + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 331 IEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---G 256
           ++++       ++RD  A+NIL+      K++DFGLA+     D  + + Q  G +    
Sbjct: 127 MAYVER--MNYVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIK 180
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           + APE    GR T K DV+SFG++L EL +  R 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            ++ H  LV+L    +  E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 68  KKIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
             R   ++G G FG VYKG WI +         V + +A+K L+     + +KE L E  
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGE------NVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-----LPWTLRIKV 192
            +  +  P + +L+G CL    +L V + MP G L +H+     R      L W ++I  
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI-- 128
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
               A+G+S+L +   ++++RD  A N+L+ S  + K++DFGLA+     +  + +    
Sbjct: 129 ----AKGMSYLEDV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 182
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               + A E +   R T + DV+S+GV + EL++
Sbjct: 183 VPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 75
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--IKVAIGAAR 198
           +  H N++  +G+        +V ++    SL +HL    A    + ++  I +A   AR
Sbjct: 76  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTAR 131
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+ +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + 
Sbjct: 132 GMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 259 APEYL---ATGRLTAKCDVYSFGVVLLELLSGR 288
           APE +    +   + + DVY+FG+VL EL++G+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 33/213 (15%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 75
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--IKVAIGAAR 198
           +  H N++  +G+    +   +V ++    SL +HL    A    + ++  I +A   AR
Sbjct: 76  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTAR 131
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+ +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + 
Sbjct: 132 GMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 259 APEYL---ATGRLTAKCDVYSFGVVLLELLSGR 288
           APE +    +   + + DVY+FG+VL EL++G+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 64
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + ++   A G
Sbjct: 65  KKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 124 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 180
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 64
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KGSL + L     + L     + ++   A G
Sbjct: 65  KKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 124 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTA 180
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KG L + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 87  IGEGGFGYVYKGWID-EHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G +  ++TL A +       + ++  P   +   ++L E   L Q  HP
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK-------SCRETLPPDLKA--KFLQEARILKQYSHP 172
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI----GAARGLS 201
           N+V+LIG C   +   +V E +  G     L   GAR     LR+K  +     AA G+ 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGME 227
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR----GY 257
           +L    +  I+RD  A N L+  +   K+SDFG+++    G    V     G R     +
Sbjct: 228 YLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VXAASGGLRQVPVKW 281
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            APE L  GR +++ DV+SFG++L E  S
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +  T           +A+K LKP G    + +L E   +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKP-GTMSPEAFLQEAQVM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L    +  E   +V EYM KG L + L     + L     + +A   A G
Sbjct: 68  KKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     + T         + + A
Sbjct: 127 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 183
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           PE    GR T K DV+SFG++L EL +  R 
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG VYKG ID HT E        V+A+K +   E     ++   E+  L Q   P
Sbjct: 27  IGKGSFGEVYKG-IDNHTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + +  G  L      ++ EY+  GS  + L + G  PL  T    +     +GL +LH 
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLHS 134
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             ++ I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 266 GRLTAKCDVYSFGVVLLELLSG 287
                K D++S G+  +EL  G
Sbjct: 191 SAYDFKADIWSLGITAIELAKG 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQL 142
           + ++GEG FG VY+G    H       G  + +AVK  K +    +KE ++SE   +  L
Sbjct: 29  NRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            HP++VKLIG  ++ E   ++ E  P G L  H   R    L     +  ++   + +++
Sbjct: 83  DHPHIVKLIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           L       ++RD    NIL+ S    KL DFGL++     D    S   +  + + +PE 
Sbjct: 141 LESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPES 197
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           +   R T   DV+ F V + E+LS
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILS 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQL 142
           + ++GEG FG VY+G    H       G  + +AVK  K +    +KE ++SE   +  L
Sbjct: 13  NRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            HP++VKLIG  ++ E   ++ E  P G L  H   R    L     +  ++   + +++
Sbjct: 67  DHPHIVKLIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           L       ++RD    NIL+ S    KL DFGL++     D    S   +  + + +PE 
Sbjct: 125 LESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPES 181
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           +   R T   DV+ F V + E+LS
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILS 205

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 87  IGEGGFGYVYKGWID-EHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G +  ++TL A +       + ++  P   +   ++L E   L Q  HP
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK-------SCRETLPPDLKA--KFLQEARILKQYSHP 172
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI----GAARGLS 201
           N+V+LIG C   +   +V E +  G     L   GAR     LR+K  +     AA G+ 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGME 227
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +L    +  I+RD  A N L+  +   K+SDFG+++    G              + APE
Sbjct: 228 YLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            L  GR +++ DV+SFG++L E  S
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGV-----GMVIAVKKLKPEGFQGHK-EWLSEVNYLG 140
           IGEG FG V+         +A  PG+       ++AVK LK E     + ++  E   + 
Sbjct: 55  IGEGAFGRVF---------QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------------- 179
           +  +PN+VKL+G C  G+   L++EYM  G L N   R                      
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 180 --GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
             G  PL    ++ +A   A G+++L  +E++ ++RD    N L+      K++DFGL++
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + D             +  PE +   R T + DV+++GVVL E+ S
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQL 142
           + ++GEG FG VY+G    H       G  + +AVK  K +    +KE ++SE   +  L
Sbjct: 17  NRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            HP++VKLIG  ++ E   ++ E  P G L  H   R    L     +  ++   + +++
Sbjct: 71  DHPHIVKLIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           L       ++RD    NIL+ S    KL DFGL++     D    S   +  + + +PE 
Sbjct: 129 LESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPES 185
Query: 263 LATGRLTAKCDVYSFGVVLLELLS 286
           +   R T   DV+ F V + E+LS
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 18  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 61
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 62  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 119
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 120 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 178 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 27/225 (12%)
Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPE 124
               ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP 
Sbjct: 1   MALGELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP- 48
Query: 125 GFQGHKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
                 + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   
Sbjct: 49  --AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR-- 103
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           +P  +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D
Sbjct: 104 IPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID 160
Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
              ++ + +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 161 E--MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 59
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+        +V ++    SL +HL     +       I +A   A+G+
Sbjct: 60  KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 117
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP     
Sbjct: 64  ELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP---AI 109
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 110 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 166
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 167 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 221
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 222 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 43  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 86
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 87  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 144
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 145 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 34  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 145 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 64
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 65  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 122
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 35  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 146 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 26  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 137 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 27  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 138 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 27  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 138 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 87
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 88  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 145
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           IG G FG VY    D    E        V+A+KK+   G Q +++W   + EV +L +L 
Sbjct: 62  IGHGSFGAVYFA-RDVRNSE--------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN ++  G  L      LV EY   GS  + L     +PL       V  GA +GL++L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H     +I+RD KA NILL      KL DFG A      +        +GT  + APE +
Sbjct: 171 HS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVI 222
Query: 264 AT---GRLTAKCDVYSFGVVLLEL 284
                G+   K DV+S G+  +EL
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 32  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 86
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 87  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 144 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 200
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 32  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 86
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 87  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 144 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 200
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG VYKG W   H   A +     ++ V    P+  Q  K   +EV  L +  H 
Sbjct: 21  IGSGSFGTVYKGKW---HGDVAVK-----MLNVTAPTPQQLQAFK---NEVGVLRKTRHV 69
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+ +LH 
Sbjct: 70  NILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA 127
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + APE +  
Sbjct: 128 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 266 GR---LTAKCDVYSFGVVLLELLSGR 288
                 + + DVY+FG+VL EL++G+
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           +GEG +G VYK          A+   G ++A+K+++     EG       + E++ L +L
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           HHPN+V LI          LV+E+M K  L+  L           ++I +     RG++ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY-QLLRGVAH 134
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H+   ++++RD K  N+L++S+   KL+DFGLA+A     R++  T  + T  Y AP+ 
Sbjct: 135 CHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDV 190
Query: 263 L-ATGRLTAKCDVYSFGVVLLELLSGR 288
           L  + + +   D++S G +  E+++G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLH 143
           IG G FG VY          A       V+A+KK+   G Q +++W   + EV +L +L 
Sbjct: 23  IGHGSFGAVYF---------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN ++  G  L      LV EY   GS  + L     +PL       V  GA +GL++L
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H     +I+RD KA NILL      KL DFG A      +        +GT  + APE +
Sbjct: 132 HS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVI 183
Query: 264 AT---GRLTAKCDVYSFGVVLLEL 284
                G+   K DV+S G+  +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 140 IHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           +GEG +G VYK          A+   G ++A+K+++     EG       + E++ L +L
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           HHPN+V LI          LV+E+M K  L+  L           ++I +     RG++ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY-QLLRGVAH 134
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H+   ++++RD K  N+L++S+   KL+DFGLA+A     R++  T  + T  Y AP+ 
Sbjct: 135 CHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDV 190
Query: 263 L-ATGRLTAKCDVYSFGVVLLELLSGR 288
           L  + + +   D++S G +  E+++G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 59
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 60  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 117
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 36  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 79
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 80  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 137
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 138 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK------VAIGAA 197
           H N++ +         R    E M    L  HL       L  T  +             
Sbjct: 100 HENIIGINDII-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRG 256
           RGL ++H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR 
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 257 YAAPEYLATGR-LTAKCDVYSFGVVLLELLSGR 288
           Y APE +   +  T   D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 374 DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 428
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 429 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 485
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 486 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 542
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 30  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 84
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 85  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 141
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 142 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 198
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 140 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 142 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 140 IHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLK-----PEGFQGHKEWLSEVNYLG 140
           IG G FG VYKG W  +             +AVK L      P+  Q  K   +EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFK---NEVGVLR 87
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +  H N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+
Sbjct: 88  KTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 145
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + AP
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 261 EYLATGR---LTAKCDVYSFGVVLLELLSGR 288
           E +        + + DVY+FG+VL EL++G+
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 140 IHSA--NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 37  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 148 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 140 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 375 DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 429
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 430 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 486
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 487 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 543
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 160 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG VYKG W   H   A +     ++ V    P+  Q  K   +EV  L +  H 
Sbjct: 16  IGSGSFGTVYKGKW---HGDVAVK-----MLNVTAPTPQQLQAFK---NEVGVLRKTRHV 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N++  +G+    +   +V ++    SL +HL     +       I +A   A+G+ +LH 
Sbjct: 65  NILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + APE +  
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 266 GR---LTAKCDVYSFGVVLLELLSGR 288
                 + + DVY+FG+VL EL++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 21/219 (9%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQG 128
           ++K+  + +     +GEG F  VYK         A       ++A+KK+K     E   G
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYK---------ARDKNTNQIVAIKKIKLGHRSEAKDG 54
Query: 129 -HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
            ++  L E+  L +L HPN++ L+       N  LV+++M +  LE  +        P  
Sbjct: 55  INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSH 113
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           ++  + +   +GL +LH+    +++RD K +N+LLD     KL+DFGLAK+  + +R + 
Sbjct: 114 IKAYMLM-TLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYX 170
Query: 248 STQVMGTRGYAAPEYLATGRLT-AKCDVYSFGVVLLELL 285
              V  TR Y APE L   R+     D+++ G +L ELL
Sbjct: 171 HQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 16  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 70
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 71  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 128 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 184
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           ELK+   +F   S +G G  G V+K       L  AR  + +     ++KP       + 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKP---AIRNQI 51
Query: 133 LSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  +  K
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQILGK 108
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           V+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   ++   
Sbjct: 109 VSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 163
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 143/317 (45%), Gaps = 48/317 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 24  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 138 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            + APE L  G  T   D++SFGVVL E+ S           AEQ       PY G   +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNE 238
Query: 316 LFRIMDIKLEGQY---PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDPAS 371
             +++   ++G Y   P      V  L   C     K+RP+  E+++ L      +D   
Sbjct: 239 --QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL------KDDLH 290
Query: 372 PSNSDPQVIYSPHVKSP 388
           PS  +    +S   K+P
Sbjct: 291 PSFPEVSFFHSEENKAP 307

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 22  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 76
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 77  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 134 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 190
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 12  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 66
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 67  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 124 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 180
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A++K+ P   Q + +  L E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAY---DNLNKVR------VAIRKISPFEHQTYCQRTLREIKILLRFR 83
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 10  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 64
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 65  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 121
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D  +   Q  G     + APE
Sbjct: 122 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPE 178
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP     
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP---AI 47
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 104
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 105 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 159
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 27/236 (11%)
Query: 61  LSCPNLKAFTFSELKNATRNFRPDSL------IGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           L   NL   +  + ++ TR+  P+        +G+G FG VYK         A      +
Sbjct: 13  LGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYK---------AQNKETSV 63
Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           + A K +  +  +  ++++ E++ L    HPN+VKL+       N  ++ E+   G+++ 
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG 234
            +     RPL  +    V       L++LH+   ++I+RD KA NIL   + + KL+DFG
Sbjct: 124 VMLEL-ERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFG 180
Query: 235 L-AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-----LTAKCDVYSFGVVLLEL 284
           + AK   T  R       +GT  + APE +            K DV+S G+ L+E+
Sbjct: 181 VSAKNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/161 (37%), Positives = 85/161 (52%), Gaps = 12/161 (7%)
Query: 143 HHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           +HP LV L   C   E+RL  V EY+  G L  H+ R+  R LP       +   +  L+
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 167
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTRGYAAP 260
           +LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G   GD T   +   GT  Y AP
Sbjct: 168 YLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 222
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
           E L         D ++ GV++ E+++GR   D   VG+  N
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI--VGSSDN 261

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP     
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP---AI 47
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 104
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 105 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 159
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP     
Sbjct: 29  ELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP---AI 74
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 75  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 131
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 132 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 186
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 136/298 (45%), Gaps = 42/298 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 22  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 136 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            + APE L  G  T   D++SFGVVL E+ S           AEQ       PY G   +
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNE 236
Query: 316 LFRIMDIKLEGQY---PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDP 369
             +++   ++G Y   P      V  L   C     K+RP+  E+++ L+    P  P
Sbjct: 237 --QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 136/298 (45%), Gaps = 42/298 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 139 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            + APE L  G  T   D++SFGVVL E+ S           AEQ       PY G   +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNE 239
Query: 316 LFRIMDIKLEGQY---PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDP 369
             +++   ++G Y   P      V  L   C     K+RP+  E+++ L+    P  P
Sbjct: 240 --QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/161 (37%), Positives = 85/161 (52%), Gaps = 12/161 (7%)
Query: 143 HHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           +HP LV L   C   E+RL  V EY+  G L  H+ R+  R LP       +   +  L+
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 120
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTRGYAAP 260
           +LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G   GD T   +   GT  Y AP
Sbjct: 121 YLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAP 175
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
           E L         D ++ GV++ E+++GR   D   VG+  N
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI--VGSSDN 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/161 (37%), Positives = 85/161 (52%), Gaps = 12/161 (7%)
Query: 143 HHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           +HP LV L   C   E+RL  V EY+  G L  H+ R+  R LP       +   +  L+
Sbjct: 79  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 135
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTRGYAAP 260
           +LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G   GD T   +   GT  Y AP
Sbjct: 136 YLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAP 190
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
           E L         D ++ GV++ E+++GR   D   VG+  N
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI--VGSSDN 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 11/216 (5%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           ++K    +F    ++G+G FG V+     +     A   +   + +     E     K  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           LS         HP L  +       EN   V EY+  G L  H+  +       +     
Sbjct: 72  LSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFY 124
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A     GL FLH   + ++YRD K  NILLD + + K++DFG+ K    GD    + +  
Sbjct: 125 AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFC 180
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L   +     D +SFGV+L E+L G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 142 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V  G   +H L   +  V  ++  +K++     G  +   E+  L    HP+
Sbjct: 24  LGVGTFGKVKVG---KHELTGHKVAVK-ILNRQKIRSLDVVG--KIRREIQNLKLFRHPH 77
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           ++KL        +  +V EY+  G L +++ + G      + R+   I +  G+ + H  
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHR- 134
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
              V++RD K  N+LLD+  NAK++DFGL+     G+    S    G+  YAAPE + +G
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVI-SG 189
Query: 267 RLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           RL A  + D++S GV+L  LL G    D   V
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/161 (37%), Positives = 85/161 (52%), Gaps = 12/161 (7%)
Query: 143 HHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           +HP LV L   C   E+RL  V EY+  G L  H+ R+  R LP       +   +  L+
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 124
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTRGYAAP 260
           +LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G   GD T   +   GT  Y AP
Sbjct: 125 YLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAP 179
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
           E L         D ++ GV++ E+++GR   D   VG+  N
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI--VGSSDN 218

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 17/219 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N++    +GEG FG V   +   HT    +  +  +I  K L     QG  E   E++YL
Sbjct: 5   NYQIVKTLGEGSFGKVKLAY---HTTTGQKVALK-IINKKVLAKSDMQGRIE--REISYL 58
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L HP+++KL       +  ++V EY     L +++ +R         R    I +A  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 115
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAA
Sbjct: 116 VEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAA 170
Query: 260 PEYLATGRLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           PE + +G+L A  + DV+S GV+L  +L  R   D   +
Sbjct: 171 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 102/227 (44%), Gaps = 32/227 (14%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL- 133
           N +    +G G FG V         +EA   G+G     + +AVK LK       KE L 
Sbjct: 47  NLQFGKTLGAGAFGKV---------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           SE+  +  L  H N+V L+G C  G   L++ EY   G L N L RR +R L       +
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKSRVLETDPAFAI 156
Query: 193 AIG-------------AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG 239
           A                A+G++FL  A +  I+RD  A N+LL +   AK+ DFGLA+  
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  V         + APE +     T + DV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 102/227 (44%), Gaps = 32/227 (14%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL- 133
           N +    +G G FG V         +EA   G+G     + +AVK LK       KE L 
Sbjct: 47  NLQFGKTLGAGAFGKV---------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           SE+  +  L  H N+V L+G C  G   L++ EY   G L N L RR +R L       +
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKSRVLETDPAFAI 156
Query: 193 AIG-------------AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG 239
           A                A+G++FL  A +  I+RD  A N+LL +   AK+ DFGLA+  
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  V         + APE +     T + DV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP     
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP---AI 47
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 104
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 105 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 159
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K          +    G+V+A K    ++KP     
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKP---AI 47
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 104
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 105 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 159
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   + + + +          +A+KK+ P   Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ + TR Y APE
Sbjct: 142 IHSA--NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHHP 145
           IGEG +G V   +  +H  +         +A+KK+ P   Q + +  L E+  L +  H 
Sbjct: 51  IGEGAYGMVSSAY--DHVRKTR-------VAIKKISPFEHQTYCQRTLREIQILLRFRHE 101
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSFLH 204
           N++ +           +   Y+ +  +E  L++   ++ L             RGL ++H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPEYL 263
            A   V++RD K SN+L+++  + K+ DFGLA+ A P  D T   T+ + TR Y APE +
Sbjct: 162 SA--NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 264 ATGR-LTAKCDVYSFGVVLLELLSGR 288
              +  T   D++S G +L E+LS R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 102/235 (43%), Gaps = 39/235 (16%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL- 133
           N +    +G G FG V         +EA   G+G     + +AVK LK       KE L 
Sbjct: 32  NLQFGKTLGAGAFGKV---------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 82
Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------------ 180
           SE+  +  L  H N+V L+G C  G   L++ EY   G L N L R+             
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 181 ---------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
                     RPL     +  +   A+G++FL  A +  I+RD  A N+LL +   AK+ 
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIG 200
Query: 232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           DFGLA+         V         + APE +     T + DV+S+G++L E+ S
Sbjct: 201 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 17/219 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N++    +GEG FG V   +   HT    +  +  +I  K L     QG  E   E++YL
Sbjct: 15  NYQIVKTLGEGSFGKVKLAY---HTTTGQKVALK-IINKKVLAKSDMQGRIE--REISYL 68
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L HP+++KL       +  ++V EY     L +++ +R         R    I +A  
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAA
Sbjct: 126 VEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAA 180
Query: 260 PEYLATGRLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           PE + +G+L A  + DV+S GV+L  +L  R   D   +
Sbjct: 181 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 218

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 73
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 131
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 132 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 17/219 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N++    +GEG FG V   +   HT    +  +  +I  K L     QG  E   E++YL
Sbjct: 14  NYQIVKTLGEGSFGKVKLAY---HTTTGQKVALK-IINKKVLAKSDMQGRIE--REISYL 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L HP+++KL       +  ++V EY     L +++ +R         R    I +A  
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 124
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAA
Sbjct: 125 VEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAA 179
Query: 260 PEYLATGRLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           PE + +G+L A  + DV+S GV+L  +L  R   D   +
Sbjct: 180 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDXX 206
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 70
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 128
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 129 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 139 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + APE L  G  T   D++SFGVVL E+ S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 17/219 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N++    +GEG FG V   +   HT    +  +  +I  K L     QG  E   E++YL
Sbjct: 9   NYQIVKTLGEGSFGKVKLAY---HTTTGQKVALK-IINKKVLAKSDMQGRIE--REISYL 62
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L HP+++KL       +  ++V EY     L +++ +R         R    I +A  
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 119
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAA
Sbjct: 120 VEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAA 174
Query: 260 PEYLATGRLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           PE + +G+L A  + DV+S GV+L  +L  R   D   +
Sbjct: 175 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 212

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 79
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 137
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 138 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 72
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 130
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 131 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 71
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 129
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 130 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 70
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIA 128
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 129 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L P   Q   +   EV  +
Sbjct: 16  NYRLQKTIGKGNFAKVK---LARHVLTGREVAVK-IIDKTQLNPTSLQ---KLFREVRIM 68
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFR-QIVSA 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD + N K++DFG +     G++        G+  YAA
Sbjct: 127 VQYCHQ--KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAA 181
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSG 287
           PE     +    + DV+S GV+L  L+SG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 69
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 128 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 33  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T    + + TR Y APE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLH 143
           S IGEG +G V   +     L   R      +A+KK+ P   Q + +  L E+  L +  
Sbjct: 34  SYIGEGAYGMVCSAY---DNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSF 202
           H N++ +           +   Y+ +  +E  L++    + L             RGL +
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGYAAPE 261
           +H A   V++RD K SN+LL++  + K+ DFGLA+ A P  D T    + + TR Y APE
Sbjct: 145 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 262 YLATGR-LTAKCDVYSFGVVLLELLSGR 288
            +   +  T   D++S G +L E+LS R
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V KG+   + ++     V + I   +      +   E L+E N + QL 
Sbjct: 16  DKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 70
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +P +V++IG C + E+ +LV E    G L  +L  +  R +     I++    + G+ +L
Sbjct: 71  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAPE 261
            E+    ++RD  A N+LL ++  AK+SDFGL+KA    D      Q  G     + APE
Sbjct: 128 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENXYKAQTHGKWPVKWYAPE 184
Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            +   + ++K DV+SFGV++ E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           +G GGFGYV + WI + T        G  +A+K+ + E    ++E W  E+  + +L+HP
Sbjct: 22  LGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 146 NLVKLIGFCLDGENRL-------LVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIGA 196
           N+V       DG  +L       L  EY   G L  +L  F          +R  ++   
Sbjct: 73  NVVSAREVP-DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DI 130
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLD---SEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  L +LHE   ++I+RD K  NI+L         K+ D G AK    G+   + T+ +G
Sbjct: 131 SSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           T  Y APE L   + T   D +SFG +  E ++G R
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           +G GGFGYV + WI + T        G  +A+K+ + E    ++E W  E+  + +L+HP
Sbjct: 23  LGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 146 NLVKLIGFCLDGENRL-------LVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIGA 196
           N+V       DG  +L       L  EY   G L  +L  F          +R  ++   
Sbjct: 74  NVVSAREVP-DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DI 131
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLD---SEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  L +LHE   ++I+RD K  NI+L         K+ D G AK    G+   + T+ +G
Sbjct: 132 SSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 186
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           T  Y APE L   + T   D +SFG +  E ++G R
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 61  LSCPNLKAFTFSELKNATRNFRPDSL------IGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           L   NL   +  + ++ TR+  P+        +G+G FG VYK         A      +
Sbjct: 13  LGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYK---------AQNKETSV 63
Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           + A K +  +  +  ++++ E++ L    HPN+VKL+       N  ++ E+   G+++ 
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG 234
            +     RPL  +    V       L++LH+   ++I+RD KA NIL   + + KL+DFG
Sbjct: 124 VMLEL-ERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFG 180
Query: 235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-----LTAKCDVYSFGVVLLEL 284
           ++       +   S   +GT  + APE +            K DV+S G+ L+E+
Sbjct: 181 VSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 72
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 130
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 131 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           ++G+G FG V         + A R G   + A+K LK +      +    + E   L  L
Sbjct: 26  VLGKGSFGKV---------MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             P  +  +  C    +RL  V EY+  G L  H+ + G    P  +     I    GL 
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI--GLF 134
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH+  + +IYRD K  N++LDSE + K++DFG+ K       T  + +  GT  Y APE
Sbjct: 135 FLHK--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAPE 190
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRRAVD 292
            +A        D +++GV+L E+L+G+   D
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 117/221 (52%), Gaps = 27/221 (12%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----KLKPEGFQG 128
           ELK+   +F   S +G G  G V+K         + +P  G+V+A K    ++KP     
Sbjct: 21  ELKD--DDFEKISELGAGNGGVVFK--------VSHKPS-GLVMARKLIHLEIKP---AI 66
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWT 187
             + + E+  L + + P +V   G F  DGE  + + E+M  GSL+  L + G   +P  
Sbjct: 67  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR--IPEQ 123
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           +  KV+I   +GL++L E + ++++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 124 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 178
Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +   +GTR Y +PE L     + + D++S G+ L+E+  GR
Sbjct: 179 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 75
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 133
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 134 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 69
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 128 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 71
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 129
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 130 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 94
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 152
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 153 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 72
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 130
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 131 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 72
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 130
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 131 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 69
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 128 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 63
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 121
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 122 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 76
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 134
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 135 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 136/298 (45%), Gaps = 42/298 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 139 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            + APE L  G  T   D++SFGVVL E+ S           AEQ       PY G   +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNE 239
Query: 316 LFRIMDIKLEGQY---PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDP 369
             +++   ++G Y   P      V  L   C     K+RP+  E+++ L+    P  P
Sbjct: 240 --QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           K + ++F+    +G G FG V       H + +   G     A+K LK E     K+ + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRV-------HLIRSRHNG--RYYAMKVLKKEIVVRLKQ-VE 51
Query: 135 EVN----YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
             N     L  + HP ++++ G   D +   ++ +Y+  G L + L R+  R  P  +  
Sbjct: 52  HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQR-FPNPVAK 109
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A      L +LH  +  +IYRD K  NILLD   + K++DFG AK  P      V+  
Sbjct: 110 FYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYX 162
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           + GT  Y APE ++T       D +SFG+++ E+L+G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 206
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 69
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 128 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 29  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 147 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 199
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 205 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 25  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 143 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 195
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 206
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-----MVIAVKKLKPEGFQGHKEWL- 133
           N +    +G G FG V         +EA   G+G     + +AVK LK       KE L 
Sbjct: 47  NLQFGKTLGAGAFGKV---------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--- 189
           SE+  +  L  H N+V L+G C  G   L++ EY   G L N L R+    L ++     
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 190 -----------IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                      +  +   A+G++FL  A +  I+RD  A N+LL +   AK+ DFGLA+ 
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   V         + APE +     T + DV+S+G++L E+ S
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 25/235 (10%)
Query: 61  LSCPNLKAFTFSELKNATRNFRPDSL------IGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           L   NL   +  + ++ TR+  P+        +G+G FG VYK         A      +
Sbjct: 13  LGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYK---------AQNKETSV 63
Query: 115 VIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           + A K +  +  +  ++++ E++ L    HPN+VKL+       N  ++ E+   G+++ 
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG 234
            +     RPL  +    V       L++LH+   ++I+RD KA NIL   + + KL+DFG
Sbjct: 124 VMLEL-ERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFG 180
Query: 235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-----LTAKCDVYSFGVVLLEL 284
           +  +             +GT  + APE +            K DV+S G+ L+E+
Sbjct: 181 V--SAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 28  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 146 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 198
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +F+   LIG GGFG V+K    +H ++      G    +K++K    +  +E    V  L
Sbjct: 12  DFKEIELIGSGGFGQVFKA---KHRID------GKTYVIKRVKYNNEKAERE----VKAL 58
Query: 140 GQLHHPNLVKLIGFCLDGENR-----------------LLVYEYMPKGSLENHLFRRGAR 182
            +L H N+V   G C DG +                   +  E+  KG+LE  + +R   
Sbjct: 59  AKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L   L +++     +G+ ++H   +++I RD K SNI L      K+ DFGL  +    
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
            +   S    GT  Y +PE +++     + D+Y+ G++L ELL
Sbjct: 176 GKRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           ++K    +F    ++G+G FG V+     +     A   +   + +     E     K  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           LS         HP L  +       EN   V EY+  G L  H+  +       +     
Sbjct: 71  LSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFY 123
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A     GL FLH   + ++YRD K  NILLD + + K++DFG+ K    GD    +    
Sbjct: 124 AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFC 179
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L   +     D +SFGV+L E+L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V    ++       +    M +AVK LKP      +E L SE+  L  L +H
Sbjct: 47  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-----GARPLPWTL----------- 188
            N+V L+G C  G   L++ EY   G L N L R+      ++  P  +           
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  +   A+G++FL  A +  I+RD  A NILL      K+ DFGLA+         V 
Sbjct: 163 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   + APE +     T + DV+S+G+ L EL S
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 21  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L +                 +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 139 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 191
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 30  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 146 LVSCTYQLARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V    ++       +    M +AVK LKP      +E L SE+  L  L +H
Sbjct: 31  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-----GARPLPWTL----------- 188
            N+V L+G C  G   L++ EY   G L N L R+      ++  P  +           
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  +   A+G++FL  A +  I+RD  A NILL      K+ DFGLA+         V 
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   + APE +     T + DV+S+G+ L EL S
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 138/303 (45%), Gaps = 52/303 (17%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++RD  A N ++  +F  K+ DFG+     T D    +    G +
Sbjct: 139 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGM-----TRDIYETAYYRKGGK 191
Query: 256 G-----YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           G     + APE L  G  T   D++SFGVVL E+ S           AEQ       PY 
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQ 234
Query: 311 GDRRKLFRIMDIKLEGQY---PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP 366
           G   +  +++   ++G Y   P      V  L   C     K+RP+  E+++ L+    P
Sbjct: 235 GLSNE--QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 292
Query: 367 RDP 369
             P
Sbjct: 293 SFP 295

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 66
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 124
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 125 EGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 36/259 (13%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK---EW 132
           N   NFR +  IG G F  VY+         AA    G+ +A+KK++       K   + 
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYR---------AACLLDGVPVALKKVQIFDLMDAKARADC 79
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRI 190
           + E++ L QL+HPN++K     ++     +V E    G L   +  F++  R +P     
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
           K  +     L  +H   ++V++RD K +N+ + +    KL D GL +   +  +T  +  
Sbjct: 140 KYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHS 195
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           ++GT  Y +PE +       K D++S G +L E+ +                     P+ 
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA------------------LQSPFY 237
Query: 311 GDRRKLFRIMDIKLEGQYP 329
           GD+  L+ +     +  YP
Sbjct: 238 GDKMNLYSLCKKIEQCDYP 256

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V    ++       +    M +AVK LKP      +E L SE+  L  L +H
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-----GARPLPWTL----------- 188
            N+V L+G C  G   L++ EY   G L N L R+      ++  P  +           
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  +   A+G++FL  A +  I+RD  A NILL      K+ DFGLA+         V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   + APE +     T + DV+S+G+ L EL S
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V    ++       +    M +AVK LKP      +E L SE+  L  L +H
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-----GARPLPWTL----------- 188
            N+V L+G C  G   L++ EY   G L N L R+      ++  P  +           
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  +   A+G++FL  A +  I+RD  A NILL      K+ DFGLA+         V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   + APE +     T + DV+S+G+ L EL S
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQL-HH 144
           +G G FG V    ++       +    M +AVK LKP      +E L SE+  L  L +H
Sbjct: 49  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-----GARPLPWTL----------- 188
            N+V L+G C  G   L++ EY   G L N L R+      ++  P  +           
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  +   A+G++FL  A +  I+RD  A NILL      K+ DFGLA+         V 
Sbjct: 165 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   + APE +     T + DV+S+G+ L EL S
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L ++                +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 247
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +  +    + +SE+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------I 190
            N++ L+G C       ++ EY  KG+L  +L  R    L +                 +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+   
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 206
Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS--EVN 137
           +F    ++G+G FG V+         +  RP  G + A+K LK    +      +  E +
Sbjct: 29  HFELLKVLGQGSFGKVFL------VRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 138 YLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLR-IKVAIG 195
            L  ++HP +VKL  +    E +L L+ +++  G L    F R ++ + +T   +K  + 
Sbjct: 83  ILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA 137
Query: 196 A-ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
             A GL  LH     +IYRD K  NILLD E + KL+DFGL+K     ++   S    GT
Sbjct: 138 ELALGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGT 193
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y APE +     +   D +S+GV++ E+L+G
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 35  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 151 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK-LKPEGFQGHKEW-LSEVNYLGQLHH 144
           IGEG +G V+K               G ++A+KK L+ E     K+  L E+  L QL H
Sbjct: 11  IGEGSYGVVFK---------CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           PNLV L+          LV+EY     L  H   R  R +P  L   +     + ++F H
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
           +     I+RD K  NIL+      KL DFG A+   TG   +   +V  TR Y +PE L 
Sbjct: 120 K--HNCIHRDVKPENILITKHSVIKLCDFGFARL-LTGPSDYYDDEV-ATRWYRSPELLV 175
Query: 265 -TGRLTAKCDVYSFGVVLLELLSG 287
              +     DV++ G V  ELLSG
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 107/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+    + Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSXQEYSDWKEKKTYLNPWKKI 233

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 32  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 148 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V  G   EH L   +  V  ++  +K++     G  +   E+  L    HP+
Sbjct: 19  LGVGTFGKVKIG---EHQLTGHKVAVK-ILNRQKIRSLDVVGKIK--REIQNLKLFRHPH 72
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           ++KL        +  +V EY+  G L +++ + G        R+   I +A  + + H  
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
              V++RD K  N+LLD+  NAK++DFGL+     G+    S    G+  YAAPE + +G
Sbjct: 130 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVI-SG 184
Query: 267 RLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           RL A  + D++S GV+L  LL G    D   V
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 69
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 70  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 127
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 128 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKG 185
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 186 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 228
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 229 LSNE--QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++ EY  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      +++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 22/220 (10%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLS 134
           +++  F+    +G G +  VYKG              G+ +A+K++K +  +G     + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIR 52
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           E++ + +L H N+V+L    +  EN+L LV+E+M    L+ ++  R     P  L + + 
Sbjct: 53  EISLMKELKHENIVRLYD-VIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 194 ----IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
                   +GL+F HE   ++++RD K  N+L++     KL DFGLA+A      T  S 
Sbjct: 111 KYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGR 288
            V  T  Y AP+ L   R  +   D++S G +L E+++G+
Sbjct: 169 VV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEIXINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+ +L+     + +KE L E  
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIMELREATSPKANKEILDEAY 103
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 161
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 162 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEIXINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINAMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEIXINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 73
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 131
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFG AK     ++ + +        +
Sbjct: 132 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 78
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 136
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 137 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKG 194
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 195 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 237
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 238 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 13  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 63
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 121
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 122 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 71
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 129
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFG AK     ++ + +        +
Sbjct: 130 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 71
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 129
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFG AK     ++ + +        +
Sbjct: 130 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 49/236 (20%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +F+   LIG GGFG V+K    +H ++      G    ++++K    +  +    EV  L
Sbjct: 13  DFKEIELIGSGGFGQVFKA---KHRID------GKTYVIRRVKYNNEKAER----EVKAL 59
Query: 140 GQLHHPNLVKLIGFCLDG-------------------ENR-----------LLVYEYMPK 169
            +L H N+V   G C DG                   EN             +  E+  K
Sbjct: 60  AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 170 GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK 229
           G+LE  + +R    L   L +++     +G+ ++H   +++I+RD K SNI L      K
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLIHRDLKPSNIFLVDTKQVK 176
Query: 230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
           + DFGL  +     +    T+  GT  Y +PE +++     + D+Y+ G++L ELL
Sbjct: 177 IGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++  G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 76
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L++ + MP G L +++ R     +     +   +  A
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 134
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 135 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++  G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 69
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 128 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 234

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS----PLQVAVKTL-PEV 72
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + +L+H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 73  CSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 191 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 71
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 129
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFG AK     ++ + +        +
Sbjct: 130 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 69
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFG AK     ++ + +        +
Sbjct: 128 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEA-ARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG +G V    ++  T EA A   V M  AV    PE  +       E+     L+H 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDC--PENIK------KEICINKMLNHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
               + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE L  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 266 GRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
               A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++  G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 76
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 134
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        +
Sbjct: 135 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN 137
            F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAY 76
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            +  + +P++ +L+G CL    +L+  + MP G L +++ R     +     +   +  A
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 134
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+++L +  +++++RD  A N+L+ +  + K++DFG AK     ++ + +        +
Sbjct: 135 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A E +     T + DV+S+GV + EL++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      +  +I   +L P   Q   +   EV  +
Sbjct: 13  NYRLLKTIGKGNFAKVK---LARHILTGREVAIK-IIDKTQLNPTSLQ---KLFREVRIM 65
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   L+ EY   G + ++L   G R      R K        
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFR-QIVSA 123
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  +++++RD KA N+LLD++ N K++DFG +     G +        G+  YAA
Sbjct: 124 VQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAA 178
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSG 287
           PE     +    + DV+S GV+L  L+SG
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 102/231 (44%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG 125
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 86
Query: 126 F--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
           +  Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 87  YSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P+G +   L +        T      
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 122 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 173
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 86
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + +L+H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 87  CSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V  G   EH L   +  V  ++  +K++     G  +   E+  L    HP+
Sbjct: 19  LGVGTFGKVKIG---EHQLTGHKVAVK-ILNRQKIRSLDVVGKIK--REIQNLKLFRHPH 72
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           ++KL        +  +V EY+  G L +++ + G        R+   I +A  + + H  
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR- 129
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
              V++RD K  N+LLD+  NAK++DFGL+     G+    S    G+  YAAPE + +G
Sbjct: 130 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVI-SG 184
Query: 267 RLTA--KCDVYSFGVVLLELLSGRRAVDKTRV 296
           RL A  + D++S GV+L  LL G    D   V
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 84
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQ 142
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 143 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 243
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 244 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 143 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 194
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T++ G
Sbjct: 117 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++R+  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 139 IADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + APE L  G  T   D++SFGVVL E+ S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 84
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 142
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 143 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 243
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 244 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      +  +I   +L P   Q   +   EV  +
Sbjct: 16  NYRLLKTIGKGNFAKVK---LARHILTGREVAIK-IIDKTQLNPTSLQ---KLFREVRIM 68
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   L+ EY   G + ++L   G R      R K        
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFR-QIVSA 126
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  +++++RD KA N+LLD++ N K++DFG +     G +        G   YAA
Sbjct: 127 VQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAA 181
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSG 287
           PE     +    + DV+S GV+L  L+SG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++  Y  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  RT +S    G
Sbjct: 118 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----G 169
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G    +  +  +      +AVK +      +   E+L+E + +      
Sbjct: 26  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IKVAIG 195
           ++V+L+G    G+  L+V E M  G L+++L  R  RP         P TL+  I++A  
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+   ++ ++R+  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 140 IADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            + APE L  G  T   D++SFGVVL E+ S
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 75
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 76  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 133
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 134 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 191
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 192 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 234
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 235 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V     ++HT        G  +AVKK+     Q  +   +EV  +   HH N
Sbjct: 53  IGEGSTGIVCIA-TEKHT--------GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V +    L G+   +V E++  G+L + +   R     +       V +   R LS+LH
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH 158
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL S+   KLSDFG                ++GT  + APE ++
Sbjct: 159 N--QGVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKXLVGTPYWMAPEVIS 214
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 137
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMY 195
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 73
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 133
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 134 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 185
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 186 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 78
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 136
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 137 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 194
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 195 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 237
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 238 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +   E     ++   E+  L Q    
Sbjct: 31  IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L G    ++ EY+  GS  + L R G  P        +     +GL +LH 
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAG--PFDEFQIATMLKEILKGLDYLHS 138
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 139 EKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 266 GRLTAKCDVYSFGVVLLELLSGR 288
               +K D++S G+  +EL  G 
Sbjct: 195 SAYDSKADIWSLGITAIELAKGE 217

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 77
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 135
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 136 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 193
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 194 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 236
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 237 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS----PLQVAVKTL-PEV 98
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 99  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 158
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 216
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 217 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 74
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL--------PWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 75  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQ 132
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 133 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 190
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 191 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 233
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 234 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 34  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS----PLQVAVKTL-PEV 88
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 89  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 148
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 206
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 207 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 71
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 129
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 130 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 187
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 188 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 230
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 231 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 89/191 (46%), Gaps = 31/191 (16%)
Query: 126 FQGHKEWLSEVNYLGQ--LHHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRR 179
            Q  + W SE        + H NL++ I     G N      L+  +  KGSL ++L   
Sbjct: 48  LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL--- 104
Query: 180 GARPLPWTLRIKVAIGAARGLSFLHE---------AEQQVIYRDFKASNILLDSEFNAKL 230
               + W     VA   +RGLS+LHE          +  + +RDFK+ N+LL S+  A L
Sbjct: 105 KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVL 164
Query: 231 SDFGLAK----AGPTGDRTHVSTQVMGTRGYAAPEYLATG-----RLTAKCDVYSFGVVL 281
           +DFGLA       P GD TH     +GTR Y APE L            + D+Y+ G+VL
Sbjct: 165 ADFGLAVRFEPGKPPGD-THGQ---VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 220
Query: 282 LELLSGRRAVD 292
            EL+S  +A D
Sbjct: 221 WELVSRCKAAD 231

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 77
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 135
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + 
Sbjct: 136 MAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 193
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 194 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 236
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 237 LSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKV---KLARHILTGKEVAV-RIIDKTQLNSSSLQ---KLFREVRIM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFR-QIVSA 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD++ N K++DFG +     G++     +  G+  YAA
Sbjct: 126 VQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAA 180
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           PE     +    + DV+S GV+L  L+SG    D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 130/314 (41%), Gaps = 48/314 (15%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVN 137
           +N      +GEG FG V K     H     R G    +AVK LK        ++ LSE N
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-TAFHL--KGRAGY-TTVAVKMLKENASPSELRDLLSEFN 78
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR------------------ 179
            L Q++HP+++KL G C      LL+ EY   GSL   L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 180 ----GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
                 R L     I  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
           ++     D     +Q      + A E L     T + DV+SFGV+L E+++         
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------- 247
Query: 296 VGAEQNLVDWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSM 353
           +G          PY G    +LF ++      + P   +  +  L LQC   E   RP  
Sbjct: 248 LG--------GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 354 SEVLSALEQLPPPR 367
           +++   LE++   R
Sbjct: 300 ADISKDLEKMMVKR 313

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 118 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCG 169
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 71
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS----PLQVAVKTL-PEV 78
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 79  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 138
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 139 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 196
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 197 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS----PLQVAVKTL-PEV 72
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 73  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 191 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 71
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 131
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 84/178 (47%), Gaps = 8/178 (4%)
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           L+H N+VK  G   +G  + L  EY   G L + +      P P   R    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y APE
Sbjct: 119 YLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 262 YLATGRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW--AKPYLGDRRKL 316
            L      A+  DV+S G+VL  +L+G    D+      Q   DW   K YL   +K+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI 233

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 138/295 (46%), Gaps = 43/295 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEVNYLGQLHHP 145
           +G+G FG VY+G       +     V    A+K + +    +   E+L+E + + + +  
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRV----AIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IKVAIG 195
           ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I++A  
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      + +   
Sbjct: 169 IADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G   +
Sbjct: 227 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNE 269
Query: 316 LFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
             +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 270 --QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV  +
Sbjct: 8   NYRLLKTIGKGNFAKVK---LARHILTGKEVAVK-IIDKTQLNSSSLQ---KLFREVRIM 60
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G     W    +      + 
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEARAKFRQI 115
Query: 200 LSFLHEAEQQ-VIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           +S +    Q+ +++RD KA N+LLD++ N K++DFG +     G++        G+  YA
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYA 172
Query: 259 APEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           APE     +    + DV+S GV+L  L+SG    D
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 63
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 64  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 123
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 181
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 182 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 14/212 (6%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEV 136
           A  +F     +G+G FG VY         E  R  +  +  + K + E      +   EV
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLA------REKQRKFILALKVLFKAQLEKAGVEHQLRREV 56
Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
                L HPN+++L G+  D     L+ EY P G++   L +        T      +  
Sbjct: 57  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-- 114
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + GT  
Sbjct: 115 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 168
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           Y  PE +       K D++S GV+  E L G+
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +   E     ++   E+  L Q   P
Sbjct: 30  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L      ++ EY+  GS  + L   G  PL  T    +     +GL +LH 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 137
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL      KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 138 EKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 266 GRLTAKCDVYSFGVVLLELLSGR 288
               +K D++S G+  +EL  G 
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL-HH 144
           +GEG FG V     +   ++  +P   + +AVK LK +  +    + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWTL 188
            N++ L+G C       ++  Y  KG+L  +L  R  RP                + +  
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D    +
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           T       + APE L     T + DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 122 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCG 173
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 117 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 59
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 117
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 175
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYS 196

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 86
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 87  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 146
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 122 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 173
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 122 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 173
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 174 TLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 137
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 195
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 72
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 73  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 191 AQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 120 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 171
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 130/314 (41%), Gaps = 48/314 (15%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVN 137
           +N      +GEG FG V K     H     R G    +AVK LK        ++ LSE N
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-TAFHL--KGRAGY-TTVAVKMLKENASPSELRDLLSEFN 78
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR------------------ 179
            L Q++HP+++KL G C      LL+ EY   GSL   L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 180 ----GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
                 R L     I  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
           ++     D     +Q      + A E L     T + DV+SFGV+L E+++         
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------- 247
Query: 296 VGAEQNLVDWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSM 353
           +G          PY G    +LF ++      + P   +  +  L LQC   E   RP  
Sbjct: 248 LG--------GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 354 SEVLSALEQLPPPR 367
           +++   LE++   R
Sbjct: 300 ADISKDLEKMMVKR 313

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 63
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 121
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 122 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 179
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYS 200

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 117 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMY 180
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 112
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 113 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 117 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 67  KAFTFSELKNATR-NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE- 124
           K  + S+LK   R N      +G G FG VY+G +     + +     + +AVK L PE 
Sbjct: 35  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 89
Query: 125 -GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              Q   ++L E   + + +H N+V+ IG  L    R ++ E M  G L++ L     RP
Sbjct: 90  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 149
Query: 184 -----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL 235
                L     + VA   A G  +L   E   I+RD  A N LL        AK+ DFG+
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 207
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           A+              M    +  PE    G  T+K D +SFGV+L E+ S
Sbjct: 208 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKV---KLARHILTGKEVAVK-IIDKTQLNSSSLQ---KLFREVRIM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFR-QIVSA 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD++ N K++DFG +     G++        G+  YAA
Sbjct: 126 VQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 180
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           PE     +    + DV+S GV+L  L+SG    D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 116 IAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           +A+K++  E  Q    E L E+  + Q HHPN+V      +  +   LV + +  GS+ +
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 175 ---HLFRRGARP---LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA 228
              H+  +G      L  +    +      GL +LH+  Q  I+RD KA NILL  + + 
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 160
Query: 229 KLSDFGLAKAGPTG---DRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLEL 284
           +++DFG++    TG    R  V    +GT  + APE +   R    K D++SFG+  +EL
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 285 LSG 287
            +G
Sbjct: 221 ATG 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 129/314 (41%), Gaps = 48/314 (15%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVN 137
           +N      +GEG FG V K     H     R G    +AVK LK        ++ LSE N
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-TAFHL--KGRAGY-TTVAVKMLKENASPSELRDLLSEFN 78
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR------------------ 179
            L Q++HP+++KL G C      LL+ EY   GSL   L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 180 ----GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
                 R L     I  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
           ++     D     +Q      + A E L     T + DV+SFGV+L E+++         
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------- 247
Query: 296 VGAEQNLVDWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI-SEAKVRPSM 353
           +G          PY G    +LF ++      + P   +  +  L LQC   E   RP  
Sbjct: 248 LG--------GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 354 SEVLSALEQLPPPR 367
           +++   LE++   R
Sbjct: 300 ADISKDLEKMMVKR 313

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKV---KLARHILTGKEVAVK-IIDKTQLNSSSLQ---KLFREVRIM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFR-QIVSA 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD++ N K++DFG +     G++        G+  YAA
Sbjct: 126 VQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 180
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           PE     +    + DV+S GV+L  L+SG    D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 116 IAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN 174
           +A+K++  E  Q    E L E+  + Q HHPN+V      +  +   LV + +  GS+ +
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 175 ---HLFRRGARP---LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA 228
              H+  +G      L  +    +      GL +LH+  Q  I+RD KA NILL  + + 
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 155
Query: 229 KLSDFGLAKAGPTG---DRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLEL 284
           +++DFG++    TG    R  V    +GT  + APE +   R    K D++SFG+  +EL
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215
Query: 285 LSG 287
            +G
Sbjct: 216 ATG 218

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 180
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYS 201

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHH 144
           +GE  FG VYKG    H    A       +A+K LK +  +G   +E+  E     +L H
Sbjct: 34  LGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQH 88
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR------GARPLPWTLR--------I 190
           PN+V L+G     +   +++ Y   G L   L  R      G+     T++        +
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +    A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D   +   
Sbjct: 149 HLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +    + APE +  G+ +   D++S+GVVL E+ S
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKV---KLARHILTGKEVAV-RIIDKTQLNSSSLQ---KLFREVRIM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFR-QIVSA 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD++ N K++DFG +     G++        G+  YAA
Sbjct: 126 VQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 180
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           PE     +    + DV+S GV+L  L+SG    D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIK 191
           L EV  L  L HPN++KL  F  D  N  LV E    G L + +  R     +   + IK
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNA--KLSDFGLAKAGPTGDRTHVS 248
             +    G+++LH  +  +++RD K  N+LL+S E +A  K+ DFGL+       +    
Sbjct: 144 QVLS---GVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--- 195
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + +GT  Y APE L   +   KCDV+S GV+L  LL+G
Sbjct: 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 87  IGEGGFGYV-YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V Y  W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 70
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLE- 128
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
             +Q ++RD  A N L++ +   K+SDFGL++     + T         R ++ PE L  
Sbjct: 129 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 186
Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + ++K D+++FGV++ E+ S
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYS 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +   E     ++   E+  L Q   P
Sbjct: 15  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L      ++ EY+  GS  + L   G  PL  T    +     +GL +LH 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL      KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 123 EKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 266 GRLTAKCDVYSFGVVLLELLSGR 288
               +K D++S G+  +EL  G 
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLS 134
           N + +F+  SL+GEG +G V           A     G ++A+KK++P +        L 
Sbjct: 8   NISSDFQLKSLLGEGAYGVV---------CSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  L    H N++ +               Y+ +  ++  L R  +  +     I+  I
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 195 -GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK---------AGPTGDR 244
               R +  LH +   VI+RD K SN+L++S  + K+ DFGLA+         + PTG +
Sbjct: 119 YQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 245 THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGR 288
           + + T+ + TR Y APE + T  + +   DV+S G +L EL   R
Sbjct: 177 SGM-TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 143 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCG 194
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 33/233 (14%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVN 137
            N     ++G G FG V    ++      ++ GV + +AVK LK +     +E L SE+ 
Sbjct: 45  ENLEFGKVLGSGAFGKV----MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 138 YLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP------------- 183
            + QL  H N+V L+G C       L++EY   G L N+L  R  R              
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQK 158
Query: 184 ----------LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
                     L +   +  A   A+G+ FL    +  ++RD  A N+L+      K+ DF
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           GLA+   +     V         + APE L  G  T K DV+S+G++L E+ S
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +   E     ++   E+  L Q   P
Sbjct: 15  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L      ++ EY+  GS  + L   G  PL  T    +     +GL +LH 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 122
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL      KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 123 EKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 266 GRLTAKCDVYSFGVVLLELLSGR 288
               +K D++S G+  +EL  G 
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P+G +   L +        T      
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 122 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXG 173
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 120 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 171
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLS 134
           N + +F+  SL+GEG +G V           A     G ++A+KK++P +        L 
Sbjct: 8   NISSDFQLKSLLGEGAYGVV---------CSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  L    H N++ +               Y+ +  ++  L R  +  +     I+  I
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 195 -GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK---------AGPTGDR 244
               R +  LH +   VI+RD K SN+L++S  + K+ DFGLA+         + PTG +
Sbjct: 119 YQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 245 THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGR 288
           + + T+ + TR Y APE + T  + +   DV+S G +L EL   R
Sbjct: 177 SGM-TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 55
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 116 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 167
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 168 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 137/299 (45%), Gaps = 51/299 (17%)
Query: 87  IGEGGFGYVYKGWI-----DEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ 141
           +G+G FG VY+G       DE     A   V    ++++          E+L+E + + +
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--------RIEFLNEASVMKE 71
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IK 191
            +  ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I+
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQ 129
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           +A   A G+++L+    + ++RD  A N  +  +F  K+ DFG+ +     D      + 
Sbjct: 130 MAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 187
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +    + +PE L  G  T   DV+SFGVVL E+ +           AEQ       PY G
Sbjct: 188 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQG 230
Query: 312 DRRKLFRIMDIKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL-EQLPP 365
              +  +++   +EG     P     M+  L   C     K+RPS  E++S++ E++ P
Sbjct: 231 LSNE--QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKV---KLARHILTGKEVAVK-IIDKTQLNSSSLQ---KLFREVRIM 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFR-QIVSA 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD++ N K++DFG +     G++        G   YAA
Sbjct: 126 VQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAA 180
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           PE     +    + DV+S GV+L  L+SG    D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHH 144
           +GE  FG VYKG    H    A       +A+K LK +  +G   +E+  E     +L H
Sbjct: 17  LGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQH 71
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR------GARPLPWTLR--------I 190
           PN+V L+G     +   +++ Y   G L   L  R      G+     T++        +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +    A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D   +   
Sbjct: 132 HLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            +    + APE +  G+ +   D++S+GVVL E+ S
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 28  IGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALE 130
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH    QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  + APE
Sbjct: 131 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPE 186
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +       K D++S G++ +E++ G 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 117 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           D  +G G FG V +G          +  + + I V K   E     +E + E   + QL 
Sbjct: 15  DIELGCGNFGSVRQG-----VYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 68
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-LPWTLRIKVAIGAARGLSF 202
           +P +V+LIG C   E  +LV E    G L  H F  G R  +P +   ++    + G+ +
Sbjct: 69  NPYIVRLIGVC-QAEALMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR--GYAAP 260
           L E  +  ++RD  A N+LL +   AK+SDFGL+KA    D ++ + +  G     + AP
Sbjct: 126 LEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAP 182
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLS 286
           E +   + +++ DV+S+GV + E LS
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 60
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + G
Sbjct: 121 L--ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 172
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIK 191
           L EV  L QL HPN++KL  F  D  N  LV E    G L +  + R+    +   + +K
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVS 248
             +    G ++LH  +  +++RD K  N+LL+S+      K+ DFGL+     G +    
Sbjct: 112 QVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM--- 163
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + +GT  Y APE L   +   KCDV+S GV+L  LL G
Sbjct: 164 KERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG V+KG ID  T +        V+A+K +   E     ++   E+  L Q   P
Sbjct: 35  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 85
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            + K  G  L      ++ EY+  GS  + L   G  PL  T    +     +GL +LH 
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 142
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+RD KA+N+LL      KL+DFG+  AG   D        +GT  + APE +  
Sbjct: 143 EKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 266 GRLTAKCDVYSFGVVLLELLSGR 288
               +K D++S G+  +EL  G 
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           ++G+G FG V         + + R G   + AVK LK +      +    + E   L   
Sbjct: 348 VLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             P  +  +  C    +RL  V EY+  G L  H+ + G    P  +     I  A GL 
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--AIGLF 456
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FL    + +IYRD K  N++LDSE + K++DFG+ K       T  +    GT  Y APE
Sbjct: 457 FLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPE 512
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +A        D ++FGV+L E+L+G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL--KPEGFQGHKEWLSEVNYLGQLH 143
           L+GEG +G V K               G ++A+KK     +     K  + E+  L QL 
Sbjct: 32  LVGEGSYGMVMK---------CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLEN-HLFRRGARPLPWTLRIKVAIGAARGLSF 202
           H NLV L+  C   +   LV+E++    L++  LF  G   L + +  K       G+ F
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGF 139
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAAP 260
            H     +I+RD K  NIL+      KL DFG A+  A P      V    + TR Y AP
Sbjct: 140 CH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYDDEVATRWYRAP 193
Query: 261 EYLATGRLTAK-CDVYSFGVVLLELLSG 287
           E L       K  DV++ G ++ E+  G
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIK 191
           L EV  L QL HPN++KL  F  D  N  LV E    G L +  + R+    +   + +K
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVS 248
             +    G ++LH  +  +++RD K  N+LL+S+      K+ DFGL+     G +    
Sbjct: 129 QVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM--- 180
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + +GT  Y APE L   +   KCDV+S GV+L  LL G
Sbjct: 181 KERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           ++   ++G+G FG V    + +  +      V  VI+ +++K +     +  L EV  L 
Sbjct: 28  YKGQRVLGKGSFGEVI---LCKDKITGQECAVK-VISKRQVKQK--TDKESLLREVQLLK 81
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           QL HPN++KL  F  D     LV E    G L + +  R  +        ++      G+
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGI 139
Query: 201 SFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +++H  + ++++RD K  N+LL+S   + N ++ DFGL+       +       +GT  Y
Sbjct: 140 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYY 194
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE L  G    KCDV+S GV+L  LLSG
Sbjct: 195 IAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L EV  L +L HPN++KL     D  +  +V E    G L + + +R         RI  
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVST 249
            + +  G++++H  +  +++RD K  NILL+S   + + K+ DFGL+       +     
Sbjct: 129 QVFS--GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--- 181
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             +GT  Y APE L  G    KCDV+S GV+L  LLSG
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           ++   ++G+G FG V    + +  +      V  VI+ +++K +     +  L EV  L 
Sbjct: 51  YKGQRVLGKGSFGEVI---LCKDKITGQECAV-KVISKRQVKQK--TDKESLLREVQLLK 104
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           QL HPN++KL  F  D     LV E    G L + +  R  +        ++      G+
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGI 162
Query: 201 SFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +++H  + ++++RD K  N+LL+S   + N ++ DFGL+       +       +GT  Y
Sbjct: 163 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 217
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE L  G    KCDV+S GV+L  LLSG
Sbjct: 218 IAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           ++   ++G+G FG V    + +  +      V  VI+ +++K +     +  L EV  L 
Sbjct: 52  YKGQRVLGKGSFGEVI---LCKDKITGQECAV-KVISKRQVKQK--TDKESLLREVQLLK 105
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           QL HPN++KL  F  D     LV E    G L + +  R  +        ++      G+
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGI 163
Query: 201 SFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +++H  + ++++RD K  N+LL+S   + N ++ DFGL+       +       +GT  Y
Sbjct: 164 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 218
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE L  G    KCDV+S GV+L  LLSG
Sbjct: 219 IAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L EV  L +L HPN++KL     D  +  +V E    G L + + +R         RI  
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVST 249
            + +  G++++H  +  +++RD K  NILL+S   + + K+ DFGL+       +     
Sbjct: 129 QVFS--GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---K 181
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             +GT  Y APE L  G    KCDV+S GV+L  LLSG
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L EV  L +L HPN++KL     D  +  +V E    G L + + +R         RI  
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVST 249
            + +  G++++H  +  +++RD K  NILL+S   + + K+ DFGL+       +     
Sbjct: 129 QVFS--GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---K 181
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             +GT  Y APE L  G    KCDV+S GV+L  LLSG
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           ++   ++G+G FG V    + +  +      V  VI+ +++K +     +  L EV  L 
Sbjct: 34  YKGQRVLGKGSFGEVI---LCKDKITGQECAVK-VISKRQVKQK--TDKESLLREVQLLK 87
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           QL HPN++KL  F  D     LV E    G L + +  R  +        ++      G+
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGI 145
Query: 201 SFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +++H  + ++++RD K  N+LL+S   + N ++ DFGL+       +       +GT  Y
Sbjct: 146 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 200
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE L  G    KCDV+S GV+L  LLSG
Sbjct: 201 IAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHK-EWLS 134
           AT  + P + IG G +G VYK         A  P  G  +A+K ++ P G +G     + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 135 EVNYLGQLH---HPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFRRGARPLPW 186
           EV  L +L    HPN+V+L+  C     D E ++ LV+E++ +  L  +L +     LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH 246
                +     RGL FLH     +++RD K  NIL+ S    KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 166
Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
               V+ T  Y APE L         D++S G +  E+ 
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 58
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K+++FG +   P+  R    T + G
Sbjct: 119 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCG 170
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 21/224 (9%)
Query: 72  SELKNATRNFRPDSLI------GEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG 125
            ELK+     + D+L+      G G FG V +G          +  + + I V K   E 
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQG-----VYRMRKKQIDVAIKVLKQGTEK 377
Query: 126 FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-L 184
               +E + E   + QL +P +V+LIG C   E  +LV E    G L  H F  G R  +
Sbjct: 378 -ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL--HKFLVGKREEI 433
Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
           P +   ++    + G+ +L E  +  ++R+  A N+LL +   AK+SDFGL+KA    D 
Sbjct: 434 PVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKA-LGADD 490
Query: 245 THVSTQVMGT--RGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           ++ + +  G     + APE +   + +++ DV+S+GV + E LS
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 16/233 (6%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNY 138
           +F+  +L+G+G F  VY+        E+   G+ + I +   K     G  + + +EV  
Sbjct: 12  DFKVGNLLGKGSFAGVYRA-------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
             QL HP++++L  +  D     LV E    G +  +L  R  +P               
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIIT 123
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+ +LH     +++RD   SN+LL    N K++DFGLA         H +  + GT  Y 
Sbjct: 124 GMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN---LVDWAKP 308
           +PE         + DV+S G +   LL GR   D   V    N   L D+  P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 58
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 119 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCG 170
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHK-EWLS 134
           AT  + P + IG G +G VYK         A  P  G  +A+K ++ P G +G     + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 135 EVNYLGQLH---HPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFRRGARPLPW 186
           EV  L +L    HPN+V+L+  C     D E ++ LV+E++ +  L  +L +     LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH 246
                +     RGL FLH     +++RD K  NIL+ S    KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 166
Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
               V+ T  Y APE L         D++S G +  E+ 
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 118 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCG 169
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 27/224 (12%)
Query: 73  ELKNATRNFRPDSL------IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF 126
           E ++  R+  P+ +      +G+G FG VYK         A     G + A K ++ +  
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYK---------AKNKETGALAAAKVIETKSE 57
Query: 127 QGHKEWLSEVNYLGQLHHPNLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLP 185
           +  ++++ E+  L    HP +VKL+G +  DG+  +++ E+ P G+++  +     R L 
Sbjct: 58  EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELD-RGLT 115
Query: 186 WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT 245
                 V       L+FLH   +++I+RD KA N+L+  E + +L+DFG++       + 
Sbjct: 116 EPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 246 HVSTQVMGTRGYAAPEYLATGRLTA-----KCDVYSFGVVLLEL 284
             S   +GT  + APE +    +       K D++S G+ L+E+
Sbjct: 174 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKNSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 117 L--ANALSYCH--SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 120 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCG 171
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           ++G+G FG V         + + R G   + AVK LK +      +    + E   L   
Sbjct: 27  VLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             P  +  +  C    +RL  V EY+  G L  H+ + G    P  +     I  A GL 
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--AIGLF 135
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FL    + +IYRD K  N++LDSE + K++DFG+ K       T  +    GT  Y APE
Sbjct: 136 FLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPE 191
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +A        D ++FGV+L E+L+G+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPW----------TLR--IK 191
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+          TL   I 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
            +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+              
Sbjct: 153 YSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                + APE +     T + DV+SFGV+L E+ S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP----EGFQGHKEWLSEVNYLGQ 141
           ++G+GG+G V++        +      G + A+K LK        +      +E N L +
Sbjct: 24  VLGKGGYGKVFQ------VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           + HP +V LI     G    L+ EY+  G L   L R G             I  A G  
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG-- 135
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTRGYAAP 260
             H  ++ +IYRD K  NI+L+ + + KL+DFGL K     G  TH      GT  Y AP
Sbjct: 136 --HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGTIEYMAP 190
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E L         D +S G ++ ++L+G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLS 134
           N + +F+  SL+GEG +G V           A     G ++A+KK++P +        L 
Sbjct: 8   NISSDFQLKSLLGEGAYGVV---------CSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  L    H N++ +               Y+ +  ++  L R  +  +     I+  I
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 195 -GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK---------AGPTGDR 244
               R +  LH +   VI+RD K SN+L++S  + K+ DFGLA+         + PTG +
Sbjct: 119 YQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 245 THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGR 288
           + +  + + TR Y APE + T  + +   DV+S G +L EL   R
Sbjct: 177 SGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K+++FG +   P+  R    T + G
Sbjct: 120 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCG 171
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHK-EWLS 134
           AT  + P + IG G +G VYK         A  P  G  +A+K ++ P G +G     + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 135 EVNYLGQLH---HPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFRRGARPLPW 186
           EV  L +L    HPN+V+L+  C     D E ++ LV+E++ +  L  +L +     LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH 246
                +     RGL FLH     +++RD K  NIL+ S    KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 166
Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
               V+ T  Y APE L         D++S G +  E+ 
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------QGHKEWLSEVNYL 139
           ++G+GG+G V++        +      G + A+K LK            H +  +E N L
Sbjct: 24  VLGKGGYGKVFQ------VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK--AERNIL 75
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            ++ HP +V LI     G    L+ EY+  G L   L R G             I  A G
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
               H  ++ +IYRD K  NI+L+ + + KL+DFGL K     D T V+    GT  Y A
Sbjct: 136 ----HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHXFCGTIEYMA 189
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSG 287
           PE L         D +S G ++ ++L+G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           E + L +++HP +VKL  +    E +L L+ +++  G L    F R ++ + +T      
Sbjct: 76  ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKF 130
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
             A   L+  H     +IYRD K  NILLD E + KL+DFGL+K   + D    +    G
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCG 188
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T  Y APE +     T   D +SFGV++ E+L+G
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
            F    L+G+G FG V         +       G   A+K LK E      E    L+E 
Sbjct: 152 EFEYLKLLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 202
Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L    HP L  L  +     +RL  V EY   G L  HL R               I 
Sbjct: 203 RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 261
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +A  L +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T  +    GT 
Sbjct: 262 SA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 316
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            Y APE L         D +  GVV+ E++ GR
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
            F    L+G+G FG V         +       G   A+K LK E      E    L+E 
Sbjct: 149 EFEYLKLLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L    HP L  L  +     +RL  V EY   G L  HL R               I 
Sbjct: 200 RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +A  L +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T  +    GT 
Sbjct: 259 SA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 313
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            Y APE L         D +  GVV+ E++ GR
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 36  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPW-----------TLR--I 190
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+           TL   I
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+             
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                 + APE +     T + DV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 28  IGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALE 130
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTRGYAAP 260
           FLH    QVI+RD K+ NILL  + + KL+DFG  A+  P   +    ++++GT  + AP
Sbjct: 131 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAP 185
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E +       K D++S G++ +E++ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL 188
           H+E  +E++ L  L HPN++KL     D +   LV E+   G L   +  R         
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGL----AKAGPT 241
            I   I +  G+ +LH  +  +++RD K  NILL+++    N K+ DFGL    +K    
Sbjct: 150 NIMKQILS--GICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            DR       +GT  Y APE L   +   KCDV+S GV++  LL G
Sbjct: 206 RDR-------LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 120 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCG 171
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 117 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           E + L +++HP +VKL  +    E +L L+ +++  G L    F R ++ + +T      
Sbjct: 76  ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKF 130
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
             A   L+  H     +IYRD K  NILLD E + KL+DFGL+K   + D    +    G
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T  Y APE +     T   D +SFGV++ E+L+G
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           E + L +++HP +VKL  +    E +L L+ +++  G L    F R ++ + +T      
Sbjct: 77  ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKF 131
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
             A   L+  H     +IYRD K  NILLD E + KL+DFGL+K   + D    +    G
Sbjct: 132 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 189
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T  Y APE +     T   D +SFGV++ E+L+G
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPW--------TLR--IKVA 193
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+        TL   I  +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
              A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+                
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + APE +     T + DV+SFGV+L E+ S
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 114 MVIAVKKLKPEGFQGHKEWLS-EVNYLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGS 171
           M +  ++L PE  +  +E    E + L Q+  HP+++ LI          LV++ M KG 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 172 LENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
           L ++L  + A     T  I  ++  A  +SFLH     +++RD K  NILLD     +LS
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEA--VSFLHA--NNIVHRDLKPENILLDDNMQIRLS 242
Query: 232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR------LTAKCDVYSFGVVLLELL 285
           DFG +     G++     ++ GT GY APE L             + D+++ GV+L  LL
Sbjct: 243 DFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 286 SG 287
           +G
Sbjct: 300 AG 301

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           L+G+G FG V         +       G   A+K LK E      E    L+E   L   
Sbjct: 17  LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HP L  L  +     +RL  V EY   G L  HL R               I +A  L 
Sbjct: 68  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LD 124
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T       GT  Y APE
Sbjct: 125 YLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPE 181
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            L         D +  GVV+ E++ GR
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHK-- 130
           L  A + +   + IGEG +G V+K           + G G  +A+K+++ + G +G    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA-------RDLKNG-GRFVALKRVRVQTGEEGMPLS 57
Query: 131 --EWLSEVNYLGQLHHPNLVKLIGFCL----DGENRL-LVYEYMPKGSLENHLFRRGARP 183
               ++ + +L    HPN+V+L   C     D E +L LV+E++ +  L  +L +     
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           +P      +     RGL FLH    +V++RD K  NIL+ S    KL+DFGLA+      
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 172
Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                T V+ T  Y APE L         D++S G +  E+ 
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWLSEVNYLGQLH 143
           +G+G FG VY          A       ++A+K   K + E      +   EV     L 
Sbjct: 20  LGKGKFGNVYL---------ARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN+++L G+  D     L+ EY P G++   L +        T      +  A  LS+ 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYC 128
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H   ++VI+RD K  N+LL S    K++DFG +   P+  R    T + GT  Y  PE +
Sbjct: 129 HS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMI 182
Query: 264 ATGRLTAKCDVYSFGVVLLELLSG 287
                  K D++S GV+  E L G
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           KN  R +R   ++G+GGFG V    +       A   +     ++K + +  +G    L+
Sbjct: 183 KNTFRQYR---VLGKGGFGEVCACQV------RATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E   L +++   +V L       +   LV   M  G L+ H++  G    P    +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
               GL  LH   ++++YRD K  NILLD   + ++SD GLA   P G         +GT
Sbjct: 294 EICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGT 348
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            GY APE +   R T   D ++ G +L E+++G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           KN  R +R   ++G+GGFG V    +       A   +     ++K + +  +G    L+
Sbjct: 183 KNTFRQYR---VLGKGGFGEVCACQV------RATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E   L +++   +V L       +   LV   M  G L+ H++  G    P    +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
               GL  LH   ++++YRD K  NILLD   + ++SD GLA   P G         +GT
Sbjct: 294 EICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGT 348
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            GY APE +   R T   D ++ G +L E+++G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +GEG FG V        T    +  V +    ++L  +    H     E++YL  L HP+
Sbjct: 17  LGEGSFGKVKLA-----THYKTQQKVALKFISRQLLKKS-DMHMRVEREISYLKLLRHPH 70
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           ++KL        + ++V EY   G L +++  +         R    I  A  + + H  
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHR- 126
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
             ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE +  G
Sbjct: 127 -HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVI-NG 181
Query: 267 RLTA--KCDVYSFGVVLLELLSGRRAVD 292
           +L A  + DV+S G+VL  +L GR   D
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
           +F    +IG+G FG V         L A      +  AVK L+ +     KE    +SE 
Sbjct: 39  DFHFLKVIGKGSFGKV---------LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER 89
Query: 137 NYL-GQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           N L   + HP LV L  F     ++L  V +Y+  G L  HL R      P        I
Sbjct: 90  NVLLKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A G  +LH     ++YRD K  NILLDS+ +  L+DFGL K     + T  ++   GT
Sbjct: 149 ASALG--YLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGT 202
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y APE L         D +  G VL E+L G
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 29  IGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALE 131
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH    QVI+R+ K+ NILL  + + KL+DFG   A  T +++  ST V GT  + APE
Sbjct: 132 FLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPE 187
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +       K D++S G++ +E++ G 
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEV 136
           + F    ++G+G FG V +  + +        G  + +AVK LK +       +E+L E 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 137 NYLGQLHHPNLVKLIGFCLDGENR------LLVYEYMPKGSLENHLF--RRGARP--LPW 186
             + +  HP++ KL+G  L    +      +++  +M  G L   L   R G  P  LP 
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH 246
              ++  +  A G+ +L  + +  I+RD  A N +L  +    ++DFGL++   +GD   
Sbjct: 137 QTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                     + A E LA    T   DV++FGV + E+++
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 120 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCG 171
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPW--------TLR--IKVA 193
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+        TL   I  +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
              A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+                
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              + APE +     T + DV+SFGV+L E+ S
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+R    IG+G F  V    +  H L      V  +I   +L     Q   +   EV   
Sbjct: 15  NYRLLKTIGKGNFAKV---KLARHILTGKEVAV-KIIDKTQLNSSSLQ---KLFREVRIX 67
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L+HPN+VKL       +   LV EY   G + ++L   G R      R K        
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHG-RXKEKEARAKFR-QIVSA 125
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + + H+  + +++RD KA N+LLD++ N K++DFG +     G++        G   YAA
Sbjct: 126 VQYCHQ--KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAA 180
Query: 260 PEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVD 292
           PE     +    + DV+S GV+L  L+SG    D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWL 133
           A  +F     +G+G FG VY          A       ++A+K   K + E      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            EV     L HPN+++L G+  D     L+ EY P G++   L +        T      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           +  A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + G
Sbjct: 117 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCG 168
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y  PE +       K D++S GV+  E L G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 28  IGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALE 130
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH    QVI+RD K+ NILL  + + KL+DFG   A  T +++  S  V GT  + APE
Sbjct: 131 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYWMAPE 186
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +       K D++S G++ +E++ G 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
            F    L+G+G FG V         +       G   A+K LK E      E    L+E 
Sbjct: 9   EFEYLKLLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 59
Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L    HP L  L  +     +RL  V EY   G L  HL R               I 
Sbjct: 60  RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +A  L +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T       GT 
Sbjct: 119 SA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTP 173
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            Y APE L         D +  GVV+ E++ GR
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY          A     G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 29  IGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-----RGLS 201
           +V  +   L G+   +V EY+  GSL + +          T   +  I A      + L 
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALE 131
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH    QVI+RD K+ NILL  + + KL+DFG   A  T +++  S  V GT  + APE
Sbjct: 132 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYWMAPE 187
Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            +       K D++S G++ +E++ G 
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
            F    L+G+G FG V         +       G   A+K LK E      E    L+E 
Sbjct: 10  EFEYLKLLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 60
Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L    HP L  L  +     +RL  V EY   G L  HL R               I 
Sbjct: 61  RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +A  L +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T       GT 
Sbjct: 120 SA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTP 174
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            Y APE L         D +  GVV+ E++ GR
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 116 IAVKKLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRL-------LVYE 165
           +AVK L+ +  +    +L    E      L+HP +V +      GE          +V E
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVME 96
Query: 166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
           Y+   +L + +   G  P+     I+V   A + L+F H+    +I+RD K +NIL+ + 
Sbjct: 97  YVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANILISAT 152
Query: 226 FNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
              K+ DFG+A+A   +G+    +  V+GT  Y +PE      + A+ DVYS G VL E+
Sbjct: 153 NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 285 LSG 287
           L+G
Sbjct: 213 LTG 215

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           ++   ++G+G FG V    + +  +      V  VI+ +++K +     +  L EV  L 
Sbjct: 28  YKGQRVLGKGSFGEVI---LCKDKITGQECAV-KVISKRQVKQK--TDKESLLREVQLLK 81
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           QL HPN+ KL  F  D     LV E    G L + +  R  +        ++      G+
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGI 139
Query: 201 SFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           ++ H  + ++++RD K  N+LL+S   + N ++ DFGL+       +       +GT  Y
Sbjct: 140 TYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---XKDKIGTAYY 194
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE L  G    KCDV+S GV+L  LLSG
Sbjct: 195 IAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 31/209 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG VYK         A     G + A K ++ +  +  ++++ E+  L    HP 
Sbjct: 19  LGDGAFGKVYK---------AKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 147 LVKLIG-FCLDGENRLLVYEYMPKGSLENHLFR--RG-ARPLPWTLRIKVAI-GAARGLS 201
           +VKL+G +  DG+  +++ E+ P G+++  +    RG   P     +I+V        L+
Sbjct: 70  IVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP-----QIQVVCRQMLEALN 123
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTRGYAAP 260
           FLH   +++I+RD KA N+L+  E + +L+DFG+ AK   T  +       +GT  + AP
Sbjct: 124 FLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAP 178
Query: 261 EYLATGRLTA-----KCDVYSFGVVLLEL 284
           E +    +       K D++S G+ L+E+
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGH--- 129
           L  A + +   + IGEG +G V+K           + G G  +A+K+++ + G +G    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA-------RDLKNG-GRFVALKRVRVQTGEEGMPLS 57
Query: 130 -KEWLSEVNYLGQLHHPNLVKLIGFCL----DGENRL-LVYEYMPKGSLENHLFRRGARP 183
               ++ + +L    HPN+V+L   C     D E +L LV+E++ +  L  +L +     
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           +P      +     RGL FLH    +V++RD K  NIL+ S    KL+DFGLA+      
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 172
Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                T V+ T  Y APE L         D++S G +  E+ 
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQLHHP 145
           +G G FG       D H +E    G+  VI  K +  +  Q   E + +E+  L  L HP
Sbjct: 30  LGSGAFG-------DVHLVEERSSGLERVI--KTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR--PLPWTLRIKVAIGAARGLSFL 203
           N++K+     D  N  +V E    G L   +    AR   L      ++       L++ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 204 HEAEQQVIYRDFKASNILL-DSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           H   Q V+++D K  NIL  D+  ++  K+ DFGLA+   + +    ST   GT  Y AP
Sbjct: 141 H--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAP 195
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP 308
           E      +T KCD++S GVV+  LL+G      T +   Q    + +P
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGH--- 129
           L  A + +   + IGEG +G V+K           + G G  +A+K+++ + G +G    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA-------RDLKNG-GRFVALKRVRVQTGEEGMPLS 57
Query: 130 -KEWLSEVNYLGQLHHPNLVKLIGFCL----DGENRL-LVYEYMPKGSLENHLFRRGARP 183
               ++ + +L    HPN+V+L   C     D E +L LV+E++ +  L  +L +     
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           +P      +     RGL FLH    +V++RD K  NIL+ S    KL+DFGLA+      
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 172
Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                T V+ T  Y APE L         D++S G +  E+ 
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 116 IAVKKLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRL-------LVYE 165
           +AVK L+ +  +    +L    E      L+HP +V +      GE          +V E
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYAT---GEAETPAGPLPYIVME 96
Query: 166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
           Y+   +L + +   G  P+     I+V   A + L+F H+    +I+RD K +NI++ + 
Sbjct: 97  YVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISAT 152
Query: 226 FNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
              K+ DFG+A+A   +G+    +  V+GT  Y +PE      + A+ DVYS G VL E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 285 LSG 287
           L+G
Sbjct: 213 LTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 116 IAVKKLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRL-------LVYE 165
           +AVK L+ +  +    +L    E      L+HP +V +      GE          +V E
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVME 96
Query: 166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
           Y+   +L + +   G  P+     I+V   A + L+F H+    +I+RD K +NI++ + 
Sbjct: 97  YVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISAT 152
Query: 226 FNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
              K+ DFG+A+A   +G+    +  V+GT  Y +PE      + A+ DVYS G VL E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 285 LSG 287
           L+G
Sbjct: 213 LTG 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
           NF    ++G+G FG V    + E          G + AVK LK +      +    ++E 
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 137 NYLG-QLHHPNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
             L    +HP L +L   C    +RL  V E++  G L  H+  + +R          A 
Sbjct: 75  RILSLARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAA 131
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
                L FLH+  + +IYRD K  N+LLD E + KL+DFG+ K G     T  +    GT
Sbjct: 132 EIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGT 187
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y APE L         D ++ GV+L E+L G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 116 IAVKKLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRL-------LVYE 165
           +AVK L+ +  +    +L    E      L+HP +V +      GE          +V E
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVME 96
Query: 166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
           Y+   +L + +   G  P+     I+V   A + L+F H+    +I+RD K +NI++ + 
Sbjct: 97  YVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISAT 152
Query: 226 FNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
              K+ DFG+A+A   +G+    +  V+GT  Y +PE      + A+ DVYS G VL E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 285 LSG 287
           L+G
Sbjct: 213 LTG 215

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPW------------TLR-- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+            TL   
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 153 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 116 IAVKKLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRL-------LVYE 165
           +AVK L+ +  +    +L    E      L+HP +V +      GE          +V E
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT---GEAETPAGPLPYIVME 96
Query: 166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
           Y+   +L + +   G  P+     I+V   A + L+F H+    +I+RD K +NI++ + 
Sbjct: 97  YVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISAT 152
Query: 226 FNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
              K+ DFG+A+A   +G+    +  V+GT  Y +PE      + A+ DVYS G VL E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 285 LSG 287
           L+G
Sbjct: 213 LTG 215

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 23/234 (9%)
Query: 66  LKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG 125
           LKA +F    +    +     IG G +G V           A R   G  +A+KK+ P  
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSS---------ARRRLTGQQVAIKKI-PNA 91
Query: 126 FQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD----GENRLLVYEYMPKGSLENHLFR 178
           F      K  L E+  L    H N++ +          GE +  VY  +     + H   
Sbjct: 92  FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS-VYVVLDLMESDLHQII 150
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
             ++PL             RGL ++H A  QVI+RD K SN+L++     K+ DFG+A+ 
Sbjct: 151 HSSQPLTLEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARG 208
Query: 239 GPT--GDRTHVSTQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGRR 289
             T   +  +  T+ + TR Y APE  L+    T   D++S G +  E+L+ R+
Sbjct: 209 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--- 133
           AT  + P + IG G +G VYK         A  P  G  +A+K ++     G    L   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVPNGGGGGGGLPIS 57
Query: 134 --SEVNYLGQLH---HPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFRRGARP 183
              EV  L +L    HPN+V+L+  C     D E ++ LV+E++ +  L  +L +     
Sbjct: 58  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG 116
Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           LP      +     RGL FLH     +++RD K  NIL+ S    KL+DFGLA+      
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYS 171
Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                T V+ T  Y APE L         D++S G +  E+ 
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQL-HH 144
           +G G FG V    I+       +      +AVK LK       H+  +SE+  L  + HH
Sbjct: 72  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 145 PNLVKLIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
            N+V L+G C   G   +++ E+   G+L  +L  +    +P+ +               
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 188 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 23/234 (9%)
Query: 66  LKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG 125
           LKA +F    +    +     IG G +G V           A R   G  +A+KK+ P  
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSS---------ARRRLTGQQVAIKKI-PNA 90
Query: 126 FQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCLD----GENRLLVYEYMPKGSLENHLFR 178
           F      K  L E+  L    H N++ +          GE +  VY  +     + H   
Sbjct: 91  FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS-VYVVLDLMESDLHQII 149
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
             ++PL             RGL ++H A  QVI+RD K SN+L++     K+ DFG+A+ 
Sbjct: 150 HSSQPLTLEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARG 207
Query: 239 GPT--GDRTHVSTQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGRR 289
             T   +  +  T+ + TR Y APE  L+    T   D++S G +  E+L+ R+
Sbjct: 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWLSEVNYLGQLH 143
           +G+G FG VY          A       ++A+K   K + E      +   EV     L 
Sbjct: 20  LGKGKFGNVYL---------ARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN+++L G+  D     L+ EY P G++   L +        T      +  A  LS+ 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYC 128
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
           H   ++VI+RD K  N+LL S    K++DFG +   P+  R      + GT  Y  PE +
Sbjct: 129 H--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMI 182
Query: 264 ATGRLTAKCDVYSFGVVLLELLSG 287
                  K D++S GV+  E L G
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 116 IAVKKLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRL-------LVYE 165
           +AVK L+ +  +    +L    E      L+HP +V +      GE          +V E
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD---TGEAETPAGPLPYIVME 113
Query: 166 YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
           Y+   +L + +   G  P+     I+V   A + L+F H+    +I+RD K +NI++ + 
Sbjct: 114 YVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISAT 169
Query: 226 FNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
              K+ DFG+A+A   +G+    +  V+GT  Y +PE      + A+ DVYS G VL E+
Sbjct: 170 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 229
Query: 285 LSG 287
           L+G
Sbjct: 230 LTG 232

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 28/179 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
           EV  L  + H N+++ IG    G     +  L+  +  KGSL + L    A  + W    
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELC 124
Query: 191 KVAIGAARGLSFLHEA--------EQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAG 239
            +A   ARGL++LHE         +  + +RD K+ N+LL +   A ++DFGLA   +AG
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLT------AKCDVYSFGVVLLELLSGRRAVD 292
            +   TH     +GTR Y APE L  G +        + D+Y+ G+VL EL S   A D
Sbjct: 185 KSAGDTHGQ---VGTRRYMAPEVL-EGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWL-SEVNYLGQLHH 144
           IG G +G   K           R   G ++  K+L      +  K+ L SEVN L +L H
Sbjct: 14  IGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 145 PNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGARP---LPWTLRIKVAIGAARG 199
           PN+V+     +D  N  L  V EY   G L + +  +G +    L     ++V       
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 200 LSFLH---EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           L   H   +    V++RD K +N+ LD + N KL DFGLA+       T  +   +GT  
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPY 181
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           Y +PE +       K D++S G +L EL +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSE 135
           N  R  + D  IG G F  VYKG   E T+E A       +  +KL     Q  KE   E
Sbjct: 23  NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVA----WCELQDRKLTKSERQRFKE---E 75
Query: 136 VNYLGQLHHPNLVKLIGF---CLDGENRL-LVYEYMPKGSLENHLFRRGARPLP----WT 187
              L  L HPN+V+        + G+  + LV E    G+L+ +L R     +     W 
Sbjct: 76  AEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWC 135
Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDFGLAKAGPTGDRTH 246
            +I       +GL FLH     +I+RD K  NI +     + K+ D GLA    T  R  
Sbjct: 136 RQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRAS 185
Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE 283
            +  V+GT  + APE     +     DVY+FG   LE
Sbjct: 186 FAKAVIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLE 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V    +            G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 159 IGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L G+   +V E++  G+L + +   R     +       V +   + LS LH
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 264
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTRGYA 258
              Q VI+RD K+ +ILL  +   KLSDFG            VS +V      +GT  + 
Sbjct: 265 A--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWM 314
Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           APE ++      + D++S G++++E++ G
Sbjct: 315 APELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWL-SEVNYLGQLHH 144
           IG G +G   K           R   G ++  K+L      +  K+ L SEVN L +L H
Sbjct: 14  IGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 145 PNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGARP---LPWTLRIKVAIGAARG 199
           PN+V+     +D  N  L  V EY   G L + +  +G +    L     ++V       
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 200 LSFLH---EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           L   H   +    V++RD K +N+ LD + N KL DFGLA+       T  +   +GT  
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPY 181
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           Y +PE +       K D++S G +L EL +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 106
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T  +
Sbjct: 107 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 165 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 106
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T   
Sbjct: 107 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 162
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 163 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 54
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 55  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 109
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T  +
Sbjct: 110 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 167
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 168 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 106
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T  +
Sbjct: 107 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 165 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 106
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T   
Sbjct: 107 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 162
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 163 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 78  TRNFRPDSL-----IGEGGFGYVYKGWIDE-HTLEAARPGVGMVIAVKKLKPEGFQGHKE 131
           TR+F  D       +G+G FG VY     + H + A +     V+   +++ EG +   +
Sbjct: 17  TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALK-----VLFKSQIEKEGVE--HQ 69
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
              E+     LHHPN+++L  +  D     L+ EY P+G L   L +        T  I 
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
             +  A  L + H   ++VI+RD K  N+LL  +   K++DFG +   P+  R      +
Sbjct: 130 EELADA--LMYCH--GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTM 181
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y  PE +       K D++  GV+  ELL G
Sbjct: 182 CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 106
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T   
Sbjct: 107 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 162
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 163 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE--- 131
           K    +F    L+G+G FG V         +       G   A+K L+ E      E   
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAH 56
Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            ++E   L    HP L  L  +     +RL  V EY   G L  HL    +R   +T   
Sbjct: 57  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEER 111
Query: 191 KVAIGA--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
               GA     L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T   
Sbjct: 112 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 167
Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               GT  Y APE L         D +  GVV+ E++ GR
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V    +            G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 39  IGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L G+   +V E++  G+L + +   R     +       V +   + LS LH
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLH 144
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL  +   KLSDFG                ++GT  + APE ++
Sbjct: 145 A--QGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAPELIS 200
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWL-SEVNYLGQLHH 144
           IG G +G   K           R   G ++  K+L      +  K+ L SEVN L +L H
Sbjct: 14  IGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 145 PNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGARP---LPWTLRIKVAIGAARG 199
           PN+V+     +D  N  L  V EY   G L + +  +G +    L     ++V       
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 200 LSFLH---EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           L   H   +    V++RD K +N+ LD + N KL DFGLA+          + + +GT  
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPY 181
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           Y +PE +       K D++S G +L EL +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V    +            G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 37  IGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L G+   +V E++  G+L + +   R     +       V +   + LS LH
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLH 142
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL  +   KLSDFG                ++GT  + APE ++
Sbjct: 143 A--QGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAPELIS 198
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 44/233 (18%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY- 138
           N +   LIG G +G VYKG +DE      RP     +AVK      F   + +++E N  
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDE------RP-----VAVKVF---SFANRQNFINEKNIY 59
Query: 139 -LGQLHHPNLVKLI----GFCLDGE-NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
            +  + H N+ + I        DG    LLV EY P GSL  +L         W    ++
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116
Query: 193 AIGAARGLSFLHEA-------EQQVIYRDFKASNILLDSEFNAKLSDFGLA------KAG 239
           A    RGL++LH         +  + +RD  + N+L+ ++    +SDFGL+      +  
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATG-------RLTAKCDVYSFGVVLLELL 285
             G+  + +   +GT  Y APE L              + D+Y+ G++  E+ 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     M +A+K  K       +E +L E   + Q  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 72  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE 128
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 129 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESIN 185
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 42/228 (18%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQLH 143
           +G+G +G V+K  ID  T        G V+AVKK+  + FQ   +      E+  L +L 
Sbjct: 17  LGKGAYGIVWKS-IDRRT--------GEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 144 -HPNLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
            H N+V L+       +R   LV++YM     + H   R A  L    +  V     + +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET---DLHAVIR-ANILEPVHKQYVVYQLIKVI 122
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT------------------- 241
            +LH     +++RD K SNILL++E + K++DFGL+++                      
Sbjct: 123 KYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 242 GDRTHVSTQVMGTRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
            D   + T  + TR Y APE  L + + T   D++S G +L E+L G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 13/184 (7%)
Query: 112 VGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHH-PNLVKLIGFCLDGENRLLVYEYMPK 169
            G VIAVK+++  G  + +K  L +++ + + H  P +V+  G  +   +  +  E M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-- 106
Query: 170 GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK 229
           G+    L +R   P+P  +  K+ +   + L +L E +  VI+RD K SNILLD     K
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIK 165
Query: 230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL-----ATGRLTAKCDVYSFGVVLLEL 284
           L DFG+  +G   D      +  G   Y APE +            + DV+S G+ L+EL
Sbjct: 166 LCDFGI--SGRLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
Query: 285 LSGR 288
            +G+
Sbjct: 223 ATGQ 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V    +            G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 28  IGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L G+   +V E++  G+L + +   R     +       V +   + LS LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLH 133
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL  +   KLSDFG                ++GT  + APE ++
Sbjct: 134 A--QGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAPELIS 189
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYK          A+   G   A+KK++     EG       + E++ L +L
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H N+VKL       +  +LV+E++ +      L       L         +    G+++
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H+  ++V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y AP+ 
Sbjct: 116 CHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDV 171
Query: 263 L-ATGRLTAKCDVYSFGVVLLELLSG 287
           L  + + +   D++S G +  E+++G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V    +            G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 82  IGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V++    L G+   +V E++  G+L + +               V +   + LS LH  
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLQALSVLHA- 188
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTRGYAAP 260
            Q VI+RD K+ +ILL  +   KLSDFG            VS +V      +GT  + AP
Sbjct: 189 -QGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMAP 239
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E ++      + D++S G++++E++ G
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V         +   R   G ++AVKK+     Q  +   +EV  +    H N
Sbjct: 32  IGEGSTGIV--------CIATVRSS-GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLF--RRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L G+   +V E++  G+L + +   R     +       V +   + LS LH
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLH 137
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL  +   KLSDFG                ++GT  + APE ++
Sbjct: 138 A--QGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAPELIS 193
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 28/236 (11%)
Query: 65  NLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE 124
           +L     S L++    F    L+G G +G VYKG    H         G + A+K +   
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVT 60
Query: 125 GFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD------GENRLLVYEYMPKGSLENHLF 177
           G +  +E   E+N L +  HH N+    G  +        +   LV E+   GS+ + + 
Sbjct: 61  GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL-A 236
                 L       +     RGLS LH+   +VI+RD K  N+LL      KL DFG+ A
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSG 287
           +   T  R +     +GT  + APE +A           K D++S G+  +E+  G
Sbjct: 178 QLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLS-EVNYLGQLH 143
            +G+GGF   Y+   D  T E      G V+    L KP      KE +S E+     L 
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVF---AGKVVPKSMLLKPH----QKEKMSTEIAIHKSLD 100
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGL 200
           +P++V   GF  D +   +V E   + SL     RR A   P   + +R  +     +G+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGV 155
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAA 259
            +LH    +VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  Y A
Sbjct: 156 QYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIA 210
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L     + + D++S G +L  LL G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYK          A+   G   A+KK++     EG       + E++ L +L
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H N+VKL       +  +LV+E++ +      L       L         +    G+++
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H+  ++V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y AP+ 
Sbjct: 116 CHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDV 171
Query: 263 L-ATGRLTAKCDVYSFGVVLLELLSG 287
           L  + + +   D++S G +  E+++G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G VYK          A+   G   A+KK++     EG       + E++ L +L
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H N+VKL       +  +LV+E++ +      L       L         +    G+++
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H+  ++V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y AP+ 
Sbjct: 116 CHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDV 171
Query: 263 L-ATGRLTAKCDVYSFGVVLLELLSG 287
           L  + + +   D++S G +  E+++G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLS-EVNYLGQLH 143
            +G+GGF   Y+   D  T E      G V+    L KP      KE +S E+     L 
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVF---AGKVVPKSMLLKPH----QKEKMSTEIAIHKSLD 100
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGL 200
           +P++V   GF  D +   +V E   + SL     RR A   P   + +R  +     +G+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGV 155
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAA 259
            +LH    +VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  Y A
Sbjct: 156 QYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIA 210
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L     + + D++S G +L  LL G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLS-EVNYLGQLH 143
            +G+GGF   Y+   D  T E      G V+    L KP      KE +S E+     L 
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVF---AGKVVPKSMLLKPH----QKEKMSTEIAIHKSLD 100
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGL 200
           +P++V   GF  D +   +V E   + SL     RR A   P   + +R  +     +G+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGV 155
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAA 259
            +LH    +VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  Y A
Sbjct: 156 QYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPNYIA 210
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L     + + D++S G +L  LL G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     M +A+K  K       +E +L E   + Q  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 72  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 128
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 129 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 185
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLS-EVNYLGQLH 143
            +G+GGF   Y+   D  T E      G V+    L KP      KE +S E+     L 
Sbjct: 33  FLGKGGFAKCYE-ITDMDTKEVF---AGKVVPKSMLLKPH----QKEKMSTEIAIHKSLD 84
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGL 200
           +P++V   GF  D +   +V E   + SL     RR A   P   + +R  +     +G+
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGV 139
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAA 259
            +LH    +VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  Y A
Sbjct: 140 QYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIA 194
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L     + + D++S G +L  LL G+
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EYMP G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   K++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EYMP G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   K++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ--LH 143
           +G+G +G V++G W   H         G  +AVK       Q    W  E        L 
Sbjct: 16  VGKGRYGEVWRGLW---H---------GESVAVKIFSSRDEQS---WFRETEIYNTVLLR 60
Query: 144 HPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
           H N++  I   +   N      L+  Y   GSL + L R+   P    L +++A+ AA G
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACG 117
Query: 200 LSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQ-V 251
           L+ LH      + +  + +RDFK+ N+L+ S     ++D GLA     G D   +     
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR 177
Query: 252 MGTRGYAAPEYLATGRLTAKC-------DVYSFGVVLLELLSGRRAV 291
           +GT+ Y APE L   ++   C       D+++FG+VL E+   RR +
Sbjct: 178 VGTKRYMAPEVLDE-QIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG VY     ++    A      V+   +L+ EG +   +   E+     L HPN
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALK----VLFKSQLEKEGVE--HQLRREIEIQSHLRHPN 76
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           ++++  +  D +   L+ E+ P+G L   L + G      +      +  A  L + H  
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA--LHYCH-- 132
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           E++VI+RD K  N+L+  +   K++DFG +   P+  R      + GT  Y  PE +   
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLDYLPPEMIEGK 188
Query: 267 RLTAKCDVYSFGVVLLELLSG 287
               K D++  GV+  E L G
Sbjct: 189 THDEKVDLWCAGVLCYEFLVG 209

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
             E+  +  L HP LV L     D E+  +V + +  G L  HL ++       T+++ +
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFI 121
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
                  L +L    Q++I+RD K  NILLD   +  ++DF +A   P    T ++T + 
Sbjct: 122 C-ELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MA 175
Query: 253 GTRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLSGRR 289
           GT+ Y APE  ++ +    +   D +S GV   ELL GRR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG VY     ++    A      V+   +L+ EG +   +   E+     L HPN
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALK----VLFKSQLEKEGVE--HQLRREIEIQSHLRHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           ++++  +  D +   L+ E+ P+G L   L + G      +      +  A  L + H  
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA--LHYCH-- 131
Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           E++VI+RD K  N+L+  +   K++DFG +   P+  R      + GT  Y  PE +   
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLDYLPPEMIEGK 187
Query: 267 RLTAKCDVYSFGVVLLELLSG 287
               K D++  GV+  E L G
Sbjct: 188 THDEKVDLWCAGVLCYEFLVG 208

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 11/177 (6%)
Query: 115 VIAVKKLKPEGFQGHKEWL-SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           ++A+K +  E  +G +  + +E+  L ++ HPN+V L      G +  L+ + +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL---LDSEFNAKL 230
           + +  +G        R+   +  A  + +LH+    +++RD K  N+L   LD +    +
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDA--VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           SDFGL+K    G    V +   GT GY APE LA    +   D +S GV+   LL G
Sbjct: 161 SDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     M +A+K  K       +E +L E   + Q  HP
Sbjct: 398 IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG     EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 452 HIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE 508
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG-----YAA 259
              ++ ++RD  A N+L+ S    KL DFGL++          ST    ++G     + A
Sbjct: 509 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMA 560
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELL 285
           PE +   R T+  DV+ FGV + E+L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 11/177 (6%)
Query: 115 VIAVKKLKPEGFQGHKEWL-SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           ++A+K +  E  +G +  + +E+  L ++ HPN+V L      G +  L+ + +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL---LDSEFNAKL 230
           + +  +G        R+   +  A  + +LH+    +++RD K  N+L   LD +    +
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDA--VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           SDFGL+K    G    V +   GT GY APE LA    +   D +S GV+   LL G
Sbjct: 161 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHP 145
           +GEG +  VYKG                ++A+K+++ E  +G     + EV+ L  L H 
Sbjct: 10  LGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+V L       ++  LV+EY+ K  L+ +L   G       +++       RGL++ H 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCHR 118
Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE-YLA 264
             Q+V++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y  P+  L 
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLG 174
Query: 265 TGRLTAKCDVYSFGVVLLELLSGR 288
           +   + + D++  G +  E+ +GR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 11/177 (6%)
Query: 115 VIAVKKLKPEGFQGHKEWL-SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           ++A+K +  E  +G +  + +E+  L ++ HPN+V L      G +  L+ + +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL---LDSEFNAKL 230
           + +  +G        R+   +  A  + +LH+    +++RD K  N+L   LD +    +
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDA--VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           SDFGL+K    G    V +   GT GY APE LA    +   D +S GV+   LL G
Sbjct: 161 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG FG   K  + + T E  R  V   I + ++     +  +E   EV  L  + HPN
Sbjct: 32  IGEGSFG---KAILVKST-EDGRQYVIKEINISRMSS---KEREESRREVAVLANMKHPN 84
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL------ENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +V+      +  +  +V +Y   G L      +  +  +  + L W ++I +A+      
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK----- 139
Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
              H  ++++++RD K+ NI L  +   +L DFG+A+         ++   +GT  Y +P
Sbjct: 140 ---HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSP 194
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
           E         K D+++ G VL EL + + A +    G+ +NLV
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLV 234

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     + +A+K  K       +E +L E   + Q  HP
Sbjct: 46  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 100 HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 156
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 157 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 213
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 214 FRRFTSASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     + +A+K  K       +E +L E   + Q  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 72  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 128
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 129 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 185
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVN 137
            N+ P  ++G G    V +  I + T +     +  V        E  Q  +E  L EV+
Sbjct: 4   ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 138 YLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L ++  HPN+++L           LV++ M KG L ++L  +       T +I  A+  
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 122
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
              +  LH+    +++RD K  NILLD + N KL+DFG +     G++     +V GT  
Sbjct: 123 V--ICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPS 175
Query: 257 YAAPEYLATGR------LTAKCDVYSFGVVLLELLSG 287
           Y APE +             + D++S GV++  LL+G
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     + +A+K  K       +E +L E   + Q  HP
Sbjct: 20  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 74  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 130
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 131 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 187
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     M +A+K  K       +E +L E   + Q  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 72  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE 128
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ +    KL DFGL++          S   +  + + APE + 
Sbjct: 129 S--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 185
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     + +A+K  K       +E +L E   + Q  HP
Sbjct: 15  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 69  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 125
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 126 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 182
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     + +A+K  K       +E +L E   + Q  HP
Sbjct: 23  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 77  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 133
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 134 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 190
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVN 137
            N+ P  ++G G    V +  I + T +     +  V        E  Q  +E  L EV+
Sbjct: 17  ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 138 YLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L ++  HPN+++L           LV++ M KG L ++L  +       T +I  A+  
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
              +  LH+    +++RD K  NILLD + N KL+DFG +     G++     +V GT  
Sbjct: 136 V--ICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPS 188
Query: 257 YAAPEYLATGR------LTAKCDVYSFGVVLLELLSG 287
           Y APE +             + D++S GV++  LL+G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     + +A+K  K       +E +L E   + Q  HP
Sbjct: 21  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG  +  EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 75  HIVKLIG--VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 131
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              ++ ++RD  A N+L+ S    KL DFGL++          S   +  + + APE + 
Sbjct: 132 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESIN 188
Query: 265 TGRLTAKCDVYSFGVVLLELL 285
             R T+  DV+ FGV + E+L
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNYLGQLHHP 145
           IGEG FG V++G      +  +     M +A+K  K       +E +L E   + Q  HP
Sbjct: 398 IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           ++VKLIG     EN + ++ E    G L + L  R    L     I  A   +  L++L 
Sbjct: 452 HIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE 508
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG-----YAA 259
              ++ ++RD  A N+L+ +    KL DFGL++          ST    ++G     + A
Sbjct: 509 S--KRFVHRDIAARNVLVSATDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMA 560
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELL 285
           PE +   R T+  DV+ FGV + E+L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   K++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFGLAK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +G+GGF   ++  I +   +    G  +V     LKP      +E +S E++    L H
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAG-KIVPKSLLLKPH----QREKMSMEISIHRSLAH 98
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGLS 201
            ++V   GF  D +   +V E   + SL     RR A   P   + LR  V      G  
Sbjct: 99  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 153
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAP 260
           +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y AP
Sbjct: 154 YLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAP 208
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L+    + + DV+S G ++  LL G+
Sbjct: 209 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE + +VY     +Y+P+    +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 11/177 (6%)
Query: 115 VIAVKKLKPEGFQGHKEWL-SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLE 173
           ++A+K +  +  +G +  + +E+  L ++ HPN+V L      G +  L+ + +  G L 
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 174 NHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL---LDSEFNAKL 230
           + +  +G        R+   +  A  + +LH+    +++RD K  N+L   LD +    +
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDA--VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           SDFGL+K    G    V +   GT GY APE LA    +   D +S GV+   LL G
Sbjct: 161 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +G+GGF   ++  I +   +    G  +V     LKP      +E +S E++    L H
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAG-KIVPKSLLLKPH----QREKMSMEISIHRSLAH 100
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGLS 201
            ++V   GF  D +   +V E   + SL     RR A   P   + LR  V      G  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 155
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAP 260
           +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y AP
Sbjct: 156 YLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAP 210
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L+    + + DV+S G ++  LL G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           F+ + + G+G FG V  G              GM +A+KK+  +    ++E L  +  L 
Sbjct: 25  FQVERMAGQGTFGTVQLG---------KEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLA 74
Query: 141 QLHHPNLVKLIG--FCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIK 191
            LHHPN+V+L    + L   +R  +Y     EY+P        + +RR   P P  +++ 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILL-DSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
                 R +  LH     V +RD K  N+L+ +++   KL DFG AK     +    +  
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVA 190
Query: 251 VMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSG 287
            + +R Y APE +      T   D++S G +  E++ G
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 16/217 (7%)
Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVN 137
            N+ P  ++G G    V +  I + T +     +  V        E  Q  +E  L EV+
Sbjct: 17  ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 138 YLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
            L ++  HPN+++L           LV++ M KG L ++L  +       T +I  A+  
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
              +  LH+    +++RD K  NILLD + N KL+DFG +     G++      V GT  
Sbjct: 136 V--ICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPS 188
Query: 257 YAAPEYLATGR------LTAKCDVYSFGVVLLELLSG 287
           Y APE +             + D++S GV++  LL+G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 47/236 (19%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGFQGHKEWLSEVNY 138
           +F   +++G+G FG V K          AR  +     A+KK++    +     LSEV  
Sbjct: 7   DFEEIAVLGQGAFGQVVK----------ARNALDSRYYAIKKIRHTE-EKLSTILSEVML 55
Query: 139 LGQLHHPNLVKLIGFCLDGEN-------------RLLVYEYMPKGSLENHLFRRG---AR 182
           L  L+H  +V+     L+  N               +  EY   G+L + +        R
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPT 241
              W L  ++       LS++H   Q +I+RD K  NI +D   N K+ DFGLAK    +
Sbjct: 116 DEYWRLFRQIL----EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 242 GDRTHVSTQ-----------VMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELL 285
            D   + +Q            +GT  Y A E L  TG    K D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW----TLR 189
            E + +   + P +V+L     D +   +V EYMP G L N L      P  W    T  
Sbjct: 124 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAE 182
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           + +A+ A   +  +H        RD K  N+LLD   + KL+DFG           H  T
Sbjct: 183 VVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT 234
Query: 250 QVMGTRGYAAPEYLAT----GRLTAKCDVYSFGVVLLELLSG 287
            V GT  Y +PE L +    G    +CD +S GV L E+L G
Sbjct: 235 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G GGFG V+     +            +   +  K +G+QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFAC---QMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR--------RGARPLPWTLRIKVAIGAA 197
            +V L        +  LV   M  G +  H++         +  R + +T +I       
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------V 299
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGT 254
            GL  LH+  + +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT
Sbjct: 300 SGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GT 352
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            G+ APE L         D ++ GV L E+++ R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G GGFG V+     +            +   +  K +G+QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFAC---QMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR--------RGARPLPWTLRIKVAIGAA 197
            +V L        +  LV   M  G +  H++         +  R + +T +I       
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------V 299
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGT 254
            GL  LH+  + +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT
Sbjct: 300 SGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GT 352
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            G+ APE L         D ++ GV L E+++ R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     QG      E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTL 199
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G G FG V+K               G+ +A K +K  G +  +E  +E++ + QL H 
Sbjct: 96  ILGGGRFGQVHK---------CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR--PLPWTLRIKVAIGAARGLSFL 203
           NL++L        + +LV EY+  G L + +         L   L +K      R     
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR----- 201
Query: 204 HEAEQQVIYRDFKASNILL---DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           H  +  +++ D K  NIL    D++   K+ DFGLA+     ++  V+    GT  + AP
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN---FGTPEFLAP 257
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E +    ++   D++S GV+   LLSG
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G GGFG V+     +            +   +  K +G+QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFAC---QMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR--------RGARPLPWTLRIKVAIGAA 197
            +V L        +  LV   M  G +  H++         +  R + +T +I       
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------V 299
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGT 254
            GL  LH+  + +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT
Sbjct: 300 SGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GT 352
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            G+ APE L         D ++ GV L E+++ R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     QG      E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G GGFG V+     +            +   +  K +G+QG    + E   L ++H  
Sbjct: 192 VLGRGGFGEVFAC---QMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSR 245
Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR--------RGARPLPWTLRIKVAIGAA 197
            +V L        +  LV   M  G +  H++         +  R + +T +I       
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------V 299
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGT 254
            GL  LH+  + +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT
Sbjct: 300 SGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GT 352
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            G+ APE L         D ++ GV L E+++ R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLV-YEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           E + + +L HP  VKL  FC   + +L     Y   G L  ++ + G+     T      
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 145
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           I +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +G
Sbjct: 146 IVSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T  Y +PE L         D+++ G ++ +L++G
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 166
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 221
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 55  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 101
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 160
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 161 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 215
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 170 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 220
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 141
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 142 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 192
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 166
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 221
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 134
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 135 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTL 184
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +G+GGF   ++  I +   +    G  +V     LKP      +E +S E++    L H
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAG-KIVPKSLLLKPH----QREKMSMEISIHRSLAH 74
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGLS 201
            ++V   GF  D +   +V E   + SL     RR A   P   + LR  V      G  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 129
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAP 260
           +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y AP
Sbjct: 130 YLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAP 184
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L+    + + DV+S G ++  LL G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 63  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 109
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 168
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 169 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 223
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 49/287 (17%)
Query: 17  HATSGDTKLPDKNGNFSMASSLKTNKSEKR-PSGNFSMPRTECD--ILSCPNLKAFTFS- 72
           HA  G       +   S+A +     S  R PS     P+TE +  +L    LK   +  
Sbjct: 34  HALQGSVSSGQAHSLTSLAKTWAARGSRSREPS-----PKTEDNEGVLLTEKLKPVDYEY 88
Query: 73  --ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK 130
             E+  AT   R    +G G FG V       H +E  +   G   AVKK++ E F+   
Sbjct: 89  REEVHWATHQLR----LGRGSFGEV-------HRMEDKQ--TGFQCAVKKVRLEVFRA-- 133
Query: 131 EWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
               E+     L  P +V L G   +G    +  E +  GSL   +  +G   LP    +
Sbjct: 134 ---EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRAL 188
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFG---------LAKAGP 240
                A  GL +LH   +++++ D KA N+LL S+  +A L DFG         L K+  
Sbjct: 189 YYLGQALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           TGD       + GT  + APE +      AK DV+S   ++L +L+G
Sbjct: 247 TGD------YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 141
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 142 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 192
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 35  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 81
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 140
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 141 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 195
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 46  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 92
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 151
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 152 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 206
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 65  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 111
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 170
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 171 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 225
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     QG      E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P     +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 40  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 86
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 145
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 146 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 200
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 106 VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 152
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 211
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 212 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 266
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 142 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L     +   D+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 32  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 78
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 137
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 138 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 192
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   +++DFGLAK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 144
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 145 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 199
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 144
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 145 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 199
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 10/213 (4%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           K    +F+   ++GEG F  V    +    L  +R     ++  + +  E    +     
Sbjct: 6   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPY--VTR 59
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 120 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 10/213 (4%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           K    +F+   ++GEG F  V    +    L  +R     ++  + +  E    +     
Sbjct: 5   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPY--VTR 58
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 119 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +G+GGF   ++  I +   +    G  +V     LKP      +E +S E++    L H
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAG-KIVPKSLLLKPH----QREKMSMEISIHRSLAH 80
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGLS 201
            ++V   GF  D +   +V E   + SL     RR A   P   + LR  V      G  
Sbjct: 81  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 135
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAP 260
           +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y AP
Sbjct: 136 YLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAP 190
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L+    + + DV+S G ++  LL G+
Sbjct: 191 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 17  HATSGDTKLPDKNGNFSMASSLKTNKSEKR-PSGNFSMPRTECD--ILSCPNLKAFTFS- 72
           HA  G       +   S+A +     S  R PS     P+TE +  +L    LK   +  
Sbjct: 15  HALQGSVSSGQAHSLTSLAKTWAARGSRSREPS-----PKTEDNEGVLLTEKLKPVDYEY 69
Query: 73  --ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK 130
             E+  AT   R    +G G FG V       H +E  +   G   AVKK++ E F+   
Sbjct: 70  REEVHWATHQLR----LGRGSFGEV-------HRMEDKQ--TGFQCAVKKVRLEVFRA-- 114
Query: 131 EWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
               E+     L  P +V L G   +G    +  E +  GSL   +  +G   LP    +
Sbjct: 115 ---EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRAL 169
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLA---KAGPTGDRTH 246
                A  GL +LH   +++++ D KA N+LL S+  +A L DFG A   +    G    
Sbjct: 170 YYLGQALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
               + GT  + APE +      AK DV+S   ++L +L+G
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 28  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 74
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 133
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 134 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 188
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +G+GGF   ++  I +   +    G  +V     LKP      +E +S E++    L H
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAG-KIVPKSLLLKPH----QREKMSMEISIHRSLAH 76
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGLS 201
            ++V   GF  D +   +V E   + SL     RR A   P   + LR  V      G  
Sbjct: 77  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 131
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAP 260
           +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y AP
Sbjct: 132 YLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAP 186
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L+    + + DV+S G ++  LL G+
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 35/230 (15%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNY 138
           +F P   +G GGFG V+         EA         A+K+++ P      ++ + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVF---------EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL-FRRGARPLPW----------- 186
           L +L HP +V+     L+      +    PK  L   +   R      W           
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 187 -TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT 245
            ++ + + +  A  + FLH   + +++RD K SNI    +   K+ DFGL  A    +  
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 246 HV----------STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                        T  +GT+ Y +PE +     + K D++S G++L ELL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +G+GGF   ++  I +   +    G  +V     LKP      +E +S E++    L H
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAG-KIVPKSLLLKPH----QREKMSMEISIHRSLAH 76
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WTLRIKVAIGAARGLS 201
            ++V   GF  D +   +V E   + SL     RR A   P   + LR  V      G  
Sbjct: 77  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 131
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAP 260
           +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y AP
Sbjct: 132 YLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAP 186
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L+    + + DV+S G ++  LL G+
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 143 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG VY+  + +          G ++A+KK+     Q  +    E+  + +L H 
Sbjct: 31  VIGNGSFGVVYQAKLCDS---------GELVAIKKV----LQDKRFKNRELQIMRKLDHC 77
Query: 146 NLVKL-IGFCLDGENRLLVY-----EYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAA 197
           N+V+L   F   GE +  VY     +Y+P+    +  H + R  + LP            
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLF 136
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           R L+++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +R 
Sbjct: 137 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 191
Query: 257 YAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
           Y APE +      T+  DV+S G VL ELL G+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V     ++H+        G  +AVK +     Q  +   +EV  +    H N
Sbjct: 53  IGEGSTGIVCLAR-EKHS--------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +V++    L GE   ++ E++  G+L + +   R     +       V     + L++LH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLH 158
Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
              Q VI+RD K+ +ILL  +   KLSDFG   A  + D       ++GT  + APE ++
Sbjct: 159 A--QGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPK-RKXLVGTPYWMAPEVIS 214
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
                 + D++S G++++E++ G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
            R   ++ EGGF +VY         EA   G G   A+K+L     + ++  + EV ++ 
Sbjct: 30  LRVRRVLAEGGFAFVY---------EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 141 QLH-HPNLVKLIGFCL----------DGENRLLVYEYMPKGSLENHLFRRGAR-PLPWTL 188
           +L  HPN+V+   FC            G+   L+   + KG L   L +  +R PL    
Sbjct: 81  KLSGHPNIVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
            +K+     R +  +H  +  +I+RD K  N+LL ++   KL DFG A
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 10/213 (4%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           K    +F+   ++GEG F  V    +    L  +R     ++  + +  E    +     
Sbjct: 3   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPY--VTR 56
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 117 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 143 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 118 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 140 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 140 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 142 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 140 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 142 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 145 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 142 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 140 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSE 135
           N  + F    ++G G F  V+            +   G + A+K +K           +E
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFL---------VKQRLTGKLFALKCIKKSPAFRDSSLENE 56
Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAI 194
           +  L ++ H N+V L        +  LV + +  G L + +  RG       +L I+  +
Sbjct: 57  IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL 116
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNIL-LDSEFNAKL--SDFGLAKAGPTGDRTHVSTQV 251
            A +   +LHE    +++RD K  N+L L  E N+K+  +DFGL+K    G    + +  
Sbjct: 117 SAVK---YLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTA 167
Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT GY APE LA    +   D +S GV+   LL G
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 142 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 142 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 71  FSELKNATRN-------FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           F + KN   N       F    +IG GGFG VY            +   G + A+K L  
Sbjct: 174 FCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDK 224
Query: 124 EGF---QGHKEWLSEVNYLGQLHHPN--LVKLIGFCLDGENRL-LVYEYMPKGSLENHLF 177
           +     QG    L+E   L  +   +   +  + +     ++L  + + M  G L  HL 
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           + G       +R   A     GL  +H   + V+YRD K +NILLD   + ++SD GLA 
Sbjct: 285 QHGVFS-EADMRFYAA-EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA- 339
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSG 287
              +  + H S   +GT GY APE L  G    +  D +S G +L +LL G
Sbjct: 340 CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 71  FSELKNATRN-------FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           F + KN   N       F    +IG GGFG VY            +   G + A+K L  
Sbjct: 174 FCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDK 224
Query: 124 EGF---QGHKEWLSEVNYLGQLHHPN--LVKLIGFCLDGENRL-LVYEYMPKGSLENHLF 177
           +     QG    L+E   L  +   +   +  + +     ++L  + + M  G L  HL 
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           + G       +R   A     GL  +H   + V+YRD K +NILLD   + ++SD GLA 
Sbjct: 285 QHGVFS-EADMRFYAA-EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA- 339
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSG 287
              +  + H S   +GT GY APE L  G    +  D +S G +L +LL G
Sbjct: 340 CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 71  FSELKNATRN-------FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           F + KN   N       F    +IG GGFG VY            +   G + A+K L  
Sbjct: 173 FCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDK 223
Query: 124 EGF---QGHKEWLSEVNYLGQLHHPN--LVKLIGFCLDGENRL-LVYEYMPKGSLENHLF 177
           +     QG    L+E   L  +   +   +  + +     ++L  + + M  G L  HL 
Sbjct: 224 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 283
Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           + G       +R   A     GL  +H   + V+YRD K +NILLD   + ++SD GLA 
Sbjct: 284 QHGVFS-EADMRFYAA-EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA- 338
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSG 287
              +  + H S   +GT GY APE L  G    +  D +S G +L +LL G
Sbjct: 339 CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 71  FSELKNATRN-------FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           F + KN   N       F    +IG GGFG VY            +   G + A+K L  
Sbjct: 174 FCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDK 224
Query: 124 EGF---QGHKEWLSEVNYLGQLHHPN--LVKLIGFCLDGENRL-LVYEYMPKGSLENHLF 177
           +     QG    L+E   L  +   +   +  + +     ++L  + + M  G L  HL 
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           + G       +R   A     GL  +H   + V+YRD K +NILLD   + ++SD GLA 
Sbjct: 285 QHGVFS-EADMRFYAA-EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA- 339
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSG 287
              +  + H S   +GT GY APE L  G    +  D +S G +L +LL G
Sbjct: 340 CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 124 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYL 139
           F     +G G F  V         + A     G + AVK +  +  +G +  + +E+  L
Sbjct: 24  FEFKETLGTGAFSEV---------VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAA 197
            ++ H N+V L        +  LV + +  G L + +  +G        TL I+  + A 
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL-IRQVLDA- 132
Query: 198 RGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
             + +LH     +++RD K  N+L    D E    +SDFGL+K    GD   V +   GT
Sbjct: 133 --VYYLHR--MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGT 185
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GY APE LA    +   D +S GV+   LL G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R   +T  +
Sbjct: 170 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGATWTL 219
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 139 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P L KL     D  N  +V EY P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E + + +L HP  VKL     D E       Y   G L  ++ + G+     T      I
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 139 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             Y +PE L         D+++ G ++ +L++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P L KL     D  N  +V EY P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E      ++ P LVKL     D  N  +V EY P G + +HL R G    P       
Sbjct: 90  LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   K++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P L KL     D  N  +V EY P G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   K++DFG AK      RT     + 
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLC 200
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL KP +   
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSKPFQSII 75
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 132
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 188
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 189 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   IG G +G V           A     G+ +AVKKL +P +   
Sbjct: 21  TIWEVPERYQNLSP---IGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 125
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TD 181
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 182 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 47/236 (19%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGFQGHKEWLSEVNY 138
           +F   +++G+G FG V K          AR  +     A+KK++    +     LSEV  
Sbjct: 7   DFEEIAVLGQGAFGQVVK----------ARNALDSRYYAIKKIRHTE-EKLSTILSEVML 55
Query: 139 LGQLHHPNLVKLIGFCLDGEN-------------RLLVYEYMPKGSLENHLFRRG---AR 182
           L  L+H  +V+     L+  N               +  EY    +L + +        R
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPT 241
              W L  ++       LS++H   Q +I+RD K  NI +D   N K+ DFGLAK    +
Sbjct: 116 DEYWRLFRQIL----EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 242 GDRTHVSTQ-----------VMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELL 285
            D   + +Q            +GT  Y A E L  TG    K D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHK 130
           K    NF    ++G G +G V+         + +    G + A+K LK        +  +
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFL------VRKISGHDTGKLYAMKVLKKATIVQKAKTTE 103
Query: 131 EWLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLR 189
              +E   L  +     +  + +    E +L L+ +Y+  G L  HL +R  R     ++
Sbjct: 104 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQ 162
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I V       L  LH+    +IYRD K  NILLDS  +  L+DFGL+K     D T  + 
Sbjct: 163 IYVG-EIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAY 218
Query: 250 QVMGTRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSG 287
              GT  Y AP+ +  G        D +S GV++ ELL+G
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V   + D  T        G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAF-DTKT--------GLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW----TLRI 190
           E + +   + P +V+L     D     +V EYMP G L N L      P  W    T  +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEV 177
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +A+ A   + F+H        RD K  N+LLD   + KL+DFG              T 
Sbjct: 178 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 251 VMGTRGYAAPEYLAT----GRLTAKCDVYSFGVVLLELLSG 287
           V GT  Y +PE L +    G    +CD +S GV L E+L G
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 127
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TA 183
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 184 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +  +   
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
                  I   +   RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 124 DDHVQFLIYQIL---RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 127
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TA 183
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 184 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW----TLRI 190
           E + +   + P +V+L     D     +V EYMP G L N L      P  W    T  +
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEV 182
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +A+ A   + F+H        RD K  N+LLD   + KL+DFG              T 
Sbjct: 183 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 234
Query: 251 VMGTRGYAAPEYLAT----GRLTAKCDVYSFGVVLLELLSG 287
           V GT  Y +PE L +    G    +CD +S GV L E+L G
Sbjct: 235 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 127
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TA 183
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 184 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLX 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +  +   
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
                  I   +   RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 124 DDHVQFLIYQIL---RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW----TLRI 190
           E + +   + P +V+L     D     +V EYMP G L N L      P  W    T  +
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEV 182
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +A+ A   + F+H        RD K  N+LLD   + KL+DFG              T 
Sbjct: 183 VLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 234
Query: 251 VMGTRGYAAPEYLAT----GRLTAKCDVYSFGVVLLELLSG 287
           V GT  Y +PE L +    G    +CD +S GV L E+L G
Sbjct: 235 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 150 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 199
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLA 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 126
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 182
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 183 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 169
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 170 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 219
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 125
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TD 181
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 182 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 135
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 136 QI--VLTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKR--VKGRT---WXLC 186
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 187 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQ 127
           FT  +LK+          IG G +G V K           +P  G ++AVK+++     +
Sbjct: 19  FTAEDLKDLGE-------IGRGAYGSVNKM--------VHKPS-GQIMAVKRIRSTVDEK 62
Query: 128 GHKEWLSEVNYLGQLHH-PNLVKLIGFCLDGENRLLVYEYMPKG--SLENHLFRRGARPL 184
             K+ L +++ + +    P +V+  G      +  +  E M         +++      +
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI 122
Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
           P  +  K+ +   + L+ L E   ++I+RD K SNILLD   N KL DFG+  +G   D 
Sbjct: 123 PEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDS 179
Query: 245 THVSTQVMGTRGYAAPEYL----ATGRLTAKCDVYSFGVVLLELLSGR 288
               T+  G R Y APE +    +      + DV+S G+ L EL +GR
Sbjct: 180 I-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 127
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 183
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 184 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 122
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 178
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 179 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 199
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 143
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT     + 
Sbjct: 144 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLC 194
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 195 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 125
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 181
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 182 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 125
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 181
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 182 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 15  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 62
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 119
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 175
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 176 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 122
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 178
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 179 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 122
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 178
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 179 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 83
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 140
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 196
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 197 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 116
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 172
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 173 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 27  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 131
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TD 187
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 188 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 13  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 117
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 173
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 174 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 132
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 188
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 189 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 132
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 188
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 189 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 13  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 117
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 173
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 174 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 126
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 182
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 183 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 35  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 82
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 139
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 195
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 196 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 14  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 61
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 118
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 119 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 174
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 175 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+++D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 27  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 131
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 187
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 188 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 126
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARH--TD 182
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 183 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 39  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 143
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 199
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 200 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 122
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARH--TD 178
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 179 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +  +P   IG G  G V           A    +G+ +AVKKL +P   Q 
Sbjct: 19  TFTVLKR-YQQLKP---IGSGAQGIV---------CAAFDTVLGINVAVKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  L  ++H N++ L+          + ++  LV E M     +        
Sbjct: 66  HAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                + T  + TR Y APE +      A  D++S G ++ EL+ G
Sbjct: 179 N---FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 30/229 (13%)
Query: 68  AFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EG 125
           A T  E+    +N  P   +G G +G V           A     G  +AVKKL +P + 
Sbjct: 10  AKTIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQS 57
Query: 126 FQGHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRG 180
               K    E+  L  + H N++ L+        L+  N + +  ++    L N    + 
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKC 115
Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
           A+     ++  +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   
Sbjct: 116 AKLTDDHVQFLI-YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           T D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 171 TDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 111 GVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--GENRLLVYEYMP 168
           G  +V+ V K++    +  +++  E   L    HPN++ ++G C      +  L+  +MP
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 169 KGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA 228
            GSL N L       +  +  +K A+  ARG++FLH  E  +      + ++++D +  A
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA 152
Query: 229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLE 283
           ++S   +  +  +  R       M    + APE L      T R +A  D++SF V+L E
Sbjct: 153 RISMADVKFSFQSPGR-------MYAPAWVAPEALQKKPEDTNRRSA--DMWSFAVLLWE 203
Query: 284 LLS 286
           L++
Sbjct: 204 LVT 206

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 35/281 (12%)
Query: 25  LPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPD 84
           + D +GN +  ++    K ++RP  N S        LS    K F F +L    ++  P 
Sbjct: 77  IEDHSGNGTFVNTELVGKGKRRPLNNNSEI-----ALSLSRNKVFVFFDLTVDDQSVYPK 131
Query: 85  SL---------IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-- 133
           +L         +G G  G V   +      +  +     +I+ +K      +     L  
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAF----ERKTCKKVAIRIISKRKFAIGSAREADPALNV 187
Query: 134 -SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
            +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L        
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 244
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVST 249
                  + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T
Sbjct: 245 FYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 300
Query: 250 QVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
            + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQGHKEWLSEVNYLGQLHH 144
           +G G +G V   +             G+ IAVKKL +P +     K    E+  L  + H
Sbjct: 59  VGSGAYGSVCSSY---------DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 109
Query: 145 PNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            N++ L+        L+  N + +  ++    L N +     + L       +     RG
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRG 166
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           L ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + TR Y A
Sbjct: 167 LKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWYRA 219
Query: 260 PEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           PE +          D++S G ++ ELL+GR
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y APE + +       D ++ GV++ ++ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G V+K         A       ++A+K+++     EG       L E+  L +L
Sbjct: 10  IGEGTYGTVFK---------AKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKEL 58
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H N+V+L       +   LV+E+  +  L+ +         P  ++        +GL F
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGF 116
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H   + V++RD K  N+L++     KL+DFGLA+A     R + +  V  T  Y  P+ 
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172
Query: 263 LATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
           L   +L +   D++S G +  EL +  R +         N VD         +++FR++ 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPL------FPGNDVD------DQLKRIFRLLG 220
Query: 322 IKLEGQYP 329
              E Q+P
Sbjct: 221 TPTEEQWP 228

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 126
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 182
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 183 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L         
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYF 120
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQ 250
                 + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T 
Sbjct: 121 YQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 251 VMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
           + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 39  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 143
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+     
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR----- 196
Query: 243 DRTHVSTQVMG---TRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
              H   ++ G   TR Y APE +          D++S G ++ ELL+GR
Sbjct: 197 ---HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ D+GLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L         
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYF 120
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQ 250
                 + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T 
Sbjct: 121 YQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 251 VMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
           + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 35/281 (12%)
Query: 25  LPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPD 84
           + D +GN +  ++    K ++RP  N S        LS    K F F +L    ++  P 
Sbjct: 91  IEDHSGNGTFVNTELVGKGKRRPLNNNSEIA-----LSLSRNKVFVFFDLTVDDQSVYPK 145
Query: 85  SL---------IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL-- 133
           +L         +G G  G V   +      +  +     +I+ +K      +     L  
Sbjct: 146 ALRDEYIMSKTLGSGACGEVKLAF----ERKTCKKVAIRIISKRKFAIGSAREADPALNV 201
Query: 134 -SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
            +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L        
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 258
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVST 249
                  + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T
Sbjct: 259 FYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 314
Query: 250 QVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
            + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 315 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L         
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYF 120
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQ 250
                 + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T 
Sbjct: 121 YQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 251 VMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
           + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L         
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYF 126
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQ 250
                 + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T 
Sbjct: 127 YQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 181
Query: 251 VMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
           + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           +E+  L +L+HP ++K+  F  D E+  +V E M  G L + +   G + L         
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYF 119
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQ 250
                 + +LHE    +I+RD K  N+LL S+      K++DFG +K    G+ + + T 
Sbjct: 120 YQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 174
Query: 251 VMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSG 287
           + GT  Y APE L    T       D +S GV+L   LSG
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +  +   
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT 123
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
                  I   +   RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGL +   T 
Sbjct: 124 DDHVQFLIYQIL---RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 116
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 172
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 173 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 35  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 82
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 139
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 195
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 196 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 140
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 196
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 197 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           HPN+VKL     D  +  LV E +  G L   + ++  +    T    +       +S +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHM 122
Query: 204 HEAEQQVIYRDFKASNILLDSE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           H+    V++RD K  N+L   E      K+ DFG A+  P  D   + T    T  YAAP
Sbjct: 123 HDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAP 178
Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E L        CD++S GV+L  +LSG+
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 26  TIWEVPERYQNLAP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 130
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T 
Sbjct: 131 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TD 186
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 187 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++   D+ T        G   AVKK++ E F+     + E+     L  P 
Sbjct: 66  VGRGSFGEVHR-MKDKQT--------GFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-RGLSFLHE 205
           +V L G   +G    +  E +  GSL   + + G  P     R    +G A  GL +LH 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQALEGLEYLHT 168
Query: 206 AEQQVIYRDFKASNILLDSEFN-AKLSDFG---------LAKAGPTGDRTHVSTQVMGTR 255
             +++++ D KA N+LL S+ + A L DFG         L K+  TGD       + GT 
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD------YIPGTE 220
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE +      AK D++S   ++L +L+G
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++   D+ T        G   AVKK++ E F+     + E+     L  P 
Sbjct: 82  VGRGSFGEVHR-MKDKQT--------GFQCAVKKVRLEVFR-----VEELVACAGLSSPR 127
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-RGLSFLHE 205
           +V L G   +G    +  E +  GSL   + + G  P     R    +G A  GL +LH 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQALEGLEYLHT 184
Query: 206 AEQQVIYRDFKASNILLDSEFN-AKLSDFG---------LAKAGPTGDRTHVSTQVMGTR 255
             +++++ D KA N+LL S+ + A L DFG         L K+  TGD       + GT 
Sbjct: 185 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD------YIPGTE 236
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE +      AK D++S   ++L +L+G
Sbjct: 237 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 42/245 (17%)
Query: 71  FSELKNAT--RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP--EGF 126
           F  +KN     N+    LIG G +GYVY  + D++T +         +A+KK+    E  
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAY-DKNTEKN--------VAIKKVNRMFEDL 66
Query: 127 QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYE--YMPKGSLENHLFRRGARPL 184
              K  L E+  L +L    +++L    +  +  LL ++  Y+     ++ L +    P+
Sbjct: 67  IDCKRILREITILNRLKSDYIIRLYDLIIPDD--LLKFDELYIVLEIADSDLKKLFKTPI 124
Query: 185 PWTLR-IKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
             T   IK  +     G +F+HE+   +I+RD K +N LL+ + + K+ DFGLA+   + 
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 243 DRTHVSTQV--------------------MGTRGYAAPE-YLATGRLTAKCDVYSFGVVL 281
             T++   +                    + TR Y APE  L     T   D++S G + 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 282 LELLS 286
            ELL+
Sbjct: 243 AELLN 247

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT  Y AP  + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 47/236 (19%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGV-GMVIAVKKLKPEGFQGHKEWLSEVNY 138
           +F   +++G+G FG V K          AR  +     A+KK++    +     LSEV  
Sbjct: 7   DFEEIAVLGQGAFGQVVK----------ARNALDSRYYAIKKIRHTE-EKLSTILSEVXL 55
Query: 139 LGQLHHPNLVKLIGFCLDGEN-------------RLLVYEYMPKGSLENHLFRRG---AR 182
           L  L+H  +V+     L+  N               +  EY    +L + +        R
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPT 241
              W L  ++       LS++H   Q +I+R+ K  NI +D   N K+ DFGLAK    +
Sbjct: 116 DEYWRLFRQIL----EALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 242 GDRTHVSTQ-----------VMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELL 285
            D   + +Q            +GT  Y A E L  TG    K D YS G++  E +
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +IG G FG V++  + E             +A+KK+     Q  +    E+  +  + HP
Sbjct: 47  VIGNGSFGVVFQAKLVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHP 92
Query: 146 NLVKLIGFCLDGENRL------LVYEYMPKGSLE-NHLFRRGARPLPWTLRIKVAIGAAR 198
           N+V L  F     ++       LV EY+P+     +  + +  + +P  L         R
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            L+++H     + +RD K  N+LLD      KL DFG AK    G+    +   + +R Y
Sbjct: 153 SLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICSRYY 207
Query: 258 AAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
            APE +      T   D++S G V+ EL+ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 140
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+     
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR----- 193
Query: 243 DRTHVSTQVMG---TRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
              H   ++ G   TR Y APE +          D++S G ++ ELL+GR
Sbjct: 194 ---HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 123/317 (38%), Gaps = 59/317 (18%)
Query: 87  IGEGGFGYV--YKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
           +GEGGF YV   +G  D H             A+K++     Q  +E   E +     +H
Sbjct: 37  LGEGGFSYVDLVEGLHDGH-----------FYALKRILCHEQQDREEAQREADMHRLFNH 85
Query: 145 PNLVKLIGFCL----DGENRLLVYEYMPKGSLENHLFRRGAR-------PLPWTLRIKVA 193
           PN+++L+ +CL          L+  +  +G+L N + R   +        + W L     
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL----- 140
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG---LAKAGPTGDRTHVSTQ 250
           +G  RGL  +H   +   +RD K +NILL  E    L D G    A     G R  ++ Q
Sbjct: 141 LGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 251 VMG----TRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
                  T  Y APE  +      +  + DV+S G VL  ++ G    D           
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------ 252
Query: 304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQL 363
                  GD   L     + +  Q P+  + +  +L      +   RP +  +LS LE L
Sbjct: 253 -------GDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
Query: 364 PPPRDPASPSNSDPQVI 380
            PP    +P     Q++
Sbjct: 305 QPP----APGQHTTQIL 317

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++   D+ T        G   AVKK++ E F+     + E+     L  P 
Sbjct: 80  LGRGSFGEVHR-MKDKQT--------GFQCAVKKVRLEVFR-----VEELVACAGLSSPR 125
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA-RGLSFLHE 205
           +V L G   +G    +  E +  GSL   + + G  P     R    +G A  GL +LH 
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQALEGLEYLHT 182
Query: 206 AEQQVIYRDFKASNILLDSEFN-AKLSDFG---------LAKAGPTGDRTHVSTQVMGTR 255
             +++++ D KA N+LL S+ + A L DFG         L K+  TGD       + GT 
Sbjct: 183 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD------YIPGTE 234
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE +      AK D++S   ++L +L+G
Sbjct: 235 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+     
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR----- 173
Query: 243 DRTHVSTQVMG---TRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
              H   ++ G   TR Y APE +          D++S G ++ ELL+GR
Sbjct: 174 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+     
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR----- 173
Query: 243 DRTHVSTQVMG---TRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
              H   ++ G   TR Y APE +          D++S G ++ ELL+GR
Sbjct: 174 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +  +P   IG G  G V           A    +G+ +AVKKL +P   Q 
Sbjct: 17  TFTVLKR-YQQLKP---IGSGAQGIV---------CAAFDTVLGINVAVKKLSRPFQNQT 63
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  L  ++H N++ L+          + ++  LV E M     +        
Sbjct: 64  HAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 123
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 124 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAST 176
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                + T  + TR Y APE +         D++S G ++ EL+ G
Sbjct: 177 N---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR------RGARPLPWTLRIKVAIGA 196
            HPN++ L     DG+   +V E M  G L + + R      R A  + +T+        
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI-------- 125
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEF----NAKLSDFGLAKAGPTGDRTHVSTQVM 252
            + + +LH   Q V++RD K SNIL   E     + ++ DFG AK     +   ++    
Sbjct: 126 TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--C 181
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            T  + APE L      A CD++S GV+L  +L+G
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++               G V   K +            +E++ + QLHHP 
Sbjct: 59  LGSGAFGVVHR---------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           L+ L     D    +L+ E++  G L + +     + +     I     A  GL  +H  
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH-- 166
Query: 207 EQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
           E  +++ D K  NI+ +++   + K+ DFGLA      +   V+T    T  +AAPE + 
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVD 223
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
              +    D+++ GV+   LLSG
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 116
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+     
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR----- 169
Query: 243 DRTHVSTQVMG---TRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
              H   ++ G   TR Y APE +          D++S G ++ ELL+GR
Sbjct: 170 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L+E   L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            I       +LH  +  +IYRD K  N+L+D +   +++DFG AK      R    T  +
Sbjct: 149 QI--VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXL 198
Query: 253 -GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            GT    APE + +       D ++ GV++ E+ +G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+  FGLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 134 SEVNYLGQLHHPNLVKLIGFCLD-GENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
            E+  L +L HPN+VKL+    D  E+ L +V+E + +G +   +     +PL       
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARF 141
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                 +G+ +LH   Q++I+RD K SN+L+  + + K++DFG++      D    +T  
Sbjct: 142 YFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-- 197
Query: 252 MGTRGYAAPEYLATGR--LTAKC-DVYSFGVVLLELLSGR 288
           +GT  + APE L+  R   + K  DV++ GV L   + G+
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 62
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L          G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 123 LDHERMSYLL-----YQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 233 QWNKVIEQ 240

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP--EGFQGHKEWLSEVNYLGQLH 143
           LIG G +G         H  EA       V+A+KK+    E     K  L E+  L +L+
Sbjct: 60  LIGTGSYG---------HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 144 HPNLVKLIGFCL--DGENRLLVYEYMPKGSLE-NHLFRRGARPLPWT-LRIKVAI-GAAR 198
           H ++VK++   +  D E    +Y  +     +   LFR    P+  T L IK  +     
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT---PVYLTELHIKTLLYNLLV 167
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-------------GPTGDRT 245
           G+ ++H A   +++RD K +N L++ + + K+ DFGLA+               P  D  
Sbjct: 168 GVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 246 HVST---------QVMG---TRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLS 286
           ++ T         Q+ G   TR Y APE  L     T   DV+S G +  ELL+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IGEG +G V+K         A       ++A+K+++     EG       L E+  L +L
Sbjct: 10  IGEGTYGTVFK---------AKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKEL 58
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H N+V+L       +   LV+E+  +  L+ +         P  ++        +GL F
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGF 116
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            H   + V++RD K  N+L++     KL++FGLA+A     R + +  V  T  Y  P+ 
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172
Query: 263 LATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
           L   +L +   D++S G +  EL +  R +         N VD         +++FR++ 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL------FPGNDVD------DQLKRIFRLLG 220
Query: 322 IKLEGQYP 329
              E Q+P
Sbjct: 221 TPTEEQWP 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 57  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 100
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 160
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 161 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 271 QWNKVIEQ 278

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR---GARPLPWTLRIKVAIGAARG 199
            HPN++ L     DG++  LV E M  G L + + R+     R   + L     IG  + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH---TIG--KT 133
Query: 200 LSFLHEAEQQVIYRDFKASNIL-LDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           + +LH   Q V++RD K SNIL +D   N    ++ DFG AK     +   ++     T 
Sbjct: 134 VEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TA 189
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE L        CD++S G++L  +L+G
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVVAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLV-----GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S GV++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 19  TFTVLKRY-QNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 62
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 233 QWNKVIEQ 240

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 19  TFTVLKRY-QNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 62
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 233 QWNKVIEQ 240

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR---GARPLPWTLRIKVAIGAARG 199
            HPN++ L     DG++  LV E M  G L + + R+     R   + L     IG  + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH---TIG--KT 133
Query: 200 LSFLHEAEQQVIYRDFKASNIL-LDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           + +LH   Q V++RD K SNIL +D   N    ++ DFG AK     +   ++     T 
Sbjct: 134 VEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TA 189
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE L        CD++S G++L  +L+G
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 57  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 100
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 160
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 161 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 271 QWNKVIEQ 278

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 43/241 (17%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP--EGFQGHKEWLSEVN 137
           N+    LIG G +GYVY  +                +A+KK+    E     K  L E+ 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAY---------DKNANKNVAIKKVNRMFEDLIDCKRILREIT 79
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYE--YMPKGSLENHLFRRGARPLPWTLR-IKVAI 194
            L +L    +++L    +  +  LL ++  Y+     ++ L +    P+  T + +K  +
Sbjct: 80  ILNRLKSDYIIRLHDLIIPED--LLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTIL 137
Query: 195 -GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS----- 248
                G  F+HE+   +I+RD K +N LL+ + + K+ DFGLA+   +    H+      
Sbjct: 138 YNLLLGEKFIHES--GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 249 ------------------TQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGRR 289
                             T  + TR Y APE  L     T   D++S G +  ELL+  +
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMK 255
Query: 290 A 290
           +
Sbjct: 256 S 256

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 20  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 63
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 123
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 124 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 234 QWNKVIEQ 241

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G+ +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 18  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 61
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 62  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 121
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 122 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 174
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 175 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 231
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 232 QWNKVIEQ 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 62
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 233 QWNKVIEQ 240

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 62
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 233 QWNKVIEQ 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 20  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 63
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 123
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 124 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 234 QWNKVIEQ 241

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 62
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L          G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 123 LDHERMSYLL-----YQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLART 175
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 233 QWNKVIEQ 240

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 13  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 56
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 57  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 116
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 117 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 169
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 170 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 227 QWNKVIEQ 234

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 12  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 55
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 115
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 116 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 226 QWNKVIEQ 233

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G+G +G VY G    + +          IA+K++     +  +    E+     L H 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVR---------IAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 146 NLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLP--------WTLRIKVAIGA 196
           N+V+ +G F  +G  ++ + E +P GSL + L R    PL         +T +I      
Sbjct: 80  NIVQYLGSFSENGFIKIFM-EQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQI------ 131
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTR 255
             GL +LH+   Q+++RD K  N+L+++     K+SDFG +K          +    GT 
Sbjct: 132 LEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTL 187
Query: 256 GYAAPEYLATG-RLTAK-CDVYSFGVVLLELLSGR 288
            Y APE +  G R   K  D++S G  ++E+ +G+
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 13  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 56
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 57  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 116
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 117 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 169
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 170 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 227 QWNKVIEQ 234

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KP-EGFQ 127
           T  E+    +N  P   +G G +G V           A     G  +AVKKL +P +   
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGF-----CLDGENRLLVYEYMPKGSLENHLFRRGAR 182
             K    E+  L  + H N++ L+        L+  N + +  ++    L N +     +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQ 120
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L       +     RGL ++H A+  +I+RD K SN+ ++ +   K+ DF LA+   T 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARH--TD 176
Query: 243 DRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
           D     T  + TR Y APE +          D++S G ++ ELL+GR
Sbjct: 177 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLV-----GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S GV++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 43/248 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYV---YKGWIDEHTLEAARPGVGMVIAVKKL-KPEG 125
           TF+ LK   +N +P   IG G  G V   Y   +D +            +A+KKL +P  
Sbjct: 12  TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 55
Query: 126 FQGH-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFR 178
            Q H K    E+  +  ++H N++ L+          + ++  LV E M     +     
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME 115
Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
                + + L          G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+ 
Sbjct: 116 LDHERMSYLL-----YQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLART 168
Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE------LLSGRRAVD 292
             T   + + T  + TR Y APE +         D++S G ++ E      L  GR  +D
Sbjct: 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
Query: 293 KTRVGAEQ 300
           +     EQ
Sbjct: 226 QWNKVIEQ 233

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+     +G+G F  V +       LE A      +I  KKL    FQ  +    E    
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFA----AKIINTKKLSARDFQKLER---EARIC 82
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAAR 198
            +L HPN+V+L     +     LV++ +  G L E+ + R        +  I+  +    
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---E 139
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            +++ H     +++R+ K  N+LL S+      KL+DFGLA      +  H      GT 
Sbjct: 140 SIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 194
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GY +PE L     +   D+++ GV+L  LL G
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+     +G+G F  V +       LE A      +I  KKL    FQ  +    E    
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFA----AKIINTKKLSARDFQKLER---EARIC 59
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAAR 198
            +L HPN+V+L     +     LV++ +  G L E+ + R        +  I+  +    
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---E 116
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            +++ H     +++R+ K  N+LL S+      KL+DFGLA      +  H      GT 
Sbjct: 117 SIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 171
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GY +PE L     +   D+++ GV+L  LL G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 20  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 66
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 67  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 126
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 127 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 180 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+     +G+G F  V +       LE A      +I  KKL    FQ  +    E    
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFA----AKIINTKKLSARDFQKLER---EARIC 58
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAAR 198
            +L HPN+V+L     +     LV++ +  G L E+ + R        +  I+  +    
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---E 115
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            +++ H     +++R+ K  N+LL S+      KL+DFGLA      +  H      GT 
Sbjct: 116 SIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 170
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GY +PE L     +   D+++ GV+L  LL G
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 130/302 (43%), Gaps = 45/302 (14%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-H 144
           L+GEG +  V +G +            G   AVK ++ +          EV  L Q   +
Sbjct: 20  LLGEGAYAKV-QGAVSLQN--------GKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
            N+++LI F  D     LV+E +  GS+  H+ ++         R+   + AA  L FLH
Sbjct: 71  KNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFLH 128
Query: 205 EAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDR-THVSTQVM----GTRG 256
              + + +RD K  NIL +S       K+ DF L       +  T ++T  +    G+  
Sbjct: 129 T--KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 257 YAAPEYLA--TGRLT---AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           Y APE +   T + T    +CD++S GVVL  +LSG        VG       W      
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF----VGHCGADCGW------ 236
Query: 312 DRRKLFRIMDIKL-----EGQY--PQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLP 364
           DR ++ R+   KL     EG+Y  P K    ++  A   IS+  VR +  + LSA + L 
Sbjct: 237 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDA-KQRLSAAQVLQ 295
Query: 365 PP 366
            P
Sbjct: 296 HP 297

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G+G +G VY G    + +          IA+K++     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVR---------IAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 146 NLVKLIG-FCLDGENRLLVYEYMPKGSLENHLFRRGARPLP--------WTLRIKVAIGA 196
           N+V+ +G F  +G  ++ + E +P GSL + L R    PL         +T +I      
Sbjct: 66  NIVQYLGSFSENGFIKIFM-EQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQI------ 117
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTR 255
             GL +LH+   Q+++RD K  N+L+++     K+SDFG +K          +    GT 
Sbjct: 118 LEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTL 173
Query: 256 GYAAPEYLATG-RLTAK-CDVYSFGVVLLELLSGR 288
            Y APE +  G R   K  D++S G  ++E+ +G+
Sbjct: 174 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           T  E++   R+ +P   +G G +G V    +D  T        G  +A+KKL +P  FQ 
Sbjct: 19  TAWEVRAVYRDLQP---VGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRP--FQS 64
Query: 129 H---KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPK--GSLENHLF 177
               K    E+  L  + H N++ L+          D  +  LV  +M    G L  H  
Sbjct: 65  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE- 123
Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           + G   + +     +     +GL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+
Sbjct: 124 KLGEDRIQF-----LVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
              +     V      TR Y APE +    R T   D++S G ++ E+++G+
Sbjct: 177 QADSEMXGXVV-----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           N+     +G+G F  V +       LE A      +I  KKL    FQ  +    E    
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFA----AKIINTKKLSARDFQKLER---EARIC 59
Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAAR 198
            +L HPN+V+L     +     LV++ +  G L E+ + R        +  I+  +    
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---E 116
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            +++ H     +++R+ K  N+LL S+      KL+DFGLA      +  H      GT 
Sbjct: 117 SIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 171
Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GY +PE L     +   D+++ GV+L  LL G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 81/178 (45%), Gaps = 6/178 (3%)
Query: 111 GVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--GENRLLVYEYMP 168
           G  +V+ V K++    +  +++  E   L    HPN++ ++G C      +  L+  + P
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 169 KGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA 228
            GSL N L       +  +  +K A+  ARG +FLH  E  +      + ++ +D +  A
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTA 152
Query: 229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           ++S   +  +  +  R +    V        PE   T R +A  D +SF V+L EL++
Sbjct: 153 RISXADVKFSFQSPGRXYAPAWVAPEALQKKPE--DTNRRSA--DXWSFAVLLWELVT 206

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 116 IAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKL--------------IGFCLDGENRL 161
           +A+KK+     Q  K  L E+  + +L H N+VK+              +G   +  +  
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 162 LVYEYMPK---GSLENH-LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKA 217
           +V EYM       LE   L    AR   + L         RGL ++H A   V++RD K 
Sbjct: 99  IVQEYMETDLANVLEQGPLLEEHARLFMYQL--------LRGLKYIHSA--NVLHRDLKP 148
Query: 218 SNILLDSE-FNAKLSDFGLAKAGP--TGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCD 273
           +N+ +++E    K+ DFGLA+        + H+S  ++ T+ Y +P  L +    T   D
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAID 207
Query: 274 VYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG--DRRKLFRIM 320
           +++ G +  E+L+G+          +  L+  + P +   DR++L  ++
Sbjct: 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEV 136
           +R  + +GEG +G VYK  ID  T E         +A+K+++     EG  G    + EV
Sbjct: 36  YRRITKLGEGTYGEVYKA-IDTVTNET--------VAIKRIRLEHEEEGVPGTA--IREV 84
Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI--KVAI 194
           + L +L H N+++L           L++EY      EN L +   +    ++R+      
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-----KLSDFGLAKAGPTGDRTHVST 249
               G++F H   ++ ++RD K  N+LL     +     K+ DFGLA+A     R    T
Sbjct: 140 QLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--T 195
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELL 285
             + T  Y  PE L   R  +   D++S   +  E+L
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLV-----GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 35/172 (20%)
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP-- 185
           G  +W++ ++Y  Q              D  N  LV +Y   G L   L +   R LP  
Sbjct: 131 GDSKWITTLHYAFQ--------------DDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEE 175
Query: 186 ----WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
               +   + +AI +   L ++H        RD K  NIL+D   + +L+DFG +     
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLM 226
Query: 242 GDRTHVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGR 288
            D T  S+  +GT  Y +PE L       GR   +CD +S GV + E+L G 
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 21  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 67
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 68  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 127
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 128 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 180
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + +    + TR Y APE +         D++S G ++ E++ G
Sbjct: 181 ---SFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT 178
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
              + + T  + TR Y APE +         D++S G ++ E++ G
Sbjct: 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 31/267 (11%)
Query: 32  FSMASSLKTNKSEKRPSGNFSMPRT------ECDILSCPNLKAFTFSELKNATRNFRPDS 85
            S +   K N   K P   F  P+T      + D  +C ++    F E+K    +  P  
Sbjct: 1   MSQSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNF-EVK--ADDLEPIM 57
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNY-LGQLH 143
            +G G +G V K               G ++AVK+++     Q  K  L +++  +  + 
Sbjct: 58  ELGRGAYGVVEK---------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 108
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKG--SLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            P  V   G      +  +  E M          +  +G + +P  +  K+A+   + L 
Sbjct: 109 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALE 167
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
            LH ++  VI+RD K SN+L+++    K+ DFG+  +G   D     T   G + Y APE
Sbjct: 168 HLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDSV-AKTIDAGCKPYMAPE 223
Query: 262 ----YLATGRLTAKCDVYSFGVVLLEL 284
                L     + K D++S G+ ++EL
Sbjct: 224 RINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 37/245 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 24  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 70
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 71  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 130
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 131 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 183
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS------GRRAVDKTR 295
              + + T  + TR Y APE +         D++S G ++ E++       GR  +D+  
Sbjct: 184 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 240
Query: 296 VGAEQ 300
              EQ
Sbjct: 241 KVIEQ 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 37/245 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 13  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 59
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 60  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 119
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T
Sbjct: 120 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 172
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS------GRRAVDKTR 295
              + + T  + TR Y APE +         D++S G ++ E++       GR  +D+  
Sbjct: 173 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 229
Query: 296 VGAEQ 300
              EQ
Sbjct: 230 KVIEQ 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR------RGARPLPWTLRIKVAIGA 196
            HPN++ L     DG+   +V E    G L + + R      R A  + +T+        
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTI-------- 125
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEF----NAKLSDFGLAKAGPTGDRTHVSTQVM 252
            + + +LH   Q V++RD K SNIL   E     + ++ DFG AK     +   + T   
Sbjct: 126 TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLXTPCY 182
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            T  + APE L      A CD++S GV+L   L+G
Sbjct: 183 -TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEWLSEVNYLGQL 142
           IG+G FG V+K         A     G  +A+KK+    + EGF      L E+  L  L
Sbjct: 26  IGQGTFGEVFK---------ARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 143 HHPNLVKLIGFCLDGE---NRL-----LVYEYMPK---GSLENHLFRRGARPLPWTLRIK 191
            H N+V LI  C       NR      LV+++      G L N L +     +   +++ 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS--T 249
           +      GL ++H    ++++RD KA+N+L+  +   KL+DFGLA+A      +  +   
Sbjct: 135 L-----NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLS 286
             + T  Y  PE L   R      D++  G ++ E+ +
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS------EVNYLG 140
           +G G F  V K           + G G   A K +K       +  +S      EVN L 
Sbjct: 13  LGSGQFAIVRK---------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           ++ HPN++ L     +  + +L+ E +  G L + L  + +       +    I    G+
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 121
Query: 201 SFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            +LH   +++ + D K  NI LLD        KL DFG+A     G+       + GT  
Sbjct: 122 HYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 176
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           + APE +    L  + D++S GV+   LLSG
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 13/118 (11%)
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           + + I  A  + FLH   + +++RD K SNI    +   K+ DFGL  A    +      
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 250 QVM----------GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL-SGRRAVDKTRV 296
             M          GT+ Y +PE +     + K D++S G++L ELL S    +++ R+
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI 282

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 135 EVNYLGQLHHPNLVKLIGFC-LDGENRLLVYEYMPKG-SLENHLFRRGARPLPWTLRIKV 192
           E    G+L  P++V +  F  +DG+  L V   +  G  L   L R+G    P  + I  
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQ--LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVR 141
Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
            IG+    +          +RD K  NIL+ ++  A L DFG+A A      T +   V 
Sbjct: 142 QIGS----ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV- 196
Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  Y APE  +    T + D+Y+   VL E L+G
Sbjct: 197 GTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS------EVNYLG 140
           +G G F  V K           + G G   A K +K       +  +S      EVN L 
Sbjct: 20  LGSGQFAIVRK---------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           ++ HPN++ L     +  + +L+ E +  G L + L  + +       +    I    G+
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 128
Query: 201 SFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            +LH   +++ + D K  NI LLD        KL DFG+A     G+       + GT  
Sbjct: 129 HYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 183
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           + APE +    L  + D++S GV+   LLSG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEWLSEVNYLGQL 142
           IG+G FG V+K         A     G  +A+KK+    + EGF      L E+  L  L
Sbjct: 26  IGQGTFGEVFK---------ARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 143 HHPNLVKLIGFCLDGE---NRL-----LVYEYMPK---GSLENHLFRRGARPLPWTLRIK 191
            H N+V LI  C       NR      LV+++      G L N L +     +   +++ 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS--T 249
           +      GL ++H    ++++RD KA+N+L+  +   KL+DFGLA+A      +  +   
Sbjct: 135 L-----NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLS 286
             + T  Y  PE L   R      D++  G ++ E+ +
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEWLSEVNYLGQL 142
           IG+G FG V+K         A     G  +A+KK+    + EGF      L E+  L  L
Sbjct: 25  IGQGTFGEVFK---------ARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 73
Query: 143 HHPNLVKLIGFCLDGE---NRL-----LVYEYMPK---GSLENHLFRRGARPLPWTLRIK 191
            H N+V LI  C       NR      LV+++      G L N L +     +   +++ 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS--T 249
           +      GL ++H    ++++RD KA+N+L+  +   KL+DFGLA+A      +  +   
Sbjct: 134 L-----NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLS 286
             + T  Y  PE L   R      D++  G ++ E+ +
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL----KPEGFQGHKEWLSEVNYLGQL 142
           IG+G FG V+K         A     G  +A+KK+    + EGF      L E+  L  L
Sbjct: 26  IGQGTFGEVFK---------ARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 143 HHPNLVKLIGFCLDGE---NRL-----LVYEYMPK---GSLENHLFRRGARPLPWTLRIK 191
            H N+V LI  C       NR      LV+++      G L N L +     +   +++ 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS--T 249
           +      GL ++H    ++++RD KA+N+L+  +   KL+DFGLA+A      +  +   
Sbjct: 135 L-----NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLS 286
             + T  Y  PE L   R      D++  G ++ E+ +
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS------EVNYLG 140
           +G G F  V K           + G G   A K +K       +  +S      EVN L 
Sbjct: 34  LGSGQFAIVRK---------CRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           ++ HPN++ L     +  + +L+ E +  G L + L  + +       +    I    G+
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 142
Query: 201 SFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            +LH   +++ + D K  NI LLD        KL DFG+A     G+       + GT  
Sbjct: 143 HYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 197
Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           + APE +    L  + D++S GV+   LLSG
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--SEVNYLGQLH 143
           IG+G FG V++G W  E             +AVK       +  + W   +E+     L 
Sbjct: 50  IGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVMLR 94
Query: 144 HPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           H N++  I      +N+         LV +Y   GSL ++L R     +     IK+A+ 
Sbjct: 95  HENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 147
Query: 196 AARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVS 248
            A GL+ LH      + +  + +RD K+ NIL+       ++D GLA +     D   ++
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 249 -TQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLEL 284
               +GT+ Y APE L             + D+Y+ G+V  E+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           F  +S +G G    VY+           + G     A+K LK       K   +E+  L 
Sbjct: 55  FEVESELGRGATSIVYR---------CKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLL 103
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR-- 198
           +L HPN++KL           LV E +  G L + +  +G          + A  A +  
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE------RDAADAVKQI 157
Query: 199 --GLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
              +++LHE    +++RD K  N+L  +   +   K++DFGL+K     +   +   V G
Sbjct: 158 LEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCG 212
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T GY APE L       + D++S G++   LL G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 120
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 121 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 217
Query: 311 GDRRK 315
           GD ++
Sbjct: 218 GDTKQ 222

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++               G   A K +        +    E+  +  L HP 
Sbjct: 59  LGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV L     D    +++YE+M  G L   +     + +     ++      +GL  +H  
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH-- 166
Query: 207 EQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
           E   ++ D K  NI+  ++ +   KL DFGL           V+T   GT  +AAPE   
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
              +    D++S GV+   LLSG
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--SEVNYLGQLH 143
           IG+G FG V++G W  E             +AVK       +  + W   +E+     L 
Sbjct: 37  IGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVMLR 81
Query: 144 HPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           H N++  I      +N+         LV +Y   GSL ++L R     +     IK+A+ 
Sbjct: 82  HENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 134
Query: 196 AARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVS 248
            A GL+ LH      + +  + +RD K+ NIL+       ++D GLA +     D   ++
Sbjct: 135 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 194
Query: 249 -TQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLEL 284
               +GT+ Y APE L             + D+Y+ G+V  E+
Sbjct: 195 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 120
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 121 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 217
Query: 311 GDRRK 315
           GD ++
Sbjct: 218 GDTKQ 222

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 43/239 (17%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           +   R+      +G+G +G V++G W  E+            +AVK       +  K W 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 134 SEVNYLG--QLHHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWT 187
            E        L H N++  I   +   +      L+  Y   GSL ++L       L   
Sbjct: 49  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTV 105
Query: 188 LRIKVAIGAARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA--KAG 239
             +++ +  A GL+ LH      + +  + +RD K+ NIL+       ++D GLA   + 
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKC-------DVYSFGVVLLELLSGRRAV 291
            T      +   +GT+ Y APE L    +   C       D+++FG+VL E+   RR V
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--SEVNYLGQLH 143
           IG+G FG V++G W  E             +AVK       +  + W   +E+     L 
Sbjct: 12  IGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVMLR 56
Query: 144 HPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           H N++  I      +N+         LV +Y   GSL ++L R     +     IK+A+ 
Sbjct: 57  HENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 109
Query: 196 AARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVS 248
            A GL+ LH      + +  + +RD K+ NIL+       ++D GLA +     D   ++
Sbjct: 110 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 169
Query: 249 -TQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLEL 284
               +GT+ Y APE L             + D+Y+ G+V  E+
Sbjct: 170 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--SEVNYLGQLH 143
           IG+G FG V++G W  E             +AVK       +  + W   +E+     L 
Sbjct: 17  IGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVMLR 61
Query: 144 HPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           H N++  I      +N+         LV +Y   GSL ++L R     +     IK+A+ 
Sbjct: 62  HENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 114
Query: 196 AARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVS 248
            A GL+ LH      + +  + +RD K+ NIL+       ++D GLA +     D   ++
Sbjct: 115 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 174
Query: 249 -TQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLEL 284
               +GT+ Y APE L             + D+Y+ G+V  E+
Sbjct: 175 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           RGL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+           T  + TR Y
Sbjct: 134 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWY 186
Query: 258 AAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
            APE +          D++S G ++ ELL G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 43/308 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-------MVIAVKKLK 122
            F +++N    F  +  +G+G F  ++KG          R  VG         + +K L 
Sbjct: 1   VFHKIRNEDLIF--NESLGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLD 49
Query: 123 PEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR 182
                  + +    + + +L H +LV   G C+ G+  +LV E++  GSL+ +L ++   
Sbjct: 50  KAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKN 108
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPT 241
            +    +++VA   A  + FL   E  +I+ +  A NILL  E + K  +    K + P 
Sbjct: 109 CINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 242 GDRTHVSTQVMGTR-GYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE 299
              T +   ++  R  +  PE +   + L    D +SFG  L E+ SG            
Sbjct: 167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG----------- 215
Query: 300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
               D     L  +RKL    D     Q P   A  +A L   C+  E   RPS   ++ 
Sbjct: 216 ----DKPLSALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268
Query: 359 ALEQLPPP 366
            L  L  P
Sbjct: 269 DLNSLFTP 276

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 37/245 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+    
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 176
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS------GRRAVDKTR 295
           G    +  +V+ TR Y APE +         D++S G ++ E++       GR  +D+  
Sbjct: 177 GTSFMMEPEVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWN 235
Query: 296 VGAEQ 300
              EQ
Sbjct: 236 KVIEQ 240

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--SEVNYLGQLH 143
           IG+G FG V++G W  E             +AVK       +  + W   +E+     L 
Sbjct: 11  IGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVMLR 55
Query: 144 HPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           H N++  I      +N+         LV +Y   GSL ++L R     +     IK+A+ 
Sbjct: 56  HENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 108
Query: 196 AARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVS 248
            A GL+ LH      + +  + +RD K+ NIL+       ++D GLA +     D   ++
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 249 -TQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLEL 284
               +GT+ Y APE L             + D+Y+ G+V  E+
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 11/131 (8%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L++ E M  G L + +  RG +        ++       + FLH     + +RD K  N+
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENL 140
Query: 221 LLDS-EFNA--KLSDFGLAKAGPTGDRTHVSTQV-MGTRGYAAPEYLATGRLTAKCDVYS 276
           L  S E +A  KL+DFG AK     + T  + Q    T  Y APE L   +    CD++S
Sbjct: 141 LYTSKEKDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 195
Query: 277 FGVVLLELLSG 287
            GV++  LL G
Sbjct: 196 LGVIMYILLCG 206

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 17/203 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++               G   A K +        +    E+  +  L HP 
Sbjct: 165 LGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           LV L     D    +++YE+M  G L   +     + +     ++      +GL  +H  
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH-- 272
Query: 207 EQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA 264
           E   ++ D K  NI+  ++ +   KL DFGL           V+T   GT  +AAPE   
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 265 TGRLTAKCDVYSFGVVLLELLSG 287
              +    D++S GV+   LLSG
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 24/231 (10%)
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           LV+E M  GS+ +H+ +R  R         V    A  L FLH   + + +RD K  NIL
Sbjct: 88  LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENIL 143
Query: 222 LDSEFN---AKLSDFGLAKA-GPTGDRTHVSTQVM----GTRGYAAPEYLATGRLTA--- 270
            +        K+ DFGL       GD + +ST  +    G+  Y APE +      A   
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 271 --KCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQY 328
             +CD++S GV+L  LLSG       R G++    D  +     +  LF  +    EG+Y
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPF-VGRCGSDCGW-DRGEACPACQNMLFESIQ---EGKY 258
Query: 329 --PQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDP 377
             P K    ++  A   IS+  VR +   + +A     P     +P N+ P
Sbjct: 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 13/208 (6%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
            +IG+G F  V +        E  +     ++ V K         ++   E +    L H
Sbjct: 30  EVIGKGAFSVVRRCI----NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI--GAARGLSF 202
           P++V+L+          +V+E+M    L   + +R      ++  +           L +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
            H+    +I+RD K  N+LL S+ N+   KL DFG+A     G+   V+   +GT  + A
Sbjct: 146 CHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFMA 201
Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSG 287
           PE +         DV+  GV+L  LLSG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           RGL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+           T  + TR Y
Sbjct: 142 RGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWY 194
Query: 258 AAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
            APE +          D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 11/131 (8%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L++ E M  G L + +  RG +        ++       + FLH     + +RD K  N+
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENL 159
Query: 221 LLDS-EFNA--KLSDFGLAKAGPTGDRTHVSTQV-MGTRGYAAPEYLATGRLTAKCDVYS 276
           L  S E +A  KL+DFG AK     + T  + Q    T  Y APE L   +    CD++S
Sbjct: 160 LYTSKEKDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 277 FGVVLLELLSG 287
            GV++  LL G
Sbjct: 215 LGVIMYILLCG 225

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL--SEVNYLGQLH 143
           IG+G FG V++G W  E             +AVK       +  + W   +E+     L 
Sbjct: 14  IGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVMLR 58
Query: 144 HPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           H N++  I      +N+         LV +Y   GSL ++L R     +     IK+A+ 
Sbjct: 59  HENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 111
Query: 196 AARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVS 248
            A GL+ LH      + +  + +RD K+ NIL+       ++D GLA +     D   ++
Sbjct: 112 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 171
Query: 249 -TQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLEL 284
               +GT+ Y APE L             + D+Y+ G+V  E+
Sbjct: 172 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
           T  ++    +G+G F  V +       + A +    M+I  KKL     + H++   E  
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCV----KVLAGQEYAAMIINTKKLSA---RDHQKLEREAR 62
Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGA 196
               L HPN+V+L     +  +  L+++ +  G L E+ + R        +  I+  + A
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMG 253
                 LH  +  V++R+ K  N+LL S+      KL+DFGLA       +        G
Sbjct: 123 V-----LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T GY +PE L         D+++ GV+L  LL G
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           RGL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+           T  + TR Y
Sbjct: 142 RGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWY 194
Query: 258 AAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
            APE +          D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 43/308 (13%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVG-------MVIAVKKLK 122
            F +++N    F  +  +G+G F  ++KG          R  VG         + +K L 
Sbjct: 1   VFHKIRNEDLIF--NESLGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLD 49
Query: 123 PEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR 182
                  + +    + + +L H +LV   G C  G+  +LV E++  GSL+ +L ++   
Sbjct: 50  KAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKN 108
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPT 241
            +    +++VA   A  + FL   E  +I+ +  A NILL  E + K  +    K + P 
Sbjct: 109 CINILWKLEVAKQLAWAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 242 GDRTHVSTQVMGTR-GYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE 299
              T +   ++  R  +  PE +   + L    D +SFG  L E+ SG            
Sbjct: 167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG----------- 215
Query: 300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
               D     L  +RKL    D     Q P   A  +A L   C+  E   RPS   ++ 
Sbjct: 216 ----DKPLSALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268
Query: 359 ALEQLPPP 366
            L  L  P
Sbjct: 269 DLNSLFTP 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +            I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 124 --LNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 43/239 (17%)
Query: 75  KNATRNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           +   R       +G+G +G V++G W  E+            +AVK       +  K W 
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 77
Query: 134 SEVNYLG--QLHHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWT 187
            E        L H N++  I   +   +      L+  Y   GSL ++L       +   
Sbjct: 78  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-C 136
Query: 188 LRIKVAIGAARGLSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA--KAG 239
           LRI ++I  A GL+ LH      + +  + +RD K+ NIL+       ++D GLA   + 
Sbjct: 137 LRIVLSI--ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 194
Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKC-------DVYSFGVVLLELLSGRRAV 291
            T      +   +GT+ Y APE L    +   C       D+++FG+VL E+   RR V
Sbjct: 195 STNQLDVGNNPRVGTKRYMAPEVLDE-TIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 31/186 (16%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVA 193
           EV+ L Q+ HPN++ L     +  + +L+ E +  G L + L ++ +      T  IK  
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVST 249
           +    G+++LH   +++ + D K  NI LLD      + KL DFGLA     G       
Sbjct: 125 LD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            + GT  + APE +    L  + D++S GV+   LLSG                  A P+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 218
Query: 310 LGDRRK 315
           LGD ++
Sbjct: 219 LGDTKQ 224

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG--QLH 143
           +G+G +G V++G W  E+            +AVK       +  K W  E        L 
Sbjct: 16  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 144 HPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
           H N++  I   +   +      L+  Y   GSL ++L       L     +++ +  A G
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 200 LSFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLA--KAGPTGDRTHVSTQV 251
           L+ LH      + +  + +RD K+ NIL+       ++D GLA   +  T      +   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 252 MGTRGYAAPEYLATGRLTAKC-------DVYSFGVVLLELLSGRRAV 291
           +GT+ Y APE L    +   C       D+++FG+VL E+   RR V
Sbjct: 178 VGTKRYMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 29/185 (15%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  + +  L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 195 GAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       
Sbjct: 122 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                  A P+L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFL 218
Query: 311 GDRRK 315
           GD ++
Sbjct: 219 GDTKQ 223

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 37/245 (15%)
Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQG 128
           TF+ LK   +N +P   IG G  G V   +  +  LE         +A+KKL +P   Q 
Sbjct: 19  TFTVLKR-YQNLKP---IGSGAQGIVCAAY--DAILERN-------VAIKKLSRPFQNQT 65
Query: 129 H-KEWLSEVNYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGA 181
           H K    E+  +  ++H N++ L+          + ++  +V E M     +        
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             + + L   +      G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+    
Sbjct: 126 ERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 176
Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS------GRRAVDKTR 295
           G    +  +V+ TR Y APE +         D++S G ++ E++       GR  +D+  
Sbjct: 177 GTSFMMEPEVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 235
Query: 296 VGAEQ 300
              EQ
Sbjct: 236 KVIEQ 240

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 146
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   + +     T+   T  Y APE L   +    CD++S 
Sbjct: 147 LYTSKRPNAILKLTDFGFAKETTSHNSL---TEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 204 GVIMYILLCG 213

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 99/249 (39%), Gaps = 58/249 (23%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G +G V +  I+  T       +     ++++ P+  +  K   +EV  + +LHHPN
Sbjct: 34  IGQGSYGVV-RVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPN 89
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLEN-------------------------------- 174
           + +L     D +   LV E    G L +                                
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 175 -----HLFRRGARPLPWTLRIKVAIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSE 225
                H FR     L +  R K+     R     L +LH   Q + +RD K  N L  + 
Sbjct: 150 INGSIHGFRES---LDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTN 204
Query: 226 --FNAKLSDFGLAKAG---PTGDRTHVSTQVMGTRGYAAPEYLATGRLTA--KCDVYSFG 278
             F  KL DFGL+K       G+   ++T+  GT  + APE L T   +   KCD +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 279 VVLLELLSG 287
           V+L  LL G
Sbjct: 264 VLLHLLLMG 272

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR 189
           K  L E+  L   HHPN++ L    +  E        M K  L   L R     +    R
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHDQR 128
Query: 190 IKVA--------IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
           I ++             GL  LHEA   V++RD    NILL    +  + DF LA+    
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 242 -GDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             ++TH  T     R Y APE +   +  T   D++S G V+ E+ + R+A+
Sbjct: 187 DANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR 189
           K  L E+  L   HHPN++ L    +  E        M K  L   L R     +    R
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHDQR 128
Query: 190 IKVA--------IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
           I ++             GL  LHEA   V++RD    NILL    +  + DF LA+    
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 242 -GDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAV 291
             ++TH  T     R Y APE +   +  T   D++S G V+ E+ + R+A+
Sbjct: 187 DANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 33/230 (14%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           E++    +F    +IG G FG V    +       A   +     +K+ +   F+  ++ 
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 133 L--SEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTL- 188
           L   +  ++  LH         +    EN L LV +Y   G L   L  +    LP  + 
Sbjct: 128 LVNGDCQWITALH---------YAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMA 177
Query: 189 -----RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
                 + +AI +   L ++H        RD K  N+LLD   + +L+DFG +      D
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDD 228
Query: 244 RTHVSTQVMGTRGYAAPEYL-----ATGRLTAKCDVYSFGVVLLELLSGR 288
            T  S+  +GT  Y +PE L       G+   +CD +S GV + E+L G 
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 60/315 (19%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS---EV 136
            +R   L+G+GGFG V+ G      L+ A      +  + + +  G+    + ++   EV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVA------IKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 137 NYLGQLH----HPNLVKLIGFCLDGENRLLVYEY-MPKGSLENHLFRRGARPL---PWTL 188
             L ++     HP +++L+ +    E  +LV E  +P   L +++  +G  PL   P   
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRC 143
Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-AKLSDFGLAKAGPTGDRTHV 247
                + A +     H   + V++RD K  NIL+D     AKL DFG      +G   H 
Sbjct: 144 FFGQVVAAIQ-----HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG------SGALLHD 192
Query: 248 S--TQVMGTRGYAAPEYLATGRLTA-KCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD 304
              T   GTR Y+ PE+++  +  A    V+S G++L +++ G    ++ +   E  L  
Sbjct: 193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL-- 250
Query: 305 WAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV-LSALEQ 362
                                  +P   +     L  +C++ +   RPS+ E+ L    Q
Sbjct: 251 ----------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
Query: 363 LPPPRDPASPSNSDP 377
            P    P +PS   P
Sbjct: 289 TPAEDVPLNPSKGGP 303

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G F  V +       + A +     +I  KKL     + H++   E      L HPN
Sbjct: 30  LGKGAFSVVRRCV----KVLAGQEYAAKIINTKKLSA---RDHQKLEREARICRLLKHPN 82
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           +V+L     +  +  L+++ +  G L E+ + R        +  I+  + A      LH 
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHC 137
Query: 206 AEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            +  V++RD K  N+LL S+      KL+DFGLA       +        GT GY +PE 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEV 195
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           L         D+++ GV+L  LL G
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 33/230 (14%)
Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           E++    +F    +IG G FG V    +       A   +     +K+ +   F+  ++ 
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 133 L--SEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTL- 188
           L   +  ++  LH         +    EN L LV +Y   G L   L  +    LP  + 
Sbjct: 144 LVNGDCQWITALH---------YAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMA 193
Query: 189 -----RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
                 + +AI +   L ++H        RD K  N+LLD   + +L+DFG +      D
Sbjct: 194 RFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDD 244
Query: 244 RTHVSTQVMGTRGYAAPEYL-----ATGRLTAKCDVYSFGVVLLELLSGR 288
            T  S+  +GT  Y +PE L       G+   +CD +S GV + E+L G 
Sbjct: 245 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 154
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 155 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 212 GVIMYILLCG 221

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 192
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 193 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 250 GVIMYILLCG 259

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 198
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 199 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 256 GVIMYILLCG 265

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGV--GMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
           I  GG G++Y   +D +     RP V  G+V +            +++L+EV       H
Sbjct: 88  IAHGGLGWIYLA-LDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV------H 138
Query: 145 PNLVKLIGFCLDGENR-----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
           P++V++  F    +        +V EY+   SL+    R   + LP    I   +     
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAYLLEILPA 194
Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           LS+LH     ++Y D K  NI+L +E   KL D G         R +    + GT G+ A
Sbjct: 195 LSYLHSI--GLVYNDLKPENIML-TEEQLKLIDLGAVS------RINSFGYLYGTPGFQA 245
Query: 260 PEYLATGRLTAKCDVYSFGVVLLEL 284
           PE + TG  T   D+Y+ G  L  L
Sbjct: 246 PEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGH---KEWLSEVNYLGQL 142
           +G G +G V    ID+ +        G  +A+KKL +P  FQ     K    E+  L  +
Sbjct: 50  VGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRP--FQSEIFAKRAYRELLLLKHM 98
Query: 143 HHPNLVKLIGFCLDGENRLLVYE-YMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            H N++ L+       +    Y+ Y+    ++  L +             +     +GL 
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLK 158
Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---TRGYA 258
           ++H A   V++RD K  N+ ++ +   K+ DFGLA+        H   ++ G   TR Y 
Sbjct: 159 YIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYR 208
Query: 259 APE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
           APE  L+        D++S G ++ E+L+G+
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 153
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 154 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 211 GVIMYILLCG 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 152
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 153 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 210 GVIMYILLCG 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 86/212 (40%), Gaps = 36/212 (16%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V +   D+ T E        ++AVK ++  G    +    E+     L HPN
Sbjct: 28  IGSGNFG-VARLMRDKLTKE--------LVAVKYIE-RGAAIDENVQREIINHRSLRHPN 77
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR-------- 198
           +V+     L   +  ++ EY   G L   +   G          + +   AR        
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLS 127
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           G+S+ H    Q+ +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 128 GVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 182
Query: 257 YAAPEYLATGRLTAK-CDVYSFGVVLLELLSG 287
           Y APE L       K  DV+S GV L  +L G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 146
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 147 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 204 GVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 147
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 148 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 205 GVIMYILLCG 214

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           ++ IG G +G V           A + G  +  A KK+     +    +  E+  +  L 
Sbjct: 14  ENTIGRGSWGEVKI---------AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           HPN+++L     D  +  LV E    G L E  + +R  R       +K  + A   +++
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAY 121
Query: 203 LHEAEQQVIYRDFKASNILL--DS-EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGY 257
            H+    V +RD K  N L   DS +   KL DFGLA     G   RT V     GT  Y
Sbjct: 122 CHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTPYY 174
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            +P+ L  G    +CD +S GV++  LL G
Sbjct: 175 VSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 54/223 (24%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL-KPEGFQGH---KEWLSEVNYLGQL 142
           +G G +G V    ID+ +        G  +A+KKL +P  FQ     K    E+  L  +
Sbjct: 32  VGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRP--FQSEIFAKRAYRELLLLKHM 80
Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV---------- 192
            H N++ L+              + P  SL N        P   T   K+          
Sbjct: 81  QHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI 128
Query: 193 ---AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
                   +GL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        H   
Sbjct: 129 QYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADA 178
Query: 250 QVMG---TRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
           ++ G   TR Y APE  L+        D++S G ++ E+L+G+
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 148
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 149 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 206 GVIMYILLCG 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V +   D+   E        ++AVK ++  G +  +    E+     L HPN
Sbjct: 27  IGAGNFG-VARLMRDKQANE--------LVAVKYIE-RGEKIDENVKREIINHRSLRHPN 76
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGL 200
           +V+     L   +  +V EY   G L   +   G      AR     L          G+
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------ISGV 128
Query: 201 SFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           S+ H    QV +RD K  N LLD       K++DFG +KA     +       +GT  Y 
Sbjct: 129 SYAH--AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPAYI 183
Query: 259 APEYLATGRLTAKC-DVYSFGVVLLELLSG 287
           APE L       K  DV+S GV L  +L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 162
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 163 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 220 GVIMYILLCG 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 148
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD++S 
Sbjct: 149 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 278 GVVLLELLSG 287
           GV++  LL G
Sbjct: 206 GVIMYILLCG 215

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
           ++ IG G +G V           A + G  +  A KK+     +    +  E+  +  L 
Sbjct: 31  ENTIGRGSWGEVKI---------AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           HPN+++L     D  +  LV E    G L E  + +R  R       +K  + A   +++
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAY 138
Query: 203 LHEAEQQVIYRDFKASNILL--DS-EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGY 257
            H+    V +RD K  N L   DS +   KL DFGLA     G   RT V     GT  Y
Sbjct: 139 CHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTPYY 191
Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            +P+ L  G    +CD +S GV++  LL G
Sbjct: 192 VSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 2/97 (2%)
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 201 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 258
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 17/139 (12%)
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           LV+E M  GS+ +H+ +R  R         V    A  L FLH   + + +RD K  NIL
Sbjct: 88  LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENIL 143
Query: 222 LDSEFN---AKLSDFGLAKA-GPTGDRTHVSTQVM----GTRGYAAPEYLATGRLTA--- 270
            +        K+ DF L       GD + +ST  +    G+  Y APE +      A   
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 271 --KCDVYSFGVVLLELLSG 287
             +CD++S GV+L  LLSG
Sbjct: 204 DKRCDLWSLGVILYILLSG 222

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 2/97 (2%)
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 203 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 260
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 261 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 2/104 (1%)
Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
           P+     I  +   ARG+ FL  + ++ I+RD  A NILL      K+ DFGLA+     
Sbjct: 195 PITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                         + APE +     + K DV+S+GV+L E+ S
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 2/97 (2%)
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 196 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 2/97 (2%)
Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+            
Sbjct: 194 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 251
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                  + APE +     T + DV+SFGV+L E+ S
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNY 138
           +  P   +G G +G V K     H      P  G ++AVK+++     Q  K  L +++ 
Sbjct: 8   DLEPIMELGRGAYGVVEKM---RHV-----PS-GQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 139 -LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKG--SLENHLFRRGARPLPWTLRIKVAIG 195
            +  +  P  V   G      +  +  E M          +  +G + +P  +  K+A+ 
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG-QTIPEDILGKIAVS 117
Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
             + L  LH ++  VI+RD K SN+L+++    K+ DFG+  +G   D         G +
Sbjct: 118 IVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDIDA-GCK 173
Query: 256 GYAAPE----YLATGRLTAKCDVYSFGVVLLEL 284
            Y APE     L     + K D++S G+ ++EL
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V +   D+ + E        ++AVK ++  G +  +    E+     L HPN
Sbjct: 26  IGSGNFG-VARLMRDKQSNE--------LVAVKYIE-RGEKIDENVKREIINHRSLRHPN 75
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGL 200
           +V+     L   +  +V EY   G L   +   G      AR     L          G+
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------ISGV 127
Query: 201 SFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           S+ H    QV +RD K  N LLD       K+ DFG +K+     +       +GT  Y 
Sbjct: 128 SYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 182
Query: 259 APEYLATGRLTAKC-DVYSFGVVLLELLSG 287
           APE L       K  DV+S GV L  +L G
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 162 LVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN 219
           ++ EY+P  +L   L  F R  R +P  L         R + F+H     + +RD K  N
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQN 171
Query: 220 ILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE-YLATGRLTAKCDVYSF 277
           +L++S+ N  KL DFG AK     +    S   + +R Y APE  L     T   D++S 
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEP---SVAXICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 278 GVVLLELLSGR 288
           G V  EL+ G+
Sbjct: 229 GCVFGELILGK 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 21/165 (12%)
Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL---ENHLF---RRGAR 182
           + ++ +E+  +  + +   +   G   + +   ++YEYM   S+   + + F   +    
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 183 PLPWTLRIKVAIGAA-RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
            +P  + IK  I +     S++H  E+ + +RD K SNIL+D     KLSDFG ++    
Sbjct: 147 FIPIQV-IKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEY--- 201
Query: 242 GDRTHVSTQVMGTRG---YAAPEYLA--TGRLTAKCDVYSFGVVL 281
                V  ++ G+RG   +  PE+ +  +    AK D++S G+ L
Sbjct: 202 ----MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V +   D+ + E        ++AVK ++  G +       E+     L HPN
Sbjct: 27  IGSGNFG-VARLMRDKQSNE--------LVAVKYIE-RGEKIAANVKREIINHRSLRHPN 76
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGL 200
           +V+     L   +  +V EY   G L   +   G      AR     L          G+
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------ISGV 128
Query: 201 SFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           S+ H    QV +RD K  N LLD       K+ DFG +K+     +       +GT  Y 
Sbjct: 129 SYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 183
Query: 259 APEYLATGRLTAKC-DVYSFGVVLLELLSG 287
           APE L       K  DV+S GV L  +L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 18/231 (7%)
Query: 61  LSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK 120
           L   NL     +     T +++    +G+G F  V +      T E A      +I  KK
Sbjct: 13  LGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYA----AKIINTKK 68
Query: 121 LKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRR 179
           L     + H++   E      L HPN+V+L     +     LV++ +  G L E+ + R 
Sbjct: 69  LSA---RDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE 125
Query: 180 GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLA 236
                  +  I   + +       H  +  +++RD K  N+LL S+      KL+DFGLA
Sbjct: 126 YYSEADASHCIHQILESVN-----HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA 180
Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                  +        GT GY +PE L         D+++ GV+L  LL G
Sbjct: 181 IEVQGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 8/130 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           L+V E +  G L + +  RG +        ++       + +LH     + +RD K  N+
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI--NIAHRDVKPENL 192
Query: 221 LLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           L  S+  NA  KL+DFG AK   T     ++T    T  Y APE L   +    CD +S 
Sbjct: 193 LYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDXWSL 249
Query: 278 GVVLLELLSG 287
           GV+   LL G
Sbjct: 250 GVIXYILLCG 259

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
            L+GEG +G V K  +D  TL   R    +     +  P G    K+   E+  L +L H
Sbjct: 11  DLLGEGSYGKV-KEVLDSETL-CRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRH 65
Query: 145 PNLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            N+++L+    + E +   +V EY   G ++  L     +  P             GL +
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP--TGDRTHVSTQVMGTRGYAAP 260
           LH   Q ++++D K  N+LL +    K+S  G+A+A      D T  ++Q  G+  +  P
Sbjct: 125 LHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPP 180
Query: 261 EYLATGRLT---AKCDVYSFGVVLLELLSG 287
           E +A G  T    K D++S GV L  + +G
Sbjct: 181 E-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G F  V +       L         +I  KKL     + H++   E      L H N
Sbjct: 12  IGKGAFSVVRRCV----KLCTGHEYAAKIINTKKLSA---RDHQKLEREARICRLLKHSN 64
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           +V+L     +     LV++ +  G L E+ + R        +  I+  + A      LH 
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHC 119
Query: 206 AEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            +  V++RD K  N+LL S+      KL+DFGLA     GD+        GT GY +PE 
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPEV 177
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           L         D+++ GV+L  LL G
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 101/253 (39%), Gaps = 39/253 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G+VY         +          A+K+++  G         E+  L +L HPN
Sbjct: 29  VGRGTYGHVY-------KAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPN 79
Query: 147 LVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARP------LPWTLRIKVAIGAAR 198
           ++ L    L   +R   L+++Y          F R ++       LP  +   +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSE----FNAKLSDFGLAK-----AGPTGDRTHVST 249
           G+ +LH     V++RD K +NIL+  E       K++D G A+       P  D      
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----D 193
Query: 250 QVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP 308
            V+ T  Y APE L   R  T   D+++ G +  ELL+             Q  +  + P
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI-----FHCRQEDIKTSNP 248
Query: 309 YLGDR-RKLFRIM 320
           Y  D+  ++F +M
Sbjct: 249 YHHDQLDRIFNVM 261

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVA 193
           EV+ L Q+ H N++ L     +  + +L+ E +  G L + L ++ +      T  IK  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVST 249
           +    G+++LH   +++ + D K  NI LLD      + KL DFGLA     G       
Sbjct: 125 LD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            + GT  + APE +    L  + D++S GV+   LLSG                  A P+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 218
Query: 310 LGDRRK 315
           LGD ++
Sbjct: 219 LGDTKQ 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVA 193
           EV+ L Q+ H N++ L     +  + +L+ E +  G L + L ++ +      T  IK  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVST 249
           +    G+++LH   +++ + D K  NI LLD      + KL DFGLA     G       
Sbjct: 125 LD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            + GT  + APE +    L  + D++S GV+   LLSG                  A P+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 218
Query: 310 LGDRRK 315
           LGD ++
Sbjct: 219 LGDTKQ 224

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 161 LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI 220
           +L+ EY   G + +      A  +     I++      G+ +LH+    +++ D K  NI
Sbjct: 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNI 162
Query: 221 LLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
           LL S +   + K+ DFG+++    G    +  ++MGT  Y APE L    +T   D+++ 
Sbjct: 163 LLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 278 GVVLLELLS 286
           G++   LL+
Sbjct: 220 GIIAYMLLT 228

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVA 193
           EV+ L Q+ H N++ L     +  + +L+ E +  G L + L ++ +      T  IK  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVST 249
           +    G+++LH   +++ + D K  NI LLD      + KL DFGLA     G       
Sbjct: 125 LD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            + GT  + APE +    L  + D++S GV+   LLSG                  A P+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 218
Query: 310 LGDRRK 315
           LGD ++
Sbjct: 219 LGDTKQ 224

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVA 193
           EV+ L Q+ H N++ L     +  + +L+ E +  G L + L ++ +      T  IK  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVST 249
           +    G+++LH   +++ + D K  NI LLD      + KL DFGLA     G       
Sbjct: 125 LD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            + GT  + APE +    L  + D++S GV+   LLSG                  A P+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 218
Query: 310 LGDRRK 315
           LGD ++
Sbjct: 219 LGDTKQ 224

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 61/145 (42%), Gaps = 27/145 (18%)
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           + +E + K + E  L     +P P      +A      L FLHE   Q+ + D K  NIL
Sbjct: 99  IAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENIL 155
Query: 222 -LDSEFNA------------------KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            ++SEF                    +++DFG A    T D  H +T ++ TR Y  PE 
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPEV 210
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           +        CDV+S G +L E   G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVA 193
           EV+ L Q+ H N++ L     +  + +L+ E +  G L + L ++ +      T  IK  
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNI-LLDSEF---NAKLSDFGLAKAGPTGDRTHVST 249
           +    G+++LH   +++ + D K  NI LLD      + KL DFGLA     G       
Sbjct: 125 LD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---K 176
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            + GT  + APE +    L  + D++S GV+   LLSG                  A P+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 218
Query: 310 LGDRRK 315
           LGD ++
Sbjct: 219 LGDTKQ 224

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 61/145 (42%), Gaps = 27/145 (18%)
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           + +E + K + E  L     +P P      +A      L FLHE   Q+ + D K  NIL
Sbjct: 108 IAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENIL 164
Query: 222 -LDSEFNA------------------KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            ++SEF                    +++DFG A    T D  H +T ++ TR Y  PE 
Sbjct: 165 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPEV 219
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           +        CDV+S G +L E   G
Sbjct: 220 ILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKL-KPEGFQGHKEWLSEVNYLGQLHH 144
           IG+G +G V+ G W  E             +AVK     E     +E  +E+     + H
Sbjct: 45  IGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEASWFRE--TEIYQTVLMRH 90
Query: 145 PNLVKLIGFCLDGENRL----LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
            N++  I   + G        L+ +Y   GSL ++L    +  L     +K+A  +  GL
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGL 147
Query: 201 SFLH------EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV----STQ 250
             LH      + +  + +RD K+ NIL+       ++D GLA      D   V    +T+
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTR 206
Query: 251 VMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLELLSGRRAV 291
           V GT+ Y  PE L         +     D+YSFG++L E+   RR V
Sbjct: 207 V-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 61/145 (42%), Gaps = 27/145 (18%)
Query: 162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
           + +E + K + E  L     +P P      +A      L FLHE   Q+ + D K  NIL
Sbjct: 131 IAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENIL 187
Query: 222 -LDSEFNA------------------KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
            ++SEF                    +++DFG A    T D  H +T ++ TR Y  PE 
Sbjct: 188 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPEV 242
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           +        CDV+S G +L E   G
Sbjct: 243 ILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 42/193 (21%)
Query: 144 HPNLVKLIGFCLDGENRLL----------VYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           HPN+++   +C +  +R L          + + +   ++ +   +      P +L  ++A
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLD--SEFNAK-----------LSDFGLAK--- 237
            G A      H    ++I+RD K  NIL+   S F A            +SDFGL K   
Sbjct: 126 SGVA------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATG-------RLTAKCDVYSFGVVLLELLSGRRA 290
           +G +  RT+++    GT G+ APE L          RLT   D++S G V   +LS  + 
Sbjct: 180 SGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 291 VDKTRVGAEQNLV 303
               +   E N++
Sbjct: 239 PFGDKYSRESNII 251

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V +   D+ + E        ++AVK ++  G +  +    E+     L HPN
Sbjct: 27  IGSGNFG-VARLMRDKQSNE--------LVAVKYIE-RGEKIDENVKREIINHRSLRHPN 76
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGL 200
           +V+     L   +  +V EY   G L   +   G      AR     L          G+
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------ISGV 128
Query: 201 SFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           S+ H    QV +RD K  N LLD       K+  FG +K+     +       +GT  Y 
Sbjct: 129 SYCH--AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ---PKDTVGTPAYI 183
Query: 259 APEYLATGRLTAKC-DVYSFGVVLLELLSG 287
           APE L       K  DV+S GV L  +L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V +   D+ + E        ++AVK ++  G +  +    E+     L HPN
Sbjct: 27  IGSGNFG-VARLMRDKQSNE--------LVAVKYIE-RGEKIDENVKREIINHRSLRHPN 76
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGL 200
           +V+     L   +  +V EY   G L   +   G      AR     L          G+
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------ISGV 128
Query: 201 SFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           S+ H    QV +RD K  N LLD       K+  FG +K+     +       +GT  Y 
Sbjct: 129 SYCH--AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ---PKSTVGTPAYI 183
Query: 259 APEYLATGRLTAKC-DVYSFGVVLLELLSG 287
           APE L       K  DV+S GV L  +L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 72/175 (41%), Gaps = 39/175 (22%)
Query: 128 GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLP- 185
           G + W++      QLH         F    EN L LV EY   G L   L + G R +P 
Sbjct: 118 GDRRWIT------QLH---------FAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPA 161
Query: 186 -----WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
                +   I +AI +   L ++H        RD K  NILLD   + +L+DFG +    
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVH--------RDIKPDNILLDRCGHIRLADFG-SCLKL 212
Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTA-------KCDVYSFGVVLLELLSGR 288
             D T  S   +GT  Y +PE L              +CD ++ GV   E+  G+
Sbjct: 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           +  DSLIG+G FG V K +     +E     +  +I  KK      Q     L  +N   
Sbjct: 56  YEIDSLIGKGSFGQVVKAY---DRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
                 +V L    +   +  LV+E M   +L + L     R +   L  K A      L
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 201 SFLHEAEQQVIYRDFKASNILLDS--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            FL   E  +I+ D K  NILL +      K+ DFG   +   G R +   Q + +R Y 
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIY---QXIQSRFYR 225
Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           +PE L         D++S G +L+E+ +G
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 53/251 (21%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS------EVNYL 139
           L+G GGFG VY G          R    + +A+K ++ +      E  +      EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 140 GQLH--HPNLVKLIGFCLDGENRLLVYEYM-PKGSLENHLFRRG------ARPLPWTLRI 190
            ++      +++L+ +    ++ +L+ E M P   L + +  RG      AR   W +  
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV-- 123
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLD-SEFNAKLSDFGLAKAGPTGDRTHVST 249
              + A R     H     V++RD K  NIL+D +    KL DFG   +G     T V T
Sbjct: 124 ---LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYT 171
Query: 250 QVMGTRGYAAPEYLATGRLTAK-CDVYSFGVVLLELLSGR------------RAVDKTRV 296
              GTR Y+ PE++   R   +   V+S G++L +++ G             +   + RV
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 297 GAE-QNLVDWA 306
            +E Q+L+ W 
Sbjct: 232 SSECQHLIRWC 242

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 9/158 (5%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E +    L HP++V+L+          +V+E+M    L   + +R      ++  +    
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 137
Query: 195 --GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDRTHVST 249
                  L + H+    +I+RD K   +LL S+ N+   KL  FG+A     G+   V+ 
Sbjct: 138 MRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAG 193
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             +GT  + APE +         DV+  GV+L  LLSG
Sbjct: 194 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 38/189 (20%)
Query: 144 HPNLVKLIGFCLDGENRLL----------VYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           HPN+++   +C +  +R L          + + +   ++ +   +      P +L  ++A
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLD--SEFNAK-----------LSDFGLAKAGP 240
            G A      H    ++I+RD K  NIL+   S F A            +SDFGL K   
Sbjct: 144 SGVA------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 241 TGD---RTHVSTQVMGTRGYAAPEYLATG---RLTAKCDVYSFGVVLLELLSGRRAVDKT 294
           +G    R +++    GT G+ APE L      RLT   D++S G V   +LS  +     
Sbjct: 198 SGQXXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256
Query: 295 RVGAEQNLV 303
           +   E N++
Sbjct: 257 KYSRESNII 265

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           +  DSLIG+G FG V K +     +E     +  +I  KK      Q     L  +N   
Sbjct: 56  YEIDSLIGKGSFGQVVKAY---DRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
                 +V L    +   +  LV+E M   +L + L     R +   L  K A      L
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 201 SFLHEAEQQVIYRDFKASNILLDS--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            FL   E  +I+ D K  NILL +      K+ DFG   +   G R +   Q + +R Y 
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIY---QXIQSRFYR 225
Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           +PE L         D++S G +L+E+ +G
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 9/158 (5%)
Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E +    L HP++V+L+          +V+E+M    L   + +R      ++  +    
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 195 --GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDRTHVST 249
                  L + H+    +I+RD K   +LL S+ N+   KL  FG+A     G+   V+ 
Sbjct: 136 MRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAG 191
Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             +GT  + APE +         DV+  GV+L  LLSG
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 38/189 (20%)
Query: 144 HPNLVKLIGFCLDGENRLL----------VYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           HPN+++   +C +  +R L          + + +   ++ +   +      P +L  ++A
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLD--SEFNAK-----------LSDFGLAKAGP 240
            G A      H    ++I+RD K  NIL+   S F A            +SDFGL K   
Sbjct: 144 SGVA------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 241 TGD---RTHVSTQVMGTRGYAAPEYLATG---RLTAKCDVYSFGVVLLELLSGRRAVDKT 294
           +G    R +++    GT G+ APE L      RLT   D++S G V   +LS  +     
Sbjct: 198 SGQXXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256
Query: 295 RVGAEQNLV 303
           +   E N++
Sbjct: 257 KYSRESNII 265

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           +  DSLIG+G FG V K +     +E     +  +I  KK      Q     L  +N   
Sbjct: 37  YEIDSLIGKGSFGQVVKAY---DRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHD 92
Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
                 +V L    +   +  LV+E M   +L + L     R +   L  K A      L
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 151
Query: 201 SFLHEAEQQVIYRDFKASNILLDS--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            FL   E  +I+ D K  NILL +      K+ DFG   +   G R +   Q + +R Y 
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIY---QXIQSRFYR 206
Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           +PE L         D++S G +L+E+ +G
Sbjct: 207 SPEVLLGMPYDLAIDMWSLGCILVEMHTG 235

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G F  V +       +   +     +I  KKL     + H++   E      L HPN
Sbjct: 12  LGKGAFSVVRRCM----KIPTGQEYAAKIINTKKLSA---RDHQKLEREARICRLLKHPN 64
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           +V+L     +     LV++ +  G L E+ + R        +  I+  + +       H 
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN-----HC 119
Query: 206 AEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
               +++RD K  N+LL S+      KL+DFGLA     GD+        GT GY +PE 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPEV 177
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           L         D+++ GV+L  LL G
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
            + +P  +  K+A+   + L  LH ++  VI+RD K SN+L+++    K  DFG+  +G 
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKXCDFGI--SGY 186
Query: 241 TGDRTHVSTQVMGTRGYAAPE----YLATGRLTAKCDVYSFGVVLLEL 284
             D         G + Y APE     L     + K D++S G+  +EL
Sbjct: 187 LVDDVAKDIDA-GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G F  V +       +   +     +I  KKL     + H++   E      L HPN
Sbjct: 12  LGKGAFSVVRRC----MKIPTGQEYAAKIINTKKLSA---RDHQKLEREARICRLLKHPN 64
Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           +V+L     +     LV++ +  G L E+ + R        +  I+  + +       H 
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN-----HC 119
Query: 206 AEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
               +++RD K  N+LL S+      KL+DFGLA     GD+        GT GY +PE 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPEV 177
Query: 263 LATGRLTAKCDVYSFGVVLLELLSG 287
           L         D+++ GV+L  LL G
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 88/227 (38%), Gaps = 40/227 (17%)
Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH- 143
           S +GEG FG V +    +H    AR  + ++  V+K K            E+N L +++ 
Sbjct: 39  STLGEGTFGRVVQ--CVDHRRGGARVALKIIKNVEKYKEAA-------RLEINVLEKINE 89
Query: 144 ----HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
               + NL   +    D    + +   +   S  + L      P P      +A    + 
Sbjct: 90  KDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQA 149
Query: 200 LSFLHEAEQQVIYRDFKASNILL---DSEFNAKLS----------------DFGLAKAGP 240
           + FLH+   ++ + D K  NIL    D E    L                 DFG A    
Sbjct: 150 VKFLHD--NKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA---- 203
Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T D  H ST ++ TR Y APE +     +  CDV+S G ++ E   G
Sbjct: 204 TFDHEHHST-IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG 249

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 85  SLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH 143
            LIG+G FG VY G W   H   A R     +I +++   +  +  K    EV    Q  
Sbjct: 39  ELIGKGRFGQVYHGRW---HGEVAIR-----LIDIERDNEDQLKAFKR---EVMAYRQTR 87
Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           H N+V  +G C+   + L +   + KG     + R     L      ++A    +G+ +L
Sbjct: 88  HENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGL------AKAGPTGDRTHVSTQVMGTRGY 257
           H   + ++++D K+ N+  D+     ++DFGL       +AG   D+  +     G   +
Sbjct: 147 H--AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCH 200
Query: 258 AAPEYLATGR---------LTAKCDVYSFGVVLLEL 284
            APE +              +   DV++ G +  EL
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 42/193 (21%)
Query: 144 HPNLVKLIGFCLDGENRLL----------VYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           HPN+++   +C +  +R L          + + +   ++ +   +      P +L  ++A
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLD--SEFNAK-----------LSDFGLAKAGP 240
            G A      H    ++I+RD K  NIL+   S F A            +SDFGL K   
Sbjct: 126 SGVA------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 241 TGD---RTHVSTQVMGTRGYAAPEYLATG-------RLTAKCDVYSFGVVLLELLSGRRA 290
           +G    R +++    GT G+ APE L          RLT   D++S G V   +LS  + 
Sbjct: 180 SGQXXFRXNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 291 VDKTRVGAEQNLV 303
               +   E N++
Sbjct: 239 PFGDKYSRESNII 251

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 53/251 (21%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS------EVNYL 139
           L+G GGFG VY G          R    + +A+K ++ +      E  +      EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 140 GQLH--HPNLVKLIGFCLDGENRLLVYEY-MPKGSLENHLFRRGA------RPLPWTLRI 190
            ++      +++L+ +    ++ +L+ E   P   L + +  RGA      R   W +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-- 151
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLD-SEFNAKLSDFGLAKAGPTGDRTHVST 249
              + A R     H     V++RD K  NIL+D +    KL DFG   +G     T V T
Sbjct: 152 ---LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYT 199
Query: 250 QVMGTRGYAAPEYLATGRLTAK-CDVYSFGVVLLELLSGR------------RAVDKTRV 296
              GTR Y+ PE++   R   +   V+S G++L +++ G             +   + RV
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 259
Query: 297 GAE-QNLVDWA 306
            +E Q+L+ W 
Sbjct: 260 SSECQHLIRWC 270

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 53/251 (21%)
Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS------EVNYL 139
           L+G GGFG VY G          R    + +A+K ++ +      E  +      EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 140 GQLH--HPNLVKLIGFCLDGENRLLVYEY-MPKGSLENHLFRRGA------RPLPWTLRI 190
            ++      +++L+ +    ++ +L+ E   P   L + +  RGA      R   W +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-- 152
Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLD-SEFNAKLSDFGLAKAGPTGDRTHVST 249
              + A R     H     V++RD K  NIL+D +    KL DFG   +G     T V T
Sbjct: 153 ---LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYT 200
Query: 250 QVMGTRGYAAPEYLATGRLTAK-CDVYSFGVVLLELLSGR------------RAVDKTRV 296
              GTR Y+ PE++   R   +   V+S G++L +++ G             +   + RV
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV 260
Query: 297 GAE-QNLVDWA 306
            +E Q+L+ W 
Sbjct: 261 SSECQHLIRWC 271
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	441
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-174
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-152
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-63
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-49
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  518 bits (1336), Expect = 0.0
 Identities = 117/315 (37%), Positives = 176/315 (55%), Gaps = 29/315 (9%)

Query: 61  LSCPNLKAFTFSELKNATRNFRP------DSLIGEGGFGYVYKGWIDEHTLEAARPGVGM 114
           +S     +F+F ELKN T NF         + +GEGGFG VYKG+++             
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NT 55

Query: 115 VIAVKKLK----PEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKG 170
            +AVKKL         +  +++  E+  + +  H NLV+L+GF  DG++  LVY YMP G
Sbjct: 56  TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115

Query: 171 SLENHLF-RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK 229
           SL + L    G  PL W +R K+A GAA G++FLHE     I+RD K++NILLD  F AK
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAK 173

Query: 230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           +SDFGLA+A     +T ++++++GT  Y APE L  G +T K D+YSFGVVLLE+++G  
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 232

Query: 290 AVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAK 348
           AVD+ R    Q L+D  +    + + +   +D K+           +  +A QC+  +  
Sbjct: 233 AVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289

Query: 349 VRPSMSEVLSALEQL 363
            RP + +V   L+++
Sbjct: 290 KRPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  489 bits (1261), Expect = e-174
 Identities = 125/333 (37%), Positives = 180/333 (54%), Gaps = 27/333 (8%)

Query: 34  MAS--SLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGG 91
           M S  S  TN      S ++ +P                  +L+ AT NF    LIG G 
Sbjct: 1   MGSKYSKATNSINDALSSSYLVP---------FESYRVPLVDLEEATNNFDHKFLIGHGV 51

Query: 92  FGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLI 151
           FG VYKG + +          G  +A+K+  PE  QG +E+ +E+  L    HP+LV LI
Sbjct: 52  FGKVYKGVLRD----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101

Query: 152 GFCLDGENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQ 209
           GFC +    +L+Y+YM  G+L+ HL+        + W  R+++ IGAARGL +LH   + 
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RA 159

Query: 210 VIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT 269
           +I+RD K+ NILLD  F  K++DFG++K G   D+TH+ST V GT GY  PEY   GRLT
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219

Query: 270 AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYP 329
            K DVYSFGVVL E+L  R A+ ++      NL +WA     +  +L +I+D  L  +  
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIR 278

Query: 330 QKGAYMVAILALQCISE-AKVRPSMSEVLSALE 361
            +        A++C++  ++ RPSM +VL  LE
Sbjct: 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  433 bits (1117), Expect = e-152
 Identities = 132/318 (41%), Positives = 193/318 (60%), Gaps = 19/318 (5%)

Query: 51  FSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARP 110
           F +P  E   +    LK F+  EL+ A+ NF   +++G GGFG VYKG + +        
Sbjct: 2   FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------- 53

Query: 111 GVGMVIAVKKLKPEGFQGHK-EWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPK 169
             G ++AVK+LK E  QG + ++ +EV  +    H NL++L GFC+    RLLVY YM  
Sbjct: 54  --GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111

Query: 170 GSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHE-AEQQVIYRDFKASNILLDSEF 226
           GS+ + L  R     PL W  R ++A+G+ARGL++LH+  + ++I+RD KA+NILLD EF
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171

Query: 227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            A + DFGLAK     D THV+T V GT G+ APEYL+TG+ + K DV+ +GV+LLEL++
Sbjct: 172 EAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230

Query: 287 GRRAVDKTRVGAEQ--NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCI 344
           G+RA D  R+  +    L+DW K  L +++ L  ++D+ L+G Y  +    +  +AL C 
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCT 289

Query: 345 -SEAKVRPSMSEVLSALE 361
            S    RP MSEV+  LE
Sbjct: 290 QSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  254 bits (651), Expect = 4e-82
 Identities = 77/320 (24%), Positives = 121/320 (37%), Gaps = 42/320 (13%)

Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG 128
                L   +   +   +   G FG V+K  +               +AVK    +  Q 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ- 61

Query: 129 HKEWL--SEVNYLGQLHHPNLVKLIGFCLDGEN----RLLVYEYMPKGSLENHLFRRGAR 182
              W    EV  L  + H N+++ IG    G +      L+  +  KGSL + L      
Sbjct: 62  --SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--- 116

Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQ--------VIYRDFKASNILLDSEFNAKLSDFG 234
            + W     +A   ARGL++LHE            + +RD K+ N+LL +   A ++DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-----RLTAKCDVYSFGVVLLELLSGRR 289
           LA     G     +   +GTR Y APE L            + D+Y+ G+VL EL S   
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 290 AVDKTRVGAEQNLVD--WAKPYLGDRRKL--FRIMDIKLEGQYPQ-KGAYMVAILALQCI 344
           A D           +     P L D +++   +     L   + +  G  M+     +C 
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296

Query: 345 SE-AKVRPSMSEVLSALEQL 363
              A+ R S   V   + Q+
Sbjct: 297 DHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  206 bits (525), Expect = 4e-63
 Identities = 68/348 (19%), Positives = 118/348 (33%), Gaps = 57/348 (16%)

Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG 128
              SE      N +   LIG G +G VYKG +D              +AVK       Q 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ- 50

Query: 129 HKEWLSEVN--YLGQLHHPNLVKLIGFCLDGE-----NRLLVYEYMPKGSLENHLFRRGA 181
              +++E N   +  + H N+ + I              LLV EY P GSL  +L     
Sbjct: 51  --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-- 106

Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQ-------VIYRDFKASNILLDSEFNAKLSDFG 234
               W    ++A    RGL++LH    +       + +RD  + N+L+ ++    +SDFG
Sbjct: 107 -TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 235 LAK------AGPTGDRTHVSTQVMGTRGYAAPEYL-------ATGRLTAKCDVYSFGVVL 281
           L+           G+  + +   +GT  Y APE L              + D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 282 LELLSGRRAVDKTRVGAEQNL----VDWAKPYLGDRRKLFRIM----DIKLEGQYPQKGA 333
            E+      +       E  +         P   D + L              +      
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 334 YMVAILALQCISE-AKVRPSMSEVLSALEQL----PPPRDPASPSNSD 376
             +      C  + A+ R +       + +L       +  +  ++  
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  201 bits (513), Expect = 1e-61
 Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 48/294 (16%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLH 143
           IG G FG V++  W             G  +AVK L  + F      E+L EV  + +L 
Sbjct: 45  IGAGSFGTVHRAEWH------------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR-PLPWTLRIKVAIGAARGLSF 202
           HPN+V  +G      N  +V EY+ +GSL   L + GAR  L    R+ +A   A+G+++
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEY 262
           LH     +++R+ K+ N+L+D ++  K+ DFGL++   +   +  S    GT  + APE 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEV 210

Query: 263 LATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDI 322
           L       K DVYSFGV+L EL + +                  +P+        +++  
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQ------------------QPWGN--LNPAQVVAA 250

Query: 323 KLEGQY----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL-----PPP 366
                     P+     VA +   C + E   RPS + ++  L  L     PPP
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  200 bits (510), Expect = 3e-61
 Identities = 75/325 (23%), Positives = 121/325 (37%), Gaps = 49/325 (15%)

Query: 79  RNFRPDSL-----IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           R FRP  L     +G+G FG   K                G V+ +K+L     +  + +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54

Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           L EV  +  L HPN++K IG     +    + EY+  G+L   + +      PW+ R+  
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSF 113

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK------------AGP 240
           A   A G+++LH     +I+RD  + N L+    N  ++DFGLA+               
Sbjct: 114 AKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ 300
                     V+G   + APE +       K DV+SFG+VL E++    A          
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYLP 227

Query: 301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA 359
             +D+     G                 P         + ++C   + + RPS  ++   
Sbjct: 228 RTMDFGLNVRGFLD-----RYC------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276

Query: 360 LEQLPPPRDPASPSNSDPQVIYSPH 384
           LE L      A      PQ+     
Sbjct: 277 LETL--RMHLAGHLPLGPQLEQLDR 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  194 bits (495), Expect = 4e-59
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 56/297 (18%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-------KEWLSEVNY 138
           IG+GGFG V+KG  + +            V+A+K L     +G        +E+  EV  
Sbjct: 27  IGKGGFGLVHKGRLVKD----------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           +  L+HPN+VKL G   +     +V E++P G L + L  +   P+ W++++++ +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDS-----EFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           G+ ++      +++RD ++ NI L S        AK++DFGL++        H  + ++G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 254 TRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
              + APE +       T K D YSF ++L  +L+G                    P+  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG------------------PFDE 230

Query: 312 -DRRKLFRIMDIKLEGQYPQKGAYM---VAILALQCIS-EAKVRPSMSEVLSALEQL 363
               K+  I  I+ EG  P         +  +   C S + K RP  S ++  L +L
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  194 bits (495), Expect = 5e-59
 Identities = 81/310 (26%), Positives = 130/310 (41%), Gaps = 50/310 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V K                  +A+K+++ E  +  K ++ E+  L +++HPN
Sbjct: 16  VGRGAFGVVCKAKWR-----------AKDVAIKQIESESER--KAFIVELRQLSRVNHPN 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP-LPWTLRIKVAIGAARGLSFLHE 205
           +VKL G CL+     LV EY   GSL N L      P       +   +  ++G+++LH 
Sbjct: 63  IVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 206 AEQQ-VIYRDFKASNILLDSEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL 263
            + + +I+RD K  N+LL +     K+ DFG A      D     T   G+  + APE  
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 175

Query: 264 ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK 323
                + KCDV+S+G++L E+++ R                  KP+       FRIM   
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRR------------------KPFDEIGGPAFRIMWAV 217

Query: 324 LEGQYPQKGAYM---VAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQV 379
             G  P     +   +  L  +C S +   RPSM E++  +  L           +D  +
Sbjct: 218 HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL-----MRYFPGADEPL 272

Query: 380 IYSPHVKSPM 389
            Y      P 
Sbjct: 273 QYPCQHSLPP 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (492), Expect = 6e-59
 Identities = 66/289 (22%), Positives = 114/289 (39%), Gaps = 50/289 (17%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLH 143
           + E   G ++KG W             G  I VK LK   +     +++  E   L    
Sbjct: 18  LNENHSGELWKGRWQ------------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65

Query: 144 HPNLVKLIGFCLD--GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           HPN++ ++G C      +  L+  +MP GSL N L       +  +  +K A+  ARG++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           FLH  E  +      + ++++D +  A++S   +         +  S   M    + APE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE 178

Query: 262 YL---ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
            L            D++SF V+L EL++                     P+  D   +  
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------VPF-ADLSNMEI 219

Query: 319 IMDIKLEGQYPQKGAYM---VAILALQCISE-AKVRPSMSEVLSALEQL 363
            M + LEG  P     +   V+ L   C++E    RP    ++  LE++
Sbjct: 220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (481), Expect = 2e-57
 Identities = 83/312 (26%), Positives = 124/312 (39%), Gaps = 65/312 (20%)

Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGH 129
           F+EL            IG GGFG VY+  WI            G  +AVK  + +  +  
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDI 46

Query: 130 ----KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP 185
               +    E      L HPN++ L G CL   N  LV E+   G L   L     + +P
Sbjct: 47  SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIP 103

Query: 186 WTLRIKVAIGAARGLSFLH-EAEQQVIYRDFKASNILLDSEF--------NAKLSDFGLA 236
             + +  A+  ARG+++LH EA   +I+RD K+SNIL+  +           K++DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV 296
           +      RT   +   G   + APE +     +   DV+S+GV+L ELL+G         
Sbjct: 164 R---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE-------- 211

Query: 297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQY----PQKGAYMVAILALQC-ISEAKVRP 351
                      P+ G       +       +     P       A L   C   +   RP
Sbjct: 212 ----------VPFRG--IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259

Query: 352 SMSEVLSALEQL 363
           S + +L  L  +
Sbjct: 260 SFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (483), Expect = 5e-57
 Identities = 71/376 (18%), Positives = 130/376 (34%), Gaps = 100/376 (26%)

Query: 33  SMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGF 92
            M  SL + +S  R +   S+   E DI          F +L+           IG+G F
Sbjct: 3   EMNLSLLSARSFPRKASQTSIFLQEWDIP---------FEQLEIGEL-------IGKGRF 46

Query: 93  GYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLHHPNLVK 149
           G VY G W  E             +A++ +  E       K +  EV    Q  H N+V 
Sbjct: 47  GQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ 209
            +G C+   +  ++       +L + + R     L      ++A    +G+ +LH   + 
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKG 150

Query: 210 VIYRDFKASNILLDSEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
           ++++D K+ N+  D      ++DFGL         G R        G   + APE +   
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 267 RL---------TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
                      +   DV++ G +  EL +                     P+        
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE------------------WPF-------- 243

Query: 318 RIMDIKLEGQYPQKGAYMV-----------------AILALQCIS-EAKVRPSMSEVLSA 359
                  + Q  +   + +                 + + L C + E + RP+ ++++  
Sbjct: 244 -------KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

Query: 360 LEQLP-PPRDPASPSN 374
           LE+LP   R  + P +
Sbjct: 297 LEKLPKRNRRLSHPGH 312

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  188 bits (479), Expect = 1e-56
 Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 56/295 (18%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLH 143
           IG G FG VYKG W  +             +AVK L          + + +EV  L +  
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           H N++  +G+        +V ++    SL +HL             I +A   ARG+ +L
Sbjct: 79  HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYL 136

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE-- 261
           H   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  + APE  
Sbjct: 137 HA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 262 -YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR------- 313
               +   + + DVY+FG+VL EL++G+                   PY           
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQL------------------PYSNINNRDQIIE 236

Query: 314 ---RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP 364
              R        K+    P++    +  L  +C+  +   RPS   +L+ +E+L 
Sbjct: 237 MVGRGSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (448), Expect = 5e-52
 Identities = 62/312 (19%), Positives = 117/312 (37%), Gaps = 60/312 (19%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSE--VNYLGQL 142
            +G+G +G V++G W  E+            +AVK       +  K W  E  +     L
Sbjct: 15  CVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVML 59

Query: 143 HHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
            H N++  I   +   +      L+  Y   GSL ++L       L     +++ +  A 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIAS 116

Query: 199 GLSFLHEAEQQ------VIYRDFKASNILLDSEFNAKLSDFGLA--KAGPTGDRTHVSTQ 250
           GL+ LH           + +RD K+ NIL+       ++D GLA   +  T      +  
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 251 VMGTRGYAAPE------YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD 304
            +GT+ Y APE       +       + D+++FG+VL E+          R+ +   + D
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--------RRMVSNGIVED 228

Query: 305 WAKPYLGDRRKLFRIMDIK----LEGQYP------QKGAYMVAILAL--QC-ISEAKVRP 351
           +  P+           D++    ++ Q P           + ++  L  +C       R 
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288

Query: 352 SMSEVLSALEQL 363
           +   +   L ++
Sbjct: 289 TALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  175 bits (445), Expect = 3e-51
 Identities = 64/312 (20%), Positives = 108/312 (34%), Gaps = 60/312 (19%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSE--VNYLGQL 142
            IG+G +G V+ G W  E             +AVK            W  E  +     +
Sbjct: 44  QIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWFRETEIYQTVLM 88

Query: 143 HHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
            H N++  I   + G        L+ +Y   GSL ++L       L     +K+A  +  
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVS 145

Query: 199 GLSFLHEAEQQ------VIYRDFKASNILLDSEFNAKLSDFGLA--KAGPTGDRTHVSTQ 250
           GL  LH           + +RD K+ NIL+       ++D GLA      T +       
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 251 VMGTRGYAAPEYLATGRLTA------KCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD 304
            +GT+ Y  PE L               D+YSFG++L E+          R  +   + +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--------RRCVSGGIVEE 257

Query: 305 WAKPYLGDRRKLFRIMDIK----LEGQYPQ--------KGAYMVAILALQCIS-EAKVRP 351
           +  PY           D++    ++   P         +    +  L  +C +     R 
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317

Query: 352 SMSEVLSALEQL 363
           +   V   L ++
Sbjct: 318 TALRVKKTLAKM 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (428), Expect = 8e-49
 Identities = 68/312 (21%), Positives = 110/312 (35%), Gaps = 60/312 (19%)

Query: 86  LIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSE--VNYLGQL 142
            IG+G FG V++G W  E             +AVK       +  + W  E  +     L
Sbjct: 49  SIGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVML 93

Query: 143 HHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
            H N++  I              LV +Y   GSL ++L R     +     IK+A+  A 
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTAS 150

Query: 199 GLSFLHEAEQQ------VIYRDFKASNILLDSEFNAKLSDFGLA--KAGPTGDRTHVSTQ 250
           GL+ LH           + +RD K+ NIL+       ++D GLA      T         
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 251 VMGTRGYAAPEYL------ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD 304
            +GT+ Y APE L             + D+Y+ G+V  E+          R        D
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--------RRCSIGGIHED 262

Query: 305 WAKPYLGDRRKLFRIMDIKL----EGQYPQ--------KGAYMVAILALQCIS-EAKVRP 351
           +  PY         + +++     +   P         +   ++A +  +C       R 
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322

Query: 352 SMSEVLSALEQL 363
           +   +   L QL
Sbjct: 323 TALRIKKTLSQL 334

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  158 bits (403), Expect = 2e-45
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 25/287 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V          +  +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 18  LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 147 LVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C     R   L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYLG 131

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG---YAAPE 261
              ++ I+RD    NIL+++E   K+ DFGL K  P         +         + APE
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIFWYAPE 187

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
            L   + +   DV+SFGVVL EL +           AE   +            +F +++
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIE 243

Query: 322 IKLEGQY----PQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQL 363
             L+       P      + ++  +C  +    RPS  ++   ++Q+
Sbjct: 244 -LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  157 bits (399), Expect = 6e-45
 Identities = 76/292 (26%), Positives = 118/292 (40%), Gaps = 35/292 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V          +      G  +AVK LKPE G     +   E+  L  L+H 
Sbjct: 29  LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 146 NLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           N+VK  G C +       L+ E++P GSL+ +L +   +       +K A+   +G+ +L
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-LKYAVQICKGMDYL 142

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAP 260
               +Q ++RD  A N+L++SE   K+ DFGL KA  T    +             + AP
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD--DRDSPVFWYAP 198

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
           E L   +     DV+SFGV L ELL+                L      +      + R+
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFLKMIGPTHGQ--MTVTRL 252

Query: 320 MDIKLEGQY--PQ-----KGAYMVAILALQC-ISEAKVRPSMSEVLSALEQL 363
           ++  L+     P         Y    L  +C   +   R S   ++   E L
Sbjct: 253 VN-TLKEGKRLPCPPNCPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGFEAL 300

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  158 bits (401), Expect = 6e-45
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 25/287 (8%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V          +  +   G V+AVKKL+    +  +++  E+  L  L H N
Sbjct: 49  LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 147 LVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G C     R   L+ EY+P GSL ++L +   R     L ++      +G+ +L 
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYL- 161

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG---YAAPE 261
              ++ I+RD    NIL+++E   K+ DFGL K  P     +   +         + APE
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE--PGESPIFWYAPE 218

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
            L   + +   DV+SFGVVL EL +           AE   +            +F +++
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIE 274

Query: 322 IKLEGQY----PQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQL 363
             L+       P      + ++  +C  +    RPS  ++   ++Q+
Sbjct: 275 -LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  156 bits (397), Expect = 2e-44
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 15/205 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G+G FG V          +      G ++AVK+L+  G    +++  E+  L  LH   
Sbjct: 31  LGKGNFGSVELC-----RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 147 LVKLIGFCLD--GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           +VK  G       ++  LV EY+P G L + L R  AR     L +  +    +G+ +L 
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-LLYSSQICKGMEYLG 144

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG---YAAPE 261
              ++ ++RD  A NIL++SE + K++DFGLAK  P     +V  +    +    + APE
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--PGQSPIFWYAPE 200

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS 286
            L+    + + DV+SFGVVL EL +
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (394), Expect = 7e-44
 Identities = 73/312 (23%), Positives = 134/312 (42%), Gaps = 56/312 (17%)

Query: 78  TRNFRPDSL-----IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKE 131
            R  +         +G G FG VYKG             V + +A+K+L+     + +KE
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKE 63

Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
            L E   +  + +P++ +L+G CL      L+ + MP G L +++           L + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LN 121

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
             +  A+G+++L   ++++++RD  A N+L+ +  + K++DFGLAK     ++ + +   
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-- 177

Query: 252 MGTR---GYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK 307
            G +    + A E +     T + DV+S+GV + EL++ G +                  
Sbjct: 178 -GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------ 218

Query: 308 PYLGDRRKLFRIMDIKLEGQY--PQ-----KGAYMVAILALQC-ISEAKVRPSMSEVLSA 359
           PY G       I    LE     PQ        YM   +  +C + +A  RP   E++  
Sbjct: 219 PYDG--IPASEISS-ILEKGERLPQPPICTIDVYM---IMRKCWMIDADSRPKFRELIIE 272

Query: 360 LEQLPPPRDPAS 371
             ++   RDP  
Sbjct: 273 FSKM--ARDPQR 282

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  156 bits (397), Expect = 8e-44
 Identities = 76/290 (26%), Positives = 114/290 (39%), Gaps = 52/290 (17%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           IG G FG V+ G    ++TL          +AVK  +         ++L E   L Q  H
Sbjct: 122 IGRGNFGEVFSGRLRADNTL----------VAVKSCRETLPPDLKAKFLQEARILKQYSH 171

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           PN+V+LIG C   +   +V E +  G     L R     L     +++   AA G+ +L 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY-----AA 259
              +  I+RD  A N L+  +   K+SDFG+++    G          G          A
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTA 283

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
           PE L  GR +++ DV+SFG++L E  S G                    PY        +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGAS------------------PYPN--LSNQQ 323

Query: 319 IMDIKLEGQY----PQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQL 363
             +  +E       P+     V  L  QC   E   RPS S +   L+ +
Sbjct: 324 TRE-FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  152 bits (387), Expect = 5e-43
 Identities = 88/300 (29%), Positives = 132/300 (44%), Gaps = 33/300 (11%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V          +    G G ++AVK LK + G Q    W  E++ L  L+H 
Sbjct: 39  LGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 146 NLVKLIGFCLD--GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           +++K  G C D    +  LV EY+P GSL ++L           L +  A     G+++L
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQL-LLFAQQICEGMAYL 150

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG-----YA 258
           H   Q  I+RD  A N+LLD++   K+ DFGLAKA P G         +   G     + 
Sbjct: 151 HA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWY 204

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
           APE L   +     DV+SFGV L ELL+      D ++    + L             + 
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLELIGIAQGQ--MTVL 258

Query: 318 RIMDIKLEGQY---PQKGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLPPPRDPASPS 373
           R+ ++   G+    P K    V  L   C  +EA  RP+   ++  L+ +       +PS
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  148 bits (376), Expect = 2e-41
 Identities = 79/346 (22%), Positives = 143/346 (41%), Gaps = 56/346 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +G G FG VYKG             V + +A+K+L+     + +KE L E   +  + +P
Sbjct: 23  LGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           ++ +L+G CL      L+ + MP G L +++           L +   +  A+G+++L  
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYL-- 133

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
            ++++++RD  A N+L+ +  + K++DFGLAK     ++ + +    G +    + A E 
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GGKVPIKWMALES 190

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
           +     T + DV+S+GV + EL++ G +                  PY G       I  
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDG--IPASEISS 230

Query: 322 IKLEGQY--PQ-----KGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLPPPRDPASPS 373
             LE     PQ        YM   + ++C + +A  RP   E++    ++   RDP    
Sbjct: 231 -ILEKGERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKM--ARDP---- 280

Query: 374 NSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSPLPPH 419
                VI          P   +    L +  D    +     L P 
Sbjct: 281 -QRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQ 325

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  145 bits (369), Expect = 5e-41
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 24/208 (11%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG G FG V+ G W+++             +A+K ++ EG    ++++ E   + +L HP
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G CL+     LV E+M  G L ++L  +       TL + + +    G+++L  
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYL-- 120

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
            E  VI+RD  A N L+      K+SDFG+ +     D  + S+   GT+    +A+PE 
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSST--GTKFPVKWASPEV 176

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRR 289
            +  R ++K DV+SFGV++ E+ S G+ 
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  145 bits (368), Expect = 1e-40
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 30/211 (14%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V  G W  ++            +AVK +K EG     E+  E   + +L HP
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LVK  G C       +V EY+  G L N+L   G    P  L +++      G++FL  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-LEMCYDVCEGMAFL-- 120

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG------YAA 259
              Q I+RD  A N L+D +   K+SDFG+        R  +  Q + + G      ++A
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT-------RYVLDDQYVSSVGTKFPVKWSA 173

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           PE     + ++K DV++FG+++ E+ S G+ 
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (369), Expect = 1e-40
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK---EWLSEVNYLGQL 142
           +G+G FG V +G W        A  G  + +AVK LKP+     +   +++ EVN +  L
Sbjct: 26  LGDGSFGVVRRGEW-------DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            H NL++L G  L      +V E  P GSL + L +     L  TL  + A+  A G+ +
Sbjct: 79  DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGY 136

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAA 259
           L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V  +    +    + A
Sbjct: 137 L--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           PE L T   +   D + FGV L E+ + G+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (368), Expect = 1e-40
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +G G FG V +G +              + +A+K LK        +E + E   + QL +
Sbjct: 18  LGCGNFGSVRQGVYR--------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           P +V+LIG C   E  +LV E    G L   L  +        +  ++    + G+ +L 
Sbjct: 70  PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL- 126

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPE 261
             E+  ++RD  A N+LL +   AK+SDFGL+KA    D  + +      +    + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPE 183

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS-GRR 289
            +   + +++ DV+S+GV + E LS G++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  146 bits (370), Expect = 1e-40
 Identities = 80/339 (23%), Positives = 145/339 (42%), Gaps = 59/339 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V+KG             + + + +K ++ + G Q  +     +  +G L H 
Sbjct: 21  LGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           ++V+L+G C  G +  LV +Y+P GSL +H+ +      P  L +   +  A+G+ +L  
Sbjct: 76  HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-LNWGVQIAKGMYYL-- 131

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
            E  +++R+  A N+LL S    +++DFG+A   P  D+  + +     +    + A E 
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKTPIKWMALES 188

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
           +  G+ T + DV+S+GV + EL++ G                    PY G   +L  + D
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAE------------------PYAG--LRLAEVPD 228

Query: 322 IKLEGQY--PQ-----KGAYMVAILALQC-ISEAKVRPSMSEVLSALEQLPPPRDPASPS 373
             LE      Q        YM   + ++C + +  +RP+  E+ +   ++   RDP    
Sbjct: 229 -LLEKGERLAQPQICTIDVYM---VMVKCWMIDENIRPTFKELANEFTRM--ARDP---- 278

Query: 374 NSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSP 412
              P+ +       P     P     L N     V + P
Sbjct: 279 ---PRYLVIKRESGPGIAPGPE-PHGLTNKKLEEVELEP 313

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (378), Expect = 2e-40
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 30/209 (14%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           IG+G FG V  G +             G  +AVK +K +     + +L+E + + QL H 
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246

Query: 146 NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           NLV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPE 261
                 ++RD  A N+L+  +  AK+SDFGL K          S+     +    + APE
Sbjct: 306 -EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPE 356

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS-GRR 289
            L   + + K DV+SFG++L E+ S GR 
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV 385

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  148 bits (376), Expect = 2e-40
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G+G FG V+ G W                +A+K LK  G    + +L E   + +L H 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L     + E   +V EYM KGSL + L     + L     + +A   A G++++  
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 296

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
                ++RD +A+NIL+      K++DFGLA+     + T         + + APE    
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALY 355

Query: 266 GRLTAKCDVYSFGVVLLELLS 286
           GR T K DV+SFG++L EL +
Sbjct: 356 GRFTIKSDVWSFGILLTELTT 376

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  144 bits (366), Expect = 3e-40
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQ 141
           D  +G G FG V KG+            V   +AVK LK E        E L+E N + Q
Sbjct: 22  DKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           L +P +V++IG C   E+ +LV E    G L  +L  +  R +     I++    + G+ 
Sbjct: 75  LDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 131

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYA 258
           +L   E   ++RD  A N+LL ++  AK+SDFGL+KA    +  + +      +    + 
Sbjct: 132 YL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWY 187

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           APE +   + ++K DV+SFGV++ E  S G++
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (377), Expect = 4e-40
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G +G VY+G W              + +AVK LK E     +E+L E   + ++ HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHP 276

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           NLV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
            ++  I+R+  A N L+      K++DFGL++   TGD             + APE LA 
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 266 GRLTAKCDVYSFGVVLLELLS 286
            + + K DV++FGV+L E+ +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  151 bits (382), Expect = 4e-40
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 20/272 (7%)

Query: 26  PDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDS 85
           P K G  ++ S  K   +EK+   + ++  +E D  +    +  T++         + + 
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391

Query: 86  L-----IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNY 138
           +     IGEG FG V++G ++             M +A+K  K        +++L E   
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFLQEALT 444

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           + Q  HP++VKLIG   +     ++ E    G L + L  R       +L I  A   + 
Sbjct: 445 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASL-ILYAYQLST 502

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            L++L    ++ ++RD  A N+L+ S    KL DFGL++          S   +  +  A
Sbjct: 503 ALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
            PE +   R T+  DV+ FGV + E+L  G +
Sbjct: 561 -PESINFRRFTSASDVWMFGVCMWEILMHGVK 591

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  144 bits (365), Expect = 5e-40
 Identities = 72/235 (30%), Positives = 105/235 (44%), Gaps = 36/235 (15%)

Query: 72  SELKNATRNFRPD---------SLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKL 121
            EL  A ++              +IG G FG VY G  +D         G  +  AVK L
Sbjct: 9   PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD-------NDGKKIHCAVKSL 61

Query: 122 KPE-GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN-RLLVYEYMPKGSLENHLFRR 179
                     ++L+E   +    HPN++ L+G CL  E   L+V  YM  G L N +   
Sbjct: 62  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121

Query: 180 GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG 239
              P    L I   +  A+G+ +L  A ++ ++RD  A N +LD +F  K++DFGLA+  
Sbjct: 122 THNPTVKDL-IGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178

Query: 240 PTGD--RTHVSTQV------MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              +    H  T        M      A E L T + T K DV+SFGV+L EL++
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWM------ALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (364), Expect = 5e-40
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G +G VY+G W                +AVK LK E     +E+L E   + ++ HP
Sbjct: 21  LGGGQYGEVYEGVWKKYSL----------TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHP 69

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           NLV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  + +L  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 127

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA------- 258
            ++  I+RD  A N L+      K++DFGL++         ++         A       
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIKWT 179

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           APE LA  + + K DV++FGV+L E+ + G  
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (366), Expect = 7e-40
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 15/208 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           IG G FG VYKG      L+ +     + +A+K LK     +   ++L E   +GQ  H 
Sbjct: 52  IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+++L G     +  +++ EYM  G+L+  L  +        L + +  G A G+ +L  
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKYL-- 163

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
           A    ++RD  A NIL++S    K+SDFGL++          +T   G +    + APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEA 221

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRR 289
           ++  + T+  DV+SFG+V+ E+++ G R
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (368), Expect = 7e-40
 Identities = 74/271 (27%), Positives = 111/271 (40%), Gaps = 28/271 (10%)

Query: 30  GNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSL--- 86
                   L T+  +K  S N          +    L       +++         +   
Sbjct: 35  DGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFN 94

Query: 87  --IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL 142
             IG G FG VY G  +D         G  +  AVK L          ++L+E   +   
Sbjct: 95  EVIGRGHFGCVYHGTLLD-------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147

Query: 143 HHPNLVKLIGFCLDGEN-RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
            HPN++ L+G CL  E   L+V  YM  G L N +      P    L I   +  A+G+ 
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 206

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG------TR 255
           FL  A ++ ++RD  A N +LD +F  K++DFGLA+     +   V  +           
Sbjct: 207 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM- 263

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              A E L T + T K DV+SFGV+L EL++
Sbjct: 264 ---ALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (362), Expect = 1e-39
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V  G W  ++            +A+K +K EG     E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L G C       ++ EYM  G L N+L     R     L +++       + +L  
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYL-- 136

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
             +Q ++RD  A N L++ +   K+SDFGL++     + T       G++    ++ PE 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEV 192

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRR 289
           L   + ++K D+++FGV++ E+ S G+ 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (361), Expect = 1e-39
 Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 35/220 (15%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G+G F  ++KG   +              + +K L        + +    + + +L H 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           +LV   G C+ G+  +LV E++  GSL+ +L ++    +    +++VA   A  + FL  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL-- 129

Query: 206 AEQQVIYRDFKASNILLDSEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            E  +I+ +  A NILL  E +         KLSD G++              V+     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177

Query: 258 ------AAPEYLATGRL-TAKCDVYSFGVVLLELLS-GRR 289
                   PE +   +      D +SFG  L E+ S G +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  142 bits (360), Expect = 2e-39
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 28/208 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V  G    +            +AVK +K +     + +L+E + + QL H N
Sbjct: 29  IGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHSN 75

Query: 147 LVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           LV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++     + +L  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-- 133

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
                ++RD  A N+L+  +  AK+SDFGL K          S+     +    + APE 
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEA 185

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRR 289
           L   + + K DV+SFG++L E+ S GR 
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRV 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (369), Expect = 3e-39
 Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 29/242 (11%)

Query: 58  CDILSCPNLKAFTFSELKNATRNFRPDSL-----IGEGGFGYVYKG-WIDEHTLEAARPG 111
           C  LS P + +      +        +SL     +G G FG V+   +            
Sbjct: 162 CQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK------- 214

Query: 112 VGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGS 171
               +AVK +K  G    + +L+E N +  L H  LVKL       E   ++ E+M KGS
Sbjct: 215 ----VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268

Query: 172 LENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS 231
           L + L        P    I  +   A G++F+   ++  I+RD +A+NIL+ +    K++
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIA 326

Query: 232 DFGLAKAGPTGDRTHVSTQVMGTRG---YAAPEYLATGRLTAKCDVYSFGVVLLELLS-G 287
           DFGLA+     + T       G +    + APE +  G  T K DV+SFG++L+E+++ G
Sbjct: 327 DFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382

Query: 288 RR 289
           R 
Sbjct: 383 RI 384

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (358), Expect = 4e-39
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +GEG FG VY+G + +         G  + +AVK  K +      ++++SE   +  L H
Sbjct: 20  LGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           P++VKLIG     E   ++ E  P G L ++L R        TL +  ++   + +++L 
Sbjct: 73  PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYL- 129

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPE 261
                 ++RD    NIL+ S    KL DFGL++     D  +       TR    + +PE
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VTRLPIKWMSPE 184

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS-GRR 289
            +   R T   DV+ F V + E+LS G++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  141 bits (358), Expect = 5e-39
 Identities = 70/211 (33%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           IG+G FG VY G +ID+           +  A+K L      Q  + +L E   +  L+H
Sbjct: 29  IGKGHFGVVYHGEYIDQ-------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81

Query: 145 PNLVKLIGFCLDGENRLL-VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           PN++ LIG  L  E     +  YM  G L   +      P    L I   +  ARG+ +L
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYL 140

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK----AGPTGDRTHVSTQV----MGTR 255
             AEQ+ ++RD  A N +LD  F  K++DFGLA+          + H   ++        
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT--- 195

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              A E L T R T K DV+SFGV+L ELL+
Sbjct: 196 ---ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (358), Expect = 8e-39
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHH 144
           IG G  G V  G        +       + +A+K LK     +  +++LSE + +GQ  H
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRD-------VPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           PN+++L G    G   ++V EYM  GSL+  L R           + +  G   G+ +L 
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL- 167

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPE 261
            ++   ++RD  A N+L+DS    K+SDFGL++          +T   G +    + APE
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAPE 224

Query: 262 YLATGRLTAKCDVYSFGVVLLELLS-GRR 289
            +A    ++  DV+SFGVV+ E+L+ G R
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  146 bits (369), Expect = 8e-39
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G+G FG V+ G W                +A+K LK  G    + +L E   + +L H 
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L     + E   +V EYM KGSL + L     + L     + +A   A G++++  
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT 265
                ++RD +A+NIL+      K++DFGLA+     + T         + + APE    
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALY 438

Query: 266 GRLTAKCDVYSFGVVLLELLS 286
           GR T K DV+SFG++L EL +
Sbjct: 439 GRFTIKSDVWSFGILLTELTT 459

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  141 bits (357), Expect = 9e-39
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLH 143
           +GEG FG V +G    E        G  + +AVK +K +    +  +E+LSE   +    
Sbjct: 42  LGEGEFGSVMEGNLKQE-------DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94

Query: 144 HPNLVKLIGFCLDGENR-----LLVYEYMPKGSLENHLFRRGARPLPWTLR----IKVAI 194
           HPN+++L+G C++  ++     +++  +M  G L  +L        P  +     +K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQV- 251
             A G+ +L  + +  ++RD  A N +L  +    ++DFGL+K   +GD  R     ++ 
Sbjct: 155 DIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 252 ---MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              +      A E LA    T+K DV++FGV + E+ +
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  139 bits (353), Expect = 2e-38
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 24/208 (11%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +G G FG V+ G +                +AVK LK +G      +L+E N + QL H 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-----------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
            LV+L       E   ++ EYM  GSL + L       L     + +A   A G++F+  
Sbjct: 69  RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
            E+  I+RD +A+NIL+    + K++DFGLA+     + T       G +    + APE 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEA 181

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRR 289
           +  G  T K DV+SFG++L E+++ GR 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRI 209

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (357), Expect = 4e-38
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 16/208 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHP 145
           +G G FG V  G +   + +       + +A+K LK     +  +++L E + +GQ  HP
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKE------ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
           N+++L G     +  ++V EYM  GSL++ L +  A+     L + +  G A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGMKYL-- 163

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYAAPEY 262
           ++   ++RD  A NIL++S    K+SDFGL +          +T+  G +    + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEA 221

Query: 263 LATGRLTAKCDVYSFGVVLLELLS-GRR 289
           +A  + T+  DV+S+G+VL E++S G R
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  139 bits (353), Expect = 4e-38
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLH 143
           +G+G FG V +     E        G  + +AVK LK +       +E+L E   + +  
Sbjct: 31  LGKGEFGSVREAQLKQE-------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83

Query: 144 HPNLVKLIGFCLDGENR------LLVYEYMPKGSLENHLFRRGARPLPWTLR----IKVA 193
           HP++ KL+G  L    +      +++  +M  G L   L        P+ L     ++  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQV 251
           +  A G+ +L  + +  I+RD  A N +L  +    ++DFGL++   +GD  R   ++++
Sbjct: 144 VDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 252 ----MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               +      A E LA    T   DV++FGV + E+++
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (349), Expect = 6e-38
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 27/212 (12%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           IGEG FG V++G ++             + +A+K  K        +++L E   + Q  H
Sbjct: 23  IGEGQFGDVHQGIYMSPENPA-------LAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH 204
           P++VKLIG         ++ E    G L + L  R       +L I  A   +  L++L 
Sbjct: 76  PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAYL- 132

Query: 205 EAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG------YA 258
              ++ ++RD  A N+L+ S    KL DFGL+       R    +             + 
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKGKLPIKWM 184

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           APE +   R T+  DV+ FGV + E+L  G +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  143 bits (362), Expect = 1e-37
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 84  DSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQ 141
           D  +G G FG V +G +              + +A+K LK        +E + E   + Q
Sbjct: 341 DIELGCGNFGSVRQGVYR--------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           L +P +V+LIG C   E  +LV E    G L   L  +        +  ++    + G+ 
Sbjct: 393 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMK 450

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR---GYA 258
           +L   E+  ++R+  A N+LL +   AK+SDFGL+KA    D  + +      +    + 
Sbjct: 451 YL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 506

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLS-GRR 289
           APE +   + +++ DV+S+GV + E LS G++
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (342), Expect = 6e-37
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 31/229 (13%)

Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK--KLKPEGFQG 128
              + N  R  + D  IG G F  VYKG +D  T         + +A    + +      
Sbjct: 18  AVGMSNDGRFLKFDIEIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSE 68

Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLD---GENRLLVY-EYMPKGSLENHLFRRGARPL 184
            + +  E   L  L HPN+V+          G+  +++  E M  G+L+ +L R     +
Sbjct: 69  RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128

Query: 185 P----WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDFGLAKAG 239
                W  +I       +GL FLH     +I+RD K  NI +     + K+ D GLA   
Sbjct: 129 KVLRSWCRQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

Query: 240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
               R   +  V+GT  + APE           DVY+FG+ +LE+ +  
Sbjct: 183 ----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  136 bits (345), Expect = 6e-37
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 33/218 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +G+G FG VY+G       +          +A+K +      +   E+L+E + + + + 
Sbjct: 33  LGQGSFGMVYEG-----VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP--------LPWTLR--IKVAI 194
            ++V+L+G    G+  L++ E M +G L+++L  R  RP         P +L   I++A 
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTHVSTQV- 251
             A G+++L     + ++RD  A N ++  +F  K+ DFG+ +     D  R      + 
Sbjct: 146 EIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203

Query: 252 ---MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              M      +PE L  G  T   DV+SFGVVL E+ +
Sbjct: 204 VRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (345), Expect = 7e-37
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 42/224 (18%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-H 143
           +IGEG FG V K           + G+ M  A+K++K       H+++  E+  L +L H
Sbjct: 32  VIGEGNFGQVLKA-------RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
           HPN++ L+G C       L  EY P G+L + L  R +R L                   
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQ 142

Query: 190 --IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
             +  A   ARG+ +L  +++Q I+RD  A NIL+   + AK++DFGL++          
Sbjct: 143 QLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------- 192

Query: 248 STQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
              V  T G     + A E L     T   DV+S+GV+L E++S
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  136 bits (345), Expect = 8e-37
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V+             P    M++AVK LK       +++  E   L  L H 
Sbjct: 49  LGEGAFGKVFLA-----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-----------GARPLPWTLR--IKV 192
           ++V+  G C +G   L+V+EYM  G L   L                 P P  L   + V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM 252
           A   A G+ +L  A    ++RD    N L+      K+ DFG+++   + D        +
Sbjct: 164 ASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----V 216

Query: 253 GTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           G R      +  PE +   + T + DV+SFGVVL E+ +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (340), Expect = 2e-36
 Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           +GEG FG V+             P    M++AVK LK       K++  E   L  L H 
Sbjct: 23  LGEGAFGKVFLA-----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR---------------- 189
           ++VK  G C DG+  ++V+EYM  G L   L  R   P    L                 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
           + +A   A G+ +L  A Q  ++RD    N L+ +    K+ DFG+++   + D   V  
Sbjct: 136 LHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193

Query: 250 QV------MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                   M       PE +   + T + DV+SFGV+L E+ +
Sbjct: 194 HTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (334), Expect = 2e-35
 Identities = 63/217 (29%), Positives = 90/217 (41%), Gaps = 31/217 (14%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +G G FG VY+G         +      + +AVK L      Q   ++L E   + + +H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW-----TLR--IKVAIGAA 197
            N+V+ IG  L    R ++ E M  G L++ L  R  RP P       +   + VA   A
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            G  +L   E   I+RD  A N LL        AK+ DFG+A+               G 
Sbjct: 151 CGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGG 203

Query: 255 RGY-----AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                     PE    G  T+K D +SFGV+L E+ S
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (332), Expect = 2e-35
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 39/224 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +GE  FG VYKG      L    PG     +A+K LK +      +E+  E     +L H
Sbjct: 17  LGEDRFGKVYKG-----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------- 189
           PN+V L+G     +   +++ Y   G L   L      P                     
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL--VMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 190 -IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD--RTH 246
            + +    A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D  +  
Sbjct: 130 FVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187

Query: 247 VSTQV----MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            ++ +    M      APE +  G+ +   D++S+GVVL E+ S
Sbjct: 188 GNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  130 bits (330), Expect = 3e-35
 Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 57/301 (18%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           K    +F+   LIG GGFG V+K    +H ++      G    +K++K      +++   
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKA---KHRID------GKTYVIKRVKYN----NEKAER 53

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL----------------LVYEYMPKGSLENHLFR 178
           EV  L +L H N+V   G     +                   +  E+  KG+LE  + +
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
           R    L   L +++     +G+ ++H   +++I RD K SNI L      K+ DFGL  +
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 239 -GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
               G RT       GT  Y +PE +++     + D+Y+ G++L ELL            
Sbjct: 172 LKNDGKRT---RSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV---------- 217

Query: 298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVL 357
                           +    + D  +   + +K   ++  L L    + + RP+ SE+L
Sbjct: 218 --------CDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKL-LS--KKPEDRPNTSEIL 266

Query: 358 S 358
            
Sbjct: 267 R 267

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (335), Expect = 3e-35
 Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 31/217 (14%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +G G FG VY+G      +         + +AVK L      Q   ++L E   + + +H
Sbjct: 79  LGHGAFGEVYEG-----QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL-----PWTLR--IKVAIGAA 197
            N+V+ IG  L    R ++ E M  G L++ L  R  RP         +   + VA   A
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            G  +L   E   I+RD  A N LL        AK+ DFG+A+               G 
Sbjct: 192 CGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGG 244

Query: 255 RGY-----AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                     PE    G  T+K D +SFGV+L E+ S
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (329), Expect = 8e-35
 Identities = 68/306 (22%), Positives = 125/306 (40%), Gaps = 41/306 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
           NFR +  IG G F  VY+               G+ +A+KK++       K     + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRA-ACLLD--------GVPVALKKVQIFDLMDAKARADCIKEI 83

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAI 194
           + L QL+HPN++K     ++     +V E    G L   +  F++  R +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
                L  +H   ++V++RD K +N+ + +    KL D GL +   +   T   + V GT
Sbjct: 144 QLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GT 199

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR 314
             Y +PE +       K D++S G +L E+ + +                   P+ GD+ 
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS------------------PFYGDKM 241

Query: 315 KLFRIMDIKLEGQYPQ--KGAYMVAI--LALQCIS-EAKVRPSMSEVLSALEQLPPPRDP 369
            L+ +     +  YP      Y   +  L   CI+ + + RP ++ V    +++      
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301

Query: 370 ASPSNS 375
           +   + 
Sbjct: 302 SLEHHH 307

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (330), Expect = 9e-35
 Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 34/281 (12%)

Query: 13  SLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFS 72
           S+SS        L     + S        ++E       +      D             
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD------------Y 51

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           E +           +G G FG V++   D+ T        G   AVKK++ E F+     
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRM-KDKQT--------GFQCAVKKVRLEVFR----- 97

Query: 133 LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           + E+     L  P +V L G   +G    +  E +  GSL   + + G   LP    +  
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYY 155

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAK--AGPTGDRTHVST 249
              A  GL +LH   +++++ D KA N+LL S+   A L DFG A         ++ ++ 
Sbjct: 156 LGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 250 QVM-GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
             + GT  + APE +      AK D++S   ++L +L+G  
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  135 bits (341), Expect = 1e-34
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNY 138
            +     +G GGFGYV + WI + T        G  +A+K+ + E    ++E W  E+  
Sbjct: 15  PWEMKERLGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQI 65

Query: 139 LGQLHHPNLVKLI------GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           + +L+HPN+V               +  LL  EY   G L  +L +         L+   
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGP 122

Query: 193 AIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDRT 245
                      L +LHE   ++I+RD K  NI+L         K+ D G AK    G   
Sbjct: 123 IRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--- 177

Query: 246 HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
            + T+ +GT  Y APE L   + T   D +SFG +  E ++G R
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (326), Expect = 4e-34
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-HH 144
           +GEG FG V         ++  +P   + +AVK LK +   +   + +SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------- 189
            N++ L+G C       ++ EY  KG+L  +L  R  RP                     
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 190 -IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D  ++ 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 211

Query: 249 TQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                T G     + APE L     T + DV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  128 bits (323), Expect = 5e-34
 Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 41/237 (17%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
             +F   +++G+G FG V K     + L+          A+KK++    +     LSEV 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA---RNALD------SRYYAIKKIRHTEEK-LSTILSEVM 54

Query: 138 YLGQLHHPNLVKLIGFCLDGENRL-------------LVYEYMPKGSLENHLFRRGARPL 184
            L  L+H  +V+     L+  N +             +  EY   G+L + +        
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQ 113

Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK------- 237
                 ++       LS++H   Q +I+RD K  NI +D   N K+ DFGLAK       
Sbjct: 114 QRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171

Query: 238 ------AGPTGDRTHVSTQVMGTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELLSG 287
                     G   ++++ + GT  Y A E L  TG    K D+YS G++  E++  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (326), Expect = 7e-34
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-HH 144
           +GEG FG V         ++  +P   + +AVK LK +   +   + +SE+  +  +  H
Sbjct: 89  LGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------- 189
            N++ L+G C       ++ EY  KG+L  +L  R  RP                     
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 190 -IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +      ARG+ +L  A Q+ I+RD  A N+L+      K++DFGLA+     D  ++ 
Sbjct: 205 LVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 257

Query: 249 TQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                T G     + APE L     T + DV+SFGV++ E+ +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  129 bits (325), Expect = 1e-33
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 34/223 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-HH 144
           +GEG FG V     +   L+  +P     +AVK LK +   +   + +SE+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------- 189
            N++ L+G C       ++ EY  KG+L  +L  +  RP                     
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 190 -IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
            +  A   ARG+ +L  A ++ I+RD  A N+L+  +   K++DFGLA+     D  H+ 
Sbjct: 193 LVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 245

Query: 249 TQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
                T G     + APE L     T + DV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  128 bits (323), Expect = 2e-33
 Identities = 48/251 (19%), Positives = 79/251 (31%), Gaps = 22/251 (8%)

Query: 52  SMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPG 111
           S P T       P +K    +E +  ++      L+GEG F  VY+              
Sbjct: 40  SYPNTFEWQCKLPAIK--PKTEFQLGSKLVYVHHLLGEGAFAQVYEA---TQGDLNDAK- 93

Query: 112 VGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGS 171
                 +K  KP            +  L        +K     L     +LV E    G+
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 172 LENHLFRRGA---RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL------ 222
           L N +        + +P  L I  A+     +  +H+ E  +I+ D K  N +L      
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLE 211

Query: 223 -----DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSF 277
                D      L D G +       +  + T    T G+   E L+      + D +  
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271

Query: 278 GVVLLELLSGR 288
              +  +L G 
Sbjct: 272 AATVYCMLFGT 282

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (322), Expect = 2e-33
 Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 19/233 (8%)

Query: 62  SCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKL 121
               +   T +    +   +     IGEG FG                   G    +K++
Sbjct: 7   HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILV-KSTED--------GRQYVIKEI 57

Query: 122 KPEGFQGHKEW---LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
                   KE      EV  L  + HPN+V+      +  +  +V +Y   G L   +  
Sbjct: 58  NISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA 116

Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
           +          +   +     L  +H+  +++++RD K+ NI L  +   +L DFG+A+ 
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

Query: 239 -GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
              T +       + GT  Y +PE         K D+++ G VL EL + + A
Sbjct: 175 LNSTVELAR--ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (320), Expect = 2e-33
 Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 45/231 (19%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           +GEG FG V K                   +AVK LK        ++ LSE N L Q++H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT-----VAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------- 189
           P+++KL G C      LL+ EY   GSL   L  R +R +                    
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 190 ---------IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
                    I  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL++   
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSR--- 198

Query: 241 TGDRTHVSTQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             D     + V  ++G     + A E L     T + DV+SFGV+L E+++
Sbjct: 199 --DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (319), Expect = 2e-33
 Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 36/233 (15%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WL 133
             +   +    ++G+G    V++    + T        G + A+K      F    +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRL--LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
            E   L +L+H N+VKL     +   R   L+ E+ P GSL   L         + L   
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPES 112

Query: 192 VAIGAAR----GLSFLHEAEQQVIYRDFKASNILL----DSEFNAKLSDFGLAKAGPTGD 243
             +   R    G++ L   E  +++R+ K  NI+     D +   KL+DFG A+     D
Sbjct: 113 EFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRL--------TAKCDVYSFGVVLLELLSGR 288
                +   GT  Y  P+      L         A  D++S GV      +G 
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (318), Expect = 3e-33
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 19/213 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS----EV 136
           ++    +G GG   VY     +  L          +A+K +     +  +E L     EV
Sbjct: 13  YKIVDKLGGGGMSTVYLAE--DTILN--IK-----VAIKAIFIP-PREKEETLKRFEREV 62

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
           +   QL H N+V +I    + +   LV EY+   +L  ++   G  PL     I      
Sbjct: 63  HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQI 120

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
             G+   H+   ++++RD K  NIL+DS    K+ DFG+AKA      T  +  V+GT  
Sbjct: 121 LDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           Y +PE           D+YS G+VL E+L G  
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  126 bits (319), Expect = 4e-33
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 41/229 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVG-MVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHH 144
           IGEG FG V++            P     ++AVK LK E       ++  E   + +  +
Sbjct: 55  IGEGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR--------------- 189
           PN+VKL+G C  G+   L++EYM  G L   L       +                    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 190 -------IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
                  + +A   A G+++L  +E++ ++RD    N L+      K++DFGL++   + 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 243 DRTHVSTQVMGTRGY-----AAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           D                     PE +   R T + DV+++GVVL E+ S
Sbjct: 228 D-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  127 bits (321), Expect = 4e-33
 Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 36/233 (15%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WL 133
             +   +    ++G+G    V++    + T        G + A+K      F    +  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRL--LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
            E   L +L+H N+VKL     +   R   L+ E+ P GSL   L         + L   
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPES 112

Query: 192 VAIGAAR----GLSFLHEAEQQVIYRDFKASNILL----DSEFNAKLSDFGLAKAGPTGD 243
             +   R    G++ L   E  +++R+ K  NI+     D +   KL+DFG A+     D
Sbjct: 113 EFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRL--------TAKCDVYSFGVVLLELLSGR 288
                +   GT  Y  P+      L         A  D++S GV      +G 
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (316), Expect = 5e-33
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G+G +G VY G  D            + IA+K++     +  +    E+     L H 
Sbjct: 29  VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP--------WTLRIKVAIGAA 197
           N+V+ +G   +     +  E +P GSL   L R    PL         +T +I       
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQI------L 132

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
            GL +LH  + Q+++RD K  N+L+++     K+SDFG +K          +    GT  
Sbjct: 133 EGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQ 188

Query: 257 YAAPE---YLATGRLTAKCDVYSFGVVLLELLSGRR 289
           Y APE       G      D++S G  ++E+ +G+ 
Sbjct: 189 YMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  126 bits (318), Expect = 5e-33
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-HH 144
           +G G FG V +        E A     + +AVK LK        +  +SE+  +  L  H
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAV----LKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPL------------PWTLR--I 190
            N+V L+G C  G   L++ EY   G L N L  R    +              + R  +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTASTRDLL 167

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
             +   A+G++FL  A +  I+RD  A N+LL +   AK+ DFGLA+     D  + S  
Sbjct: 168 HFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNY 220

Query: 251 VMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           ++         + APE +     T + DV+S+G++L E+ S
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (316), Expect = 6e-33
 Identities = 55/213 (25%), Positives = 85/213 (39%), Gaps = 19/213 (8%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS----EV 136
           +R   L+G GG G VY+    E T+         ++A+K +          + +    E 
Sbjct: 36  YRLRRLVGRGGMGDVYEA---EDTV------RERIVALKLMSET-LSSDPVFRTRMQREA 85

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
              G+L  P++V +  F        +    +    L   L R+G    P  + I      
Sbjct: 86  RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI--VRQI 143

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
              L   H A     +RD K  NIL+ ++  A L DFG+A A      T +    +GT  
Sbjct: 144 GSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           Y APE  +    T + D+Y+   VL E L+G  
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (314), Expect = 1e-32
 Identities = 70/226 (30%), Positives = 99/226 (43%), Gaps = 40/226 (17%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-H 143
           +G G FG V +         +AA     M +AVK LKP       +  +SE+  L  L +
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAA-----MTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP----------------LPWT 187
           H N+V L+G C  G   L++ EY   G L N L  R  R                 L   
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALD 143

Query: 188 LR--IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT 245
           L   +  +   A+G++FL  A +  I+RD  A NILL      K+ DFGLA+     D  
Sbjct: 144 LEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIK 196

Query: 246 HVSTQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           + S  V+         + APE +     T + DV+S+G+ L EL S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (312), Expect = 3e-32
 Identities = 68/313 (21%), Positives = 117/313 (37%), Gaps = 42/313 (13%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           +++     +GEGGF YV                 G   A+K++     Q  +E   E + 
Sbjct: 29  KHYLFIQKLGEGGFSYVDL---------VEGLHDGHFYALKRILCHEQQDREEAQREADM 79

Query: 139 LGQLHHPNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLR--IKV 192
               +HPN+++L+ +CL          L+  +  +G+L N + R   +    T    + +
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRTHVST 249
            +G  RGL  +H   +   +RD K +NILL  E    L D G          G R  ++ 
Sbjct: 140 LLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 250 QVM----GTRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL 302
           Q       T  Y APE  +      +  + DV+S G VL  ++ G    D      +   
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV- 256

Query: 303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQ 362
                        +   + I    ++      ++  + +    +   RP +  +LS LE 
Sbjct: 257 ----------ALAVQNQLSIPQSPRHSSALWQLLNSM-MT--VDPHQRPHIPLLLSQLEA 303

Query: 363 LPPPRDPASPSNS 375
           L PP  P   +  
Sbjct: 304 LQPPA-PGQHTTQ 315

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  123 bits (310), Expect = 5e-32
 Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 39/225 (17%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-H 143
           +G G FG V +            R      +AVK LK       H+  +SE+  L  + H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 144 HPNLVKLIGFCLDGEN-RLLVYEYMPKGSLENHLFRRGARPL--------------PWTL 188
           H N+V L+G C       +++ E+   G+L  +L  R  R                  TL
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 189 R--IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH 246
              I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ DFGLA+     D   
Sbjct: 148 EHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYK 200

Query: 247 VSTQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
               V          + APE +     T + DV+SFGV+L E+ S
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (308), Expect = 7e-32
 Identities = 59/219 (26%), Positives = 85/219 (38%), Gaps = 34/219 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEV 136
           +F+  S +G G +G V+K    +          G + AVK+     F+G K+    L+EV
Sbjct: 58  SFQRLSRLGHGSYGEVFKV-RSKED--------GRLYAVKRSMSP-FRGPKDRARKLAEV 107

Query: 137 NYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP------WTLR 189
               ++  HP  V+L     +G    L  E     SL+ H    G   LP      +   
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRD 165

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
                     L+ LH   Q +++ D K +NI L      KL DFGL     T        
Sbjct: 166 T------LLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--V 215

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           Q  G   Y APE L         DV+S G+ +LE+    
Sbjct: 216 QE-GDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNM 252

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (309), Expect = 1e-31
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 45/231 (19%)

Query: 87  IGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL-H 143
           +G G FG V             +     + +AVK LK +      +  +SE+  + QL  
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVS-----IQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR-------------- 189
           H N+V L+G C       L++EY   G L N+L  R  R                     
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEEEED 165

Query: 190 ---------IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
                    +  A   A+G+ FL    +  ++RD  A N+L+      K+ DFGLA+   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR--- 220

Query: 241 TGDRTHVSTQVMGTRG-----YAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             D    S  V+         + APE L  G  T K DV+S+G++L E+ S
Sbjct: 221 --DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (307), Expect = 1e-31
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS----EV 136
           +    ++G GG   V+     +      R      +AVK L+ +       +      E 
Sbjct: 14  YELGEILGFGGMSEVHLAR--DLRDH--RD-----VAVKVLRAD-LARDPSFYLRFRREA 63

Query: 137 NYLGQLHHPNLVKL--IGFCLDGENRL--LVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
                L+HP +V +   G        L  +V EY+   +L + +   G  P+     I+V
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV 121

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST-QV 251
              A + L+F H+    +I+RD K +NI++ +    K+ DFG+A+A      +   T  V
Sbjct: 122 IADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           +GT  Y +PE      + A+ DVYS G VL E+L+G  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (312), Expect = 1e-31
 Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 48/293 (16%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +F P  ++G G  G +                    +AVK++ PE F        EV  L
Sbjct: 25  SFCPKDVLGHGAEGTIVYR--GMFD--------NRDVAVKRILPECFSFAD---REVQLL 71

Query: 140 GQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
            +   HPN+++      D + + +  E     +L+ ++ ++    L       +      
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTS 129

Query: 199 GLSFLHEAEQQVIYRDFKASNILL-----DSEFNAKLSDFGLAKAGPTGDRT-HVSTQVM 252
           GL+ LH     +++RD K  NIL+       +  A +SDFGL K    G  +    + V 
Sbjct: 130 GLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 253 GTRGYAAPEYL---ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
           GT G+ APE L        T   D++S G V   ++S                     P+
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----------------PF 230

Query: 310 --LGDRRKLFRIMDIKLEGQYPQKGAYMVAI-LALQCIS-EAKVRPSMSEVLS 358
                R+    +    L+  +P+K   ++A  L  + I+ + + RPS   VL 
Sbjct: 231 GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  121 bits (305), Expect = 2e-31
 Identities = 53/230 (23%), Positives = 101/230 (43%), Gaps = 35/230 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNY 138
           +F P   +G GGFG V++    ++ ++          A+K+++ P      ++ + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---KNKVD------DCNYAIKRIRLPNRELAREKVMREVKA 56

Query: 139 LGQLHHPNLVKLIGFCLDGEN---------RLLVY---EYMPKGSLENHL-FRRGARPLP 185
           L +L HP +V+     L+            ++ +Y   +   K +L++ +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 186 WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA------- 238
            ++ + + +  A  + FLH   + +++RD K SNI    +   K+ DFGL  A       
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 239 ---GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                        T  +GT+ Y +PE +     + K D++S G++L ELL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (302), Expect = 3e-31
 Identities = 60/222 (27%), Positives = 90/222 (40%), Gaps = 22/222 (9%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEV 136
            ++     IG G +G   K           R   G ++  K+L          +  +SEV
Sbjct: 6   EDYEVLYTIGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLL--VYEYMPKGSLENHL--FRRGARPLPWTLRIKV 192
           N L +L HPN+V+     +D  N  L  V EY   G L + +    +  + L     ++V
Sbjct: 57  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116

Query: 193 AIGAARGLSFLHE---AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVS 248
                  L   H        V++RD K +N+ LD + N KL DFGLA+            
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK-- 174

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRA 290
           T V GT  Y +PE +       K D++S G +L EL +    
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (314), Expect = 5e-31
 Identities = 52/222 (23%), Positives = 80/222 (36%), Gaps = 42/222 (18%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-------FQGHKEWL 133
           +     I  GG G++Y            RP     + +K L   G               
Sbjct: 82  YEVKGCIAHGGLGWIYLA---LDRNVNGRP-----VVLKGLVHSGDAEAQAMAM------ 127

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRL-----LVYEYMPKGSLENHLFRRGARPLPWTL 188
           +E  +L ++ HP++V++  F    +        +V EY+   SL+        + LP   
Sbjct: 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAE 183

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHV 247
            I   +     LS+LH     ++Y D K  NI+L  E   KL D G        G     
Sbjct: 184 AIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG----- 235

Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
              + GT G+ APE +     T   D+Y+ G  L  L     
Sbjct: 236 --YLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (302), Expect = 6e-31
 Identities = 57/307 (18%), Positives = 112/307 (36%), Gaps = 53/307 (17%)

Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH- 129
           F  +    R +     IG GG   V++  ++E            + A+K +  E      
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQT 69

Query: 130 -KEWLSEVNYLGQLHHPNL--VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW 186
              + +E+ YL +L   +   ++L  + +  +   +V E      L + L ++ +     
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE 128

Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTH 246
                  +     +  +H+    +++ D K +N L+      KL DFG+A        + 
Sbjct: 129 RKSYWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 183

Query: 247 VSTQVMGTRGYAAPEYL-----------ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
           V    +GT  Y  PE +           +  +++ K DV+S G +L  +  G+       
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------ 237

Query: 296 VGAEQNLVDWAKPYLGDR---RKLFRIMDIKLEGQYPQKGAYMVAILALQC-ISEAKVRP 351
                       P+        KL  I+D   E ++P      +  +   C   + K R 
Sbjct: 238 ------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

Query: 352 SMSEVLS 358
           S+ E+L+
Sbjct: 286 SIPELLA 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (301), Expect = 1e-30
 Identities = 62/352 (17%), Positives = 124/352 (35%), Gaps = 59/352 (16%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH--KEWLSEVNYLGQLH 143
            IG GG   V++  ++E            + A+K +  E         + +E+ YL +L 
Sbjct: 16  QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 144 HPNL--VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
             +   ++L  + +  +   +V E      L + L ++ +            +     + 
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVH 122

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
            +H+    +++ D K +N L+      KL DFG+A        + V    +GT  Y  PE
Sbjct: 123 TIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 262 YL-----------ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
            +           +  +++ K DV+S G +L  +  G+                   P+ 
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------PFQ 221

Query: 311 GDR---RKLFRIMDIKLEGQYPQKGAYMVAILALQC-ISEAKVRPSMSEVLS---ALEQL 363
                  KL  I+D   E ++P      +  +   C   + K R S+ E+L+      Q 
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281

Query: 364 PPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSP 415
            P    A  +  + + +    +     PNS  +    +  Y+        + 
Sbjct: 282 HPVNQMAKGTTEEMKYVLG-QLVGLNSPNS--ILKAAKTLYEHYSGGESHNS 330

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  118 bits (298), Expect = 4e-30
 Identities = 43/234 (18%), Positives = 82/234 (35%), Gaps = 41/234 (17%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS----- 134
           ++R    + +G F  +      E              A+KK +    +  +++       
Sbjct: 32  DYRIIRTLNQGKFNKIILC---EKD--------NKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 135 ------------EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR 182
                       E+  +  + +   +   G   + +   ++YEYM   S+          
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 183 PLPWTLRIKVAIGA------ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
              +T  I + +            S++H  E+ + +RD K SNIL+D     KLSDFG +
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGES 199

Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT--AKCDVYSFGVVLLELLSGR 288
           +               GT  +  PE+ +       AK D++S G+ L  +    
Sbjct: 200 EYMVDKKIK---G-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  118 bits (297), Expect = 9e-30
 Identities = 69/407 (16%), Positives = 139/407 (34%), Gaps = 59/407 (14%)

Query: 30  GNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGE 89
           G     S +K   + K    +   P    D     +  A     +K   R +     IG 
Sbjct: 9   GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGS 66

Query: 90  GGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNL 147
           GG   V++  ++E            + A+K +  E    Q    + +E+ YL +L   + 
Sbjct: 67  GGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 148 --VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHE 205
             ++L  + +  +   +V E      L + L ++ +            +     +  +H+
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQ 173

Query: 206 AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL-- 263
               +++ D K +N L+      KL DFG+A        + V    +G   Y  PE +  
Sbjct: 174 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 264 ---------ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR- 313
                    +  +++ K DV+S G +L  +  G+                   P+     
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------TPFQQIIN 272

Query: 314 --RKLFRIMDIKLEGQYPQKGAYMVAILALQC-ISEAKVRPSMSEVLSA--LEQLPPPRD 368
              KL  I+D   E ++P      +  +   C   + K R S+ E+L+   ++    P +
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

Query: 369 PASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSP 415
             +   ++        +     PNS  +    +  Y+        + 
Sbjct: 333 QMAKGTTEEMKYVLGQLVGLNSPNS--ILKAAKTLYEHYSGGESHNS 377

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 3e-29
 Identities = 79/377 (20%), Positives = 140/377 (37%), Gaps = 57/377 (15%)

Query: 52  SMPRTECDILSCPNLKAFTFSELKNATRN---FRPDSLIGEGGFGYVYKGWIDEHTLEAA 108
            +   E D      L+AF   + K        F   S +G G  G V+K    + +    
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKV-SHKPS---- 57

Query: 109 RPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYM 167
               G+V+A K +  E       + + E+  L + + P +V   G         +  E+M
Sbjct: 58  ----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113

Query: 168 PKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN 227
             GSL+     + A  +P  +  KV+I   +GL++L E + ++++RD K SNIL++S   
Sbjct: 114 DGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGE 170

Query: 228 AKLSDFGLA-KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
            KL DFG++ +   +   + V     GTR Y +PE L     + + D++S G+ L+E+  
Sbjct: 171 IKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225

Query: 287 GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISE 346
           GR                   P      K   +M          +               
Sbjct: 226 GR------------------YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 347 AKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIYSPH---------VKSP-MRPNSPHL 396
                    +   L+ +     P  PS      ++S           +K+P  R +   L
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSG-----VFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 397 KSH--LRNNYDSPVNMS 411
             H  ++ +    V+ +
Sbjct: 323 MVHAFIKRSDAEEVDFA 339

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (287), Expect = 4e-29
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLG 140
            +G+G FG VY    ++ +          ++A+K     +L+  G +       EV    
Sbjct: 16  PLGKGKFGNVYLA-REKQS--------KFILALKVLFKAQLEKAGVEHQLR--REVEIQS 64

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
            L HPN+++L G+  D     L+ EY P G++   L +        T      +  A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANAL 122

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           S+ H   ++VI+RD K  N+LL S    K++DFG +   P+  RT     + GT  Y  P
Sbjct: 123 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D-LCGTLDYLPP 176

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E +       K D++S GV+  E L G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  113 bits (286), Expect = 6e-29
 Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 24/216 (11%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWL 133
           R +     +G+GGF   ++   D  T          V A K      L     +      
Sbjct: 15  RRYVRGRFLGKGGFAKCFEI-SDADT--------KEVFAGKIVPKSLLLKPHQREKMS-- 63

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            E++    L H ++V   GF  D +   +V E   + SL     RR A   P        
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVM 252
           I    G  +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V     
Sbjct: 124 I--VLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 176

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L+    + + DV+S G ++  LL G+
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (289), Expect = 7e-29
 Identities = 37/309 (11%), Positives = 69/309 (22%), Gaps = 56/309 (18%)

Query: 16  SHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELK 75
           SH  +GD+ + D              ++ K P+            +   N +    S L 
Sbjct: 2   SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTAT---VWPQNAETTVDSLLS 58

Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW--- 132
              R  +    +  G    V+    D               A+K           E    
Sbjct: 59  QGERKLKLVEPLRVGDRSVVFLV-RDVER--------LEDFALKVFTMGAENSRSELERL 109

Query: 133 LSEVNYLGQLHHPNLVKLIGFC--------------------------LDGENRLLVYEY 166
                   +L   +  +                                   N LL+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 167 MPKGSLEN-----HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL 221
                LE                       +     R  + L    + +++  F   N+ 
Sbjct: 170 A-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLF 226

Query: 222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL--ATGRLTAKCDVYSFGV 279
           +  +    L D        T               YA  E+L  +T   T   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 280 VLLELLSGR 288
            +  +    
Sbjct: 282 SIYRVWCLF 290

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (289), Expect = 1e-28
 Identities = 38/254 (14%), Positives = 82/254 (32%), Gaps = 46/254 (18%)

Query: 72  SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLE---------AARPGVGMVIAVKK-- 120
           SEL    R     +++G+       +   D+ T E           RP    +  +K+  
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124

Query: 121 ---------LKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE--NRLLVYEYM-- 167
                       +  + H  ++   + +       ++++     D    +R  +Y  M  
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184

Query: 168 PKGSLENHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE 225
              +    L    +  + L    R+++ +   R L+ LH     +++   +  +I+LD  
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQR 242

Query: 226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----------GRLTAKCDV 274
               L+ F          R         +RG+  PE  A              +T   D 
Sbjct: 243 GGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 275 YSFGVVLLELLSGR 288
           ++ G+V+  +    
Sbjct: 297 WALGLVIYWIWCAD 310

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  113 bits (285), Expect = 2e-28
 Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 24/216 (11%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWL 133
           R +     +G+GGF   ++   D  T          V A K      L     +      
Sbjct: 41  RRYVRGRFLGKGGFAKCFEI-SDADT--------KEVFAGKIVPKSLLLKPHQREKMS-- 89

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
            E++    L H ++V   GF  D +   +V E   + SL     RR A   P        
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRTHVSTQVM 252
           I    G  +LH    +VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V     
Sbjct: 150 I--VLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 202

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L+    + + DV+S G ++  LL G+
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  112 bits (282), Expect = 2e-28
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLG 140
            +G+G FG VY    ++            ++A+K     +L+ EG +       E+    
Sbjct: 21  PLGKGKFGNVYLA-REKQN--------KFIMALKVLFKSQLEKEGVEHQLR--REIEIQS 69

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
            L HPN++++  +  D +   L+ E+ P+G L   L + G      +      +  A  L
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADAL 127

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            + HE  ++VI+RD K  N+L+  +   K++DFG +   P   R        GT  Y  P
Sbjct: 128 HYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPP 181

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGR 288
           E +       K D++  GV+  E L G 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  115 bits (289), Expect = 7e-28
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 20/225 (8%)

Query: 69  FTFSELKNATRN-FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ 127
           + + E +  T+N FR   ++G+GGFG V                 G + A KKL+ +  +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCA---------CQVRATGKMYACKKLEKKRIK 223

Query: 128 GHKEW---LSEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARP 183
             K     L+E   L +++   +V L  +  + ++ L LV   M  G L+ H++  G   
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282

Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
            P    +  A     GL  LH   ++++YRD K  NILLD   + ++SD GLA   P G 
Sbjct: 283 FPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
                 +V GT GY APE +   R T   D ++ G +L E+++G+
Sbjct: 341 TIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (278), Expect = 9e-28
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G  G VY   +D  T        G  +A++++  +     +  ++E+  + +  +PN
Sbjct: 28  IGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V  +   L G+   +V EY+  GSL + +       +       V     + L FLH  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET--CMDEGQIAAVCRECLQALEFLHS- 134

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
             QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  + APE +   
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 267 RLTAKCDVYSFGVVLLELLSG 287
               K D++S G++ +E++ G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (276), Expect = 2e-27
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 23/223 (10%)

Query: 72  SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGF 126
           + +     +F+  +L+G+G F  VY+     HT        G+ +A+K      +   G 
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRA-ESIHT--------GLEVAIKMIDKKAMYKAGM 54

Query: 127 QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPW 186
               +  +EV    QL HP++++L  +  D     LV E    G +  +L  R       
Sbjct: 55  VQRVQ--NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN 112

Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-KAGPTGDRT 245
             R  +      G+ +LH     +++RD   SN+LL    N K++DFGLA +     ++ 
Sbjct: 113 EARHFMH-QIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169

Query: 246 HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +      GT  Y +PE         + DV+S G +   LL GR
Sbjct: 170 YTLC---GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (278), Expect = 2e-27
 Identities = 70/341 (20%), Positives = 124/341 (36%), Gaps = 56/341 (16%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
              R   ++ EGGF +VY+         A   G G   A+K+L     + ++  + EV +
Sbjct: 28  LRLRVRRVLAEGGFAFVYE---------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78

Query: 139 LGQL-HHPNLVKLIGFCLDGENR-------LLVYEYMPKGSLENHLFRRGAR-PLPWTLR 189
           + +L  HPN+V+       G+          L+   + KG L   L +  +R PL     
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA---GPTGDRTH 246
           +K+     R +  +H  +  +I+RD K  N+LL ++   KL DFG A      P    + 
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 247 VSTQVM-------GTRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLSGRRAVDKTRV 296
               ++        T  Y  PE +       +  K D+++ G +L  L   +   +    
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258

Query: 297 GAEQN---LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSM 353
               N    +            L R M   L+   P++                  R S+
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAM---LQVN-PEE------------------RLSI 296

Query: 354 SEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSP 394
           +EV+  L+++   R+    S     +  +    S      P
Sbjct: 297 AEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  109 bits (275), Expect = 3e-27
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 17/217 (7%)

Query: 72  SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE 131
           +   +    F     IG+G FG V+KG ID  T          V+A+K +  E  +   E
Sbjct: 15  NLKADPEELFTKLEKIGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIE 65

Query: 132 WLS-EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
            +  E+  L Q   P + K  G  L      ++ EY+  GS    L   G  PL  T   
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG--PLDETQIA 122

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +     +GL +LH   ++ I+RD KA+N+LL      KL+DFG+A    T  +   +T 
Sbjct: 123 TILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT- 178

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            +GT  + APE +      +K D++S G+  +EL  G
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  112 bits (283), Expect = 3e-27
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 20/215 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
            F    ++G GGFG V+                G + A KKL  +  +  K +   + E 
Sbjct: 186 WFLDFRVLGRGGFGEVFA---------CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L ++H   +V L  +  + +  L LV   M  G +  H++        +     +   
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 196 A--ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           A    GL  LH+  + +IYRD K  N+LLD + N ++SD GLA     G          G
Sbjct: 296 AQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-G 351

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T G+ APE L         D ++ GV L E+++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 4e-27
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IGEG  G V     ++H+        G  +AVK +     Q  +   +EV  +    H N
Sbjct: 53  IGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA 206
           +V++    L GE   ++ E++  G+L + +  +    L       V     + L++LH  
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQV--RLNEEQIATVCEAVLQALAYLHA- 159

Query: 207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG 266
            Q VI+RD K+ +ILL  +   KLSDFG   A  + D     + V GT  + APE ++  
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 267 RLTAKCDVYSFGVVLLELLSG 287
               + D++S G++++E++ G
Sbjct: 217 LYATEVDIWSLGIMVIEMVDG 237

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (277), Expect = 5e-27
 Identities = 43/213 (20%), Positives = 75/213 (35%), Gaps = 22/213 (10%)

Query: 87  IGEG--GFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQL 142
           IG+G      V      + T        G  + V+++  E            E++     
Sbjct: 33  IGKGFEDLMTVNLA-RYKPT--------GEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           +HPN+V      +      +V  +M  GS ++ +       +       +  G  + L +
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFG-LAKAGPTGDRTHV----STQVMGTRGY 257
           +H      ++R  KAS+IL+  +    LS           G R  V        +    +
Sbjct: 144 IHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 258 AAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
            +PE L        AK D+YS G+   EL +G 
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (279), Expect = 5e-27
 Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 46/242 (19%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
           ++       + ++G G  G V      + + +      G  +AVK++  +          
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVF----QGSFQ------GRPVAVKRMLIDFCDIAL---M 57

Query: 135 EVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSL-----ENHLFRRGARPLPWTL 188
           E+  L +   HPN+++            +  E     +L       ++     +      
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-------------FNAKLSDFGL 235
            I +    A G++ LH    ++I+RD K  NIL+ +                  +SDFGL
Sbjct: 117 PISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174

Query: 236 AK---AGPTGDRTHVSTQVMGTRGYAAPEYL-------ATGRLTAKCDVYSFGVVLLELL 285
            K   +G +  RT+++    GT G+ APE L          RLT   D++S G V   +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 286 SG 287
           S 
Sbjct: 234 SK 235

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (273), Expect = 5e-27
 Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 39/222 (17%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           +     +G+G FG VYK   ++ T        G + A K ++ +  +  ++++ E+  L 
Sbjct: 21  WEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILA 71

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
              HP +VKL+G         ++ E+ P G+++  +     R L       V       L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA-- 258
           +FLH   +++I+RD KA N+L+  E + +L+DFG            VS + + T      
Sbjct: 131 NFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFG------------VSAKNLKTLQKRDS 176

Query: 259 --------APEYLATGRLT-----AKCDVYSFGVVLLELLSG 287
                   APE +    +       K D++S G+ L+E+   
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (277), Expect = 8e-27
 Identities = 61/256 (23%), Positives = 98/256 (38%), Gaps = 52/256 (20%)

Query: 61  LSCPNLKAFTFSELKNATRNFRPDSL---------IGEGGFGYVYKGWIDEHTLEAARPG 111
           LS    K F F +L    ++  P +L         +G G  G V     +  T       
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA-FERKT------- 159

Query: 112 VGMVIAVK-----KLKPEGFQGHKEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRLLV 163
               +A++     K      +     L+   E+  L +L+HP ++K+  F  D E+  +V
Sbjct: 160 -CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIV 217

Query: 164 YEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKA 217
            E M  G L + +           +   + +           + +LH  E  +I+RD K 
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQM--------LLAVQYLH--ENGIIHRDLKP 267

Query: 218 SNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL---TAK 271
            N+LL S   +   K++DFG +K             + GT  Y APE L +         
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRA 324

Query: 272 CDVYSFGVVLLELLSG 287
            D +S GV+L   LSG
Sbjct: 325 VDCWSLGVILFICLSG 340

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (272), Expect = 9e-27
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 16/210 (7%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
              F     +GEG +G VYK  I + T        G ++A+K++  E     +E + E++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKA-IHKET--------GQIVAIKQVPVE--SDLQEIIKEIS 76

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            + Q   P++VK  G      +  +V EY   GS+ + + R   + L       +     
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTL 135

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +GL +LH    + I+RD KA NILL++E +AKL+DFG+A    T      +T + GT  +
Sbjct: 136 KGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVI-GTPFW 191

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            APE +         D++S G+  +E+  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  108 bits (272), Expect = 1e-26
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 30/213 (14%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           +G G +  VYKG +++ T        G+ +A+K++K +     +E      + E++ + +
Sbjct: 13  LGNGTYATVYKG-LNKTT--------GVYVALKEVKLD----SEEGTPSTAIREISLMKE 59

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           L H N+V+L           LV+E+M    K  +++       R L   L         +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTRG 256
           GL+F HE   ++++RD K  N+L++     KL DFGLA+A   P    +    +V+ T  
Sbjct: 120 GLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173

Query: 257 YAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           Y AP+ L   R  +   D++S G +L E+++G+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (274), Expect = 2e-26
 Identities = 37/261 (14%), Positives = 77/261 (29%), Gaps = 61/261 (23%)

Query: 72  SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK--------- 122
           SEL    R     +++G+       +   D+ T        G    V             
Sbjct: 71  SELGERPRTLVRGTVLGQEDPYAYLEAT-DQET--------GESFEVHVPYFTERPPSNA 121

Query: 123 -------------------PEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG--ENRL 161
                               +  + H  ++   + +       ++++     D    +R 
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181

Query: 162 LVYEYMPK--GSLENHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKA 217
            +Y  M     +    L    +  + L    R+++ +   R L+ LH     +++   + 
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRP 239

Query: 218 SNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA----------TGR 267
            +I+LD      L+ F          R   S      RG+A PE  A             
Sbjct: 240 VDIVLDQRGGVFLTGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTL 293

Query: 268 LTAKCDVYSFGVVLLELLSGR 288
           +T   D ++ G+ +  +    
Sbjct: 294 MTFAFDTWTLGLAIYWIWCAD 314

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (276), Expect = 2e-26
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 35/214 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWLSEVNYLGQLH 143
           +G+G FG V     D+ T        G   AVK   K + +     +  L EV  L QL 
Sbjct: 34  LGKGSFGEVILC-KDKIT--------GQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAA 197
           HPN++KL  F  D     LV E    G L + +  R       A  +     I+  +   
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSG- 138

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
             ++++H  + ++++RD K  N+LL+S   + N ++ DFGL+       +       +GT
Sbjct: 139 --ITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             Y APE L  G    KCDV+S GV+L  LLSG 
Sbjct: 192 AYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  109 bits (273), Expect = 5e-26
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 40/235 (17%)

Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKP 123
           F  S+  + +  ++    +G G +G V     D+ T         +  A+K      +  
Sbjct: 27  FITSKKGHLSEMYQRVKKLGSGAYGEVLLC-RDKVT--------HVERAIKIIRKTSVST 77

Query: 124 EGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--- 180
                + + L EV  L  L HPN++KL  F  D  N  LV E    G L + +  R    
Sbjct: 78  SS---NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134

Query: 181 ---ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFG 234
              A  +     IK  +     +++LH  +  +++RD K  N+LL+S   +   K+ DFG
Sbjct: 135 EVDAAVI-----IKQVLSG---VTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184

Query: 235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           L+       +     + +GT  Y APE L   +   KCDV+S GV+L  LL+G  
Sbjct: 185 LSAVFENQKKMK---ERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYP 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (265), Expect = 7e-26
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 22/213 (10%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHHP 145
           IG G    V                    +A+K++  E  Q   + L  E+  + Q HHP
Sbjct: 23  IGSGATAVVQAA-YCAPK--------KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA------RG 199
           N+V      +  +   LV + +  GS+ + +    A+    +  +  +  A        G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTRG 256
           L +LH+     I+RD KA NILL  + + +++DFG++     G    R  V    +GT  
Sbjct: 134 LEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 257 YAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           + APE +   R    K D++SFG+  +EL +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 7e-26
 Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 32/237 (13%)

Query: 66  LKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG 125
           L     S L++    F    L+G G +G VYKG     T        G + A+K +   G
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVMDVTG 61

Query: 126 FQGHKEWLSEVNYLGQL-HHPNLVKLIG-----FCLDGENRL-LVYEYMPKGSLENHLFR 178
               +E   E+N L +  HH N+    G          +++L LV E+   GS+ + +  
Sbjct: 62  -DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 179 RGARPLPWTLRIKVAI---GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL 235
                L       +A       RGLS LH+   +VI+RD K  N+LL      KL DFG+
Sbjct: 121 TKGNTLK---EEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT-----AKCDVYSFGVVLLELLSG 287
           + A         +T  +GT  + APE +A           K D++S G+  +E+  G
Sbjct: 176 S-AQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (265), Expect = 1e-25
 Identities = 63/270 (23%), Positives = 95/270 (35%), Gaps = 62/270 (22%)

Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKP 123
           F    L    + +     IG+G +G V    I+  T          + A+K     K++ 
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVA-IENQT--------RAIRAIKIMNKNKIRQ 66

Query: 124 EGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARP 183
              +  +   +EV  + +LHHPN+ +L     D +   LV E    G L + L       
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126

Query: 184 LPWTLRIKVAIG-------------------------------AAR-------GLSFLHE 205
                   V                                   +         L +LH 
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186

Query: 206 AEQQVIYRDFKASNILLDSEFNA--KLSDFGLAK---AGPTGDRTHVSTQVMGTRGYAAP 260
             Q + +RD K  N L  +  +   KL DFGL+K       G+   ++T+  GT  + AP
Sbjct: 187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAP 243

Query: 261 EYLATGRL--TAKCDVYSFGVVLLELLSGR 288
           E L T       KCD +S GV+L  LL G 
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (261), Expect = 2e-25
 Identities = 51/309 (16%), Positives = 98/309 (31%), Gaps = 69/309 (22%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKK--LKPEGFQGHKEWLSE 135
           T  F     IG G FG V+K  +            G + A+K+      G    +  L E
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC-VKRLD--------GCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 136 VNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTLRIKV 192
           V     L  H ++V+      + ++ L+  EY   GSL + +    R            +
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLD-------------------SEFNAKLSDF 233
            +   RGL ++H     +++ D K SNI +                    ++   K+ D 
Sbjct: 121 LLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELLSGRRAVD 292
           G          +    +  G   + A E L        K D+++  + ++          
Sbjct: 179 GHVTR-----ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA----- 227

Query: 293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIK---LEGQYPQKGAYMVAILALQCIS-EAK 348
                         +P   +  +   I   +   +     Q+   ++       I  + +
Sbjct: 228 --------------EPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK----VMIHPDPE 269

Query: 349 VRPSMSEVL 357
            RPS   ++
Sbjct: 270 RRPSAMALV 278

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 2e-25
 Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 36/214 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-----LSEVNYLGQ 141
           IGEG +G V+K   +  T        G ++A+KK                 L E+  L Q
Sbjct: 11  IGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESED---DPVIKKIALREIRMLKQ 58

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           L HPNLV L+          LV+EY    ++ + L  R  R +P  L   +     + ++
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVN 116

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTRGYAA 259
           F H+     I+RD K  NIL+      KL DFG A+   GP+        +V  TR Y +
Sbjct: 117 FCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVA-TRWYRS 170

Query: 260 PEYLATGRLTAKC-----DVYSFGVVLLELLSGR 288
           PE L    +         DV++ G V  ELLSG 
Sbjct: 171 PELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (260), Expect = 2e-25
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 27/224 (12%)

Query: 78  TRNFRPDSL-----IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKE 131
           +   + D L     +G G +G V K      +        G ++AVK+++     Q  K 
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKM-RHVPS--------GQIMAVKRIRATVNSQEQKR 51

Query: 132 WLSEVN-YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHL--FRRGARPLPWTL 188
            L +++  +  +  P  V   G      +  +  E M   SL+          + +P  +
Sbjct: 52  LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
             K+A+   + L  LH  +  VI+RD K SN+L+++    K+ DFG+  +G   D     
Sbjct: 111 LGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKD 167

Query: 249 TQVMGTRGYAAPEYLATGRL----TAKCDVYSFGVVLLELLSGR 288
               G + Y APE +         + K D++S G+ ++EL   R
Sbjct: 168 IDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (263), Expect = 3e-25
 Identities = 69/304 (22%), Positives = 118/304 (38%), Gaps = 46/304 (15%)

Query: 8   KKVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDIL---SCP 64
           ++    +         +      +     S   N   +    N + P+   ++      P
Sbjct: 20  RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79

Query: 65  NLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK----- 119
             +   ++  K   + + P  +IG G    V +  +   T        G   AVK     
Sbjct: 80  EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC-VHRAT--------GHEFAVKIMEVT 130

Query: 120 --KLKPEGFQGHKEWL-SEVNYLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENH 175
             +L PE  +  +E    E + L Q+  HP+++ LI          LV++ M KG L ++
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDY 190

Query: 176 LFRRG------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK 229
           L  +        R +  +L           +SFLH     +++RD K  NILLD     +
Sbjct: 191 LTEKVALSEKETRSIMRSL--------LEAVSFLHA--NNIVHRDLKPENILLDDNMQIR 240

Query: 230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTA------KCDVYSFGVVLLE 283
           LSDFG +     G++     ++ GT GY APE L             + D+++ GV+L  
Sbjct: 241 LSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297

Query: 284 LLSG 287
           LL+G
Sbjct: 298 LLAG 301

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (260), Expect = 3e-25
 Identities = 64/244 (26%), Positives = 93/244 (38%), Gaps = 42/244 (17%)

Query: 58  CDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIA 117
                    +   F         +    ++G+G FG V K   D  T            A
Sbjct: 3   HHHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKC-KDRIT--------QQEYA 51

Query: 118 VK-----KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL 172
           VK       K +          EV  L +L HPN++KL     D  +  +V E    G L
Sbjct: 52  VKVINKASAKNKDTSTIL---REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108

Query: 173 ------ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-- 224
                         A  +     IK        ++++H  +  +++RD K  NILL+S  
Sbjct: 109 FDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMH--KHNIVHRDLKPENILLESKE 158

Query: 225 -EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE 283
            + + K+ DFGL+       +       +GT  Y APE L  G    KCDV+S GV+L  
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYI 214

Query: 284 LLSG 287
           LLSG
Sbjct: 215 LLSG 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (268), Expect = 3e-25
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 45/225 (20%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK------------PEGFQGHKEWL- 133
           +G G +G V     +++             A+K +K             +  +   E + 
Sbjct: 44  LGSGAYGEVLLC-KEKNG--------HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWT 187
           +E++ L  L HPN++KL     D +   LV E+   G L   +  R       A  +   
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI--- 151

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDR 244
             +K  +     + +LH  +  +++RD K  NILL++     N K+ DFGL+       +
Sbjct: 152 --MKQILSG---ICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 245 THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
                  +GT  Y APE L   +   KCDV+S GV++  LL G  
Sbjct: 205 LR---DRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (260), Expect = 3e-25
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 44/235 (18%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK--------KLKPEGF 126
                N+ P  ++G G    V +  I + T            AVK            E  
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTGGGSFSAEEV 63

Query: 127 QGHKEWL-SEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG---- 180
           Q  +E    EV+ L ++  HPN+++L           LV++ M KG L ++L  +     
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 181 --ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
              R +   L           +  LH+    +++RD K  NILLD + N KL+DFG +  
Sbjct: 124 KETRKIMRAL--------LEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTA------KCDVYSFGVVLLELLSG 287
              G++     +V GT  Y APE +             + D++S GV++  LL+G
Sbjct: 174 LDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (261), Expect = 3e-25
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 32/211 (15%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP 145
           ++G G F  V+       T        G + A+K +K           +E+  L ++ H 
Sbjct: 16  VLGSGAFSEVFLV-KQRLT--------GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARG 199
           N+V L        +  LV + +  G L + +  RG      A  +     I+  + A   
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA--- 118

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           + +LHE    +++RD K  N+L  +        ++DFGL+K    G    + +   GT G
Sbjct: 119 VKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPG 172

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           Y APE LA    +   D +S GV+   LL G
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  106 bits (266), Expect = 4e-25
 Identities = 66/246 (26%), Positives = 98/246 (39%), Gaps = 42/246 (17%)

Query: 58  CDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIA 117
                    +   F         +    ++G+G FG V K   D  T            A
Sbjct: 3   HHHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKC-KDRIT--------QQEYA 51

Query: 118 VK-----KLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL 172
           VK       K +        L EV  L +L HPN++KL     D  +  +V E    G L
Sbjct: 52  VKVINKASAKNKDTS---TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108

Query: 173 ENHLFRRG------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-- 224
            + + +R       A  +     IK        ++++H  +  +++RD K  NILL+S  
Sbjct: 109 FDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMH--KHNIVHRDLKPENILLESKE 158

Query: 225 -EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLE 283
            + + K+ DFGL+       +       +GT  Y APE L  G    KCDV+S GV+L  
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYI 214

Query: 284 LLSGRR 289
           LLSG  
Sbjct: 215 LLSGTP 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  103 bits (260), Expect = 5e-25
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN-YLGQLHH 144
           IG G +G V K  + + +        G ++AVK+++     +  K+ L +++  +     
Sbjct: 30  IGRGAYGSVNKM-VHKPS--------GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLEN---HLFRRGARPLPWTLRIKVAIGAARGLS 201
           P +V+  G      +  +  E M   S +    +++      +P  +  K+ +   + L+
Sbjct: 81  PYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG--DRTHVSTQVMGTRGYAA 259
            L E   ++I+RD K SNILLD   N KL DFG++     G    +   T+  G R Y A
Sbjct: 140 HLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMA 193

Query: 260 PEYLATGRL----TAKCDVYSFGVVLLELLSGR 288
           PE +           + DV+S G+ L EL +GR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (261), Expect = 5e-25
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 21/212 (9%)

Query: 87  IGEGGFGYVYKGWIDEHTLE--AARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
           IG+G F  V +  I+  T +  A +     ++ V K         ++   E +    L H
Sbjct: 32  IGKGPFSVVRRC-INRETGQQFAVK-----IVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----GL 200
           P++V+L+          +V+E+M    L   + +R      ++    VA    R     L
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA--VASHYMRQILEAL 143

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            + H  +  +I+RD K   +LL S+ N+   KL  FG+A     G+   V+   +GT  +
Sbjct: 144 RYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHF 199

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
            APE +         DV+  GV+L  LLSG  
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  103 bits (260), Expect = 5e-25
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTL--EAARPGVGMVIAVKKLKPEGFQGHKEW--LSE 135
            F    ++G+G FG V+        L  + +      + A+K LK    +         E
Sbjct: 25  QFELLKVLGQGSFGKVF--------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA- 193
            + L +++HP +VKL  +    E +L L+ +++  G L   L +          +  +A 
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAE 134

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 252
           +  A  L  LH     +IYRD K  NILLD E + KL+DFGL+K     ++         
Sbjct: 135 LALA--LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFC 187

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE +     T   D +SFGV++ E+L+G 
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 6e-25
 Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 39/227 (17%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGH 129
              + N+     +G+G F  V +  + + T        G+  A K     KL    FQ  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRC-VHKTT--------GLEFAAKIINTKKLSARDFQKL 52

Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARP 183
           +    E     +L HPN+V+L     +     LV++ +  G L   +  R       A  
Sbjct: 53  E---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 109

Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGP 240
               +           +++ H     +++R+ K  N+LL S+      KL+DFGLA    
Sbjct: 110 CIQQI--------LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             +         GT GY +PE L     +   D+++ GV+L  LL G
Sbjct: 160 DSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (260), Expect = 6e-25
 Identities = 71/266 (26%), Positives = 106/266 (39%), Gaps = 40/266 (15%)

Query: 35  ASSLKTNKSEKRPSGNFSMPRTE-CDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFG 93
              + T ++         MP       L  P++    F +  +  + F     IG G FG
Sbjct: 11  DYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDLREIGHGSFG 68

Query: 94  YVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQLHHPNLVKL 150
            VY    D             V+A+KK+   G Q +++W   + EV +L +L HPN ++ 
Sbjct: 69  AVYFA-RDVRN--------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQV 210
            G  L      LV EY    + +  L     +PL       V  GA +GL++LH     +
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS--HNM 175

Query: 211 IYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ------VMGTRGYAAPEYLA 264
           I+RD KA NILL      KL DFG             ++        +GT  + APE + 
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFG------------SASIMAPANSFVGTPYWMAPEVIL 223

Query: 265 TGRLT---AKCDVYSFGVVLLELLSG 287
                    K DV+S G+  +EL   
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAER 249

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (258), Expect = 7e-25
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSE 135
            +F+   ++GEG F  V           A         A+K L+        +      E
Sbjct: 30  EDFKFGKILGEGSFSTVVL---------ARELATSREYAIKILEKRHIIKENKVPYVTRE 80

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-I 194
            + + +L HP  VKL     D E       Y   G L  ++ + G+     T R   A I
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTAEI 139

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
            +A  L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   +GT
Sbjct: 140 VSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             Y +PE L         D+++ G ++ +L++G 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (257), Expect = 8e-25
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 34/215 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           IGEG +G V+K   +  T          ++A+K+++ +      E      L E+  L +
Sbjct: 10  IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDD---DEGVPSSALREICLLKE 57

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           L H N+V+L       +   LV+E+     K   ++         L   +         +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLK 112

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTRG 256
           GL F H   + V++RD K  N+L++     KL++FGLA+A   P    +    +V+ T  
Sbjct: 113 GLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLW 166

Query: 257 YAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRA 290
           Y  P+ L   +L +   D++S G +  EL +  R 
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (259), Expect = 9e-25
 Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 35/229 (15%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE- 131
           ++K+  + +     +GEG F  VYK   D++T          ++A+KK+K       K+ 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDG 54

Query: 132 ----WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPL 184
                L E+  L +L HPN++ L+       N  LV+++M    +  ++++        L
Sbjct: 55  INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-------SL 107

Query: 185 PWTLR-IKVAIG-AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GP 240
             T   IK  +    +GL +LH+    +++RD K +N+LLD     KL+DFGLAK+   P
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
               TH   QV+ TR Y APE L   R+     D+++ G +L ELL   
Sbjct: 166 NRAYTH---QVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  101 bits (255), Expect = 1e-24
 Identities = 60/238 (25%), Positives = 93/238 (39%), Gaps = 37/238 (15%)

Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
            +               F     +G G FG V+    +  +        G+   +K +  
Sbjct: 7   HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLV-EERSS--------GLERVIKTINK 57

Query: 124 EGFQGHKEWL-SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL---------- 172
           +  Q   E + +E+  L  L HPN++K+     D  N  +V E    G L          
Sbjct: 58  DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 173 ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAK 229
              L       L     +K  + A   L++ H   Q V+++D K  NIL          K
Sbjct: 118 GKALSEGYVAEL-----MKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIK 167

Query: 230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           + DFGLA+   + + +   T   GT  Y APE      +T KCD++S GVV+  LL+G
Sbjct: 168 IIDFGLAELFKSDEHS---TNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTG 221

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (257), Expect = 2e-24
 Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 35/303 (11%)

Query: 1   MGNCYSWKKVDASLSSHA----TSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRT 56
           MG+ +        L +      +  ++   D     + A  + +N          S   +
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTS 60

Query: 57  ECDILSCPNLKAFTFSELKNATRNFR------PDSLIGEGGFGYVYKGWIDEHTLEAARP 110
              +        F    +                 ++G G FG V+K   +  T      
Sbjct: 61  ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC-EETAT------ 113

Query: 111 GVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKG 170
             G+ +A K +K  G +  +E  +E++ + QL H NL++L        + +LV EY+  G
Sbjct: 114 --GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171

Query: 171 SLENHLFRRGARPLPWTLRIKVAIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSEF 226
            L + +         + L     I   +    G+  +H  +  +++ D K  NIL  +  
Sbjct: 172 ELFDRIIDES-----YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRD 224

Query: 227 NA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLEL 284
               K+ DFGLA+     ++        GT  + APE +    ++   D++S GV+   L
Sbjct: 225 AKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYML 281

Query: 285 LSG 287
           LSG
Sbjct: 282 LSG 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 2e-24
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 31/238 (13%)

Query: 65  NLKAFTFSELKNATRNFRPDSL-----IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK 119
           + K   +  +         + L     +G G  G V+K      T        G VIAVK
Sbjct: 6   SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKT--------GHVIAVK 56

Query: 120 KLKPEG-FQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF 177
           +++  G  + +K  L +++ + + H  P +V+  G  +   +  +  E M   + +  L 
Sbjct: 57  QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LK 114

Query: 178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           +R   P+P  +  K+ +   + L +L E +  VI+RD K SNILLD     KL DFG++ 
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGIS- 172

Query: 238 AGPTG--DRTHVSTQVMGTRGYAAPEYLATGRL-----TAKCDVYSFGVVLLELLSGR 288
               G         +  G   Y APE +            + DV+S G+ L+EL +G+
Sbjct: 173 ----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  104 bits (261), Expect = 3e-24
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 32/220 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    +IG GGFG VY            +   G + A+K L  +  +  +     L+E 
Sbjct: 190 DFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 137 NYLGQLH---HPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
             L  +     P +V +  +     ++L  + + M  G L  HL + G           +
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DM 294

Query: 193 AIGAAR---GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
              AA    GL  +H   + V+YRD K +NILLD   + ++SD GLA       + H   
Sbjct: 295 RFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--A 349

Query: 250 QVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGR 288
            V GT GY APE L  G    +  D +S G +L +LL G 
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (257), Expect = 3e-24
 Identities = 68/398 (17%), Positives = 125/398 (31%), Gaps = 80/398 (20%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G +G+VYK        +          A+K+++  G         E+  L +L HPN
Sbjct: 29  VGRGTYGHVYKA-------KRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 147 LVKLIGFCLD-GENRL-LVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIGAA---- 197
           ++ L    L   + ++ L+++Y        ++ H   +  +         V +       
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-------PVQLPRGMVKS 132

Query: 198 ------RGLSFLHEAEQQVIYRDFKASNILLDSEFNA----KLSDFGLAKA--GPTGDRT 245
                  G+ +LH     V++RD K +NIL+  E       K++D G A+    P     
Sbjct: 133 LLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 246 HVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR--------RAVDKTRV 296
            +   V+ T  Y APE L   R  T   D+++ G +  ELL+                  
Sbjct: 191 DLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249

Query: 297 GAEQ-----------NLVDW-----------AKPYLGDRRKLFRIMDIKLEGQYPQKGAY 334
             +Q              DW                         +   +E    +  + 
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309

Query: 335 MVAILALQCISEAKVRPSMSEVLSA--LEQLPPPRDPASPSNSDPQVIYSPH----VKSP 388
              +L      +   R +  + +      + P P           Q+ Y        + P
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFA---GCQIPYPKREFLTEEEP 366

Query: 389 MRPNSPHLKSHLRNNYDSPVNMSPRSPLPPHMKSPILK 426
                   +   + N  +     P +    H + P LK
Sbjct: 367 DDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  101 bits (254), Expect = 4e-24
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-----LS 134
            +    L+GEG +G V K   ++ T        G ++A+KK          +      + 
Sbjct: 26  KYENLGLVGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESDD---DKMVKKIAMR 73

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           E+  L QL H NLV L+  C   +   LV+E++   ++ + L       L + +  K   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLF 131

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVM 252
               G+ F H     +I+RD K  NIL+      KL DFG A+    P         +V 
Sbjct: 132 QIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---EVA 186

Query: 253 GTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGR 288
            TR Y APE L    +     DV++ G ++ E+  G 
Sbjct: 187 -TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (256), Expect = 4e-24
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQL 142
            IG+G FG V             +     + A+K +  +      E      E+  +  L
Sbjct: 22  AIGKGSFGKVCI---------VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-IGAARGLS 201
            HP LV L     D E+  +V + +  G L  HL +          ++ +  +  A  L 
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-KLFICELVMA--LD 129

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +L    Q++I+RD K  NILLD   +  ++DF +A   P   +    T + GT+ Y APE
Sbjct: 130 YLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPE 184

Query: 262 YLATGRL---TAKCDVYSFGVVLLELLSGRR 289
             ++ +    +   D +S GV   ELL GRR
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =   99 bits (250), Expect = 5e-24
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G +G V    + + T         +  A KK+     +    +  E+  +  L HPN
Sbjct: 17  IGRGSWGEVKIA-VQKGT--------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSL------ENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +++L     D  +  LV E    G L      +       A  +     +K  + A   +
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA---V 119

Query: 201 SFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           ++ H  +  V +RD K  N L  +   +   KL DFGLA     G         +GT  Y
Sbjct: 120 AYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYY 174

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            +P+ L  G    +CD +S GV++  LL G
Sbjct: 175 VSPQVL-EGLYGPECDEWSAGVMMYVLLCG 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  100 bits (251), Expect = 6e-24
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 35/213 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           +GEG +G VYK          A+   G ++A+K+++ +      E      + E++ L +
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKE 75

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           LHHPN+V LI          LV+E+M    K  L+ +        L  +          R
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-----KTGLQDSQIKIYLYQLLR 130

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTRG 256
           G++  H  + ++++RD K  N+L++S+   KL+DFGLA+A   P    TH   +V+ T  
Sbjct: 131 GVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLW 184

Query: 257 YAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           Y AP+ L   +  +   D++S G +  E+++G+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  100 bits (251), Expect = 7e-24
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 37/221 (16%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLS 134
            +     +GEG +  VYKG   + T          ++A+K+++ E    H+E      + 
Sbjct: 3   TYIKLDKLGEGTYATVYKGK-SKLT--------DNLVALKEIRLE----HEEGAPCTAIR 49

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIK 191
           EV+ L  L H N+V L       ++  LV+EY+    K  L++         +     +K
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-----GNIINMHN-VK 103

Query: 192 VAIG-AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVS 248
           + +    RGL++ H   Q+V++RD K  N+L++     KL+DFGLA+A   PT    +  
Sbjct: 104 LFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN-- 159

Query: 249 TQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
            +V+ T  Y  P+ L      + + D++  G +  E+ +GR
Sbjct: 160 -EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  101 bits (253), Expect = 9e-24
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 25/207 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++  +++ T        G V   K +            +E++ + QLHHP 
Sbjct: 59  LGSGAFGVVHRC-VEKAT--------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----GLSF 202
           L+ L     D    +L+ E++  G L + +         + +     I   R    GL  
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKH 164

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           +H  E  +++ D K  NI+ +++  +  K+ DFGLA      +   +      T  +AAP
Sbjct: 165 MH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E +    +    D+++ GV+   LLSG
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 35/213 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           IGEG +G VYK          A+   G   A+KK++ E      E      + E++ L +
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKE 56

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           L H N+VKL       +  +LV+E++    K  L+          L         +    
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLN 111

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTRG 256
           G+++ H  +++V++RD K  N+L++ E   K++DFGLA+A   P    TH   +++ T  
Sbjct: 112 GIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLW 165

Query: 257 YAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           Y AP+ L   +  +   D++S G +  E+++G 
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLE--AARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQLH 143
           +G G F  V K   ++ T    AA+      I  ++ +       +E +  EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKKC-REKSTGLEYAAK-----FIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----G 199
           H N++ L     +  + +L+ E +  G L + L ++ +      L  + A    +    G
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDG 127

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +++LH   +++ + D K  NI+L  +     + KL DFGLA     G        + GT 
Sbjct: 128 VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTP 182

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE +    L  + D++S GV+   LLSG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 40/207 (19%), Positives = 80/207 (38%), Gaps = 26/207 (12%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           +G G FG V++  ++  +              K +K +G         E++ L    H N
Sbjct: 13  LGRGEFGIVHRC-VETSS--------KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRN 62

Query: 147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----GLSF 202
           ++ L       E  ++++E++    +   +           L  +  +         L F
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQF 117

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
           LH     + + D +  NI+  +  ++  K+ +FG A+    GD   +   +     Y AP
Sbjct: 118 LH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSG 287
           E      ++   D++S G ++  LLSG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  101 bits (253), Expect = 2e-23
 Identities = 67/214 (31%), Positives = 89/214 (41%), Gaps = 21/214 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
            F    L+G+G FG V         +       G   A+K LK E      E    L+E 
Sbjct: 149 EFEYLKLLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L    HP L  L  +     +RL  V EY   G L  HL R          R   A  
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGA-E 256

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GT 254
               L +LH +E+ V+YRD K  N++LD + + K++DFGL K G     T    +   GT
Sbjct: 257 IVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGT 312

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             Y APE L         D +  GVV+ E++ GR
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 39/222 (17%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HH 144
           ++GEG    V    I+  T            AVK ++ +          EV  L Q   H
Sbjct: 20  VLGEGAHARVQTC-INLIT--------SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAAR 198
            N+++LI F  + +   LV+E M  GS+ +H+ +R       A  +   +        A 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV--------AS 122

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKA-GPTGDRTHVSTQVM-- 252
            L FLH   + + +RD K  NIL +        K+ DF L       GD + +ST  +  
Sbjct: 123 ALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 253 --GTRGYAAPEYLATGRLTAK-----CDVYSFGVVLLELLSG 287
             G+  Y APE +      A      CD++S GV+L  LLSG
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 30/216 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW-----LSEVNYLGQ 141
           IG G +G VYK   D H+        G  +A+K ++     G         + EV  L +
Sbjct: 17  IGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 142 LH---HPNLVKLI----GFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           L    HPN+V+L+        D E ++ LV+E++ +  L  +L +     LP      + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 252
               RGL FLH     +++RD K  NIL+ S    KL+DFGLA+        T     V+
Sbjct: 127 RQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV 181

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            T  Y APE L         D++S G +  E+   +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 34/215 (15%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWL-SEVNYLG 140
           +G G F  V K    + T        G   A K     +L        +E +  EVN L 
Sbjct: 13  LGSGQFAIVRKC-RQKGT--------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR-- 198
           ++ HPN++ L     +  + +L+ E +  G L + L  + +      L    A    +  
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQI 117

Query: 199 --GLSFLHEAEQQVIYRDFKASNILLDSEFNA----KLSDFGLAKAGPTGDRTHVSTQVM 252
             G+ +LH   +++ + D K  NI+L  +       KL DFG+A     G+       + 
Sbjct: 118 LDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           GT  + APE +    L  + D++S GV+   LLSG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 28/212 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLE--AARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQLH 143
           +G G F  V K   ++ T    AA+      I  ++ +       +E +  EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKKC-REKSTGLEYAAK-----FIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----G 199
           HPN++ L     +  + +L+ E +  G L + L ++ +      L  + A    +    G
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDG 127

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           +++LH   +++ + D K  NI+L  +     + KL DFGLA     G        + GT 
Sbjct: 128 VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTP 182

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE +    L  + D++S GV+   LLSG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 33/230 (14%)

Query: 69  FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLE--AARPGVGMVIAVKKLKPEGF 126
           F  +     + N+     +G+G F  V +  + + T    AA+     +I  KKL    F
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAK-----IINTKKLSARDF 72

Query: 127 QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ 180
           Q  +    E     +L HPN+V+L     +     LV++ +  G L   +  R       
Sbjct: 73  QKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 129

Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAK 237
           A        I+  + +   +++ H     +++R+ K  N+LL S+      KL+DFGLA 
Sbjct: 130 ASHC-----IQQILES---IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                +         GT GY +PE L     +   D+++ GV+L  LL G
Sbjct: 180 EVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 66/215 (30%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    L+G+G FG V         +       G   A+K L+ E      E    ++E 
Sbjct: 6   DFDYLKLLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-I 194
             L    HP L  L  +     +RL  V EY   G L  HL R          R   A I
Sbjct: 57  RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGAEI 114

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM-G 253
            +A  L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T    +   G
Sbjct: 115 VSA--LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 167

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y APE L         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 38/220 (17%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS----EVNYLGQ 141
           L+GEG +G V +   D  TL           AVK LK +  +      +    E+  L +
Sbjct: 12  LLGEGSYGKVKEVL-DSETLCRR--------AVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 142 LHHPNLVKLIGFCLDGENRL---LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           L H N+++L+   L  E +    +V EY   G  E  +              +  +  A 
Sbjct: 63  LRHKNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQAH 112

Query: 199 --------GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
                   GL +LH   Q ++++D K  N+LL +    K+S  G+A+A            
Sbjct: 113 GYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 251 VMGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
             G+  +  PE           K D++S GV L  + +G 
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTL--EAARPGVGMVIAVKKLKPEGFQGHK---EW-L 133
            F    ++G+GG+G V+           +      G + A+K LK      +        
Sbjct: 18  CFELLRVLGKGGYGKVF--------QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69

Query: 134 SEVNYLGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           +E N L ++ HP +V LI +      +L L+ EY+  G L   L R G           +
Sbjct: 70  AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYL 127

Query: 193 A-IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           A I  A  L  LH+  + +IYRD K  NI+L+ + + KL+DFGL K           T  
Sbjct: 128 AEISMA--LGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THT 180

Query: 252 M-GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             GT  Y APE L         D +S G ++ ++L+G 
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 4e-23
 Identities = 62/298 (20%), Positives = 99/298 (33%), Gaps = 32/298 (10%)

Query: 2   GNCYSWK-----KVDASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRT 56
           G  Y ++     K   S     T+      D+          +  K  +      S    
Sbjct: 75  GKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDN 134

Query: 57  ECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVI 116
               +           +  +   ++     +G G FG V++   +  T        G   
Sbjct: 135 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV-TERAT--------GNNF 185

Query: 117 AVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL-ENH 175
           A K +        +    E+  +  L HP LV L     D    +++YE+M  G L E  
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245

Query: 176 LFRRGARPLPWTLRIKVAIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSEFNA--K 229
                       +    A+   R    GL  +H  E   ++ D K  NI+  ++ +   K
Sbjct: 246 ADEHN------KMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELK 297

Query: 230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           L DFGL           V     GT  +AAPE      +    D++S GV+   LLSG
Sbjct: 298 LIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 26/220 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTL--EAARPGVGMVIAVKKLKPEGFQGHKEW----L 133
           NF    ++G G +G V+        L  + +    G + A+K LK        +      
Sbjct: 55  NFELLKVLGTGAYGKVF--------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106

Query: 134 SEVNYLGQL-HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           +E   L  +   P LV L  +    E +L L+ +Y+  G L  HL +R         +I 
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIY 164

Query: 192 VA-IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
           V  I  A  L  LH+    +IYRD K  NILLDS  +  L+DFGL+K     +       
Sbjct: 165 VGEIVLA--LEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD- 219

Query: 251 VMGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
             GT  Y AP+ +  G        D +S GV++ ELL+G 
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 42/215 (19%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWLSEVNYLGQL- 142
           IG G +    +  I + T         M  AVK   K K +  +       E+  L +  
Sbjct: 30  IGVGSYSVCKRC-IHKAT--------NMEFAVKIIDKSKRDPTE-------EIEILLRYG 73

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGA 196
            HPN++ L     DG+   +V E M  G L + + R+       A  + +T+        
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI-------- 125

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNA----KLSDFGLAKAGPTGDRTHVSTQVM 252
            + + +LH   Q V++RD K SNIL   E       ++ DFG AK     +   +     
Sbjct: 126 TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPC 181

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            T  + APE L      A CD++S GV+L  +L+G
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.4 bits (243), Expect = 9e-23
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 40/214 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK---KLKPEGFQGHKEWLSEVNYLGQL- 142
           +GEG F    K  + + +            AVK   K      Q       E+  L    
Sbjct: 19  LGEGSFSICRKC-VHKKS--------NQAFAVKIISKRMEANTQ------KEITALKLCE 63

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGA 196
            HPN+VKL     D  +  LV E +  G L   + ++       A  +     ++  + A
Sbjct: 64  GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA 118

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMG 253
              +S +H+    V++RD K  N+L   E  N   K+ DFG A+  P  +          
Sbjct: 119 ---VSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCF 171

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T  YAAPE L        CD++S GV+L  +LSG
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLE--AARPGVGMVIAVKKLKPEGFQGHKEWL-SEVNYLGQLH 143
           +G G F  V K   ++ T    AA+      I  ++ K       +E +  EV+ L ++ 
Sbjct: 19  LGSGQFAVVKKC-REKSTGLQYAAK-----FIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----G 199
           HPN++ L     +  + +L+ E +  G L + L  +       +L  + A    +    G
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNG 126

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNA----KLSDFGLAKAGPTGDRTHVSTQVMGTR 255
           + +LH    Q+ + D K  NI+L          K+ DFGLA     G+       + GT 
Sbjct: 127 VYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTP 181

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            + APE +    L  + D++S GV+   LLSG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 57/233 (24%), Positives = 87/233 (37%), Gaps = 43/233 (18%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGH 129
           K     +     +G G  G V     +  T           +A+K     K      +  
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIKIISKRKFAIGSAREA 56

Query: 130 KEWLS---EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSL------ENHLFRRG 180
              L+   E+  L +L+HP ++K+  F  D E+  +V E M  G L         L    
Sbjct: 57  DPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT 115

Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFGLAK 237
            +           + A   + +LH  E  +I+RD K  N+LL S   +   K++DFG +K
Sbjct: 116 CKLY-----FYQMLLA---VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRL---TAKCDVYSFGVVLLELLSG 287
                        + GT  Y APE L +          D +S GV+L   LSG
Sbjct: 166 ILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 66/242 (27%), Positives = 101/242 (41%), Gaps = 39/242 (16%)

Query: 65  NLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE 124
           N  A      +     F+ + + G+G FG V  G  ++ T        GM +A+KK+   
Sbjct: 9   NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLG-KEKST--------GMSVAIKKV--- 56

Query: 125 GFQGHKEW----LSEVNYLGQLHHPNLVKLI------GFCLDGENRL-LVYEYMPKGSLE 173
             Q    +    L  +  L  LHHPN+V+L       G     +  L +V EY+P  +L 
Sbjct: 57  -IQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH 113

Query: 174 NHL--FRRGARPLPWTLRIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-K 229
                + R     P  L IKV +    R +  LH     V +RD K  N+L++      K
Sbjct: 114 RCCRNYYRRQVAPPPIL-IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172

Query: 230 LSDFGLAKA-GPTGDRTH-VSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLS 286
           L DFG AK   P+      +      +R Y APE +   +  T   D++S G +  E++ 
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC-----SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

Query: 287 GR 288
           G 
Sbjct: 228 GE 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 37/269 (13%)

Query: 35  ASSLKTNKSEKRPS--GNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLIGEGGF 92
            S  ++ K  ++PS  G+  + R +        +        +    ++    +IG G F
Sbjct: 8   TSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSF 67

Query: 93  GYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIG 152
           G VY+      +        G ++A+KK+     Q  +    E+  + +L H N+V+L  
Sbjct: 68  GVVYQA-KLCDS--------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 114

Query: 153 -FCLDGENRL-----LVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAI-GAARGLSFL 203
            F   GE +      LV +Y+P+ ++      + R  + LP  + +K+ +    R L+++
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYI 172

Query: 204 HEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAAP 260
           H     + +RD K  N+LLD +    KL DFG AK    G+   +++      +R Y AP
Sbjct: 173 HSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRYYRAP 225

Query: 261 EYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           E +      T+  DV+S G VL ELL G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 33/214 (15%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +GEG +G V    ++  T           +AVK +  +      E +  E+     L+H
Sbjct: 14  TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 145 PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR------ 198
            N+VK  G   +G  + L  EY   G L + +               +    A+      
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQL 114

Query: 199 --GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
             G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  
Sbjct: 115 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 257 YAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
           Y APE L   R       DV+S G+VL  +L+G 
Sbjct: 173 YVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGE 205

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           IGEG +G V+K    ++         G  +A+K+++ +     +E      + EV  L  
Sbjct: 19  IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTG---EEGMPLSTIREVAVLRH 67

Query: 142 LH---HPNLVKLI----GFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
           L    HPN+V+L         D E +L LV+E++ +  L  +L +     +P      + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 252
               RGL FLH    +V++RD K  NIL+ S    KL+DFGLA+        T     V+
Sbjct: 127 FQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV 181

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            T  Y APE L         D++S G +  E+   +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 59/216 (27%), Positives = 81/216 (37%), Gaps = 29/216 (13%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           +IG G F  V                 G V A+K +         E   +  E + L   
Sbjct: 68  VIGRGAFSEVAV---------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118

Query: 143 HHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGAR-PLPWTLRIKVA-IGAARG 199
               + +L  F    EN L LV EY   G L   L + G R P     R  +A I  A  
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA-- 174

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           +  +H      ++RD K  NILLD   + +L+DFG                V GT  Y +
Sbjct: 175 IDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLS 231

Query: 260 PEYL-------ATGRLTAKCDVYSFGVVLLELLSGR 288
           PE L        TG    +CD ++ GV   E+  G+
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 28/211 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLE--AARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-H 143
           +G G F  V +  I + T +  AA+      +  ++   +      E L E+  L     
Sbjct: 37  LGRGKFAVVRQC-ISKSTGQEYAAK-----FLKKRRRGQDC---RAEILHEIAVLELAKS 87

Query: 144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----G 199
            P ++ L     +    +L+ EY   G  E  +F      L   +     I   +    G
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           + +LH+    +++ D K  NILL S +   + K+ DFG+++             +MGT  
Sbjct: 144 VYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPE 198

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           Y APE L    +T   D+++ G++   LL+ 
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 80/384 (20%), Positives = 118/384 (30%), Gaps = 80/384 (20%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           +IG G FG V                   V A+K L         E   +  E + L   
Sbjct: 81  VIGRGAFGEVAV---------VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR-PLPWTLRIKVA-IGAARGL 200
               +  L     D  N  LV +Y   G L   L +   R P     R  +A +  A  +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--I 188

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
             +H+     ++RD K  NIL+D   + +L+DFG             S  V GT  Y +P
Sbjct: 189 DSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISP 245

Query: 261 EYLATGRLTAK-----CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP-YLGDRR 314
           E L             CD +S GV + E+L G                    P Y     
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE------------------TPFYAESLV 287

Query: 315 KLF-RIMDIKLEGQYPQKGAYMVA-----ILALQC----------ISEAKVRPSMSEVL- 357
           + + +IM+ K   Q+P +   +       I  L C          I + K  P  S +  
Sbjct: 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347

Query: 358 SALEQLPPP-----RDPASPSNSDPQVIYSPHVKSPMRPNSPHLK--------------S 398
             +     P       P   SN D       + ++   P                     
Sbjct: 348 DNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSC 407

Query: 399 HLRNNYDSPVNMSPRSPLPPHMKS 422
            L +     V   P S    + +S
Sbjct: 408 VLSDRSCLRVTAGPTSAENLYFQS 431

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 44/219 (20%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLG 140
            +G G FG V  G   EH L       G  +AVK     K++     G  +   E+  L 
Sbjct: 18  TLGVGTFGKVKIG---EHQL------TGHKVAVKILNRQKIRSLDVVGKIK--REIQNLK 66

Query: 141 QLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR- 198
              HP+++KL    +       +V EY+  G L +++ + G          +V    AR 
Sbjct: 67  LFRHPHIIKLYQ-VISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARR 115

Query: 199 -------GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                   + + H     V++RD K  N+LLD+  NAK++DFGL+     G+    S   
Sbjct: 116 LFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 171

Query: 252 MGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
            G+  YAAPE ++ GRL    + D++S GV+L  LL G 
Sbjct: 172 -GSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGT 208

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 23/213 (10%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
            F     +G G FG V                 G   A+K L  +     K+    L+E 
Sbjct: 42  QFDRIKTLGTGSFGRVML---------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-IG 195
             L  ++ P LVKL     D  N  +V EY+  G + +HL R G    P   R   A I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIV 151

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
                 +LH     +IYRD K  N+L+D +   +++DFG AK      RT     + GT 
Sbjct: 152 LT--FEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTP 202

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
              APE + +       D ++ GV++ E+ +G 
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 40/222 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK----PEGFQGHKEWLSEVNYLGQL 142
           IG+G FG V+K      T        G  +A+KK+      EGF      L E+  L  L
Sbjct: 25  IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITA--LREIKILQLL 73

Query: 143 HHPNLVKLIGFCLDGENRL--------LVYEYMP---KGSLENHLFRRGARPLPWTLR-I 190
            H N+V LI  C    +          LV+++      G L N         + +TL  I
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEI 126

Query: 191 K-VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--GPTGDRTHV 247
           K V      GL ++H    ++++RD KA+N+L+  +   KL+DFGLA+A       + + 
Sbjct: 127 KRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 248 STQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
            T  + T  Y  PE L   R      D++  G ++ E+ +  
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.3 bits (237), Expect = 5e-22
 Identities = 42/228 (18%), Positives = 81/228 (35%), Gaps = 19/228 (8%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
             +   R  +  + +   G    +  W++    +       + +  +             
Sbjct: 47  AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106

Query: 133 LS--EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLP---WT 187
               ++  +      N V  +          +  +   K +L++ + RR +         
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA--------- 238
           L I + I  A  + FLH   + +++RD K SNI    +   K+ DFGL  A         
Sbjct: 167 LHIFIQI--AEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222

Query: 239 -GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELL 285
                      T  +GT+ Y +PE +     + K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 19/82 (23%), Positives = 38/82 (46%), Gaps = 10/82 (12%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVN 137
            +F P   +G GGFG V++    ++ ++          A+K+++ P      ++ + EV 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEA---KNKVD------DCNYAIKRIRLPNRELAREKVMREVK 56

Query: 138 YLGQLHHPNLVKLIGFCLDGEN 159
            L +L HP +V+     L+   
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPP 78

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    +IG G +  V         L         + A+K +K E     ++     +E 
Sbjct: 10  DFDLLRVIGRGSYAKV---------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60

Query: 137 NYLGQ-LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA- 193
           +   Q  +HP LV L   C   E+RL  V EY+  G L  H+ R+   P     R   A 
Sbjct: 61  HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAE 118

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 252
           I  A  L++LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G     T   T    
Sbjct: 119 ISLA--LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFC 171

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L         D ++ GV++ E+++GR
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 41/216 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLGQ 141
           IG+G F  V       H L       G  +A+K     +L P   Q       EV  +  
Sbjct: 23  IGKGNFAKVKLA---RHIL------TGREVAIKIIDKTQLNPTSLQKLF---REVRIMKI 70

Query: 142 LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAI 194
           L+HPN+VKL    ++ E  L L+ EY   G + ++L   G      AR     +      
Sbjct: 71  LNHPNIVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------ 123

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
                + + H+  +++++RD KA N+LLD++ N K++DFG +     G +        G 
Sbjct: 124 --VSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GA 176

Query: 255 RGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
             YAAPE    G+     + DV+S GV+L  L+SG 
Sbjct: 177 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGS 211

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 40/218 (18%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLGQ 141
           +GEG +G VYK  ID  T           +A+K+++ E     +E      + EV+ L +
Sbjct: 42  LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEHE---EEGVPGTAIREVSLLKE 89

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMP---KGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           L H N+++L           L++EY     K  ++ +        +   +          
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQLIN 143

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNA-----KLSDFGLAKA--GPTGDRTHVSTQV 251
           G++F H   ++ ++RD K  N+LL     +     K+ DFGLA+A   P    TH   ++
Sbjct: 144 GVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EI 198

Query: 252 MGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           + T  Y  PE L   R  +   D++S   +  E+L   
Sbjct: 199 I-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 44/218 (20%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HH 144
           ++G G  G V +      T        G   A+K L         +   EV++  Q    
Sbjct: 36  VLGLGVNGKVLEC-FHRRT--------GQKCALKLLYD-----SPKARQEVDHHWQASGG 81

Query: 145 PNLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRG--------ARPLPWTLRIKV 192
           P++V ++    +  +     L++ E M  G L + +  RG        A  +   +    
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI---- 137

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NA--KLSDFGLAKAGPTGDRTHVST 249
                  + FLH     + +RD K  N+L  S+  +A  KL+DFG AK         + T
Sbjct: 138 ----GTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQT 188

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
               T  Y APE L   +    CD++S GV++  LL G
Sbjct: 189 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 95.4 bits (238), Expect = 7e-22
 Identities = 72/210 (34%), Positives = 94/210 (44%), Gaps = 25/210 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQ- 141
           +IG+G FG V         L A      +  AVK L+ +     KE    +SE N L + 
Sbjct: 45  VIGKGSFGKV---------LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95

Query: 142 LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-IGAARG 199
           + HP LV L  F     ++L  V +Y+  G L  HL R      P   R   A I +A  
Sbjct: 96  VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASA-- 151

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTRGYA 258
           L +LH     ++YRD K  NILLDS+ +  L+DFGL K     + T   T    GT  Y 
Sbjct: 152 LGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYL 206

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           APE L         D +  G VL E+L G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 35/215 (16%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS-EVNYLGQLHH 144
            +GEG +G V    ++  T           +AVK +  +      E +  E+     L+H
Sbjct: 14  TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 145 PNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR----- 198
            N+VK  G      N   L  EY   G L + +               +    A+     
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQ 113

Query: 199 ---GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
              G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT 
Sbjct: 114 LMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 256 GYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
            Y APE L   R       DV+S G+VL  +L+G 
Sbjct: 172 PYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGE 205

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 38/227 (16%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGH 129
              T  ++    +G+G F  V +  +            G   A       KL     Q  
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRC-VKVLA--------GQEYAAMIINTKKLSARDHQKL 57

Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARP 183
           +    E      L HPN+V+L     +  +  L+++ +  G L   +  R       A  
Sbjct: 58  E---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 114

Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA---KLSDFGLAKAGP 240
                 I+  + A   +   H+    V++R+ K  N+LL S+      KL+DFGLA    
Sbjct: 115 C-----IQQILEA---VLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
                       GT GY +PE L         D+++ GV+L  LL G
Sbjct: 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 36/215 (16%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG G FG V++      + E         +A+KK+     Q  +    E+  +  + HPN
Sbjct: 48  IGNGSFGVVFQA-KLVESDE---------VAIKKV----LQDKRFKNRELQIMRIVKHPN 93

Query: 147 LVKLIGF-----CLDGENRL-LVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAI-GAA 197
           +V L  F         E  L LV EY+P+ ++      + +  + +P  L IK+ +    
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLL 151

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGT 254
           R L+++H     + +RD K  N+LLD      KL DFG AK           +      +
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-----S 204

Query: 255 RGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGR 288
           R Y APE +      T   D++S G V+ EL+ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    ++G+G FG V         + + R G   + AVK LK +      +    + E 
Sbjct: 21  DFNFLMVLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71

Query: 137 NYLGQ-LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA- 193
             L      P L +L   C    +RL  V EY+  G L  H+ + G    P       A 
Sbjct: 72  RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAAE 129

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 252
           I     L FL    + +IYRD K  N++LDSE + K++DFG+ K       T   T+   
Sbjct: 130 IAIG--LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFC 182

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE +A        D ++FGV+L E+L+G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 96.2 bits (239), Expect = 2e-21
 Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    ++G+G FG V         + + R G   + AVK LK +      +    + E 
Sbjct: 342 DFNFLMVLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392

Query: 137 NYLGQ-LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
             L      P L +L   C    +RL  V EY+  G L  H+ + G    P  +     I
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM-G 253
             A GL FL    + +IYRD K  N++LDSE + K++DFG+ K       T   T+   G
Sbjct: 452 --AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 504

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T  Y APE +A        D ++FGV+L E+L+G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    +IG G +  V         L         + A++ +K E     ++     +E 
Sbjct: 53  DFDLLRVIGRGSYAKV---------LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103

Query: 137 NYLGQ-LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA- 193
           +   Q  +HP LV L   C   E+RL  V EY+  G L  H+ R+   P     R   A 
Sbjct: 104 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAE 161

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 252
           I  A  L++LHE  + +IYRD K  N+LLDSE + KL+D+G+ K G     T   T    
Sbjct: 162 ISLA--LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFC 214

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L         D ++ GV++ E+++GR
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 61/211 (28%), Positives = 82/211 (38%), Gaps = 24/211 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSEVNYLGQL 142
           +IG G FG V                   V A+K L         +   +  E + +   
Sbjct: 76  VIGRGAFGEVQL---------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-IGAARGLS 201
           + P +V+L     D     +V EYMP G L N +      P  W  R   A +  A  L 
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWA-RFYTAEVVLA--LD 182

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
            +H      I+RD K  N+LLD   + KL+DFG              T V GT  Y +PE
Sbjct: 183 AIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239

Query: 262 YL----ATGRLTAKCDVYSFGVVLLELLSGR 288
            L      G    +CD +S GV L E+L G 
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 63/216 (29%), Positives = 88/216 (40%), Gaps = 25/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    ++G+G FG V           A         A+K LK +      +    + E 
Sbjct: 18  DFILHKMLGKGSFGKV---------FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 137 NYLGQ-LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA- 193
             L     HP L  +       +  L  V EY+  G L  H+       L        A 
Sbjct: 69  RVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-TFYAAE 126

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 252
           I     L FLH   + ++YRD K  NILLD + + K++DFG+ K    GD     T    
Sbjct: 127 IILG--LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFC 179

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L   +     D +SFGV+L E+L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 50/226 (22%), Positives = 84/226 (37%), Gaps = 40/226 (17%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWL- 133
            +   S +G G FG+V+         +         + VK     K+  + +    +   
Sbjct: 25  KYSTMSPLGSGAFGFVWTA---VDKEK------NKEVVVKFIKKEKVLEDCWIEDPKLGK 75

Query: 134 --SEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGS-LENHLFRRG------ARPL 184
              E+  L ++ H N++K++    +     LV E    G  L   + R        A  +
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135

Query: 185 PWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDR 244
              L           + +L    + +I+RD K  NI++  +F  KL DFG A     G  
Sbjct: 136 FRQL--------VSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185

Query: 245 THVSTQVMGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
            +      GT  Y APE L  G      + +++S GV L  L+   
Sbjct: 186 FYTFC---GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEE 227

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 61/269 (22%), Positives = 99/269 (36%), Gaps = 34/269 (12%)

Query: 28  KNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTFSELKNATRNFRPDSLI 87
            + + S    L T     +   + +           P+      S     +  F  +S +
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYW-IDGSNRDALSDFFEVESEL 61

Query: 88  GEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL 147
           G G    VY+           + G     A+K LK       K   +E+  L +L HPN+
Sbjct: 62  GRGATSIVYR---------CKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNI 110

Query: 148 VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG------ARPLPWTLRIKVAIGAARGLS 201
           +KL           LV E +  G L + +  +G      A      +           ++
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI--------LEAVA 162

Query: 202 FLHEAEQQVIYRDFKASNILL---DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           +LHE    +++RD K  N+L      +   K++DFGL+K             V GT GY 
Sbjct: 163 YLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYC 217

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSG 287
           APE L       + D++S G++   LL G
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCG 246

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 69/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           NF    ++G+G FG V         + A     G + AVK LK +      +    ++E 
Sbjct: 24  NFEFIRVLGKGSFGKV---------MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74

Query: 137 NYLGQ-LHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVA- 193
             L    +HP L +L   C    +RL  V E++  G L  H+ +          R   A 
Sbjct: 75  RILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-RFYAAE 132

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 252
           I +A  L FLH+  + +IYRD K  N+LLD E + KL+DFG+ K G     T   T    
Sbjct: 133 IISA--LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFC 185

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           GT  Y APE L         D ++ GV+L E+L G 
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 91.4 bits (228), Expect = 9e-21
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEVNYLGQL 142
            +G G FG V+                G   A+K LK E     K+      E   L  +
Sbjct: 13  TLGTGSFGRVHL---------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA-IGAARGLS 201
            HP ++++ G   D +   ++ +Y+  G L + L +    P P   +   A +  A  L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCLA--LE 120

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE 261
           +LH   + +IYRD K  NILLD   + K++DFG AK     D T+  T + GT  Y APE
Sbjct: 121 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY--T-LCGTPDYIAPE 173

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGR 288
            ++T       D +SFG+++ E+L+G 
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGY 200

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 44/219 (20%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLG 140
            +G G FG V  G   +H L       G  +AVK     K++     G      E+  L 
Sbjct: 23  TLGVGTFGKVKVG---KHEL------TGHKVAVKILNRQKIRSLDVVGKIR--REIQNLK 71

Query: 141 QLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR- 198
              HP+++KL    +   + + +V EY+  G L +++ + G          ++    +R 
Sbjct: 72  LFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESRR 120

Query: 199 -------GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                  G+ + H     V++RD K  N+LLD+  NAK++DFGL+     G+    S   
Sbjct: 121 LFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176

Query: 252 MGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
            G+  YAAPE ++ GRL    + D++S GV+L  LL G 
Sbjct: 177 -GSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGT 213

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 39/230 (16%)

Query: 86  LIGEGGFGYVYKGW------------IDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
            IG+G +G V   +            + +  L                   G        
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 134 S-----EVNYLGQLHHPNLVKLIGFCLDGENRL---LVYEYMPKGSLENHLFRRGARPLP 185
                 E+  L +L HPN+VKL+   LD  N     +V+E + +G +             
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV----MEVPTLK-- 132

Query: 186 WTLRIKVAIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             L    A    +    G+ +LH   Q++I+RD K SN+L+  + + K++DFG++     
Sbjct: 133 -PLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFK 188

Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLT---AKCDVYSFGVVLLELLSGR 288
           G    +S  V GT  + APE L+  R        DV++ GV L   + G+
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 45/219 (20%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLG 140
            +GEG FG V       H            +A+K      LK        E   E++YL 
Sbjct: 16  TLGEGSFGKVKLA---THYK------TQQKVALKFISRQLLKKSDMHMRVE--REISYLK 64

Query: 141 QLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR- 198
            L HP+++KL    +     + +V EY   G L +++  +           ++     R 
Sbjct: 65  LLRHPHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTEDEGRR 112

Query: 199 -------GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                   + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S   
Sbjct: 113 FFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-- 168

Query: 252 MGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
            G+  YAAPE +  G+L    + DV+S G+VL  +L GR
Sbjct: 169 -GSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGR 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 36/224 (16%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLS 134
            ++   L+G GGFG VY G I             + +A+K     ++   G   +   + 
Sbjct: 44  QYQVGPLLGSGGFGSVYSG-IRVSD--------NLPVAIKHVEKDRISDWGELPNGTRVP 94

Query: 135 -EVNYLGQLHH--PNLVKLIGFCLDGENRLLVYEY-MPKGSLENHLFRRGARPLPWTLRI 190
            EV  L ++      +++L+ +    ++ +L+ E   P   L + +  RGA      L+ 
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA------LQE 148

Query: 191 KVAIGAAR----GLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAKAGPTGDRT 245
           ++A          +   H     V++RD K  NIL+D      KL DFG   A       
Sbjct: 149 ELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 205

Query: 246 HVSTQVMGTRGYAAPEYLATGRLTA-KCDVYSFGVVLLELLSGR 288
                  GTR Y+ PE++   R       V+S G++L +++ G 
Sbjct: 206 TDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 51/228 (22%), Positives = 93/228 (40%), Gaps = 42/228 (18%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWL- 133
            +R   L+G+GGFG V+ G       +       + +A+K     ++             
Sbjct: 32  EYRLGPLLGKGGFGTVFAG---HRLTD------RLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 134 SEVNYLGQLH----HPNLVKLIGFCLDGENRLLVYEY-MPKGSLENHLFRRG------AR 182
            EV  L ++     HP +++L+ +    E  +LV E  +P   L +++  +G      +R
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142

Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPT 241
                +           +   H   + V++RD K  NIL+D      KL DFG   A   
Sbjct: 143 CFFGQV--------VAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLH 191

Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLT-AKCDVYSFGVVLLELLSGR 288
            +         GTR Y+ PE+++  +       V+S G++L +++ G 
Sbjct: 192 DEPYTDFD---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 37/214 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHP 145
           +G G  G V +   ++ T            A+K L+        +   EV    +    P
Sbjct: 70  LGLGINGKVLQI-FNKRT--------QEKFALKMLQD-----CPKARREVELHWRASQCP 115

Query: 146 NLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRGARPLPWTLR-----IKVAIGA 196
           ++V+++    +        L+V E +  G L + +  RG +    T R     +K    A
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEA 173

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQVMG 253
              + +LH     + +RD K  N+L  S+  NA  KL+DFG AK   + +   ++T    
Sbjct: 174 ---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-Y 225

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
           T  Y APE L   +    CD++S GV++  LL G
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 58/220 (26%), Positives = 82/220 (37%), Gaps = 48/220 (21%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK-----KLKPEGFQGHKEWLSEVNYLG 140
            IG G FG       D+ T          ++AVK         E  Q       E+    
Sbjct: 27  DIGSGNFGVARLM-RDKLT--------KELVAVKYIERGAAIDENVQ------REIINHR 71

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR-- 198
            L HPN+V+     L   +  ++ EY   G L   +   G          + +   AR  
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFF 121

Query: 199 ------GLSFLHEAEQQVIYRDFKASNILLDSEF--NAKLSDFGLAKAGPTGDRTHVSTQ 250
                 G+S+ H    Q+ +RD K  N LLD       K+ DFG +K+     +    + 
Sbjct: 122 FQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--ST 177

Query: 251 VMGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGR 288
           V GT  Y APE L   +       DV+S GV L  +L G 
Sbjct: 178 V-GTPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGA 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 45/228 (19%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
            + ++    IG G  G V     D              +A+KKL    FQ     K    
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKL-SRPFQNQTHAKRAYR 73

Query: 135 EVNYLGQLHHPNLVKLI-----GFCLDGENRL-LVYEYMP-------KGSLEN-HLFRRG 180
           E+  +  ++H N++ L+        L+    + +V E M        +  L++  +    
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM---- 129

Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
              L + +          G+  LH A   +I+RD K SNI++ S+   K+ DFGLA    
Sbjct: 130 -SYLLYQM--------LCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---R 175

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           T   + + T  + TR Y APE +         D++S G ++ E++ G 
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 31/221 (14%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
            + ++    IG G  G V     D              +A+KKL    FQ     K    
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKL-SRPFQNQTHAKRAYR 110

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL------LVYEYMPKGSLENHLFRRGARPLPWTL 188
           E+  +  ++H N++ L+      +         LV E M     + +L +     L    
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL-DHE 164

Query: 189 RIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           R+   +     G+  LH A   +I+RD K SNI++ S+   K+ DFGLA+   T   + +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 219

Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            T  + TR Y APE +         D++S G ++ E++  +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 62/237 (26%), Positives = 95/237 (40%), Gaps = 59/237 (24%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
              +   S IGEG +G V     D            + +A+KK+ P  F+     +  L 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISP--FEHQTYCQRTLR 74

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-----LVYEYMP--------KGSLEN------- 174
           E+  L +  H N++ +                +V + M            L N       
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134

Query: 175 -HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF 233
             + R                    GL ++H A   V++RD K SN+LL++  + K+ DF
Sbjct: 135 YQILR--------------------GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDF 172

Query: 234 GLAK-AGPTGDRTHVSTQVMGTRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
           GLA+ A P  D T   T+ + TR Y APE  L +   T   D++S G +L E+LS R
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 53/229 (23%), Positives = 81/229 (35%), Gaps = 36/229 (15%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW----- 132
              +     I  G +G V           A     G+ +A+K++      G         
Sbjct: 21  QSPYTVQRFISSGSYGAVC----------AGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 133 ------LSEVNYLGQLHHPNLVKLIGFCLDGENRL-----LVYEYMPKGSLENHLFRRGA 181
                 L E+  L   HHPN++ L    +  E        LV E M    L   +     
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQR 128

Query: 182 RPLPWTLRIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
             +     I+  +     GL  LHEA   V++RD    NILL    +  + DF LA+   
Sbjct: 129 IVIS-PQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 241 TGDRTHVSTQVMGTRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
                   T  +  R Y APE  +     T   D++S G V+ E+ + +
Sbjct: 186 ADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.4 bits (209), Expect = 6e-18
 Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 63/258 (24%)

Query: 74  LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWL 133
           L+ +++ +     +G G FG V +   D  +        G   A+KK+     Q  +   
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEV-FDIES--------GKRFALKKV----LQDPRYKN 48

Query: 134 SEVNYLGQLHHPNLVKLIGF-------------------------------------CLD 156
            E++ +  L H N++KL+ +                                        
Sbjct: 49  RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108

Query: 157 GENRL-LVYEYMPKGSLENHL--FRRGARPLPWTLRIKVAI-GAARGLSFLHEAEQQVIY 212
               L ++ EY+P  +L   L  F R  R +P    I + I    R + F+H     + +
Sbjct: 109 QNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL--GICH 164

Query: 213 RDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TA 270
           RD K  N+L++S+ N  KL DFG AK     +   V+     +R Y APE +      T 
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC--SRFYRAPELMLGATEYTP 221

Query: 271 KCDVYSFGVVLLELLSGR 288
             D++S G V  EL+ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 50/237 (21%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN 137
              +     +G GG G V+   +D              +A+KK+     Q  K  L E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIVLTDPQSVKHALREIK 60

Query: 138 YLGQLHHPNLVKLI-------------GFCLDGENRL-LVYEYMP--------KGSLEN- 174
            + +L H N+VK+                 L   N + +V EYM         +G L   
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 175 HLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDF 233
           H      R   + L         RGL ++H A   V++RD K +N+ +++E    K+ DF
Sbjct: 121 HA-----RLFMYQL--------LRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDF 165

Query: 234 GLAK-AGPTGDRTHVSTQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
           GLA+   P        ++ + T+ Y +P   L+    T   D+++ G +  E+L+G+
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 37/213 (17%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHP 145
           +G G +  V++   +              + VK LKP      K+   E+  L  L   P
Sbjct: 44  LGRGKYSEVFEAI-NITN--------NEKVVVKILKPV---KKKKIKREIKILENLRGGP 91

Query: 146 NLVKLIGFCLDGENR--LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI-GAARGLSF 202
           N++ L     D  +R   LV+E+     + N  F++  + L     I+  +    + L +
Sbjct: 92  NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLT-DYDIRFYMYEILKALDY 145

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNA-KLSDFGLAKAGPTGDRTHVSTQVM----GTRGY 257
            H     +++RD K  N+++D E    +L D+GLA         +   Q       +R +
Sbjct: 146 CHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLA-------EFYHPGQEYNVRVASRYF 196

Query: 258 AAPEYLATGRL-TAKCDVYSFGVVLLELLSGRR 289
             PE L   ++     D++S G +L  ++  + 
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 59/245 (24%), Positives = 92/245 (37%), Gaps = 68/245 (27%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
           + +F+  SL+GEG +G V      + T        G ++A+KK++P  F         L 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEP--FDKPLFALRTLR 58

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-----LVYEYMP--------KGSLEN-H----- 175
           E+  L    H N++ +                ++ E M            L + H     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118

Query: 176 ---LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD 232
              L                     R +  LH +   VI+RD K SN+L++S  + K+ D
Sbjct: 119 YQTL---------------------RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCD 155

Query: 233 FGLA----KAGPTGDRTHVSTQVM----GTRGYAAPEY-LATGRLTAKCDVYSFGVVLLE 283
           FGLA    ++             M     TR Y APE  L + + +   DV+S G +L E
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

Query: 284 LLSGR 288
           L   R
Sbjct: 216 LFLRR 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 48/229 (20%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
            + +   + +G G +G V    ID+ +        G  +A+KKL    FQ     K    
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKL-SRPFQSEIFAKRAYR 72

Query: 135 EVNYLGQLHHPNLVKLI-----GFCLDGENRL-LVYEYMP-------KGSL-ENHLFRRG 180
           E+  L  + H N++ L+        L       LV  +M             E  +    
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI---- 128

Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
            + L + +         +GL ++H A   V++RD K  N+ ++ +   K+ DFGLA+   
Sbjct: 129 -QYLVYQM--------LKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH-- 175

Query: 241 TGDRTHVSTQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
                   T  + TR Y APE  L+        D++S G ++ E+L+G+
Sbjct: 176 ---ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.7 bits (189), Expect = 8e-16
 Identities = 32/212 (15%), Positives = 59/212 (27%), Gaps = 47/212 (22%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVN 137
           +R     G       ++   D       R      +A+  + P+G       +E LS   
Sbjct: 33  YRLLIFHGGVPPLQFWQAL-DTAL---DRQ-----VALTFVDPQGVLPDDVLQETLSRTL 83

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            L ++  P + +++         L+V E++  GSL+  +      P    +R       A
Sbjct: 84  RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSP-VGAIRA--MQSLA 139

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
                 H A   V       S + +  + +  L+                          
Sbjct: 140 AAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA----------------------T 175

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
                        + D+   G  L  LL  R 
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNRW 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 33/222 (14%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
              +R    +G G +G V    +D  T        G  +A+KKL    FQ     K    
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKL-YRPFQSELFAKRAYR 73

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL------LVYEYMPKGSLENHLFRRGARPLPWTL 188
           E+  L  + H N++ L+      E         LV  +M  G+    L +     L    
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLGED- 128

Query: 189 RIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
           RI+  +    +GL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+   +      
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----- 181

Query: 248 STQVMGTRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
            T  + TR Y APE  L   R T   D++S G ++ E+++G+
Sbjct: 182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 46/250 (18%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
             N+    LIG G +GYVY    D++T           +A+KK+    F+     K  L 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKV-NRMFEDLIDCKRILR 74

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL-----LVYEYMPKGSLENHLFRRGARPLPWTLR 189
           E+  L +L    +++L    +  +        +V E     S    LF+     L     
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-IFLT-EEH 130

Query: 190 IKVAIG-AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
           IK  +     G +F+HE+   +I+RD K +N LL+ + + K+ DFGLA+   +   T++ 
Sbjct: 131 IKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 249 TQVMG--------------------TRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSG 287
             +                      TR Y APE  L     T   D++S G +  ELL+ 
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

Query: 288 RRAVDKTRVG 297
            ++       
Sbjct: 249 LQSHINDPTN 258

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 33/222 (14%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
              ++  S +G G +G V   + D  T        G+ +AVKKL    FQ     K    
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF-DTKT--------GLRVAVKKL-SRPFQSIIHAKRTYR 77

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRL------LVYEYMPKGSLENHLFRRGARPLPWTL 188
           E+  L  + H N++ L+       +        LV   M    L N++ +   + L    
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL-NNIVK--CQKLT-DD 132

Query: 189 RIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
            ++  I    RGL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+          
Sbjct: 133 HVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADE 185

Query: 248 STQVMGTRGYAAPE-YLATGRLTAKCDVYSFGVVLLELLSGR 288
            T  + TR Y APE  L         D++S G ++ ELL+GR
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 61/312 (19%), Positives = 115/312 (36%), Gaps = 72/312 (23%)

Query: 12  ASLSSHATSGDTKLPDKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFTF 71
           +  ++ A   ++               +      +P+ +   P ++  I           
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI----------- 51

Query: 72  SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-- 129
                    +    LIG G +G+V +   D+            V+A+KK+    F+    
Sbjct: 52  ------PDRYEIRHLIGTGSYGHVCEA-YDKLE--------KRVVAIKKILRV-FEDLID 95

Query: 130 -KEWLSEVNYLGQLHHPNLVKLIGFC----LDGENRL-LVYEYMPKGSLENHLFR--RGA 181
            K  L E+  L +L+H ++VK++       ++  + L +V E       ++   +  R  
Sbjct: 96  CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTP 150

Query: 182 RPLPWTLRIKVAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
             L   L IK  +     G+ ++H A   +++RD K +N L++ + + K+ DFGLA+   
Sbjct: 151 VYLT-ELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

Query: 241 TGDRTHVSTQVMG-------------------------TRGYAAPE-YLATGRLTAKCDV 274
             +  +    +                           TR Y APE  L     T   DV
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267

Query: 275 YSFGVVLLELLS 286
           +S G +  ELL+
Sbjct: 268 WSIGCIFAELLN 279

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 76.4 bits (187), Expect = 6e-15
 Identities = 73/453 (16%), Positives = 135/453 (29%), Gaps = 116/453 (25%)

Query: 27  DKNGNFSMASSLKTNKSEKRPSGNFSMPRTECDILSCPNLKAFT---------FSELKNA 77
             N  F + S +KT   +++PS    M   + D L   + + F          + +L+ A
Sbjct: 88  RINYKF-LMSPIKT--EQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQA 143

Query: 78  TRNFRPDSLI---GEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS 134
               RP   +   G  G G   K W+    L+           V+      F+    WL+
Sbjct: 144 LLELRPAKNVLIDGVLGSG---KTWV---ALDVCLS-----YKVQCKMD--FKIF--WLN 188

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
               L   + P  V      L+   +LL Y+  P  +       R        LRI    
Sbjct: 189 ----LKNCNSPETV------LEMLQKLL-YQIDPNWT------SRSDHSSNIKLRIHSIQ 231

Query: 195 GAARGLSFLHEAEQQ--VIYRDFKASNILLDSEFNAKL----SDFGLAKAGPTGDRTHVS 248
              R L    +  +   ++  + + +        + K+        +         TH+S
Sbjct: 232 AELRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR------VGAE-QN 301
                +      E  +   L  K           +L    R V  T       +    ++
Sbjct: 291 -LDHHSMTLTPDEVKS---LLLKY----LDCRPQDL---PREVLTTNPRRLSIIAESIRD 339

Query: 302 LVD----WAKPYLGDRRKLFRIMDIKLEGQYP--QKGAY-MVAILALQCISEAKVRPSMS 354
            +     W K    D  KL  I++  L    P   +  +  +++        A + P+  
Sbjct: 340 GLATWDNW-KHVNCD--KLTTIIESSLNVLEPAEYRKMFDRLSVFP----PSAHI-PT-- 389

Query: 355 EVLSALEQLPPPRDP-------ASPS----NSDPQVIYSPHVKSPMRPNSPHLKS-H--L 400
            +LS +       D           S          I  P +   ++    +  + H  +
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449

Query: 401 RNNYDSPVNMSPRSPLPP------------HMK 421
            ++Y+ P        +PP            H+K
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 44/238 (18%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH---KEWLS 134
            R +     +G+G +G V+K  ID  T        G V+AVKK+  + FQ     +    
Sbjct: 8   LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKI-FDAFQNSTDAQRTFR 57

Query: 135 EVNYLGQLH-HPNLVKLIG-FCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
           E+  L +L  H N+V L+     D +  + LV++YM   +  + + R  A  L   +  +
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIR--ANILE-PVHKQ 112

Query: 192 VAI-GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA-------------- 236
             +    + + +LH     +++RD K SNILL++E + K++DFGL+              
Sbjct: 113 YVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 237 -KAGPTGDRTHVSTQVM----GTRGYAAPEY-LATGRLTAKCDVYSFGVVLLELLSGR 288
                  +       ++     TR Y APE  L + + T   D++S G +L E+L G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 64/217 (29%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHP 145
           +G G  G V +   ++ T            A+K L+        +   EV    +    P
Sbjct: 26  LGLGINGKVLQI-FNKRT--------QEKFALKMLQ-----DCPKARREVELHWRASQCP 71

Query: 146 NLVKLIGFCLDGENR----LLVYEYMPKGSLENHLFRRG--------ARPLPWTLRIKVA 193
           ++V+++    +        L+V E +  G L + +  RG        A  +     +K  
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSI 126

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NA--KLSDFGLAKAGPTGDRTHVSTQ 250
             A   + +LH     + +RD K  N+L  S+  NA  KL+DFG AK            +
Sbjct: 127 GEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------E 169

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
             G   Y              CD++S GV++  LL G
Sbjct: 170 TTG-EKY-----------DKSCDMWSLGVIMYILLCG 194

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 2/114 (1%)

Query: 173 ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD 232
           E          L     I  +   A+G+ FL  A ++ I+RD  A NILL  +   K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICD 236

Query: 233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
           FGLA+                   + APE +     T + DV+SFGV+L E+ S
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 7/105 (6%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQL 142
              +G G FG V +           +      +AVK LK       H+  +SE+  L  +
Sbjct: 27  GKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82

Query: 143 -HHPNLVKLIGFCLDGENRLLV-YEYMPKGSLENHLFRRGARPLP 185
            HH N+V L+G C      L+V  E+   G+L  +L  +    +P
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 30/215 (13%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLSEVNYLGQL- 142
           SLIG+G FG V K + D              +A+K +K  + F    +   EV  L  + 
Sbjct: 60  SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAF--LNQAQIEVRLLELMN 108

Query: 143 -------HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
                  ++  +V L    +   +  LV+E +   +L + L     R +   L  K A  
Sbjct: 109 KHDTEMKYY--IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 253
               L FL   E  +I+ D K  NILL +   +  K+ DFG +          +   +  
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQ- 220

Query: 254 TRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
           +R Y +PE L         D++S G +L+E+ +G 
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 43/225 (19%), Positives = 88/225 (39%), Gaps = 38/225 (16%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH- 143
             +G G F  V+    D              +A+K ++ +     +    E+  L +++ 
Sbjct: 25  RKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74

Query: 144 ----------HPNLVKLIG-FCLDGENRL---LVYEYMPKGSLENHLFRRGARPLPWTLR 189
                       +++KL+  F   G N +   +V+E +   +L   + +   R +P    
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE------FNAKLSDFGLAKAGPTGD 243
            +++     GL ++H     +I+ D K  N+L++           K++D G A       
Sbjct: 134 KQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWY 188

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             H +  +  TR Y +PE L         D++S   ++ EL++G 
Sbjct: 189 DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 38/173 (21%), Positives = 66/173 (38%), Gaps = 19/173 (10%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLS---- 134
           R ++  S       G +Y+      TL           ++ KL  +  +   E       
Sbjct: 42  RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSL-KLDAKDGRLFNEQNFFQRA 99

Query: 135 ----EVNYLGQLHHPNLV---KLIGF-CLDGENRLLVYEYMPKGSLENHLFRRGARPLPW 186
               +VN   +L+   L+     +GF     + R LV   + + SL++ L       L  
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSE 158

Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK--LSDFGLAK 237
              ++VA      L FLHE E   ++ +  A NI +D E  ++  L+ +G A 
Sbjct: 159 RSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 48/224 (21%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQL 142
             +IG+G FG V K + D              +A+K ++  + F  H++   E+  L  L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRF--HRQAAEEIRILEHL 150

Query: 143 ------HHPNLVKLIGF-------CLDGENRLL---VYEYMPKGSLENHLFRRGARPLPW 186
                 +  N++ ++         C+  E  LL   +YE + K            +    
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKF---------QGFSL 199

Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDR 244
            L  K A    + L  LH+   ++I+ D K  NILL  +  +  K+ DFG +      + 
Sbjct: 200 PLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEH 253

Query: 245 THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             V T +  +R Y APE +   R     D++S G +L ELL+G 
Sbjct: 254 QRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 51/223 (22%), Positives = 82/223 (36%), Gaps = 34/223 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK--KLKPEGFQGHKEWLSEVN 137
            +R    IG G FG +Y G  D           G  +A+K   +K +  Q H E      
Sbjct: 10  RYRLGRKIGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKTKHPQLHIES----K 56

Query: 138 YLGQLHH-PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
               +     +  +     +G+  ++V E +   SLE  LF   +R       + +A   
Sbjct: 57  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQM 114

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK---LSDFGLAKA-GPTGDRTHV----S 248
              + ++H   +  I+RD K  N L+          + DFGLAK         H+    +
Sbjct: 115 ISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 249 TQVMGTRGYA---APEYLATGRLTAKCDVYSFGVVLLELLSGR 288
             + GT  YA       +   R   + D+ S G VL+    G 
Sbjct: 173 KNLTGTARYASINTHLGIEQSR---RDDLESLGYVLMYFNLGS 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 45/223 (20%), Positives = 81/223 (36%), Gaps = 32/223 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +++    IGEG FG +++G  +              +A+K           +   E    
Sbjct: 11  HYKVGRRIGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRR--SDAPQLRDEYRTY 59

Query: 140 GQLHH-PNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
             L     +  +  F  +G + +LV + +   SLE  L     R          A     
Sbjct: 60  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQMLA 117

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAK-----LSDFGLAKA-GPTGDRTHV----S 248
            +  +H  E+ ++YRD K  N L+    +       + DFG+ K       + H+     
Sbjct: 118 RVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 249 TQVMGTRGYAAPEYLAT--GR-LTAKCDVYSFGVVLLELLSGR 288
             + GT  Y +   + T  GR  + + D+ + G V +  L G 
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 34/180 (18%), Positives = 69/180 (38%), Gaps = 33/180 (18%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
             ++    IG+GGFG +Y   ++                VK    +    +    +E+ +
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVG----SDAPCVVKVEPSD----NGPLFTELKF 86

Query: 139 LGQLHHPNLV---------------KLIGFCLDGEN----RLLVYEYMPKGSLENHLFRR 179
             +   P  +               K  G  L  +N    R ++ +      L+  ++  
Sbjct: 87  YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEA 144

Query: 180 GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK--LSDFGLAK 237
            A+       +++++     L ++HE E   ++ D KASN+LL+ +   +  L D+GLA 
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.6 bits (138), Expect = 2e-09
 Identities = 44/274 (16%), Positives = 72/274 (26%), Gaps = 75/274 (27%)

Query: 63  CPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK 122
           C       FS     T   +    IGEG FG V++  I +HT           +A+K + 
Sbjct: 5   CSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQT-IADHTP----------VAIKIIA 52

Query: 123 PEG--------FQGHKEWLSEVNYLGQLH---------HPNLVKLIGFCL---------- 155
            EG         +  +E L E+    +L              + L               
Sbjct: 53  IEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112

Query: 156 --------------------DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
                                 +   +V E+   G     L +   +         +   
Sbjct: 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQ 169

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAG--PTGDRTHVSTQVMG 253
               L+       +  +RD    N+LL      KL      K+   P+            
Sbjct: 170 LTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228

Query: 254 TR----------GYAAPEYLATGRLTAKCDVYSF 277
           +R            +  E L TG    + D+Y  
Sbjct: 229 SRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 43/165 (26%), Positives = 64/165 (38%), Gaps = 23/165 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK--KLKPEGFQGHKEWLSEVN 137
           NFR    IG G FG +  G  + +T           +A+K   +K    Q H E+     
Sbjct: 10  NFRVGKKIGCGNFGELRLG-KNLYT--------NEYVAIKLEPMKSRAPQLHLEYRFYKQ 60

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
                  P   ++  F   G+   +V E +   SLE  LF    R       + +AI   
Sbjct: 61  LGSGDGIP---QVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLI 115

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAK-----LSDFGLAK 237
             + ++H   + +IYRD K  N L+    N       + DF LAK
Sbjct: 116 SRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 35/180 (19%), Positives = 64/180 (35%), Gaps = 36/180 (20%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
             +     IG GGFG +Y      +             A   +K E +Q +    SE+ +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLA-FPTNK--------PEKDARHVVKVE-YQENGPLFSELKF 86

Query: 139 LGQLHHPNLV---------------KLIGF----CLDGENRLLVYEYMPKGSLENHLFRR 179
             ++   + +                  G           R +V E +    L+    + 
Sbjct: 87  YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQN 145

Query: 180 GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK--LSDFGLAK 237
           G       L++   I     L ++HE E   ++ D KA+N+LL  +   +  L+D+GL+ 
Sbjct: 146 GTFKKSTVLQL--GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 84/410 (20%), Positives = 137/410 (33%), Gaps = 73/410 (17%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
            FR    IG G FG +Y G  +  T           +A+K    +    H + L E    
Sbjct: 8   KFRLGRKIGSGSFGEIYLG-TNIQT--------NEEVAIKLENVK--TKHPQLLYESKIY 56

Query: 140 GQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
             L     +  +  F ++G+  +LV + +   SLE  LF   +R L     + +A     
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMIN 114

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAK---LSDFGLAKA-GPTGDRTHV----STQ 250
            + F+H   +  ++RD K  N L+     A    + DFGLAK    T    H+    +  
Sbjct: 115 RVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 251 VMGTRGYAAPEYLAT--GR-LTAKCDVYSFGVVLLELLSGR------RAVDKT----RVG 297
           + GT  YA+   + T  G   + + D+ S G VL+  L G       +A  K     ++ 
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229

Query: 298 AE------------------------QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGA 333
            +                        ++L    KP     ++LFR  D+ +   +     
Sbjct: 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR--DLFIREGFQFDYV 287

Query: 334 YMVAILALQCISEAKVRPSMSEVLSALEQLPPPRDPASPSNSDPQVIYSPHVKSPMRPNS 393
           +   IL  Q    A   P      +    L PP       +   +   S       R   
Sbjct: 288 FDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAP 347

Query: 394 PHL-------KSHLRNNYDSPVNMSPRSPLPPHMKSPILKSPRGRCFSSQ 436
           P +       K       D+  +  P       +      S R    SS+
Sbjct: 348 PPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSR 397

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 42/217 (19%), Positives = 71/217 (32%), Gaps = 70/217 (32%)

Query: 135 EVNYLGQL-----HHPN---LVKLIG-FCLDGEN---RLLVYEYMPKG-SLENHLFRRGA 181
           E+  L  +     + PN   +V+L+  F + G N     +V+E +  G  L   + +   
Sbjct: 83  EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNY 140

Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---------------- 225
           + LP     K+     +GL +LH  + ++I+ D K  NILL                   
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199

Query: 226 ---------------------------------FNAKLSDFGLAKAGPTGDRTHVSTQVM 252
                                               K++D G A         H +  + 
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQ 255

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
            TR Y + E L         D++S   +  EL +G  
Sbjct: 256 -TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 53/241 (21%), Positives = 88/241 (36%), Gaps = 68/241 (28%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLSEVNYLGQL- 142
             +GEG FG V +   D    ++        +A+K ++    +   +    E+N L ++ 
Sbjct: 25  GNLGEGTFGKVVECL-DHARGKS-------QVALKIIRNVGKY--REAARLEINVLKKIK 74

Query: 143 -------HHPNLVKLIGF-------CLDGENRLL---VYEYMPKGSLENHLFRRGARPLP 185
                       V +  +       C+  E  LL    +E++ + +          +P P
Sbjct: 75  EKDKENKFL--CVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNF---------QPYP 121

Query: 186 WTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA----------------- 228
                 +A      L FLHE   Q+ + D K  NIL  +                     
Sbjct: 122 LPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

Query: 229 --KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS 286
             +++DFG A    T D  H +T ++ TR Y  PE +        CDV+S G +L E   
Sbjct: 180 SIRVADFGSA----TFDHEHHTT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 287 G 287
           G
Sbjct: 235 G 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 52/250 (20%), Positives = 84/250 (33%), Gaps = 82/250 (32%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK-PEGFQGHKEWLSEVNYLGQL- 142
             +G+G FG V                     AVK ++  + +   +    E + L ++ 
Sbjct: 41  RKMGDGTFGRVLLCQ-HIDN--------KKYYAVKVVRNIKKY--TRSAKIEADILKKIQ 89

Query: 143 ----HHPNLVKLIGF-------CLDGENRLL---VYEYMPKGSLENHLFRRGARPLPWTL 188
               ++ N+VK  G        CL  E   L   +YE      +  + +           
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEI-----ITRNNYN----GFHIED 138

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-------------------- 228
                I   + L++L +    + + D K  NILLD  +                      
Sbjct: 139 IKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 229 -----KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPE------YLATGRLTAKCDVYSF 277
                KL DFG A    T    +  + ++ TR Y APE      +          D++SF
Sbjct: 197 KSTGIKLIDFGCA----TFKSDYHGS-IINTRQYRAPEVILNLGW------DVSSDMWSF 245

Query: 278 GVVLLELLSG 287
           G VL EL +G
Sbjct: 246 GCVLAELYTG 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 56/236 (23%), Positives = 90/236 (38%), Gaps = 58/236 (24%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP-EGFQGHKEWLSEVNYLGQLH 143
             +GEG FG V +   D           G  +AVK +K  + +   +   SE+  L  L+
Sbjct: 20  DTLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLN 69

Query: 144 HP------NLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
                     V+++    +    + +V+E +   S  + +   G  P       K+A   
Sbjct: 70  TTDPNSTFRCVQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNA-------------------KLSDFGLAK 237
            + ++FLH    ++ + D K  NIL                          K+ DFG A 
Sbjct: 128 CKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184

Query: 238 AGPTGDRTHVSTQVMGTRGYAAPE------YLATGRLTAKCDVYSFGVVLLELLSG 287
              T D  H ST ++ TR Y APE      +      +  CDV+S G +L+E   G
Sbjct: 185 ---TYDDEHHST-LVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	441
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.9
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.65
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.58
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.43
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.6
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.24
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.22
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.95
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.16
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.79
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.46
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.83
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.42
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	80.39

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.6e-59  Score=445.27  Aligned_cols=263  Identities=26%  Similarity=0.434  Sum_probs=214.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|.+.+.||+|+||+||+|.+..    .....++..||||+++.......++|.+|+++|++|+|||||+++++|.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYN----LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECS----CC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC----cccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            578889999999999999998753    2233457899999998776666778999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRG-----------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      ..|||||||++|+|.++|...+           ...+++.+++.|+.||+.||+|||+  ++|+||||||+||||+.++.
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCc
Confidence            9999999999999999997542           3469999999999999999999999  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~  306 (441)
                      +||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.......        
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------  238 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------  238 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence            99999999986544333333334569999999999999999999999999999999999 899997543211        


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                               +...+........|......+..|+..||+ ||++|||+++|.+.|+.+.
T Consensus       239 ---------~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          239 ---------VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             ---------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     111111111223345555677889999998 9999999999999998654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-58  Score=446.12  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=208.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|.+.+.||+|+||+||+|.+..    ..+..++..||||+++.......++|.+|+++|++|+|||||+++++|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESS----SCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECC----cccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            467788999999999999998753    2234457899999998776666778999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          159 NRLLVYEYMPKGSLENHLFRRG-------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      ..|||||||++|+|.++|....             ..++++.+++.|+.||+.||+|||+  ++||||||||+||||+.+
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCC
Confidence            9999999999999999997542             2358999999999999999999999  899999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhh
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~  304 (441)
                      +.+||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.......   +  
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~--  269 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A--  269 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H--
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H--
Confidence            9999999999987654444444456789999999999999999999999999999999999 899997543211   1  


Q ss_pred             hhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          305 WAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       305 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                  ...+........|......+..|+..||. ||++||||.||++.|+.+..
T Consensus       270 ------------~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          270 ------------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             ------------HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------------HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                        11111111223445555677889999998 99999999999999987643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-59  Score=453.63  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++++.||+|+||+||+|...         .+++.||||+++....  ...+.+.+|+++|++|+|||||+++++|.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   94 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKST---------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE   94 (350)
T ss_dssp             CCEEEEEEC------CEEEEEET---------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            58999999999999999997654         3578999999976533  334678999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++.+|||||||+||+|.++|..+....+++.+++.|+.||+.||+|||+  +|||||||||+||||+.+|.+||+|||+|
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla  172 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIA  172 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999999999987766678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      +.....  .......+||+.|||||++.+..|+.++|||||||+||||+||+.||........                +
T Consensus       173 ~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------------~  234 (350)
T 4b9d_A          173 RVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL----------------V  234 (350)
T ss_dssp             SCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------H
T ss_pred             eeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------H
Confidence            864321  1223456899999999999999999999999999999999999999975432110                1


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..++.... ...+......+..|+..|+. ||++|||++|++++
T Consensus       235 ~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          235 LKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11111111 11222334456677888887 99999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4e-58  Score=438.93  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=211.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++++.+.||+|+||+||+|.+..    ..+...++.||||+++.... ...++|.+|+.+|++|+|||||+++++|.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFG----PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcC----CccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            356778899999999999998753    22334577899999976533 3456799999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      +..+||||||++|+|.++|..+.              ...+++.+++.|+.||+.||+|||+  ++||||||||+||||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEEC
Confidence            99999999999999999996542              1358999999999999999999999  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhh
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNL  302 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~  302 (441)
                      +++.+||+|||+++.....+.........||+.|||||++.++.|+.++|||||||+||||+| |+.||.......   +
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~  256 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V  256 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999986544333333455689999999999999999999999999999999999 899997543211   1


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                    ...+........|..+...+..|+..||. ||++||+|.||++.|+.+
T Consensus       257 --------------~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 --------------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --------------HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                          11111112223455556678889999998 999999999999999854

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-57  Score=430.28  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||+||+|.+..            .||||+++...  ....+.|.+|+.+|++|+|||||++++++.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~  102 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT  102 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3578889999999999999997542            48999987543  234567999999999999999999999876


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      + +..|||||||+||+|.++|.... ..+++.+++.|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+
T Consensus       103 ~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          103 K-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             S-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             C-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccC
Confidence            4 57899999999999999997544 359999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      |+..............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||........  +.....     
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~-----  251 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVG-----  251 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHH-----
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHh-----
Confidence            987544333334456789999999999974   3589999999999999999999999975332111  000000     


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                           ...........+......+..|+..||. ||++||||.||++.|+.++.
T Consensus       252 -----~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          252 -----RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             -----TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             -----cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                 0000000112233444567788889998 99999999999999887643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-57  Score=432.28  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||++.+..   ....+.+.+|+++|++|+|||||+++++|.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~---------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAREL---------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEEC---------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            57999999999999999997544         458899999996532   234567899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..||||||++||+|.++|.+.+  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.+|.+||+|||+
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGl  178 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT  178 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence            9999999999999999999997765  49999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+............+.+||+.|||||++.+..|+.++|||||||++|||+||+.||........                
T Consensus       179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----------------  242 (311)
T 4aw0_A          179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI----------------  242 (311)
T ss_dssp             CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----------------
Confidence            9876544444445677999999999999999999999999999999999999999975432111                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                      +..++...  ..+|......+..|+..|+. ||++||+++|++
T Consensus       243 ~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          243 FAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            11111111  12333334456677888887 999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.3e-57  Score=434.11  Aligned_cols=249  Identities=24%  Similarity=0.302  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ..|++.+.||+|+||+||+|...         .+|+.||||+++.......+.+.+|+++|++|+|||||+++++|.+++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~---------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEEC---------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            56999999999999999997654         358899999997665555667889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .+|||||||+||+|.+++.+.   .+++..+..|+.||+.||+|||+  ++||||||||+||||+.+|.+||+|||+|+.
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  219 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  219 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence            999999999999999998653   49999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      .....  ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.........   .             .
T Consensus       220 ~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~-------------~  281 (346)
T 4fih_A          220 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K-------------M  281 (346)
T ss_dssp             CCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H-------------H
T ss_pred             cCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H-------------H
Confidence            54322  2235678999999999999999999999999999999999999999754321111   0             0


Q ss_pred             hhccc-ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIK-LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~-~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +.... .....+......+..|+..|+. ||++|||++|++++
T Consensus       282 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          282 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00000 0011122333456677788887 99999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.9e-56  Score=427.81  Aligned_cols=250  Identities=26%  Similarity=0.292  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.|++.++||+|+||+||+|.+.         .+|+.||||+++.+...     .+|+.+|++|+|||||+++++|.+++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~---------~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDK---------QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hheEeCcEeccCCCeEEEEEEEC---------CCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            56888899999999999997654         45889999999765432     36999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEcccCCcc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDFGLAK  237 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFg~a~  237 (441)
                      .+|||||||+||+|.++|.+.+  .+++..+..|+.||+.||+|||+  ++||||||||+||||+.+| ++||+|||+|+
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             EEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            9999999999999999997765  49999999999999999999998  8999999999999999987 69999999998


Q ss_pred             cCCCCCcc---ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          238 AGPTGDRT---HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ........   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||..........             
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------------  266 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-------------  266 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-------------
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------------
Confidence            65432211   12234689999999999999999999999999999999999999997543221111             


Q ss_pred             hhhhhhccc-ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          315 KLFRIMDIK-LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       315 ~l~~~~~~~-~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                         .+.... .....+......+..|+..|+. ||++|||+.||++.|..
T Consensus       267 ---~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          267 ---KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ---HHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence               011000 0011233344566677788887 99999999999988764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.9e-56  Score=436.79  Aligned_cols=250  Identities=23%  Similarity=0.307  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.|++.+.||+|+||.||+|...         .+|+.||||++........+.+.+|+.+|++|+|||||+++++|.+++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~---------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeeEeccCcCcEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            57999999999999999997654         358899999997766666677899999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      .+|||||||+||+|.+++...   .+++.++..|+.||+.||+|||+  +|||||||||+||||+.+|.+||+|||+|+.
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceE
Confidence            999999999999999998653   39999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      .....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.             .
T Consensus       297 ~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------------~  361 (423)
T 4fie_A          297 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------------D  361 (423)
T ss_dssp             CCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------H
T ss_pred             CCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------------c
Confidence            54322  22356789999999999999999999999999999999999999997543211110000             0


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...  .....+......+..|+..|+. ||++|||+.|++++
T Consensus       362 ~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          362 NLP--PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             SCC--CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000  0011122233455677788887 99999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.3e-56  Score=431.56  Aligned_cols=271  Identities=26%  Similarity=0.352  Sum_probs=217.5

Q ss_pred             HHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCC-CCcc
Q 013557           71 FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHH-PNLV  148 (441)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-pnIv  148 (441)
                      .++++...++|++.+.||+|+||+||+|.+..    ......++.||||+++..... ..+.+.+|+++|.+++| ||||
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEET----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcC----CCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence            33344445789999999999999999998754    223344678999999765433 34668999999999965 8999


Q ss_pred             cEEEEEEcC-CeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          149 KLIGFCLDG-ENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       149 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      +++++|.+. +.+|||||||++|+|.++|....              ...+++..++.++.||+.||+|||+  ++||||
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHR  209 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHR  209 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecC
Confidence            999998764 56899999999999999997532              2348999999999999999999999  899999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCC
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVD  292 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~  292 (441)
                      ||||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987654444334456689999999999999999999999999999999998 999997


Q ss_pred             ccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ......                .+...+........|......+..|+..||. ||++|||+.||+++|+.+
T Consensus       290 ~~~~~~----------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          290 GVKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             TCCCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHHH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            543211                1112222222233455555667788889998 999999999999998765

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-55  Score=410.59  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=188.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||+|..         ..+++.||||++++...   .....+.+|+++|++++|||||++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYH---------TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEEC---------TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            6899999999999999999654         34588999999875432   23467899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..|+||||+ +|+|.+++.+++  .+++..+..++.||+.||+|||+  +||+||||||+|||++.++++||+|||+
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGl  158 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGL  158 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCC
Confidence            999999999999 679999997654  59999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      |+......   ...+.+||+.|||||++.+..| +.++|||||||++|+|+||+.||.......   +..          
T Consensus       159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~----------  222 (275)
T 3hyh_A          159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK----------  222 (275)
T ss_dssp             C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----------
T ss_pred             CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH----------
Confidence            98654322   2345789999999999998876 579999999999999999999997543211   100          


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .+...  ...+|......+..|+..|+. ||++|||++|++++
T Consensus       223 ---~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          223 ---NISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---HHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---HHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               11110  011233334456677788887 99999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3e-55  Score=414.52  Aligned_cols=245  Identities=26%  Similarity=0.386  Sum_probs=193.3

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc---
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD---  156 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  156 (441)
                      ++.+.||+|+||+||+|.+..         ++..||+|++.....  ...+.+.+|+++|++|+|||||+++++|.+   
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   99 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             EeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence            667789999999999976543         577899999865432  234668999999999999999999999875   


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEECC-CCcEEEcc
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLDS-EFNAKLSD  232 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~~-~~~~kl~D  232 (441)
                       +..+|||||||+||+|.+++.+..  .+++..+..|+.||+.||+|||+  ++  |+||||||+||||+. +|.+||+|
T Consensus       100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCCEEEEe
Confidence             356899999999999999997654  59999999999999999999998  66  999999999999985 78999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||+|+.....    ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.......  .+....      
T Consensus       176 FGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i------  242 (290)
T 3fpq_A          176 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV------  242 (290)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH------
T ss_pred             CcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHH------
Confidence            9999864322    3456789999999999874 69999999999999999999999996432111  111100      


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             .........+......+..|+..|+. ||++|||++|++++
T Consensus       243 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          243 -------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00000001112222346678888888 99999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-55  Score=419.91  Aligned_cols=251  Identities=26%  Similarity=0.298  Sum_probs=197.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||+||+|....      ...+++.||||+++....  .....+.+|+++|++|+|||||+++++|.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            579999999999999999986532      234578999999975432  223467889999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..|||||||+||+|.++|.+.+  .+++.++..++.||+.||+|||+  +||+||||||+|||++.+|.+||+|||+|
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            999999999999999999997765  49999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      +......  ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||........                +
T Consensus       174 ~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------------~  235 (304)
T 3ubd_A          174 KESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET----------------M  235 (304)
T ss_dssp             EC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------H
T ss_pred             eeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH----------------H
Confidence            8643322  123457899999999999999999999999999999999999999975432111                1


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH-----HHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM-----SEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~-----~evl~~  359 (441)
                      ..+....  ..+|......+..|+..|+. ||++||++     +|++++
T Consensus       236 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          236 TMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            1111111  12344444566778888888 99999984     677643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-54  Score=411.97  Aligned_cols=268  Identities=25%  Similarity=0.360  Sum_probs=195.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHH--HHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW--LSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|.+.+.||+|+||+||+|.+.           |+.||||+++...   .+.+  ..|+..+.+++|||||+++++|.+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~   68 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            56888899999999999999763           6689999997542   2333  345666678899999999999986


Q ss_pred             CC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc------CCCeEEeccCCCcEEECCCC
Q 013557          157 GE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA------EQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       157 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------~~~ivH~Dlkp~Nill~~~~  226 (441)
                      ++    .+||||||+++|+|.++|...   ++++..+..++.|++.||+|||+.      ..+|+||||||+||||+.++
T Consensus        69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~  145 (303)
T 3hmm_A           69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             cCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence            54    579999999999999999764   389999999999999999999972      13899999999999999999


Q ss_pred             cEEEcccCCcccCCCCCcc--ceeeeccCCCCcCchhhhhcC------CCCchhhhHHHhHHHHHHHhCCCCCCcccccc
Q 013557          227 NAKLSDFGLAKAGPTGDRT--HVSTQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA  298 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltg~~pf~~~~~~~  298 (441)
                      ++||+|||+++........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||+.||.......
T Consensus       146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~  225 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence            9999999999864332211  122346799999999999764      36779999999999999999998875432111


Q ss_pred             chhhhhhhccccccchhhhh-hhcccccCCCch-----hHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          299 EQNLVDWAKPYLGDRRKLFR-IMDIKLEGQYPQ-----KGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~-----~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      . ....+. +.......+.. +.....+...|.     .....+..|+..||. ||++||||.||++.|+++..
T Consensus       226 ~-p~~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          226 L-PYYDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             C-TTTTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c-cchhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0 000000 00000011111 112222222222     334567789999998 99999999999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.6e-53  Score=402.70  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=184.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||+++.... ...+.+.+|+++|++|+|||||+++++|.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   75 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK   75 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEET---------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence            46999999999999999997654         3578999999865433 2345689999999999999999999998754


Q ss_pred             C------------eeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          158 E------------NRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       158 ~------------~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      +            ..|+|||||+||+|.+++..+.. ....+..++.++.||+.||+|||+  ++|+||||||+|||++.
T Consensus        76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECT
T ss_pred             CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECC
Confidence            4            36999999999999999976543 235667789999999999999999  89999999999999999


Q ss_pred             CCcEEEcccCCcccCCCCCcc----------ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          225 EFNAKLSDFGLAKAGPTGDRT----------HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ++.+||+|||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            999999999999865432211          11234679999999999999999999999999999999996   77532


Q ss_pred             ccccchhhhhhhccccccchhhhhhhcccccCCCchh---HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          295 RVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQK---GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..    ...           .+..+.    ...+|..   .......|+..|+. ||++|||+.|++++
T Consensus       231 ~~----~~~-----------~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          231 ME----RVR-----------TLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HH----HHH-----------HHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cH----HHH-----------HHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            10    000           000000    1112221   11223457778887 99999999999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.9e-50  Score=393.44  Aligned_cols=205  Identities=26%  Similarity=0.353  Sum_probs=173.1

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      ...++|++.+.||+|+||+||+|+.+.      +..+++.||||++....  ...++.+|+++|+.+ +||||++++++|
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQL------QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEB------TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcc------cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            456889999999999999999987542      22357789999987653  356688999999998 699999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcEEEccc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDF  233 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~kl~DF  233 (441)
                      .+.+..||||||++||+|.+++.     .+++.++..++.||+.||+|||+  +||+||||||+|||++.+ +.+||+||
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            99999999999999999999882     38999999999999999999999  999999999999999877 79999999


Q ss_pred             CCcccCCCCCc--------------------------cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHh
Q 013557          234 GLAKAGPTGDR--------------------------THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLS  286 (441)
Q Consensus       234 g~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ellt  286 (441)
                      |+|+.......                          .......+||+.|+|||++.+. .|+.++||||+||++|||+|
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99975432211                          0112345799999999999875 58999999999999999999


Q ss_pred             CCCCCCccc
Q 013557          287 GRRAVDKTR  295 (441)
Q Consensus       287 g~~pf~~~~  295 (441)
                      |+.||....
T Consensus       243 G~~Pf~~~~  251 (361)
T 4f9c_A          243 GRYPFYKAS  251 (361)
T ss_dssp             TCSSSSCCS
T ss_pred             CCCCCCCCC
Confidence            999996443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=400.50  Aligned_cols=204  Identities=26%  Similarity=0.373  Sum_probs=172.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|...         .+|+.||||+++....  ...+.+.+|+++|++|+|||||++++++.
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~---------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRR---------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEEEEEecccCeEEEEEEEC---------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            367999999999999999997654         4588999999975432  23456889999999999999999999876


Q ss_pred             c------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 D------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      .      .+..|||||||+ |+|.+++..+  ..+++..+..++.||+.||+|||+  +|||||||||+|||++.+|.+|
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEE
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEE
Confidence            3      367899999995 6899999654  369999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCC--ccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          230 LSDFGLAKAGPTGD--RTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       230 l~DFg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |+|||+|+......  ......+.+||+.|||||++.+. .|+.++|||||||++|||++|++||....
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            99999998653321  12233467899999999998875 56999999999999999999999997554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.5e-50  Score=412.31  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHH---HHHHHHHhcCCCCCcccEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEW---LSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~hpnIv~l~~  152 (441)
                      ++|++.++||+|+||+||+|...         .+|+.||||++++...   .....+   ..++.+++.++|||||++++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~---------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~  259 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY  259 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEEC---------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence            68999999999999999996544         4688999999864321   122223   34467778889999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      +|.+.+.+||||||++||+|.++|.+.+  .+++..+..|+.||+.||+|||+  +|||||||||+||||+.+|++||+|
T Consensus       260 ~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~D  335 (689)
T 3v5w_A          260 AFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISD  335 (689)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecc
Confidence            9999999999999999999999997765  49999999999999999999998  9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      ||+|+......    ..+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||..........+..       
T Consensus       336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-------  404 (689)
T 3v5w_A          336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------  404 (689)
T ss_dssp             CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH-------
T ss_pred             cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------
Confidence            99998654322    245689999999999964 579999999999999999999999997543221111111       


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                            .+..  ....+|......+..|+..|+. ||++|++     ++||+++
T Consensus       405 ------~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          405 ------MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ------HHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ------hhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                  1111  1122344444556778888887 9999998     6888653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.6e-50  Score=414.72  Aligned_cols=251  Identities=20%  Similarity=0.264  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||+||+|...         .+|+.||+|++........+.+.+|+++|+.|+|||||+++++|.+.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~---------~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTER---------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            468999999999999999996544         46889999999876666667789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC--CcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~--~~~kl~DFg~  235 (441)
                      ..+|||||||+||+|.++|.... ..+++.++..++.||+.||+|||+  ++|+||||||+|||++.+  +.+||+|||+
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccc
Confidence            99999999999999999986443 359999999999999999999999  899999999999999864  8999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..........              
T Consensus       304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~--------------  366 (573)
T 3uto_A          304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR--------------  366 (573)
T ss_dssp             CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--------------
T ss_pred             eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH--------------
Confidence            98764432   3456789999999999999999999999999999999999999997543221111              


Q ss_pred             hhhhhccc--ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIK--LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~--~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        .+....  ............+..|+..|+. ||++||++.|++++
T Consensus       367 --~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          367 --NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             --HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              111000  0001111223345567778887 99999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.1e-49  Score=379.96  Aligned_cols=277  Identities=43%  Similarity=0.715  Sum_probs=225.9

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      +...+++|++.+.||+|+||.||+|.+.          .+..||||++........+.+.+|+.+|+.++||||++++++
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3456789999999999999999998643          267899999987766667789999999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +.+.+..++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEEC
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999999999999865432  358999999999999999999999  899999999999999999999999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.............|..... 
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-  260 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-  260 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-
Confidence            9999986443332223344568999999999999999999999999999999999999997655444444444432211 


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ....+...++.......+......+..++..|+. ||++||++.+|++.|+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1122333344444445566667778888889998 999999999999999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.7e-48  Score=372.35  Aligned_cols=289  Identities=44%  Similarity=0.751  Sum_probs=231.6

Q ss_pred             CCCCCccccHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHh
Q 013557           62 SCPNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLG  140 (441)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~  140 (441)
                      .......+++.++....++|++.+.||+|+||.||+|...          .+..||||++...... ....+.+|+.+++
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~   82 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMIS   82 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence            3455678899999999999999999999999999997532          3678999999765322 2336889999999


Q ss_pred             cCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhHhcCC---CeEEecc
Q 013557          141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGA--RPLPWTLRIKVAIGAARGLSFLHEAEQ---QVIYRDF  215 (441)
Q Consensus       141 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~~L~~lH~~~~---~ivH~Dl  215 (441)
                      .++||||+++++++.+....++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||+  +   +|+||||
T Consensus        83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~ivH~Dl  160 (326)
T 3uim_A           83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDV  160 (326)
T ss_dssp             TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSSCEECCCC
T ss_pred             hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCC
Confidence            99999999999999999999999999999999999976532  359999999999999999999999  7   9999999


Q ss_pred             CCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          216 KASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       216 kp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+...
T Consensus       161 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (326)
T 3uim_A          161 KAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR  239 (326)
T ss_dssp             SGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred             chhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence            99999999999999999999986543222 23344569999999999999999999999999999999999999996332


Q ss_pred             c--ccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          296 V--GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       296 ~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      .  ........|....... ..+..+.+.......+......+..++..|+. ||++||++.+|+++|+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          240 LANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HTTTSCSBHHHHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             cccccchhHHHHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            1  1122233343332222 22334444455556667777788888889998 9999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.9e-47  Score=373.40  Aligned_cols=265  Identities=25%  Similarity=0.402  Sum_probs=212.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+....  ......+..||||+++.... ...+.+.+|+.+|+++ +||||++++++|.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            468999999999999999999764211  11234567899999976533 2346789999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +.+..|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+  ++|+||||||+|||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIl  235 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEE
Confidence            99999999999999999999976532              348899999999999999999999  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.......  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999986543332222234467889999999999999999999999999999999 999997543211  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                     +...+........+......+..|+..|+. +|++||++.||++.|+++
T Consensus       314 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 ---------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             ---------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                           111111111222344445567788888988 999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-46  Score=359.82  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=206.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++........+.+.+|+.++++++||||+++++++.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV   88 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBT---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEEC---------CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence            3468999999999999999997543         3578999999876655667788999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++...   .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           89 GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999999999999764   38999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............  .         
T Consensus       164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~---------  230 (297)
T 3fxz_A          164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--T---------  230 (297)
T ss_dssp             EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H---------
T ss_pred             eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h---------
Confidence            76543322  2345679999999999999999999999999999999999999997443211100000  0         


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ........+......+..|+..|+. ||++||++.|+++.
T Consensus       231 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          231 ----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ----HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                0011112233444566778888888 99999999999865

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=363.21  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|....         ++..+|+|++........+.+.+|+++|++++||||+++++++.+.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   79 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD   79 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence            4678999999999999999976543         4778999998776666677899999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           80 KRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             CeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence            99999999999999999997643 359999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccc------------eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh
Q 013557          238 AGPTGDRTH------------VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW  305 (441)
Q Consensus       238 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~  305 (441)
                      .........            ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----  232 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----  232 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----
Confidence            643322111            0114579999999999999999999999999999999999999986433211110    


Q ss_pred             hccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          306 AKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       306 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                             ............    +......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       233 -------~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          233 -------GLNVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             -------SBCHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------hhhhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                   000111111111    22223345677888888 99999999999999987653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-47  Score=364.00  Aligned_cols=258  Identities=30%  Similarity=0.445  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+.           +..||||++.....  ...+.+.+|+++|++++||||+++++++.
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            568999999999999999998653           56799999876543  23456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEECCCCcEEEcc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      +....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+  ++  |+||||||+|||++.++.+||+|
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECC
Confidence            99999999999999999999965432 238999999999999999999998  78  99999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............         
T Consensus       183 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---------  251 (309)
T 3p86_A          183 FGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---------  251 (309)
T ss_dssp             CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---------
T ss_pred             CCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------
Confidence            99997533221  1233567999999999999999999999999999999999999999754321111100         


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                             .........+......+..|+..|+. +|++||++.+|++.|+.+...
T Consensus       252 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          252 -------GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                   00111122333444567778888888 999999999999999876544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-45  Score=353.03  Aligned_cols=284  Identities=40%  Similarity=0.671  Sum_probs=224.2

Q ss_pred             CCccccHHHHHHHhcCCCCC------CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC----cccHHHHHH
Q 013557           65 NLKAFTFSELKNATRNFRPD------SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG----FQGHKEWLS  134 (441)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~  134 (441)
                      ....|++.++..++++|...      +.||+|+||.||+|...           +..+|||++....    ....+.+.+
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~   79 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQ   79 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHH
Confidence            45678999999999998877      99999999999998642           5689999986532    223467889


Q ss_pred             HHHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       135 E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      |+.++++++||||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+  ++|+||
T Consensus        80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~  157 (307)
T 2nru_A           80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHR  157 (307)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECS
T ss_pred             HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecC
Confidence            9999999999999999999999999999999999999999996432 3469999999999999999999999  899999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCc
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDK  293 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~  293 (441)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|+.||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999986544333323344679999999999864 589999999999999999999999975


Q ss_pred             cccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          294 TRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ......  +..+..........+...++... ...+......+..++..|+. +|++||++.+|++.|+++.+
T Consensus       237 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          237 HREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             CcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            443211  11111111111122223333322 23455566677788888998 99999999999999987643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.4e-47  Score=364.77  Aligned_cols=269  Identities=26%  Similarity=0.341  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+.           ++.||||++.... ........|+.+|++++||||+++++++.+.
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            468999999999999999998653           5689999997543 2334456789999999999999999999875


Q ss_pred             C----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC----------CeEEeccCCCcEEEC
Q 013557          158 E----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ----------QVIYRDFKASNILLD  223 (441)
Q Consensus       158 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~----------~ivH~Dlkp~Nill~  223 (441)
                      .    ..++||||+++|+|.+++....   +++..++.++.|++.||.|||+  .          +|+||||||+|||++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~--~~~~l~~~~~~~ivH~Dlkp~Nill~  165 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHE--DIPGLKDGHKPAISHRDIKSKNVLLK  165 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTC--CEEEETTEEECEEECSCCSGGGEEEC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHh--hccccccccCCCEEeCCCChHhEEEC
Confidence            4    4699999999999999996643   8999999999999999999998  7          999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-----CCCchhhhHHHhHHHHHHHhCCCCCCcccccc
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-----RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA  298 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~pf~~~~~~~  298 (441)
                      .++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||+||+.||.......
T Consensus       166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  245 (322)
T 3soc_A          166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY  245 (322)
T ss_dssp             TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred             CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence            9999999999999765443322223346799999999999863     45668899999999999999999997543322


Q ss_pred             chhhhhhhccccccchhhhhh-hcccccCCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          299 EQNLVDWAKPYLGDRRKLFRI-MDIKLEGQY-----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ........... .....+... .........     .......+..|+..|+. ||++|||+.||++.|+++.
T Consensus       246 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          246 MLPFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            21111110000 000111111 111111111     12234457788888988 9999999999999998654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.1e-47  Score=369.59  Aligned_cols=273  Identities=26%  Similarity=0.366  Sum_probs=215.0

Q ss_pred             ccHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCC
Q 013557           69 FTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPN  146 (441)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpn  146 (441)
                      +...+.....++|++.+.||+|+||.||+|.+..    ..+...++.||||+++.... ...+.+.+|+++|.++ +|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn   87 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN   87 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEecc----ccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence            3444455567899999999999999999987643    22445678999999976533 2345689999999999 7999


Q ss_pred             cccEEEEEEcCCe-eEEEEEeCCCCCHHHHHHhcCC--------------------------------------------
Q 013557          147 LVKLIGFCLDGEN-RLLVYEYMPKGSLENHLFRRGA--------------------------------------------  181 (441)
Q Consensus       147 Iv~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------  181 (441)
                      |+++++++.+.+. .++||||+++|+|.+++.....                                            
T Consensus        88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            9999999887654 8999999999999999976432                                            


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          182 --------------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       182 --------------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                                          ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                                128899999999999999999999  8999999999999999999999999999986544


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ...........||+.|+|||++.+..++.++|||||||++|||+| |+.||.......                .+...+
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~  309 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRL  309 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----------------HHHHHH
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----------------HHHHHH
Confidence            433333445678999999999999999999999999999999998 999997543211                111111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ........+......+..++..|+. ||++||++.||+++|+.+
T Consensus       310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1111222233334456677788888 999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-46  Score=362.20  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=203.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++.....  ...+.+.+|+++|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   83 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHI---------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI   83 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3568999999999999999997653         3578999999865422  3345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||+++++|.+++....  .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           84 ETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             EECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeecc
Confidence            99999999999999999999997765  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCC-chhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT-AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      +++......   .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||+.........            
T Consensus       160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------------  224 (328)
T 3fe3_A          160 FSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE------------  224 (328)
T ss_dssp             CCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred             CceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence            998654332   23456799999999999988875 79999999999999999999997543221110            


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          .+...  ....|......+..|+..|+. ||++|||++|++++
T Consensus       225 ----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          225 ----RVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----HHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----HHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                11110  111233334456677888888 99999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=360.64  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+...      ...+..||||+++.... ...+.+.+|+.+|++++||||+++++++.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVP------GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCT------TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecC------CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            46799999999999999999976532      12356799999976532 334668999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence            999999999999999999986543 359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......                
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------  262 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----------------  262 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----------------
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----------------
Confidence            865432211 12223456788999999999999999999999999999999 999996443211                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       +...+........+......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       263 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          263 -VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             111111111222333444567778888888 99999999999999987643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.2e-46  Score=356.69  Aligned_cols=263  Identities=30%  Similarity=0.389  Sum_probs=211.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|....    ......+..||||+++... ....+.+.+|+.+|++++||||+++++++.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFH----LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEET----GGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhheeeeeeecccCCeeEEEEEEec----cCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            5689999999999999999997643    2223456889999997643 2334678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEec
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGA----------------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRD  214 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~D  214 (441)
                      .+..++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||+  ++|+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~d  175 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRD  175 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccc
Confidence            9999999999999999999976542                      348899999999999999999999  8999999


Q ss_pred             cCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCc
Q 013557          215 FKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDK  293 (441)
Q Consensus       215 lkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~  293 (441)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999986544332222334467889999999999899999999999999999999 9999975


Q ss_pred             cccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          294 TRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ......                 ...+........+......+..|+..|+. ||++||++.+|++.|+++
T Consensus       256 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          256 IPPERL-----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CCGGGH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHH-----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            432111                 11111111122333444566778888888 999999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-46  Score=357.16  Aligned_cols=278  Identities=26%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc-
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD-  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  156 (441)
                      .++|++.+.||+|+||.||+|.+.     ..+...+..||||++........+.+.+|+.+|++++||||+++++++.. 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEC-----TTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEe-----cccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            468999999999999999998754     22345688999999987665666788999999999999999999999865 


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                       ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence             356899999999999999997653 348999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++........ .......++..|+|||++.+..++.++||||||+++|+|+||..||.............. ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~  239 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVF  239 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT-CCTHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc-cccchhHH
Confidence            9865432211 122234577889999999999999999999999999999999999864322111000000 00000001


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      .+...+........+......+..|+..|+. ||++||++.||++.|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1112222222233344555667788888998 9999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-46  Score=360.12  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   76 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            468999999999999999997654         3477899999865432 223557899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..|+||||+++++|.+++...  ..+++..++.++.||+.||+|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           77 GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             SSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeecc
Confidence            99999999999999999988543  359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .....+...       
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~-------  224 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK-------  224 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT-------
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc-------
Confidence            86443333233345689999999999988775 778999999999999999999997543211 111111110       


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                             .............+..|+..|+. ||++||++.|+++.-
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          225 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence                   00001112223445567778887 999999999998763

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=369.83  Aligned_cols=265  Identities=26%  Similarity=0.356  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+..    ..+...+..||||+++... ......+.+|+.+|++++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSG----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEcc----CCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            4689999999999999999998653    1233457789999997543 2344568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC---cE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGA-----RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF---NA  228 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~---~~  228 (441)
                      ....++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++   .+
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceE
Confidence            9999999999999999999976542     358999999999999999999999  8999999999999999655   59


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......         
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---------  294 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------  294 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence            9999999974322111122334568999999999999999999999999999999998 999997543211         


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                              +...+........+......+..|+..|+. +|++||++.+|++.|+.+..
T Consensus       295 --------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          295 --------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             --------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                    111111111122233344556778888888 99999999999999986543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-46  Score=361.01  Aligned_cols=267  Identities=26%  Similarity=0.378  Sum_probs=211.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|.....    .....+..||||+++.... ...+.+.+|+.+|++++||||+++++++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            457899999999999999999976531    1123467899999986533 23456899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG----------------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      +.+..++||||+++++|.+++....                      ...+++..++.++.||+.||.|||+  ++|+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~  198 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR  198 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence            9999999999999999999997642                      1468999999999999999999999  899999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCC
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVD  292 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~  292 (441)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999975432222222334568999999999999999999999999999999999 999997


Q ss_pred             ccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      .......   ..             .+.. ......+......+..|+..|+. ||++||++.+|++.|+++...
T Consensus       279 ~~~~~~~---~~-------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          279 GMAHEEV---IY-------------YVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TSCHHHH---HH-------------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCChHHH---HH-------------HHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            4332110   00             0111 11112233444567778888888 999999999999999987653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.3e-46  Score=359.36  Aligned_cols=249  Identities=27%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++...   ......+.+|+.+|+.++||||+++++++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~   74 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence            367999999999999999997654         357899999986532   23456788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||++||+|.+++....  .+++..++.++.||+.||+|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           75 QTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999999997654  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........               
T Consensus       151 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---------------  213 (337)
T 1o6l_A          151 LCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---------------  213 (337)
T ss_dssp             TCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------
T ss_pred             chhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---------------
Confidence            998633222  123456899999999999999999999999999999999999999974332110               


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                       ...+...  ...+|......+..|+..|+. ||++||     +++||+++
T Consensus       214 -~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          214 -FELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -HHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             0011111  112333444556777888887 999999     89999865

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=365.32  Aligned_cols=267  Identities=25%  Similarity=0.390  Sum_probs=214.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|......  ......+..||||+++.... .....+.+|+++++++ +||||+++++++.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            468999999999999999999764311  11223456899999976533 2346688999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +.+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+  ++|+||||||+|||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEE
Confidence            99999999999999999999976542              358999999999999999999999  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999986544333223334567889999999999999999999999999999999 999997543211  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                     +...+........+......+..|+..|+. +|++||++.+|++.|+++..
T Consensus       302 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          302 ---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             ---------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                           111111122222333444567778888888 99999999999999987643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.1e-46  Score=359.03  Aligned_cols=262  Identities=24%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+....     ......||+|.++... ....+.+.+|+.+|++++||||++++++|.+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCC-----ceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            467999999999999999999865321     1223467999986543 2445678999999999999999999999987


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .. .++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcce
Confidence            64 789999999999999997654 359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............||+.|+|||++.+..++.++|||||||++|||+| |+.||........                
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------  228 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------  228 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH----------------
Confidence            86544333333334567889999999999999999999999999999999 9999975432211                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       ...+........+......+..|+..|+. +|++||++.+|++.|+.+..
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          229 -SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             11111122222333444567778888888 99999999999999986543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-45  Score=354.54  Aligned_cols=264  Identities=27%  Similarity=0.408  Sum_probs=212.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..    ..+...+..||||+++.... ...+.+.+|+.+|+++ +||||+++++++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhhhhHHHhhCccCCcceEEEEEee----ccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            4689999999999999999987532    12344578999999976543 3346789999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA----------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                      +.+..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||+  ++|+||||||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~N  175 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARN  175 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccce
Confidence            99999999999999999999976542                248999999999999999999999  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCcccccc
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGA  298 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~  298 (441)
                      ||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987654433333344567889999999999999999999999999999999 999997543211


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                      .+...+........+......+..|+..|+. ||++||++.+|++.|+++
T Consensus       256 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          256 ----------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             ----------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                            1111111111122233334556778888888 999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=360.07  Aligned_cols=267  Identities=27%  Similarity=0.411  Sum_probs=211.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|.+..    ......+..||||+++... ....+.+.+|+.+|.++ +||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYG----ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEES----CSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeec----cccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35789999999999999999997632    1233457789999997542 23346789999999999 899999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGA---------------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      .+.+..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+  +||+||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~  196 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR  196 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence            999999999999999999999976432                     237899999999999999999999  899999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCC
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVD  292 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~  292 (441)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986544333333344567889999999999999999999999999999998 999997


Q ss_pred             ccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ......                .+...+........+......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       277 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          277 GIPVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TCCCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCcHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            543211                1111111122222333344567778888888 99999999999999987644

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-45  Score=360.32  Aligned_cols=251  Identities=24%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------cHHHHHHHHHHHhcCCCCCcccE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------GHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      ..++|++.+.||+|+||.||+|...         .++..||+|+++.....      ..+.+.+|+.+|++++||||+++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~---------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l   80 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL   80 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEEC---------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence            4578999999999999999997654         35789999998754322      34678999999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----  226 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----  226 (441)
                      +++|.+....++||||++||+|.+++....  .+++..+..++.||+.||.|||+  +||+||||||+|||++.++    
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           81 HDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCcc
Confidence            999999999999999999999999996543  59999999999999999999999  8999999999999998877    


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........  .   
T Consensus       157 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~--~---  228 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--A---  228 (361)
T ss_dssp             CEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--H---
T ss_pred             CEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH--H---
Confidence            79999999998654432   224567999999999999999999999999999999999999999754321110  0   


Q ss_pred             ccccccchhhhhhhcccc--cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKL--EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                 .+.....  ...........+..|+..|+. ||++||++.|++++
T Consensus       229 -----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          229 -----------NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -----------HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -----------HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                       0000000  000011123445677788887 99999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-45  Score=362.34  Aligned_cols=262  Identities=27%  Similarity=0.451  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.+..      ....+..||||+++.... ...+.+.+|+.+|++++||||+++++++.+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            4689999999999999999986542      123467899999976532 334578999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            999999999999999999996543 359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......                
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------  258 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------  258 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----------------
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------
Confidence            8654322111 1122345788999999999999999999999999999998 999996433211                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       +...+........+......+..|+..|+. +|++||++.+|++.|+.+..
T Consensus       259 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          259 -VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence             111111112222233344567778888888 99999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3e-45  Score=344.16  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+..          +..||+|+++... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE   75 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            4689999999999999999986543          5579999997654 3456789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  152 (268)
T 3sxs_A           76 YPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTR  152 (268)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred             CceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccce
Confidence            99999999999999999997653 358999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........               
T Consensus       153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---------------  216 (268)
T 3sxs_A          153 YVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL---------------  216 (268)
T ss_dssp             ECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---------------
T ss_pred             ecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH---------------
Confidence            65443221 2233456778999999999899999999999999999999 999997543211110               


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                        .+........+......+..++..|+. +|++||++.++++.|+.+...
T Consensus       217 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          217 --KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             --HHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             --HHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence              001111111223334456778888888 999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-45  Score=351.54  Aligned_cols=261  Identities=24%  Similarity=0.306  Sum_probs=209.4

Q ss_pred             cccHHHHHHHhcC----------CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHH
Q 013557           68 AFTFSELKNATRN----------FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVN  137 (441)
Q Consensus        68 ~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~  137 (441)
                      .+++++++.+++.          |...+.||+|+||.||+|...         ..++.||||++........+.+.+|+.
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~   94 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVV   94 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHH
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHH
Confidence            4677888777654          667789999999999997654         247799999998766666778999999


Q ss_pred             HHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCC
Q 013557          138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKA  217 (441)
Q Consensus       138 ~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp  217 (441)
                      +|++++||||+++++++...+..++||||+++++|.+++...   .+++..+..++.|++.||.|||+  .+|+||||||
T Consensus        95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp  169 (321)
T 2c30_A           95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKS  169 (321)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSG
T ss_pred             HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCH
Confidence            999999999999999999999999999999999999988543   48999999999999999999999  8999999999


Q ss_pred             CcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccc
Q 013557          218 SNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG  297 (441)
Q Consensus       218 ~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~  297 (441)
                      +|||++.++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~  247 (321)
T 2c30_A          170 DSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV  247 (321)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             HHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999876433221  224567999999999999999999999999999999999999999744321


Q ss_pred             cchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..   ....          ........  .........+..++..|+. ||++||++.++++.
T Consensus       248 ~~---~~~~----------~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          248 QA---MKRL----------RDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH---HHHH----------HHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH---HHHH----------hcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11   0000          00000000  1112223456677788888 99999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.3e-45  Score=349.02  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         ..+..||+|.+.....   ...+.+.+|+.++++++||||+++++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~   80 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDT---------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD   80 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET---------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEEC---------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence            468999999999999999997543         3477899999854322   2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||++|++|.+++....  ++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           81 EEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999999997664  58999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++....... .......||+.|+|||++.+..++.++||||||+++|+|+||+.||........  .........   .
T Consensus       157 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~---~  230 (294)
T 4eqm_A          157 IAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSV---P  230 (294)
T ss_dssp             SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCC---C
T ss_pred             Cccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccC---C
Confidence            9986533221 122345799999999999999999999999999999999999999975432110  000000000   0


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-CHHHHHHHhhcCCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-SMSEVLSALEQLPPP  366 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-s~~evl~~L~~l~~~  366 (441)
                              ......+......+..++..|+. ||++|| +++++.+.|+.+...
T Consensus       231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                    00001112223456677778887 999998 899999999876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.3e-46  Score=359.56  Aligned_cols=262  Identities=25%  Similarity=0.445  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+....     ......|++|.+.... ......+.+|+.++++++||||+++++++. 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEG-----ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTT-----CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCC-----ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            357999999999999999999865321     1224468899875442 223345678999999999999999999986 


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcc
Confidence            457899999999999999996542 358899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............||..|+|||++.+..++.++|||||||++|+|+| |+.||...........             
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------------  229 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------------  229 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-------------
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-------------
Confidence            87655444334455678889999999999999999999999999999999 9999975432221111             


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                          +........+......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          230 ----LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----HHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----HHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                11111112222233345667788888 99999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.2e-46  Score=367.72  Aligned_cols=257  Identities=27%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.+..         .+..||||.++..... ....+.+|+++|++++||||+++++++.+
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            4678889999999999999987653         3678999999764322 23457899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s  260 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMS  260 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence            999999999999999999997543 348999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............+++.|+|||++.++.++.++|||||||++|||+| |..||.......                 
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----------------  323 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----------------  323 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----------------
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence            86433211111112235678999999999999999999999999999998 999997543211                 


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      +...+........+......+..|+..|+. ||++||++.+|++.|+.+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          324 TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            111111111222344445567788889998 999999999999999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-45  Score=345.42  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+..          +..||+|++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3678999999999999999987643          5579999997654 3456789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccc
Confidence            99999999999999999996543 358999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........                 
T Consensus       155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-----------------  216 (269)
T 4hcu_A          155 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----------------  216 (269)
T ss_dssp             GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------
T ss_pred             cccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-----------------
Confidence            643321 111223456788999999999999999999999999999999 9999975432111                 


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ...+........+......+..++..|+. +|++||++.++++.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          217 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            11111111122233334556778888888 9999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-45  Score=368.16  Aligned_cols=250  Identities=29%  Similarity=0.444  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+.           +..||||+++...  ..+.+.+|+.+|++++||||+++++++.+.
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            467888999999999999998654           5589999998653  457799999999999999999999998766


Q ss_pred             C-eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 E-NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      . ..++||||+++|+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            5 78999999999999999987766568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +.....     .....++..|+|||++.+..++.++|||||||++|||+| |+.||........                
T Consensus       337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------  395 (450)
T 1k9a_A          337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------  395 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----------------
T ss_pred             cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------
Confidence            853321     122357889999999999999999999999999999998 9999975432111                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                       ...+........+......+..|+..|+. ||++||++.+|++.|+.+.
T Consensus       396 -~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          396 -VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             11111112223344455667788899998 9999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=361.51  Aligned_cols=249  Identities=26%  Similarity=0.355  Sum_probs=198.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||+++...   ....+.+.+|..+|..+ +||||++++++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~   92 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC   92 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence            478999999999999999997654         357889999987532   23445678999999988 79999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+.+..|+||||++||+|.+++.+..  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.+|++||+||
T Consensus        93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A           93 FQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEccc
Confidence            999999999999999999999997654  49999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........              
T Consensus       169 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--------------  232 (353)
T 3txo_A          169 GMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--------------  232 (353)
T ss_dssp             TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------
T ss_pred             cceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--------------
Confidence            9998533222  223456899999999999998999999999999999999999999975432111              


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH------HHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM------SEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~------~evl~~  359 (441)
                        ...++...  ..+|......+..|+..|+. ||++||++      ++|+++
T Consensus       233 --~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          233 --FEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             --HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             --HHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence              11111111  12333344556677788887 99999998      777654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-45  Score=362.69  Aligned_cols=258  Identities=25%  Similarity=0.363  Sum_probs=201.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      .++|++.++||+|+||+||+|...         .+++.||+|++++....   ..+.+..|..+|.++ +||||++++++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            467999999999999999997654         35778999999754322   234578899999887 89999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |.+....|+||||++||+|.+++.+..  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.+|++||+||
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeec
Confidence            999999999999999999999997654  49999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........        .....
T Consensus       198 Gla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~  267 (396)
T 4dc2_A          198 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTE  267 (396)
T ss_dssp             TTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCH
T ss_pred             ceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhH
Confidence            9998532222  2234678999999999999999999999999999999999999999643211100        00000


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH------HHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM------SEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~------~evl~~  359 (441)
                      ..+...+.. ....+|......+..|+..|+. ||++||++      +||+++
T Consensus       268 ~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          268 DYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             HHHHHHHhc-cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            111111111 1122344445566778888888 99999985      566544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-45  Score=374.66  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=213.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+..         .+..||||+++... ...+.+.+|+.+|++++||||++++++|.+.
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678889999999999999987653         36789999997654 3467899999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...+|||||+++|+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccce
Confidence            999999999999999999987666679999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||.......                 +
T Consensus       367 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----------------~  428 (495)
T 1opk_A          367 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------V  428 (495)
T ss_dssp             CCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------H
T ss_pred             eccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------H
Confidence            7543221 11223456789999999999999999999999999999999 999997543211                 1


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ...+........+......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            11122222223344455667788899998 99999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.9e-45  Score=354.63  Aligned_cols=279  Identities=27%  Similarity=0.370  Sum_probs=215.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE--
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL--  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--  155 (441)
                      .++|++.+.||+|+||.||+|.+.     ..+...+..||||++........+.+.+|+++|++++||||+++++++.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEC-----TTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEec-----cCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            368999999999999999998753     2234468899999998776666677999999999999999999999887  


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....++||||+++++|.+++..... .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEccccc
Confidence            45678999999999999999976432 48999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ..+... .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~-~~~~~  251 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERD-VPALS  251 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC-----CCHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccc-cccHH
Confidence            9865433221 12223468888999999999999999999999999999999999986432211000 000000 00111


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      .+...+........+......+..|+..|+. ||++||++.+|++.|+.+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            2222222233333444555667788888888 999999999999999977553

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.8e-45  Score=370.60  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=209.0

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ...++|++.+.||+|+||.||+|.+..          +..||||+++... ...+.+.+|+.+|++++||||+++++++.
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  253 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT  253 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            345789999999999999999997643          5579999998654 45778999999999999999999999986


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                       .+..++||||+++|+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence             5678999999999999999975544458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++....... .......+|..|+|||++.++.++.++|||||||++|||+| |+.||.......                
T Consensus       331 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----------------  393 (454)
T 1qcf_A          331 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------------  393 (454)
T ss_dssp             GGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------
T ss_pred             ceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----------------
Confidence            986533211 11123346788999999999999999999999999999999 999997533211                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       +...+........+......+..|+..|+. ||++||++++|++.|+.+..
T Consensus       394 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          394 -VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence             111111111222334445567788888998 99999999999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.2e-45  Score=353.13  Aligned_cols=272  Identities=26%  Similarity=0.362  Sum_probs=212.7

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCc
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNL  147 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI  147 (441)
                      ...+.....++|++.+.||+|+||.||+|.+..    ..+...++.||||+++.... ...+.+.+|+.+|.++ +||||
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i   93 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   93 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEec----CCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence            334444456899999999999999999987542    22344678999999976533 2345688999999999 79999


Q ss_pred             ccEEEEEEcCC-eeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEE
Q 013557          148 VKLIGFCLDGE-NRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIY  212 (441)
Q Consensus       148 v~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH  212 (441)
                      +++++++.+.+ ..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+  ++|+|
T Consensus        94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H  171 (316)
T 2xir_A           94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIH  171 (316)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred             eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCccc
Confidence            99999987654 48999999999999999976542              127899999999999999999999  89999


Q ss_pred             eccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCC
Q 013557          213 RDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAV  291 (441)
Q Consensus       213 ~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf  291 (441)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+| |..||
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986544333333344568899999999999999999999999999999998 99999


Q ss_pred             CccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          292 DKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ........                +...+........+......+..++..|+. ||++||++.+|++.|+.+
T Consensus       252 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          252 PGVKIDEE----------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             TTCCCSHH----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccchhHH----------------HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            75432111                111111111112233334456677788888 999999999999999865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-45  Score=351.55  Aligned_cols=262  Identities=24%  Similarity=0.406  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+....     ......|++|.+.... ....+.+.+|+.+|++++||||+++++++.+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTT-----CSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCC-----ceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            468999999999999999999865321     1223467889886542 3456778999999999999999999999987


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .. .++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            64 789999999999999997654 359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...............||+.|+|||++.+..++.++|||||||++|+|++ |+.||........                
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------  228 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------  228 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------
Confidence            87544333333334567889999999999999999999999999999999 9999975432211                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       ...+........+......+..|+..|+. ||++||++.||++.|+.+..
T Consensus       229 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          229 -SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             11111122222333344556778888888 99999999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=351.98  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=201.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------cHHHHHHHHHHHhcCCCCCcccE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------GHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      ..++|++.+.||+|+||.||+|...         .++..||+|+++.....      ..+.+.+|+.+|++++||||+++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   79 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL   79 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceEeceEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcE
Confidence            3467999999999999999997654         35778999998654321      35678999999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----  226 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----  226 (441)
                      ++++.+....++||||+++++|.+++...  ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++    
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           80 HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSC
T ss_pred             EEEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCC
Confidence            99999999999999999999999999654  359999999999999999999999  8999999999999999887    


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............  
T Consensus       156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--  230 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--  230 (326)
T ss_dssp             CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--
T ss_pred             CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--
Confidence            79999999998654322   1234679999999999999999999999999999999999999996443211110000  


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ....            .............+..|+..|+. ||++||++.+++++
T Consensus       231 ~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          231 AVNY------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HTCC------------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hcCC------------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000            00000011123445677788887 99999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.1e-45  Score=352.11  Aligned_cols=264  Identities=25%  Similarity=0.392  Sum_probs=192.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|.+....      .....||||+++...  ....+.+.+|+.++++++||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccC------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            3568999999999999999998765321      112379999997652  23456789999999999999999999999


Q ss_pred             EcCCee------EEEEEeCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          155 LDGENR------LLVYEYMPKGSLENHLFRRG----ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       155 ~~~~~~------~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      .+....      ++||||+++++|.+++....    ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECT
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcC
Confidence            877665      99999999999999986532    1258999999999999999999999  89999999999999999


Q ss_pred             CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhh
Q 013557          225 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~  303 (441)
                      ++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |+.||.........   
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---  249 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---  249 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---
Confidence            99999999999986544333223334567889999999999999999999999999999999 89999754321111   


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                    ..+........+......+..|+..|+. ||++||++.++++.|+++..
T Consensus       250 --------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          250 --------------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             --------------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                          1111111112233334567788888888 99999999999999986543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=364.12  Aligned_cols=255  Identities=20%  Similarity=0.233  Sum_probs=200.9

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||.||+|...         .++..+|+|++.....  ...+.+.+|+.+|++++||||++++++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~---------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   78 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKV---------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS   78 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEET---------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence            45678999999999999999997543         3578999999876543  234568899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC---CCCcEEE
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD---SEFNAKL  230 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~---~~~~~kl  230 (441)
                      +.+.+..|+||||++||+|.+++..+.  .+++..+..++.||+.||.|||+  +||+||||||+|||++   .++.+||
T Consensus        79 ~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL  154 (444)
T 3soa_A           79 ISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKL  154 (444)
T ss_dssp             EECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred             EEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEE
Confidence            999999999999999999999997754  49999999999999999999999  8999999999999998   4578999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||................  .
T Consensus       155 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~  230 (444)
T 3soa_A          155 ADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA--Y  230 (444)
T ss_dssp             CCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C
T ss_pred             ccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--C
Confidence            99999986543321  2245679999999999999899999999999999999999999996543211110000000  0


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                  .............+..|+..|+. ||++||++.|++++
T Consensus       231 ------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 ------------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ------------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                        00000011223445667777777 99999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.6e-45  Score=341.11  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=192.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||+|.+.           +..+|||+++....    ...+.+.+|+++++.++||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            357899999999999999998653           56799999875432    234678899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC---eEEeccCCCcEEECC------
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ---VIYRDFKASNILLDS------  224 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~---ivH~Dlkp~Nill~~------  224 (441)
                      +.+.+..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+  ++   |+||||||+|||++.      
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             EecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccccc
Confidence            9999999999999999999998843   358999999999999999999999  77   999999999999986      


Q ss_pred             --CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          225 --EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       225 --~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                        ++.+||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--  223 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA--  223 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--
T ss_pred             ccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence              6789999999997643322    22457899999999999999999999999999999999999999754321110  


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                    ............+......+..++..|+. +|++||++.|+++.|+.+
T Consensus       224 --------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 --------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                          01111111222334444567788888888 999999999999999754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-45  Score=351.97  Aligned_cols=250  Identities=19%  Similarity=0.209  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|...         .++..+|+|.+.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             hhceEeeeEEecCCCeEEEEEEEC---------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            578999999999999999997654         357789999987543 3455688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC--CCcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS--EFNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~--~~~~kl~DFg~  235 (441)
                      +..++||||++|++|.+++.... ..+++..++.++.||+.||.|||+  +||+||||||+|||++.  ++.+||+|||+
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence            99999999999999999986543 358999999999999999999999  89999999999999987  78999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........               
T Consensus       151 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------------  212 (321)
T 1tki_A          151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---------------  212 (321)
T ss_dssp             CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------
T ss_pred             CeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---------------
Confidence            98754432   234567999999999999888999999999999999999999999754321110               


Q ss_pred             hhhhhcccccCC--CchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQ--YPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~--~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ..+........  ........+..|+..|+. ||++||++.|++++
T Consensus       213 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          213 -ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             01110000000  001123345677788887 99999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=346.65  Aligned_cols=272  Identities=19%  Similarity=0.293  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|....         +++.||||+++.... ...+.+.+|+++|++++||||+++++++.+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            4679999999999999999976543         477899999975432 345678899999999999999999999887


Q ss_pred             CC--eeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE----CCCCcEE
Q 013557          157 GE--NRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL----DSEFNAK  229 (441)
Q Consensus       157 ~~--~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill----~~~~~~k  229 (441)
                      ..  ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+  ++|+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEE
Confidence            65  78999999999999999976432 348999999999999999999999  899999999999999    7788899


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhh--------cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA--------TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-  300 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-  300 (441)
                      |+|||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||......... 
T Consensus       157 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          157 LTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             EccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            999999986544322   23457999999999987        577899999999999999999999999643321111 


Q ss_pred             h-hhhhhccccc-cchhhhhhh--------cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          301 N-LVDWAKPYLG-DRRKLFRIM--------DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       301 ~-~~~~~~~~~~-~~~~l~~~~--------~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      . .......... ....+....        ...............+..++..|+. ||++||+++|+++.....
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1 1111100000 000000000        0001112345566777888888888 999999999999998643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.3e-45  Score=352.15  Aligned_cols=266  Identities=24%  Similarity=0.392  Sum_probs=209.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+....  ......+..||||+++.... ...+.+.+|+.+|+++ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            468999999999999999999764311  11224577899999976532 3346688999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGA--------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      +.+..++||||+++++|.+++.....              ..+++..++.++.||+.||.|||+  ++|+||||||+|||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL  189 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEE
Confidence            99999999999999999999976432              248999999999999999999999  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ 
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence            99999999999999986544332222334467889999999998899999999999999999999 9999975432111 


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                                      ...+........+......+..++..|+. +|++||++.+|++.|+++.
T Consensus       269 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          269 ----------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             ----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------------HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                            11111111112233344556778888888 9999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-45  Score=349.59  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++...   ....+.+.+|+.+|+.++||||+++++++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            357999999999999999997654         357899999986532   13456678999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....|+||||++||+|.+++....  .+++..++.++.||+.||+|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecC
Confidence            99999999999999999999997654  48999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......                
T Consensus       152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------------  210 (318)
T 1fot_A          152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------  210 (318)
T ss_dssp             SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred             cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------
Confidence            99864321     235689999999999999999999999999999999999999996433211                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      ....++...  ..++......+..|+..|+. ||++||     ++++|+++
T Consensus       211 ~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          211 TYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            011111111  12333334556677777877 999999     88998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-45  Score=353.14  Aligned_cols=268  Identities=24%  Similarity=0.385  Sum_probs=210.4

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ....++|++.+.||+|+||.||+|.+..    ......+..||||.+..... .....+.+|+.+|++++||||++++++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecC----ccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3456789999999999999999987652    12223467899999976532 334568899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRG--------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      +.+.+..++||||+++++|.+++....        ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.+
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCC
Confidence            999999999999999999999986532        1357899999999999999999999  899999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhh
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~  304 (441)
                      +.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.........   .
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---R  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---H
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---H
Confidence            9999999999975433222112223456889999999999999999999999999999999 88998754321110   0


Q ss_pred             hhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          305 WAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       305 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                   .+.. ......+......+..|+..|+. +|++||++.++++.|+++..
T Consensus       252 -------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 -------------FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -------------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------------HHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                         0001 11111233334556778888888 99999999999999987644

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.5e-45  Score=345.11  Aligned_cols=254  Identities=23%  Similarity=0.370  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+..          +..||||+++... ...+.+.+|++++.+++||||+++++++.+.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            4689999999999999999986543          5579999998654 3456789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             CCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccc
Confidence            99999999999999999996533 349999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...... ........+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.........                
T Consensus       169 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~----------------  231 (283)
T 3gen_A          169 YVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------  231 (283)
T ss_dssp             GBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------
T ss_pred             cccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH----------------
Confidence            643321 111223456788999999999999999999999999999998 99999754321111                


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                       ..+........+......+..|+..|+. +|++||++.++++.|+.+
T Consensus       232 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          232 -EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence             1111111222233334567778888888 999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-44  Score=354.34  Aligned_cols=255  Identities=22%  Similarity=0.246  Sum_probs=199.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-----cccHHHHHHHHHHHhcCCCCCcccEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-----FQGHKEWLSEVNYLGQLHHPNLVKLI  151 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~  151 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++....     ....+.+.+|+.+|+.++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~   92 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINR---------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL   92 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3467999999999999999997654         357899999985321     12456789999999999999999999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--  227 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--  227 (441)
                      +++.+.+..|+||||++|++|.+++...  ....+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.  
T Consensus        93 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             EEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTC
T ss_pred             EEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCC
Confidence            9999999999999999999999888653  23458999999999999999999999  89999999999999987654  


Q ss_pred             -EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          228 -AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       228 -~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                       +||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............  
T Consensus       171 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~--  246 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK--  246 (351)
T ss_dssp             CEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH--
T ss_pred             cEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc--
Confidence             9999999998654322  12345679999999999999999999999999999999999999997532111000000  


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       .....        .....    ......+..|+..|+. ||++||++.+++++
T Consensus       247 -~~~~~--------~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          247 -GKYKM--------NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -TCCCC--------CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -CCCCC--------Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             00000        00000    1123345667777887 99999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-44  Score=366.22  Aligned_cols=258  Identities=28%  Similarity=0.409  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+.+.+|+.+|++++||||+++++++.+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  250 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE  250 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            35678899999999999999997653          3569999998654 346789999999999999999999999876


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       +..++||||+++|+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccc
Confidence             678999999999999999975544468999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +....... .......++..|+|||++.++.++.++|||||||++|||+| |+.||.......                 
T Consensus       328 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------  389 (452)
T 1fmk_A          328 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------  389 (452)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------
T ss_pred             eecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence            86543221 12223457889999999999999999999999999999999 999997433211                 


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      +...+........+......+..|+..|+. +|++||++++|++.|+.+...
T Consensus       390 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          390 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            111111111222344445567788889998 999999999999999977543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=354.48  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCC--CCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHH--PNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--pnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||++...          .+..||||++.....  ...+.+.+|+.+|.+++|  +||++++++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   77 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   77 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence            467999999999999999997543          267899999865432  234668899999999976  999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+....++|||+ .+++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++ ++.+||+||
T Consensus        78 ~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DF  151 (343)
T 3dbq_A           78 EITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF  151 (343)
T ss_dssp             EECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred             EeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeec
Confidence            9999999999995 5889999997654  58999999999999999999999  8999999999999997 578999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhc-----------CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      |+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......     
T Consensus       152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----  226 (343)
T 3dbq_A          152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----  226 (343)
T ss_dssp             SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----
T ss_pred             ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----
Confidence            99987544333323345679999999999975           67899999999999999999999999643211     


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                                ...+..+++......++......+..|+..|+. ||++||++.|++++.
T Consensus       227 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          227 ----------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             ----------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                      011222222233333444444566788888888 999999999998763

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.4e-45  Score=347.35  Aligned_cols=274  Identities=28%  Similarity=0.405  Sum_probs=209.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+.     ..+...++.||||+++... ....+.+.+|+.+|++++||||+++++++.+
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEC-----TTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEc-----cccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            356899999999999999998754     2244568899999997543 2345778999999999999999999999987


Q ss_pred             C--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          157 G--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       157 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .  ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccc
Confidence            6  67899999999999999996554 359999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc--
Q 013557          235 LAKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG--  311 (441)
Q Consensus       235 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  311 (441)
                      ++......... .......||..|+|||++.+..++.++||||||+++|+|+||..|+......    ......+...  
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~  247 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQM  247 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccccc
Confidence            99865443221 2233456888999999999999999999999999999999999986532111    1111111110  


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ....+...+........+......+..|+..|+. ||++||++.++++.|+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0111222222222223344455667788889998 999999999999999754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=358.32  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++....   ....+.+.+|+.+|+.++||||++++++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKN---------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            367999999999999999997654         357889999986432   23456788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....|+||||+.||+|.+++....  .+++..++.++.||+.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccc
Confidence            99999999999999999999996543  59999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      +++......   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..............      
T Consensus       161 ~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------  231 (384)
T 4fr4_A          161 IAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------  231 (384)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH------
T ss_pred             eeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH------
Confidence            998654332   2345689999999999964   4589999999999999999999999974432221111111      


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-HHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-MSEVLS  358 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-~~evl~  358 (441)
                              +. .....++......+..|+..|+. ||++||+ +++|++
T Consensus       232 --------~~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          232 --------FE-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------HH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------Hh-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    11 01112344444566777888888 9999998 777764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-44  Score=355.48  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||.||+|...         .++..||+|++.....  ...+.+.+|+.+|++++||||++++++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~   96 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS   96 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45678999999999999999997654         3577899999975533  234568899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC---cEEE
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF---NAKL  230 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~---~~kl  230 (441)
                      +.+.+..|+||||++||+|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++   .+||
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A           97 IQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEE
Confidence            999999999999999999999986543  58999999999999999999999  8999999999999998654   5999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   +...     
T Consensus       173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~-----  241 (362)
T 2bdw_A          173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQ-----  241 (362)
T ss_dssp             CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-----
T ss_pred             eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH-----
Confidence            9999998654322   2234679999999999999899999999999999999999999997543211   1000     


Q ss_pred             ccchhhhhhhcccc--cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKL--EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              +.....  ...........+..|+..|+. ||++||++.+++++
T Consensus       242 --------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          242 --------IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             --------HHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --------HHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    000000  000011223445667777877 99999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.3e-45  Score=354.14  Aligned_cols=264  Identities=26%  Similarity=0.394  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|......    .......||+|.+..... ...+.+.+|+.+|+++ +||||+++++++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCS----SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCC----cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            578999999999999999998765321    122346899999976532 3346688999999999 8999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      +.+..++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+  ++|+||||||+|||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEEC
Confidence            9999999999999999999997542            3458999999999999999999999  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhh
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNL  302 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~  302 (441)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+| |..||.......    
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  274 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----  274 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----
Confidence            999999999999986433332223334567889999999999999999999999999999999 999997543211    


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                  .+...+........+......+..|+..|+. ||.+||++.+|++.|+.+
T Consensus       275 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          275 ------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                        1111111111122233334556778888888 999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-44  Score=342.98  Aligned_cols=258  Identities=25%  Similarity=0.350  Sum_probs=194.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+...      ...+..+|+|.++.... ...+.+.+|+.++++++||||+++++++. 
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            46899999999999999999876432      12356799999876432 33456889999999999999999999974 


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccccc
Confidence            567899999999999999997553 358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.........   .           
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~-----------  228 (281)
T 1mp8_A          164 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G-----------  228 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H-----------
T ss_pred             cccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H-----------
Confidence            865332211 1223456789999999999999999999999999999997 99999754321110   0           


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        . +........+......+..++..|+. ||++||++.+|++.|+.+
T Consensus       229 --~-i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          229 --R-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             --H-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --H-HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              0 00011112233344556778888888 999999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-44  Score=352.79  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=201.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++....   ...+.+.+|..+|.++ +||||++++++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            357999999999999999997654         3578999999976432   2345578899999988 89999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+....|+||||++||+|.+++....  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.+|++||+||
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCG
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999997654  48999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........        ....
T Consensus       155 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------~~~~  224 (345)
T 3a8x_A          155 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTE  224 (345)
T ss_dssp             GGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CH
T ss_pred             cccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc--------cccH
Confidence            9998532222  12345689999999999999999999999999999999999999996432211000        0000


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH------HHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM------SEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~------~evl~~  359 (441)
                      ..+...+... ...+|......+..|+..|+. ||++||++      .+++++
T Consensus       225 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          225 DYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            1111111111 112344444556777888887 99999996      566644

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=357.32  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|...         .++..+|+|++..........+.+|+.+|+.++||||+++++++.+.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK  120 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC---------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence            468999999999999999997654         35778999999776555566789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC--CCcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS--EFNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~--~~~~kl~DFg~  235 (441)
                      ...++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.  ++.+||+|||+
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEeccc
Confidence            99999999999999999886443 358999999999999999999999  89999999999999974  46799999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  +......       
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~i~~~-------  265 (387)
T 1kob_A          198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQNVKRC-------  265 (387)
T ss_dssp             CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHHHC-------
T ss_pred             ceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--HHHHHhC-------
Confidence            98654332   23445799999999999999999999999999999999999999975432111  0000000       


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           ...............+..|+..|+. ||++||++.|+++.
T Consensus       266 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          266 -----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                 0001111112233456677888887 99999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-45  Score=356.00  Aligned_cols=250  Identities=27%  Similarity=0.371  Sum_probs=201.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLI  151 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~  151 (441)
                      ...++|++.+.||+|+||.||+|...         .+++.||||+++...   ......+..|..+|..+ +||||++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~   84 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF   84 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence            34578999999999999999997654         357899999997532   23456678899999877 899999999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +++.+.+..|+||||++||+|.+++....  .+++..+..++.||+.||+|||+  +||+||||||+|||++.+|.+||+
T Consensus        85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~  160 (345)
T 1xjd_A           85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIA  160 (345)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEe
Confidence            99999999999999999999999997654  48999999999999999999999  899999999999999999999999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   .        
T Consensus       161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~--------  227 (345)
T 1xjd_A          161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---F--------  227 (345)
T ss_dssp             CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H--------
T ss_pred             EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---H--------
Confidence            9999986432221  23456899999999999999999999999999999999999999975432111   0        


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH-HHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS-EVLS  358 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~-evl~  358 (441)
                           ..+...  ...++......+..|+..|+. ||++||++. +|++
T Consensus       228 -----~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          228 -----HSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -----HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -----HHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                 011110  112333344556677788887 999999997 6653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-44  Score=340.22  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+.           +..+|||+++....  ...+.+.+|+.++++++||||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            357999999999999999998764           56799999876532  33456899999999999999999999998


Q ss_pred             cC--CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEECCCCcEEEc
Q 013557          156 DG--ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       156 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +.  ...++||||+++|+|.+++.......+++..++.++.|++.||.|||+  ++  |+||||||+|||++.++.++|+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT--SSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc--CCCceecCCCccceEEEcCCcceeEE
Confidence            87  788999999999999999987665579999999999999999999998  77  9999999999999999999999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCc---hhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTA---KCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      |||++.....       ....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||........         
T Consensus       156 ~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------  219 (271)
T 3kmu_A          156 MADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------  219 (271)
T ss_dssp             GGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---------
T ss_pred             eccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---------
Confidence            8887754222       2346899999999998765544   89999999999999999999974432111         


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                             .............+......+..++..|+. ||++||++.++++.|+.+.
T Consensus       220 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          220 -------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             -------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                   111111112222334445567778888888 9999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-45  Score=365.86  Aligned_cols=253  Identities=25%  Similarity=0.302  Sum_probs=199.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++....   .....+.+|+.+|+.++||||++++++
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4578999999999999999997654         3577899999864211   123347789999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |.+....|+||||++||+|.+++...   .+++..+..++.||+.||+|||+  ++|+||||||+|||++.+|++||+||
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999998654   38999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCC----CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR----LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |+++....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||........          
T Consensus       213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------  281 (410)
T 3v8s_A          213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----------  281 (410)
T ss_dssp             TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------
T ss_pred             ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH----------
Confidence            99986543221 1233568999999999998765    78999999999999999999999975432111          


Q ss_pred             cccchhhhhhhcccccCCCch--hHHHHHHHHHHHHhc-CCCC--CCCHHHHHHHh
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQ--KGAYMVAILALQCIS-EAKV--RPSMSEVLSAL  360 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~l~~~c~~-~P~~--RPs~~evl~~L  360 (441)
                            ...++.......+|.  .....+..|+..|+. +|++  ||+++||+++-
T Consensus       282 ------~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          282 ------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             ------HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             ------HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence                  111111110111121  223455667777777 6777  99999999763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-44  Score=353.32  Aligned_cols=250  Identities=26%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++...   ....+.+..|..+|..+ +||||+++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~   88 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS   88 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence            3468999999999999999997654         347789999987542   23456688999999998 7999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      ++.+.+..|+||||++||+|.+++....  .+++..++.++.||+.||+|||+  +||+||||||+|||++.+|.+||+|
T Consensus        89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~D  164 (353)
T 2i0e_A           89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD  164 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEe
Confidence            9999999999999999999999997654  48999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +          
T Consensus       165 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~----------  229 (353)
T 2i0e_A          165 FGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----------  229 (353)
T ss_dssp             CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----------
T ss_pred             CCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---H----------
Confidence            99998633222  12345689999999999999999999999999999999999999997543211   0          


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                         ...++...  ..+|......+..|+..|+. ||++||+     +++|+++
T Consensus       230 ---~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          230 ---FQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---HHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               11111111  12333444556677788887 9999995     5777654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-44  Score=343.60  Aligned_cols=267  Identities=23%  Similarity=0.315  Sum_probs=196.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||+||+|...          .++.||+|++......  ....+.+|+++|++++||||+++++++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            4578999999999999999998653          2678999998754322  245688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           89 HSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             CCSSCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCc
Confidence            999999999999975 8888886543 459999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhhc-cccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWAK-PYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~-~~~~  311 (441)
                      +++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ....... +...
T Consensus       165 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  242 (311)
T 3niz_A          165 LARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR  242 (311)
T ss_dssp             TCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred             CceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence            998643222  12234578999999999976 56899999999999999999999999754432211 1111000 0000


Q ss_pred             cc---hhhhhhhccccc--CCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DR---RKLFRIMDIKLE--GQY-----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~---~~l~~~~~~~~~--~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..   ..+.........  ...     .......+..|+..|+. ||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00   000000000000  000     01112344567777777 99999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.5e-45  Score=344.94  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=212.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|.+..         .+..||+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            45789999999999999999987653         46789999997643 345778999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++.......+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999987776779999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........                
T Consensus       159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------  221 (288)
T 3kfa_A          159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------  221 (288)
T ss_dssp             GTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------
T ss_pred             eeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------
Confidence            86543322 22334457889999999999999999999999999999999 9999975432211                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                       ...+........+......+..|+..|+. ||++||++.+|++.|+.+
T Consensus       222 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          222 -YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence             11111122222333444567778888888 999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-44  Score=353.03  Aligned_cols=245  Identities=24%  Similarity=0.293  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|...         .+++.||||+++...   ....+.+.+|+.+|+.++||||+++++++.
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            57999999999999999997654         357899999986532   234567889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....|+||||++||+|.+++....  .+++..++.++.||+.||+|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~  187 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEccccc
Confidence            9999999999999999999997654  48999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........                
T Consensus       188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------  246 (350)
T 1rdq_E          188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----------------  246 (350)
T ss_dssp             CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH----------------
Confidence            9864332     2345799999999999999999999999999999999999999974332110                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                      ...+....  ..+|......+..|+..|+. ||++||+     +++|+++
T Consensus       247 ~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          247 YEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            01111111  12233344556778888887 9999998     8888764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.7e-45  Score=354.15  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=200.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .++..||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   78 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHY---------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI   78 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            468999999999999999997653         3577899999864321   2235688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....++||||+ +|+|.+++....  .+++..++.++.||+.||.|||+  .||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           79 TTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             ECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             EeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEec
Confidence            9999999999999 789999987655  49999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ++.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+........             
T Consensus       154 ~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------  217 (336)
T 3h4j_B          154 LSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------  217 (336)
T ss_dssp             CTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------
T ss_pred             cceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------
Confidence            998654332   2245679999999999988776 78999999999999999999999754321110             


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ..+. ......+......+..|+..|+. ||++|||++|+++.
T Consensus       218 ----~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          218 ----KKVN-SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ----CCCC-SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ----HHHH-cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                0000 00112233344556778888888 99999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-44  Score=349.71  Aligned_cols=259  Identities=19%  Similarity=0.182  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++.....  ...+.+|+.++++| +||||+++++++.+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNL---------YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEET---------TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEEC---------CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            468999999999999999997643         3478999999865432  34577899999999 89999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc-----EEEc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-----AKLS  231 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~-----~kl~  231 (441)
                      ....++||||+ +++|.+++... ...+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.     +||+
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           77 GKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             CCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            99999999999 99999999764 3469999999999999999999999  89999999999999999887     9999


Q ss_pred             ccCCcccCCCCCccc-----eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          232 DFGLAKAGPTGDRTH-----VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       232 DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      |||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i  232 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI  232 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence            999998643322111     123567999999999999999999999999999999999999999764332221111110


Q ss_pred             -ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          307 -KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       307 -~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                       ......       ........    .. .+..|+..|+. +|.+||++.+|++.|+.+
T Consensus       233 ~~~~~~~-------~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          233 GDTKRAT-------PIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHHHHS-------CHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhhccC-------CHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             000000       00001111    12 56677778887 999999999999988754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=344.57  Aligned_cols=254  Identities=29%  Similarity=0.475  Sum_probs=195.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+.           ++.||||++...  ...+.+.+|+++|++++||||+++++++.+ 
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   72 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-   72 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            357889999999999999998653           467999999754  345678999999999999999999998764 


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcC-CCeEEeccCCCcEEECCCCc-EEEcccC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAE-QQVIYRDFKASNILLDSEFN-AKLSDFG  234 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~-~~ivH~Dlkp~Nill~~~~~-~kl~DFg  234 (441)
                       ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.. ++|+||||||+|||++.++. +||+|||
T Consensus        73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           73 -PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             -TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             -CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence             48999999999999999975443 24788999999999999999999732 58999999999999998886 7999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++......     .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........  +.        
T Consensus       152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~~--------  216 (307)
T 2eva_A          152 TACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WA--------  216 (307)
T ss_dssp             C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--HH--------
T ss_pred             cccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--HH--------
Confidence            99754321     2234689999999999999999999999999999999999999974332111100  00        


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                           .........+......+..|+..|+. ||++||++.+|++.|+.+...
T Consensus       217 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          217 -----VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             -----HHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             -----HhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                 00011111222333456678888888 999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-44  Score=348.29  Aligned_cols=252  Identities=26%  Similarity=0.360  Sum_probs=194.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||+|....      +...++.||+|+++....    .....+.+|+.+|+.++||||++++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            4679999999999999999986532      234578999999976532    234457889999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+.+..|+||||+++++|.+++....  .+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeC
Confidence            999999999999999999999997654  48999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........              
T Consensus       166 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------  229 (327)
T 3a62_A          166 GLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--------------  229 (327)
T ss_dssp             SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------------
T ss_pred             CcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--------------
Confidence            9997532221  123356799999999999999999999999999999999999999975432110              


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                        +..++..  ....+......+..|+..|+. ||++||     ++.+++++
T Consensus       230 --~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          230 --IDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             --HHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             --HHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence              0111111  112233334556777888887 999999     77888765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-45  Score=367.71  Aligned_cols=258  Identities=23%  Similarity=0.273  Sum_probs=200.6

Q ss_pred             HHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCccc
Q 013557           73 ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      ++....++|++.++||+|+||+||+|....         +++.||+|+++....   .....+.+|+.+|..++||||++
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            334456899999999999999999976543         477899999864211   11233788999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ++++|.+.+..||||||++||+|.+++.+.. ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+|
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEE
Confidence            9999999999999999999999999997632 359999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhh
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~  304 (441)
                      |+|||+++....... ......+||+.|+|||++.     ++.|+.++|||||||++|||++|+.||.........    
T Consensus       216 L~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~----  290 (437)
T 4aw2_A          216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----  290 (437)
T ss_dssp             ECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----
T ss_pred             EcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH----
Confidence            999999976433221 2233468999999999997     457899999999999999999999999754321110    


Q ss_pred             hhccccccchhhhhhhcccccCCCc---hhHHHHHHHHHHHHhc-CCCC--CCCHHHHHHH
Q 013557          305 WAKPYLGDRRKLFRIMDIKLEGQYP---QKGAYMVAILALQCIS-EAKV--RPSMSEVLSA  359 (441)
Q Consensus       305 ~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~~~~l~~~c~~-~P~~--RPs~~evl~~  359 (441)
                                  ..++.......+|   ......+..|+..|+. +|++  ||+++||+++
T Consensus       291 ------------~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          291 ------------GKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ------------HHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ------------HhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                        1111100001111   1123445566666766 6666  9999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.3e-44  Score=340.44  Aligned_cols=253  Identities=29%  Similarity=0.534  Sum_probs=201.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-------HHHHHHHHHHHhcCCCCCcccE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-------HKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      .++|++.+.||+|+||.||+|....         +++.||+|++.......       .+.+.+|+.++++++||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            4689999999999999999976543         47789999986543221       1678899999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEECCCCc-
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLDSEFN-  227 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~~~~~-  227 (441)
                      ++++.+..  ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++  |+||||||+|||++.++. 
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTT
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCC
Confidence            99986654  79999999999999886543 469999999999999999999998  78  999999999999988776 


Q ss_pred             ----EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhh--cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          228 ----AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA--TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       228 ----~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                          +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||..........
T Consensus       164 ~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  238 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF  238 (287)
T ss_dssp             CSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred             CceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence                99999999975332     234567999999999984  4557899999999999999999999997543221110


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .              ..+.........+......+..|+..|+. ||++||++.+|++.|+++
T Consensus       239 ~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          239 I--------------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             H--------------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             H--------------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1              01111112223344445567788888888 999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.9e-45  Score=355.48  Aligned_cols=212  Identities=25%  Similarity=0.285  Sum_probs=183.4

Q ss_pred             CccccHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC--
Q 013557           66 LKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH--  143 (441)
Q Consensus        66 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--  143 (441)
                      ...+++.+.....++|++.+.||+|+||.||+|....         .++.||||+++.. ......+..|+.+++.++  
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~   91 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQND   91 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhccc
Confidence            3445555556677899999999999999999976543         4778999999753 233456778999999986  


Q ss_pred             ---CCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcE
Q 013557          144 ---HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI  220 (441)
Q Consensus       144 ---hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Ni  220 (441)
                         ||||+++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+||
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NI  168 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENI  168 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccE
Confidence               999999999999999999999999 8999999988776679999999999999999999999  8999999999999


Q ss_pred             EECC-------------------------CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhH
Q 013557          221 LLDS-------------------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVY  275 (441)
Q Consensus       221 ll~~-------------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw  275 (441)
                      |++.                         ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw  243 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMW  243 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchH
Confidence            9975                         788999999999864332     2346799999999999999999999999


Q ss_pred             HHhHHHHHHHhCCCCCCccc
Q 013557          276 SFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       276 SlG~il~elltg~~pf~~~~  295 (441)
                      ||||++|+|++|+.||....
T Consensus       244 slG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          244 SFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHHHCCCCCCCCc
Confidence            99999999999999997544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-44  Score=353.91  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=190.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||++...         .+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDK---------LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEET---------TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            468999999999999999997654         357799999997543 3346688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--EEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--AKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--~kl~DFg~  235 (441)
                      ...++||||+++|+|.+++....  .+++..++.++.|++.||.|||+  +||+||||||+|||++.++.  +||+|||+
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~  164 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGY  164 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence            99999999999999999997654  49999999999999999999999  89999999999999987765  99999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCch-hhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAK-CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++......   ......||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.........  ..          
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~----------  229 (361)
T 3uc3_A          165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RK----------  229 (361)
T ss_dssp             C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HH----------
T ss_pred             cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HH----------
Confidence            97432221   2234579999999999998888665 89999999999999999999753321110  00          


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+..+................+..|+..|+. ||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          230 TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0111111111100111223455677788887 99999999999976

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-44  Score=357.30  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=194.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCC--CCCcccEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLH--HPNLVKLIGFC  154 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~l~~~~  154 (441)
                      ++|++.+.||+|+||.||+|...          .+..||||++.....  ...+.+.+|+.+|++|+  ||||+++++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~  125 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE  125 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence            56999999999999999997543          267899999865432  33467899999999996  59999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      ...+..|+||| +.+++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++ ++.+||+|||
T Consensus       126 ~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          126 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             ECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecC
Confidence            99999999999 56889999997654  58999999999999999999998  8999999999999996 5799999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhc-----------CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhh
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~  303 (441)
                      +++..............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......     
T Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----  274 (390)
T 2zmd_A          200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----  274 (390)
T ss_dssp             SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----
T ss_pred             ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----
Confidence            9987544332223345679999999999975           368999999999999999999999996432110     


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                ..+..+++......++......+..|+..|+. ||++||++.|+++.
T Consensus       275 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          275 ----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                      11122222222222333334556778888888 99999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-44  Score=347.87  Aligned_cols=272  Identities=31%  Similarity=0.445  Sum_probs=209.5

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc--C
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--G  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~  157 (441)
                      |++.+.||+|+||.||++.+.     +.+...++.||||+++.... ...+.+.+|+++|++++||||+++++++.+  .
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEEC-----SCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HhhhheecCCCCeEEEEEEEc-----cCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            489999999999999998764     34555788999999986532 334568999999999999999999999987  4


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      ...++||||+++++|.+++....   +++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccccc
Confidence            67899999999999999986543   8999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ........ .......||..|+|||++.+..++.++||||||+++|+|+||+.||........ ....+..... ....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHHH
Confidence            75443221 122345688899999999998999999999999999999999999864321110 0000000000 01112


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ...+........+......+..|+..|+. ||++||++.+|++.|+.+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            22233333333445555667788888888 9999999999999998654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-44  Score=341.57  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=191.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..            .+|||+++....  ...+.+.+|+.+|++++||||+++++++ 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            5689999999999999999986532            489999875432  3346689999999999999999999965 


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      .....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEcccee
Confidence            5567899999999999999986543 459999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      +................||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......  .+.......   
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~---  241 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG---  241 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHT---
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccc---
Confidence            97644322222334567999999999986   5678899999999999999999999997543211  111110000   


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                            ... .............+..|+..|+. +|++||++.+|++.|+.+..
T Consensus       242 ------~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 ------SLS-PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ------SCC-CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ------ccC-cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                  000 00011122334556778888888 99999999999999987653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.8e-45  Score=345.01  Aligned_cols=261  Identities=25%  Similarity=0.334  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|........  ....+..||+|++........+.+.+|+.+|++++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDY--GQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGG--GCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEeccccc--ccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            46799999999999999999976542110  0112357999999776666677899999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--------EE
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--------AK  229 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--------~k  229 (441)
                      +..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.        +|
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999997643 348999999999999999999999  89999999999999998877        99


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCC-CCCccccccchhhhhhhc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRR-AVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~-pf~~~~~~~~~~~~~~~~  307 (441)
                      |+|||++.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|.. ||.............   
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~---  232 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---  232 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---
Confidence            999999875422      123458899999999987 679999999999999999999654 443322111100000   


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCCCC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRD  368 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~~~  368 (441)
                                    .  ....+......+..|+..|+. ||++||++.++++.|+.+..+..
T Consensus       233 --------------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          233 --------------D--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             --------------T--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             --------------c--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                          0  011111122345677788888 99999999999999998877543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=344.48  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=192.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--------------------------cHHH
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--------------------------GHKE  131 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~  131 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++......                          ..+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNE---------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEET---------TTTEEEEEEEEECC-------------------------------CH
T ss_pred             ecceEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            468999999999999999997654         34778999998654321                          1245


Q ss_pred             HHHHHHHHhcCCCCCcccEEEEEEc--CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 013557          132 WLSEVNYLGQLHHPNLVKLIGFCLD--GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ  209 (441)
Q Consensus       132 ~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~  209 (441)
                      +.+|+++|++++||||+++++++.+  ....++||||+++++|.+++.   ...+++..++.++.||+.||.|||+  ++
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~  157 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHY--QK  157 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--CC
Confidence            7899999999999999999999986  568899999999999988642   2359999999999999999999999  89


Q ss_pred             eEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC---CCchhhhHHHhHHHHHHHh
Q 013557          210 VIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLS  286 (441)
Q Consensus       210 ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~ellt  286 (441)
                      |+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|+|++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            9999999999999999999999999998654322  1234567999999999998665   3788999999999999999


Q ss_pred             CCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          287 GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       287 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      |+.||.........   .             .+................+..|+..|+. ||++||++.|++++
T Consensus       236 g~~pf~~~~~~~~~---~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          236 GQCPFMDERIMCLH---S-------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCSSCCSSHHHHH---H-------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCCCCccHHHHH---H-------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            99999754321100   0             0000000000111223456677788887 99999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.2e-44  Score=339.62  Aligned_cols=266  Identities=22%  Similarity=0.268  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||+++.....  ....+.+|+.+|++++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEEC---------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            57999999999999999997654         34778999998754322  24668899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  148 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            9999999999976 6767665433 359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCccccccc--hhhhhhh-cccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE--QNLVDWA-KPYLGD  312 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~~~~~~--~~~~~~~-~~~~~~  312 (441)
                      +......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........  ....... .+....
T Consensus       149 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             EECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             eecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            8643222  1223457899999999998766 79999999999999999999888643221111  0111100 000000


Q ss_pred             chhhhhhhccc---------ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIK---------LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~---------~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ........+..         ............+..|+..|+. ||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000000000         0001112233455677788887 99999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=346.82  Aligned_cols=263  Identities=25%  Similarity=0.431  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||.||+|.+...     ....+..||||.++.... .....+.+|+.++++++||||+++++++.+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecC-----CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            35678889999999999999976532     122356799999976532 234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence            999999999999999999997643 359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......                
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------------  258 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------  258 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----------------
Confidence            865432211 11123346789999999999999999999999999999999 999996433211                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       +...+........+......+..|+..|+. +|++||++.+|++.|+++..
T Consensus       259 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          259 -VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             -HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             111111111112233334556778888888 99999999999999986543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-44  Score=345.49  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=186.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++.... .....+.+|+.+|++++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNK---------TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT   74 (317)
T ss_dssp             ---------------CEEEEEECS---------SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred             ccceeEeeEECCCCCEEEEEEEEC---------CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence            468999999999999999997543         3578999999865432 234678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRG----ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      ++..++||||++ ++|.+++....    ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECc
Confidence            999999999997 59999986542    2358999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhhc-cc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWAK-PY  309 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~-~~  309 (441)
                      ||+++.......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ..... +.
T Consensus       152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999986432211  2234578999999999976 4689999999999999999999999975443221111 11000 00


Q ss_pred             ccc------------------chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          310 LGD------------------RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~------------------~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...                  ...+...+....    +......+..|+..|+. ||++||++.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000                  000011111111    11223356677788887 99999999999865

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4e-44  Score=344.27  Aligned_cols=262  Identities=25%  Similarity=0.418  Sum_probs=196.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|.+.+.||+|+||.||+|.+..      +...+..||+|+++....  ...+.+.+|+.++++++||||+++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             CHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            45789999999999999999987643      223467899999975532  2346688999999999999999999998


Q ss_pred             EcCC-----eeEEEEEeCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          155 LDGE-----NRLLVYEYMPKGSLENHLFRR----GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       155 ~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      .+..     ..++||||+++++|.+++...    ....+++..++.++.||+.||.|||+  ++|+||||||+|||++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCC
Confidence            8755     359999999999999998532    33569999999999999999999998  899999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhh
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~  304 (441)
                      +.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.........    
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----  259 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY----  259 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH----
Confidence            9999999999986543332222334567889999999999999999999999999999999 88898754321110    


Q ss_pred             hhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          305 WAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       305 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                   ..+........+......+..++..|+. +|++||++.+|++.|+.+
T Consensus       260 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          260 -------------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             -------------HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                         1111111112233344566778888888 999999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.5e-44  Score=347.85  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=193.1

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++.... ...+.+.+|+.+|++++||||++++++|.
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   74 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL   74 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4568999999999999999997654         3477899999875432 34567899999999999999999999986


Q ss_pred             cCC---------------------------------------------------------eeEEEEEeCCCCCHHHHHHh
Q 013557          156 DGE---------------------------------------------------------NRLLVYEYMPKGSLENHLFR  178 (441)
Q Consensus       156 ~~~---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~  178 (441)
                      +..                                                         ..++||||+++++|.+++..
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  154 (332)
T 3qd2_B           75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR  154 (332)
T ss_dssp             ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred             EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence            543                                                         37999999999999999976


Q ss_pred             cCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCcc----------ce
Q 013557          179 RGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT----------HV  247 (441)
Q Consensus       179 ~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~----------~~  247 (441)
                      ... ....+..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++........          ..
T Consensus       155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~  232 (332)
T 3qd2_B          155 RCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT  232 (332)
T ss_dssp             CCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred             ccCccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence            543 235667789999999999999999  89999999999999999999999999999865433211          11


Q ss_pred             eeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCC
Q 013557          248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQ  327 (441)
Q Consensus       248 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  327 (441)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..|+....     ...             ..    .....
T Consensus       233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~-------------~~----~~~~~  290 (332)
T 3qd2_B          233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RII-------------TD----VRNLK  290 (332)
T ss_dssp             CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHH-------------HH----HHTTC
T ss_pred             ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHH-------------HH----hhccC
Confidence            234579999999999999999999999999999999999977643110     000             00    00011


Q ss_pred             Cc---hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          328 YP---QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       328 ~~---~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+   ......+..|+..|+. ||++||++.|++++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            11   1112334667788888 99999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.1e-44  Score=342.77  Aligned_cols=256  Identities=22%  Similarity=0.362  Sum_probs=194.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhc--CCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ--LHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|.+.           +..||||++...   ....+..|.+++..  ++||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            3578999999999999999998653           668999998653   34556667777666  7999999999986


Q ss_pred             Ec----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCeEEeccCCCcEEE
Q 013557          155 LD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH--------EAEQQVIYRDFKASNILL  222 (441)
Q Consensus       155 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH--------~~~~~ivH~Dlkp~Nill  222 (441)
                      .+    ....++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +  ++|+||||||+|||+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEE
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEE
Confidence            54    3468999999999999999943   35999999999999999999999        7  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccc--eeeeccCCCCcCchhhhhcC------CCCchhhhHHHhHHHHHHHhC-------
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTRGYAAPEYLATG------RLTAKCDVYSFGVVLLELLSG-------  287 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltg-------  287 (441)
                      +.++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999997543322111  12234799999999999876      445799999999999999999       


Q ss_pred             ---CCCCCccccccchhhhhhhccccccchhhhhhh-cccccCC-----CchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          288 ---RRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM-DIKLEGQ-----YPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       288 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~-----~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                         +.||..........            ..+.... .......     .+......+..|+..|+. ||++||++.+|+
T Consensus       227 ~~~~~pf~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSF------------EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             CCCCCTTTTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             ccccccccccCCCCcch------------hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence               77775332111100            0000000 0000111     123345667888889998 999999999999


Q ss_pred             HHhhcC
Q 013557          358 SALEQL  363 (441)
Q Consensus       358 ~~L~~l  363 (441)
                      +.|+++
T Consensus       295 ~~L~~i  300 (301)
T 3q4u_A          295 KTLTKI  300 (301)
T ss_dssp             HHHHHH
T ss_pred             HHHhcc
Confidence            999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=363.01  Aligned_cols=260  Identities=21%  Similarity=0.249  Sum_probs=201.4

Q ss_pred             HHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCccc
Q 013557           73 ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      +.....++|++.+.||+|+||.||+|...         .+++.||||++++...   .....+.+|..+|..++||||++
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~---------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  125 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMK---------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ  125 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence            33445689999999999999999997654         3578999999865321   12234788999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ++++|.+.+..||||||++||+|.+++.+.+ ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.+|++|
T Consensus       126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEE
Confidence            9999999999999999999999999997654 259999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhh-------cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccc-hh
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-------TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE-QN  301 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~-~~  301 (441)
                      |+|||+++....... ......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||........ ..
T Consensus       203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999986543221 1223468999999999997       35689999999999999999999999975432111 01


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhcCCCCC---CCHHHHHHH
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVR---PSMSEVLSA  359 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~R---Ps~~evl~~  359 (441)
                      ...+...           +  .. ...+......+..|+..|+.+|++|   |+++||+++
T Consensus       282 i~~~~~~-----------~--~~-p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYKEH-----------L--SL-PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHHHH-----------C--CC-C----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred             HHhcccC-----------c--CC-CccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence            1110000           0  00 0011223345667777888888887   699999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.4e-44  Score=338.66  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+...      ...+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNH------KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECT------TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCC------CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            46899999999999999999876432      2345679999997653 2345678999999999999999999999765


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             -CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCC
Confidence             46789999999999999997654 358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.........               
T Consensus       161 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---------------  224 (281)
T 3cc6_A          161 RYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---------------  224 (281)
T ss_dssp             GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---------------
T ss_pred             ccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---------------
Confidence            865432211 1233457889999999999999999999999999999998 99999643321111               


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        ..+........+......+..++..|+. +|++||++.++++.|+.+
T Consensus       225 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          225 --GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             --HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence              1111111111233334556778888888 999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-44  Score=353.98  Aligned_cols=272  Identities=17%  Similarity=0.186  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-----------HHHHHHHHHHHhcCCCCC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-----------HKEWLSEVNYLGQLHHPN  146 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpn  146 (441)
                      .++|++.+.||+|+||.||+|.+....    ....++.||||++.......           ...+..|+..+..++|+|
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSS----CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCcc----ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            468999999999999999999775421    12246789999987653211           112445667788889999


Q ss_pred             cccEEEEEEcC----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          147 LVKLIGFCLDG----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       147 Iv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      |+++++++.+.    ...||||||+ |++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||+
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill  185 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL  185 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEE
Confidence            99999998764    4589999999 999999997643 459999999999999999999999  899999999999999


Q ss_pred             C--CCCcEEEcccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          223 D--SEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       223 ~--~~~~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +  .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  8899999999999764322111     11134569999999999999999999999999999999999999997533


Q ss_pred             cccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ....  ...+....  ....+..+++..+.   .......+..++..|+. +|++||++.+|++.|+.+.
T Consensus       266 ~~~~--~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          266 KDPK--YVRDSKIR--YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             TCHH--HHHHHHHH--HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCHH--HHHHHHHH--hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            2211  11111000  01112233332221   11223456677888888 9999999999999987543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=347.29  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE--
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL--  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--  155 (441)
                      .++|++.+.||+|+||.||++...         ..++.||||++........+.+.+|+.+++.++||||+++++++.  
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGL---------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEec---------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            468999999999999999997653         347899999987665556677899999999999999999999987  


Q ss_pred             --cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          156 --DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       156 --~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                        .....++||||+++++|.+++...  ....+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEE
Confidence              345789999999999999998753  33569999999999999999999999  899999999999999999999999


Q ss_pred             ccCCcccCCCCCccc-------eeeeccCCCCcCchhhhhcCC---CCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          232 DFGLAKAGPTGDRTH-------VSTQVMGTRGYAAPEYLATGR---LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       232 DFg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                      |||++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||......... 
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-  255 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-  255 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-
Confidence            999987532211000       011345799999999987554   688999999999999999999999632111000 


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCCC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPR  367 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~~  367 (441)
                                    +............+......+..|+..|+. ||++||++.+|++.|+.+..+.
T Consensus       256 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          256 --------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             --------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             --------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                          000001011111122233456677788887 9999999999999999886543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-44  Score=371.20  Aligned_cols=258  Identities=28%  Similarity=0.409  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+.+.+|+++|++|+|+||+++++++.+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            35678889999999999999997653          3569999998654 346789999999999999999999999876


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       +..||||||+++|+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence             678999999999999999975544458999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +...... ........++..|+|||++.++.++.++|||||||+||||++ |+.||.......                 
T Consensus       411 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----------------  472 (535)
T 2h8h_A          411 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------  472 (535)
T ss_dssp             TTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----------------
T ss_pred             eecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence            8653221 111223456789999999999999999999999999999999 999997433211                 


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      +...+........+......+..|+..|+. ||++||++++|++.|+.+...
T Consensus       473 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          473 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            111111111122334445567788889998 999999999999999977543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-44  Score=336.20  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+..          +..||+|++..... ..+.+.+|++++++++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3678999999999999999987642          55799999986543 456789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccc
Confidence            99999999999999999997643 358999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...... ........|+..|+|||++.+..++.++||||||+++|+|++ |+.||........                 
T Consensus       153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----------------  214 (267)
T 3t9t_A          153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----------------  214 (267)
T ss_dssp             GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------
T ss_pred             cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-----------------
Confidence            643211 111223457789999999999999999999999999999999 8999975332110                 


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ...+........+......+..++..|+. +|++||++.++++.|+.+.
T Consensus       215 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          215 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            01111111112233334556778888888 9999999999999998653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.3e-44  Score=354.16  Aligned_cols=207  Identities=19%  Similarity=0.242  Sum_probs=177.4

Q ss_pred             hcCCCCCCeeeec--CceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEG--GFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|  +||.||+|...         .+++.||||+++....  ...+.+.+|+.+|++++||||++++++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            4689999999999  99999997654         3578999999975432  234567889999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+.+..|+||||+++|+|.+++.......+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccc
Confidence            9999999999999999999999987755679999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCc-----cceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          234 GLAKAGPTGDR-----THVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       234 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |.+........     ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||....
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            98864321110     111223478999999999987  578999999999999999999999997543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=350.92  Aligned_cols=256  Identities=19%  Similarity=0.207  Sum_probs=200.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC---CCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH---HPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||+|.+..    ..+...++.||||+++..   ....+..|++++..++   |+||+.++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGD----LNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecC----CcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            35789999999999999999986532    123445788999999765   3456777888888886   9999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC------
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRR---GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS------  224 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~------  224 (441)
                      +...+..|+||||+++|+|.+++...   ....+++..++.++.||+.||+|||+  ++|+||||||+|||++.      
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC-
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999999753   33469999999999999999999998  89999999999999998      


Q ss_pred             -----CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccc
Q 013557          225 -----EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE  299 (441)
Q Consensus       225 -----~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~  299 (441)
                           ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 899999999999754322333344567899999999999999999999999999999999999999853221100


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCC-CCHHHHHHHhhcC
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR-PSMSEVLSALEQL  363 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~R-Ps~~evl~~L~~l  363 (441)
                                     .+..    .. ...+  ....+..+...|+. +|.+| |+++++.+.|+.+
T Consensus       294 ---------------~~~~----~~-~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 ---------------KPEG----LF-RRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ---------------EECS----CC-TTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ---------------eech----hc-cccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                           0000    00 0111  23456667777777 88776 6888887777643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-44  Score=341.34  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|....          +..||||.+.... ...+.+.+|+++|++++||||+++++++. 
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            34689999999999999999987542          5579999997653 34677899999999999999999999976 


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++.......+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            4568999999999999999865433358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   .             
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~-------------  219 (279)
T 1qpc_A          157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V-------------  219 (279)
T ss_dssp             EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-------------
T ss_pred             ccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H-------------
Confidence            86543221 11223456889999999998899999999999999999999 899997433211   0             


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                       ...+........+......+..|+..|+. +|++||++.+|++.|+.+.
T Consensus       220 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          220 -IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence             01111111112233334566778888888 9999999999999998653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.7e-44  Score=341.01  Aligned_cols=262  Identities=17%  Similarity=0.163  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         ..++.||||++....  ....+.+|+.+++.+ +|+||+++++++.+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   77 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE   77 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence            468999999999999999997643         347899999986543  234577899999999 79999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc-----EEEc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN-----AKLS  231 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~-----~kl~  231 (441)
                      ....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.     +||+
T Consensus        78 ~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           78 GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             CceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            99999999999 999999997653 359999999999999999999998  89999999999999987766     9999


Q ss_pred             ccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          232 DFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       232 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      |||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus       154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            99999865432211     1124567999999999999999999999999999999999999999764322221111100


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ...      .........    .......+..|+..|+. +|++||++.+|++.|+++.
T Consensus       234 ~~~------~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          234 GEK------KQSTPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HHH------HHHSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             Hhh------ccCccHHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            000      000000001    11123456677788887 9999999999999988654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-44  Score=345.65  Aligned_cols=258  Identities=22%  Similarity=0.306  Sum_probs=191.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         ..++.||||+++......   ...+.+|+.++++++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDL---------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEEC---------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            568999999999999999997643         347899999997653332   34688999999999999999999998


Q ss_pred             EcCCe----eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          155 LDGEN----RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       155 ~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      .....    .|+||||++|++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEE
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEE
Confidence            76543    499999999999999997654  48999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          231 SDFGLAKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      +|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  .......
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~  235 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVRED  235 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHCC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcCC
Confidence            999999864332211 1223457999999999999999999999999999999999999999754321110  0000000


Q ss_pred             cccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH-Hhhc
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS-ALEQ  362 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~-~L~~  362 (441)
                      .            .............+..|+..|+. ||++||++.+++. .+.+
T Consensus       236 ~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          236 P------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             C------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             C------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            0            00000011123446677788887 9999997766553 4443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-44  Score=348.04  Aligned_cols=265  Identities=26%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+..    ..+...+..||||.+.... ......+.+|+.++++++||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSG----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcC----CCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4689999999999999999987542    1133457789999997543 2345568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---CcE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGA-----RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNA  228 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~~  228 (441)
                      ....|+||||+++++|.+++.....     ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.+   ..+
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceE
Confidence            9999999999999999999976542     348999999999999999999999  899999999999999844   469


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.......   ..    
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----  255 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL----  255 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HH----
Confidence            9999999874322222222334568999999999999999999999999999999998 999997443211   11    


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                ..+........+......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       256 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          256 ----------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             ----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                      1111111112233334556778888888 99999999999999986543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.2e-44  Score=368.71  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.++||+|+||.||+|...         .+++.||+|++....   ......+.+|+.+|+.++||||+++++++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            467999999999999999997654         357899999986532   12345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||++||+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.+|++||+|||
T Consensus       254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFG  331 (576)
T 2acx_A          254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLG  331 (576)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecc
Confidence            999999999999999999999977666669999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........             .
T Consensus       332 la~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-------------~  395 (576)
T 2acx_A          332 LAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------E  395 (576)
T ss_dssp             TCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-------------H
T ss_pred             cceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-------------H
Confidence            998654332   234568999999999999989999999999999999999999999754321110             0


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      .+...+. .....++......+..|+..|+. ||++||     +++||+++
T Consensus       396 ~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          396 EVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             HHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            1111111 11122334444566777888887 999999     78898764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=350.11  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=186.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|....         +++.||||+++...  ..+.+.+|+.+|++++||||+++++++.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            45789999999999999999976543         46789999997543  34567889999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---CCcEEEccc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDF  233 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~~~~kl~DF  233 (441)
                      ....++||||+++++|.+++....  .+++..++.++.||+.||.|||+  .+|+||||||+|||++.   ++.+||+||
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccC
Confidence            999999999999999999996543  58999999999999999999999  89999999999999975   789999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..          
T Consensus       196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----------  260 (349)
T 2w4o_A          196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF----------  260 (349)
T ss_dssp             C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH----------
T ss_pred             ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH----------
Confidence            9998643321   22356799999999999999999999999999999999999999964332110  00          


Q ss_pred             hhhhhhhccc--ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIK--LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~--~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         ..+....  ............+..|+..|+. ||++||++.++++.
T Consensus       261 ---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          261 ---RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ---HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0011100  0001112233456677888888 99999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-43  Score=337.25  Aligned_cols=265  Identities=22%  Similarity=0.304  Sum_probs=194.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||.||+|...          .+..+|+|++.....  .....+.+|+.+|++++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            57899999999999999998652          367899999865432  224678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  147 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLA  147 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccc
Confidence            9999999999975 9999886543 358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhh-ccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWA-KPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~-~~~~~~~  313 (441)
                      +......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... ...... .+.....
T Consensus       148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (288)
T 1ob3_A          148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW  225 (288)
T ss_dssp             HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence            7543211  112345789999999999764 5899999999999999999999999754322111 111100 0000000


Q ss_pred             hhhhhh--hcccc-------cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRI--MDIKL-------EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~--~~~~~-------~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ......  .+...       ...........+..|+..|+. ||++||+++|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000  00000       001111223445677788887 99999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.6e-44  Score=338.72  Aligned_cols=250  Identities=29%  Similarity=0.447  Sum_probs=196.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|...           +..||||+++...  ..+.+.+|+.++++++||||+++++++.+.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            468999999999999999998653           5689999997653  456789999999999999999999987654


Q ss_pred             -CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          158 -ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       158 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       +..++||||+++++|.+++.......+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccc
Confidence             478999999999999999976554448899999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ......     .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||........                
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----------------  223 (278)
T 1byg_A          165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------  223 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH----------------
T ss_pred             cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------
Confidence            754322     123457889999999999999999999999999999998 9999975432111                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                       ...+........+......+..++..|+. ||++||++.++++.|+.+.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          224 -VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             -HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence             01111111122233344567778888888 9999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-43  Score=333.74  Aligned_cols=248  Identities=22%  Similarity=0.309  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|....         .+..+|+|++........+.+.+|++++++++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED   77 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45789999999999999999976543         467899999977655667889999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEEccc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLSDF  233 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl~DF  233 (441)
                      ....++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            999999999999999999987654  48999999999999999999999  899999999999999   78889999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.........  ..         
T Consensus       154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~---------  218 (277)
T 3f3z_A          154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM--LK---------  218 (277)
T ss_dssp             TTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH---------
T ss_pred             ccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH--HH---------
Confidence            9997654332   2234579999999999875 4999999999999999999999999754321111  00         


Q ss_pred             hhhhhhhcccccCCCch----hHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQ----KGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~----~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           +....  ...+.    .....+..|+..|+. ||++||++.++++.
T Consensus       219 -----~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          219 -----IREGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -----HHHCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -----HHhCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000  00111    123456677788887 99999999999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.3e-44  Score=338.26  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             hcCCCCCC-eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDS-LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|.+.+ .||+|+||.||+|.+..       ...+..||||+++.....  ..+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecC-------CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            45788887 99999999999986432       234678999999765322  246789999999999999999999998


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                       +.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence             5667899999999999999997654  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccccc
Q 013557          235 LAKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       235 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......              
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------------  228 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------  228 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------------
Confidence            99865433221 11223356789999999998889999999999999999999 999997543211              


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                         +...+........+......+..++..|+. ||++||++.+|++.|+.+
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          229 ---VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               111111111122334445567788888888 999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=334.95  Aligned_cols=253  Identities=21%  Similarity=0.257  Sum_probs=198.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC----cccHHHHHHHHHHHhcCCCCCcccEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG----FQGHKEWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      ..++|++.+.||+|+||.||+|...         .++..+|+|+++...    ......+.+|+.++++++||||+++++
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   73 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDS---------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD   73 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBT---------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEEC---------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            3578999999999999999997543         357789999987542    123467899999999999999999999


Q ss_pred             EEE--cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          153 FCL--DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       153 ~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ++.  +....++||||++++ |.+++.......+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           74 VLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             EEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEe
Confidence            984  456789999999875 8888877666679999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC--CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL--TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      +|||++................||+.|+|||++.+...  +.++||||||+++|+|++|+.||.........        
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------  222 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF--------  222 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--------
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--------
Confidence            99999986543333333445679999999999986543  77999999999999999999999754321110        


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                               ..+... ....+......+..++..|+. ||++||++.++++.
T Consensus       223 ---------~~i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          223 ---------ENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---------HHHHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------HHHhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     000000 011222334456677888888 99999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.4e-44  Score=354.20  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=189.0

Q ss_pred             hcCCCCC-CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhc-CCCCCcccEEEEEE
Q 013557           78 TRNFRPD-SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ-LHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~  155 (441)
                      .++|.+. ++||+|+||+||+|...         .++..||||+++.     ...+.+|+.++.+ ++||||++++++|.
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~---------~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~  125 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYE  125 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEEC---------CCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence            4567776 78999999999997654         3578899999863     2456789988754 48999999999987


Q ss_pred             c----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---CCcE
Q 013557          156 D----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNA  228 (441)
Q Consensus       156 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~~~~  228 (441)
                      .    ....||||||++||+|.+++.......+++..++.++.||+.||.|||+  ++|+||||||+|||++.   ++.+
T Consensus       126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCE
T ss_pred             ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccE
Confidence            5    5678999999999999999987665679999999999999999999999  89999999999999998   7889


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~  307 (441)
                      ||+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ....   
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---  277 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---  277 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---
Confidence            999999998643322   234567999999999999999999999999999999999999999754321100 0000   


Q ss_pred             cccccchhhhhhhccc--ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          308 PYLGDRRKLFRIMDIK--LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                                .+....  ............+..|+..|+. ||++||++.||+++-
T Consensus       278 ----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          278 ----------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             ----------HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ----------HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                      000000  0000011233456678888888 999999999999863

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=339.31  Aligned_cols=269  Identities=26%  Similarity=0.318  Sum_probs=196.3

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-----ccHHHHHHHHHHHhcC---CCCCc
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-----QGHKEWLSEVNYLGQL---HHPNL  147 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~hpnI  147 (441)
                      ...++|++.+.||+|+||+||+|..         ..+++.||||++.....     .....+.+|+.+++++   +||||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARD---------PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEEC---------TTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccccceEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence            3467999999999999999999754         33578999999864321     1234566788777776   49999


Q ss_pred             ccEEEEEEcCC-----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          148 VKLIGFCLDGE-----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       148 v~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      +++++++....     ..++||||+. ++|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||+
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILV  153 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEE
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE
Confidence            99999998765     5799999996 599999987766669999999999999999999999  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-  301 (441)
                      +.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... 
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  230 (308)
T 3g33_A          154 TSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  230 (308)
T ss_dssp             CTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred             cCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999998654322   2245679999999999999999999999999999999999999997544222111 


Q ss_pred             hhhhhcccc-ccchhhhhhhcccccCC-------CchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          302 LVDWAKPYL-GDRRKLFRIMDIKLEGQ-------YPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       302 ~~~~~~~~~-~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ......... .................       ........+..|+..|+. ||++|||+.|++++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            111000000 00000000000000000       001123445667777777 99999999999865

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.2e-44  Score=360.30  Aligned_cols=248  Identities=26%  Similarity=0.377  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|.+.+.||+|+||.||+|...         .+++.||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEET---------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            468999999999999999997654         3578999999865321   2345788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||++||+|.+++..+.  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEecc
Confidence            99999999999999999999986543  59999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      +++......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+.......              
T Consensus       162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--------------  224 (476)
T 2y94_A          162 LSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--------------  224 (476)
T ss_dssp             SCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--------------
T ss_pred             chhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--------------
Confidence            998754332   2345679999999999988765 6899999999999999999999975432111              


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ...+....  ...+......+..|+..|+. ||++||++.+|+++
T Consensus       225 --~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          225 --FKKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --HHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --HHHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence              00111110  11222333456677888888 99999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.9e-44  Score=361.51  Aligned_cols=250  Identities=27%  Similarity=0.333  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC---CcccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE---GFQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .++..||||+++..   .......+.+|+.+|+.++||||++++++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEc---------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            467999999999999999997543         35789999998753   223345678899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+ .+||+||||||+|||++.++.+||+|||
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999999999999997654  48999999999999999999996 2689999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........             
T Consensus       295 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------------  359 (446)
T 4ejn_A          295 LCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------------  359 (446)
T ss_dssp             CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred             CceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-------------
Confidence            998633222  22345789999999999999999999999999999999999999996543211110             


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                         .+...  ...++......+..|+..|+. ||++||     +++|++++
T Consensus       360 ---~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          360 ---LILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---HHHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence               11111  112233344556777888888 999999     99999865

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=351.80  Aligned_cols=260  Identities=29%  Similarity=0.421  Sum_probs=193.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc-
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD-  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  156 (441)
                      ..|++.+.||+|+||.||+|.+...      ......+|||.++... ....+.+.+|+.+|++++||||+++++++.+ 
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  162 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEET------TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECC------CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            3467788999999999999976431      1224578999987543 2345678999999999999999999998754 


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccc
Confidence            567899999999999999996543 458999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCcc--ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccc
Q 013557          237 KAGPTGDRT--HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      +........  .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||..........            
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~------------  307 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------  307 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH------------
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH------------
Confidence            864332211  11233467889999999999999999999999999999999 677776433211110            


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                           .+........+......+..++..|+. +|++||++.+|++.|+.+.
T Consensus       308 -----~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          308 -----YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 000011111233344567778888888 9999999999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-44  Score=351.76  Aligned_cols=245  Identities=28%  Similarity=0.348  Sum_probs=190.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHH-HhcCCCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNY-LGQLHHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||+|...         .++..||||+++....   .....+..|..+ ++.++||||++++++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~  107 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS  107 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence            467999999999999999997654         3477899999976532   223456677776 567899999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |.+.+..|+||||++||+|.+++.+..  .+++..++.++.||+.||+|||+  +||+||||||+|||++.+|++||+||
T Consensus       108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          108 FQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeC
Confidence            999999999999999999999997654  48999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........              
T Consensus       184 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--------------  247 (373)
T 2r5t_A          184 GLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--------------  247 (373)
T ss_dssp             CBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--------------
T ss_pred             ccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--------------
Confidence            9998532221  123456899999999999999999999999999999999999999974432110              


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSE  355 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~e  355 (441)
                        ...++....  .++......+..|+..|+. ||++||++.+
T Consensus       248 --~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          248 --YDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --HHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --HHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence              111111111  1233334456677788887 9999999853

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=337.13  Aligned_cols=259  Identities=29%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      .|++.++||+|+||.||+|.+...      ...+..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             EEccCceeccCCCceEEEEEEecC------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            456678999999999999876432      22355799999876433 33467889999999999999999999998766


Q ss_pred             ee-EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          159 NR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       159 ~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      .. ++||||+.+++|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             CCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            55 9999999999999999653 3458999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCc--cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCC-Cccccccchhhhhhhccccccch
Q 013557          238 AGPTGDR--THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV-DKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      .......  ........+|+.|+|||++.+..++.++||||||+++|+|++|..|+ .......                
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------  236 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------  236 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------
Confidence            5433221  11223456789999999999999999999999999999999966554 3222111                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                       +...+........+......+..++..|+. +|++||++.++++.|+++.
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          237 -LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             111111111122233334566778888888 9999999999999988653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=345.61  Aligned_cols=277  Identities=26%  Similarity=0.388  Sum_probs=210.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||.||+|.+.     ..+...+..||||++........+.+.+|+++|++++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEEC-----TTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEec-----cccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            457899999999999999998753     223446889999999876655667899999999999999999999998765


Q ss_pred             C--eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          158 E--NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       158 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            4  7899999999999999997654 358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +......... .......++..|+|||++.+..++.++||||||+++|+|+||..||......... .............
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~  270 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR-MIGNDKQGQMIVF  270 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH-HHCTTCCTHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH-hhccccchhhhHH
Confidence            9865433221 1122345778899999999888999999999999999999999988632111000 0000000000000


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      .+...+........+......+..|+..|+. +|++||++.+|++.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1112222222222344445667788888988 999999999999999865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-43  Score=338.73  Aligned_cols=261  Identities=28%  Similarity=0.413  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE-
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL-  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-  155 (441)
                      ..+|++.+.||+|+||.||+|.+...      ......+|+|.+..... ...+.+.+|+.++++++||||+++++++. 
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ceehhhcceeeecCCceEEEEEEecC------CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            45788899999999999999976432      12345789999876432 34467889999999999999999999864 


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      .+...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccc
Confidence            5567899999999999999996533 458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCcc--ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRT--HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ++........  .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.........            
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~------------  242 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------------  242 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH------------
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH------------
Confidence            9864332211  12234567889999999999999999999999999999999 55566533221110            


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                           ..+........+......+..++..|+. +|++||++.++++.|+.+.
T Consensus       243 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          243 -----VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 0000011111223334456778888888 9999999999999998653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=337.08  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=203.6

Q ss_pred             cCCCCCC-eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDS-LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|.+.+ .||+|+||.||+|.+..       ...+..||||+++.... ...+.+.+|++++++++||||+++++++ .
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~   80 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q   80 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred             HHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence            4666666 99999999999987542       12367899999986532 3456788999999999999999999998 4


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccce
Confidence            56789999999999999998643 3459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ......... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||........               
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------  222 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---------------  222 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---------------
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---------------
Confidence            865432221 11223456889999999998899999999999999999998 9999975432111               


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                        ...+........+......+..++..|+. +|++||++.+|++.|+.+.
T Consensus       223 --~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          223 --MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             --HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              11111111122334445567778888998 9999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=349.12  Aligned_cols=247  Identities=26%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  163 (441)
                      .+.||+|+||.||+|...         .++..||+|+++.......+.+.+|+++|++++||||+++++++.+.+..+||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEET---------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             EEECC-----CEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEecCcCEEEEEEEEc---------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            568999999999997654         34778999999877666677899999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE--CCCCcEEEcccCCcccCCC
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL--DSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill--~~~~~~kl~DFg~a~~~~~  241 (441)
                      |||+++++|.+++.... ..+++..++.++.||+.||.|||+  .+|+||||||+|||+  +.++.+||+|||+++....
T Consensus       165 ~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             EECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            99999999999886543 358999999999999999999999  899999999999999  6678999999999986543


Q ss_pred             CCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhc
Q 013557          242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD  321 (441)
Q Consensus       242 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  321 (441)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  +........           
T Consensus       242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~-----------  305 (373)
T 2x4f_A          242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRW-----------  305 (373)
T ss_dssp             TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCC-----------
T ss_pred             ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccC-----------
Confidence            322   2345799999999999988999999999999999999999999975432111  111000000           


Q ss_pred             ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       322 ~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       .............+..|+..|+. ||++||++.|+++.
T Consensus       306 -~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          306 -DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             -CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00000011223456677788888 99999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=341.41  Aligned_cols=247  Identities=24%  Similarity=0.275  Sum_probs=191.1

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||+||+|....         +++.||||++.....  .....+..|+..+.++ +|+||++++++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            34689999999999999999976543         477899999865432  2233455666666655 89999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      |.+....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+  .+|+||||||+|||++.++.+||+||
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          126 WEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCC
T ss_pred             EEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccc
Confidence            99999999999999 679999887654 359999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..+|.....     ......      
T Consensus       202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~------  266 (311)
T 3p1a_A          202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQLRQ------  266 (311)
T ss_dssp             TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHHHTT------
T ss_pred             eeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHhc------
Confidence            9987643322   2234569999999999875 799999999999999999999776643211     000000      


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              .......+......+..|+..|+. ||++||++.|+++.
T Consensus       267 --------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 --------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                    000000111223456777888888 99999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.2e-44  Score=348.10  Aligned_cols=259  Identities=25%  Similarity=0.281  Sum_probs=197.3

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC-----CcccHHHHHHHHHHHhcCCCCCcc
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-----GFQGHKEWLSEVNYLGQLHHPNLV  148 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv  148 (441)
                      +....++|++.+.||+|+||.||+|...         .++..+|+|++...     .....+.+.+|+.+|++++||||+
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   91 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIEN---------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA   91 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEEC---------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4567789999999999999999997654         34778999998643     223456789999999999999999


Q ss_pred             cEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcC--------------------------------------CCCCCHHHHH
Q 013557          149 KLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------------------------------------ARPLPWTLRI  190 (441)
Q Consensus       149 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~~~~~~~~  190 (441)
                      ++++++.+.+..++||||++||+|.+++....                                      ...+++..++
T Consensus        92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (345)
T 3hko_A           92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS  171 (345)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred             eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence            99999999999999999999999999884210                                      1123577788


Q ss_pred             HHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC--cEEEcccCCcccCCCCC--ccceeeeccCCCCcCchhhhhc-
Q 013557          191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF--NAKLSDFGLAKAGPTGD--RTHVSTQVMGTRGYAAPEYLAT-  265 (441)
Q Consensus       191 ~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~--~~kl~DFg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-  265 (441)
                      .++.||+.||+|||+  ++|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+ 
T Consensus       172 ~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  249 (345)
T 3hko_A          172 NIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT  249 (345)
T ss_dssp             HHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred             HHHHHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence            999999999999999  8999999999999998776  89999999997532211  1112345679999999999975 


Q ss_pred             -CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCc--hhHHHHHHHHHHH
Q 013557          266 -GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQ  342 (441)
Q Consensus       266 -~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~  342 (441)
                       ..++.++|||||||++|+|++|+.||........                +..++........+  ......+..|+..
T Consensus       250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT----------------ISQVLNKKLCFENPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH----------------HHHHHhcccccCCcccccCCHHHHHHHHH
Confidence             6789999999999999999999999975432111                11111111111111  1123456677788


Q ss_pred             Hhc-CCCCCCCHHHHHHH
Q 013557          343 CIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       343 c~~-~P~~RPs~~evl~~  359 (441)
                      |+. +|++||++.++++.
T Consensus       314 ~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHS
T ss_pred             HcCCChhHCCCHHHHhcC
Confidence            888 99999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=346.58  Aligned_cols=270  Identities=19%  Similarity=0.200  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-----------cHHHHHHHHHHHhcCCCCC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-----------GHKEWLSEVNYLGQLHHPN  146 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn  146 (441)
                      .++|++.+.||+|+||.||+|.....      ...+..+|||++......           ....+.+|+.++..++|||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            46799999999999999999876531      123668999998755321           1223667889999999999


Q ss_pred             cccEEEEEEc----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          147 LVKLIGFCLD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       147 Iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      |+++++++.+    ....|+||||+ +++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||+
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLL  184 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEE
Confidence            9999999987    77899999999 999999986554  59999999999999999999999  899999999999999


Q ss_pred             CCCC--cEEEcccCCcccCCCCCc-----cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          223 DSEF--NAKLSDFGLAKAGPTGDR-----THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       223 ~~~~--~~kl~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8877  999999999976432111     111134579999999999999999999999999999999999999996432


Q ss_pred             cccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ..... ..........   .+...+.....   .......+..++..|+. ||++||++++|++.|+.+..
T Consensus       265 ~~~~~-~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          265 KDPVA-VQTAKTNLLD---ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             TCHHH-HHHHHHHHHH---TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cccHH-HHHHHHhhcc---cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11111 1000000000   00000000000   01223456677788888 99999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-43  Score=334.57  Aligned_cols=247  Identities=27%  Similarity=0.424  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|....         .+..||+|++.....   .....+.+|+.++++++||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   78 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence            4689999999999999999976543         467899999864321   2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....++||||+++++|.+++....  .+++..++.++.|++.||.|||+  .||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           79 HDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEecc
Confidence            99999999999999999999997654  48999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..........             
T Consensus       155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------  217 (279)
T 3fdn_A          155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------------  217 (279)
T ss_dssp             EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred             ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------------
Confidence            986533221    234578999999999999999999999999999999999999997543211110             


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .+.  ......+......+..|+..|+. ||++||++.||+++
T Consensus       218 ---~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          218 ---RIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---HHH--HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---HHH--hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               000  01112333344556778888888 99999999999976

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-43  Score=341.80  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------cHHHHHHHHHHHhcCCCCCcccE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------GHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      ..++|++.+.||+|+||.||+|...         .++..||+|+++.....      ..+.+.+|+.+|++++||||+++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   80 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL   80 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEEC---------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceE
Confidence            3567999999999999999997654         35778999998654322      35678999999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----  226 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----  226 (441)
                      ++++.+....++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++    
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           81 HDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcC
Confidence            999999999999999999999999996543  58999999999999999999999  8999999999999999887    


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ....
T Consensus       157 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~  231 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANIT  231 (321)
T ss_dssp             CEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHH
T ss_pred             CEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHH
Confidence            79999999998654322   123457999999999999999999999999999999999999999754321110  0000


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ......        ....    .......+..|+..|+. ||++||++.|++++
T Consensus       232 ~~~~~~--------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          232 SVSYDF--------DEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             TTCCCC--------CHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hccccc--------Chhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000        0000    11123456677888888 99999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-43  Score=345.86  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFC  154 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  154 (441)
                      ...++|++.+.||+|+||.||+|...         .+++.||||++......    ..+|+++|.++ +||||+++++++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~   85 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHK---------ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY   85 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE
Confidence            34678999999999999999997654         35789999999765322    34688888888 799999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC----CcEEE
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE----FNAKL  230 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~----~~~kl  230 (441)
                      .+....|+||||++||+|.+++....  .+++..+..++.||+.||+|||+  +||+||||||+|||+..+    +.+||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           86 DDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            99999999999999999999997654  59999999999999999999999  899999999999998543    35999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+......  
T Consensus       162 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--  237 (342)
T 2qr7_A          162 CDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--  237 (342)
T ss_dssp             CCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--
T ss_pred             EECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--
Confidence            99999986433221  23456799999999999988899999999999999999999999975322211111111000  


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       .        ...............+..|+..|+. ||++||++.+++++
T Consensus       238 -~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          238 -G--------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -C--------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -C--------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0        0011111122334456677777877 99999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-43  Score=337.98  Aligned_cols=262  Identities=23%  Similarity=0.341  Sum_probs=195.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|....         .+..||||+++....   .....+.+|+.++++++||||+++++++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4579999999999999999976542         477899999875332   3345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      .+.+..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEe
Confidence            9999999999999999999998642  34568999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... +...       
T Consensus       180 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-------  249 (310)
T 2wqm_A          180 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKK-------  249 (310)
T ss_dssp             C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHH-------
T ss_pred             ccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHH-------
Confidence            99987643322  1223457899999999999999999999999999999999999999643321111 0000       


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                            +................+..|+..|+. ||++||++.+|++.|+++.+.
T Consensus       250 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          250 ------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             ------HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                  000001111112234456778888888 999999999999999877553

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-43  Score=334.67  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=195.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         ..+..+|+|++.... ....+.+.+|+++|++++||||+++++++.
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   90 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE   90 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence            3467999999999999999997654         347789999986543 234577899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKL  230 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl  230 (441)
                      +....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEE
Confidence            999999999999999999998643  23469999999999999999999999  899999999999999   45678999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||++.......   ......||+.|+|||++. +.++.++||||||+++|+|++|+.||.............+..+  
T Consensus       169 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--  242 (285)
T 3is5_A          169 IDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--  242 (285)
T ss_dssp             CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--
T ss_pred             EeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--
Confidence            9999997643322   233567999999999986 5789999999999999999999999975442221111111110  


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                  ...... ......+..|+..|+. ||++||++.||++.
T Consensus       243 ------------~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          243 ------------NYAVEC-RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ------------CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ------------cccccc-CcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        000000 0112345567777887 99999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-43  Score=343.30  Aligned_cols=249  Identities=24%  Similarity=0.289  Sum_probs=174.7

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  162 (441)
                      .+.||+|+||.||+|...         .+++.||||++...   ....+.+|+.+|+.+. ||||+++++++.+....|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK---------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEET---------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEEC---------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            488999999999997654         34788999998653   3456788999999996 9999999999999999999


Q ss_pred             EEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC---cEEEcccCCcccC
Q 013557          163 VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF---NAKLSDFGLAKAG  239 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~---~~kl~DFg~a~~~  239 (441)
                      ||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++   .+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            999999999999997654  59999999999999999999999  8999999999999997765   7999999999864


Q ss_pred             CCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          240 PTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       240 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........         ....+..+
T Consensus       160 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---------~~~~~~~i  228 (325)
T 3kn6_A          160 PPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS---------AVEIMKKI  228 (325)
T ss_dssp             CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC---------HHHHHHHH
T ss_pred             CCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc---------HHHHHHHH
Confidence            3322  123456789999999999999999999999999999999999999975432110000         00000011


Q ss_pred             hcccccCCC--chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          320 MDIKLEGQY--PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       320 ~~~~~~~~~--~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .........  .......+..|+..|+. ||++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            110000000  01123456677788887 99999999998755

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.7e-44  Score=336.29  Aligned_cols=250  Identities=27%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ...++|++.+.||+|+||.||+|....         +++.||+|+++...    ..+.+|++++++++||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD   74 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence            456789999999999999999976542         47789999997543    34568999999999999999999886


Q ss_pred             c----------------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          156 D----------------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       156 ~----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                      .                ....++||||+++++|.+++.......+++..++.++.||+.||.|||+  ++|+||||||+|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~N  152 (284)
T 2a19_B           75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSN  152 (284)
T ss_dssp             EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred             ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHH
Confidence            4                4457999999999999999987655679999999999999999999999  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccc
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE  299 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~  299 (441)
                      ||++.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||....    
T Consensus       153 il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  225 (284)
T 2a19_B          153 IFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----  225 (284)
T ss_dssp             EEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----
T ss_pred             EEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----
Confidence            999999999999999998654332   1234569999999999999999999999999999999999998864211    


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                       ..             ...+...    ..+......+..++..|+. ||++||++.|+++.|+.+..
T Consensus       226 -~~-------------~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          226 -KF-------------FTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -HH-------------HHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -HH-------------HHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence             00             0001111    1122223445677888888 99999999999999987654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-43  Score=334.40  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         .++..||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR   75 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence            4578999999999999999997654         3477899999865432 33467889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           76 EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             ETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCC
Confidence            999999999999999999988543  358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .....|...      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~------  224 (276)
T 2yex_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK------  224 (276)
T ss_dssp             CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT------
T ss_pred             ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc------
Confidence            976433222222345679999999999987765 778999999999999999999997543211 111111110      


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              .............+..|+..|+. ||++||++.++++.
T Consensus       225 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          225 --------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                    00001112223445677888887 99999999999764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=367.00  Aligned_cols=256  Identities=26%  Similarity=0.385  Sum_probs=200.1

Q ss_pred             CCCCCC-eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           80 NFRPDS-LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++.+.+ .||+|+||.||+|.+..       ...+..||||+++.... ...+.+.+|+++|++++||||+++++++.+ 
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-  407 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-  407 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred             ceeEcCcEEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence            344444 79999999999997642       12356799999986532 356789999999999999999999999876 


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            5689999999999999999654 3459999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchh
Q 013557          238 AGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       238 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......                 
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------  547 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------  547 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----------------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------
Confidence            65432211 11122345789999999999999999999999999999998 999997543211                 


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      +...+........+......+..|+..|+. +|++||++.+|++.|+.+
T Consensus       548 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          548 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111111122223344455667788899998 999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=338.38  Aligned_cols=260  Identities=23%  Similarity=0.360  Sum_probs=196.7

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC--CCCCcccEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL--HHPNLVKLIG  152 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~  152 (441)
                      ....++|++.+.||+|+||.||+|.+.           +..||||++...   ....+..|.+++..+  +||||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~   98 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIA   98 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEE
Confidence            345678999999999999999998653           568999998643   234455666666655  8999999999


Q ss_pred             EEEcC----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC--------CeEEeccCCCcE
Q 013557          153 FCLDG----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ--------QVIYRDFKASNI  220 (441)
Q Consensus       153 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~--------~ivH~Dlkp~Ni  220 (441)
                      ++.+.    ...++||||+++|+|.+++...   .+++..++.++.|++.||.|||+  .        +|+||||||+||
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A           99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHT--EIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             EEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHS--CBCSTTCBCCEECSCCCGGGE
T ss_pred             EEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH--hhhhhccCCCEEecccchHHE
Confidence            99877    7899999999999999999654   48999999999999999999998  6        999999999999


Q ss_pred             EECCCCcEEEcccCCcccCCCCCccc--eeeeccCCCCcCchhhhhcCCCCch------hhhHHHhHHHHHHHhCC----
Q 013557          221 LLDSEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTRGYAAPEYLATGRLTAK------CDVYSFGVVLLELLSGR----  288 (441)
Q Consensus       221 ll~~~~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~il~elltg~----  288 (441)
                      |++.++.+||+|||+++.........  ......||+.|+|||++.+..+...      +|||||||++|||+||.    
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            99999999999999997543322111  1124579999999999987766654      99999999999999994    


Q ss_pred             ------CCCCccccccchhhhhhhccccccchhhhhhh-cccccCCCc-----hhHHHHHHHHHHHHhc-CCCCCCCHHH
Q 013557          289 ------RAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM-DIKLEGQYP-----QKGAYMVAILALQCIS-EAKVRPSMSE  355 (441)
Q Consensus       289 ------~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~e  355 (441)
                            .||........            ....+.... ........+     ......+..|+..|+. ||++||++.+
T Consensus       254 ~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          254 IVEEYQLPYHDLVPSDP------------SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             BCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccccccHhhhcCCCC------------chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence                  44432211100            000000100 111112222     2455667888899998 9999999999


Q ss_pred             HHHHhhcCCC
Q 013557          356 VLSALEQLPP  365 (441)
Q Consensus       356 vl~~L~~l~~  365 (441)
                      |++.|+.+..
T Consensus       322 ll~~L~~l~~  331 (337)
T 3mdy_A          322 VKKTLAKMSE  331 (337)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9999987644

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-43  Score=338.26  Aligned_cols=261  Identities=20%  Similarity=0.245  Sum_probs=196.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||+|...         ..++.||||++.......   .+.+.+|+.++++++||||++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~  102 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDT---------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF  102 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEc---------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence            3578999999999999999997654         247789999997653322   3668899999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Df  178 (309)
T 2h34_A          103 GEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDF  178 (309)
T ss_dssp             EEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSC
T ss_pred             EeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecC
Confidence            999999999999999999999997654  48999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........   .......   
T Consensus       179 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~---  251 (309)
T 2h34_A          179 GIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG---AHINQAI---  251 (309)
T ss_dssp             CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH---HHHHSCC---
T ss_pred             ccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH---HHhccCC---
Confidence            99976433221 1223457899999999999889999999999999999999999999754322110   0000000   


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-CHHHHHHHhhcCCCC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-SMSEVLSALEQLPPP  366 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-s~~evl~~L~~l~~~  366 (441)
                               ......+......+..|+..|+. ||++|| +++++++.|+++...
T Consensus       252 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          252 ---------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ---------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ---------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                     00001122223456677888888 999999 999999999876544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=344.86  Aligned_cols=244  Identities=22%  Similarity=0.287  Sum_probs=199.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--------cHHHHHHHHHHHhcCCCCCc
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--------GHKEWLSEVNYLGQLHHPNL  147 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnI  147 (441)
                      ...++|++.+.||+|+||.||+|...         ..+..||||+++.....        ....+.+|+.+|++++||||
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I   91 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDK---------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI   91 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEET---------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB
T ss_pred             ccccceEEEeEEEecCCEEEEEEEEC---------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE
Confidence            35678999999999999999997644         34788999998765321        22346789999999999999


Q ss_pred             ccEEEEEEcCCeeEEEEEeCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          148 VKLIGFCLDGENRLLVYEYMPKG-SLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       148 v~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      +++++++.+.+..++||||+.+| +|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A           92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTS
T ss_pred             eeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCC
Confidence            99999999999999999998766 9999986544  49999999999999999999999  8999999999999999999


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW  305 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~  305 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......        
T Consensus       168 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------  236 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------  236 (335)
T ss_dssp             CEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------
T ss_pred             cEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------
Confidence            99999999998654332   2235679999999999988776 78999999999999999999999642110        


Q ss_pred             hccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          306 AKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       306 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                    ....  ...+......+..|+..|+. ||++||++.++++.
T Consensus       237 --------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 --------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          0000  01122233456677888888 99999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.4e-43  Score=340.58  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|.+.+.||+|+||.||++....         .+..+|+|++.....   ...+.+.+|+.+++.++||||+++++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4689999999999999999976543         477899999865422   2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeecc
Confidence            99999999999999999999987654  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  .           
T Consensus       187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~-----------  251 (335)
T 2owb_A          187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--L-----------  251 (335)
T ss_dssp             TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--H-----------
T ss_pred             CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--H-----------
Confidence            9986432221  223467999999999999989999999999999999999999999754321110  0           


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .+...  ....+......+..|+..|+. ||++||++.++++.
T Consensus       252 ---~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          252 ---RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---HHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---HHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00000  011222333456678888888 99999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-43  Score=342.69  Aligned_cols=258  Identities=29%  Similarity=0.444  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCcc--EEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGM--VIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      .++|++.+.||+|+||.||+|....         .+.  .+++|.++... ....+.+.+|+.+|+++ +||||++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            3689999999999999999987643         233  45899886532 23345688999999999 89999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                      +.+.+..++||||+++++|.+++....              ...+++..++.++.||+.||.|||+  ++|+||||||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~N  172 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARN  172 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccce
Confidence            999999999999999999999997543              2468999999999999999999999  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCcccccc
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGA  298 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~  298 (441)
                      ||++.++.+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.......
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~  249 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  249 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence            999999999999999987432211   1223457889999999998889999999999999999998 999997543211


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                      .                 ...+........+......+..|+..|+. +|++||++.++++.|+.+...
T Consensus       250 ~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          250 L-----------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             H-----------------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             H-----------------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0                 11111111112233334556778888888 999999999999998865443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.8e-43  Score=331.79  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|....         .+..||+|++.....  ...+.+.+|+.++++++||||+++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   74 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            45789999999999999999976543         477899999865432  2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc---EEEc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLS  231 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~---~kl~  231 (441)
                      .+....++||||+++++|.+++....  .+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.   +||+
T Consensus        75 ~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           75 QEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            99999999999999999999987664  48999999999999999999999  89999999999999987655   9999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................  . 
T Consensus       151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~-  224 (284)
T 3kk8_A          151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--Y-  224 (284)
T ss_dssp             CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C-
T ss_pred             eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc--c-
Confidence            999997654322   2234679999999999999999999999999999999999999996543211111000000  0 


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                 .............+..|+..|+. ||++||++.|+++.
T Consensus       225 -----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 -----------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -----------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -----------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                       00000111223446677778887 99999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-43  Score=345.26  Aligned_cols=248  Identities=29%  Similarity=0.395  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .+.|++.+.||+|+||.||+|...         .++..||||++.....   ...+.+.+|+++|++++||||+++++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  123 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY  123 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEc---------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            356889999999999999997643         3477899999865432   2235688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       124 ~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          124 LREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999997 58888886543 359999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      ++.....      .....||+.|+|||++.   ++.++.++|||||||++|||++|+.||.......  .+.        
T Consensus       200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~--------  263 (348)
T 1u5q_A          200 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY--------  263 (348)
T ss_dssp             TCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH--------
T ss_pred             CceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHH--------
Confidence            9986432      13457999999999985   5678999999999999999999999996433211  000        


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                            .+.........+......+..|+..|+. +|++||+++++++..
T Consensus       264 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          264 ------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ------HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                  1111111111122233456678888888 999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-43  Score=351.36  Aligned_cols=205  Identities=28%  Similarity=0.416  Sum_probs=163.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCC-CCCcccEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLH-HPNLVKLIG  152 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~  152 (441)
                      ...++|++.+.||+|+||.||+|...         .+++.||||++....  ......+.+|+.+|.++. ||||+++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~   76 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDR---------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN   76 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEET---------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEEC---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence            45689999999999999999997654         357899999986532  234556889999999997 999999999


Q ss_pred             EEEcCC--eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          153 FCLDGE--NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       153 ~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ++...+  ..|+||||++ ++|.+++...   .+++..+..++.||+.||+|||+  .||+||||||+|||++.++.+||
T Consensus        77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl  150 (388)
T 3oz6_A           77 VLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKV  150 (388)
T ss_dssp             EEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEe
Confidence            997544  7899999997 5999988653   48999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCC-------------------ccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCC
Q 013557          231 SDFGLAKAGPTGD-------------------RTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       231 ~DFg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      +|||+++......                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI  230 (388)
T ss_dssp             CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence            9999997542210                   1112234679999999999986 6789999999999999999999999


Q ss_pred             CCccc
Q 013557          291 VDKTR  295 (441)
Q Consensus       291 f~~~~  295 (441)
                      |....
T Consensus       231 f~~~~  235 (388)
T 3oz6_A          231 FPGSS  235 (388)
T ss_dssp             CCCSS
T ss_pred             CCCCC
Confidence            97544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.6e-43  Score=337.96  Aligned_cols=266  Identities=25%  Similarity=0.277  Sum_probs=196.3

Q ss_pred             hcCCCCC-CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPD-SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .+.|++. +.||+|+||.||+|...         .+++.||||++..........+.+|+.+|.++ +||||+++++++.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~   81 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINL---------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE   81 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECS---------SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEc---------CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4678884 78999999999997543         35789999999776555677899999999985 7999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc---EEEcc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN---AKLSD  232 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~---~kl~D  232 (441)
                      +.+..|+||||+++++|.+++....  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.   +||+|
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           82 EEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEE
Confidence            9999999999999999999997654  48999999999999999999999  89999999999999998776   99999


Q ss_pred             cCCcccCCCCCc-----cceeeeccCCCCcCchhhhhc-----CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          233 FGLAKAGPTGDR-----THVSTQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       233 Fg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      ||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...........
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            999875432111     111223469999999999975     4588999999999999999999999975432210000


Q ss_pred             hhhhccccccchhhhhhhcccccCCCch----hHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQ----KGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...  ........+...+.... ...+.    .....+..|+..|+. ||++||++.|++++
T Consensus       238 ~~~--~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          238 RGE--ACPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             -----CCHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccc--cchhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000  00000000111111000 01111    123456678888887 99999999999886

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=335.38  Aligned_cols=267  Identities=26%  Similarity=0.345  Sum_probs=194.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .++..||||++......  ..+.+.+|+.++++++||||+++++++.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   72 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR   72 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence            368999999999999999997654         34778999998655332  2455789999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            999999999999999999887544  358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhh-hhccccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD-WAKPYLGDR  313 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~  313 (441)
                      +.......  .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............. .........
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          149 ARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence            98643222  12234578999999999986 568999999999999999999999997554322211110 000000000


Q ss_pred             hhh------hhhhc-ccccCCCc-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKL------FRIMD-IKLEGQYP-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l------~~~~~-~~~~~~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...      ..... .......+     ......+..|+..|+. ||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000      00000 00000000     1122345667888888 99999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-43  Score=358.10  Aligned_cols=196  Identities=25%  Similarity=0.358  Sum_probs=153.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||++....  ....+.+.+|+.+|++++||||+++++++.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK---------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC---------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC---------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            468999999999999999997654         347899999986542  234567889999999999999999999984


Q ss_pred             c-----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 D-----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      .     ....|+||||+ +++|.+++...  ..+++..++.++.||+.||+|||+  .+|+||||||+|||++.++.+||
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEE
T ss_pred             cCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEee
Confidence            3     35789999998 56999988654  359999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCcc-------------------------ceeeeccCCCCcCchhhh-hcCCCCchhhhHHHhHHHHHH
Q 013557          231 SDFGLAKAGPTGDRT-------------------------HVSTQVMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLEL  284 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~el  284 (441)
                      +|||+++........                         ......+||+.|+|||++ .+..|+.++|||||||++|||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999865322110                         123456789999999986 456799999999999999999


Q ss_pred             HhC
Q 013557          285 LSG  287 (441)
Q Consensus       285 ltg  287 (441)
                      ++|
T Consensus       278 ltg  280 (458)
T 3rp9_A          278 LNM  280 (458)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            993

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-43  Score=361.33  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.++||+|+||.||+|...         .+++.||+|++.....   .....+.+|+.+|++++||||+++++++.
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMK---------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE  255 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            67889999999999999997654         3578999999865422   23466889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +....|+||||++||+|.+++....  ...+++..++.++.||+.||.|||+  +||+||||||+|||++.+|++||+||
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeec
Confidence            9999999999999999999997643  3469999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..........  .         
T Consensus       334 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~---------  400 (543)
T 3c4z_A          334 GLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E---------  400 (543)
T ss_dssp             TTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--H---------
T ss_pred             ceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--H---------
Confidence            99986543321  2234589999999999999999999999999999999999999997543211100  0         


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH-----HHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM-----SEVLS  358 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~-----~evl~  358 (441)
                       ....++..  ...++......+..|+..|+. ||++||++     ++|++
T Consensus       401 -~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          401 -LKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -HHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -HHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             00011111  112344445566778888888 99999975     66654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-43  Score=346.78  Aligned_cols=201  Identities=29%  Similarity=0.447  Sum_probs=174.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         .++..||+|++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            468999999999999999997654         3477899999876532 334668899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||.|||+  . +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence            999999999999999999997654  48999999999999999999998  5 899999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       179 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          179 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             CHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             Ccccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8643211    1234579999999999999999999999999999999999999997544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-43  Score=343.26  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=204.0

Q ss_pred             HHHHHHHhcCCCCC-CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcC-CCCC
Q 013557           71 FSELKNATRNFRPD-SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQL-HHPN  146 (441)
Q Consensus        71 ~~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpn  146 (441)
                      +.......++|.+. +.||+|+||.||+|...         .+++.||+|+++...  ......+.+|+.++..+ +|||
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   90 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISK---------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR   90 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence            34456777889888 89999999999997654         347799999987542  23457789999999999 5799


Q ss_pred             cccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC--
Q 013557          147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS--  224 (441)
Q Consensus       147 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~--  224 (441)
                      |+++++++.+....++||||+++|+|.+++.......+++..++.++.|++.||+|||+  +||+||||||+|||++.  
T Consensus        91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBT
T ss_pred             EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCC
Confidence            99999999999999999999999999999866555679999999999999999999999  89999999999999998  


Q ss_pred             -CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhh
Q 013557          225 -EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       225 -~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~  303 (441)
                       ++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  245 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI  245 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence             7899999999998653322   123457999999999999999999999999999999999999999754321111000


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..              ................+..|+..|+. ||++||+++++++.
T Consensus       246 ~~--------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQ--------------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HH--------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hh--------------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00              00011111122234456677888888 99999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.9e-43  Score=368.83  Aligned_cols=250  Identities=29%  Similarity=0.409  Sum_probs=197.5

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  162 (441)
                      +.||+|+||.||+|.+..       ...++.||||+++....  ...+.+.+|+++|++++||||+++++++.+ +..++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            479999999999986532       23467899999976432  235779999999999999999999999865 46899


Q ss_pred             EEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCC
Q 013557          163 VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG  242 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~  242 (441)
                      ||||+++|+|.+++....  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       447 v~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             EEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            999999999999996544  58999999999999999999999  89999999999999999999999999999865432


Q ss_pred             Cc-cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          243 DR-THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       243 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      .. ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......                 +...+
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i  585 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAML  585 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHH
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHH
Confidence            21 112223456889999999999999999999999999999998 999997543211                 11222


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ........+......+..|+..|+. ||++||++.+|++.|+.+
T Consensus       586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2222223344455667788888998 999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.5e-43  Score=332.37  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|.+.+.||+|+||.||+|...         ..+..+|+|++.....   ...+.+.+|+.+++.++||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            468999999999999999997654         3477899999865422   2345688999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEecc
Confidence            99999999999999999999887654  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  .           
T Consensus       161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~-----------  225 (294)
T 2rku_A          161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--L-----------  225 (294)
T ss_dssp             TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--H-----------
T ss_pred             CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-----------
Confidence            9986432221  223457999999999999888999999999999999999999999754321110  0           


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .+...  ....+......+..|+..|+. ||++||++.++++.
T Consensus       226 ---~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          226 ---RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---HHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---HHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               00000  011223333456678888888 99999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.1e-43  Score=357.32  Aligned_cols=199  Identities=25%  Similarity=0.322  Sum_probs=165.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC--CcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE--GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT  131 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence            578999999999999999997544         35788999999754  2233566889999999999999999999996


Q ss_pred             cC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ..      ...|+||||+++ +|.+.+..    .+++..+..++.||+.||+|||+  .||+||||||+|||++.++.+|
T Consensus       132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEE
T ss_pred             cCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEE
Confidence            54      457999999976 57776632    38999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |+|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998654322   2345689999999999999999999999999999999999999997544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=330.81  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=197.1

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCCe
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGEN  159 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  159 (441)
                      +|....+||+|+||.||+|....         ++..||||.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            45556699999999999976543         477899999977655556778999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-CCcEEEcccCCcc
Q 013557          160 RLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-EFNAKLSDFGLAK  237 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFg~a~  237 (441)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++. ++.+||+|||++.
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            999999999999999997653 2356789999999999999999999  89999999999999987 8899999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCC--CCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ......  .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||......... .             
T Consensus       172 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~-------------  235 (295)
T 2clq_A          172 RLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M-------------  235 (295)
T ss_dssp             ESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H-------------
T ss_pred             ccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H-------------
Confidence            643321  1223457899999999997654  889999999999999999999999643211100 0             


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ............+......+..|+..|+. ||++||++.++++.
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          236 -FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -HHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -HhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00000011122333444566778888888 99999999999865

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.8e-43  Score=335.44  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=199.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++.........+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQR---------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES   77 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence            4578999999999999999997654         3477899999976554455678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEEccc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLSDF  233 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl~DF  233 (441)
                      ....++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             CCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccC
Confidence            999999999999999999997654  48999999999999999999999  899999999999999   77889999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      |++......    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  ........   
T Consensus       154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~---  224 (304)
T 2jam_A          154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF--EKIKEGYY---  224 (304)
T ss_dssp             STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHCCC---
T ss_pred             CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHcCCC---
Confidence            999754322    123456999999999999999999999999999999999999999754321100  00000000   


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                               .............+..++..|+. ||++||++.++++.
T Consensus       225 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 ---------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ---------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ---------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                     00111112233456677778887 99999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.8e-44  Score=336.34  Aligned_cols=255  Identities=24%  Similarity=0.325  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||+|.+.....  ...+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII   75 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            468999999999999999997654         3477899999875432  33456889999999999999999999875


Q ss_pred             --cCCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCC-----eEEeccCCCcEEECCCC
Q 013557          156 --DGENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAEQQ-----VIYRDFKASNILLDSEF  226 (441)
Q Consensus       156 --~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-----ivH~Dlkp~Nill~~~~  226 (441)
                        .....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+  .+     |+||||||+|||++.++
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSS
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCC
Confidence              467899999999999999999753  23458999999999999999999998  67     99999999999999999


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||+++......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   +.   
T Consensus       154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---  225 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---  225 (279)
T ss_dssp             CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---
T ss_pred             CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HH---
Confidence            99999999997643321  11234578999999999999999999999999999999999999997543211   00   


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                                 ..+........+......+..++..|+. +|++||++.||++.+..
T Consensus       226 -----------~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          226 -----------GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -----------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------HHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                       0000011112233334566778888888 99999999999987753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-43  Score=341.02  Aligned_cols=267  Identities=20%  Similarity=0.237  Sum_probs=189.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++......  ...+.+|+.+|++++||||+++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDT---------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI  102 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEEC---------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence            4568999999999999999997544         347899999997653322  34577999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE-----CCCCcEE
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL-----DSEFNAK  229 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill-----~~~~~~k  229 (441)
                      .+.+..++||||+++ +|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||+     +.++.+|
T Consensus       103 ~~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          103 HHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             EETTEEEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             ecCCEEEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEE
Confidence            999999999999975 9999997654  48999999999999999999999  899999999999999     4455699


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhh-
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWA-  306 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~-  306 (441)
                      |+|||+++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... ...... 
T Consensus       178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999997643221  122345789999999999874 4899999999999999999999999754321111 000000 


Q ss_pred             ccccccchhhhhh----------hcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRI----------MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~----------~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .+...........          ....+....+......+..|+..|+. ||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000000000000          00000000011123445677788888 99999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=352.21  Aligned_cols=272  Identities=19%  Similarity=0.286  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|....         ++..||||+++.... ...+.+.+|+++|++++||||+++++++.+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            4679999999999999999976543         477999999976432 345678899999999999999999999987


Q ss_pred             CC--eeEEEEEeCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE----CCCCcEE
Q 013557          157 GE--NRLLVYEYMPKGSLENHLFRRGA-RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL----DSEFNAK  229 (441)
Q Consensus       157 ~~--~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill----~~~~~~k  229 (441)
                      ..  ..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+  ++|+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~k  156 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYK  156 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEE
Confidence            65  77999999999999999865432 348999999999999999999999  899999999999999    7778899


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc--------CCCCchhhhHHHhHHHHHHHhCCCCCCccccccc--
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT--------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE--  299 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~--  299 (441)
                      |+|||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||........  
T Consensus       157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          157 LTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             ECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             EecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            99999998654322   2234679999999999875        5678899999999999999999999964322111  


Q ss_pred             hhhhhhhccccc-cchhhhhhh--------cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          300 QNLVDWAKPYLG-DRRKLFRIM--------DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       300 ~~~~~~~~~~~~-~~~~l~~~~--------~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ............ ....+....        ...............+..++..|+. ||++||++.++++.++.+
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            111111100000 000000000        0001112335566677788888888 999999999999888754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.2e-43  Score=355.74  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCC-CCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH-PNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~  156 (441)
                      .++|++.++||+|+||.||+|.+.         ..+..||||++.....  ...+.+|+++++.|+| ++|..+..++.+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI---------QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET---------TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            478999999999999999998654         2477899998765432  2347789999999976 566777777788


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEEccc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLSDF  233 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl~DF  233 (441)
                      ....+|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+  ++|+||||||+||||   +.++.+||+||
T Consensus        75 ~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           75 GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeC
Confidence            88999999999 899999996543 359999999999999999999999  899999999999999   57889999999


Q ss_pred             CCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          234 GLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       234 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      |+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.................
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            999865432211     112356799999999999999999999999999999999999999976443222211111000


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                           ..+...+. .+...+    ...+..|+..|+. +|++||++.+|++.|+.+
T Consensus       231 -----~~~~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          231 -----KKVATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             -----HHHHSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             -----ccccccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                 00000000 111122    2456677888888 999999999999888754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-42  Score=338.07  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhc--CCCCCcccEE
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQ--LHHPNLVKLI  151 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~  151 (441)
                      .....++|++.+.||+|+||.||+|.+.           ++.||||++...   ....+.+|++++..  ++||||++++
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~  102 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI  102 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence            3456789999999999999999998653           668999999653   34567889998887  7899999999


Q ss_pred             EEEEcCC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCeEEeccCCCc
Q 013557          152 GFCLDGE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH--------EAEQQVIYRDFKASN  219 (441)
Q Consensus       152 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH--------~~~~~ivH~Dlkp~N  219 (441)
                      +++....    ..++||||+++|+|.+++.+.   .+++..++.++.|++.||.|||        +  .+|+||||||+|
T Consensus       103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~N  177 (342)
T 1b6c_B          103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKN  177 (342)
T ss_dssp             EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGG
T ss_pred             eeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHH
Confidence            9998876    789999999999999999654   4899999999999999999999        6  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccc--eeeeccCCCCcCchhhhhcCC------CCchhhhHHHhHHHHHHHhC----
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTRGYAAPEYLATGR------LTAKCDVYSFGVVLLELLSG----  287 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltg----  287 (441)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||+||    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999997543322111  123457999999999998653      33689999999999999999    


Q ss_pred             ------CCCCCccccccchhhhhhhccccccchhhhh-hhcccccCCCc-----hhHHHHHHHHHHHHhc-CCCCCCCHH
Q 013557          288 ------RRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR-IMDIKLEGQYP-----QKGAYMVAILALQCIS-EAKVRPSMS  354 (441)
Q Consensus       288 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~  354 (441)
                            ..||......... .           ..+.. +.........+     ......+..|+..|+. ||++||++.
T Consensus       258 ~~~~~~~~p~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPS-V-----------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCC-H-----------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CcccccccCccccCcCccc-H-----------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence                  6666533211100 0           00111 11111122222     2445567788899998 999999999


Q ss_pred             HHHHHhhcCCC
Q 013557          355 EVLSALEQLPP  365 (441)
Q Consensus       355 evl~~L~~l~~  365 (441)
                      +|++.|+++..
T Consensus       326 ~i~~~L~~i~~  336 (342)
T 1b6c_B          326 RIKKTLSQLSQ  336 (342)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999987643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.8e-43  Score=330.77  Aligned_cols=246  Identities=21%  Similarity=0.244  Sum_probs=196.1

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcC-CCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQL-HHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++...  ......+.+|+.++..+ +||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~   79 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA   79 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            4578999999999999999997654         347789999987542  23355688999999999 89999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC------
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRG--ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE------  225 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~------  225 (441)
                      +.+.+..++||||+++++|.+++....  ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.+      
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC--------
T ss_pred             eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCccc
Confidence            999999999999999999999997642  2458999999999999999999999  899999999999999844      


Q ss_pred             -------------CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          226 -------------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       226 -------------~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                                   ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                         479999999998654322      23589999999999865 5668999999999999999999876


Q ss_pred             CccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          292 DKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .....     ..              .+.. ......+......+..|+..|+. ||++||++.+++++
T Consensus       232 ~~~~~-----~~--------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          232 RNGDQ-----WH--------------EIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             SSSHH-----HH--------------HHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cchhH-----HH--------------HHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            43211     00              0001 11112233334556778888888 99999999999865

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-44  Score=345.91  Aligned_cols=256  Identities=24%  Similarity=0.335  Sum_probs=184.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEE-
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCL-  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~-  155 (441)
                      ..+|++.+.||+|+||.||+|.+.         .+++.||||++........+.+.+|+.++.++. ||||+++++++. 
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDV---------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CceEEEEEEEccCCceEEEEEEEC---------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            458999999999999999997654         347789999987665556677899999999996 999999999984 


Q ss_pred             -------cCCeeEEEEEeCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEECCC
Q 013557          156 -------DGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLDSE  225 (441)
Q Consensus       156 -------~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~~~  225 (441)
                             .....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+  .+  |+||||||+|||++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECTT
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECCC
Confidence                   3445799999995 6999988652 33469999999999999999999998  77  9999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccc----------eeeeccCCCCcCchhhh---hcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          226 FNAKLSDFGLAKAGPTGDRTH----------VSTQVMGTRGYAAPEYL---ATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      +.+||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998654322111          11134689999999998   56678999999999999999999999996


Q ss_pred             ccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ......                    ++........+......+..|+..|+. ||++||++.|+++.|+.+..
T Consensus       255 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          255 DGAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            432110                    000000001111112235667888888 99999999999999987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.1e-43  Score=330.92  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc------ccHHHHHHHHHHHhcCCCCCcccEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------QGHKEWLSEVNYLGQLHHPNLVKLI  151 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~  151 (441)
                      .++|++.+.||+|+||.||+|...         .++..+|+|+++....      ...+.+.+|+.+|++++||||++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   74 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH   74 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence            357999999999999999997654         3477899999865432      1357789999999999999999999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----c
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----N  227 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----~  227 (441)
                      +++.+....++||||+++++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+||+++.++    .
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           75 DIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCC
T ss_pred             heecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCc
Confidence            99999999999999999999999997654  48999999999999999999999  8999999999999998877    7


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      +||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  .....
T Consensus       151 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~  225 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL--TNISA  225 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHT
T ss_pred             eEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH--HHhHh
Confidence            9999999998643322   123456899999999999999999999999999999999999999754321110  00000


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...            .............+..++..|+. ||++||++.++++.
T Consensus       226 ~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          226 VNY------------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             TCC------------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             ccc------------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            000            00000011223456677888888 99999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=341.03  Aligned_cols=266  Identities=23%  Similarity=0.316  Sum_probs=191.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-HHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||+|...         .++..||||+++...... ...+.+|+.+|++++||||+++++++.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            57999999999999999997654         347789999987543221 11345799999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  148 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR  148 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred             CEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence            99999999997 59999887654 358999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhh-hhhc-cccccch
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV-DWAK-PYLGDRR  314 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~-~~~~-~~~~~~~  314 (441)
                      ......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .... +......
T Consensus       149 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          149 AKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP  226 (324)
T ss_dssp             CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence            543221  12234578999999999976 56899999999999999999999999765432211111 1000 0000000


Q ss_pred             hhh---hhhcccccCC-------CchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLF---RIMDIKLEGQ-------YPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~---~~~~~~~~~~-------~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...   ..........       ........+..|+..|+. ||++|||++|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000   0000000000       001122345677788887 99999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.5e-43  Score=330.33  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|....         .+..||||++....   ......+.+|+.++++++||||+++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            3679999999999999999976543         46789999986432   12346788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEeccc
Confidence            99999999999999999999997654  48999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........              
T Consensus       160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------------  221 (284)
T 2vgo_A          160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--------------  221 (284)
T ss_dssp             TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------------
T ss_pred             ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH--------------
Confidence            987543221    23457899999999999989999999999999999999999999754321110              


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ..+...  ....+......+..++..|+. ||++||++.+++++
T Consensus       222 --~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          222 --RRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             --HHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             --HHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence              011110  112233334556678888887 99999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1e-42  Score=332.85  Aligned_cols=249  Identities=26%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .+.|++.+.||+|+||.||+|...         ..+..||||++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   91 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   91 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEEC---------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            467999999999999999997654         347789999986543 2345778999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++||||+++++|.+++..   ..+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           92 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             TTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccc
Confidence            9999999999999999999854   358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........   .            
T Consensus       167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~------------  229 (303)
T 3a7i_A          167 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---F------------  229 (303)
T ss_dssp             EECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H------------
T ss_pred             eecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---H------------
Confidence            7643322  1223457899999999999999999999999999999999999999744321110   0            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        .+........+......+..|+..|+. +|++||++.+|++.
T Consensus       230 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          230 --LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              000011111222333456778888888 99999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=332.09  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=180.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         ..++.||||++.....   ...+.+.+|+.++++++||||+++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESI---------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF   80 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEc---------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence            467999999999999999997653         2477899999864321   2246788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           81 EDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             ECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeec
Confidence            99999999999999999999986543 468999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........             
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------  222 (278)
T 3cok_A          158 LATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------------  222 (278)
T ss_dssp             TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------
T ss_pred             ceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------------
Confidence            9986432221  1234578999999999998889999999999999999999999997543211100             


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                         .+....  ...+......+..|+..|+. ||++||++.++++.
T Consensus       223 ---~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          223 ---KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ----CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence               000000  11223334456678888888 99999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=340.88  Aligned_cols=268  Identities=24%  Similarity=0.343  Sum_probs=191.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHH--HhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY--LGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...           ++.||||++...   ....+..|.++  +..++|+||+++++.+.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheeccc
Confidence            468999999999999999998553           568999998643   23444455555  44589999999998654


Q ss_pred             c-----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC---------CeEEeccCCCcEE
Q 013557          156 D-----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ---------QVIYRDFKASNIL  221 (441)
Q Consensus       156 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~---------~ivH~Dlkp~Nil  221 (441)
                      .     ....++||||+++|+|.+++....   .++..++.++.||+.||.|||+  .         +|+||||||+|||
T Consensus        78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~Nil  152 (336)
T 3g2f_A           78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRNVL  152 (336)
T ss_dssp             EECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGGEE
T ss_pred             ccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccceEE
Confidence            2     235789999999999999996654   5899999999999999999998  7         9999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCC------ccceeeeccCCCCcCchhhhhc-------CCCCchhhhHHHhHHHHHHHhCC
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGD------RTHVSTQVMGTRGYAAPEYLAT-------GRLTAKCDVYSFGVVLLELLSGR  288 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~elltg~  288 (441)
                      ++.++.+||+|||+++......      .........||+.|+|||++.+       ..++.++|||||||++|||++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            9999999999999997643221      1112234579999999999986       35667899999999999999998


Q ss_pred             CCCCccccc-cchhhhhhhccccccchhhhhhh-cccccCCCc------hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          289 RAVDKTRVG-AEQNLVDWAKPYLGDRRKLFRIM-DIKLEGQYP------QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       289 ~pf~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~------~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .||...... ..................+.... ........+      ......+..|+..|+. ||++|||+.|+++.
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            776433221 11111000000000000000000 011111111      2244567788888888 99999999999999


Q ss_pred             hhcCC
Q 013557          360 LEQLP  364 (441)
Q Consensus       360 L~~l~  364 (441)
                      |+++.
T Consensus       313 L~~ll  317 (336)
T 3g2f_A          313 MAELM  317 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=338.36  Aligned_cols=271  Identities=24%  Similarity=0.319  Sum_probs=193.7

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-----HHHHHHHHHHHhcCCCCCccc
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-----HKEWLSEVNYLGQLHHPNLVK  149 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~  149 (441)
                      ....++|++.+.||+|+||.||+|...         .+++.||||+++......     .+.+.+|+.++++++||||++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   76 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDK---------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG   76 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECS---------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCe
Confidence            345678999999999999999997543         357889999997543221     235789999999999999999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      +++++.+....++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             EEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEE
Confidence            99999999999999999976 8988886543 458899999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhh-h
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDW-A  306 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~-~  306 (441)
                      |+|||+++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......... ..... .
T Consensus       153 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~  230 (346)
T 1ua2_A          153 LADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG  230 (346)
T ss_dssp             ECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999998653322  123346789999999999764 5899999999999999999999999754321111 11110 0


Q ss_pred             ccccccchhhhhhhcccccCCC---c-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHh
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQY---P-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSAL  360 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~---~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L  360 (441)
                      .+............+.......   +     ......+..|+..|+. ||++|||+.|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            0000000000000000000000   0     1223456677777877 999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=344.97  Aligned_cols=259  Identities=27%  Similarity=0.332  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      .++|++.+.||+|+||.||+|....      ....++.||||+++....    ...+.+.+|+.+|+++ +||||+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            3689999999999999999987532      223578999999875421    2334567899999999 6999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      ++.+....++||||+++++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEee
Confidence            9999999999999999999999997654  48999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcC--CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG--RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      ||+++....... .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..........  .      
T Consensus       203 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~------  273 (355)
T 1vzo_A          203 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--E------  273 (355)
T ss_dssp             SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--H------
T ss_pred             CCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--H------
Confidence            999976432221 122346799999999999863  47899999999999999999999997433211110  0      


Q ss_pred             ccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHHhh
Q 013557          311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSALE  361 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~L~  361 (441)
                           +...+. .....++......+..|+..|+. ||++||     +++|+++..-
T Consensus       274 -----~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          274 -----ISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             -----HHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             -----HHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                 000000 01112334444566778888888 999999     9999987653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.1e-43  Score=331.97  Aligned_cols=263  Identities=20%  Similarity=0.222  Sum_probs=195.8

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEE-
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFC-  154 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-  154 (441)
                      ...++|++.+.||+|+||.||+|...         ..++.||||++.....  ...+.+|+.+++.++|++++..+..+ 
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEc---------CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec
Confidence            35678999999999999999997643         3477899998654432  23477899999999887766665554 


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEEc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLS  231 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl~  231 (441)
                      .+....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||+   +.++.+||+
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           75 AEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             CCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEe
Confidence            6778889999999 999999986543 359999999999999999999999  899999999999999   788999999


Q ss_pred             ccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhh-h
Q 013557          232 DFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD-W  305 (441)
Q Consensus       232 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~-~  305 (441)
                      |||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            99999864332211     11235679999999999999999999999999999999999999997543222111111 0


Q ss_pred             hccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          306 AKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       306 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      .....       ........    ......+..|+..|+. +|++||++.+|++.|+.+.
T Consensus       231 ~~~~~-------~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          231 SEKKM-------STPIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHH-------HSCHHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hcccc-------cchhhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            00000       00000000    1113456677888888 9999999999999988654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-42  Score=329.85  Aligned_cols=248  Identities=26%  Similarity=0.379  Sum_probs=194.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      +.|++.+.||+|+||.||+|....         .+..||+|.+....  ....+.+.+|+.+|++++||||+++++++..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            457888999999999999986543         46789999986543  2334568899999999999999999999875


Q ss_pred             ----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEEC-CCCcEE
Q 013557          157 ----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLD-SEFNAK  229 (441)
Q Consensus       157 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~-~~~~~k  229 (441)
                          ....++||||+++++|.+++....  .+++..++.++.||+.||.|||+  .+  |+||||||+|||++ .++.+|
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~k  172 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCCCEE
Confidence                456899999999999999997654  48999999999999999999998  77  99999999999998 788999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |+|||++......    ......||+.|+|||++. +.++.++|||||||++|+|++|+.||........  .....   
T Consensus       173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~---  242 (290)
T 1t4h_A          173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV---  242 (290)
T ss_dssp             ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH---
T ss_pred             EeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHH---
Confidence            9999999754332    234567999999999887 5699999999999999999999999964322111  10000   


Q ss_pred             cccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                .........+......+..|+..|+. ||++||++.+++++
T Consensus       243 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          243 ----------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                      00000001112222456778888888 99999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=340.42  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=196.3

Q ss_pred             HHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEE
Q 013557           73 ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLI  151 (441)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  151 (441)
                      ++....++|++.+.||+|+||.||+|....         .++.||||++.... .....+.+|+.+++++ +||||++++
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~   87 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY   87 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeee
Confidence            344557889999999999999999986542         47789999986543 3456788999999999 799999999


Q ss_pred             EEEEc------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          152 GFCLD------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       152 ~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      +++..      ....++||||+++++|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.+
T Consensus        88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTT
T ss_pred             eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCC
Confidence            99986      5688999999999999999987655569999999999999999999999  899999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ  300 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~  300 (441)
                      +.+||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.........
T Consensus       166 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  243 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  243 (326)
T ss_dssp             CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence            999999999987643221  1123457999999999997     567899999999999999999999999643321110


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        ..              +.........+......+..|+..|+. ||++||++.++++.
T Consensus       244 --~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          244 --FL--------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             --HH--------------HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --HH--------------hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              00              000000011112223456677888887 99999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-42  Score=338.98  Aligned_cols=257  Identities=26%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             HHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--------cHHHHHHHHHHHhcC
Q 013557           71 FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--------GHKEWLSEVNYLGQL  142 (441)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l  142 (441)
                      +.......++|++.+.||+|+||.||+|...         .+|..||||+++.....        ..+.+.+|+.+++++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  156 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV  156 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHh
Confidence            3444566788999999999999999997654         24778999998654311        134578899999999


Q ss_pred             -CCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          143 -HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       143 -~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                       +||||+++++++......++||||++|++|.+++....  .+++..+..++.||+.||.|||+  .||+||||||+|||
T Consensus       157 ~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENIL  232 (365)
T ss_dssp             TTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             cCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence             79999999999999999999999999999999997654  48999999999999999999999  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc------CCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT------GRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ++.++.+||+|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||....
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence            9999999999999998654332   2235679999999999874      358889999999999999999999996432


Q ss_pred             cccchhhhhhhccccccchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          296 VGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .....   .             .+.........+  ......+..|+..|+. ||++||++.++++.
T Consensus       310 ~~~~~---~-------------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          310 QILML---R-------------MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHH---H-------------HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHH---H-------------HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11100   0             000000000000  0112346677788887 99999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.7e-43  Score=369.04  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcC-CCCCcccEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQL-HHPNLVKLIG  152 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~  152 (441)
                      ..++|++.++||+|+||.||+|...         .+++.||||+++...   ....+.+..|..+|..+ +||||+.+++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES---------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            3468999999999999999997654         357789999987531   23346678899999988 7999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      ++.+.+..||||||++||+|.+++....  .+++..++.++.||+.||+|||+  ++|+||||||+||||+.+|++||+|
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~D  485 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD  485 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECC
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEee
Confidence            9999999999999999999999997765  49999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||+++......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......              
T Consensus       486 FGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--------------  549 (674)
T 3pfq_A          486 FGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------------  549 (674)
T ss_dssp             CTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred             cceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--------------
Confidence            99998533222  12346789999999999999999999999999999999999999997543211              


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCH-----HHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM-----SEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~-----~evl~~  359 (441)
                        .+..++...  ..+|......+..|+..|+. ||++||++     +||+++
T Consensus       550 --~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          550 --LFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --HHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --HHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence              111111111  12344445566777888887 99999997     777643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.3e-43  Score=333.94  Aligned_cols=262  Identities=27%  Similarity=0.404  Sum_probs=195.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|.+...      .+.+..||||+++....   ...+.+.+|++++++++||||+++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccC------CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            46899999999999999999876431      12244799999876432   3356788999999999999999999998


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.. .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcccc
Confidence            8764 899999999999999997653 348999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccc-eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhcccccc
Q 013557          235 LAKAGPTGDRTH-VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       235 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.........            
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------------  234 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------  234 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------------
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------------
Confidence            998654332211 1223467889999999998889999999999999999999 99999754321110            


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                          ..+.........+......+..++..|+. +|++||++.+|++.|+++..
T Consensus       235 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          235 ----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                01111111111222334556677888888 99999999999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-42  Score=354.44  Aligned_cols=252  Identities=26%  Similarity=0.342  Sum_probs=194.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|...         .++..+|||++....  ......+.+|+.+|+.++||||++++++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  105 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDK---------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF  105 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEET---------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4567999999999999999997654         347789999987543  23356788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---CcEEEc
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKLS  231 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~~kl~  231 (441)
                      .+....|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||++..   +.+||+
T Consensus       106 ~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          106 EDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEE
Confidence            99999999999999999999987664  48999999999999999999999  899999999999999764   459999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||++.......   ......||+.|+|||++. +.|+.++|||||||++|+|++|..||...........+.....   
T Consensus       182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---  254 (494)
T 3lij_A          182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY---  254 (494)
T ss_dssp             CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred             ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Confidence            999998654322   234567999999999986 5799999999999999999999999975432211111000000   


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                 .............+..|+..|+. ||++|||+.+++++
T Consensus       255 -----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 -----------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -----------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                       00000001123445677788887 99999999999854

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-42  Score=354.32  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||+||+|...         .+++.||||++....  ......+.+|+.+|++++||||++++++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   89 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI   89 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEET---------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            35678999999999999999997654         357789999985432  2345678999999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC---CCCcEEE
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD---SEFNAKL  230 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~---~~~~~kl  230 (441)
                      +.+....|+||||+.+++|.+++....  .+++..+..++.||+.||.|||+  +||+||||||+|||++   .++.+||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           90 LEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEE
Confidence            999999999999999999999987664  48999999999999999999999  8999999999999995   4567999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||+++......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...........        
T Consensus       166 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------  233 (486)
T 3mwu_A          166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR--------  233 (486)
T ss_dssp             CSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------
T ss_pred             EECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------
Confidence            9999998654322   2335679999999999975 699999999999999999999999975432111100        


Q ss_pred             ccchhhhhhhcccccCCC--chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQY--PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~--~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              +.........  .......+..|+..|+. ||++|||+.+++++
T Consensus       234 --------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          234 --------VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --------HHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --------HHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    0000000000  11223456677888888 99999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-42  Score=331.04  Aligned_cols=263  Identities=20%  Similarity=0.203  Sum_probs=200.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEE-EE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGF-CL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~-~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         ..++.||||++.....  ...+.+|+.+++.++|++++..+.+ +.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEc---------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence            3578999999999999999997653         3477999999865432  3467899999999998876655554 46


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEEcc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLSD  232 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl~D  232 (441)
                      +....++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           76 EGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence            777889999999 899999996443 359999999999999999999999  899999999999999   4788999999


Q ss_pred             cCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh-h
Q 013557          233 FGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW-A  306 (441)
Q Consensus       233 Fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~-~  306 (441)
                      ||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. .
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            9999864432221     112355799999999999999999999999999999999999999975432221111110 0


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ....       ........    ......+..|+..|+. ||++||++.+|++.|+.+..
T Consensus       232 ~~~~-------~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          232 EKKM-------STPIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHH-------HSCHHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccc-------CCchHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            0000       00000011    1122446677888888 99999999999999986543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.6e-43  Score=356.69  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ..++|++.+.||+|+||.||+|...         .++..||||++....   ......+.+|+.+|++++||||++++++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   94 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDK---------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF   94 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3568999999999999999997644         357899999986543   2346778999999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---CCCCcEEE
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKL  230 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---~~~~~~kl  230 (441)
                      +.+....++||||+.+++|.+++....  .+++..+..++.||+.||.|||+  ++|+||||||+|||+   +.++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEE
Confidence            999999999999999999999986654  59999999999999999999999  899999999999999   46789999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||+++......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..........         
T Consensus       171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------  237 (484)
T 3nyv_A          171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK---------  237 (484)
T ss_dssp             CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------
T ss_pred             EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH---------
Confidence            9999998654332   2234579999999999975 79999999999999999999999997543211110         


Q ss_pred             ccchhhhhhhcccccCCC--chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQY--PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~--~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             .+.........  .......+..|+..|+. +|++|||+.|++++
T Consensus       238 -------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          238 -------KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -------HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                   00000000000  11223456677788888 99999999999865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-42  Score=353.09  Aligned_cols=250  Identities=26%  Similarity=0.335  Sum_probs=197.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-------------ccHHHHHHHHHHHhcCC
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-------------QGHKEWLSEVNYLGQLH  143 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~  143 (441)
                      ..++|++.+.||+|+||+||+|...         .++..+|||++.....             ...+.+.+|+.+|++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEK---------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             cccceEEEeEecccCCeEEEEEEEC---------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            4678999999999999999997654         3477899999875432             23466889999999999


Q ss_pred             CCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       144 hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      ||||+++++++.+....|+||||++||+|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLE  180 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEES
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEe
Confidence            9999999999999999999999999999999997654  49999999999999999999999  8999999999999998


Q ss_pred             CCC---cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch
Q 013557          224 SEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ  300 (441)
Q Consensus       224 ~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~  300 (441)
                      .++   .+||+|||++.......   ......||+.|+|||++. +.++.++|||||||++|+|++|..||.........
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  256 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII  256 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            876   69999999998654332   224567999999999987 57999999999999999999999999754322111


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCC--chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQY--PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..+.                ........  .......+..|+..|+. ||++|||+.|++++
T Consensus       257 ~~i~----------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          257 KKVE----------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHH----------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH----------------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1100                00000000  01122345677788887 99999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=345.41  Aligned_cols=272  Identities=17%  Similarity=0.198  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCccc--------
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVK--------  149 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------  149 (441)
                      .++|++.+.||+|+||.||+|....... ......++.||||.+...     ..+.+|++++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLT-CDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCcc-ccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            3689999999999999999987653210 011113678999998654     35778999999999999987        


Q ss_pred             -------EEEEEEc-CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          150 -------LIGFCLD-GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       150 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                             +++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||.|||+  ++|+||||||+|||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl  191 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIF  191 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEE
Confidence                   6777765 78899999999 9999999987644569999999999999999999999  89999999999999


Q ss_pred             ECCCC--cEEEcccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcc
Q 013557          222 LDSEF--NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT  294 (441)
Q Consensus       222 l~~~~--~~kl~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~  294 (441)
                      ++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999764322111     1113357999999999999999999999999999999999999999754


Q ss_pred             ccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          295 RVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      ..... ........+......+   ..   ...........+..|+..|+. ||++||++.+|++.|+++..
T Consensus       272 ~~~~~-~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          272 LPNTE-DIMKQKQKFVDKPGPF---VG---PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             TTCHH-HHHHHHHHHHHSCCCE---EC---TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CcCHH-HHHHHHHhccCChhhh---hh---hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            32111 1111111000000000   00   000001123456677788887 99999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-42  Score=330.07  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=183.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHH-HHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKE-WLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~-~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||+++..... .... +.++...++.++||||+++++++.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   76 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHV---------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF   76 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEec---------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence            468999999999999999997653         34789999999765322 2222 444555578889999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEEECCCCcEEEcc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      +.+..++||||+++ +|.+++..  .....+++..++.++.|++.||.|||+  + +|+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~D  153 (290)
T 3fme_A           77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCD  153 (290)
T ss_dssp             CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred             ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999975 88887754  234569999999999999999999998  7 999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhh----hcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL----ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      ||++.......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||........         
T Consensus       154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------  221 (290)
T 3fme_A          154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------  221 (290)
T ss_dssp             C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---------
T ss_pred             cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---------
Confidence            99997643322   22334799999999996    456789999999999999999999999974322111         


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            .+...+........+......+..|+..|+. ||++||++.|++++
T Consensus       222 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          222 ------QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ------HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ------HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                  1111111111111122233456677788888 99999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-42  Score=347.81  Aligned_cols=201  Identities=27%  Similarity=0.384  Sum_probs=166.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||+++...  ....+.+.+|+.+|++++|+||+++++++.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDK---------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            578999999999999999997654         357889999997542  233467899999999999999999999987


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..     ...|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||+  .||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEE
Confidence            66     57899999986 5999998654  359999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCcc--------------------ceeeeccCCCCcCchhhh-hcCCCCchhhhHHHhHHHHHHHhCCC
Q 013557          231 SDFGLAKAGPTGDRT--------------------HVSTQVMGTRGYAAPEYL-ATGRLTAKCDVYSFGVVLLELLSGRR  289 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltg~~  289 (441)
                      +|||+++........                    ......+||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            999999865332211                    123456899999999986 45679999999999999999998655


Q ss_pred             CCC
Q 013557          290 AVD  292 (441)
Q Consensus       290 pf~  292 (441)
                      ||.
T Consensus       251 p~~  253 (432)
T 3n9x_A          251 SHI  253 (432)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            553

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.9e-43  Score=349.42  Aligned_cols=252  Identities=24%  Similarity=0.317  Sum_probs=188.4

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--------ccHHHHHHHHHHHhcCCCCC
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--------QGHKEWLSEVNYLGQLHHPN  146 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpn  146 (441)
                      ....++|.+.+.||+|+||.||+|....         +++.||||++.....        .....+.+|+.+|++++|||
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  201 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC  201 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC
Confidence            3567899999999999999999976543         477899999865321        11224789999999999999


Q ss_pred             cccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          147 LVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       147 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      |+++++++.. +..|+||||+++|+|.+++...  ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++
T Consensus       202 iv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          202 IIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             BCCCCEEEES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSS
T ss_pred             EeeEEEEEec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCC
Confidence            9999999754 5689999999999999988544  359999999999999999999999  8999999999999997544


Q ss_pred             ---cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccch
Q 013557          227 ---NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ  300 (441)
Q Consensus       227 ---~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~  300 (441)
                         .+||+|||+++......   .....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........ 
T Consensus       277 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-  352 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-  352 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-
T ss_pred             CcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-
Confidence               59999999998754322   2345679999999999853   5688899999999999999999999975332111 


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCc---hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYP---QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       +.              ..+........+   ......+..|+..|+. ||++||+++|++++
T Consensus       353 -~~--------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          353 -LK--------------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -HH--------------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HH--------------HHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             00              000000000000   1123446677788887 99999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.7e-42  Score=337.07  Aligned_cols=268  Identities=22%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++......  ....+.+|+.+|+.++||||+++++++.
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   86 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEET---------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceeEEEEEecCCCcEEEEEEEC---------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence            468999999999999999997654         34778999998654322  2456789999999999999999999988


Q ss_pred             c--------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 D--------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +        .+..++||||+++ +|.+.+.... ..+++..++.++.||+.||.|||+  +||+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             EC--------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSC
T ss_pred             ccccccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCC
Confidence            7        4468999999975 8888775443 359999999999999999999999  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCc--cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhh
Q 013557          228 AKLSDFGLAKAGPTGDR--THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVD  304 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~  304 (441)
                      +||+|||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  242 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  242 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999976432211  112234578999999999976 458999999999999999999999997654322211111


Q ss_pred             -hhcccccc----ch--hhhhhhcccccCCCchh--------HHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          305 -WAKPYLGD----RR--KLFRIMDIKLEGQYPQK--------GAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       305 -~~~~~~~~----~~--~l~~~~~~~~~~~~~~~--------~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ........    ..  .....+.. ........        ....+..|+..|+. ||++||+++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCChhhccccccchhhccccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             10000000    00  00000000 00000000        02235677888888 99999999999876

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=331.04  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=196.8

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ...++|++.+.||+|+||.||+|....         ++..||||++....  ..+.+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            456789999999999999999976543         47789999997643  4567889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           95 KNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999999986433 358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  ....         
T Consensus       172 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~---------  238 (314)
T 3com_A          172 AGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI--FMIP---------  238 (314)
T ss_dssp             CEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHH---------
T ss_pred             chhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHh---------
Confidence            97643221  1223457899999999999989999999999999999999999999743321110  0000         


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        .  ........+......+..|+..|+. ||++||++.++++.
T Consensus       239 --~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          239 --T--NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             --H--SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --c--CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              0  0000001122334456678888888 99999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.4e-43  Score=339.95  Aligned_cols=267  Identities=25%  Similarity=0.369  Sum_probs=195.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .++..||||++......  ..+.+.+|+.++++++||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   94 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK   94 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence            468999999999999999997654         34778999998654322  2345789999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A           95 KKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCC
Confidence            9999999999999988888765433  59999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-hhhhhccccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-LVDWAKPYLGDR  313 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~  313 (441)
                      ++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... ............
T Consensus       171 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          171 ARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            97643322  122345789999999999875 68999999999999999999999997544221110 000000000000


Q ss_pred             hh-------hhhhhcccccCCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RK-------LFRIMDIKLEGQY-----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~-------l~~~~~~~~~~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..       .............     .......+..|+..|+. ||++||++.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00       0000000000000     01223456777888888 99999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.9e-43  Score=333.69  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=196.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|....         ++..+|+|++........+.+.+|+.+++.++||||+++++++.+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH   87 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence            45789999999999999999976543         477899999987666677889999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           88 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             C-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            999999999999999999886643 359999999999999999999999  89999999999999999999999999987


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      ......  ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||........  ........  
T Consensus       165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--  238 (302)
T 2j7t_A          165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSD--  238 (302)
T ss_dssp             HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC--
T ss_pred             cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccC--
Confidence            531110  01122456899999999984     56789999999999999999999999975432110  01100000  


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                 ......+......+..++..|+. ||++||++.+++++
T Consensus       239 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 -----------PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -----------CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -----------CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                       00001123334456778888888 99999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-42  Score=325.87  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=192.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++....   ....+.+.+|+.+++.++||||+++++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            468999999999999999997654         247789999986432   12345788999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecc
Confidence            99999999999999999999997654  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ++.......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........   .          
T Consensus       157 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~----------  220 (276)
T 2h6d_A          157 LSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---F----------  220 (276)
T ss_dssp             GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----------
T ss_pred             cccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H----------
Confidence            998654322   2234578999999999987765 5899999999999999999999975332111   0          


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ..+.... ...+......+..++..|+. ||++||++.++++.
T Consensus       221 ----~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          221 ----KKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----HHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----HHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                0000000 11223333456677888888 99999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-42  Score=346.13  Aligned_cols=201  Identities=24%  Similarity=0.332  Sum_probs=174.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC------CCCCcccE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL------HHPNLVKL  150 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l  150 (441)
                      ...+|++.+.||+|+||.||+|...         .++..||||+++... .....+.+|+.+++.+      +|+||+++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~---------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDH---------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEEC---------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            3567999999999999999997654         347789999997642 3345567788887776      57799999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--E
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--A  228 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--~  228 (441)
                      ++++......++||||+. ++|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.  +
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCE
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcce
Confidence            999999999999999995 699999988776679999999999999999999999  89999999999999999887  9


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999764322     234579999999999999999999999999999999999999997554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=340.04  Aligned_cols=261  Identities=21%  Similarity=0.297  Sum_probs=190.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++.....  ...+.+.+|+++|+.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             cceEEEeEEeeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            468999999999999999997653         3578999999965422  23456889999999999999999999997


Q ss_pred             cCC------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DGE------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ...      ..|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEE
Confidence            653      469999999 88999998653   48999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-hhhhhc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-LVDWAK  307 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-~~~~~~  307 (441)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus       169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  243 (367)
T 1cm8_A          169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  243 (367)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999864321     234578999999999987 679999999999999999999999997544221111 111000


Q ss_pred             ccc-c-----cchhhhhhhc-------ccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYL-G-----DRRKLFRIMD-------IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~-~-----~~~~l~~~~~-------~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ... .     ........+.       .......+ .....+..|+..|+. ||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT-NASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT-TCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCC-CCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000 0     0000000000       00111111 223445566777777 99999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-42  Score=343.73  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC--------CCCccc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH--------HPNLVK  149 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~  149 (441)
                      .++|++.+.||+|+||.||+|...         ..++.||||+++.. ....+.+.+|+.+|+.++        |+||++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDI---------QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             CCeEEEEEEeeecCCeeEEEEEec---------CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            478999999999999999997654         34788999999754 234566889999999885        788999


Q ss_pred             EEEEEE----cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEEECC
Q 013557          150 LIGFCL----DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNILLDS  224 (441)
Q Consensus       150 l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nill~~  224 (441)
                      +++++.    +....|+||||+ +++|.+++.......+++..++.++.||+.||.|||+  + ||+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~  182 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEec
Confidence            999987    566899999999 6688888877665679999999999999999999998  7 9999999999999997


Q ss_pred             CC-------------------------------------------------cEEEcccCCcccCCCCCccceeeeccCCC
Q 013557          225 EF-------------------------------------------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTR  255 (441)
Q Consensus       225 ~~-------------------------------------------------~~kl~DFg~a~~~~~~~~~~~~~~~~gt~  255 (441)
                      ++                                                 .+||+|||++......     .....||+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~  257 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR  257 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence            75                                                 7999999999864322     23457899


Q ss_pred             CcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch----hh---hhhhcc--------------ccccch
Q 013557          256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ----NL---VDWAKP--------------YLGDRR  314 (441)
Q Consensus       256 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~----~~---~~~~~~--------------~~~~~~  314 (441)
                      .|+|||++.+..++.++|||||||++|||+||+.||.........    .+   ......              +.....
T Consensus       258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            999999999999999999999999999999999999754322111    00   000000              000000


Q ss_pred             h-----------hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          315 K-----------LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       315 ~-----------l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .           +...+..  ....+......+..|+..|+. ||++||+++|++++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0           0000000  112344556667788888888 99999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-42  Score=332.18  Aligned_cols=251  Identities=24%  Similarity=0.302  Sum_probs=192.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--------ccHHHHHHHHHHHhcCCCCCc
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--------QGHKEWLSEVNYLGQLHHPNL  147 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnI  147 (441)
                      ...++|++.+.||+|+||.||+|...         .+++.||||++.....        .....+.+|+.+|++++||||
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   77 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI   77 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEc---------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC
Confidence            45578999999999999999997654         3477899999875432        122347899999999999999


Q ss_pred             ccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          148 VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       148 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +++++++.... .|+||||+++++|.+++...  ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             CCEEEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSS
T ss_pred             ceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCC
Confidence            99999987665 89999999999999998644  358999999999999999999999  89999999999999987664


Q ss_pred             ---EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          228 ---AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       228 ---~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                         +||+|||+++......   ......||+.|+|||++.   +..++.++|||||||++|+|++|..||........  
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--  227 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--  227 (322)
T ss_dssp             SCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--
T ss_pred             CCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--
Confidence               9999999998643321   223457999999999974   46789999999999999999999999975432111  


Q ss_pred             hhhhhccccccchhhhhhhcccccCCC---chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQY---PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +...              +........   .......+..|+..|+. ||++||++.++++.
T Consensus       228 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          228 LKDQ--------------ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHH--------------HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHH--------------HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            0000              000000000   01123455677788887 99999999999853

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-42  Score=331.67  Aligned_cols=253  Identities=22%  Similarity=0.322  Sum_probs=193.9

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCC--CCCcccEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLH--HPNLVKLI  151 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~l~  151 (441)
                      ...++|++.+.||+|+||.||++...          .+..||||++.....  .....+.+|+.++.+++  |+||++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            34578999999999999999997543          267899999865432  33466889999999997  59999999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +++.+.+..++||| +.+++|.+++....  .+++..++.++.|++.||.|||+  ++|+||||||+|||+++ +.+||+
T Consensus        95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           95 DYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             EEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEe
Confidence            99999999999999 55889999997654  58999999999999999999999  89999999999999965 799999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhc-----------CCCCchhhhHHHhHHHHHHHhCCCCCCccccccch
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-----------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ  300 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~  300 (441)
                      |||++................||+.|+|||++.+           ..++.++||||||+++|+|++|+.||.......  
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  246 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--  246 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--
Confidence            9999986543332222335579999999999875           468889999999999999999999996432111  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                   ..+..+++.......+......+..|+..|+. ||++||++.|+++.
T Consensus       247 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 -------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                         11112222222222333334566778888888 99999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8e-42  Score=331.11  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC------CcccEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP------NLVKLI  151 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~  151 (441)
                      .++|++.+.||+|+||.||+|...        ...++.||||+++... ...+.+.+|+.+++.++|+      +|++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            468999999999999999998652        2246789999997542 3356678899999888665      499999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-------
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-------  224 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-------  224 (441)
                      +++.+.+..++||||+ +++|.+++......++++..++.++.||+.||+|||+  ++|+||||||+|||++.       
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEE
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccccccc
Confidence            9999999999999999 8899999988776679999999999999999999999  89999999999999987       


Q ss_pred             ------------CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          225 ------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       225 ------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                                  ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                        668999999999864322     234578999999999999999999999999999999999999997


Q ss_pred             ccccccchhhhhh-hcccccc--------------------chh----hhhhhcc-cccCCCchhHHHHHHHHHHHHhc-
Q 013557          293 KTRVGAEQNLVDW-AKPYLGD--------------------RRK----LFRIMDI-KLEGQYPQKGAYMVAILALQCIS-  345 (441)
Q Consensus       293 ~~~~~~~~~~~~~-~~~~~~~--------------------~~~----l~~~~~~-~~~~~~~~~~~~~~~~l~~~c~~-  345 (441)
                      ............. ..+....                    ...    +...... ......+......+..|+..|+. 
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            5543221111110 0000000                    000    0000000 00011223345567778888888 


Q ss_pred             CCCCCCCHHHHHHH
Q 013557          346 EAKVRPSMSEVLSA  359 (441)
Q Consensus       346 ~P~~RPs~~evl~~  359 (441)
                      ||++||++.|+++.
T Consensus       316 dP~~Rpt~~ell~h  329 (339)
T 1z57_A          316 DPAKRITLREALKH  329 (339)
T ss_dssp             STTTSCCHHHHTTS
T ss_pred             CcccccCHHHHhcC
Confidence            99999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.3e-42  Score=339.75  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=192.5

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ....++|++.+.||+|+||.||+|...         .++..||||++.....    ...+|+.+|+.++||||++++++|
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDI---------ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhhee
Confidence            345678999999999999999997654         3578999999865422    223699999999999999999998


Q ss_pred             Ec--------------------------------------CCeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHH
Q 013557          155 LD--------------------------------------GENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAI  194 (441)
Q Consensus       155 ~~--------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~  194 (441)
                      ..                                      ....++||||+++ +|.+.+..  .....+++..++.++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            44                                      3348899999974 88887754  3345699999999999


Q ss_pred             HHHHHHHHhHhcCCCeEEeccCCCcEEEC-CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchh
Q 013557          195 GAARGLSFLHEAEQQVIYRDFKASNILLD-SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKC  272 (441)
Q Consensus       195 ~i~~~L~~lH~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s  272 (441)
                      ||+.||.|||+  +||+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+. .++.++
T Consensus       149 qi~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          149 QLFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcch
Confidence            99999999998  8999999999999998 67899999999998653332   22345789999999998875 489999


Q ss_pred             hhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc-cchhhhhh------------hcccccCCCchhHHHHHHHH
Q 013557          273 DVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRI------------MDIKLEGQYPQKGAYMVAIL  339 (441)
Q Consensus       273 DvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~l~~~------------~~~~~~~~~~~~~~~~~~~l  339 (441)
                      |||||||++|+|++|+.||........  +......... ....+...            .........+......+..|
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  301 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence            999999999999999999975432211  1111100000 00000000            00000011222234456778


Q ss_pred             HHHHhc-CCCCCCCHHHHHHH
Q 013557          340 ALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       340 ~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +..|+. ||++|||+.|++++
T Consensus       302 i~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHccCChhhCCCHHHHhcC
Confidence            888888 99999999999854

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.4e-42  Score=336.62  Aligned_cols=199  Identities=25%  Similarity=0.319  Sum_probs=162.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         ..+..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   94 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   94 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeEeeeeEecCCEEEEEEEEC---------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence            468999999999999999997643         347789999986532  233456889999999999999999999997


Q ss_pred             cCC------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DGE------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ...      ..|+||||+++ +|.+++.    ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~k  167 (371)
T 2xrw_A           95 PQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK  167 (371)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEE
T ss_pred             cccccccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEE
Confidence            665      78999999975 7888874    238999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998643221   2234679999999999999999999999999999999999999997543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-42  Score=331.69  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=183.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         ..+..||||.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCA---------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEEC---------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            3578999999999999999997653         2467899999875432 33456889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRR------GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ..+..++||||+++++|.+++...      ....+++..++.++.||+.||.|||+  ++|+||||||+||+++.++.+|
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEE
Confidence            999999999999999999998641      23458999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCc---cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh
Q 013557          230 LSDFGLAKAGPTGDR---THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW  305 (441)
Q Consensus       230 l~DFg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~  305 (441)
                      |+|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..........  ..
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~  239 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LT  239 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HH
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--HH
Confidence            999999875432211   112234579999999999976 568999999999999999999999997543221110  00


Q ss_pred             hccccccchhhh-hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          306 AKPYLGDRRKLF-RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       306 ~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ...   ....+. ...+..    ........+..|+..|+. ||++||++.++++.
T Consensus       240 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          240 LQN---DPPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HTS---SCCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hcc---CCCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000   000000 000001    111223446677888888 99999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.8e-43  Score=346.59  Aligned_cols=241  Identities=16%  Similarity=0.160  Sum_probs=184.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC---CcccHHHHHHHH---HHHhcCCCCCcccEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE---GFQGHKEWLSEV---NYLGQLHHPNLVKLI  151 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~l~  151 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++...   .....+.+.+|+   ++|++++||||++++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEEC---------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            467889999999999999997653         34779999998643   223456788999   455566899999998


Q ss_pred             -------EEEEcCCe-----------------eEEEEEeCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHH
Q 013557          152 -------GFCLDGEN-----------------RLLVYEYMPKGSLENHLFRRGA-----RPLPWTLRIKVAIGAARGLSF  202 (441)
Q Consensus       152 -------~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~L~~  202 (441)
                             +++.+.+.                 .|+||||+ +|+|.+++.....     ..+++..++.++.||+.||+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   77766543                 79999999 6799999976432     123357888899999999999


Q ss_pred             hHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-----------CCCch
Q 013557          203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-----------RLTAK  271 (441)
Q Consensus       203 lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~  271 (441)
                      ||+  ++|+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.+
T Consensus       222 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  293 (377)
T 3byv_A          222 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS  293 (377)
T ss_dssp             HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred             HHh--CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence            999  8999999999999999999999999999985322     2345678 999999999887           89999


Q ss_pred             hhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCC
Q 013557          272 CDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR  350 (441)
Q Consensus       272 sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~R  350 (441)
                      +|||||||++|||++|+.||........                ...+.. .     .......+..|+..|+. ||++|
T Consensus       294 ~DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          294 FDAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC------CC----------------SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhC
Confidence            9999999999999999999964331110                000000 0     01122445677788888 99999


Q ss_pred             CCHHHHHH
Q 013557          351 PSMSEVLS  358 (441)
Q Consensus       351 Ps~~evl~  358 (441)
                      |++.++++
T Consensus       352 pt~~e~l~  359 (377)
T 3byv_A          352 LLPLQAME  359 (377)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-41  Score=324.78  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---------ccHHHHHHHHHHHhcCC-CC
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---------QGHKEWLSEVNYLGQLH-HP  145 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hp  145 (441)
                      ...++|++.+.||+|+||.||+|...         .+++.||||+++....         ...+.+.+|+.+|+++. ||
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~   84 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP   84 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             chhhccceeeeecCCCceEEEEEEEc---------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            34578999999999999999997654         3478899999865431         12345789999999995 99


Q ss_pred             CcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC
Q 013557          146 NLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       146 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~  225 (441)
                      ||+++++++.+....++||||+++++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+||+++.+
T Consensus        85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDD  160 (298)
T ss_dssp             TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTT
T ss_pred             CEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCC
Confidence            99999999999999999999999999999997654  48999999999999999999999  899999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhh------cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccc
Q 013557          226 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLA------TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAE  299 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~  299 (441)
                      +.+||+|||++.......   ......||+.|+|||++.      ...++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  237 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM  237 (298)
T ss_dssp             CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence            999999999998654322   223457899999999985      45688999999999999999999999964332111


Q ss_pred             hhhhhhhccccccchhhhhhhccccc--CCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLE--GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..                .+......  ..........+..|+..|+. ||++||++.++++.
T Consensus       238 ~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          238 LR----------------MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HH----------------HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HH----------------HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            00                00000000  01112233456677888887 99999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.2e-42  Score=331.88  Aligned_cols=259  Identities=19%  Similarity=0.241  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|...         ..++.||||+++..   ..+.+.+|+.+|++++ ||||+++++++.+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEEC---------CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            468999999999999999997654         34778999999754   3567889999999997 9999999999987


Q ss_pred             --CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEccc
Q 013557          157 --GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDF  233 (441)
Q Consensus       157 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~DF  233 (441)
                        ....++||||+.+++|.+++.     .+++..+..++.||+.||.|||+  ++|+||||||+|||++.++ .+||+||
T Consensus       103 ~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          103 PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             TTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence              677899999999999999873     28899999999999999999999  8999999999999999776 8999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc--
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL--  310 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--  310 (441)
                      |+++.......   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+........  
T Consensus       176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~  251 (330)
T 3nsz_A          176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTE  251 (330)
T ss_dssp             TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHH
T ss_pred             CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCc
Confidence            99986543322   234578999999999987 6789999999999999999999999954332111 1111000000  


Q ss_pred             -----------ccchhhhhhhcc--------cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 -----------GDRRKLFRIMDI--------KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 -----------~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                 ............        ......+......+..|+..|+. ||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                       000000000000        01111122234556778888888 99999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-42  Score=338.20  Aligned_cols=273  Identities=22%  Similarity=0.282  Sum_probs=195.0

Q ss_pred             cHHHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-----------cHHHHHHHHHH
Q 013557           70 TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-----------GHKEWLSEVNY  138 (441)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~  138 (441)
                      ...++....++|++.+.||+|+||.||+|....          +..||||++......           ..+.+.+|+.+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   82 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE----------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL   82 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT----------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC----------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence            456677888999999999999999999976432          678999998643221           12678999999


Q ss_pred             HhcCCCCCcccEEEEEEc-----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          139 LGQLHHPNLVKLIGFCLD-----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       139 l~~l~hpnIv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      |++++||||+++++++..     ....|+||||+. |+|.+++... ...+++..++.++.||+.||.|||+  ++|+||
T Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~  158 (362)
T 3pg1_A           83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE--AGVVHR  158 (362)
T ss_dssp             HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCC
T ss_pred             HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CcCEec
Confidence            999999999999999853     346899999997 5898888644 3469999999999999999999999  899999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      ||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence            999999999999999999999997533222   2234578999999999987 678999999999999999999999997


Q ss_pred             ccccccch-hhhhhhccc-cc-----cchhhhhhhcccccCC-------CchhHHHHHHHHHHHHhc-CCCCCCCHHHHH
Q 013557          293 KTRVGAEQ-NLVDWAKPY-LG-----DRRKLFRIMDIKLEGQ-------YPQKGAYMVAILALQCIS-EAKVRPSMSEVL  357 (441)
Q Consensus       293 ~~~~~~~~-~~~~~~~~~-~~-----~~~~l~~~~~~~~~~~-------~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl  357 (441)
                      ........ ......... ..     ........+.......       ........+..|+..|+. ||++||++.|++
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            54422111 111110000 00     0000000000000000       011123446677788887 999999999998


Q ss_pred             HH
Q 013557          358 SA  359 (441)
Q Consensus       358 ~~  359 (441)
                      ++
T Consensus       316 ~h  317 (362)
T 3pg1_A          316 RH  317 (362)
T ss_dssp             TS
T ss_pred             cC
Confidence            76

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7e-42  Score=342.22  Aligned_cols=260  Identities=26%  Similarity=0.346  Sum_probs=190.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|++.+.||+|+||.||+|.+..         +++.||||++.....    ...+|+++|++++||||++++++|...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~  119 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSS  119 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEecc
Confidence            3468999999999999999986643         477899999865421    234699999999999999999988532


Q ss_pred             ------CeeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-CcE
Q 013557          158 ------ENRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNA  228 (441)
Q Consensus       158 ------~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~~  228 (441)
                            ...++||||+++ +|.+++..  .....+++..++.++.||+.||.|||+  ++|+||||||+|||++.+ +.+
T Consensus       120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~  196 (420)
T 1j1b_A          120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVL  196 (420)
T ss_dssp             ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEE
T ss_pred             CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeE
Confidence                  236799999976 77776643  334569999999999999999999998  899999999999999965 568


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+.....
T Consensus       197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~  271 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIK  271 (420)
T ss_dssp             EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence            9999999986533221   2345789999999999765 7999999999999999999999999754321  11111111


Q ss_pred             cccc-cchhhhhhhccc--------c-----cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLG-DRRKLFRIMDIK--------L-----EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~-~~~~l~~~~~~~--------~-----~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .... ....+.. +...        .     ...++......+..|+..|+. ||++||++.|++++
T Consensus       272 ~lg~p~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          272 VLGTPTREQIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCHHHHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0000 0000000 0000        0     000112223456677777887 99999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.7e-42  Score=359.35  Aligned_cols=259  Identities=25%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|.+...      ...+..+|||+++.... ...+.+.+|+.+|++++||||+++++++.
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSP------ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCS------SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecC------CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            357899999999999999999976532      12356899999876432 23467899999999999999999999985


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                       ++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCC
Confidence             457899999999999999997543 358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      ++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||........   .           
T Consensus       538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~-----------  602 (656)
T 2j0j_A          538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I-----------  602 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-----------
T ss_pred             CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---H-----------
Confidence            9875432211 1223457889999999999999999999999999999997 9999975432111   0           


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                         ..+........+......+..|+..|+. ||++||++.+|++.|+.+
T Consensus       603 ---~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          603 ---GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               0011111112233344566778888888 999999999999998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-41  Score=334.44  Aligned_cols=268  Identities=23%  Similarity=0.283  Sum_probs=197.0

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         .++..||||++..... ...+.+.+|+++|.+++||||+++++++.
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   95 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDN---------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR   95 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEEC---------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence            3468999999999999999997654         3477899999975432 23466889999999999999999999987


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..     ...|+||||+. ++|.+++...   .+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A           96 APTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             CSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             cCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEE
Confidence            54     46899999996 5999988654   38999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCc-cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhhc
Q 013557          231 SDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWAK  307 (441)
Q Consensus       231 ~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~  307 (441)
                      +|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .....
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  249 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  249 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence            99999986432211 111234579999999998765 4589999999999999999999999975543221111 11100


Q ss_pred             ccccc-c-----hhhhhhhccccc-CCC-----chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLGD-R-----RKLFRIMDIKLE-GQY-----PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~-~-----~~l~~~~~~~~~-~~~-----~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..... .     ............ ...     .......+..|+..|+. ||++||++.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000 0     000000000000 000     01122345677778887 99999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=333.54  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=194.5

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|++.+.||+|+||.||+|.+..            .+|+|+++....  ...+.+.+|+.++++++||||+++++++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            35789999999999999999986542            389998875422  2234567899999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++ ++.+||+|||
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecC
Confidence            99999999999999999999986543 458999999999999999999999  8999999999999998 6799999999


Q ss_pred             CcccCCCCC---ccceeeeccCCCCcCchhhhhc---------CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh
Q 013557          235 LAKAGPTGD---RTHVSTQVMGTRGYAAPEYLAT---------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL  302 (441)
Q Consensus       235 ~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~  302 (441)
                      ++.......   .........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||.......... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-  253 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-  253 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence            987532211   1112233468999999999874         457889999999999999999999997543211110 


Q ss_pred             hhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCCC
Q 013557          303 VDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPP  366 (441)
Q Consensus       303 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~~  366 (441)
                       ..              .........+......+..|+..|+. +|++||++.+|++.|+.+...
T Consensus       254 -~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          254 -QM--------------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -HH--------------HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -Hh--------------ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             00              00000000111122345677788888 999999999999999987654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-41  Score=334.82  Aligned_cols=204  Identities=27%  Similarity=0.310  Sum_probs=174.2

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CC-----Cccc
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HP-----NLVK  149 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~  149 (441)
                      ...++|++.+.||+|+||+||+|...         .+++.||||+++... .....+..|+.+++.++ |+     +|++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDR---------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEc---------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            34679999999999999999997654         347789999997542 33456778888888885 55     4999


Q ss_pred             EEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC--CCCc
Q 013557          150 LIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD--SEFN  227 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~--~~~~  227 (441)
                      +++++...+..++||||+. ++|.+++.......+++..+..++.|++.||.|||+++.+|+||||||+|||++  .++.
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence            9999999999999999996 599999987765679999999999999999999996557999999999999995  4778


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999865322     234679999999999999999999999999999999999999997544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-42  Score=339.16  Aligned_cols=253  Identities=14%  Similarity=0.039  Sum_probs=177.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHH---HHhcCCCCCcccEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVN---YLGQLHHPNLVKLI  151 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~hpnIv~l~  151 (441)
                      ..+|++.+.||+|+||.||+|.+..         +++.||||++.....   ...+.+.+|+.   +|+. +||||++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~  130 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDR  130 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence            3458899999999999999976543         477999999987543   23445677754   5555 799988755


Q ss_pred             -------EEEEcC-----------------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHH
Q 013557          152 -------GFCLDG-----------------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLR------IKVAIGAARGLS  201 (441)
Q Consensus       152 -------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~i~~~i~~~L~  201 (441)
                             +++...                 ...||||||++ |+|.+++..... .+.+..+      +.++.||+.||+
T Consensus       131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~  208 (371)
T 3q60_A          131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAA  208 (371)
T ss_dssp             -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHH
Confidence                   555433                 33799999998 799999976432 2455555      677899999999


Q ss_pred             HhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc--CCCCchhhhHHHhH
Q 013557          202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGV  279 (441)
Q Consensus       202 ~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~  279 (441)
                      |||+  ++|+||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||
T Consensus       209 ~LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          209 NLQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHHH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHHH--CCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            9999  8999999999999999999999999999986432     1224567799999999987  67999999999999


Q ss_pred             HHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          280 VLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       280 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      ++|||++|+.||..........   |.....      ...................+..|+..|+. ||++||++.++++
T Consensus       282 il~elltg~~Pf~~~~~~~~~~---~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGS---WKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTC---CCBCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCcCcccccc---hhhhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999997553221110   000000      00000011111112334556777888887 9999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-41  Score=334.87  Aligned_cols=260  Identities=25%  Similarity=0.324  Sum_probs=187.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ..+|++.+.||+|+||.||+|....          +..+|+|++......    ..+|+++|+.++||||++++++|...
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEec
Confidence            4579999999999999999987643          234788877543211    23699999999999999999998654


Q ss_pred             C------eeEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC-CCCcE
Q 013557          158 E------NRLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD-SEFNA  228 (441)
Q Consensus       158 ~------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~-~~~~~  228 (441)
                      .      ..++||||+++ +|.+.+..  .....+++..++.++.||+.||+|||+  +||+||||||+|||++ .++.+
T Consensus       105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEE
T ss_pred             CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcE
Confidence            3      37899999977 44444432  234569999999999999999999999  8999999999999999 78999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  .+.....
T Consensus       182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~  256 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK  256 (394)
T ss_dssp             EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            9999999986533321   2345789999999999765 58999999999999999999999997544221  1111111


Q ss_pred             cccccchhhhhhhcc-----ccc--------CCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLGDRRKLFRIMDI-----KLE--------GQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~-----~~~--------~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ............+..     ...        ..++......+..|+..|+. ||++||++.|++++
T Consensus       257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            000000000000000     000        00111223456677788887 99999999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-42  Score=335.95  Aligned_cols=264  Identities=18%  Similarity=0.225  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-----------------HHHHHHHHHHHh
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-----------------HKEWLSEVNYLG  140 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~  140 (441)
                      .++|++.+.||+|+||.||+|..           .+..||||.+.......                 .+.+.+|+.+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   98 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT   98 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence            46899999999999999999865           37789999986432211                 177899999999


Q ss_pred             cCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEec
Q 013557          141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENH------LFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRD  214 (441)
Q Consensus       141 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~D  214 (441)
                      +++||||+++++++.+.+..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ .+||+|||
T Consensus        99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~d  177 (348)
T 2pml_X           99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRD  177 (348)
T ss_dssp             TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCC
T ss_pred             hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecC
Confidence            99999999999999999999999999999999998      654435679999999999999999999996 37899999


Q ss_pred             cCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCc-hhhhHHHhHHHHHHHhCCCCCC
Q 013557          215 FKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTA-KCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       215 lkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~il~elltg~~pf~  292 (441)
                      |||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||.
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999864332    23456799999999999877 5666 9999999999999999999997


Q ss_pred             ccccccchhhhhhh-cc---ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          293 KTRVGAEQNLVDWA-KP---YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       293 ~~~~~~~~~~~~~~-~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .....  ....... ..   +..........................+..|+..|+. ||.+||++.|++++
T Consensus       254 ~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          254 LKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            54321  1111110 00   0000000000000000000012233456677788888 99999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=339.46  Aligned_cols=206  Identities=24%  Similarity=0.343  Sum_probs=157.4

Q ss_pred             hcCCCC-CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRP-DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .+.|++ .++||+|+||.||+|.+..       ...+..||||++....  ....+.+|+.+|++|+||||+++++++..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS   89 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence            455776 5689999999999987542       2246789999997653  23567899999999999999999999954


Q ss_pred             --CCeeEEEEEeCCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE----C
Q 013557          157 --GENRLLVYEYMPKGSLENHLFRR-------GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL----D  223 (441)
Q Consensus       157 --~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill----~  223 (441)
                        ....|+||||+.+ +|.+++...       ....+++..++.++.||+.||.|||+  ++|+||||||+|||+    +
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSST
T ss_pred             CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCC
Confidence              6789999999964 888887532       12248999999999999999999999  899999999999999    6


Q ss_pred             CCCcEEEcccCCcccCCCCCc-cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          224 SEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      .++.+||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            778999999999986533211 1122356799999999999874 58999999999999999999999996543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-41  Score=331.79  Aligned_cols=268  Identities=23%  Similarity=0.282  Sum_probs=195.6

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   79 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHK---------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQR   79 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEEC---------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence            3578999999999999999997654         3477899999975432 23456789999999999999999999876


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..     ...++||||+. ++|.+++...   .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             CSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEE
T ss_pred             ccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEE
Confidence            54     67899999996 5999988653   48999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccc--------eeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          231 SDFGLAKAGPTGDRTH--------VSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                      +|||+++.........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  233 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL  233 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999998643221110        1223578999999998865 678999999999999999999999997554221111


Q ss_pred             h-hhhhc-cccc------cchhhhhhhcccccC------CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          302 L-VDWAK-PYLG------DRRKLFRIMDIKLEG------QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       302 ~-~~~~~-~~~~------~~~~l~~~~~~~~~~------~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      . ..... +...      ........+......      .........+..|+..|+. ||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0 00000 0000      000000110000000      0001223445677788887 99999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.4e-41  Score=322.57  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=190.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..++|++.+.||+|+||.||+|...         ..+..||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNA---------LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLE   73 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             ccccchhhheeccCCcEEEEEEEEc---------CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence            4568999999999999999997654         34778999998643 2345678899999999999999999998865


Q ss_pred             -------------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          157 -------------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       157 -------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                                   ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFID  150 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEc
Confidence                         356799999999999999997543 357889999999999999999999  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCc------------cceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCC
Q 013557          224 SEFNAKLSDFGLAKAGPTGDR------------THVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRA  290 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p  290 (441)
                      .++.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            999999999999976432110            1112345789999999999864 68999999999999999998   4


Q ss_pred             CCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          291 VDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       291 f~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      |.....  ........           ...........+......+..|+..|+. ||++||++.++++.
T Consensus       228 ~~~~~~--~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          228 FSTGME--RVNILKKL-----------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             CSSHHH--HHHHHHHH-----------HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCCchh--HHHHHHhc-----------cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            432110  00000000           0001112222334444556778888888 99999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.6e-41  Score=319.74  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           76 NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++|++.+.||+|+||.||+|...         ..++.||||++....  ......+.+|++++++++||||++++++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   89 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI   89 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence            45679999999999999999997654         347789999986532  2346778999999999999999999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---CcEEE
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FNAKL  230 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~~kl  230 (441)
                      +.+....++||||+++++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+||+++.+   +.+||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           90 LEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEE
Confidence            999999999999999999999987654  48999999999999999999999  899999999999999764   46999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL  310 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  310 (441)
                      +|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.........   .      
T Consensus       166 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~------  232 (287)
T 2wei_A          166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---K------  232 (287)
T ss_dssp             CSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------
T ss_pred             eccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH---H------
Confidence            9999998643322   1223468899999999875 5899999999999999999999999754321110   0      


Q ss_pred             ccchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          311 GDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       311 ~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             .+.........+  ......+..++..|+. ||++||++.++++.
T Consensus       233 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          233 -------RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -------HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                   000000000001  1123445677788887 99999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.1e-41  Score=333.08  Aligned_cols=262  Identities=16%  Similarity=0.241  Sum_probs=198.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-----------CCC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-----------HPN  146 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpn  146 (441)
                      .++|++.+.||+|+||.||+|...         ..++.||||++.... .....+.+|+.++++++           |+|
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEec---------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            468999999999999999997643         347889999997542 33456788999998886           899


Q ss_pred             cccEEEEEEcCC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEE
Q 013557          147 LVKLIGFCLDGE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNIL  221 (441)
Q Consensus       147 Iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nil  221 (441)
                      |+++++++....    ..++|||++ +++|.+++.......+++..++.++.||+.||.|||+  + ||+||||||+|||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVL  164 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeE
Confidence            999999988654    789999999 8899999987666679999999999999999999998  7 9999999999999


Q ss_pred             EC------CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          222 LD------SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       222 l~------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ++      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            94      4457999999999764322     234578999999999999999999999999999999999999997543


Q ss_pred             cccc----hhhhhh---hccc--------------cccchh-----------hhhhhcccccCCCchhHHHHHHHHHHHH
Q 013557          296 VGAE----QNLVDW---AKPY--------------LGDRRK-----------LFRIMDIKLEGQYPQKGAYMVAILALQC  343 (441)
Q Consensus       296 ~~~~----~~~~~~---~~~~--------------~~~~~~-----------l~~~~~~~~~~~~~~~~~~~~~~l~~~c  343 (441)
                      ....    ..+...   ....              ......           +...+.  .....+......+..|+..|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGG
T ss_pred             ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHH
Confidence            2110    011000   0000              000000           000000  01124455667777888999


Q ss_pred             hc-CCCCCCCHHHHHHH
Q 013557          344 IS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       344 ~~-~P~~RPs~~evl~~  359 (441)
                      +. ||++||+++|++++
T Consensus       318 L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             GCSSTTTCBCHHHHHTC
T ss_pred             hccCccccCCHHHHhhC
Confidence            98 99999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.4e-42  Score=337.54  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=180.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .++..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   98 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   98 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEET---------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCceEEeeEEeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            478999999999999999997543         357899999997542  233566889999999999999999999987


Q ss_pred             cC------CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DG------ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ..      ...|+|||++ +++|.+++..   ..+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred             cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEE
Confidence            54      5679999999 7899998854   359999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhhc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWAK  307 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~  307 (441)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .....
T Consensus       173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  247 (367)
T 2fst_X          173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  247 (367)
T ss_dssp             ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999864321     234679999999999987 6789999999999999999999999975442211111 11000


Q ss_pred             cc-cc-----cchhhhhhhcccccC-CCc-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PY-LG-----DRRKLFRIMDIKLEG-QYP-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~-~~-----~~~~l~~~~~~~~~~-~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .. ..     ........+...... ..+     ......+..|+..|+. ||++||++.|++++
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00 00     000000111000000 000     0112345667777877 99999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.7e-41  Score=325.20  Aligned_cols=269  Identities=27%  Similarity=0.349  Sum_probs=198.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcC---CCCCcccEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQL---HHPNLVKLI  151 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~  151 (441)
                      ..++|++.+.||+|+||.||+|....        ..++.||+|+++....  .....+.+|+.+++.+   +||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            45789999999999999999986531        2367899999864321  1123456677777666   899999999


Q ss_pred             EEEE-----cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC
Q 013557          152 GFCL-----DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF  226 (441)
Q Consensus       152 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~  226 (441)
                      +++.     .....++||||+. |+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCC
Confidence            9987     5667899999997 599999987766669999999999999999999999  8999999999999999999


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDW  305 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~  305 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .....
T Consensus       158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  234 (326)
T 1blx_A          158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  234 (326)
T ss_dssp             CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            99999999997643221   223467899999999999999999999999999999999999999754322111 11110


Q ss_pred             hc-ccccc-------chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          306 AK-PYLGD-------RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       306 ~~-~~~~~-------~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .. +....       .......................+..|+..|+. ||++||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 00000       000000000000001112234456678888888 99999999999865

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.9e-41  Score=329.68  Aligned_cols=271  Identities=24%  Similarity=0.316  Sum_probs=187.5

Q ss_pred             HHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEE
Q 013557           73 ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  152 (441)
                      ......++|++.+.||+|+||.||+|...         .++..||||++.... .....+.+|++.+..++||||+++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~   86 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQS   86 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHH
Confidence            34566789999999999999999997654         347789999886543 22345677888889999999999999


Q ss_pred             EEEcCCe-------eEEEEEeCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          153 FCLDGEN-------RLLVYEYMPKGSLENHLFR--RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       153 ~~~~~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      +|.....       .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||.+.++|+||||||+|||++
T Consensus        87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  165 (360)
T 3e3p_A           87 YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN  165 (360)
T ss_dssp             EEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE
T ss_pred             hhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe
Confidence            9875433       7899999976 66555542  234468999999999999999999993338999999999999999


Q ss_pred             C-CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          224 S-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       224 ~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                      . ++.+||+|||+++......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........  
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--  240 (360)
T 3e3p_A          166 EADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--  240 (360)
T ss_dssp             TTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred             CCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--
Confidence            7 8999999999998654332   223457899999999997654 89999999999999999999999975442211  


Q ss_pred             hhhhhccccccchhhhhhhcc----------------cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          302 LVDWAKPYLGDRRKLFRIMDI----------------KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +.................+..                .............+..|+..|+. ||++||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111111000000000000000                00011112234556778888888 99999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=327.27  Aligned_cols=267  Identities=23%  Similarity=0.313  Sum_probs=191.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEE--
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCL--  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++........+.+.+|+.++++++||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN---------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS   80 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET---------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence            468999999999999999997654         347789999987665556677899999999999999999999874  


Q ss_pred             ------------cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          156 ------------DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       156 ------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                                  +....++||||+. |+|.+++..   ..+++..++.++.|++.||+|||+  ++|+||||||+|||++
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFIN  154 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEE
T ss_pred             ccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEc
Confidence                        3467899999997 599998853   358999999999999999999999  8999999999999997


Q ss_pred             -CCCcEEEcccCCcccCCCCCc-cceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccch
Q 013557          224 -SEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ  300 (441)
Q Consensus       224 -~~~~~kl~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~  300 (441)
                       .++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             567899999999986432211 111234467999999999876 67899999999999999999999999755422111


Q ss_pred             hhhhhhccccc--cchhhhhh----hccccc-CC-----CchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          301 NLVDWAKPYLG--DRRKLFRI----MDIKLE-GQ-----YPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       301 ~~~~~~~~~~~--~~~~l~~~----~~~~~~-~~-----~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .......+...  ....+...    +..... ..     ........+..++..|+. ||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            11000000000  00000000    000000 00     011223456778888888 99999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-41  Score=326.14  Aligned_cols=254  Identities=25%  Similarity=0.355  Sum_probs=174.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHH-HHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVN-YLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||+++.... .....+..|+. +++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHK---------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEET---------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEc---------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            368999999999999999997654         3477899999976532 23345566666 677789999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEEECCCCcEEEc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFR---RGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      +.+..++||||+.+ +|.+++..   .....+++..+..++.|++.||.|||+  . +|+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEc
Confidence            99999999999975 88887753   234568999999999999999999998  7 99999999999999999999999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhh----hcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL----ATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      |||+++......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||........ .+...  
T Consensus       169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~--  242 (327)
T 3aln_A          169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQV--  242 (327)
T ss_dssp             CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCC--
T ss_pred             cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-HHHHH--
Confidence            999998653322   12234799999999998    456789999999999999999999999975321100 00000  


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                        .       ......+...........+..|+..|+. ||++||++.+|++
T Consensus       243 --~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 --V-------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             --C-------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --h-------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              0       0000001111112233456778888888 9999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-41  Score=328.91  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=170.9

Q ss_pred             HhcCCCCCC-eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHH-HHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDS-LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEV-NYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|.+.+ +||+|+||.||+|...         .+++.||||++...     ....+|+ ..++.++||||+++++++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~   91 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVY   91 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHH
Confidence            457898854 6999999999997654         34779999998653     1222333 345667999999999998


Q ss_pred             Ec----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC---Cc
Q 013557          155 LD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE---FN  227 (441)
Q Consensus       155 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~---~~  227 (441)
                      ..    ....++||||+++|+|.+++.......+++..++.++.||+.||.|||+  ++|+||||||+|||++.+   +.
T Consensus        92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A           92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCC
T ss_pred             hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCce
Confidence            76    4558999999999999999987766679999999999999999999999  899999999999999864   55


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhc
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  307 (441)
                      +||+|||+++.....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............   
T Consensus       170 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---  242 (336)
T 3fhr_A          170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---  242 (336)
T ss_dssp             EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred             EEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---
Confidence            999999999864322    1234578999999999988889999999999999999999999996443211100000   


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            ..+ ..................+..|+..|+. ||++||++.|+++.
T Consensus       243 ------~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          243 ------RRI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------Hhh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  000 0000000101112233456677788887 99999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.2e-41  Score=325.87  Aligned_cols=201  Identities=23%  Similarity=0.336  Sum_probs=172.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC------cccEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN------LVKLI  151 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~  151 (441)
                      .++|++.+.||+|+||.||+|.....        .+..||||+++... ...+.+.+|+.++++++|++      ++.++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            47899999999999999999865431        13689999997542 33556788999999987655      89999


Q ss_pred             EEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE---------
Q 013557          152 GFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---------  222 (441)
Q Consensus       152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill---------  222 (441)
                      +++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||+         
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccc
Confidence            9999999999999999 6788888877766679999999999999999999998  899999999999999         


Q ss_pred             ----------CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          223 ----------DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       223 ----------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                                +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                      56788999999999864322     234579999999999999999999999999999999999999997


Q ss_pred             ccc
Q 013557          293 KTR  295 (441)
Q Consensus       293 ~~~  295 (441)
                      ...
T Consensus       241 ~~~  243 (355)
T 2eu9_A          241 THE  243 (355)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=324.69  Aligned_cols=244  Identities=25%  Similarity=0.413  Sum_probs=188.8

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------cHHHHHHHHHHHhcC----CC
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------GHKEWLSEVNYLGQL----HH  144 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h  144 (441)
                      ....++|++.+.||+|+||.||+|...         ..++.||||++......      ....+.+|+.++.++    +|
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h   97 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRL---------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH   97 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECT---------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEc---------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCC
Confidence            456788999999999999999997543         34778999999765332      122356789998888    89


Q ss_pred             CCcccEEEEEEcCCeeEEEEEe-CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          145 PNLVKLIGFCLDGENRLLVYEY-MPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       145 pnIv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      +||+++++++.+.+..++|||+ +.+++|.+++....  .+++..++.++.||+.||.|||+  ++|+||||||+|||++
T Consensus        98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~  173 (312)
T 2iwi_A           98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILID  173 (312)
T ss_dssp             SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEE
T ss_pred             CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEe
Confidence            9999999999999999999999 78999999997654  48999999999999999999999  8999999999999999


Q ss_pred             -CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCC-chhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          224 -SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLT-AKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       224 -~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                       .++.+||+|||++.......    .....||..|+|||++.+..+. .++||||||+++|+|++|+.||.....     
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----  244 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----  244 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence             78999999999998654322    2345689999999999877764 589999999999999999999963210     


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .                 ...  ....+......+..++..|+. +|++||++.|+++.
T Consensus       245 ~-----------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 I-----------------LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             H-----------------HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             H-----------------hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0                 000  011222333456677888888 99999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4e-41  Score=331.38  Aligned_cols=262  Identities=19%  Similarity=0.268  Sum_probs=193.2

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      ..++|.+.+.||+|+||.||+|...         .+++.||||++......  ..+.+.+|+.+++.++||||+++++++
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccccEEEEeEEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            3578999999999999999997654         35789999999764322  246688999999999999999999999


Q ss_pred             EcCCee------EEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          155 LDGENR------LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       155 ~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      ...+..      ++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+
T Consensus       111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCE
T ss_pred             eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCE
Confidence            877655      99999997 58888762    248999999999999999999999  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhh
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWA  306 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~  306 (441)
                      ||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ......
T Consensus       184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  258 (371)
T 4exu_A          184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  258 (371)
T ss_dssp             EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999999854321     234678999999999987 67899999999999999999999999754422111 111100


Q ss_pred             ccccc------cchhhhhhhcccccCCC------chhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLG------DRRKLFRIMDIKLEGQY------PQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~------~~~~l~~~~~~~~~~~~------~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .....      ........+........      .......+..|+..|+. ||++||++.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00000      00000000000000000      11223456677788888 99999999999876

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-41  Score=327.06  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=196.2

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------cHHHHHHHHHHHhcCC--CCC
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------GHKEWLSEVNYLGQLH--HPN  146 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpn  146 (441)
                      ....++|++.+.||+|+||.||+|...         .+++.||||++......      ....+.+|+.++++++  |+|
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEET---------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            345678999999999999999997654         34778999998654321      1234667999999996  599


Q ss_pred             cccEEEEEEcCCeeEEEEEeCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC-C
Q 013557          147 LVKLIGFCLDGENRLLVYEYMPK-GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD-S  224 (441)
Q Consensus       147 Iv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~-~  224 (441)
                      |+++++++.+.+..++|||++.+ ++|.+++....  .+++..++.++.||+.||.|||+  .+|+||||||+|||++ .
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLN  185 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCC
Confidence            99999999999999999999976 89999997654  48999999999999999999999  8999999999999999 6


Q ss_pred             CCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhh
Q 013557          225 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV  303 (441)
Q Consensus       225 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~  303 (441)
                      ++.+||+|||+++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     ..
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~  256 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II  256 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH
T ss_pred             CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hh
Confidence            7899999999998654322    234579999999999987776 6789999999999999999999964210     00


Q ss_pred             hhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       304 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .                 ..  ...+......+..|+..|+. ||++||++.+|++.
T Consensus       257 ~-----------------~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          257 R-----------------GQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             H-----------------CC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c-----------------cc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0                 00  01112223456678888888 99999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=324.17  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=192.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|...         .+++.||||++.....  ...+.+.+|+.+|+.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CceEEEeeeEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            468999999999999999997654         3578999999976432  22456889999999999999999999998


Q ss_pred             cCCe------eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DGEN------RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ....      .|+||||+. ++|.+++.    ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~k  166 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELK  166 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEE
Confidence            7654      499999997 58888762    248999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-hhhhhc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-LVDWAK  307 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-~~~~~~  307 (441)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ......
T Consensus       167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  241 (353)
T 3coi_A          167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  241 (353)
T ss_dssp             ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred             EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999864321     234578999999999987 678999999999999999999999997544221110 000000


Q ss_pred             cc-c---c--cchhhhhhhc---ccccC---CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          308 PY-L---G--DRRKLFRIMD---IKLEG---QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       308 ~~-~---~--~~~~l~~~~~---~~~~~---~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      .. .   .  ........+.   .....   .........+..|+..|+. ||++||++.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 0   0  0000000000   00000   1112234556677788887 99999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=317.41  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=175.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHH-HHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKE-WLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~-~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|....         +++.||||++...... .... +..+..+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            4679999999999999999976543         4778999999765332 2223 444555688889999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCC-CeEEeccCCCcEEECCCCcEEEcccC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQ-QVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      +.+..++||||+ ++.+..++.. ....+++..++.++.|++.||.|||+  + +|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999 5555555443 23469999999999999999999998  5 89999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      ++.......   ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||........  .       
T Consensus       171 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-------  238 (318)
T 2dyl_A          171 ISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V-------  238 (318)
T ss_dssp             TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H-------
T ss_pred             CchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H-------
Confidence            997643322   223457899999999994     45688999999999999999999999974321110  0       


Q ss_pred             cccchhhhhhhcccccCCCc--hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYP--QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                            +..++.. .....+  ......+..|+..|+. ||.+||++.+|++.
T Consensus       239 ------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          239 ------LTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ------HHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ------HHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                  0000000 000011  1123456677788888 99999999999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.5e-40  Score=330.51  Aligned_cols=252  Identities=24%  Similarity=0.283  Sum_probs=181.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  157 (441)
                      +.|.+.+.||+|+||+||.+..          ..++.||||++...   ..+.+.+|+.+|.++ +||||+++++++.+.
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~----------~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS----------FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE----------SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             heeeccCeEeeCCCeEEEEEEE----------ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            4566678999999999985422          23779999998653   245678899999886 899999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-------
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARP-----LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-------  225 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-------  225 (441)
                      +..|+||||+. |+|.+++.......     ..+..++.++.||+.||+|||+  ++|+||||||+|||++.+       
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCccccccc
Confidence            99999999995 59999997654221     1233457899999999999999  899999999999999654       


Q ss_pred             ------CcEEEcccCCcccCCCCCcc--ceeeeccCCCCcCchhhhhc-------CCCCchhhhHHHhHHHHHHHh-CCC
Q 013557          226 ------FNAKLSDFGLAKAGPTGDRT--HVSTQVMGTRGYAAPEYLAT-------GRLTAKCDVYSFGVVLLELLS-GRR  289 (441)
Q Consensus       226 ------~~~kl~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-g~~  289 (441)
                            +.+||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||+| |+.
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  48999999999865432211  11234579999999999976       568999999999999999999 999


Q ss_pred             CCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          290 AVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       290 pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ||....... ..........            ..............+..|+..|+. ||++||++.+|+++
T Consensus       239 Pf~~~~~~~-~~i~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          239 PFGDKYSRE-SNIIRGIFSL------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TTCSTTTHH-HHHHHTCCCC------------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCchhhH-HHHhcCCCCc------------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            996432211 1111100000            000111123344566778888888 99999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=330.48  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=181.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      ..+|.+.++||+|+||+||....          ..++.||||++.......   +.+|+++|+.+ +||||+++++++.+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~----------~~~~~vAvK~~~~~~~~~---~~~E~~~l~~l~~HpnIv~l~~~~~~   89 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM----------FDNRDVAVKRILPECFSF---ADREVQLLRESDEHPNVIRYFCTEKD   89 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE----------SSSSEEEEEEECTTTEEE---CHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE----------eCCeEEEEEEECHHHHHH---HHHHHHHHHhccCCCCcCeEEEEEec
Confidence            34688899999999999653221          136789999997654332   45799999999 79999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-----CCcEEEc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-----EFNAKLS  231 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-----~~~~kl~  231 (441)
                      ....|+||||+. |+|.+++..... .+.+..++.++.||+.||.|||+  ++|+||||||+|||++.     ...+||+
T Consensus        90 ~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           90 RQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             CCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            999999999996 599999976543 35555678899999999999999  89999999999999953     2358899


Q ss_pred             ccCCcccCCCCCc-cceeeeccCCCCcCchhhhh---cCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhh
Q 013557          232 DFGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLA---TGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       232 DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~  306 (441)
                      |||+++....... ........||+.|+|||++.   +..++.++|||||||++|||++ |..||.............  
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~--  243 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--  243 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT--
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc--
Confidence            9999986543221 11233567999999999997   4567889999999999999999 899986432211100000  


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                       .           .. .............+..|+..|+. ||++||++.+|++
T Consensus       244 -~-----------~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 -A-----------CS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -C-----------CC-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -c-----------CC-ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             0           00 00001122334456678888888 9999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-39  Score=307.72  Aligned_cols=232  Identities=16%  Similarity=0.168  Sum_probs=179.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||.||+|...         .+++.||||++.......   .+.+.+|+.++.+++||||+++++++
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDT---------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEET---------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEec---------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            467999999999999999997654         347889999998654332   36789999999999999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+.+..|+||||++|++|.+++.. +   ....++..++.|++.||+|||+  +||+||||||+|||++.+|.+||+++|
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~-~---~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADT-S---PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EECCcEEEEEEecCCCCHHHHHhc-C---CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc
Confidence            999999999999999999999843 2   4566788999999999999999  899999999999999999999998543


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                                            |++       .++.++|||||||++|||+||+.||..........  ...........
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~~~~~  223 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTAGQPI  223 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECCBCTTSCBC
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHHHHhccCCC
Confidence                                  333       37899999999999999999999997543211000  00000000000


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      .. .    ..    .......+..|+..|+. ||++| |+.|+++.|+++..
T Consensus       224 ~~-~----~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          224 EP-A----DI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CH-H----HH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             Ch-h----hc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00 0    00    11223446677888888 99999 99999999987654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.6e-40  Score=341.32  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=194.0

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.         +..++..||||+++... ....+.+.+|+.+|++++||||+++++++..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~---------~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~   83 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWI---------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG   83 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCC---------CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEE---------ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence            4789999999999999999854         34457889999987642 2335668899999999999999999998765


Q ss_pred             ------CCeeEEEEEeCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc--
Q 013557          157 ------GENRLLVYEYMPKGSLENHLFRRG-ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN--  227 (441)
Q Consensus       157 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~--  227 (441)
                            .+..++||||++||+|.+++.... ...+++..++.++.|++.||.|||+  .||+||||||+|||++.++.  
T Consensus        84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSC
T ss_pred             cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCce
Confidence                  677899999999999999997643 2358899999999999999999999  89999999999999997765  


Q ss_pred             -EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          228 -AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       228 -~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                       +||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|.
T Consensus       162 ~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~  233 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH  233 (676)
T ss_dssp             EEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred             eEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence             9999999998754332   22456799999999999999999999999999999999999999964321     11111


Q ss_pred             ccccccchh---hhhhh--------cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHH
Q 013557          307 KPYLGDRRK---LFRIM--------DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEV  356 (441)
Q Consensus       307 ~~~~~~~~~---l~~~~--------~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~ev  356 (441)
                      .........   .....        ...............+..++..|+. ||++||++.++
T Consensus       234 ~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             TTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            110000000   00000        0001112334456677888888888 99999999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-39  Score=341.64  Aligned_cols=238  Identities=25%  Similarity=0.365  Sum_probs=186.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||.||+|.+..        ..++.||||++..... .....+.+|+.+|++++||||+++++++.+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            4789999999999999999987642        1367899999875432 334568899999999999999999999987


Q ss_pred             CCe-----eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEc
Q 013557          157 GEN-----RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLS  231 (441)
Q Consensus       157 ~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~  231 (441)
                      .+.     .||||||++|++|.+++..    .+++..++.++.||+.||.|||+  +||+||||||+|||++.+ .+||+
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEEC
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEE
Confidence            665     7999999999999987743    59999999999999999999999  899999999999999986 89999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||+++.....      ....||+.|+|||++.++ ++.++|||||||++|+|++|..||.......          .. 
T Consensus       224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~-  285 (681)
T 2pzi_A          224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP-  285 (681)
T ss_dssp             CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC-
T ss_pred             ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------cc-
Confidence            99999865332      345799999999999865 4899999999999999999998876321100          00 


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-HHHHHHHhh
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-MSEVLSALE  361 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-~~evl~~L~  361 (441)
                      .             ..........+..|+..|+. ||++||+ ++++...|.
T Consensus       286 ~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          286 E-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             T-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             c-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            0             00001112345677888888 9999995 555555544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.7e-38  Score=303.19  Aligned_cols=228  Identities=21%  Similarity=0.307  Sum_probs=176.7

Q ss_pred             hcCCCCC-CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHH-hcCCCCCcccEEEEEE
Q 013557           78 TRNFRPD-SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL-GQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+. ++||+|+||.||+|...         .+++.||+|+++.     ...+.+|+.++ +.++||||+++++++.
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~   81 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYE   81 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEc---------CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhh
Confidence            4677777 78999999999997654         3477999999854     34567899988 5558999999999988


Q ss_pred             c----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---CCcE
Q 013557          156 D----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNA  228 (441)
Q Consensus       156 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~~~~  228 (441)
                      +    ....++||||+++++|.+++.......+++..++.++.|++.||.|||+  ++|+||||||+|||++.   ++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCE
T ss_pred             hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcE
Confidence            6    6788999999999999999988766679999999999999999999999  89999999999999998   7889


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      ||+|||++....                        +..++.++|||||||++|+|++|+.||..........      .
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------~  209 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------G  209 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------C
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------H
Confidence            999999986421                        2457789999999999999999999996433211000      0


Q ss_pred             ccccchhhhhhhcccccCCCc----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYP----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             +...+. ......+    ......+..|+..|+. ||++||++.|++++
T Consensus       210 -------~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          210 -------MKTRIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -------SCCSSC-TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHHHHh-hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   000000 0000011    1223456677888888 99999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-38  Score=318.32  Aligned_cols=241  Identities=17%  Similarity=0.165  Sum_probs=175.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCC-CCc------
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHH-PNL------  147 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnI------  147 (441)
                      .++|.+.++||+|+||+||+|.+.         .+++.||||+++....   ...+.+.+|+.+++.++| .|.      
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~  147 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  147 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             ceeEEEecccccCCCEEEEEEEec---------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence            345778899999999999997654         3477999999874322   235678899999999987 321      


Q ss_pred             ---c------------cEEEEEEc-----CCeeEEEEEeCCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHH
Q 013557          148 ---V------------KLIGFCLD-----GENRLLVYEYMPKGSLENHLF-----RRGARPLPWTLRIKVAIGAARGLSF  202 (441)
Q Consensus       148 ---v------------~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~i~~~i~~~L~~  202 (441)
                         +            .++.++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||+|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  226 (413)
T 3dzo_A          148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  226 (413)
T ss_dssp             TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence               1            11111111     22457777776 679999885     2223457788999999999999999


Q ss_pred             hHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhh----------hcCCCCchh
Q 013557          203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYL----------ATGRLTAKC  272 (441)
Q Consensus       203 lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~s  272 (441)
                      ||+  ++|+||||||+|||++.++.+||+|||+++....     .....+| +.|+|||++          .+..++.++
T Consensus       227 LH~--~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  298 (413)
T 3dzo_A          227 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF  298 (413)
T ss_dssp             HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred             HHh--CCcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence            999  8999999999999999999999999999876332     1345578 999999999          445688899


Q ss_pred             hhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC
Q 013557          273 DVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP  351 (441)
Q Consensus       273 DvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP  351 (441)
                      |||||||++|||++|+.||........                ...++. . ....    ...+..|+..|+. ||++||
T Consensus       299 DvwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~-~-~~~~----~~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          299 DTWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFR-S-CKNI----PQPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             HHHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGS-S-CCCC----CHHHHHHHHHHTCSSGGGSC
T ss_pred             hHHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHh-h-cccC----CHHHHHHHHHHccCChhhCc
Confidence            999999999999999999974432110                000111 0 0112    2456777888888 999999


Q ss_pred             CHHHHHH
Q 013557          352 SMSEVLS  358 (441)
Q Consensus       352 s~~evl~  358 (441)
                      ++.++++
T Consensus       357 t~~~~l~  363 (413)
T 3dzo_A          357 LPLQAME  363 (413)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHHh
Confidence            9887753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-38  Score=309.61  Aligned_cols=191  Identities=17%  Similarity=0.178  Sum_probs=159.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--------ccHHHHHHHHHHHhcCC------
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--------QGHKEWLSEVNYLGQLH------  143 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------  143 (441)
                      .++|++.+.||+|+||+||+|...           ++.||||+++....        ...+.+.+|+.+|+.++      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~   87 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD-----------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV   87 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET-----------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred             cccchheeeecccCceEEEEEEeC-----------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence            467999999999999999998652           57899999975432        23367889999988885      


Q ss_pred             ---CCCcccEEEEEE------------------------------cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHH
Q 013557          144 ---HPNLVKLIGFCL------------------------------DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI  190 (441)
Q Consensus       144 ---hpnIv~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  190 (441)
                         |+||+++.+++.                              +....||||||+++|++.+.+.+   ..+++..++
T Consensus        88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~  164 (336)
T 2vuw_A           88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAK  164 (336)
T ss_dssp             SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHH
T ss_pred             cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHH
Confidence               888887777643                              26789999999999987776643   358999999


Q ss_pred             HHHHHHHHHHHHhH-hcCCCeEEeccCCCcEEECCCC--------------------cEEEcccCCcccCCCCCccceee
Q 013557          191 KVAIGAARGLSFLH-EAEQQVIYRDFKASNILLDSEF--------------------NAKLSDFGLAKAGPTGDRTHVST  249 (441)
Q Consensus       191 ~i~~~i~~~L~~lH-~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~DFg~a~~~~~~~~~~~~~  249 (441)
                      .++.||+.||.||| +  ++|+||||||+|||++.++                    .+||+|||+++....       .
T Consensus       165 ~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred             HHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence            99999999999999 8  8999999999999999887                    899999999986432       2


Q ss_pred             eccCCCCcCchhhhhcCCCCchhhhHHHhHH-HHHHHhCCCCCC
Q 013557          250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVV-LLELLSGRRAVD  292 (441)
Q Consensus       250 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i-l~elltg~~pf~  292 (441)
                      ...||+.|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            347999999999998665 899999998777 788899999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4.1e-34  Score=295.46  Aligned_cols=173  Identities=19%  Similarity=0.120  Sum_probs=129.4

Q ss_pred             cCCCccEEEEEEcCCCCc----------ccHHHHHHHHHHHhcC-CCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHH
Q 013557          109 RPGVGMVIAVKKLKPEGF----------QGHKEWLSEVNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLF  177 (441)
Q Consensus       109 ~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  177 (441)
                      +...|..+++|.+.....          ...++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.
T Consensus       255 r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~  334 (569)
T 4azs_A          255 RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA  334 (569)
T ss_dssp             EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH
T ss_pred             cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence            334577899999865421          1235689999999999 69999999999999999999999999999999997


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCc
Q 013557          178 RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY  257 (441)
Q Consensus       178 ~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y  257 (441)
                      +.+  +++..   .|+.||+.||+|||+  +|||||||||+||||+.+|.+||+|||+|+......  ....+.+||+.|
T Consensus       335 ~~~--~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~Y  405 (569)
T 4azs_A          335 AGE--EIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFV  405 (569)
T ss_dssp             TTC--CCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHH
T ss_pred             hCC--CCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhh
Confidence            654  46654   478999999999999  999999999999999999999999999998654322  223457899999


Q ss_pred             CchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       258 ~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      ||||++.+ .+..++|+||+|+++++|+++..++
T Consensus       406 mAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          406 FVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             HHHHHC------------------CCCCTTHHHH
T ss_pred             ccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            99999975 5778899999999999887775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=7.9e-30  Score=262.00  Aligned_cols=185  Identities=18%  Similarity=0.263  Sum_probs=142.4

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc--------HHHHHHHHHHHhcCCCCCcccEEEE
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--------HKEWLSEVNYLGQLHHPNLVKLIGF  153 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~  153 (441)
                      ...++||+|+||.||+|...           +..+++|+........        .+++.+|+++|++++||||+++..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  407 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF  407 (540)
T ss_dssp             ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence            45679999999999998433           4578888764432211        2447899999999999999955555


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+.+..||||||++|++|.+++..          +..++.|++.||+|||+  ++|+||||||+|||++.  .+||+||
T Consensus       408 ~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DF  473 (540)
T 3en9_A          408 DVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDF  473 (540)
T ss_dssp             EEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCC
T ss_pred             EEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEEC
Confidence            5567788999999999999998854          56899999999999999  89999999999999998  9999999


Q ss_pred             CCcccCCCCCccc-----eeeeccCCCCcCchhhhhc--CCCCchhhhHHHhHHHHHHHhCCCCC
Q 013557          234 GLAKAGPTGDRTH-----VSTQVMGTRGYAAPEYLAT--GRLTAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       234 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~pf  291 (441)
                      |+++.........     ......||+.|||||++.+  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9998754322111     1235689999999999986  56888899999998888888777654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.4e-25  Score=211.82  Aligned_cols=151  Identities=16%  Similarity=0.059  Sum_probs=118.5

Q ss_pred             HHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc------------------ccHHHHHHH
Q 013557           74 LKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------------------QGHKEWLSE  135 (441)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E  135 (441)
                      +......|.+.+.||+|+||.||+|.+.          .+..||||+++....                  .....+.+|
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E  154 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE  154 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHH
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeC----------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHH
Confidence            3344556777799999999999998652          377899999964321                  123558899


Q ss_pred             HHHHhcCCCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc
Q 013557          136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF  215 (441)
Q Consensus       136 ~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl  215 (441)
                      +.+|++++|   +++.+++.. +..|+||||++|++|.+ +..        .....++.|++.||.|||+  .||+||||
T Consensus       155 ~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~--~giiHrDl  219 (282)
T 1zar_A          155 FRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH--RGIVHGDL  219 (282)
T ss_dssp             HHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH--TTEECSCC
T ss_pred             HHHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH--CCCEeCCC
Confidence            999999984   555554433 46699999999999988 411        2245799999999999998  89999999


Q ss_pred             CCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc
Q 013557          216 KASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT  265 (441)
Q Consensus       216 kp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  265 (441)
                      ||+|||++ ++.+||+|||+++.               +..|+|||++..
T Consensus       220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99999999 99999999999863               346789998854

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=3.7e-21  Score=179.10  Aligned_cols=136  Identities=16%  Similarity=0.073  Sum_probs=104.5

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccE--EEEEEcCCCCcc------------------------cHHHHHH
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMV--IAVKKLKPEGFQ------------------------GHKEWLS  134 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~  134 (441)
                      |.+.+.||+|+||.||+|....         .|..  ||||+++.....                        ....+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            6788999999999999987621         3667  999987543111                        0125788


Q ss_pred             HHHHHhcCCCCCc--ccEEEEEEcCCeeEEEEEeCCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhH-hc
Q 013557          135 EVNYLGQLHHPNL--VKLIGFCLDGENRLLVYEYMPK-G----SLENHLFRRGARPLPWTLRIKVAIGAARGLSFLH-EA  206 (441)
Q Consensus       135 E~~~l~~l~hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH-~~  206 (441)
                      |+.+|.+|.|++|  +.++++    ...+|||||+.+ |    +|.++...     .++..+..++.|++.+|.||| + 
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~-  189 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE-  189 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH-
Confidence            9999999988754  445543    356899999932 3    67766432     224457889999999999999 7 


Q ss_pred             CCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                       .||+||||||+|||++.  .++|+|||++..
T Consensus       190 -~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          190 -AELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             -SCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             -CCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence             89999999999999998  999999999975

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=7.6e-19  Score=170.53  Aligned_cols=136  Identities=14%  Similarity=0.085  Sum_probs=98.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--------------cHHH--------HHHHH
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--------------GHKE--------WLSEV  136 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~  136 (441)
                      .-|++.+.||.|+||.||+|...          .|+.||||+++.....              ....        ..+|.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~  164 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF  164 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred             CEEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence            34899999999999999998643          3788999987642110              0111        23577


Q ss_pred             HHHhcCCCCCc--ccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEec
Q 013557          137 NYLGQLHHPNL--VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRD  214 (441)
Q Consensus       137 ~~l~~l~hpnI--v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~D  214 (441)
                      ..|.+|.+.++  ...+++  .  ..+|||||++|++|.++..      .  .....++.|++.+|.+||+  .||||||
T Consensus       165 ~nL~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~--~gIVHrD  230 (397)
T 4gyi_A          165 AFMKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAK--HGLIHGD  230 (397)
T ss_dssp             HHHHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             HHHHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHH--CCCcCCC
Confidence            77777755443  333332  1  2479999999988866431      1  2345678999999999998  8999999


Q ss_pred             cCCCcEEECCCC----------cEEEcccCCccc
Q 013557          215 FKASNILLDSEF----------NAKLSDFGLAKA  238 (441)
Q Consensus       215 lkp~Nill~~~~----------~~kl~DFg~a~~  238 (441)
                      |||.|||++++|          .+.|+||+-+..
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999998876          389999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=1.9e-13  Score=127.03  Aligned_cols=145  Identities=14%  Similarity=-0.007  Sum_probs=111.6

Q ss_pred             HHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEE
Q 013557           75 KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGF  153 (441)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  153 (441)
                      .....+|++...++.|+.+.||++...           +..+++|............+.+|+.+|+.|. +..+.+++++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~   78 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            445567988889999999999986421           4579999986532122345778999999884 6778899999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAE--------------------------  207 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~--------------------------  207 (441)
                      +.+.+..|+||||++|.+|.+.+.       +......++.+++.+|..||+..                          
T Consensus        79 ~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T 3tm0_A           79 ERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence            998899999999999999987531       11223467888899999999710                          


Q ss_pred             -------------------------------CCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          208 -------------------------------QQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       208 -------------------------------~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                                                     ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                           358999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=3.1e-12  Score=118.22  Aligned_cols=136  Identities=15%  Similarity=0.054  Sum_probs=95.6

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC--cccEEEEEEcC
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN--LVKLIGFCLDG  157 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~  157 (441)
                      +|.+..+.+.|..+.||++...          .|..+++|......   ...+.+|+.+|+.+.+.+  +.++++++.+.
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            4444333345666999986432          24568999976542   234668999999885434  56789888888


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAE------------------------------  207 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~------------------------------  207 (441)
                      +..++||||++|.+|.  ..  .   ..   ...++.+++..|..||+..                              
T Consensus        88 ~~~~~v~e~i~G~~l~--~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             SCEEEEEECCSSEETT--TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCCEEEEEecCCcccC--cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            8899999999998884  21  1   11   2255667777777777621                              


Q ss_pred             --------------------------CCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          208 --------------------------QQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       208 --------------------------~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                                                ..++|+|++|.|||++.++.+.|+|||.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      1299999999999998776667999997653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=4.6e-11  Score=116.13  Aligned_cols=141  Identities=12%  Similarity=0.166  Sum_probs=104.7

Q ss_pred             CCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcC--CCC-cccHHHHHHHHHHHhcCC--CCCcccEEEEEEcC
Q 013557           83 PDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLK--PEG-FQGHKEWLSEVNYLGQLH--HPNLVKLIGFCLDG  157 (441)
Q Consensus        83 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~  157 (441)
                      -.+.|+.|.++.||+....           +..+++|+..  ... ......+.+|+.+|+.|.  +..+++++.++.+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            3567899999999986432           3468888876  322 122345778999999986  45678999888766


Q ss_pred             ---CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc----------------------------
Q 013557          158 ---ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA----------------------------  206 (441)
Q Consensus       158 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~----------------------------  206 (441)
                         +..|+||||++|..+.+..    ...++..+...++.+++..|..||+.                            
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence               4589999999998775421    22367888889999999999999972                            


Q ss_pred             ----------------------------CCCeEEeccCCCcEEECCCCc--EEEcccCCccc
Q 013557          207 ----------------------------EQQVIYRDFKASNILLDSEFN--AKLSDFGLAKA  238 (441)
Q Consensus       207 ----------------------------~~~ivH~Dlkp~Nill~~~~~--~kl~DFg~a~~  238 (441)
                                                  ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                        247999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.16  E-value=2.1e-11  Score=115.81  Aligned_cols=182  Identities=21%  Similarity=0.215  Sum_probs=121.5

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCC--cccEEEEEEcCC--
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPN--LVKLIGFCLDGE--  158 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~l~~~~~~~~--  158 (441)
                      .+.++.|....||+.              +..+++|+....  .....+.+|+.+|+.+ .+..  +.+++.......  
T Consensus        25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            467999999999973              235888886533  3346688999999887 3433  455555543333  


Q ss_pred             -eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------
Q 013557          159 -NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAE------------------------------  207 (441)
Q Consensus       159 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~------------------------------  207 (441)
                       ..|+|||+++|.+|.+....    .++..++..++.+++..|..||+..                              
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE  164 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence             35899999999888764321    2677777888888888888888511                              


Q ss_pred             --------------------------CCeEEeccCCCcEEECC--CCcEEEcccCCcccCCCCCccceeeeccCCCCc--
Q 013557          208 --------------------------QQVIYRDFKASNILLDS--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY--  257 (441)
Q Consensus       208 --------------------------~~ivH~Dlkp~Nill~~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y--  257 (441)
                                                ..++|+|+++.||+++.  .+.+.|+||+.+........      ......+  
T Consensus       165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~  238 (304)
T 3sg8_A          165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDE  238 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTT
T ss_pred             CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhcc
Confidence                                      24799999999999998  45678999998865322100      0001111  


Q ss_pred             -Cchhhhhc-----CCC---------CchhhhHHHhHHHHHHHhCCCCC
Q 013557          258 -AAPEYLAT-----GRL---------TAKCDVYSFGVVLLELLSGRRAV  291 (441)
Q Consensus       258 -~aPE~~~~-----~~~---------~~~sDvwSlG~il~elltg~~pf  291 (441)
                       ..|+....     +..         ....+.|++|.++|.+.+|..+|
T Consensus       239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             22332211     111         22368999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.65  E-value=2.1e-07  Score=88.14  Aligned_cols=135  Identities=20%  Similarity=0.159  Sum_probs=91.6

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC---CcccEEEEEE-cCCe
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP---NLVKLIGFCL-DGEN  159 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~  159 (441)
                      .+.++.|....||+.              +..+++|+...  ......+.+|+.+|+.|.+.   .+.+++.++. ..+.
T Consensus        24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            356888888899974              34578888532  23345688999999999642   3567777764 4556


Q ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc---------------------------------
Q 013557          160 RLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA---------------------------------  206 (441)
Q Consensus       160 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~---------------------------------  206 (441)
                      .++|||+++|.+|.+....    .++..+...++.++...|..||+.                                 
T Consensus        88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            7899999999888763211    133444444444444444444431                                 


Q ss_pred             -------------------------CCCeEEeccCCCcEEECC---CCc-EEEcccCCccc
Q 013557          207 -------------------------EQQVIYRDFKASNILLDS---EFN-AKLSDFGLAKA  238 (441)
Q Consensus       207 -------------------------~~~ivH~Dlkp~Nill~~---~~~-~kl~DFg~a~~  238 (441)
                                               ...++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                     235799999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.62  E-value=1.7e-07  Score=86.88  Aligned_cols=135  Identities=18%  Similarity=0.091  Sum_probs=93.4

Q ss_pred             eeeecCce-EEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEEE
Q 013557           86 LIGEGGFG-YVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        86 ~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  163 (441)
                      .+..|..| .||+....         ..+..+++|+-...   ....+.+|..+|+.|. +--+.+++.++.+.+..++|
T Consensus        31 ~~~~G~S~~~v~rl~~~---------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK---------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             EEECSSSSCEEEEEECC---------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             EccCCCcCCeEEEEEec---------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            34555554 68874322         23456888886542   3456788999998884 43478899999999999999


Q ss_pred             EEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc-------------------------------------
Q 013557          164 YEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA-------------------------------------  206 (441)
Q Consensus       164 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-------------------------------------  206 (441)
                      ||+++|.++.+......      .....+..+++..|..||+.                                     
T Consensus        99 me~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             EECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99999988877653211      12234455556666666631                                     


Q ss_pred             -------------------CCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          207 -------------------EQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       207 -------------------~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                                         ...++|+|+++.|||++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               01279999999999999877677999987753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.43  E-value=2.9e-07  Score=88.98  Aligned_cols=85  Identities=5%  Similarity=-0.083  Sum_probs=53.9

Q ss_pred             Cee-eecCceEEEEEEecCcccccccCC-CccEEEEEEcCCCC---cccHHHHHHHHHHHhcCC-C--CCcccEEEEEEc
Q 013557           85 SLI-GEGGFGYVYKGWIDEHTLEAARPG-VGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLH-H--PNLVKLIGFCLD  156 (441)
Q Consensus        85 ~~l-G~G~~g~Vy~~~~~~~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~  156 (441)
                      +.| +.|....+|+......    .+.. .+..+++|+.....   ......+.+|+.+|+.|. +  -.+.+++.++.+
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~----~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQ----QDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEE----ETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EECCCCCccceEEEEEEecc----cCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            556 7888899998643200    0000 14578888875432   111234667899888884 3  357788888765


Q ss_pred             C---CeeEEEEEeCCCCCHH
Q 013557          157 G---ENRLLVYEYMPKGSLE  173 (441)
Q Consensus       157 ~---~~~~lv~e~~~~g~L~  173 (441)
                      .   ...|+||||++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            5   3578999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=2e-06  Score=84.44  Aligned_cols=76  Identities=20%  Similarity=0.174  Sum_probs=48.7

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-------ccHHHHHHHHHHHhcCCC--C-CcccEEEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-------QGHKEWLSEVNYLGQLHH--P-NLVKLIGF  153 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~l~~~  153 (441)
                      .+.||.|.++.||++....         .+..++||.......       ....++..|.++|+.+..  + .+.+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            4578999999999975431         245789998653211       123456779998887732  3 34466644


Q ss_pred             EEcCCeeEEEEEeCCCC
Q 013557          154 CLDGENRLLVYEYMPKG  170 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g  170 (441)
                        +.+..++|||++++.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              345578999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=9.8e-06  Score=77.39  Aligned_cols=32  Identities=16%  Similarity=0.197  Sum_probs=28.2

Q ss_pred             CCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            47899999999999998888899999987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.03  E-value=2.4e-05  Score=73.94  Aligned_cols=136  Identities=11%  Similarity=0.055  Sum_probs=88.8

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC---CCCcccEEEEEEcCCee
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH---HPNLVKLIGFCLDGENR  160 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~  160 (441)
                      .+.|+.|....+|+....           +..+++|+....   ....+..|...|+.|.   ...+++++.++...+..
T Consensus        41 ~~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~  106 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-----------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS  106 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-----------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred             eEEeCCccceeeeEEEEC-----------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence            356889999999985421           457888987543   3556788999998883   35688999988888899


Q ss_pred             EEEEEeCCCCCHH--------H---HHHhcCC-C-------------------CCCHHHHH-----HHH-----------
Q 013557          161 LLVYEYMPKGSLE--------N---HLFRRGA-R-------------------PLPWTLRI-----KVA-----------  193 (441)
Q Consensus       161 ~lv~e~~~~g~L~--------~---~l~~~~~-~-------------------~~~~~~~~-----~i~-----------  193 (441)
                      ++||||++|..+.        .   .|+.... .                   .-+|....     ...           
T Consensus       107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~  186 (312)
T 3jr1_A          107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF  186 (312)
T ss_dssp             EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred             EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence            9999999987652        1   1222211 0                   01343221     111           


Q ss_pred             ---HHHHHH-HHHhH--hcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          194 ---IGAARG-LSFLH--EAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       194 ---~~i~~~-L~~lH--~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                         ..++.. ...|.  .....++|+|+.+.|++++.++ +.|+||.
T Consensus       187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence               111111 12332  2235799999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=8.8e-05  Score=73.22  Aligned_cols=78  Identities=18%  Similarity=0.183  Sum_probs=48.8

Q ss_pred             CCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccC--CCCcCchhhhhcCC---CCchhhhHHHhHHH
Q 013557          207 EQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG--TRGYAAPEYLATGR---LTAKCDVYSFGVVL  281 (441)
Q Consensus       207 ~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDvwSlG~il  281 (441)
                      ...++|+|+++.|||++.++ ++|+||+.+.........  . ...+  ...|++|+......   -....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--G-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--H-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--H-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            37899999999999998876 999999988753221100  0 0000  12456666543111   12235566888888


Q ss_pred             HHHHhCC
Q 013557          282 LELLSGR  288 (441)
Q Consensus       282 ~elltg~  288 (441)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8887764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.81  E-value=7.7e-05  Score=69.56  Aligned_cols=78  Identities=17%  Similarity=0.141  Sum_probs=54.8

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-C--CCcccEEEEEEcC
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-H--PNLVKLIGFCLDG  157 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~  157 (441)
                      ..-.+.+|.|..+.||+....+          |+.+++|+...........+..|+..|+.|. .  --+++++++.   
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~D----------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---   83 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELAD----------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---   83 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT----------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---
T ss_pred             eEEEEecCCCCCeEEEEEEECC----------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---
Confidence            3445678999999999976543          6789999876554444456778999988884 2  2345666542   


Q ss_pred             CeeEEEEEeCCCCCH
Q 013557          158 ENRLLVYEYMPKGSL  172 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L  172 (441)
                       ..++||||++++..
T Consensus        84 -~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 -DRTLAMEWVDERPP   97 (288)
T ss_dssp             -TTEEEEECCCCCCC
T ss_pred             -CceEEEEeecccCC
Confidence             34789999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.75  E-value=6.9e-05  Score=70.97  Aligned_cols=157  Identities=13%  Similarity=0.077  Sum_probs=84.9

Q ss_pred             cccHHHHHHHhcCCCCC-----CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC
Q 013557           68 AFTFSELKNATRNFRPD-----SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL  142 (441)
Q Consensus        68 ~~~~~~~~~~~~~y~~~-----~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  142 (441)
                      .++.+++.....+|.+.     +.|+.|....+|+.....          + .+++|+.....  ....+..|+.++..|
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L   72 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHL   72 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHH
Confidence            35566677766778763     335567778899864321          2 57899886521  123455677777766


Q ss_pred             CCCC--cccEEEE------EEcCCeeEEEEEeCCCCCHHH--------------HHHhcC-C--CC----CC---HHHHH
Q 013557          143 HHPN--LVKLIGF------CLDGENRLLVYEYMPKGSLEN--------------HLFRRG-A--RP----LP---WTLRI  190 (441)
Q Consensus       143 ~hpn--Iv~l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~--~~----~~---~~~~~  190 (441)
                      ...+  +.+++..      ....+..+++|+|++|..+..              .++... .  .+    ..   |....
T Consensus        73 ~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~  152 (322)
T 2ppq_A           73 AAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLW  152 (322)
T ss_dssp             HHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHH
T ss_pred             HHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHH
Confidence            3212  2333311      123456789999999865311              011110 0  00    11   11100


Q ss_pred             H------------HHHHHHHHHHHhHhc-----CCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          191 K------------VAIGAARGLSFLHEA-----EQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       191 ~------------i~~~i~~~L~~lH~~-----~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      .            +...+...++.++..     ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          153 DKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            0            001133445555421     2579999999999999887556899998664

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.60  E-value=0.00066  Score=64.51  Aligned_cols=32  Identities=38%  Similarity=0.446  Sum_probs=27.9

Q ss_pred             CCeEEeccCCCcEEECCC----CcEEEcccCCcccC
Q 013557          208 QQVIYRDFKASNILLDSE----FNAKLSDFGLAKAG  239 (441)
Q Consensus       208 ~~ivH~Dlkp~Nill~~~----~~~kl~DFg~a~~~  239 (441)
                      ..++|||+++.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            689999999999999874    67999999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.54  E-value=0.00012  Score=68.81  Aligned_cols=71  Identities=8%  Similarity=0.040  Sum_probs=43.9

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLL  162 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l  162 (441)
                      .+.|+.|....+|+.               ..+++|+....... .....+|+.+++.+...++ .+++.+  +.+.-++
T Consensus        23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~   84 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM   84 (301)
T ss_dssp             CEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred             eeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence            678989999999985               23788887643211 1112458887777742223 566654  3444578


Q ss_pred             EEEeC-CCCCH
Q 013557          163 VYEYM-PKGSL  172 (441)
Q Consensus       163 v~e~~-~~g~L  172 (441)
                      |+||+ +|.+|
T Consensus        85 v~e~i~~g~~l   95 (301)
T 3dxq_A           85 VTRYIAGAQTM   95 (301)
T ss_dssp             EEECCTTCEEC
T ss_pred             EEeecCCCccC
Confidence            99999 66554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.45  E-value=0.00033  Score=67.95  Aligned_cols=148  Identities=15%  Similarity=0.128  Sum_probs=83.4

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  162 (441)
                      .+.|..|-...+|+.......  ......+..+++|+.... ........+|..+++.|. +.-..++++++.+    -+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            346766778889986543210  000112467899986432 234566678999998884 3334677776543    29


Q ss_pred             EEEeCCCCCHHH--------------HH---HhcC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 013557          163 VYEYMPKGSLEN--------------HL---FRRG---ARPLP--WTLRIKVAIGAAR-------------------GLS  201 (441)
Q Consensus       163 v~e~~~~g~L~~--------------~l---~~~~---~~~~~--~~~~~~i~~~i~~-------------------~L~  201 (441)
                      ||||++|.+|..              .|   +...   .....  +.++..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998855431              11   1111   11122  3455555544321                   123


Q ss_pred             HhH----h--cCCCeEEeccCCCcEEECCC----CcEEEcccCCccc
Q 013557          202 FLH----E--AEQQVIYRDFKASNILLDSE----FNAKLSDFGLAKA  238 (441)
Q Consensus       202 ~lH----~--~~~~ivH~Dlkp~Nill~~~----~~~kl~DFg~a~~  238 (441)
                      .|.    .  ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    1  12469999999999999876    6899999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.44  E-value=0.0018  Score=61.22  Aligned_cols=140  Identities=15%  Similarity=0.098  Sum_probs=77.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCC--CcccEEEE-----EEcC
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHP--NLVKLIGF-----CLDG  157 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~-----~~~~  157 (441)
                      ..|+ |....||+....          .|..+++|...... .....+..|..++..|...  .+++++..     ....
T Consensus        32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence            3466 777889975322          24468999986432 2345666788888777421  23444432     1234


Q ss_pred             CeeEEEEEeCCCCCHH-----HH---------HHhc--CC-----CCCCHHHH----HHH---------------HHHHH
Q 013557          158 ENRLLVYEYMPKGSLE-----NH---------LFRR--GA-----RPLPWTLR----IKV---------------AIGAA  197 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~-----~~---------l~~~--~~-----~~~~~~~~----~~i---------------~~~i~  197 (441)
                      +..++||+|++|..+.     .+         ++..  ..     ........    ..+               ...+-
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            5668899999875432     11         1110  00     01121110    000               00111


Q ss_pred             HHHHHhHh-----cCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          198 RGLSFLHE-----AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       198 ~~L~~lH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++.+..     ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            12222221     135689999999999999 4 899999987764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.24  E-value=0.00085  Score=66.29  Aligned_cols=81  Identities=17%  Similarity=0.111  Sum_probs=49.7

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLL  162 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l  162 (441)
                      .+.|+.|....||+........  .....+..+++|+.....  ....+..|..+++.|...++ .++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            3567788889999875432100  001124678899884321  12456689999988853333 677776542    38


Q ss_pred             EEEeCCCCCH
Q 013557          163 VYEYMPKGSL  172 (441)
Q Consensus       163 v~e~~~~g~L  172 (441)
                      ||||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999987443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.24  E-value=0.0011  Score=65.95  Aligned_cols=74  Identities=16%  Similarity=0.033  Sum_probs=44.4

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc-ccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL-VKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv  163 (441)
                      +.|+.|-...+|+.....         .+..+++|+....... .-+-.+|..+|..|...++ .++++++.  +  .+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v  179 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRI  179 (458)
T ss_dssp             EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred             EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence            457777778899865431         1356888887543211 1112478999988864444 67777763  2  359


Q ss_pred             EEeCCCCCH
Q 013557          164 YEYMPKGSL  172 (441)
Q Consensus       164 ~e~~~~g~L  172 (441)
                      |||++|.+|
T Consensus       180 ~e~I~G~~l  188 (458)
T 2qg7_A          180 EEFMDGYAL  188 (458)
T ss_dssp             EECCCSEEC
T ss_pred             EEeeCCccC
Confidence            999987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.22  E-value=0.0024  Score=56.13  Aligned_cols=102  Identities=17%  Similarity=0.044  Sum_probs=66.9

Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCCCccceee
Q 013557          170 GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST  249 (441)
Q Consensus       170 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~  249 (441)
                      -+|.+.|...+ .+++++++|.++.|.+.+|.-+-.. ..-..+=+-|..|++..+|.|-+.+ +.+.            
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            37999887665 4799999999999999998776210 1111233457899999999987764 1111            


Q ss_pred             eccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCC
Q 013557          250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR  289 (441)
Q Consensus       250 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~  289 (441)
                        .....+.+||... ...+.+.-|||||+++|..+--..
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence              0122466888763 345678899999999999887443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.0012  Score=63.79  Aligned_cols=82  Identities=11%  Similarity=0.041  Sum_probs=43.6

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC-cccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN-LVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv  163 (441)
                      +.|+.|..-.+|+........ ......+..+++|+..... ....+...|..+++.|...+ ..++++.+  .  -++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            457778788899865432100 0000112578888875432 11112356888888874223 45777654  2  3789


Q ss_pred             EEeCCCCCH
Q 013557          164 YEYMPKGSL  172 (441)
Q Consensus       164 ~e~~~~g~L  172 (441)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.95  E-value=0.0042  Score=59.19  Aligned_cols=31  Identities=19%  Similarity=0.216  Sum_probs=27.7

Q ss_pred             CCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          208 QQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       208 ~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5799999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.79  E-value=0.025  Score=55.53  Aligned_cols=81  Identities=11%  Similarity=-0.050  Sum_probs=46.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.|..|-...+|+.........  ....+..+++++..... ...-+..+|..+++.|. +.-..++++.+.    -++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            4566677788998655321100  00114678898865432 11112246888888874 333456665432    3789


Q ss_pred             EEeCCCCCH
Q 013557          164 YEYMPKGSL  172 (441)
Q Consensus       164 ~e~~~~g~L  172 (441)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.46  E-value=0.29  Score=42.82  Aligned_cols=116  Identities=6%  Similarity=0.081  Sum_probs=78.7

Q ss_pred             CCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       143 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      .||+++.. .+-.+++.+.+.++.-+.+.=+..+     ..++...+++++..|+....+++.    -+|--|+|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence            58888876 4666677766666654322212212     237788999999999887766553    5888999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      +.++.+++.-.|+-....                   |.     .++...=+-.+=|++..+++++..|+
T Consensus       113 ~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999877543221                   11     11222223356788999999999886

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.83  E-value=0.71  Score=40.47  Aligned_cols=115  Identities=11%  Similarity=0.090  Sum_probs=78.7

Q ss_pred             CCCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HhHhcCCCeEEeccCCCcEE
Q 013557          143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS-FLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       143 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~-~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      .||++  -..+-.+++.+.+.++.-+++.=+..+.     .++...+++++..|+.... +++    .-+|--|+|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEE
Confidence            57777  4445577778777777654443334442     2778889999998887666 554    4688899999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCC
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVD  292 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~  292 (441)
                      +|.++.+++.-.|+-...                   +|..     .+..-=+-.+=|++..++.++.-|+
T Consensus       117 f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999988764322                   2221     1111112356788888999988775

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.42  E-value=0.5  Score=45.79  Aligned_cols=30  Identities=27%  Similarity=0.299  Sum_probs=25.0

Q ss_pred             CeEEeccCCCcEEE------CCCCcEEEcccCCccc
Q 013557          209 QVIYRDFKASNILL------DSEFNAKLSDFGLAKA  238 (441)
Q Consensus       209 ~ivH~Dlkp~Nill------~~~~~~kl~DFg~a~~  238 (441)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4456799999987754

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=80.39  E-value=21  Score=36.15  Aligned_cols=83  Identities=12%  Similarity=0.078  Sum_probs=48.2

Q ss_pred             ccEEEEEEcCCeeEEEEEeCCCCCHHHHHH----------hcCCCC-----CCHHHHHHHHHHHH--HHHHHhHhcCCCe
Q 013557          148 VKLIGFCLDGENRLLVYEYMPKGSLENHLF----------RRGARP-----LPWTLRIKVAIGAA--RGLSFLHEAEQQV  210 (441)
Q Consensus       148 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~-----~~~~~~~~i~~~i~--~~L~~lH~~~~~i  210 (441)
                      +..|.+...... +=+.|++++.++.+.+.          +.....     ..+..+..++..+|  ..+.|+    .||
T Consensus       402 i~~Y~Vipls~~-~GlIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI----LGi  476 (614)
T 3ls8_A          402 LTPYKVLATSTK-HGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI----LGV  476 (614)
T ss_dssp             CCCCCEEESSSS-EEEEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH----HTC
T ss_pred             eeccEEEEecCC-CceEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee----eec
Confidence            334444444333 23467777655555443          221111     12344455555443  344555    234


Q ss_pred             EEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          211 IYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       211 vH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                        +|=+++||||+.+|++.=+|||.+.
T Consensus       477 --gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          477 --GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             --CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             --cCCCCcceeEcCCCCEeeeehHHhh
Confidence              6889999999999999999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	441
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-51
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-50
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 2e-69
 Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 34/290 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVN 137
                  IG G FG VYKG                 +AVK L       Q  + + +EV 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD------------VAVKMLNVTAPTPQQLQAFKNEVG 56

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            L +  H N++  +G+        +V ++    SL +HL             I +A   A
Sbjct: 57  VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTA 114

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +G+ +LH   + +I+RD K++NI L  +   K+ DFGLA        +H   Q+ G+  +
Sbjct: 115 QGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 258 AAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR 314
            APE +        + + DVY+FG+VL EL++G+            N  D     +G   
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGY 226

Query: 315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
               +  +      P+     +  L  +C+  +   RP   ++L+++E L
Sbjct: 227 LSPDLSKV--RSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELL 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-65
 Identities = 83/347 (23%), Positives = 150/347 (43%), Gaps = 44/347 (12%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKE 131
           ELK+   +F   S +G G  G V+K    + +        G+V+A K +  E       +
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKV-SHKPS--------GLVMARKLIHLEIKPAIRNQ 50

Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
            + E+  L + + P +V   G         +  E+M  GSL+  L + G   +P  +  K
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGK 108

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
           V+I   +GL++L E + ++++RD K SNIL++S    KL DFG++          ++   
Sbjct: 109 VSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +GTR Y +PE L     + + D++S G+ L+E+  GR                   P   
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY------------------PIPP 205

Query: 312 -DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMS--EVLSALEQLPPPRD 368
            D ++L  +   ++EG   +                   RP M+  E+L  +   PPP+ 
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265

Query: 369 PASPSNSDPQ-VIYSPHVKSP-MRPNSPHLKSH--LRNNYDSPVNMS 411
           P+   + + Q  +    +K+P  R +   L  H  ++ +    V+ +
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 312

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 8e-64
 Identities = 71/310 (22%), Positives = 129/310 (41%), Gaps = 41/310 (13%)

Query: 69  FTFSELKNATRNF---------RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVK 119
           FTF +   A R F         + + +IG G FG V  G +             + +A+K
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60

Query: 120 KLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFR 178
            LK     +  +++LSE + +GQ  HPN++ L G        +++ E+M  GSL+    R
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLR 119

Query: 179 RGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA 238
           +          + +  G A G+ +L   +   ++RD  A NIL++S    K+SDFGL++ 
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 239 GPTGDRTHVSTQV---MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR 295
                     T          + APE +   + T+  DV+S+G+V+ E++S         
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------ 231

Query: 296 VGAEQNLVDWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM 353
                      +PY     + +   ++       P      +  L L C   +   RP  
Sbjct: 232 -----------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280

Query: 354 SEVLSALEQL 363
            ++++ L+++
Sbjct: 281 GQIVNTLDKM 290

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 4e-63
 Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 34/284 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
             +    +G G FG V+ G+ + HT           +AVK LK +G      +L+E N +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLM 62

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            QL H  LV+L       E   ++ EYM  GSL + L       L     + +A   A G
Sbjct: 63  KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++F+ E  +  I+RD +A+NIL+    + K++DFGLA+     +             + A
Sbjct: 122 MAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTA 178

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFR 318
           PE +  G  T K DV+SFG++L E+++  R                  PY G    ++ +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-----------------PYPGMTNPEVIQ 221

Query: 319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE 361
            ++       P      +  L   C     + RP+   + S LE
Sbjct: 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-63
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 40/288 (13%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           +  +    IG+G FG V  G              G  +AVK +K +     + +L+E + 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASV 53

Query: 139 LGQLHHPNLVKLIGFCLDGENRL-LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
           + QL H NLV+L+G  ++ +  L +V EYM KGSL ++L  RG   L     +K ++   
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
             + +L       ++RD  A N+L+  +  AK+SDFGL K     + +           +
Sbjct: 114 EAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKW 166

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKL 316
            APE L   + + K DV+SFG++L E+ S  R                  PY     + +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLKDV 209

Query: 317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
              ++   +   P      V  +   C   +A +RPS  ++   LE +
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 7e-63
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 34/287 (11%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
           ++      +G G FG V  G                 +A+K +K EG     E++ E   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIK-EGSMSEDEFIEEAKV 52

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           +  L H  LV+L G C       ++ EYM  G L N+L             +++      
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCE 111

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            + +L    +Q ++RD  A N L++ +   K+SDFGL++     D    S        ++
Sbjct: 112 AMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLF 317
            PE L   + ++K D+++FGV++ E+ S  +                  PY      +  
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTNSETA 211

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
             +   L    P   +  V  +   C   +A  RP+   +LS +  +
Sbjct: 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 66/285 (23%), Positives = 125/285 (43%), Gaps = 30/285 (10%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +      +G G +G VY+G + +           + +AVK LK +  +  +E+L E   +
Sbjct: 18  DITMKHKLGGGQYGEVYEG-VWKKY--------SLTVAVKTLKEDTMEV-EEFLKEAAVM 67

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            ++ HPNLV+L+G C       ++ E+M  G+L ++L     + +   + + +A   +  
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           + +L   ++  I+RD  A N L+      K++DFGL++    GD             + A
Sbjct: 128 MEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 184

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI 319
           PE LA  + + K DV++FGV+L E+ +   +                     D  +++ +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYEL 228

Query: 320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           ++     + P+     V  L   C       RPS +E+  A E +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 9e-62
 Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 30/283 (10%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQLHH 144
           +IG G FG VY G + ++       G  +  AVK L      G   ++L+E   +    H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 145 PNLVKLIGFCLDGENR-LLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFL 203
           PN++ L+G CL  E   L+V  YM  G L N +             I   +  A+G+ FL
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFL 146

Query: 204 HEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTRGYAAPE 261
               ++ ++RD  A N +LD +F  K++DFGLA+       D  H  T       + A E
Sbjct: 147 AS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMD 321
            L T + T K DV+SFGV+L EL++            + N  D     L  RR L     
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 255

Query: 322 IKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
                  P+     +  + L+C   +A++RPS SE++S +  +
Sbjct: 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 3e-61
 Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 49/308 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNY 138
           N     ++G G FG V            ++ GV + +AVK LK +     +E  +SE+  
Sbjct: 38  NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGAR--------------- 182
           + QL  H N+V L+G C       L++EY   G L N+L  +  +               
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 183 ------PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
                  L +   +  A   A+G+ FL    +  ++RD  A N+L+      K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRV 296
           +   +     V         + APE L  G  T K DV+S+G++L E+ S          
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV------- 264

Query: 297 GAEQNLVDWAKPYLGD--RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM 353
                      PY G       ++++    +   P      + I+   C + +++ RPS 
Sbjct: 265 ----------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314

Query: 354 SEVLSALE 361
             + S L 
Sbjct: 315 PNLTSFLG 322

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (503), Expect = 8e-61
 Identities = 72/319 (22%), Positives = 122/319 (38%), Gaps = 50/319 (15%)

Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-H 129
              L+    N      IGEG FG V++                 ++AVK LK E      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQ 60

Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------- 180
            ++  E   + +  +PN+VKL+G C  G+   L++EYM  G L   L             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 181 -------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN 227
                          PL    ++ +A   A G+++L E  ++ ++RD    N L+     
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMV 178

Query: 228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG 287
            K++DFGL++   + D             +  PE +   R T + DV+++GVVL E+ S 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 288 RRAVDKTRVGAEQNLVDWAKPYLGDRRK--LFRIMDIKLEGQYPQKGAYMVAILALQCIS 345
                              +PY G   +  ++ + D  +    P+     +  L   C S
Sbjct: 239 GL-----------------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWS 280

Query: 346 -EAKVRPSMSEVLSALEQL 363
                RPS   +   L+++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 9e-61
 Identities = 71/303 (23%), Positives = 115/303 (37%), Gaps = 40/303 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNY 138
                  +G G FG V +           +    M +AVK LKP      +E  +SE+  
Sbjct: 24  RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG----------------A 181
           L  L +H N+V L+G C  G   L++ EY   G L N L R+                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 182 RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT 241
             L     +  +   A+G++FL    +  I+RD  A NILL      K+ DFGLA+    
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 242 GDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN 301
                V         + APE +     T + DV+S+G+ L EL S   +           
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--------- 248

Query: 302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSAL 360
                 P +    K ++++        P+     +  +   C   +   RP+  +++  +
Sbjct: 249 ------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

Query: 361 EQL 363
           E+ 
Sbjct: 303 EKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-60
 Identities = 75/316 (23%), Positives = 142/316 (44%), Gaps = 35/316 (11%)

Query: 81  FRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNY 138
           F+   ++G G FG VYKG WI E         V + +A+K+L+     + +KE L E   
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEK------VKIPVAIKELREATSPKANKEILDEAYV 64

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           +  + +P++ +L+G CL      L+ + MP G L +++       +     +   +  A+
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+++L +  +++++RD  A N+L+ +  + K++DFGLAK     ++ + +        + 
Sbjct: 123 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLF 317
           A E +     T + DV+S+GV + EL++                    KPY G    ++ 
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPASEIS 223

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPPPRDPASPSNSD 376
            I++       P      V ++ ++C   +A  RP   E++    ++   RDP       
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--ARDP--QRYLV 279

Query: 377 PQVIYSPHVKSPMRPN 392
            Q     H+ SP   N
Sbjct: 280 IQGDERMHLPSPTDSN 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-60
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 34/286 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKG-WIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNY 138
                  IG G FG V+ G W++              +A+K ++ EG    ++++ E   
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-----------KDKVAIKTIR-EGAMSEEDFIEEAEV 53

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           + +L HP LV+L G CL+     LV+E+M  G L ++L  +          + + +    
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCE 112

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+++L   E  VI+RD  A N L+      K+SDFG+ +     D+   ST       +A
Sbjct: 113 GMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWA 169

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
           +PE  +  R ++K DV+SFGV++ E+ S  +   + R                   ++  
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVE 213

Query: 319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
            +        P+  +  V  +   C     + RP+ S +L  L ++
Sbjct: 214 DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-59
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 47/322 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNY 138
           + +   +IGEG FG V K  I +        G+ M  A+K++K       H+++  E+  
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEV 63

Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR--------------GARP 183
           L +L HHPN++ L+G C       L  EY P G+L + L +                A  
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           L     +  A   ARG+ +L +  +Q I+RD  A NIL+   + AK++DFGL++      
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
           +    T       + A E L     T   DV+S+GV+L E++S                 
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------- 225

Query: 304 DWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE 361
               PY G    +L+  +      + P      V  L  QC   +   RPS +++L +L 
Sbjct: 226 ----PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

Query: 362 QLPPPRDPASPSNSDPQVIYSP 383
           ++   R     +    +  Y+ 
Sbjct: 282 RMLEERKTYVNTTLYEKFTYAG 303

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-59
 Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 39/288 (13%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEV 136
           R  + D  IG G F  VYKG +D  T         + +A  +L+         + +  E 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKEEA 59

Query: 137 NYLGQLHHPNLVKLIGFCLD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
             L  L HPN+V+            +  +LV E M  G+L+ +L R     +   +    
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSW 117

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAKAGPTGDRTHVSTQV 251
                +GL FLH     +I+RD K  NI +     + K+ D GLA       R   +  V
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +GT  + APE     +     DVY+FG+ +LE+ +      + +  A+            
Sbjct: 174 IGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 221

Query: 312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
                 R+        + +     V  +   CI      R S+ ++L+
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-59
 Identities = 66/287 (22%), Positives = 125/287 (43%), Gaps = 27/287 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNY 138
                 +IG G FG VYKG +   + +   P     +A+K LK    +  + ++L E   
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           +GQ  H N+++L G     +  +++ EYM  G+  +   R           + +  G A 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTRGY 257
           G+ +L       ++RD  A NIL++S    K+SDFGL++      + T+ ++       +
Sbjct: 122 GMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
            APE ++  + T+  DV+SFG+V+ E+++                            ++ 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVM 223

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           + ++       P      +  L +QC   E   RP  ++++S L++L
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 7e-59
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 38/286 (13%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVNYLGQ 141
           D  +G G FG V KG+            V   +AVK LK E        E L+E N + Q
Sbjct: 12  DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 142 LHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLS 201
           L +P +V++IG C + E+ +LV E    G L  +L +     +     I++    + G+ 
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 121

Query: 202 FLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTRGYAAP 260
           +L E     ++RD  A N+LL ++  AK+SDFGL+KA     +     T       + AP
Sbjct: 122 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 261 EYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM 320
           E +   + ++K DV+SFGV++ E  S  +                 KPY G +     + 
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGS--EVT 220

Query: 321 DIKLEGQYPQKGAYM---VAILALQCIS-EAKVRPSMSEVLSALEQ 362
            +  +G+     A     +  L   C + + + RP  + V   L  
Sbjct: 221 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-58
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 34/292 (11%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSE 135
           ++ R    +G+G FG V +G  D  +      G  + +AVK LKP+     +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
           VN +  L H NL++L G  L    + +V E  P GSL + L +            + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQ 119

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV-STQVMGT 254
            A G+ +L    ++ I+RD  A N+LL +    K+ DFGL +A P  D  +V        
Sbjct: 120 VAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 255 RGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR 314
             + APE L T   +   D + FGV L E+ +  +                 +P++G   
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----------------EPWIGLNG 220

Query: 315 K--LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
              L +I         P+     +  + +QC + + + RP+   +   L + 
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 38/298 (12%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           + R +  +G+G FG V+ G  +              +A+K LKP G    + +L E   +
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKP-GTMSPEAFLQEAQVM 66

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            +L H  LV+L       E   +V EYM KGSL + L     + L     + +A   A G
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA 259
           ++++       ++RD +A+NIL+      K++DFGLA+     +             + A
Sbjct: 126 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 182

Query: 260 PEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFR 318
           PE    GR T K DV+SFG++L EL +  R                  PY G   R++  
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNREVLD 225

Query: 319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ----LPPPRDPAS 371
            ++       P +    +  L  QC   E + RP+   + + LE       P   P  
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 8e-58
 Identities = 75/304 (24%), Positives = 115/304 (37%), Gaps = 48/304 (15%)

Query: 64  PNLKAFTFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKP 123
           P++    F +  +  + F     IG G FG VY    D             V+A+KK+  
Sbjct: 2   PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKMSY 50

Query: 124 EGFQGHKEW---LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG 180
            G Q +++W   + EV +L +L HPN ++  G  L      LV EY    + +     + 
Sbjct: 51  SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 110

Query: 181 ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGP 240
             PL       V  GA +GL++LH     +I+RD KA NILL      KL DFG A    
Sbjct: 111 --PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--- 163

Query: 241 TGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG 297
                  +   +GT  + APE +     G+   K DV+S G+  +EL   +         
Sbjct: 164 ---IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP-------- 212

Query: 298 AEQNLVDWAKPYLGD--RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS 354
                     P         L+ I   +         +         C+    + RP+  
Sbjct: 213 ----------PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262

Query: 355 EVLS 358
            +L 
Sbjct: 263 VLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 9e-58
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 25/226 (11%)

Query: 75  KNATRNFRPD------SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG 128
           ++ TR+  P+        +G+G FG VYK   ++ T         ++ A K +  +  + 
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKA-QNKET--------SVLAAAKVIDTKSEEE 52

Query: 129 HKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTL 188
            ++++ E++ L    HPN+VKL+       N  ++ E+   G+++  +     RPL  + 
Sbjct: 53  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQ 111

Query: 189 RIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS 248
              V       L++LH  + ++I+RD KA NIL   + + KL+DFG++       +    
Sbjct: 112 IQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-- 167

Query: 249 TQVMGTRGYAAPEYLAT-----GRLTAKCDVYSFGVVLLELLSGRR 289
              +GT  + APE +            K DV+S G+ L+E+     
Sbjct: 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 32/284 (11%)

Query: 84  DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNYLGQL 142
           D  +G G FG V +G               + +A+K LK    +   +E + E   + QL
Sbjct: 14  DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66

Query: 143 HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
            +P +V+LIG C   E  +LV E    G L   L  +    +P +   ++    + G+ +
Sbjct: 67  DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKY 124

Query: 203 LHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTRGYAAPE 261
           L E  +  ++RD  A N+LL +   AK+SDFGL+KA G         +       + APE
Sbjct: 125 LEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 262 YLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG-DRRKLFRIM 320
            +   + +++ DV+S+GV + E LS  +                  PY      ++   +
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYKKMKGPEVMAFI 225

Query: 321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
           +     + P +    +  L   C   + + RP    V   +   
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-57
 Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 40/301 (13%)

Query: 87  IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN 146
           IG+G FG V++G              G  +AVK       +      +E+     L H N
Sbjct: 11  IGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHEN 58

Query: 147 LVKLIGFCLDGENRL----LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSF 202
           ++  I              LV +Y   GSL ++L R     +     IK+A+  A GL+ 
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 115

Query: 203 LHE------AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGT 254
           LH        +  + +RD K+ NIL+       ++D GLA    +   T        +GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 255 RGYAAPEYLAT------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVG----AEQNLVD 304
           + Y APE L             + D+Y+ G+V  E+                  +    D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 305 WAKPYLGDRRKLFRIMDIKLEGQYPQKGA-YMVAILALQCIS-EAKVRPSMSEVLSALEQ 362
            +   +  +    + +   +  ++    A  ++A +  +C       R +   +   L Q
Sbjct: 236 PSVEEM-RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

Query: 363 L 363
           L
Sbjct: 295 L 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 3e-57
 Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 42/290 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVN 137
           ++     IG G +G   K    +          G ++  K+L          +  +SEVN
Sbjct: 5   DYEVLYTIGTGSYGRCQKI-RRKSD--------GKILVWKELDYGSMTEAEKQMLVSEVN 55

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLL--VYEYMPKGSLENHLFRRGAR--PLPWTLRIKVA 193
            L +L HPN+V+     +D  N  L  V EY   G L + + +       L     ++V 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 194 IGAARGLSFLHE---AEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
                 L   H        V++RD K +N+ LD + N KL DFGLA+       T  +  
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
            +GT  Y +PE +       K D++S G +L EL +                     P+ 
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP------------------PFT 215

Query: 311 GDRRK--LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVL 357
              +K    +I + K   + P + +  +  +  + ++ +   RPS+ E+L
Sbjct: 216 AFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-57
 Identities = 67/283 (23%), Positives = 109/283 (38%), Gaps = 39/283 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEV 136
           +F     +G+G FG VY    ++ +          ++A+K L            +   EV
Sbjct: 7   DFEIGRPLGKGKFGNVYLA-REKQS--------KFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
                L HPN+++L G+  D     L+ EY P G++   L +                  
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITEL 115

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
           A  LS+ H   ++VI+RD K  N+LL S    K++DFG +   P+  RT     + GT  
Sbjct: 116 ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLD 169

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL 316
           Y  PE +       K D++S GV+  E L G+                   P+  +  + 
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQE 211

Query: 317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
                 ++E  +P         L  + +      RP + EVL 
Sbjct: 212 TYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 1e-56
 Identities = 64/283 (22%), Positives = 107/283 (37%), Gaps = 33/283 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNY 138
           ++     +GEG +G V    ++  T           +AVK +  +      +    E+  
Sbjct: 6   DWDLVQTLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICI 56

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
              L+H N+VK  G   +G  + L  EY   G L + +       +P     +       
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA 114

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 115 GVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 259 APEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
           APE L          DV+S G+VL  +L+G    D+                  D  + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----------------DSCQEY 216

Query: 318 RIMDIKLEGQYPQKGAYMVAI-LALQCIS-EAKVRPSMSEVLS 358
                K     P K      + L  + +      R ++ ++  
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 2e-54
 Identities = 68/293 (23%), Positives = 125/293 (42%), Gaps = 38/293 (12%)

Query: 70  TFSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH 129
           +   + +  + +     IG+G  G VY   +D  T        G  +A++++  +     
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKK 61

Query: 130 KEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR 189
           +  ++E+  + +  +PN+V  +   L G+   +V EY+  GSL + +       +     
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQI 118

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
             V     + L FLH    QVI+RD K+ NILL  + + KL+DFG              +
Sbjct: 119 AAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S 174

Query: 250 QVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY 309
            ++GT  + APE +       K D++S G++ +E++ G                    PY
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------------------PY 216

Query: 310 LGDR--RKLFRI-MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
           L +   R L+ I  +   E Q P+K + +      +C+  + + R S  E+L 
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-54
 Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 34/304 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK-EWLSEVNY 138
                  +G+G FG VY+G          +      +A+K +        + E+L+E + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------ARPLPWTLRI 190
           + + +  ++V+L+G    G+  L++ E M +G L+++L              P   +  I
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
           ++A   A G+++L+    + ++RD  A N ++  +F  K+ DFG+ +     D      +
Sbjct: 137 QMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
            +    + +PE L  G  T   DV+SFGVVL E+ +                       L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGL 239

Query: 311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL--PPPR 367
            + + L  +M+  L    P     M+  L   C     K+RPS  E++S++++   P  R
Sbjct: 240 SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

Query: 368 DPAS 371
           + + 
Sbjct: 299 EVSF 302

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 68/316 (21%), Positives = 111/316 (35%), Gaps = 51/316 (16%)

Query: 75  KNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKE 131
           K    +F+   ++GEG F  V     +  T            A+K L+            
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLA-RELAT--------SREYAIKILEKRHIIKENKVPY 54

Query: 132 WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
              E + + +L HP  VKL     D E       Y   G L  ++ + G      T    
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRF 112

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                   L +LH   + +I+RD K  NILL+ + + +++DFG AK      +   +   
Sbjct: 113 YTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG 311
           +GT  Y +PE L         D+++ G ++ +L++G                    P+  
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP------------------PFRA 212

Query: 312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA----------- 359
               L     IKLE  +P+K       L  + +  +A  R    E+              
Sbjct: 213 GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272

Query: 360 -----LEQLPPPRDPA 370
                L Q  PP+  A
Sbjct: 273 VTWENLHQQTPPKLTA 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-53
 Identities = 70/302 (23%), Positives = 122/302 (40%), Gaps = 39/302 (12%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLSEVNY 138
                  +GEG FG V         L+  +P     +AVK LK +  +    + +SE+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 139 LGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRG--------------ARP 183
           +  +  H N++ L+G C       ++ EY  KG+L  +L  R                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 184 LPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGD 243
           L     +  A   ARG+ +L    ++ I+RD  A N+L+  +   K++DFGLA+     D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
               +T       + APE L     T + DV+SFGV+L E+ +   +             
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236

Query: 304 DWAKPYLG-DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE 361
               PY G    +LF+++        P      + ++   C       RP+  +++  L+
Sbjct: 237 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 362 QL 363
           ++
Sbjct: 293 RI 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 6e-53
 Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 29/286 (10%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-WLSEVNY 138
                  IGEG FG V++G               + +A+K  K       +E +L E   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 139 LGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
           + Q  HP++VKLIG   +     ++ E    G L + L  R    L     I  A   + 
Sbjct: 62  MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLST 119

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYA 258
            L++L    ++ ++RD  A N+L+ S    KL DFGL++        + +++      + 
Sbjct: 120 ALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWM 176

Query: 259 APEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR 318
           APE +   R T+  DV+ FGV + E+L       +     +       +   G+R  +  
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGRIENGERLPMPP 232

Query: 319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL 363
                L              L  +C + +   RP  +E+ + L  +
Sbjct: 233 NCPPTLYS------------LMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 5e-51
 Identities = 74/304 (24%), Positives = 114/304 (37%), Gaps = 43/304 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-HKEWLSEVNY 138
             +    +G G FG V +           +      +AVK LK       H+  +SE+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 139 LGQ-LHHPNLVKLIGFCL-DGENRLLVYEYMPKGSLENHLFRRG--------------AR 182
           L    HH N+V L+G C   G   +++ E+   G+L  +L  +                 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 183 PLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG 242
            L     I  +   A+G+ FL    ++ I+RD  A NILL  +   K+ DFGLA+     
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 243 DRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL 302
                         + APE +     T + DV+SFGV+L E+ S                
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL--------------- 232

Query: 303 VDWAKPYLGDR--RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA 359
              A PY G +   +  R +      + P      +    L C   E   RP+ SE++  
Sbjct: 233 --GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

Query: 360 LEQL 363
           L  L
Sbjct: 291 LGNL 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  173 bits (439), Expect = 7e-51
 Identities = 64/345 (18%), Positives = 109/345 (31%), Gaps = 53/345 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           ++     +G G FG V++   +  T        G   A K +        +    E+  +
Sbjct: 27  HYDIHEELGTGAFGVVHRV-TERAT--------GNNFAAKFVMTPHESDKETVRKEIQTM 77

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
             L HP LV L     D    +++YE+M  G L   +       +     ++      +G
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKG 136

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           L  +H  E   ++ D K  NI+  ++ +   KL DFGL                 GT  +
Sbjct: 137 LCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEF 191

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK-- 315
           AAPE      +    D++S GV+   LLSG                    P+ G+     
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS------------------PFGGENDDET 233

Query: 316 LFRIMDIKLEGQYPQKGAYMVAILAL--QCIS-EAKVRPSMSEVL-----------SALE 361
           L  +                        + +  +   R ++ + L               
Sbjct: 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 362 QLPPPRDPASPSNSDPQVIYSPHVKSPMR--PNSPHLKSHLRNNY 404
           Q+P  R      +   +    P    P+    N   L+ H    Y
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEY 338

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (438), Expect = 1e-50
 Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 52/344 (15%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
            +     +G G FG V++  +++ T        G V   K +            +E++ +
Sbjct: 30  YYDILEELGSGAFGVVHRC-VEKAT--------GRVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
            QLHHP L+ L     D    +L+ E++  G L + +       +     I     A  G
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEG 139

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           L  +H  E  +++ D K  NI+ +++  +  K+ DFGLA      +          T  +
Sbjct: 140 LKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
           AAPE +    +    D+++ GV+   LLSG                    P+ G+     
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLET 236

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCIS-----EAKVRPSMSEVLS-----ALEQLPPPR 367
                + + ++ +     V+  A   I      E + R ++ + L              R
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 368 DPASPSNSDPQVIYSPHVKSPMR-------PNSPHLKSHLRNNY 404
            P+S  N   Q I   +   P          N   L+ H    Y
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEY 340

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 55/300 (18%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---------QGHK 130
           N+ P  ++G G    V +  I + T            AVK +   G          +  +
Sbjct: 4   NYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 131 EWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR 189
             L EV+ L ++  HPN+++L           LV++ M KG L ++L  +    L     
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKET 112

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVST 249
            K+       +  LH  +  +++RD K  NILLD + N KL+DFG +     G++     
Sbjct: 113 RKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167

Query: 250 QVMGTRGYAAPEYLATGRL------TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
           +V GT  Y APE +             + D++S GV++  LL+G                
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP-------------- 213

Query: 304 DWAKPYLGDRRK--LFRIMDIKLEGQYPQKGAYMVAILAL--QCIS-EAKVRPSMSEVLS 358
               P+   ++   L  IM    +   P+   Y   +  L  + +  + + R +  E L+
Sbjct: 214 ----PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  159 bits (403), Expect = 2e-46
 Identities = 64/297 (21%), Positives = 123/297 (41%), Gaps = 45/297 (15%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVN 137
           +    ++G GG   V+    D              +AVK L+ +  +    +  +  E  
Sbjct: 9   YELGEILGFGGMSEVHLA-RDLRL--------HRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 138 YLGQLHHPNLVKLIGFCLD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
               L+HP +V +          G    +V EY+   +L + +   G  P+     I+V 
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVI 117

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVM 252
             A + L+F H+    +I+RD K +NI++ +    K+ DFG+A+    +G+    +  V+
Sbjct: 118 ADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 253 GTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD 312
           GT  Y +PE      + A+ DVYS G VL E+L+G                    P+ GD
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------------------PFTGD 217

Query: 313 --RRKLFRIM--DIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-SMSEVLSALEQL 363
                 ++ +  D        +  +  +  + L+ ++   + R  + +E+ + L ++
Sbjct: 218 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 57/345 (16%), Positives = 115/345 (33%), Gaps = 43/345 (12%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
            +     +G G FG V++  ++  +              K +K +G         E++ L
Sbjct: 6   KYMIAEDLGRGEFGIVHRC-VETSS--------KKTYMAKFVKVKGTD-QVLVKKEISIL 55

Query: 140 GQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARG 199
               H N++ L       E  ++++E++    +   +       L     +         
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEA 114

Query: 200 LSFLHEAEQQVIYRDFKASNILLDSEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           L FLH     + + D +  NI+  +  ++  K+ +FG A+    GD   +   +     Y
Sbjct: 115 LQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
            APE      ++   D++S G ++  LLSG                    P+L +  +  
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQQI 211

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCIS-----EAKVRPSMSEVLSA--LEQLPPPRDPA 370
               +  E  + ++    ++I A+  +      E K R + SE L    L+Q        
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

Query: 371 SPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDSPVNMSPRSP 415
                  +  Y   +K  +       +        S   +S    
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKV 316

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 76/337 (22%), Positives = 118/337 (35%), Gaps = 56/337 (16%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    ++G+G FG V+     + T            A+K LK +      +    + E 
Sbjct: 3   DFILHKMLGKGSFGKVFLA-EFKKT--------NQFFAIKALKKDVVLMDDDVECTMVEK 53

Query: 137 NYLG-QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
             L     HP L  +       EN   V EY+  G L  H+          +     A  
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAE 111

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
              GL FLH   + ++YRD K  NILLD + + K++DFG+ K    GD         GT 
Sbjct: 112 IILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK 315
            Y APE L   +     D +SFGV+L E+L G+                   P+ G   +
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEE 209

Query: 316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSM-SEVLS------------ALE 361
                       YP+        L ++    E + R  +  ++                +
Sbjct: 210 ELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERK 269

Query: 362 QLPPP-----RDPASPSNSDPQVIYSPHVKSPMRPNS 393
           ++ PP     + P   SN D + +      S      
Sbjct: 270 EIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRAL 306

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 7e-46
 Identities = 64/345 (18%), Positives = 127/345 (36%), Gaps = 54/345 (15%)

Query: 71  FSELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHK 130
           + + ++    +    ++G G F  V     D+ T          ++A+K +  +  +G +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILA-EDKRT--------QKLVAIKCIAKKALEGKE 51

Query: 131 E-WLSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLR 189
               +E+  L ++ HPN+V L      G +  L+ + +  G L + +  +G         
Sbjct: 52  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDA 109

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILL---DSEFNAKLSDFGLAKAGPTGDRTH 246
            ++       + +LH  +  +++RD K  N+L    D +    +SDFGL+K     D   
Sbjct: 110 SRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGS 164

Query: 247 VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA 306
           V +   GT GY APE LA    +   D +S GV+   LL G                   
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP----------------- 207

Query: 307 KPYLGDRRK--LFRIMDIKLEGQYPQKGAYMVAILAL--QCIS-EAKVRPSMSEVLSALE 361
            P+  +       +I+  + E   P       +        +  + + R +  + L    
Sbjct: 208 -PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL---- 262

Query: 362 QLPPPRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSHLRNNYDS 406
                + P    ++         V   ++ N    KS  +  +++
Sbjct: 263 -----QHPWIAGDTALDKNIHQSVSEQIKKNFA--KSKWKQAFNA 300

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (403), Expect = 2e-45
 Identities = 61/216 (28%), Positives = 86/216 (39%), Gaps = 24/216 (11%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEV 136
           +F    +IG GGFG VY       T        G + A+K L  +     QG    L+E 
Sbjct: 5   DFSVHRIIGRGGFGEVYGC-RKADT--------GKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 137 N---YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVA 193
                +     P +V +       +    + + M  G L  HL + G             
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 253
           I    GL  +H   + V+YRD K +NILLD   + ++SD GLA               +G
Sbjct: 116 I--ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167

Query: 254 TRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGR 288
           T GY APE L  G    +  D +S G +L +LL G 
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE---WLSE 135
           ++F+    +G G FG V+      H         G   A+K LK E     K+      E
Sbjct: 4   QDFQILRTLGTGSFGRVHLI-RSRHN--------GRYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 136 VNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIG 195
              L  + HP ++++ G   D +   ++ +Y+  G L + L +    P P        + 
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV- 113

Query: 196 AARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
               L +LH   + +IYRD K  NILLD   + K++DFG AK  P    T       GT 
Sbjct: 114 -CLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165

Query: 256 GYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
            Y APE ++T       D +SFG+++ E+L+G  
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 74/313 (23%), Positives = 121/313 (38%), Gaps = 31/313 (9%)

Query: 76  NATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGH-KEWLS 134
           +    +   S IGEG +G V   + D            + +A+KK+ P   Q + +  L 
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAY-DNVN--------KVRVAIKKISPFEHQTYCQRTLR 55

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRR-GARPLPWTLRIKVA 193
           E+  L +  H N++ +           +   Y+    +   L++    + L         
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 115

Query: 194 IGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK-AGPTGDRTHVSTQVM 252
               RGL ++H     V++RD K SN+LL++  + K+ DFGLA+ A P  D T   T+ +
Sbjct: 116 YQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 253 GTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA--KPY 309
            TR Y APE +   +  T   D++S G +L E+LS R          + N +      P 
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAK------------VRPSMSEVL 357
             D   +  +         P K       L     S+A              R  + + L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

Query: 358 SA--LEQLPPPRD 368
           +   LEQ   P D
Sbjct: 294 AHPYLEQYYDPSD 306

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-43
 Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 49/293 (16%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW------LS 134
           +     +G G F  V K   ++ T        G+  A K +K    +  +          
Sbjct: 12  YDTGEELGSGQFAVVKKC-REKST--------GLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 135 EVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
           EV+ L ++ HPN++ L     +  + +L+ E +  G L + L  +    L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLK 120

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSE----FNAKLSDFGLAKAGPTGDRTHVSTQ 250
               G+ +LH    Q+ + D K  NI+L          K+ DFGLA     G+       
Sbjct: 121 QILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
           + GT  + APE +    L  + D++S GV+   LLSG                    P+L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS------------------PFL 217

Query: 311 GDRRK--LFRIM--DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
           GD ++  L  +   + + E +Y    + +      + +  + K R ++ + L 
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 8e-43
 Identities = 64/301 (21%), Positives = 106/301 (35%), Gaps = 32/301 (10%)

Query: 77  ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---- 132
           A + +   + IGEG +G V+K    ++         G  +A+K+++ +  +         
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56

Query: 133 -LSEVNYLGQLHHPNLVKLIGFCLDGENRLLVYEYMP----KGSLENHLFRRGARPLPWT 187
            ++ + +L    HPN+V+L   C            +        L  +L +     +P  
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 188 LRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHV 247
               +     RGL FLH    +V++RD K  NIL+ S    KL+DFGLA+          
Sbjct: 117 TIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMA 171

Query: 248 STQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT----------RVG 297
            T V+ T  Y APE L         D++S G +  E+   +     +           V 
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231

Query: 298 AEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVL 357
                 DW +     R+         +E            +L          R S    L
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

Query: 358 S 358
           S
Sbjct: 292 S 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-42
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 34/305 (11%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE-----WLSEVNYLG 140
            +GEG F  VYK   D++T          ++A+KK+K       K+      L E+  L 
Sbjct: 5   FLGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           +L HPN++ L+       N  LV+++M        + +  +  L  +      +   +GL
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGL 113

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAP 260
            +LH  +  +++RD K +N+LLD     KL+DFGLAK+  + +R +  T  + TR Y AP
Sbjct: 114 EYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169

Query: 261 EYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKT----------RVGAEQNLVDWAKPY 309
           E L   R+     D+++ G +L ELL     +                       W    
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 310 -LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSA--LEQLPPP 366
            L D         I L   +   G  ++ ++    +     R + ++ L        P P
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289

Query: 367 RDPAS 371
                
Sbjct: 290 TPGCQ 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-41
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 15/212 (7%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVN 137
           NF+    IGEG +G VYK   ++ T        G V+A+KK++ +          + E++
Sbjct: 3   NFQKVEKIGEGTYGVVYKA-RNKLT--------GEVVALKKIRLDTETEGVPSTAIREIS 53

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            L +L+HPN+VKL+          LV+E++ +  L+  +       +P  L         
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +GL+F H    +V++RD K  N+L+++E   KL+DFGLA+A     RT+ + +V+     
Sbjct: 113 QGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           A    L     +   D++S G +  E+++ R 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-41
 Identities = 58/301 (19%), Positives = 111/301 (36%), Gaps = 41/301 (13%)

Query: 86  LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HH 144
           ++G G  G V +   ++ T            A+K L+        +   EV    +    
Sbjct: 19  VLGLGINGKVLQI-FNKRT--------QEKFALKMLQD-----CPKARREVELHWRASQC 64

Query: 145 PNLVKLIGFCLD----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
           P++V+++    +     +  L+V E +  G L + +  RG +        ++       +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            +LH     + +RD K  N+L  S+      KL+DFG AK   + +          T  Y
Sbjct: 125 QYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYY 179

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
            APE L   +    CD++S GV++  LL G          A    +          +   
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------KTRI 229

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA---LEQLPPPRDPASPS 373
           R+   +       + +  V +L    +  E   R +++E ++    ++    P+ P   S
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 374 N 374
            
Sbjct: 290 R 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (363), Expect = 2e-40
 Identities = 58/301 (19%), Positives = 96/301 (31%), Gaps = 36/301 (11%)

Query: 73  ELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW 132
           EL+   R +R    IG G FG +Y G  D           G  +A+K    +    H + 
Sbjct: 2   ELRVGNR-YRLGRKIGSGSFGDIYLG-TDIAA--------GEEVAIKLECVK--TKHPQL 49

Query: 133 LSEVNYLGQLHHPNLVKLIGFCL-DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIK 191
             E      +     +  I +C  +G+  ++V E +     +   F    R       + 
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLL 107

Query: 192 VAIGAARGLSFLHEAEQQVIYRDFKASNIL---LDSEFNAKLSDFGLAKA-----GPTGD 243
           +A      + ++H   +  I+RD K  N L           + DFGLAK           
Sbjct: 108 LADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

Query: 244 RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV 303
               +  + GT  YA+         + + D+ S G VL+    G       +   ++   
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

Query: 304 DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ 362
           +          K        L   YP +     A     C S     +P  S +      
Sbjct: 226 ER------ISEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275

Query: 363 L 363
           L
Sbjct: 276 L 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 9e-40
 Identities = 58/293 (19%), Positives = 116/293 (39%), Gaps = 29/293 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVN 137
            +     IGEG +G VYK          A+   G   A+KK++ E          + E++
Sbjct: 3   KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            L +L H N+VKL       +  +LV+E++ +   +      G   L         +   
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLL 110

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
            G+++ H  +++V++RD K  N+L++ E   K++DFGLA+A     R +   +++     
Sbjct: 111 NGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYR 167

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKT----------RVGAEQNLVDWAK 307
           A    + + + +   D++S G +  E+++G                 R+    N  +W  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 308 PY-LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS 358
              L      F + +      + +        L  + +  +   R +  + L 
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (357), Expect = 1e-39
 Identities = 45/299 (15%), Positives = 87/299 (29%), Gaps = 43/299 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +++    IGEG FG +++G  +              +A+K           +   E    
Sbjct: 6   HYKVGRRIGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRR--SDAPQLRDEYRTY 54

Query: 140 GQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAAR 198
             L     +  +  F  +G + +LV + +  G     L     R          A     
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112

Query: 199 GLSFLHEAEQQVIYRDFKASNILLDSEFN-----AKLSDFGLAK-----AGPTGDRTHVS 248
            +  +HE  + ++YRD K  N L+    +       + DFG+ K                
Sbjct: 113 RVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 249 TQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP 308
             + GT  Y +         + + D+ + G V +  L G                     
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL-------------PWQGLK 217

Query: 309 YLGDRRKLFRIMDIKLEGQYPQKGAYM---VAILALQCIS-EAKVRPSMSEVLSALEQL 363
              +++K  RI + K      +  A              +      P    +     ++
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 53/303 (17%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKE------WLS 134
           ++   L+G GGFG VY G I             + +A+K ++ +      E         
Sbjct: 6   YQVGPLLGSGGFGSVYSG-IRVSD--------NLPVAIKHVEKDRISDWGELPNGTRVPM 56

Query: 135 EVNYLGQLH--HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKV 192
           EV  L ++      +++L+ +    ++ +L+ E                  L   L    
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSF 115

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLD-SEFNAKLSDFGLAKAGPTGDRTHVSTQV 251
                  +   H     V++RD K  NIL+D +    KL DFG         +  V T  
Sbjct: 116 FWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169

Query: 252 MGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYL 310
            GTR Y+ PE++   R       V+S G++L +++ G                    P+ 
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFE 211

Query: 311 GDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA--LEQLPPPR 367
            D      I+  ++   + Q+ +     L   C++     RP+  E+ +   ++ +  P+
Sbjct: 212 HDE----EIIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265

Query: 368 DPA 370
           + A
Sbjct: 266 ETA 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 4e-39
 Identities = 62/213 (29%), Positives = 86/213 (40%), Gaps = 18/213 (8%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
           +F    L+G+G FG V     ++ T        G   A+K L+ E      E    ++E 
Sbjct: 6   DFDYLKLLGKGTFGKVILV-REKAT--------GRYYAMKILRKEVIIAKDEVAHTVTES 56

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
             L    HP L  L       +    V EY   G L  HL R   R              
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEI 114

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
              L +LH   + V+YRD K  N++LD + + K++DFGL K G +   T       GT  
Sbjct: 115 VSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPE 170

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
           Y APE L         D +  GVV+ E++ GR 
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-38
 Identities = 72/348 (20%), Positives = 126/348 (36%), Gaps = 49/348 (14%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           ++    +IG G FG VY+      +        G ++A+KK+  +     +    E+  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQA-KLCDS--------GELVAIKKVLQD----KRFKNRELQIM 67

Query: 140 GQLHHPNLVKLIGFCLDGENR------LLVYEYMPKGSLENHL-FRRGARPLPWTLRIKV 192
            +L H N+V+L  F      +       LV +Y+P+        + R  + LP       
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 193 AIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAKAGPTGDRTHVSTQV 251
                R L+++H     + +RD K  N+LLD +    KL DFG AK    G+     + +
Sbjct: 128 MYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYI 183

Query: 252 MGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR-----AVDKTRVGAEQNLVDWA 306
                 A          T+  DV+S G VL ELL G+      +     V   + L    
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAI------LALQCIS-EAKVRPSMSEVLS- 358
           +  + +    +          +P    +          L  + +      R +  E  + 
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 359 --------ALEQLPPPRDPASPSNSDPQVIYS-PHVKSPMRPNSPHLK 397
                      +LP  RD  +  N   Q + S P + + + P  PH +
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIP--PHAR 349

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 6e-38
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 43/320 (13%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG--HKEWLSEVN 137
            +   + IG+G FG V+K      T        G  +A+KK+  E  +       L E+ 
Sbjct: 11  KYEKLAKIGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITALREIK 61

Query: 138 YLGQLHHPNLVKLIGFCLDGENR--------LLVYEYMPKGSLENHLFRRGARPLPWTLR 189
            L  L H N+V LI  C    +          LV+++                 L    R
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 190 IKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVS- 248
           +        GL ++H    ++++RD KA+N+L+  +   KL+DFGLA+A      +  + 
Sbjct: 122 V--MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 249 -TQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV--- 303
            T  + T  Y  PE L   R      D++  G ++ E+ +    +       +  L+   
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 304 -------DWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-----EAKVRP 351
                   W      +  +   ++  +      +  AY+    AL  I      +   R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 352 SMSEVLSA--LEQLPPPRDP 369
              + L+       P P D 
Sbjct: 298 DSDDALNHDFFWSDPMPSDL 317

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-36
 Identities = 65/350 (18%), Positives = 120/350 (34%), Gaps = 47/350 (13%)

Query: 69  FTFSELKNAT----RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE 124
           F   E+          +R    +G G +G V    +D  T        G  +A+KKL   
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRP 54

Query: 125 GF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENR------LLVYEYMPKGSLENHL 176
                  K    E+  L  + H N++ L+      E         LV  +M  G+    L
Sbjct: 55  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL 112

Query: 177 FRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA 236
            +     L       +     +GL ++H     +I+RD K  N+ ++ +   K+ DFGLA
Sbjct: 113 MKHE--KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLA 168

Query: 237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR------- 289
           +       + ++  V+     A    L   R T   D++S G ++ E+++G+        
Sbjct: 169 RQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224

Query: 290 --AVDKTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-- 345
              + +          ++ +    D  K +     +LE +         + LA+  +   
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284

Query: 346 ---EAKVRPSMSEVLSA--LEQLPPPRDPASPSNSDPQVIYSPHVKSPMR 390
              +A+ R +  E L+    E L    D       D             +
Sbjct: 285 LVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWK 334

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-36
 Identities = 58/304 (19%), Positives = 106/304 (34%), Gaps = 31/304 (10%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVN 137
            +     IGEG +G V+K   +  T          ++A+K+++ +          L E+ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALREIC 53

Query: 138 YLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAA 197
            L +L H N+V+L       +   LV+E+  +   +      G                 
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLL 111

Query: 198 RGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGY 257
           +GL F H   + V++RD K  N+L++     KL++FGLA+A     R + S +V+     
Sbjct: 112 KGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYR 168

Query: 258 AAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF 317
                      +   D++S G +  EL +  R +       +Q    +         +  
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 318 RIMDIKLEGQYPQKGAYMVAILALQCISEA-------------KVRPSMSEVLSA--LEQ 362
            +  +     YP   A    +  +  ++                 R S  E L       
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

Query: 363 LPPP 366
             PP
Sbjct: 289 FCPP 292

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 21/213 (9%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEW---LSEV 136
            F     +G G FG V      + +        G   A+K L  +     K+    L+E 
Sbjct: 42  QFDRIKTLGTGSFGRVMLV-KHKES--------GNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 137 NYLGQLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
             L  ++ P LVKL     D  N  +V EY+  G + +HL R G            A   
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQI 150

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRG 256
                +LH     +IYRD K  N+L+D +   +++DFG AK       T     + GT  
Sbjct: 151 VLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPE 203

Query: 257 YAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR 289
             APE + +       D ++ GV++ E+ +G  
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  124 bits (313), Expect = 6e-33
 Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 27/215 (12%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYL 139
           +++    +G G +  V++  I+              + VK LKP      K+   E+  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEA-INITN--------NEKVVVKILKPVK---KKKIKREIKIL 83

Query: 140 GQL-HHPNLVKLIGFCLDGENRL--LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGA 196
             L   PN++ L     D  +R   LV+E++     +        + L            
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEI 138

Query: 197 ARGLSFLHEAEQQVIYRDFKASNILLDSEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTR 255
            + L + H     +++RD K  N+++D E    +L D+GLA+    G         + +R
Sbjct: 139 LKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193

Query: 256 GYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRR 289
            +  PE L   ++     D++S G +L  ++  + 
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 18/217 (8%)

Query: 80  NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSE 135
           NF    ++G G +G V+         + +    G + A+K LK        +  +   +E
Sbjct: 25  NFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78

Query: 136 VNYLGQL-HHPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAI 194
              L  +   P LV L           L+ +Y+  G L  HL +R               
Sbjct: 79  RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVG 136

Query: 195 GAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 254
                L  LH+    +IYRD K  NILLDS  +  L+DFGL+K     D T  +    GT
Sbjct: 137 EIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGT 193

Query: 255 RGYAAPEYLATGR--LTAKCDVYSFGVVLLELLSGRR 289
             Y AP+ +  G        D +S GV++ ELL+G  
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-29
 Identities = 48/218 (22%), Positives = 83/218 (38%), Gaps = 27/218 (12%)

Query: 79  RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEV 136
           + ++    IG G  G V   + D              +A+KKL          K    E+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAY-DAVL--------DRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 137 NYLGQLHHPNLVKLIGFCL------DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
             +  ++H N++ L+          + ++  LV E M     +                 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +      G+  LH     +I+RD K SNI++ S+   K+ DFGLA+   T       T 
Sbjct: 123 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR 288
            + TR Y APE +         D++S G ++ E++  +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 4e-28
 Identities = 62/323 (19%), Positives = 114/323 (35%), Gaps = 41/323 (12%)

Query: 78  TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSE 135
              ++  S +G G +G V     D  T        G+ +AVKKL          K    E
Sbjct: 17  PERYQNLSPVGSGAYGSVCAA-FDTKT--------GLRVAVKKLSRPFQSIIHAKRTYRE 67

Query: 136 VNYLGQLHHPNLVKLIGFCLDGE-----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRI 190
           +  L  + H N++ L+            N + +  ++  G+  N++ +     L      
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQ 124

Query: 191 KVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQ 250
            +     RGL ++H     +I+RD K SN+ ++ +   K+ DFGLA+         ++  
Sbjct: 125 FLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGY 178

Query: 251 VMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR--------------AVDKTRV 296
           V      A    L         D++S G ++ ELL+GR                      
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 297 GAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEV 356
           GAE      ++      + L ++  +     +       V +L    + ++  R + ++ 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

Query: 357 LSA--LEQLPPPRDPASPSNSDP 377
           L+     Q   P D       D 
Sbjct: 299 LAHAYFAQYHDPDDEPVADPYDQ 321

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 55/356 (15%), Positives = 116/356 (32%), Gaps = 37/356 (10%)

Query: 81  FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLG 140
           +     +G G F  V+    D              +A+K ++ +     +    E+  L 
Sbjct: 15  YILVRKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGD-KVYTEAAEDEIKLLQ 64

Query: 141 QLHHPNLVKLIGFCLDGENRLLVYEYMPKGSLEN--------------HLFRRGARPLPW 186
           +++  +  K      +   +LL +      +  +               + +   R +P 
Sbjct: 65  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124

Query: 187 TLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FNAKLSDFGLAKAGPTGDRT 245
               +++     GL ++H     +I+ D K  N+L++       L    +A  G      
Sbjct: 125 IYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183

Query: 246 HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW 305
              T  + TR Y +PE L         D++S   ++ EL++G    +      E +    
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE----PDEGHSYTK 239

Query: 306 AKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCISEAKVRPSMSEVLSALEQLPP 365
              ++    +L   +   L         +  +   L+ IS+ K  P + +VL+   +   
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP-LEDVLTEKYKFSK 298

Query: 366 PRDPASPSNSDPQVIYSPHVKSPMRPNSPHLKSH--LRNNYDSPVNMSPRSPLPPH 419
                      P +   P      R ++  L +H  L++         P   L   
Sbjct: 299 DEAKEISDFLSPMLQLDPR----KRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 2e-16
 Identities = 23/157 (14%), Positives = 49/157 (31%), Gaps = 16/157 (10%)

Query: 85  SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH 144
            L+GEG    V+  + ++      +       + KK+K +   G   +        +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 145 PNLVKLIGFC----LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGL 200
             L KL G         E   ++ E +    L                  +V       +
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVLDMILEEV 116

Query: 201 SFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK 237
           +  +   + +++ D    N+L+  E    + DF  + 
Sbjct: 117 AKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	441
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.8
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.05
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.85

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-56  Score=413.62  Aligned_cols=254  Identities=25%  Similarity=0.323  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++.... ...+.+.+|+++|++++||||+++++++.+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            467999999999999999997654         3578999999865433 234568899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..||||||++||+|.+++..+  ..+++..++.++.||+.||+|||+  +||+||||||+|||++.++.+||+|||+|
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhh
Confidence            99999999999999999998543  359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      +..............+||+.|||||++.+..+ +.++|||||||++|||+||+.||........ ....+.         
T Consensus       151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~---------  220 (271)
T d1nvra_         151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK---------  220 (271)
T ss_dssp             EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH---------
T ss_pred             eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHh---------
Confidence            87544443334456789999999999998876 5789999999999999999999975432111 111110         


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                           ...............+..|+..|+. ||++|||++|++++
T Consensus       221 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         221 -----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 0000111111223344567778887 99999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=410.56  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=205.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||+||+|...         .+|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBT---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEEC---------CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            47999999999999999997543         457899999997665566778999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..||||||++||+|.+++.++   .+++.++..++.||+.||+|||+  +||+||||||+|||++.+|++||+|||+++.
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~  165 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence            999999999999999988654   49999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ......  .....+||+.|+|||++.++.|+.++|||||||++|+|+||+.||........  +.              .
T Consensus       166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~--------------~  227 (293)
T d1yhwa1         166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY--------------L  227 (293)
T ss_dssp             CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH--------------H
T ss_pred             eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HH--------------H
Confidence            543322  23456899999999999999999999999999999999999999975432111  00              0


Q ss_pred             hhcc-cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          319 IMDI-KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       319 ~~~~-~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +... ......+......+..|+..|+. ||++|||+.|++++
T Consensus       228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1000 01112233344556778888888 99999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-55  Score=409.21  Aligned_cols=260  Identities=27%  Similarity=0.433  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC--cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG--FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|.+.            ..||||+++...  ....+.|.+|+.+|++++|||||++++++.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~   74 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST   74 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence            468999999999999999998653            248999987543  234567899999999999999999999875


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      + ...++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+
T Consensus        75 ~-~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          75 A-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             S-SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             c-cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccc
Confidence            4 56899999999999999996544 359999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      |+...............||+.|||||++.+   +.|+.++|||||||++|||+||+.||............. .....  
T Consensus       151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~-~~~~~--  227 (276)
T d1uwha_         151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-GRGYL--  227 (276)
T ss_dssp             SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HHTSC--
T ss_pred             eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH-hcCCC--
Confidence            987544333334456789999999999974   358999999999999999999999997543211110000 00000  


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                              .+.. ...+......+..|+..|+. ||++|||++||++.|+.+..
T Consensus       228 --------~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         228 --------SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             --------CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                    0000 11122334566778888998 99999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-55  Score=411.32  Aligned_cols=259  Identities=24%  Similarity=0.392  Sum_probs=215.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||+||+|.+..         +++.||||+++... ...+++.+|+++|++++|||||+++++|.++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            4578899999999999999987653         47789999997653 4567899999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++|+|.+++.......+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEcccccee
Confidence            999999999999999999988777789999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... .......||+.|+|||++.++.|+.++|||||||++|||++|..||.....                ...+.
T Consensus       164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------------~~~~~  226 (287)
T d1opja_         164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVY  226 (287)
T ss_dssp             TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------HHHHH
T ss_pred             ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----------------HHHHH
Confidence            7544322 223345689999999999999999999999999999999997776542211                01122


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      +.+........+......+..|+..|+. ||++|||++||++.|+.+..
T Consensus       227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2222233334455555667888899998 99999999999999987644

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=403.83  Aligned_cols=246  Identities=27%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||+|++....   ....+.+.+|+++|++++||||+++++++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEEC---------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            47999999999999999997654         357899999986432   233567889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccce
Confidence            9999999999999999999997655  49999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......    .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.........               
T Consensus       153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---------------  213 (263)
T d2j4za1         153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---------------  213 (263)
T ss_dssp             CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------
T ss_pred             eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH---------------
Confidence            98654322    34568999999999999999999999999999999999999999754321110               


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ..+..  .....|......+..|+..|+. ||++|||++|++++
T Consensus       214 -~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         214 -KRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -HHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -HHHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence             01111  1112333444556778888888 99999999999863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-54  Score=411.13  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.++||+|+||+||+|.+....      .....||||.+..... ...+.|.+|+++|++++|||||+++++|.+.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            45677889999999999999875321      1234689999876533 3446799999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++|+|.+++.... ..+++.+++.++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccce
Confidence            99999999999999999886543 359999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccc---eeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccc
Q 013557          238 AGPTGDRTH---VSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       238 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      .........   ......||+.|||||++.++.++.++|||||||++|||+| |+.||.......               
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---------------  241 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---------------  241 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------------
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---------------
Confidence            654322211   1123457999999999999999999999999999999998 899997543211               


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                        +...+........+......+..|+..||. ||++||++.||++.|+++
T Consensus       242 --~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         242 --VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              111111122222344455667788999998 999999999999999865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=402.58  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||+||+|.+..          +..||||+++... ...+++.+|+++|++++||||++++++|.+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   73 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence            578899999999999999987643          4579999997653 44678999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  150 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF  150 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred             ceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchhee
Confidence            9999999999999999886543 458999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhC-CCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG-RRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......||+.|+|||++.+..|+.++|||||||++|||+|+ ++||......                 .+.
T Consensus       151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----------------~~~  212 (263)
T d1sm2a_         151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVV  212 (263)
T ss_dssp             ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----------------HHH
T ss_pred             ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----------------HHH
Confidence            5433222 22345789999999999999999999999999999999995 5555432211                 111


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ..+........|......+..|+..|++ ||++||+++||++.|+++
T Consensus       213 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         213 EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1111122223344445567788899998 999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=414.47  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=210.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||+||+|++...    ........||+|++.... ......+.+|+.+|.++ +|||||+++++|.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            5789999999999999999987542    222335579999986543 23345688999999998 89999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEecc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGA---------------------RPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDF  215 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dl  215 (441)
                      .+..|+||||+++|+|.++|..+..                     ..+++..++.++.||+.||+|||+  ++|+||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDl  190 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDL  190 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccC
Confidence            9999999999999999999965432                     348999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCcc
Q 013557          216 KASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKT  294 (441)
Q Consensus       216 kp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~  294 (441)
                      ||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986544444334445678999999999999999999999999999999998 89999754


Q ss_pred             ccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhh
Q 013557          295 RVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALE  361 (441)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~  361 (441)
                      ...                ..+..++........|......+..|+..|+. ||++|||++||+++|.
T Consensus       271 ~~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            321                11222222222333445555667888899998 9999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=403.39  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=190.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||+||+|...         .+|+.||||.+.....  ...+.+.+|+++|++++|||||++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            57999999999999999997654         3578999999876543  234568899999999999999999999865


Q ss_pred             --CCeeEEEEEeCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhHhcC---CCeEEeccCCCcEEECCCCcEE
Q 013557          157 --GENRLLVYEYMPKGSLENHLFRR--GARPLPWTLRIKVAIGAARGLSFLHEAE---QQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       157 --~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~---~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                        .+..|+||||++||+|.+++.+.  ....+++..++.++.||+.||+|||+..   .+|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              45689999999999999998643  3456999999999999999999999821   2499999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      |+|||+++......  .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.......   +..     
T Consensus       155 l~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~-----  224 (269)
T d2java1         155 LGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG-----  224 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH-----
T ss_pred             EeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHH-----
Confidence            99999998754322  22345789999999999999999999999999999999999999997543211   100     


Q ss_pred             cccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              .+.. ......+......+..|+..|+. ||++|||++||+++
T Consensus       225 --------~i~~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         225 --------KIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --------HHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------HHHc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                    1111 11112233334456778888888 99999999999763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=402.17  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||+||+|.++.          +..||||+++... ...+.+.+|+++|++++|||||++++++.+ 
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            4678999999999999999997642          5679999997653 446779999999999999999999998754 


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+++|+|.+++.......+++..++.++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+|+
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceE
Confidence            567999999999999998865555569999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... .......||+.|+|||++.++.++.++|||||||++|||+||..|+......                ..+.
T Consensus       158 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------------~~~~  220 (272)
T d1qpca_         158 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVI  220 (272)
T ss_dssp             ECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHH
T ss_pred             EccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence            7543322 2233457899999999999999999999999999999999976554322111                0111


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ..+........|......+..|+..|+. ||++|||+++|++.|+.
T Consensus       221 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            1111122222344445567788899998 99999999999998874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=404.87  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=203.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +.|++.+.||+|+||+||+|...         .++..||||+++.......+.+.+|+++|++++|||||++++++.+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK---------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC---------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            46899999999999999997654         357889999998766666778899999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..||||||++||+|.+++.+.. .++++.++..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhc
Confidence            9999999999999999886544 359999999999999999999999  8999999999999999999999999999975


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhh-----cCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccc
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLA-----TGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ....  ........||+.|+|||++.     +..|+.++|||||||++|||+||+.||........              
T Consensus       160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--------------  223 (288)
T d2jfla1         160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--------------  223 (288)
T ss_dssp             CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--------------
T ss_pred             cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--------------
Confidence            3211  11223567999999999984     45689999999999999999999999975432111              


Q ss_pred             hhhhhhhccc-ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRIMDIK-LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~~~~~-~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        +..+.... .....+......+..|+..|++ ||++|||++|++++
T Consensus       224 --~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         224 --LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             --HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --HHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              11111110 0111233334556778888888 99999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=392.42  Aligned_cols=253  Identities=24%  Similarity=0.373  Sum_probs=210.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||+||+|.++.          ++.||||+++... ...+++.+|+.++++++||||++++++|.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT----------TEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC----------CCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            689999999999999999998643          5689999998654 34678999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~  149 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  149 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred             ceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhee
Confidence            9999999999999999876543 358999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLF  317 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~  317 (441)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||........                 .
T Consensus       150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-----------------~  211 (258)
T d1k2pa_         150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------------A  211 (258)
T ss_dssp             CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----------------H
T ss_pred             ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-----------------H
Confidence            5443222 2334678999999999999999999999999999999998 8999975432211                 1


Q ss_pred             hhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          318 RIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ..+........|......+..|+..||. ||++|||+++|++.|.++
T Consensus       212 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1111122223344555677888999998 999999999999998653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=406.91  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||+++...   ....+.+.+|+++|++++||||++++++|.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   78 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLAREL---------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ   78 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence            57999999999999999997654         357889999986432   234567899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..|+||||++||+|.+++...+  .+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~  154 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT  154 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEeccccc
Confidence            9999999999999999999987665  49999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+..............+||+.|+|||++.+..|+.++|||||||++|||+||+.||........                
T Consensus       155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----------------  218 (288)
T d1uu3a_         155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI----------------  218 (288)
T ss_dssp             CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH----------------
Confidence            9876544333334567899999999999999999999999999999999999999975432110                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLS  358 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~  358 (441)
                      +..+...  ...+|......+..|+..|+. ||++|||++|+++
T Consensus       219 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         219 FQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            0111111  112333344556778888888 9999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=411.72  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=176.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||+|+++.... .....+.+|+.+|++++|||||+++++|.+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEET---------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             ccCCEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            578999999999999999997654         3578999999875532 234568999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..|+||||++||+|.+++.+.+  .+++..+..++.|++.||.|||+. ++|+||||||+|||++.+|.+||+|||+|
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence            999999999999999999997765  499999999999999999999961 48999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +.....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         153 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             cccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            854221    2345689999999999999999999999999999999999999997543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-53  Score=395.64  Aligned_cols=249  Identities=29%  Similarity=0.412  Sum_probs=197.3

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc--cHHHHHHHHHHHhcCCCCCcccEEEEEEcCCeeEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ--GHKEWLSEVNYLGQLHHPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  162 (441)
                      +.||+|+||+||+|.+..       ...++.||||+++.....  ..+.+.+|+++|++++|||||+++++|.+ +..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            579999999999997643       234678999999754322  24579999999999999999999999865 46789


Q ss_pred             EEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCCC
Q 013557          163 VYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTG  242 (441)
Q Consensus       163 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~~  242 (441)
                      ||||+++|+|.+++....  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            999999999999987654  59999999999999999999999  89999999999999999999999999999865433


Q ss_pred             Ccc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhhhhhh
Q 013557          243 DRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRIM  320 (441)
Q Consensus       243 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  320 (441)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......                 +...+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----------------~~~~i  223 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAML  223 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHH
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----------------HHHHH
Confidence            222 22234578999999999999999999999999999999998 899997543211                 11111


Q ss_pred             cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          321 DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                      ........|......+..|+..||. ||++||++++|++.|+.
T Consensus       224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1122223344445667788899998 99999999999888763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=397.43  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=203.6

Q ss_pred             cCCCCCCe-eeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSL-IGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~-lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|.+.+. ||+|+||+||+|.+...       ..+..||||+++.... ...+.|.+|+++|++++|||||++++++.+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            45666664 99999999999976431       2356799999976533 335679999999999999999999999875


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                       +..||||||+++|+|.+++.... ..+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhh
Confidence             46899999999999999885433 459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccch
Q 013557          237 KAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       237 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.......                
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----------------  220 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------  220 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----------------
Confidence            875443221 22234568999999999999999999999999999999998 899997543211                


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                       +...+........|......+..|+..||. +|++||++.+|++.|+.
T Consensus       221 -~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         221 -VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             111111112223344455667788999998 99999999999988864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=396.58  Aligned_cols=262  Identities=25%  Similarity=0.418  Sum_probs=201.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      +.|++.++||+|+||+||+|.++...     ......||||+++..... ...+|.+|+++|++++|||||++++++.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCC-----CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            46788899999999999999876421     122457999999765333 345689999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..++||||+.+++|.+++.... ..+++.+++.++.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999999999876543 459999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCc-cceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDR-THVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ....... ........||+.|+|||++.++.++.++|||||||++|||++|..|+......                ..+
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~  222 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEV  222 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HHH
Confidence            6543222 12223456899999999999999999999999999999999976655322110                111


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ...+........+......+..|+..||. ||++||+|.||++.|+++.
T Consensus       223 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            12222222333444455667888999998 9999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=394.21  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=192.7

Q ss_pred             CCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc--
Q 013557           81 FRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD--  156 (441)
Q Consensus        81 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  156 (441)
                      |++.+.||+|+||+||+|.+.         .++..||+|++.....  ...+.+.+|+++|++++|||||+++++|.+  
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~---------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            366778999999999997654         3477899999865432  334568899999999999999999999875  


Q ss_pred             --CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC--eEEeccCCCcEEEC-CCCcEEEc
Q 013557          157 --GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQ--VIYRDFKASNILLD-SEFNAKLS  231 (441)
Q Consensus       157 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--ivH~Dlkp~Nill~-~~~~~kl~  231 (441)
                        ....|+||||+++|+|.+++.+..  .+++..++.++.||+.||+|||+  ++  |+||||||+|||++ .++.+||+
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCCEEEe
Confidence              456799999999999999997654  48999999999999999999998  66  99999999999996 47899999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |||+++.....    .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.......  .+....     
T Consensus       158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i-----  225 (270)
T d1t4ha_         158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV-----  225 (270)
T ss_dssp             CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH-----
T ss_pred             ecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHH-----
Confidence            99999864332    2346789999999999875 69999999999999999999999996432111  111100     


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                              .........+......+..|+..|+. ||++|||++|++++
T Consensus       226 --------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         226 --------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                    00000001112222346678888888 99999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-53  Score=406.01  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=187.9

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ..+.|++.+.||+|+||+||+|...         .+++.||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   77 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDK---------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE   77 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEET---------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4567999999999999999997544         35789999998765432 2345789999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC---CCCcEEEcc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD---SEFNAKLSD  232 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~---~~~~~kl~D  232 (441)
                      +++..||||||++||+|.+++...+  .+++..+..++.||+.||+|||+  ++|+||||||+|||+.   .++.+||+|
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEec
Confidence            9999999999999999999996644  59999999999999999999999  8999999999999994   578999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ||+++......   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.........            
T Consensus       154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------------  218 (307)
T d1a06a_         154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF------------  218 (307)
T ss_dssp             C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------------
T ss_pred             cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH------------
Confidence            99998643322   234567999999999999999999999999999999999999999754321110            


Q ss_pred             chhhhhhhccc--ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIK--LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~--~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                          ..+....  .....+......+..|+..|+. ||++|||++|++++
T Consensus       219 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         219 ----EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ----HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                0111101  1111122233456677888888 99999999999885

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-52  Score=406.38  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      -++|++.+.||+|+||+||+|...         .+|+.||||++........+.+.+|+.+|++|+|||||+++++|.++
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~---------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   95 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTER---------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD   95 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred             ccCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            468999999999999999997654         35789999999877666667789999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC--CCcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS--EFNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~--~~~~kl~DFg~  235 (441)
                      +..||||||++||+|.+++.... ..+++..+..++.||+.||+|||+  +||+||||||+|||++.  ++.+||+|||+
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             CEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecch
Confidence            99999999999999999985443 359999999999999999999999  89999999999999964  57899999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......   ......||+.|||||++.+..|+.++|||||||++|+|+||+.||.........               
T Consensus       173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---------------  234 (350)
T d1koaa2         173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---------------  234 (350)
T ss_dssp             CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------
T ss_pred             heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH---------------
Confidence            98754332   334678999999999999999999999999999999999999999754321111               


Q ss_pred             hhhhhccc--ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIK--LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~--~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ..+....  ............+..|+..|+. ||++|||++|++++
T Consensus       235 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         235 -RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0111000  0001111223445677788887 99999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-52  Score=405.22  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++.........+.+|+.+|++|+|||||+++++|.++
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   98 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK   98 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            357999999999999999997543         45789999999876655566788999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC--CCCcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD--SEFNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~--~~~~~kl~DFg~  235 (441)
                      +..||||||++||+|.+++.... ..+++.+++.++.||+.||.|||+  +||+||||||+|||++  .++.+||+|||+
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             CEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeeccc
Confidence            99999999999999999875443 359999999999999999999999  8999999999999998  568999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+......   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.........               
T Consensus       176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---------------  237 (352)
T d1koba_         176 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---------------  237 (352)
T ss_dssp             CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---------------
T ss_pred             ceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---------------
Confidence            98754432   345568999999999999999999999999999999999999999754321110               


Q ss_pred             hhhhhcc--cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDI--KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~--~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                       ..+...  .............+..|+..|+. ||++|||++|++++
T Consensus       238 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         238 -QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             111110  11111122233455677888888 99999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=392.40  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      ++|++.+.||+|+||+||+|.++.          +..||||+++... ...+.|.+|+.+|++++|||||+++++|.+ +
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~   84 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E   84 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence            579999999999999999997653          3469999997654 456789999999999999999999999854 5


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..++||||+++|+|.+++.......+++.+++.++.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhh
Confidence            68999999999999999876555569999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFR  318 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~  318 (441)
                      ...... .......||+.|+|||++.++.++.++|||||||++|||+||..||......                ..+..
T Consensus       163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------------~~~~~  225 (285)
T d1fmka3         163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLD  225 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHH
T ss_pred             ccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------------HHHHH
Confidence            543322 2233467899999999999999999999999999999999976665432211                11111


Q ss_pred             hhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          319 IMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                      .+........+......+..|+..|+. ||++||++++|++.|+..-.
T Consensus       226 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            111122223344445567788899998 99999999999999986544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-52  Score=397.75  Aligned_cols=246  Identities=28%  Similarity=0.394  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      +.|++++.||+|+||+||+|...         .+++.||||+++.....   ..+.+.+|+++|++|+|||||++++++.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   85 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEEC---------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence            35899999999999999997654         35788999998765432   2356889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +++..|+||||+.+|+|..++..+.  ++++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          86 REHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             ECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeeccc
Confidence            9999999999999999977665443  59999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhc---CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcccccc
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLAT---GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGD  312 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  312 (441)
                      ++....      .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.......              
T Consensus       162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------------  221 (309)
T d1u5ra_         162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------  221 (309)
T ss_dssp             CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------------
T ss_pred             ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------------
Confidence            986432      234579999999999964   458999999999999999999999996432111              


Q ss_pred             chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                        .+..+.........+......+..|+..|+. ||++|||++|++++
T Consensus       222 --~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         222 --ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --HHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence              0111111111111122234556778888888 99999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-52  Score=396.68  Aligned_cols=265  Identities=25%  Similarity=0.356  Sum_probs=211.4

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      -.++|++.+.||+|+||+||+|++..    ..+..++..||||+++..... ..+++.+|+++|++++||||++++++|.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPG----LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEET----SSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECC----CccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            35689999999999999999998653    223345778999999765433 3456999999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEe
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG----------------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYR  213 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~  213 (441)
                      +....++||||+++|+|.+++....                      ...+++..++.++.|++.||+|||+  ++||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEee
Confidence            9999999999999999999996432                      2348899999999999999999999  899999


Q ss_pred             ccCCCcEEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCC-CCCC
Q 013557          214 DFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR-RAVD  292 (441)
Q Consensus       214 Dlkp~Nill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~-~pf~  292 (441)
                      ||||+|||+|.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998644433333344567899999999999999999999999999999999996 5676


Q ss_pred             ccccccchhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          293 KTRVGAEQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ........                 ..+........+......+..|+..||+ +|++||||.||++.|+++-
T Consensus       245 ~~~~~e~~-----------------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVI-----------------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHH-----------------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43321111                 1111111122333444567788999998 9999999999999998763

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=397.58  Aligned_cols=259  Identities=24%  Similarity=0.425  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.++||+|+||+||+|.+....     ......||+|+++... ....+.+.+|+++|++++|||||+++++|.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCC-----CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            46999999999999999999875421     1224479999986543 34467799999999999999999999999875


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                       ..+++||++.+|+|.+++.... ..+++..++.++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             -CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccce
Confidence             5678899999999999886653 469999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ...............||+.|+|||++.++.|+.++|||||||++|||+| |..||+......                 +
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----------------~  222 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I  222 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----------------H
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----------------H
Confidence            7654444333445578999999999999999999999999999999999 788887543221                 1


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ...+........|......+..|+..|+. ||++|||+.||++.|+++
T Consensus       223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            12222222223344455667788889998 999999999999998765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=398.20  Aligned_cols=248  Identities=27%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||.||+|...         .+++.||||++++..   ....+.+.+|+.+|++++||||++++++|.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   75 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence            57999999999999999997543         458899999987532   234567889999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||++||+|.+++.+..  .+++..++.++.||+.||+|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        76 ~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          76 THDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeeccc
Confidence            9999999999999999999997765  48999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.........               
T Consensus       152 a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------  214 (337)
T d1o6la_         152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---------------  214 (337)
T ss_dssp             CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------
T ss_pred             ccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH---------------
Confidence            986543222  234578999999999999999999999999999999999999999754422111               


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                       ..+...  ...+|......+..|+..|+. ||++|++     ++|++++
T Consensus       215 -~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         215 -ELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -HHHhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence             011110  112333344456677788888 9999995     8888764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=392.16  Aligned_cols=251  Identities=23%  Similarity=0.324  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc------ccHHHHHHHHHHHhcCCCCCcccE
Q 013557           77 ATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF------QGHKEWLSEVNYLGQLHHPNLVKL  150 (441)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l  150 (441)
                      ..++|++.+.||+|+||+||+|...         .+|+.||||+++....      ...+.+.+|+.+|++|+|||||++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~   78 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL   78 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            3468999999999999999997653         3578999999864322      235678999999999999999999


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC----
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF----  226 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~----  226 (441)
                      +++|.+.+..||||||++||+|.+++..+.  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.++    
T Consensus        79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          79 HEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSC
T ss_pred             EEEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCccc
Confidence            999999999999999999999999997765  49999999999999999999999  8999999999999998876    


Q ss_pred             cEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          227 NAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       227 ~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .  
T Consensus       155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~--  226 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A--  226 (293)
T ss_dssp             CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H--
T ss_pred             ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---H--
Confidence            49999999998754332   234567999999999999999999999999999999999999999754321110   0  


Q ss_pred             ccccccchhhhhhhcccc--cCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKL--EGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                 .+.....  ....+......+..|+..|+. ||++|||++|++++
T Consensus       227 -----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         227 -----------NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -----------HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0000000  000011223445678888888 99999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=386.70  Aligned_cols=249  Identities=30%  Similarity=0.458  Sum_probs=197.4

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc-C
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD-G  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~  157 (441)
                      ++|++.+.||+|+||.||+|.++           |..||||+++..  ...+.+.+|+++|++++||||++++++|.+ .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            46888999999999999998764           567999999765  345678999999999999999999999865 4


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +.+++||||+++|+|.++|..+....+++..++.++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccce
Confidence            568999999999999999976655568999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      .....     .....+|..|+|||++.++.++.++|||||||++|||+| |+.||.......   +..            
T Consensus       152 ~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~------------  211 (262)
T d1byga_         152 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP------------  211 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH------------
T ss_pred             ecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHH------------
Confidence            64322     234568999999999999999999999999999999998 687776432211   111            


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                        .+........+......+..|+..|+. ||++|||+.+|+++|+++.
T Consensus       212 --~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         212 --RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             --HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence              111122223344444567788899998 9999999999999998653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=394.32  Aligned_cols=264  Identities=26%  Similarity=0.357  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|.+..    ..+..+++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEES----TTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcC----CCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            4689999999999999999998754    23344578999999975433 3345678888888887 6899999999876


Q ss_pred             cC-CeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcE
Q 013557          156 DG-ENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNI  220 (441)
Q Consensus       156 ~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Ni  220 (441)
                      +. ...++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+  ++|+||||||+||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~NI  165 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNI  165 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCccce
Confidence            54 46899999999999999996542              2348899999999999999999999  8999999999999


Q ss_pred             EECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCC-CCCCccccccc
Q 013557          221 LLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR-RAVDKTRVGAE  299 (441)
Q Consensus       221 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~-~pf~~~~~~~~  299 (441)
                      ||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||....... 
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-  244 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  244 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            99999999999999998654443333344567999999999999999999999999999999999974 5776433211 


Q ss_pred             hhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          300 QNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       300 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                                     .+...+........+......+..|+..|+. ||++|||++||+++|+.+
T Consensus       245 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         245 ---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                           1111112122223344444566778888888 999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=386.58  Aligned_cols=257  Identities=25%  Similarity=0.342  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc-cHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ-GHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||.||+|.+...      ...+..||||.++..... ..+.+.+|+.+|++++||||+++++++. +
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   79 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecC------CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            5799999999999999999976532      223567999998754333 3456899999999999999999999985 4


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                      +..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhhe
Confidence            67899999999999999876544 468999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccchhh
Q 013557          238 AGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDRRKL  316 (441)
Q Consensus       238 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~l  316 (441)
                      ....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||.........                
T Consensus       157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~----------------  219 (273)
T d1mp8a_         157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------------  219 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------
T ss_pred             eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH----------------
Confidence            6543222 12334568999999999999999999999999999999998 89998754322111                


Q ss_pred             hhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          317 FRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                       ..+........+......+..|+..|+. ||++|||+.||++.|+.+
T Consensus       220 -~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         220 -GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1111111112334444567788889998 999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-51  Score=392.00  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||+|...         .+|+.||||+++...   ....+.+.+|+.+|++++||||+++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEEC---------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            57999999999999999997654         357899999986432   234567899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +.+..|+||||++||+|..++....  .+++..+..++.||+.||+|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCcc
Confidence            9999999999999999999887655  48899999999999999999998  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      |+.....     ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||........                
T Consensus       151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------  209 (316)
T d1fota_         151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----------------  209 (316)
T ss_dssp             CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------
T ss_pred             ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH----------------
Confidence            9875332     2356899999999999999999999999999999999999999975432111                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                      ...++...  ...|......+..++..|+. ||.+|+     ++++++++
T Consensus       210 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         210 YEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            11111111  12233334456677777777 999995     89999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.6e-51  Score=382.77  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc---HHHHHHHHHHHhcCCCCCcccEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG---HKEWLSEVNYLGQLHHPNLVKLIGFC  154 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~  154 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++.....+   ...+.+|+++|+.++||||+++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDL---------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            467999999999999999997643         357899999997654332   34688999999999999999999998


Q ss_pred             EcCC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          155 LDGE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       155 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      .+.+    ..||||||++|++|.+++...+  .+++.+++.++.||+.||+|||+  +||+||||||+|||++.++.++|
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l  152 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV  152 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCcccccee
Confidence            7654    3799999999999999987665  49999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCC-ccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccc
Q 013557          231 SDFGLAKAGPTGD-RTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPY  309 (441)
Q Consensus       231 ~DFg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  309 (441)
                      +|||.+....... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||........  +...... 
T Consensus       153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~~~~~-  229 (277)
T d1o6ya_         153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRE-  229 (277)
T ss_dssp             CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHC-
T ss_pred             ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHHHHhc-
Confidence            9999987543222 22233456899999999999999999999999999999999999999975432111  0000000 


Q ss_pred             cccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-CHHHHHHHhhcC
Q 013557          310 LGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-SMSEVLSALEQL  363 (441)
Q Consensus       310 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-s~~evl~~L~~l  363 (441)
                                 ...............+..++..|+. ||++|| +++++++.|.++
T Consensus       230 -----------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         230 -----------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -----------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                       0000001112223455667778887 999999 899999888754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=388.15  Aligned_cols=266  Identities=26%  Similarity=0.391  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||.||+|......  ......+..||||+++.... ....++.+|...+.++ +|||||+++++|.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            368999999999999999999765321  11223456899999976543 3346788999999888 7999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEE
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG--------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNIL  221 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nil  221 (441)
                      ++...++||||+++|+|.++|..+.              ...+++..++.++.||+.||+|||+  ++||||||||+|||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiL  167 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeeccccee
Confidence            9999999999999999999996543              2358999999999999999999999  89999999999999


Q ss_pred             ECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccch
Q 013557          222 LDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQ  300 (441)
Q Consensus       222 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~  300 (441)
                      ++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||.......  
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--
Confidence            99999999999999987544443333445678999999999999999999999999999999998 688886543221  


Q ss_pred             hhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          301 NLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       301 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                                     +...+........|......+..|+..|++ ||++|||+.||++.|+++.
T Consensus       246 ---------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         246 ---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                           111111122223334444567788899998 9999999999999998753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=387.81  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=213.8

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|++.++||+|+||.||+|.+..    ..+...++.||||+++.... .....+.+|+.+++++ +|||||+++++|.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEec----cccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            3688999999999999999998753    22334678999999976543 3345688999999999 6999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCc
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRG----------------ARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASN  219 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~N  219 (441)
                      +....++||||+++|+|.+++....                ...+++..+..++.||+.||+|||+  ++|+||||||+|
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~N  175 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARN  175 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccccccc
Confidence            9999999999999999999997543                2358999999999999999999999  899999999999


Q ss_pred             EEECCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhC-CCCCCcccccc
Q 013557          220 ILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSG-RRAVDKTRVGA  298 (441)
Q Consensus       220 ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~pf~~~~~~~  298 (441)
                      ||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+||...... 
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999976554444444567899999999999999999999999999999999994 5555433221 


Q ss_pred             chhhhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhc
Q 013557          299 EQNLVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQ  362 (441)
Q Consensus       299 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~  362 (441)
                                     ..+.+++........+......+..|+..|+. ||++||++.+|++.|++
T Consensus       255 ---------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         255 ---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             ---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                           11222333333333444445567778888888 99999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=383.11  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++.+.||+|+||+||+|.+...      .+....||||+++....   ...++|.+|+.+|++++||||++++++|.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~------~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECC------CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            5799999999999999999976532      12345799999876432   23467899999999999999999999997


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      + ...++||||+++|+|.+++..+.. .+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl  157 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL  157 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             e-cchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchh
Confidence            6 467899999999999998876543 59999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCcc-ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHh-CCCCCCccccccchhhhhhhccccccc
Q 013557          236 AKAGPTGDRT-HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLS-GRRAVDKTRVGAEQNLVDWAKPYLGDR  313 (441)
Q Consensus       236 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  313 (441)
                      ++........ .......|+..|+|||++.+..++.++|||||||++|||+| |+.||........   .          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~----------  224 (273)
T d1u46a_         158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---L----------  224 (273)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----------
T ss_pred             hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---H----------
Confidence            9875443322 22234568889999999999999999999999999999998 8999974432211   1          


Q ss_pred             hhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          314 RKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       314 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                         ..+.........+......+..|+..||. ||++|||+.||++.|.+.
T Consensus       225 ---~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 ---HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               11111111122233334567788899998 999999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-50  Score=392.14  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc---ccHHHHH---HHHHHHhcCCCCCcccEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF---QGHKEWL---SEVNYLGQLHHPNLVKLIG  152 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpnIv~l~~  152 (441)
                      ++|++.++||+|+||.||+|...         .+|+.||||++.....   .....+.   .|+.+++.++|||||++++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~---------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            57999999999999999997654         3578999999864321   1122233   4577888889999999999


Q ss_pred             EEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          153 FCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      +|.+.+..|+||||++||+|.++|.+..  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.+|.+||+|
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~D  150 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISD  150 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECC
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEee
Confidence            9999999999999999999999997765  48999999999999999999999  9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          233 FGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       233 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      ||+|+......    ....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||..........+...      
T Consensus       151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------  220 (364)
T d1omwa3         151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------  220 (364)
T ss_dssp             CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH------
T ss_pred             eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------
Confidence            99998654322    234679999999999975 5689999999999999999999999975443221111111      


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCC-----HHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPS-----MSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs-----~~evl~~  359 (441)
                              .. ......+......+..|+..|+. ||++||+     ++|++++
T Consensus       221 --------~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         221 --------TL-TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --------SS-SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --------cc-cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                    00 11112233334456777888888 9999999     6888754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-50  Score=392.03  Aligned_cols=245  Identities=24%  Similarity=0.297  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      ++|++++.||+|+||+||+|...         .+|+.||||++....   ....+.+.+|+++|+.++||||+++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~---------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            57999999999999999997554         357899999986432   234567899999999999999999999999


Q ss_pred             cCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCC
Q 013557          156 DGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGL  235 (441)
Q Consensus       156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~  235 (441)
                      +....++||||+.+|+|.+++.+.+  .+++..++.++.||+.||.|||+  ++||||||||+|||++.+|.+||+|||+
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~  187 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeecee
Confidence            9999999999999999999997765  49999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++.....     .....||+.|||||++.+..|+.++|||||||++|||+||+.||........                
T Consensus       188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------  246 (350)
T d1rdqe_         188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----------------  246 (350)
T ss_dssp             CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH----------------
Confidence            9875432     2346799999999999999999999999999999999999999975432110                


Q ss_pred             hhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCC-----CCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVR-----PSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~R-----Ps~~evl~~  359 (441)
                      +..+....  ...+......+..|+..|+. ||++|     |++++|+++
T Consensus       247 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         247 YEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            11111111  12233334456677888887 99998     489999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=386.13  Aligned_cols=258  Identities=29%  Similarity=0.440  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC-cccHHHHHHHHHHHhcC-CCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG-FQGHKEWLSEVNYLGQL-HHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  156 (441)
                      ++|++.++||+|+||+||+|.+....       ....||||+++... ....+.+.+|+++|.++ +|||||+++++|.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            68889999999999999999875421       12357888875432 23455789999999999 79999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRR--------------GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILL  222 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill  222 (441)
                      ++..++||||+++|+|.++|..+              ....+++..++.++.||+.||.|||+  ++|+||||||+|||+
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV  160 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEE
Confidence            99999999999999999999653              23569999999999999999999999  899999999999999


Q ss_pred             CCCCcEEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCC-CCCccccccchh
Q 013557          223 DSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRR-AVDKTRVGAEQN  301 (441)
Q Consensus       223 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~-pf~~~~~~~~~~  301 (441)
                      +.++.+||+|||+++......   ......||..|+|||.+.++.|+.++|||||||++|||++|.. ||.......   
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---  234 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---  234 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---
T ss_pred             cCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---
Confidence            999999999999998643222   1224568999999999999999999999999999999999765 565332111   


Q ss_pred             hhhhhccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                                    +...+........+......+..|+..|+. ||++||+|.||++.|+++..
T Consensus       235 --------------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 --------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             --------------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                          111111112223344445667788899998 99999999999999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=385.06  Aligned_cols=248  Identities=19%  Similarity=0.234  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEcC
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLDG  157 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  157 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++.... ....+.+|+++|++++||||++++++|.++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~---------~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            468999999999999999997654         3578899999987643 345688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC--CcEEEcccCC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE--FNAKLSDFGL  235 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~--~~~kl~DFg~  235 (441)
                      +..|||||||+||+|.++|...+ ..+++.+++.++.||+.||+|||+  +||+||||||+|||++.+  ..+||+|||+
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccch
Confidence            99999999999999999996543 359999999999999999999999  899999999999999854  4799999999


Q ss_pred             cccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchh
Q 013557          236 AKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRK  315 (441)
Q Consensus       236 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  315 (441)
                      ++......   ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||........                
T Consensus       151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----------------  211 (321)
T d1tkia_         151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------  211 (321)
T ss_dssp             CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------
T ss_pred             hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----------------
Confidence            98754432   33456799999999999999999999999999999999999999975432111                


Q ss_pred             hhhhhcccccCCCch----hHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQYPQ----KGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~~~~----~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      +..++....  .++.    .....+..|+..|+. ||++|||++|++++
T Consensus       212 ~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         212 IENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111110  0111    122345677888888 99999999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.5e-50  Score=375.00  Aligned_cols=250  Identities=26%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc---------cHHHHHHHHHHHhcCC-CCCc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ---------GHKEWLSEVNYLGQLH-HPNL  147 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnI  147 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++.....         ..+.+.+|+.+|++++ ||||
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   72 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   72 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             cccCEEceEEecCcCeEEEEEEEC---------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence            468999999999999999997653         35789999998654321         1235789999999997 9999


Q ss_pred             ccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          148 VKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       148 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +++++++.+++..||||||++||+|.++|..++  .+++.++..++.||+.||+|||+  +||+||||||+|||++.++.
T Consensus        73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCC
T ss_pred             EEEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCC
Confidence            999999999999999999999999999997655  59999999999999999999998  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhc------CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT------GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN  301 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~  301 (441)
                      +||+|||+++......   ......||+.|+|||++.+      ..++.++|||||||++|||+||+.||......... 
T Consensus       149 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-  224 (277)
T d1phka_         149 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-  224 (277)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred             eEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-
Confidence            9999999998754432   2345679999999999864      34688999999999999999999999754321111 


Q ss_pred             hhhhhccccccchhhhhhhccc--ccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          302 LVDWAKPYLGDRRKLFRIMDIK--LEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       302 ~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                     ..++...  ............+..|+..|+. ||++||+++||+++
T Consensus       225 ---------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         225 ---------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---------------HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---------------HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                           0111111  1111122333456677888888 99999999999764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=383.91  Aligned_cols=265  Identities=24%  Similarity=0.381  Sum_probs=210.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      .++|.+.+.||+|+||+||+|.+..    ......+..||||+++.... .....+.+|+++|++++||||++++++|..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC----cccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4688999999999999999998753    12223357899999976432 333468999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcE
Q 013557          157 GENRLLVYEYMPKGSLENHLFRR--------GARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNA  228 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~  228 (441)
                      +...++||||+++|+|.+++...        ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceE
Confidence            99999999999999999998642        12347899999999999999999999  899999999999999999999


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCC-CCCCccccccchhhhhhhc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGR-RAVDKTRVGAEQNLVDWAK  307 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~  307 (441)
                      ||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+||. .||.......         
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---------  243 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------  243 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---------
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence            999999998654333322333456899999999999999999999999999999999985 6665432111         


Q ss_pred             cccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCCC
Q 013557          308 PYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLPP  365 (441)
Q Consensus       308 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~~  365 (441)
                             .+..+.+ ......+......+..|+..|++ +|++|||+++|++.|++...
T Consensus       244 -------~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         244 -------VLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -------HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                   1111111 11122334444567788888998 99999999999999986544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=386.77  Aligned_cols=247  Identities=27%  Similarity=0.381  Sum_probs=200.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCC---cccHHHHHHHHHHHh-cCCCCCcccEEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEG---FQGHKEWLSEVNYLG-QLHHPNLVKLIGFC  154 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~  154 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||++++..   ....+.+..|..++. .++||||+++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~---------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEEC---------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            57999999999999999997654         458899999996432   233456777877765 68999999999999


Q ss_pred             EcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccC
Q 013557          155 LDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFG  234 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg  234 (441)
                      .+++..||||||+++|+|.+++....  .+++.++..++.||+.||+|||+  ++|+||||||+|||++.++++||+|||
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccc
Confidence            99999999999999999999997665  48999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccch
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRR  314 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  314 (441)
                      +++......  .......||+.|+|||++.+..|+.++|||||||++|||+||+.||..........             
T Consensus       149 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-------------  213 (320)
T d1xjda_         149 MCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-------------  213 (320)
T ss_dssp             TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred             hhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence            998644322  22345689999999999999999999999999999999999999997543221110             


Q ss_pred             hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHH-HHHH
Q 013557          315 KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMS-EVLS  358 (441)
Q Consensus       315 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~-evl~  358 (441)
                         .+...  ...+|......+..|+..|+. ||++||++. +|++
T Consensus       214 ---~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         214 ---SIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---HHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               11110  112333344556777888888 999999995 6764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=387.27  Aligned_cols=249  Identities=22%  Similarity=0.305  Sum_probs=195.7

Q ss_pred             hcCCCCCC-eeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 013557           78 TRNFRPDS-LIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQL-HHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  155 (441)
                      .++|.+.. +||+|+||+||+|...         .+++.||||+++.     ...+.+|+.++.++ +|||||+++++|.
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEEC---------CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            46898864 6999999999997643         3578999999854     34577899997655 8999999999987


Q ss_pred             c----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---CCcE
Q 013557          156 D----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNA  228 (441)
Q Consensus       156 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~~~~  228 (441)
                      +    ....|||||||+||+|.++|..++...+++.+++.|+.||+.||+|||+  +||+||||||+|||++.   ++.+
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCE
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccc
Confidence            5    4678999999999999999987666679999999999999999999999  89999999999999986   4679


Q ss_pred             EEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhcc
Q 013557          229 KLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKP  308 (441)
Q Consensus       229 kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  308 (441)
                      ||+|||+++......   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||...........      
T Consensus       154 Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~------  224 (335)
T d2ozaa1         154 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------  224 (335)
T ss_dssp             EECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred             cccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH------
Confidence            999999998654433   23456899999999999999999999999999999999999999964432111000      


Q ss_pred             ccccchhhhhhhcccccCCCc----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          309 YLGDRRKLFRIMDIKLEGQYP----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                             +...+. .....++    ......+..|+..|+. ||++||++.|++++
T Consensus       225 -------~~~~i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         225 -------MKTRIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----------CCC-SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------HHHHHh-cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                   000000 0000111    1223456677888888 99999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=377.70  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=199.6

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC-CcccHHHHHHHHHHHhcCCCCCcccEEEEEEc-CCeeE
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE-GFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD-GENRL  161 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~  161 (441)
                      .++||+|+||+||+|.+....      +....||||+++.. .....++|.+|+++|++++||||+++++++.+ +...+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ceEEeecCCeEEEEEEEECCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            578999999999999875421      12446899999753 33445679999999999999999999999775 56889


Q ss_pred             EEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCcccCCC
Q 013557          162 LVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPT  241 (441)
Q Consensus       162 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~~~~  241 (441)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999999999886543 457888999999999999999999  8999999999999999999999999999986543


Q ss_pred             CCcc--ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccccchhhhhh
Q 013557          242 GDRT--HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLGDRRKLFRI  319 (441)
Q Consensus       242 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~l~~~  319 (441)
                      ....  .......||+.|+|||++.++.++.++||||||+++|||+||..||.......  ....+              
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~--------------  246 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY--------------  246 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH--------------
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH--------------
Confidence            3221  12234578999999999999999999999999999999999888875332111  01110              


Q ss_pred             hcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          320 MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      +....+...|......+..|+..||. ||++||+|.||++.|+.+.
T Consensus       247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            01111122333444567788899998 9999999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=378.01  Aligned_cols=261  Identities=25%  Similarity=0.286  Sum_probs=188.3

Q ss_pred             CCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCccc-----HHHHHHHHHHHhcCCCCCcccEEEEEEcCC
Q 013557           84 DSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQG-----HKEWLSEVNYLGQLHHPNLVKLIGFCLDGE  158 (441)
Q Consensus        84 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  158 (441)
                      +++||+|+||+||+|...         .+++.||||+++......     .+.+.+|+.+|++++|||||++++++.+++
T Consensus         3 l~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~   73 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDK---------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   73 (299)
T ss_dssp             EEEEEEETTEEEEEEECS---------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             ceEeccCcCeEEEEEEEC---------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            578999999999997543         458899999997543222     245889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCccc
Q 013557          159 NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLAKA  238 (441)
Q Consensus       159 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~~  238 (441)
                      ..||||||+.++++..++.  ....+++..+..++.||+.||+|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          74 NISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccc
Confidence            9999999998876665543  23458999999999999999999999  8999999999999999999999999999986


Q ss_pred             CCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhhc-cccccchh
Q 013557          239 GPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWAK-PYLGDRRK  315 (441)
Q Consensus       239 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~  315 (441)
                      ......  .....+||+.|+|||++.+. .|+.++|||||||++|||+||+.||......... ....... +.......
T Consensus       150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         150 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             cCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            543322  22346799999999998754 5799999999999999999999999754321111 1111000 00000000


Q ss_pred             hhhhhcccccCC---Cc-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          316 LFRIMDIKLEGQ---YP-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       316 l~~~~~~~~~~~---~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ............   .+     ......+..|+..|+. ||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000000000000   00     1112345567777777 99999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=375.61  Aligned_cols=270  Identities=26%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||+++....  ...+.+.+|+++|++++|||||++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            58999999999999999997654         3578999999965432  235678899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....|+||||+.+ .+.+++.......+++..+..++.||+.||+|||+  +|||||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a  149 (298)
T d1gz8a_          73 ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLA  149 (298)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred             ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcc
Confidence            9999999999965 66666666666679999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhhhh-ccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVDWA-KPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~-~~~~~~~  313 (441)
                      +......  .......||+.|+|||++.... ++.++|||||||++|+|++|+.||......... ...... .+.....
T Consensus       150 ~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  227 (298)
T d1gz8a_         150 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  227 (298)
T ss_dssp             HHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence            8643322  1233457999999999987765 478999999999999999999999754321110 000000 0000000


Q ss_pred             hhhhhhhcc--cc----cC----CCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH--hhcC
Q 013557          314 RKLFRIMDI--KL----EG----QYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA--LEQL  363 (441)
Q Consensus       314 ~~l~~~~~~--~~----~~----~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~--L~~l  363 (441)
                      .......+.  ..    ..    ..+. ....+..|+..|+. ||++|||++|++++  ++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         228 PGVTSMPDYKPSFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTGGGSTTCCTTSCCCCCCCHHHHSTT-CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccccccccchhhhccC-CCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            000000000  00    00    0011 12344567777887 99999999999986  5444

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=376.71  Aligned_cols=268  Identities=25%  Similarity=0.353  Sum_probs=195.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHH--HHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSE--VNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|.+.+.||+|+||.||+|++.           |+.||||+++..   ..+.+..|  +..+..++||||+++++++.
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~   67 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN   67 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEE
Confidence            456888899999999999998753           678999999654   23444444  44556789999999999998


Q ss_pred             cCC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc------CCCeEEeccCCCcEEECCC
Q 013557          156 DGE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA------EQQVIYRDFKASNILLDSE  225 (441)
Q Consensus       156 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------~~~ivH~Dlkp~Nill~~~  225 (441)
                      +.+    ..|+||||+++|+|.++|.+.   .+++..++.++.|++.||.|||+.      .++|+||||||+||||+.+
T Consensus        68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~  144 (303)
T d1vjya_          68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  144 (303)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             eCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC
Confidence            654    579999999999999999764   389999999999999999999962      3699999999999999999


Q ss_pred             CcEEEcccCCcccCCCCCccc--eeeeccCCCCcCchhhhhcCC------CCchhhhHHHhHHHHHHHhCCCCCCccccc
Q 013557          226 FNAKLSDFGLAKAGPTGDRTH--VSTQVMGTRGYAAPEYLATGR------LTAKCDVYSFGVVLLELLSGRRAVDKTRVG  297 (441)
Q Consensus       226 ~~~kl~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltg~~pf~~~~~~  297 (441)
                      +.+||+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||+||||+||..||......
T Consensus       145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~  224 (303)
T d1vjya_         145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence            999999999998653322211  223567999999999987643      567899999999999999999887543221


Q ss_pred             cchhhhhhhccccccchhhh-hhhcccccCCCc-----hhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcCC
Q 013557          298 AEQNLVDWAKPYLGDRRKLF-RIMDIKLEGQYP-----QKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQLP  364 (441)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~-----~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l~  364 (441)
                      ... ..... ........+. ...........+     ......+..|+..||. ||++|||+.||++.|+++.
T Consensus       225 ~~~-~~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         225 QLP-YYDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCT-TTTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccc-hhhcc-cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            110 00000 0000000011 111111111221     2334557788999998 9999999999999998654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=372.55  Aligned_cols=241  Identities=23%  Similarity=0.371  Sum_probs=193.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------cHHHHHHHHHHHhcCC--CCCccc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------GHKEWLSEVNYLGQLH--HPNLVK  149 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~  149 (441)
                      .++|++.++||+|+||+||+|...         .+++.||||+++.....      ...++.+|+.+|++++  ||||++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~   73 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR   73 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence            468999999999999999997654         35789999998653221      1233568999999986  899999


Q ss_pred             EEEEEEcCCeeEEEEEeCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCC-Cc
Q 013557          150 LIGFCLDGENRLLVYEYMPK-GSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSE-FN  227 (441)
Q Consensus       150 l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~-~~  227 (441)
                      +++++.+.+..++||||+.+ +++.+++..+.  .+++..++.++.||+.||+|||+  ++|+||||||+|||++.+ +.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          74 LLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTE
T ss_pred             EEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCe
Confidence            99999999999999999976 67888886654  49999999999999999999999  899999999999999854 78


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCC-CchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRL-TAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      +||+|||+++.....    ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....     ..... 
T Consensus       150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~-  219 (273)
T d1xwsa_         150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRG-  219 (273)
T ss_dssp             EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHC-
T ss_pred             EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhhc-
Confidence            999999999864332    2345689999999999987775 567999999999999999999997421     00000 


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                                      .  ..++......+..|+..|+. ||++|||++|++++
T Consensus       220 ----------------~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 ----------------Q--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----------------C--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------------c--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                            0  01122223456677888888 99999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=368.06  Aligned_cols=268  Identities=26%  Similarity=0.331  Sum_probs=193.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcC---CCCCcccEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQL---HHPNLVKLIG  152 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~  152 (441)
                      .++|++++.||+|+||+||+|....        ..++.||||+++....  .....+.+|+.+|+.|   +||||+++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            5789999999999999999986532        1256799999864322  1223456777777665   7999999999


Q ss_pred             EEEc-----CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          153 FCLD-----GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       153 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      +|..     ....+++|||+.++.+.. ........+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred             eecccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCC
Confidence            9853     346799999998866544 334455569999999999999999999999  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhh-hhhh
Q 013557          228 AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNL-VDWA  306 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~  306 (441)
                      +||+|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||+||+.||........... ....
T Consensus       155 ~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  231 (305)
T d1blxa_         155 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  231 (305)
T ss_dssp             EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence            999999998864322   233467899999999999999999999999999999999999999975432211111 1100


Q ss_pred             cc-----cccc---chhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          307 KP-----YLGD---RRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       307 ~~-----~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..     +...   .......................+..|+..|+. ||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00     0000   000000000000011122223445567777777 99999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-47  Score=362.65  Aligned_cols=265  Identities=22%  Similarity=0.285  Sum_probs=193.9

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.+.||+|+||+||+|.+.          +++.||||+++....  ...+.+.+|+.+|++++||||++++++|.+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            58999999999999999998653          367899999976533  235678999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ++..+++||++.++.+..+...  ...+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a  147 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLA  147 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             CCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccc
Confidence            9999999999987666555433  3459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccch-hhhh-hhccccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ-NLVD-WAKPYLGDR  313 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~-~~~~-~~~~~~~~~  313 (441)
                      ........  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......... .... ...+.....
T Consensus       148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (286)
T d1ob3a_         148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW  225 (286)
T ss_dssp             HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence            76433221  22345689999999999764 5689999999999999999999999754321110 0000 000000000


Q ss_pred             hhhhhh---------hcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          314 RKLFRI---------MDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       314 ~~l~~~---------~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ......         ................+..|+..|++ ||++|||++|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000         00000011112223455677788887 99999999999853

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=363.29  Aligned_cols=266  Identities=21%  Similarity=0.307  Sum_probs=191.7

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++....  ...+.+.+|+++|++++|||||+++++|.
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~   87 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   87 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence            568999999999999999997643         3578999999976432  23456889999999999999999999997


Q ss_pred             cCC------eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEE
Q 013557          156 DGE------NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAK  229 (441)
Q Consensus       156 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~k  229 (441)
                      ..+      ..|+||||+ +.+|..++...   .+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred             cCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccc
Confidence            654      569999999 66787766443   49999999999999999999999  8999999999999999999999


Q ss_pred             EcccCCcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhh-hc
Q 013557          230 LSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDW-AK  307 (441)
Q Consensus       230 l~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~-~~  307 (441)
                      |+|||+++.....     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............. ..
T Consensus       162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            9999999865332     2456799999999999864 568999999999999999999999975532221111000 00


Q ss_pred             c--------ccc-cchhhhhhh----cccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH--hhcCC
Q 013557          308 P--------YLG-DRRKLFRIM----DIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA--LEQLP  364 (441)
Q Consensus       308 ~--------~~~-~~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~--L~~l~  364 (441)
                      .        ... ........+    ...+....+ .....+..|+..|+. ||++|||++|++++  |+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT-NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT-TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhcc-CCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0        000 000000000    000111111 122344567777777 99999999999986  55443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-46  Score=353.36  Aligned_cols=261  Identities=17%  Similarity=0.199  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCC-CCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHH-PNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~  156 (441)
                      .++|++.+.||+|+||+||+|.+.         .+++.||||++....  ....+.+|+++++.|+| +|++.+++++.+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            468999999999999999997654         357899999986542  23346789999999964 899999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC-----CCcEEEc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS-----EFNAKLS  231 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~-----~~~~kl~  231 (441)
                      ....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+  +||+||||||+|||++.     ++.+||+
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             CCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEc
Confidence            99999999999 789999886544 469999999999999999999998  89999999999999974     5689999


Q ss_pred             ccCCcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhh
Q 013557          232 DFGLAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWA  306 (441)
Q Consensus       232 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  306 (441)
                      |||+|+........     ......+||+.|||||++.+..++.++|||||||++|||+||+.||...............
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            99999864332111     1233567999999999999999999999999999999999999999754432221111100


Q ss_pred             ccccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          307 KPYLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       307 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ...    ..  ......+....|    ..+..++..|+. +|++||+++.+.+.|+++
T Consensus       229 ~~~----~~--~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         229 GEK----KQ--STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHH----HH--HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             Hhc----cC--CCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            000    00  000001112222    345667778887 999999999888777643

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=361.06  Aligned_cols=256  Identities=27%  Similarity=0.332  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc----ccHHHHHHHHHHHhcCCC-CCcccEEEE
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF----QGHKEWLSEVNYLGQLHH-PNLVKLIGF  153 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-pnIv~l~~~  153 (441)
                      ++|++.+.||+|+||+||+|...      ....+|+.||||+++....    ...+.+.+|+++|++++| |||++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            57999999999999999998653      2344688999999875422    234567889999999966 899999999


Q ss_pred             EEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEccc
Q 013557          154 CLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDF  233 (441)
Q Consensus       154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DF  233 (441)
                      +.+....++||||+.+|+|.+++.....  +.+..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             eccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeec
Confidence            9999999999999999999999977654  7889999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCccceeeeccCCCCcCchhhhhcC--CCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhhhhhccccc
Q 013557          234 GLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG--RLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLVDWAKPYLG  311 (441)
Q Consensus       234 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  311 (441)
                      |+++....... .......|++.|++||.+.+.  .++.++|||||||+||+|+||+.||...........         
T Consensus       174 G~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---------  243 (322)
T d1vzoa_         174 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---------  243 (322)
T ss_dssp             SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---------
T ss_pred             cchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------
Confidence            99976533222 223456799999999999765  467899999999999999999999975432211100         


Q ss_pred             cchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCC-----CHHHHHHH
Q 013557          312 DRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRP-----SMSEVLSA  359 (441)
Q Consensus       312 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RP-----s~~evl~~  359 (441)
                          +..... ......+......+..|+..|+. ||++||     +++|++++
T Consensus       244 ----i~~~~~-~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         244 ----ISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----HHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----HHHhcc-cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                000000 11112334445566677888888 999999     47888764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=362.65  Aligned_cols=267  Identities=25%  Similarity=0.331  Sum_probs=189.8

Q ss_pred             CCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCcccEEEEEEc---
Q 013557           80 NFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNLVKLIGFCLD---  156 (441)
Q Consensus        80 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---  156 (441)
                      +|+..++||+|+||+||+|...         .+++.||||+++.....    ..+|+++|++++||||++++++|..   
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC---------CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            5888899999999999997654         35789999999765322    2369999999999999999999854   


Q ss_pred             ---CCeeEEEEEeCCCCCHHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEc
Q 013557          157 ---GENRLLVYEYMPKGSLENHLF-RRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLS  231 (441)
Q Consensus       157 ---~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~  231 (441)
                         ..+.||||||++++.+..+.. ......+++..++.++.||+.||+|||+  +||+||||||+|||++.++ .+||+
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEEC
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEe
Confidence               335789999997654333332 2344569999999999999999999998  8999999999999999875 89999


Q ss_pred             ccCCcccCCCCCccceeeeccCCCCcCchhhhhc-CCCCchhhhHHHhHHHHHHHhCCCCCCccccccchh-hhhh-hcc
Q 013557          232 DFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLAT-GRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQN-LVDW-AKP  308 (441)
Q Consensus       232 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~-~~~~-~~~  308 (441)
                      |||+++......   ......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.......... .... ..+
T Consensus       166 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~  242 (350)
T d1q5ka_         166 DFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  242 (350)
T ss_dssp             CCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998654332   2234679999999999875 468999999999999999999999997543221110 0000 000


Q ss_pred             ccccch---------hhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH--hhcCC
Q 013557          309 YLGDRR---------KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA--LEQLP  364 (441)
Q Consensus       309 ~~~~~~---------~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~--L~~l~  364 (441)
                      ......         .+...................+..|+..|+. ||++|||++|++++  ++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            000000         0000000000000111223345566777777 99999999999975  44443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=356.75  Aligned_cols=205  Identities=25%  Similarity=0.333  Sum_probs=166.5

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|+..         .+++.||||++.....  .....+.+|+++|++++||||+++++++.
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            478999999999999999997654         3578999999865422  33467889999999999999999999886


Q ss_pred             c--------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCc
Q 013557          156 D--------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFN  227 (441)
Q Consensus       156 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~  227 (441)
                      .        ....|+||||+.++.+..+.  .....+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSC
T ss_pred             cccccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCc
Confidence            5        34689999999876555433  334468999999999999999999999  89999999999999999999


Q ss_pred             EEEcccCCcccCCCCCcc--ceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          228 AKLSDFGLAKAGPTGDRT--HVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       228 ~kl~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +||+|||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||....
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~  226 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  226 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence            999999999764432211  122345799999999999765 68999999999999999999999997543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=348.23  Aligned_cols=266  Identities=22%  Similarity=0.252  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++++.||+|+||+||+|+..         .+++.||||+++....  .....+.+|+.+|+.++||||++++++|.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC---------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            57999999999999999997654         3578899999865432  235678999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcccCCc
Q 013557          157 GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSDFGLA  236 (441)
Q Consensus       157 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a  236 (441)
                      ....++|||++.+++|..++...  ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||.+
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a  148 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ccceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchh
Confidence            99999999999998888877544  358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCccccccch--hhhhhh-cccccc
Q 013557          237 KAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQ--NLVDWA-KPYLGD  312 (441)
Q Consensus       237 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~--~~~~~~-~~~~~~  312 (441)
                      +.......  ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.........  ...... .+....
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             hcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence            86543322  223446788999999988665 689999999999999999999997533221111  111100 000000


Q ss_pred             chhhhhhhcc---------cccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHH
Q 013557          313 RRKLFRIMDI---------KLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSA  359 (441)
Q Consensus       313 ~~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~  359 (441)
                      ..........         .............+..|+..|+. ||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000000         00011112223345566777777 99999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-46  Score=351.90  Aligned_cols=259  Identities=20%  Similarity=0.196  Sum_probs=192.0

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCC-cccEEEEEEcC
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPN-LVKLIGFCLDG  157 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~  157 (441)
                      ++|++.+.||+|+||+||+|.+.         .+++.||||++.....  ...+..|+++++.++|+| |+.+.+++.+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             CEEEEeEEEeeCCCcEEEEEEEC---------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            57999999999999999998654         3477899998865432  235778999999998665 55556667788


Q ss_pred             CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC---CCcEEEcccC
Q 013557          158 ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS---EFNAKLSDFG  234 (441)
Q Consensus       158 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFg  234 (441)
                      +..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||+  +||+||||||+|||++.   +..+||+|||
T Consensus        76 ~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          76 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             CEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccC
Confidence            8999999999 557777665433 459999999999999999999999  89999999999999864   4579999999


Q ss_pred             CcccCCCCCcc-----ceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccccccchhhh-hhhcc
Q 013557          235 LAKAGPTGDRT-----HVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGAEQNLV-DWAKP  308 (441)
Q Consensus       235 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~~~~~~-~~~~~  308 (441)
                      +|+........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||............ .+...
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            99865432211     1234567999999999999999999999999999999999999999754332211111 11000


Q ss_pred             ccccchhhhhhhcccccCCCchhHHHHHHHHHHHHhc-CCCCCCCHHHHHHHhhcC
Q 013557          309 YLGDRRKLFRIMDIKLEGQYPQKGAYMVAILALQCIS-EAKVRPSMSEVLSALEQL  363 (441)
Q Consensus       309 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~RPs~~evl~~L~~l  363 (441)
                      ....       ........    .+..+..++..|+. +|++||++.+|.+.|+.+
T Consensus       232 ~~~~-------~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         232 KMST-------PIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHS-------CHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             cCCC-------ChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0000       00011111    22345667778887 999999999988877643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=360.52  Aligned_cols=204  Identities=26%  Similarity=0.386  Sum_probs=166.1

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc-ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF-QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ..+|++++.||+|+||+||+|...         .+++.||||+++.... ...+.+.+|+.+|++|+||||+++++++..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~   77 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDN---------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   77 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEET---------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEEC---------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence            467999999999999999997543         3578999999975432 334578899999999999999999999875


Q ss_pred             CC----eeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEEcc
Q 013557          157 GE----NRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKLSD  232 (441)
Q Consensus       157 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl~D  232 (441)
                      ..    ..+++++++.+|+|.+++..+   .+++..++.++.||+.||+|||+  +||+||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          78 PTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             SSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcc
Confidence            43    234455566799999999654   48999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCc-cceeeeccCCCCcCchhhhh-cCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          233 FGLAKAGPTGDR-THVSTQVMGTRGYAAPEYLA-TGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       233 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      ||+++....... .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||....
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            999976433211 11224567999999999985 4567899999999999999999999997544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.9e-45  Score=353.89  Aligned_cols=195  Identities=22%  Similarity=0.321  Sum_probs=167.6

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEc-
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLD-  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~-  156 (441)
                      ++|++.+.||+|+||+||+|...         .+++.||||+++..   ..+++.+|+++|+.++ ||||++++++|.. 
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            57999999999999999997643         35789999999754   3567889999999995 9999999999874 


Q ss_pred             -CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCC-cEEEcccC
Q 013557          157 -GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEF-NAKLSDFG  234 (441)
Q Consensus       157 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFg  234 (441)
                       ....++||||+.+++|..+.     +.+++..++.++.||+.||+|||+  +||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccc
Confidence             45689999999999997653     359999999999999999999999  8999999999999998755 69999999


Q ss_pred             CcccCCCCCccceeeeccCCCCcCchhhhhcC-CCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          235 LAKAGPTGDRTHVSTQVMGTRGYAAPEYLATG-RLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       235 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            9986544322   2456789999999998765 47999999999999999999999997543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-45  Score=353.25  Aligned_cols=198  Identities=25%  Similarity=0.310  Sum_probs=159.7

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEEc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCLD  156 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  156 (441)
                      ++|++.++||+|+||+||+|.+.         .+|+.||||+++....  ....++.+|+.+|++++||||++++++|..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~---------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~   87 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEET---------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCeEEEEEeecCcCeEEEEEEEC---------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence            68999999999999999997644         3588999999975532  234568899999999999999999999863


Q ss_pred             ------CCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          157 ------GENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       157 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                            ....|+||||+.+ +|.+.+.    ..+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+|+
T Consensus        88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          88 QKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             CCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceee
Confidence                  4688999999976 4555442    248999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +|||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus       161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~  222 (355)
T d2b1pa1         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_dssp             CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence            9999988644322   2345679999999999999999999999999999999999999997543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=351.08  Aligned_cols=199  Identities=27%  Similarity=0.381  Sum_probs=165.3

Q ss_pred             hcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCc--ccHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 013557           78 TRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGF--QGHKEWLSEVNYLGQLHHPNLVKLIGFCL  155 (441)
Q Consensus        78 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  155 (441)
                      .++|++.+.||+|+||+||+|...         .+++.||||+++....  ...+.+.+|+++|++|+||||+++++++.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEET---------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            568999999999999999997543         3588999999976532  33456889999999999999999999986


Q ss_pred             cC-----CeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECCCCcEEE
Q 013557          156 DG-----ENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDSEFNAKL  230 (441)
Q Consensus       156 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~~~~~kl  230 (441)
                      ..     ...+++|+++.||+|.+++..+   .+++..++.++.||+.||+|||+  +||+||||||+|||++.++.+|+
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl  162 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKI  162 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             eccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccc
Confidence            33     3446667778899999988543   49999999999999999999999  89999999999999999999999


Q ss_pred             cccCCcccCCCCCccceeeeccCCCCcCchhhhhcCC-CCchhhhHHHhHHHHHHHhCCCCCCccc
Q 013557          231 SDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGR-LTAKCDVYSFGVVLLELLSGRRAVDKTR  295 (441)
Q Consensus       231 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~pf~~~~  295 (441)
                      +|||++.....     ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus       163 ~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~  223 (348)
T d2gfsa1         163 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  223 (348)
T ss_dssp             CCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence            99999875322     223467899999999977654 6889999999999999999999997543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-39  Score=314.94  Aligned_cols=263  Identities=16%  Similarity=0.188  Sum_probs=187.5

Q ss_pred             cCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-----------CCCc
Q 013557           79 RNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-----------HPNL  147 (441)
Q Consensus        79 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI  147 (441)
                      ++|+++++||+|+||+||+|+..         .+|+.||||+++.... ..+.+.+|+++|+.++           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~---------~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            45999999999999999997654         3578999999986532 2456778999888875           4789


Q ss_pred             ccEEEEEEc--CCeeEEEEEeCCCCCH-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEECC
Q 013557          148 VKLIGFCLD--GENRLLVYEYMPKGSL-ENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLDS  224 (441)
Q Consensus       148 v~l~~~~~~--~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~~  224 (441)
                      +++++++..  ....+++|+++..+.. ...........+++..+..++.||+.||+|||+ ..||+||||||+|||++.
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeec
Confidence            999988754  4566777777655443 333444455678999999999999999999996 378999999999999986


Q ss_pred             CCc------EEEcccCCcccCCCCCccceeeeccCCCCcCchhhhhcCCCCchhhhHHHhHHHHHHHhCCCCCCcccccc
Q 013557          225 EFN------AKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAAPEYLATGRLTAKCDVYSFGVVLLELLSGRRAVDKTRVGA  298 (441)
Q Consensus       225 ~~~------~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~pf~~~~~~~  298 (441)
                      ++.      ++|+|||.+......     ....+||+.|+|||++.+..++.++|||||||++++|++|+.||.......
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            653      999999999754322     234679999999999999999999999999999999999999997443211


Q ss_pred             ch----hhhhhhccccccch----------------------------hhhhhhcccccCCCchhHHHHHHHHHHHHhc-
Q 013557          299 EQ----NLVDWAKPYLGDRR----------------------------KLFRIMDIKLEGQYPQKGAYMVAILALQCIS-  345 (441)
Q Consensus       299 ~~----~~~~~~~~~~~~~~----------------------------~l~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-  345 (441)
                      ..    .+............                            .......  ............+..|+..|+. 
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCC
Confidence            11    11110000000000                            0000000  1112234455566778888888 


Q ss_pred             CCCCCCCHHHHHHH
Q 013557          346 EAKVRPSMSEVLSA  359 (441)
Q Consensus       346 ~P~~RPs~~evl~~  359 (441)
                      ||++|||++|+|++
T Consensus       315 dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         315 DPRKRADAGGLVNH  328 (362)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3.7e-25  Score=194.62  Aligned_cols=162  Identities=15%  Similarity=0.076  Sum_probs=117.7

Q ss_pred             CCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcc------------------cHHHHHHHHHHHhcCC
Q 013557           82 RPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQ------------------GHKEWLSEVNYLGQLH  143 (441)
Q Consensus        82 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~  143 (441)
                      .+.+.||+|+||+||+|...          .|+.||||+++.....                  .......|...|.++.
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   72 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ   72 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence            45789999999999998653          2678999987532110                  0122456888999999


Q ss_pred             CCCcccEEEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCeEEeccCCCcEEEC
Q 013557          144 HPNLVKLIGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEAEQQVIYRDFKASNILLD  223 (441)
Q Consensus       144 hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ivH~Dlkp~Nill~  223 (441)
                      |.+++..+++.    ..+++|||+++..+.+         +.......++.|++.+|.|||+  +||+||||||+|||++
T Consensus        73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~  137 (191)
T d1zara2          73 GLAVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS  137 (191)
T ss_dssp             TSSSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE
T ss_pred             CCCcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeee
Confidence            99999988763    2379999998865533         3344467889999999999999  8999999999999999


Q ss_pred             CCCcEEEcccCCcccCCCCCccceeeeccCCCCcCc------hhhhhcCCCCchhhhHHHhHH
Q 013557          224 SEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTRGYAA------PEYLATGRLTAKCDVYSFGVV  280 (441)
Q Consensus       224 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlG~i  280 (441)
                      ++ .++|+|||+|.........          .|..      .+.+ .+.|+.++|+||+.--
T Consensus       138 ~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         138 EE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            65 5999999999764322111          1111      1122 3568889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.80  E-value=9.4e-09  Score=92.72  Aligned_cols=148  Identities=16%  Similarity=0.027  Sum_probs=99.5

Q ss_pred             HHHHHHhcCCCCCCeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccE
Q 013557           72 SELKNATRNFRPDSLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKL  150 (441)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l  150 (441)
                      .++......|++.+..+-++.+.||+....           +..+++|+...........+.+|...|..|. +--+.++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-----------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~v   75 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKV   75 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-----------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcE
Confidence            356666778877766555556789985432           4467888876554334445677888887774 4446788


Q ss_pred             EEEEEcCCeeEEEEEeCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhHhc------------------------
Q 013557          151 IGFCLDGENRLLVYEYMPKGSLENHLFRRGARPLPWTLRIKVAIGAARGLSFLHEA------------------------  206 (441)
Q Consensus       151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------------------------  206 (441)
                      +.++.+++..++||++++|.++.+.....    ..   ...++.+++..|..||+.                        
T Consensus        76 l~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          76 LHFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EEEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             EEEEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence            88888889999999999998876543111    11   222334444444444421                        


Q ss_pred             ---------------------------------CCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          207 ---------------------------------EQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       207 ---------------------------------~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                                                       ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                             1237999999999999977666799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=7.5e-06  Score=72.61  Aligned_cols=74  Identities=16%  Similarity=0.097  Sum_probs=50.5

Q ss_pred             eeeecCc-eEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC--CCCcccEEEEEEcCCeeEE
Q 013557           86 LIGEGGF-GYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH--HPNLVKLIGFCLDGENRLL  162 (441)
Q Consensus        86 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~l  162 (441)
                      .+..|.. +.||+.....          +..+++|........   .+..|...|+.|.  .-.+.+++.+..+++..++
T Consensus        17 ~~~~G~s~~~v~r~~~~~----------~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~   83 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG----------RPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   83 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT----------SCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             EcCCcccCCeEEEEEeCC----------CCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence            3444543 6789864332          446888987655333   3556888777763  2336778888888889999


Q ss_pred             EEEeCCCCCH
Q 013557          163 VYEYMPKGSL  172 (441)
Q Consensus       163 v~e~~~~g~L  172 (441)
                      ||++++|.++
T Consensus        84 v~~~i~G~~~   93 (255)
T d1nd4a_          84 LLGEVPGQDL   93 (255)
T ss_dssp             EEECCSSEET
T ss_pred             EEEeeecccc
Confidence            9999988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.10  E-value=6.7e-06  Score=78.21  Aligned_cols=77  Identities=18%  Similarity=0.163  Sum_probs=48.2

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCC------C-cccHHHHHHHHHHHhcCC-C--CCcccEEEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPE------G-FQGHKEWLSEVNYLGQLH-H--PNLVKLIGFC  154 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~  154 (441)
                      +.||.|..-.||+....         ..++.++||.-...      . .....+...|...|+.+. +  ..+++++.+ 
T Consensus        32 ~eig~G~~N~vfrV~~~---------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-  101 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-  101 (392)
T ss_dssp             EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred             EEeCCCceEeEEEEEeC---------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-
Confidence            46899999999986432         23567899975431      1 112344567888887662 3  345666654 


Q ss_pred             EcCCeeEEEEEeCCCCCH
Q 013557          155 LDGENRLLVYEYMPKGSL  172 (441)
Q Consensus       155 ~~~~~~~lv~e~~~~g~L  172 (441)
                       +....++|||++.+..+
T Consensus       102 -d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         102 -DTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             -ETTTTEEEECCCTTSEE
T ss_pred             -cCCCCEEEEeccCCccc
Confidence             45567899999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.10  E-value=0.00094  Score=61.06  Aligned_cols=67  Identities=16%  Similarity=0.087  Sum_probs=42.4

Q ss_pred             eEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCCCCCc--ccEE-----EEEEcCCeeEEEEE
Q 013557           93 GYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLHHPNL--VKLI-----GFCLDGENRLLVYE  165 (441)
Q Consensus        93 g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~-----~~~~~~~~~~lv~e  165 (441)
                      =.||++...          .|..+++|+.++.. ...+.+..|...|..|...+|  +..+     ..+......+.+++
T Consensus        36 N~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~  104 (325)
T d1zyla1          36 NRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  104 (325)
T ss_dssp             SEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             ceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence            478886443          36679999987653 345667788888877742222  1111     12344667889999


Q ss_pred             eCCCC
Q 013557          166 YMPKG  170 (441)
Q Consensus       166 ~~~~g  170 (441)
                      ++.|.
T Consensus       105 ~~~G~  109 (325)
T d1zyla1         105 SVGGR  109 (325)
T ss_dssp             CCCCE
T ss_pred             ecCCc
Confidence            99764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.05  E-value=0.0011  Score=62.30  Aligned_cols=80  Identities=16%  Similarity=0.086  Sum_probs=51.7

Q ss_pred             CeeeecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC-CCCcccEEEEEEcCCeeEEE
Q 013557           85 SLIGEGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH-HPNLVKLIGFCLDGENRLLV  163 (441)
Q Consensus        85 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  163 (441)
                      +.|+.|-.=.+|++...+...  ........+++++....  ....+..+|..+++.+. +.-..++++++.+    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            567778888999987654321  11223456777776532  23344568999999885 4334678877643    689


Q ss_pred             EEeCCCCCH
Q 013557          164 YEYMPKGSL  172 (441)
Q Consensus       164 ~e~~~~g~L  172 (441)
                      |||++|..|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.85  E-value=0.0026  Score=57.53  Aligned_cols=156  Identities=14%  Similarity=0.041  Sum_probs=81.6

Q ss_pred             ccHHHHHHHhcCCCCCCeee-----ecCceEEEEEEecCcccccccCCCccEEEEEEcCCCCcccHHHHHHHHHHHhcCC
Q 013557           69 FTFSELKNATRNFRPDSLIG-----EGGFGYVYKGWIDEHTLEAARPGVGMVIAVKKLKPEGFQGHKEWLSEVNYLGQLH  143 (441)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lG-----~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  143 (441)
                      .+.+++.....+|.+.++..     .|---+.|+.....          | .+++|+.....  ...++..|+++|..|.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~----------g-~yVLri~~~~~--~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC----------C-cEEEEEcCCCC--CHHHHHHHHHHHHhhh
Confidence            45678888889998876654     34345678765432          2 48999886432  2234445677777664


Q ss_pred             CCCc--ccEEE------EEEcCCeeEEEEEeCCCCCHHH--------------HHHhc--C-C----CCCC---------
Q 013557          144 HPNL--VKLIG------FCLDGENRLLVYEYMPKGSLEN--------------HLFRR--G-A----RPLP---------  185 (441)
Q Consensus       144 hpnI--v~l~~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~-~----~~~~---------  185 (441)
                      ..++  ...+-      +.........++.++.+.....              .++..  . .    ....         
T Consensus        70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (316)
T d2ppqa1          70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD  149 (316)
T ss_dssp             HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred             hccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhh
Confidence            2222  11110      1222445666777766533211              00000  0 0    0000         


Q ss_pred             ---------HHHHHHHHHHHHHHHHHhHh--cCCCeEEeccCCCcEEECCCCcEEEcccCCcc
Q 013557          186 ---------WTLRIKVAIGAARGLSFLHE--AEQQVIYRDFKASNILLDSEFNAKLSDFGLAK  237 (441)
Q Consensus       186 ---------~~~~~~i~~~i~~~L~~lH~--~~~~ivH~Dlkp~Nill~~~~~~kl~DFg~a~  237 (441)
                               .......+..+...+...+.  ...|+||+|+.++||+++.+...-|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         150 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                     00111122222222222221  13689999999999999988777899998775